<SEC-DOCUMENT>0001012477-21-000011.txt : 20210809
<SEC-HEADER>0001012477-21-000011.hdr.sgml : 20210809
<ACCEPTANCE-DATETIME>20210809092252
ACCESSION NUMBER:		0001012477-21-000011
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		81
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210809
DATE AS OF CHANGE:		20210809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVADEL PHARMACEUTICALS PLC
		CENTRAL INDEX KEY:			0001012477
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37977
		FILM NUMBER:		211155002

	BUSINESS ADDRESS:	
		STREET 1:		BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
		STREET 2:		BALLYCOOLIN
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			15
		BUSINESS PHONE:		636-449-1830

	MAIL ADDRESS:	
		STREET 1:		16640 CHESTERFIELD GROVE ROAD
		STREET 2:		SUITE 200
		CITY:			CHESTERFIELD
		STATE:			MO
		ZIP:			63005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FLAMEL TECHNOLOGIES SA
		DATE OF NAME CHANGE:	19960422
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>avdl-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:a7d49b9d-9e9c-4202-a2e9-33a099e78bd3,g:e5693fe9-19ce-4a74-abcb-b22740470bdd,d:50b89bc599794eeaa322f99bdef30cea--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:avdl="http://www.avadel.com/20210630" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:utr="http://www.xbrl.org/2009/utr" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>avdl-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF8zLTEtMS0xLTA_87043cdf-ee93-4895-b77c-f5e869056e20">0001012477</ix:nonNumeric><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF80LTEtMS0xLTA_ae6d2046-d791-4a3d-9422-ab6ba051165a">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF81LTEtMS0xLTA_093b2b67-1eac-4fce-8855-906cd3a196a9">2021</ix:nonNumeric><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF82LTEtMS0xLTA_944559f4-981e-45e2-b9e2-a903c5414961">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF83LTEtMS0xLTA_0b4c9f61-b384-4332-a7db-766d71ed4286">false</ix:nonNumeric><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt:booleantrue" name="dei:NoTradingSymbolFlag" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF84LTEtMS0xLTA_de048aa5-7619-4738-b354-f897832ea523">&#9746;</ix:nonNumeric><ix:nonNumeric contextRef="i76af2cfe33334dc9a1f13f275e6567b3_D20200101-20201231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMy0wLTEtMS0xNDk2_a9f5a3d8-5c77-42b7-b8e0-9ea3086db49c">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="icfe184fb8a604f6e9f281a0b6b76a459_D20200101-20201231" name="avdl:DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzU1_3778c0a2-5225-4d2e-a722-3095fe25bdd7">P10M</ix:nonNumeric><ix:nonNumeric contextRef="i8558d8d29eb84dbfa4e0793e914d9349_D20180216-20180216" name="avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE1OA_ebaf9a35-35f7-46d5-9322-eec1885aa043">P5D</ix:nonNumeric><ix:nonNumeric contextRef="i8558d8d29eb84dbfa4e0793e914d9349_D20180216-20180216" name="avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE3Mw_2f9ed925-ca6a-4374-8047-4f204d21b861">P5D</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="avdl-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1019bc0c2b514f86b75d4ae8aeaef1aa_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNMS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ic78036265115448883cc73f95a586e3d_I20210805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i695183555b394250b05b06d9bf6c9006_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica8983fe897240fb8db372157af242b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d69f2653c7843348a441d3a40de400f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f33bcd282a7486eba6fd7888306a035_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icadf2fd8982949eb8a9a9a8130767bb6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea8152d9127347daa7d0be2b82d42c16_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbfb2bb9bd2c454d9a2f913b904d527d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76af2cfe33334dc9a1f13f275e6567b3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54a0f1be38254190aa94a522f6ed4974_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie70c99023cd04e558a4e840886322480_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if26cf9bd950645da82a913ea028f7f6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cd9c5deb61d480c855cc24b25d34b9b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08d9e77f9bac4c3ab716300be3d8b8cf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39b86180a03145e2ab56d7861d9b72a0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd4c15b3c08b4cbd9427dacc880d2346_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c9bed8d32e44549a6e6384e81de3b5f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1938096e05e425590b24e2476286cdc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6474ac452b754332a6d49fc58fae2431_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13deb59210c04afabfb45b889d23aa75_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63df9a42f4264b208b42e799c3b3da1e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dae4c5996d045e093657ce638a3bfb4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dcc627de1534b28a106aee5209d7631_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica30a680c36b463799b9fbf697661fc8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac901e4b20854acb8c4c482c601cb2e0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9760338be14744d8883d6b1a7be11ede_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf27002e9c9248dfb7f009f24e02a4c5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25507beaf94543b3ac989067fe8f70f6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5952bd509a3b4bbd95542c5ad8829fd2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d453b62e5f4a758dc24ff5f07cdf8c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i728f1dde962144218da7200782d318a3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e185af4c95c4cbabd2d62ccb442cefe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39ce40436c834ffd88b04bc577cb05f9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fe02fc3397f469095911d0d65984e6a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i398b06c595444f7caeaba916451c29fa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47b79ad2b6fa4d43b3bc4e7c2bffdfe1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5365f5787064a8588bd454e8fd0fe11_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94cdc3283e8b4906848c3ac05797508f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a2221ed67f4b938f45988fa863f1e8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefbaf7c014bb4111b59cf750ee917f08_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i295311c4e79a486380b4c0eede6381f5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cec52b45db74ffb865d0a2e924af088_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7dba2e7aac4498891de302ca71046c7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d918ae9e9cd4e17a845a2041f236bde_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee621425bbaf4880a450697c4e2573d6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3815294ed64ba3bcb2123ce0004c19_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2da1cc6c35a94eaab32f7383d06ce563_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2a46ff8ddd543a681fb05ae9c5370ab_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i542e7a0b738049e785822075bec4dd2f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfa9a8f10ae647138ff3b9ba07a34261_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic27ceaeb4d5e4740bf0c3a9528c54d02_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a929bcc21e485a9d7ab75296127ff8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic979207f9f324f33be7b2a93a0acb9c0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b18f9096c56478ba558603f0009c83f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i81950a1669ff43e2a55fa3ab8b6bbf14_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfe184fb8a604f6e9f281a0b6b76a459_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1494e8ed82d4b2ebf75bbcb4722f663_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb55d6c3ae02430b9ec0541184cb90e7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35be439684f94754a722ac71e050ffd4_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cd000c8b6964065a504a408890f9369_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6fa5ebeb65455e950a6328bba21698_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i519f8147d1374176b85b3cdcff0e8382_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i900add1be5b84828adfa900933a618f3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87edd5f150b248eebd16c398e3be78c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ee580d62d1d4006b9c4ee3195b16fe2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5483582b0b7743da9ffaa6daeddee5c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13d7d68555c549268d32a550db3aa3a8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2312d5c712024cd18f05cfc64afe708c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f20ec5b3421400ab560dc49247ce3d5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1374539a6c0453996dd609930013a2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5900644d8ce46379de39a2d0857e260_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f54424e7f4147e3abfa224100f76762_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i391dd5fd75e44b6bb689e468e2f6998b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa665aface774b5cba45e448c5017ef5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if495a6914a2043078c2ff45ec8e8cd94_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i819166dd8aad49adb09355ff41111edc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ff9730b64194e44b1624fd8387ff601_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic787b137f02c471ab5fb441de2ccb356_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de1d5ad40c44bcc9def111356353120_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i426f38d83a8549b6ac924b573fcd11f7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i184178aa288147edb42ff605f41c2388_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3d99af014d24c818d1dc4b69ee59196_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1d78585c18940df8a7e1e5478ef6cb2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c3eac9312e543b5af4e5ec8d59fbec0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i860be6580c44499c8b2bbc5d5a7e3a36_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i224fa48116ff4bd6a9842fded9a71fdb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43f54881920b4af98a41727d8004594f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide1938867c944920ae7b3cff817479c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5be2c3dab5b048debcaabab64882d9e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c8795b315d846338c877c8df1d32455_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65d25b85bcaa41adb6ed552acf50363b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7ff608828844c6798870117de00d1e1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90450500044d427f8c232f666584b39e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5797f9c7a7484005bbcaaea47685589d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i629580901ade4561aeb0685c65e22554_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ac2b9e70ab04d8db284fd554dcbf2da_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62b61fe78c654a8eabbae48f28674623_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbec2bbcbbb34de89d1c27dd07788865_I20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7160598d23c4b518c759c6aa5a8d2b4_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="ibcdc3f2602ac4af79cdaff50261cf317_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8558d8d29eb84dbfa4e0793e914d9349_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>avdl:day</xbrli:measure></xbrli:unit><xbrli:context id="id828d13c94a04e7981051a01fa81ed95_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i619255c0fbb84c85be6f62b40e8f8667_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e8c3ff2db154d098fe60070506408f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03b1e76537a34ed8ae22e6fcbd623ceb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4a57a5a305f43858278dcd059cbe0d2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id82ee84d494f49a1aa77a11e88225b6d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35238f47c33b4c629f04849c139b24b6_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:CorporateWorkforceReductionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ddd0a37b8ed4590bc03f9c4c94308ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9ce335e1f12437bbd48bf21a9f38150_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecc1f49f09f748ce80b8c92a2ec072a3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fb7c2b0fb5945538e9a6a089566898e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76a5acc12ee8481593b5f580d0c6acce_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2a319b7a49041b68e1f28bc975ffd5f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c6b3a49597d4114b95a4bce60988c0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02d0a6c7d54a44ae842a997b5e95ed2b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1958fec3b1b4189a3494df42bf89998_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b232b5b7cd948cf83baaf96787cecc8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50064db877274880a1811d0f859ad19d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb7c4417a3344d92bec61dc810fc930e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79d6697ec0004a62b02bcf4f6ceb19aa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4b7b480e1084f46848cd8804e33cf56_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd3b0844231a4d02b15483cd3bc9cdd0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea06e402349946f6b73a2366c3ff8a04_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6ddfbe329ea4b859226b9d1e4159bbe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ecf22fe804f4dffa050dc87558edfb6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4e61467debc48beaa50fd50ce036c21_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f91b0f2c8834815aac6916157b00fa5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbba85bbb98c4e4fb64a84c0ec71d0a1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida13d64b815a426bbd81a3c5e429675b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id12d4cd39de345ecb292ceaccf92a42e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4746ea4b2111416cbd83562dad4e70a7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>avdl:segment</xbrli:measure></xbrli:unit><xbrli:context id="ia015e8c7039f4253bf52fccb4e8ecb8c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:BloxiverzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i549d337037a54337b23be1da5fc95857_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:BloxiverzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98b6eab8d7b044f4b52fe5bb3feedf68_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:VazculepMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie747eb99af0f45f29bf4b24a2ba6c818_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:VazculepMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e8aa4c10c714d95a93ab30edbd0f6ac_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:AkovazMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00da774065cf477491a056a3df163b4b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:AkovazMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfc69dd306e94f2b91c2cea091afefa7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i636d00926a694de8b3a2561a4bd15037_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d45c7fb17674e24b40b45929846b8f1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i50b89bc599794eeaa322f99bdef30cea_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjcw_83e76719-642b-475b-9b54-932d78cc1f34">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjYz_c508d4ac-6224-4b05-974a-41f32908c4a4">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended: <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yMzM_2082958f-0764-479a-a361-6fb21c9be91c">June&#160;30, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjcx_2c10ab4c-d637-42b2-abef-653db26ac870">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission File Number: 000-28508</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY0_e5663ea9-31c5-4108-a412-a3de964420c2">AVADEL PHARMACEUTICALS PLC</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6OWVkYmVkOWNiMmQyNDIyOTkwZTZhN2Q2NzM5YzhlM2QvdGFibGVyYW5nZTo5ZWRiZWQ5Y2IyZDI0MjI5OTBlNmE3ZDY3MzljOGUzZF8wLTAtMS0xLTA_0392b88c-beb7-4032-bedf-f366b6f4d1ee">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6OWVkYmVkOWNiMmQyNDIyOTkwZTZhN2Q2NzM5YzhlM2QvdGFibGVyYW5nZTo5ZWRiZWQ5Y2IyZDI0MjI5OTBlNmE3ZDY3MzljOGUzZF8wLTEtMS0xLTA_414ff189-b56c-4a12-b69c-ec90e9a4c77a">000-28508</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6OWVkYmVkOWNiMmQyNDIyOTkwZTZhN2Q2NzM5YzhlM2QvdGFibGVyYW5nZTo5ZWRiZWQ5Y2IyZDI0MjI5OTBlNmE3ZDY3MzljOGUzZF8wLTItMS0xLTA_647e18c5-574b-48ee-8eb8-e864e654efca">98-1341933</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjcy_9b85c8fd-9455-4782-a396-c18e51bf6ba0">10 Earlsfort Terrace</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjcz_75d06ac9-1982-4e31-a8d8-db539577bb17">Dublin 2</ix:nonNumeric>, <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY1_66b56298-2c6b-4e53-8f74-63179aabeec3">Ireland</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjc0_8a1426bd-5d1a-4864-8fd2-a31b9a88e7ce">D02 T380</ix:nonNumeric> </span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Office and Zip Code)</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+011-<ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY2_08b84e0b-c6dc-42bf-a9c2-cfbe4dbd92ad">1</ix:nonNumeric>-<ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY3_ff321819-9376-4880-9443-b3ba3bd2b500">485-1200</ix:nonNumeric> </span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1019bc0c2b514f86b75d4ae8aeaef1aa_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6MDg3MDNjYzg1MWFlNGVmY2E3MTE0NDA2NWI4M2FjZTkvdGFibGVyYW5nZTowODcwM2NjODUxYWU0ZWZjYTcxMTQ0MDY1YjgzYWNlOV8xLTAtMS0xLTA_a1911051-2eb7-4de6-acaa-5790e20a10fa">American Depositary Shares*</ix:nonNumeric>&#160;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1019bc0c2b514f86b75d4ae8aeaef1aa_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6MDg3MDNjYzg1MWFlNGVmY2E3MTE0NDA2NWI4M2FjZTkvdGFibGVyYW5nZTowODcwM2NjODUxYWU0ZWZjYTcxMTQ0MDY1YjgzYWNlOV8xLTEtMS0xLTA_fac49352-c505-4c1b-80f1-ce839abd7bec">AVDL</ix:nonNumeric>&#160;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1019bc0c2b514f86b75d4ae8aeaef1aa_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6MDg3MDNjYzg1MWFlNGVmY2E3MTE0NDA2NWI4M2FjZTkvdGFibGVyYW5nZTowODcwM2NjODUxYWU0ZWZjYTcxMTQ0MDY1YjgzYWNlOV8xLTItMS0xLTA_695067cc-23c9-46c9-9673-cb08d72fa1b4">The Nasdaq Global Market</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6MDg3MDNjYzg1MWFlNGVmY2E3MTE0NDA2NWI4M2FjZTkvdGFibGVyYW5nZTowODcwM2NjODUxYWU0ZWZjYTcxMTQ0MDY1YjgzYWNlOV8yLTAtMS0xLTA_8e086a40-317d-462d-aa10-722943e72be3">Ordinary Shares, nominal value $0.01 per share**</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*American Depositary Shares may be evidenced by American Depositary Receipts. Each American Depositary Share represents one (1) Ordinary Share.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Not for trading, but only in connection with the listing of American Depositary Shares on The Nasdaq Global Market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjc1_9fc24cb7-711d-4c91-973b-099d146a0853">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;<ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY4_5c39025d-86f8-4053-9952-31378173637e">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer  </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6ZTczYWIxMjVlYjNmNGI2YTk2MmQzMmQ0ZGYwYzNhZTkvdGFibGVyYW5nZTplNzNhYjEyNWViM2Y0YjZhOTYyZDMyZDRkZjBjM2FlOV8wLTItMS0xLTA_5dae123d-d509-4690-9214-6136a7e29f6a">Accelerated filer</ix:nonNumeric>  </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#254;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6ZTczYWIxMjVlYjNmNGI2YTk2MmQzMmQ0ZGYwYzNhZTkvdGFibGVyYW5nZTplNzNhYjEyNWViM2Y0YjZhOTYyZDMyZDRkZjBjM2FlOV8xLTMtMS0xLTA_7ce85343-976b-4d6c-bf41-669c2069ddab">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6ZTczYWIxMjVlYjNmNGI2YTk2MmQzMmQ0ZGYwYzNhZTkvdGFibGVyYW5nZTplNzNhYjEyNWViM2Y0YjZhOTYyZDMyZDRkZjBjM2FlOV8yLTMtMS0xLTA_67c3f772-5d95-4c0a-983a-72cb99ec84c5">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY5_515f3bfe-752f-43e8-b310-00bdd0d5a0cb">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At August&#160;5, 2021, <ix:nonFraction unitRef="shares" contextRef="ic78036265115448883cc73f95a586e3d_I20210805" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNTg0_714de0be-45d4-4225-92f6-187810a1995b">58,596,238</ix:nonFraction> ordinary shares, nominal value $0.01 each, of the Company were outstanding.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.782%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page #</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_10">Cautionary Note Regarding Forward Looking Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_10">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_13">PART I - FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_16">Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_91">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_91">25</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_112">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_112">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_115">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_115">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_118">PART II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_121">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_121">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_124">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_124">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_127">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_130">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_130">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_133">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_133">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_136">Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_136">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_139">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i50b89bc599794eeaa322f99bdef30cea_139">37</a></span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We own various trademark registrations and applications, and unregistered trademarks, including Avadel&#8482;, Micropump&#8482;, LiquiTime&#8482; and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medusa&#8482;. All other trade names, trademarks and service marks of other companies appearing in this Quarterly Report are the property of their respective holders. Solely for convenience, the trademarks and trade names in this Quarterly Report may be referred to without the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;and &#8482; symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend to use or display other companies&#8217; trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may use our website, our LinkedIn or our Twitter account (@AvadelPharma) to distribute material information. Our financial and other material information is routinely posted to and accessible on the Investors section of our website, available at&#160;www.avadel.com. Investors are encouraged to review the Investors section of our website because we may post material information on that site that is not otherwise disseminated by us. Information that is contained in and can be accessed through our website, LinkedIn account or our Twitter posts are not incorporated into, and does not form a part of, this Quarterly Report. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 2 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Disclosure Regarding Forward-Looking Statements</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;). Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but are not always, made through the use of words or phrases such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; and similar expressions, or the negative of these terms, or similar expressions. Accordingly, these statements involve estimates, assumptions, risks and uncertainties which could cause actual results to differ materially from those expressed in them. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements that are based on our management&#8217;s belief and assumptions and on information currently available to our management. These statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our reliance on a single lead product candidate, FT218, the timing of and our ability to obtain regulatory approval, if at all;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain desired regulatory exclusivity for FT218, including orphan drug exclusivity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to successfully commercialize FT218 in a timely manner or at all, if approved;  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ability of FT218, if approved and launched commercially, to gain market acceptance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to enter into strategic partnerships for the commercialization, manufacturing and distribution of FT218, if approved;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on a limited number of suppliers for the manufacturing of our lead product candidate and certain raw materials in our lead product candidate and any failure of such suppliers to deliver sufficient quantities of these raw materials, which could have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to finance our operations on acceptable terms, either through the raising of capital, the incurrence of convertible or other indebtedness or through strategic financing or commercialization partnerships;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations about the potential market size and market participation for our lead product candidate, if approved and commercialized;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations about pending and potential future patent infringement claims against us;  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any further restructuring actions that may be required and our ability to obtain any required consents (including any consents required pursuant to the Indenture governing our exchange notes due 2023, or the 2023 Notes); </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to continue to service the 2023 Notes, including making the ongoing interest payments on the 2023 Notes, settling exchanges of the 2023 Notes in cash or completing any required repurchases of the 2023 Notes; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact of COVID-19 on our business and future operating results;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to hire and retain members of our management team and our employees; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition existing today or that will likely arise in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are neither promises nor guarantees of future performance due to a variety of risks and uncertainties and other factors more fully discussed in the &#8220;Risk Factors&#8221; section in Part I, Item 1A of the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on March 9, 2021 and the risk factors and cautionary statements described in other documents that we file from time to time with the SEC. Given these uncertainties, readers should not place undue reliance on our forward-looking statements. These forward-looking statements speak only as of the date on which the statements were made and are not guarantees of future performance. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to revise any forward-looking statements to reflect events or developments occurring after the date of this quarterly report, even if new information becomes available in the future.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 3 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION&#160;</span></div><div id="i50b89bc599794eeaa322f99bdef30cea_16"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. &#160;&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS&#160;</span></div><div id="i50b89bc599794eeaa322f99bdef30cea_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMy0yLTEtMS0w_eb0c92af-8548-42ef-a3fe-6c619ce51491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMy00LTEtMS0w_19cd7f69-a6a8-4838-a159-69a563474464">10,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMy02LTEtMS0w_0007c612-b237-43c9-b8a1-737af248a4dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMy04LTEtMS0w_6b481c01-1bda-4373-ab15-1781dea0b918">22,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNS0yLTEtMS0w_aa76004a-0ed5-498f-baf5-1742d00f2e34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNS00LTEtMS0w_44d6f025-7623-49a4-8423-a9820da9024b">3,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNS02LTEtMS0w_a6270ed7-6019-4685-8251-3c81fce21c11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNS04LTEtMS0w_b2ed0cdc-71be-43e7-998d-36befcba2322">5,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNi0yLTEtMS0w_e8c88b16-44d1-49a7-a4c6-0dc3101f8074">6,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNi00LTEtMS0w_d22ac5c0-10b9-49f3-a18e-8fa781e5c2b9">4,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNi02LTEtMS0w_ef93182a-abba-44c1-99d8-954bf6e976eb">10,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNi04LTEtMS0w_f5e802d7-49ff-4250-94f9-9acab4a1102e">9,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNy0yLTEtMS0w_dba3d722-085d-4c0e-bf1d-129cb9c96690">15,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNy00LTEtMS0w_129a39fb-69cd-4fe4-98e1-df5fc57c80c1">7,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNy02LTEtMS0w_2e643baa-c0ae-4c5c-970f-f7e4360f85d9">26,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNy04LTEtMS0w_26def7e0-995d-4cfb-b034-f054fb587c0f">15,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOC0yLTEtMS0w_7f128277-aef2-4117-ac6e-6cce99b9cdc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOC00LTEtMS0w_44fa1388-2c16-44c7-b0e3-e7e157e17204">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOC02LTEtMS0w_e1d339bf-7c98-465f-9f16-a57aeeb584dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOC04LTEtMS0w_dde49888-f1f0-4987-9bbe-188682b45e83">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOS0yLTEtMS0w_6a4c5156-6753-4483-8abe-afb70feb20ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOS00LTEtMS0w_a9f2136c-eeda-4780-acc9-c161532ea089">918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOS02LTEtMS0w_10ee71d6-233d-46a2-934d-fa74290f2e00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOS04LTEtMS0w_618c1950-5c15-495d-8a90-080d0f3fa4f6">3,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTAtMi0xLTEtMA_b283fec6-12c7-4199-b6b4-49e0af3642d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTAtNC0xLTEtMA_150ac07c-f46e-4d82-b4cc-84495c03e170">45,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTAtNi0xLTEtMA_71d54f28-dece-4ac0-8c60-5816feeed99f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTAtOC0xLTEtMA_d9bf1e2b-c3a6-4990-a1b8-aadf216fd412">45,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTEtMi0xLTEtMA_469e8308-ac9c-4b5c-9fe4-b9a107c90d12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTEtNC0xLTEtMA_979da852-34ba-4e93-8e99-8a3129babe1b">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTEtNi0xLTEtMA_2b36a5a1-0fc2-48ae-9dfa-cc195a9cc0fd">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTEtOC0xLTEtMA_1a36700e-6985-43b8-bdec-0a0b008862d3">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense (income)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTItMi0xLTEtMA_bad34970-e5b9-408f-ab58-ea1ba26a78b4">21,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTItNC0xLTEtMA_fd7eaaa2-032a-43fe-99f5-91aaa23a8091">30,178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTItNi0xLTEtMA_b2f5d4ca-c0d3-4fef-b65f-d084f539b6ec">36,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTItOC0xLTEtMA_074c9556-5c2d-46b1-89b7-6183114ac069">11,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTMtMi0xLTEtMA_39da5509-ca6f-43bd-ac1f-11404159de85">21,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTMtNC0xLTEtMA_6dc554e6-14f4-4c2c-9276-a15ddb381fd5">40,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTMtNi0xLTEtMA_8f194359-2327-43b8-b34c-8531fe88a27b">36,747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTMtOC0xLTEtMA_4a51f6ba-9b9e-43de-8e27-746a734f595f">33,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTQtMi0xLTEtMA_7978fee7-871f-4c91-a382-752f15231989">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTQtNC0xLTEtMA_76283dbb-6684-402b-a27c-3baacfb9c188">741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTQtNi0xLTEtMA_f1d8c560-b739-4238-9b5a-fa86aceb1e6f">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTQtOC0xLTEtMA_417e8247-8366-4cf5-81f0-09cc29a48e10">1,119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTUtMi0xLTEtMA_b990f977-f42f-499b-ac26-6add0cb52263">1,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTUtNC0xLTEtMA_9390171b-ed96-4e13-b3d0-a3c8b104a33a">3,237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTUtNi0xLTEtMA_c113cfe8-54dc-47ec-b4d6-62af1b0ed4d8">3,859</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTUtOC0xLTEtMA_7f0aad2a-5365-43a6-949f-9a10fd206a28">6,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from release of certain liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" name="avdl:GainLossOnReleaseOfCertainLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTYtMi0xLTEtMTExMw_5dc11591-0d9c-4d82-9f76-93c3ff69f87f">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="avdl:GainLossOnReleaseOfCertainLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTYtNC0xLTEtMTExNQ_3cddee22-a5aa-43dd-ae38-2a4ad6f32c00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="avdl:GainLossOnReleaseOfCertainLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTYtNi0xLTEtMA_84be1b72-fd50-4d5f-b5dc-37b6ce56dea6">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="avdl:GainLossOnReleaseOfCertainLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTYtOC0xLTEtMA_ba4a9c5f-4b3c-4d10-97f6-0d36e0225abd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense - changes in fair value of contingent consideration payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTctMi0xLTEtMA_2e58572b-15ae-4585-97b6-866d1b1e4af7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTctNC0xLTEtMA_9734c134-8b28-4426-baa9-f97db8a1d8d1">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTctNi0xLTEtMA_dca92baf-c376-4999-94b7-36755daf23ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTctOC0xLTEtMA_f2e65327-96e1-4a64-b1b0-7e1a30bab400">435</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss) income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTgtMi0xLTEtMA_7c6dec19-af97-4430-8b6b-f83c84204379">23,346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTgtNC0xLTEtMA_21e91a13-a37e-4ea0-99a8-bf0124b2b487">36,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTgtNi0xLTEtMA_e88005a5-e6bc-4e8f-bd4c-7a64e4151de6">39,398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTgtOC0xLTEtMA_0caf7cf0-224c-40bf-831a-e8095f4cff06">25,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (benefit) expense </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTktMi0xLTEtMA_110362ef-d922-4822-8026-38d8dde5ba12">3,765</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTktNC0xLTEtMA_e6625379-40bc-45c1-8621-213b1a1914c5">5,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTktNi0xLTEtMA_97a0aca1-443a-42e9-a040-fb94a0d07f2d">6,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTktOC0xLTEtMA_8fac7b6d-37af-49c4-babb-818fc6d60016">4,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjAtMi0xLTEtMA_be44abe6-38da-4a7b-a6ad-c66c917414d3">19,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjAtNC0xLTEtMA_00a2f95b-4b7e-41a7-af31-8ea253d06c88">30,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjAtNi0xLTEtMA_f7a32062-9151-4e1f-86df-a35bec5a0a1d">33,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjAtOC0xLTEtMA_d998c12e-c7fa-45df-8da5-17e768d72a21">30,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjItMi0xLTEtMA_23321c83-348e-4973-9cfb-44f2b1bd749f">0.33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjItNC0xLTEtMA_5ea3ac30-91d2-4d04-959d-3345d04e1c86">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjItNi0xLTEtMA_e9c674d7-a100-4d9a-a8fb-71c3da7b7c9d">0.56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjItOC0xLTEtMA_41cb16a5-9ebd-4ad6-b63b-de1945356814">0.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjMtMi0xLTEtMA_c25c4b2c-c78c-45a6-9a99-023073c8be63">0.33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjMtNC0xLTEtMA_d15b9f63-aa45-4d35-a647-ca8d04cb193e">0.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjMtNi0xLTEtMA_19ccec66-72fc-44ba-99e6-d644f3e1ec81">0.56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjMtOC0xLTEtMA_513fa979-2643-4401-adb6-8444720e2130">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding - basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjUtMi0xLTEtMA_af22ec6d-38df-4eac-970c-e8de4bffc802">58,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjUtNC0xLTEtMA_d9ec4807-8de6-4180-861f-2e5aa6545534">54,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjUtNi0xLTEtMA_b04250f6-7e2c-45bb-bff2-e1e3363abe32">58,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjUtOC0xLTEtMA_c5fe5138-9037-439c-b66d-b0c7d193d01f">47,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjYtMi0xLTEtMA_c8f542ab-0631-424f-8cc5-cda138365a60">58,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjYtNC0xLTEtMA_6de2933c-4ebd-48d8-8487-77e80b3f67b5">69,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjYtNi0xLTEtMA_c4428f01-759b-47a1-a9d2-f53b64bc7899">58,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjYtOC0xLTEtMA_bf21e3e3-0b05-451a-a2db-a97291a71650">63,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 4 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfMy0yLTEtMS0w_be44abe6-38da-4a7b-a6ad-c66c917414d3">19,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfMy00LTEtMS0w_00a2f95b-4b7e-41a7-af31-8ea253d06c88">30,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfMy02LTEtMS0w_f7a32062-9151-4e1f-86df-a35bec5a0a1d">33,026</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfMy04LTEtMS0w_d998c12e-c7fa-45df-8da5-17e768d72a21">30,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation loss (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNS0yLTEtMS0w_a0332955-77d7-41a9-87cb-70a0904275fb">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNS00LTEtMS0w_1e4a1534-7461-41e0-8bd2-974957bce385">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNS02LTEtMS0w_8af59f55-41e1-40b3-bd4f-a6cb3af52d5c">602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNS04LTEtMS0w_8954f619-0dcf-4041-978e-676bad4ec9aa">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income, net of  $(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0wLTEtMS0wL3RleHRyZWdpb246ZDRlNDE2MDg4NjJiNDhmMGJmMjQ1MGIxZTQyOTA0YWJfMTA5OTUxMTYyNzg1OQ_407ccac9-deb9-4224-838c-5fe692cb9753">78</ix:nonFraction>),  $(<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0wLTEtMS0wL3RleHRyZWdpb246ZDRlNDE2MDg4NjJiNDhmMGJmMjQ1MGIxZTQyOTA0YWJfMTA5OTUxMTYyNzg2NQ_525364d7-b037-4fc4-bb74-b62282e494f5">81</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0wLTEtMS0wL3RleHRyZWdpb246ZDRlNDE2MDg4NjJiNDhmMGJmMjQ1MGIxZTQyOTA0YWJfNDE_18b4c151-0c20-4283-b277-19273133432e">133</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0wLTEtMS0wL3RleHRyZWdpb246ZDRlNDE2MDg4NjJiNDhmMGJmMjQ1MGIxZTQyOTA0YWJfNDg_f84ceaf4-0cf8-43b0-8aef-ae05cca052dd">130</ix:nonFraction>) tax, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0yLTEtMS0w_8371d6e7-ec68-4289-be6e-53dbf1994972">160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi00LTEtMS0w_a4c5187c-be1b-49b3-8c40-3363f85c23e9">927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi02LTEtMS0w_a4fa5810-be4c-4b71-864e-d06db3ec546c">697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi04LTEtMS0w_38d3e7bf-9ae8-49ca-99c6-17af5397a16c">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNy0yLTEtMS0w_e532ab5a-b189-419d-9bf6-fb4eb81747d2">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNy00LTEtMS0w_79e55e52-1518-45b8-9e49-4a2ced4149f1">1,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNy02LTEtMS0w_fe3a7125-df65-41fa-ab73-9b414bf4acbb">1,299</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNy04LTEtMS0w_f42c4e82-0b09-4104-a266-ab7583276b8a">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfOC0yLTEtMS0w_e18fac73-6df7-4c71-b2d9-b22a181d789c">19,625</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfOC00LTEtMS0w_5bddcb9a-61d1-4741-b6e2-10ef2ddd3267">31,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfOC02LTEtMS0w_987c85fb-a12b-478b-9c39-a10fd35f27c1">34,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfOC04LTEtMS0w_cc50949e-7869-4fd4-bda3-2c4d59019b70">30,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 5 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:63.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNC0yLTEtMS0w_4ddc9351-8a12-4385-a98b-fb46af5afa2d">67,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNC00LTEtMS0w_4c23ca8b-ca15-408e-984c-0da118da0988">71,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNS0yLTEtMS0w_a792e006-b48c-4ad7-add8-85044f54c100">135,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNS00LTEtMS0w_de8e0b1b-fcc7-43d6-9929-a5a51ccdc3bd">149,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfOC0yLTEtMS0w_e566cbae-e9d2-4bac-95e3-7753e57af56d">2,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfOC00LTEtMS0w_05a47fc5-980d-47e5-af2d-c9144b2a96a4">3,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfOS0yLTEtMS0w_53aa5ab9-7ea8-4a16-9478-c787b2168521">25,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfOS00LTEtMS0w_41399f71-cfb6-43ac-b569-ee3609aa10c7">38,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTAtMi0xLTEtMA_d1ad9c73-0628-420f-93c5-56897cd473db">230,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTAtNC0xLTEtMA_1d74efe9-af48-42c3-ae92-a33d86f805b5">263,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTEtMi0xLTEtMA_d380d0e1-9c91-4efe-bc34-d665a306ef07">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTEtNC0xLTEtMA_919df937-06fb-4597-8a9a-528625c28deb">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTItMi0xLTEtMA_0981e611-3b03-4e2b-8be1-dfab50cbf665">2,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTItNC0xLTEtMA_2c61ff35-455f-4a56-9b6f-d65fe7ce4ae8">2,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTMtMi0xLTEtMA_d66d15d9-3d17-4786-8dbf-f28de72a31bb">16,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTMtNC0xLTEtMA_fb049b10-dfbf-4f6a-b953-136579c445eb">16,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTUtMi0xLTEtMA_fcedcbe1-7287-4dc6-88d2-a4368f2e87bc">983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTUtNC0xLTEtMA_1e6d0292-869f-47bd-b028-38ecfa5bcbea">3,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTYtMi0xLTEtMA_8d566361-c548-4205-9df7-415b40afc44d">31,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTYtNC0xLTEtMA_e1131c4d-0599-4faa-94f3-6bccc01d046a">24,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTctMi0xLTEtMA_9b4c2586-e224-45a8-85bb-c790346f8994">282,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTctNC0xLTEtMA_8ffa101f-6455-4851-b60c-ce38bde9a07b">311,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjItMi0xLTEtMA_71f05ed9-150d-4963-8cbc-a1cc270f7289">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjItNC0xLTEtMA_1197edce-53a2-4907-9971-f1b13e324e90">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjMtMi0xLTEtMA_91b9cfce-1333-4ad4-ae15-6406d9e10deb">5,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjMtNC0xLTEtMA_147e1a48-bc96-4448-b282-488ee97e322e">2,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjQtMi0xLTEtMA_0b057b46-35c0-4357-9d2b-8b0467872ab8">7,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjQtNC0xLTEtMA_281995cb-bfa6-4fe9-a13b-820af98fbfab">6,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjYtMi0xLTEtMA_439c6787-1b55-400f-9683-c5e8a4278867">3,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjYtNC0xLTEtMA_9d05c6e8-e331-48dc-b40b-e0fd802681f6">5,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjctMi0xLTEtMA_43f92ae9-a1af-46cc-8e54-294f19cb5d31">16,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjctNC0xLTEtMA_57d92cd6-a406-4bac-aee6-50ab7907e27f">15,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjgtMi0xLTEtMA_d812668f-4f3b-4cee-b482-ec25383b696e">141,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjgtNC0xLTEtMA_c2878cc9-8df5-414c-9e82-29377f3ff78a">128,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzAtMi0xLTEtMA_1f19f3c2-a862-4db1-8c74-57599a9f4726">1,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzAtNC0xLTEtMA_e34cca18-ced0-45e6-ba19-4ca82a644e4c">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzEtMi0xLTEtMA_a2e408b8-d783-43ba-a198-ac21625a9603">4,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzEtNC0xLTEtMA_9c51f340-8c7f-4b1d-a8ab-4b1c69dec089">4,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzItMi0xLTEtMA_d1e6075c-5070-46e4-928c-f00bb10cb8f3">163,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzItNC0xLTEtMA_8aec312e-3000-439d-ba2d-14da8199db20">149,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares, nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzM5_04af2bce-2da8-4e54-bae5-98c4fc0c37af"><ix:nonFraction unitRef="usdPerShare" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzM5_941379c1-6fca-4ed4-bc95-c9b38afea73b">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzUz_6fbeae75-175a-4dbe-97ec-cd478abd10b9"><ix:nonFraction unitRef="shares" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzUz_7eef6b4f-0cc5-4957-97c3-2cd23dea30b6">50,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzc1_ab79fb0c-b742-41f1-9a21-2a4c65447d84"><ix:nonFraction unitRef="shares" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzc1_e1b2ddcf-8f12-41c4-8d09-55abfe9ad8a7">488</ix:nonFraction></ix:nonFraction> issued and outstanding at June&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzExMQ_7c8f2577-4fae-40f6-93d9-de9dd566e071"><ix:nonFraction unitRef="shares" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzExMQ_ae01df5a-50b7-481f-bab9-75c80a43d90f">488</ix:nonFraction></ix:nonFraction> issued and outstanding at December&#160;31, 2020, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMi0xLTEtMA_2ffb4dad-609f-432e-bbd2-bc3d3e467832">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtNC0xLTEtMA_0f8d2e5f-bcc3-4331-9671-ade7624b33d5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares, nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzM4_4841ae98-d536-453f-8aed-e7dfbb7c0837"><ix:nonFraction unitRef="usdPerShare" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzM4_ff2080d4-e9cd-499d-8b73-e425c4880d9c">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzUy_087afaac-63d5-48c0-9b94-53b710a35373"><ix:nonFraction unitRef="shares" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzUy_d6fb286e-1463-404e-8ab3-7328422f3e07">500,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5Xzc0_0d02c78f-117c-415a-a76e-623b30226530"><ix:nonFraction unitRef="shares" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5Xzc0_27b46a39-f41e-449f-ad9c-e98a9a73098e">58,488</ix:nonFraction></ix:nonFraction> issued and outstanding at June&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzExMA_cee9638e-2de1-4e0e-9558-deb740deb9f9"><ix:nonFraction unitRef="shares" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzExMA_ea7fdd64-c22d-462b-9ff2-e4671e1b4bc9">58,396</ix:nonFraction></ix:nonFraction> issued and outstanding at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMi0xLTEtMA_3cb4a539-656c-4904-ba29-7aa6a2268c4d">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtNC0xLTEtMA_327ecb89-639a-4f46-94e6-dabb002a29d4">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzctMi0xLTEtMA_852d851f-62f2-4064-be2d-8d7aef2bd15f">544,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzctNC0xLTEtMA_2aeb7475-3b7f-401d-96b5-78e2ab780fc4">566,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzgtMi0xLTEtMA_f35ab531-afae-40d6-89f2-87bd2a166eb1">403,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzgtNC0xLTEtMA_34d07fbc-f4a2-4b2a-a5d2-abd81b73aa0a">384,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzktMi0xLTEtMA_917b5486-822a-41cc-a6c5-35bac29edf94">22,350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzktNC0xLTEtMA_dc483204-9175-4647-9893-6f15779157cc">21,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNDAtMi0xLTEtMA_e9854407-ec72-4ce4-a4bc-4b16ef095636">118,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNDAtNC0xLTEtMA_a172df69-2756-4961-b780-d14940e3c819">162,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNDEtMi0xLTEtMA_10e1aeee-5b96-4b93-94af-6539c0cedf50">282,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNDEtNC0xLTEtMA_187d1405-5be0-4d55-8fb4-c4b2eb92dbfa">311,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 6 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June&#160;30, 2021 </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.458%"><tr><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>shareholders&#8217;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d69f2653c7843348a441d3a40de400f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0yLTEtMS0w_d70dd5b4-790c-4641-8b62-a2039daddbc2">58,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d69f2653c7843348a441d3a40de400f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi00LTEtMS0w_c3266461-20cd-43e6-989e-91662f198ba1">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f33bcd282a7486eba6fd7888306a035_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi02LTEtMS0w_19635dbd-3be6-4194-9769-a9c86d211e11">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f33bcd282a7486eba6fd7888306a035_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi04LTEtMS0w_5081cc3f-31b2-4e85-bb73-2a35d611efcd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icadf2fd8982949eb8a9a9a8130767bb6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0xMC0xLTEtMA_5f075251-6b5f-494f-9074-14be3e00d434">566,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea8152d9127347daa7d0be2b82d42c16_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0xMi0xLTEtMA_4dca8b56-05fb-4de2-867f-7cff05668043">384,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbfb2bb9bd2c454d9a2f913b904d527d_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0xNC0xLTEtMA_d99839d9-6ded-4825-948f-de7a5907b4fd">21,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0xNi0xLTEtMA_dab9cee1-fe85-4eb4-aeb4-755dc43f30dd">162,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMy0wLTEtMS0xNDk2_a9f5a3d8-5c77-42b7-b8e0-9ea3086db49c">Impact of the adoption of ASU 2020-06</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54a0f1be38254190aa94a522f6ed4974_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMy0xMC0xLTEtMA_5d9adcd7-cc00-4f62-8aa7-c83805448ae9">26,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie70c99023cd04e558a4e840886322480_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMy0xMi0xLTEtMA_8048fd04-e326-462c-adc1-8744437dffc4">13,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if26cf9bd950645da82a913ea028f7f6a_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMy0xNi0xLTEtMA_2b9c1548-0db8-4877-9af8-c4bc8e94b611">12,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd9c5deb61d480c855cc24b25d34b9b_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNC0xMi0xLTEtMA_f225c9e4-45a8-4e71-938e-6088572a1d6b">13,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNC0xNi0xLTEtMA_bf34de4b-3f2d-4121-ac2b-0b926c85a772">13,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08d9e77f9bac4c3ab716300be3d8b8cf_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNS0xNC0xLTEtMA_19403e7b-f335-4628-bfd4-28c63d0436c7">1,255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNS0xNi0xLTEtMA_6f49e596-0992-40e5-a983-b02de6333d6e">1,255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNi0yLTEtMS0w_6f51a8bf-b4c3-4fac-871a-eb0579873ff4">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNi0xMC0xLTEtMA_3f41f222-c8f7-41ba-a38b-b5c8c8a04e53">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNi0xNi0xLTEtMA_642291af-76cc-4b2e-be0c-601a39d50c56">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNy0yLTEtMS0w_5712ff1c-4ab9-4fb5-837e-5c28826bc863">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNy00LTEtMS0w_b121ffdc-89f8-45c3-b797-d58e2066a259">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNy0xMC0xLTEtMA_deb18509-8c79-4a86-8b99-d96e22230822">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNy0xNi0xLTEtMA_2eab86d2-b283-4a29-8a61-d64f8ff28132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOC0yLTEtMS0w_163e3a44-8b26-45b3-b27a-c502171a49ec">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOC0xMC0xLTEtMA_e5e02f29-f962-4833-bbe1-3daa9d1c991a">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOC0xNi0xLTEtMA_ac7f41bb-9d46-4e1f-9eba-f060d5624e62">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOS0xMC0xLTEtMA_6bbb7977-e8b8-4db9-940e-7e68ed596095">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOS0xNi0xLTEtMA_017a7fd3-0539-4b52-86ff-7a3cde3d3ea8">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39b86180a03145e2ab56d7861d9b72a0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMi0xLTEtMA_12a8a4f6-d915-4451-b85c-4cd1fbc16524">58,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39b86180a03145e2ab56d7861d9b72a0_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtNC0xLTEtMA_93ab5836-462a-4889-bfb7-e62ccd18c40c">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd4c15b3c08b4cbd9427dacc880d2346_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtNi0xLTEtMA_536ce4ca-4925-4b94-a167-fcf2abd81fe3">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd4c15b3c08b4cbd9427dacc880d2346_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtOC0xLTEtMA_9570a052-0e81-4631-b6a7-28307dc8d1b5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9bed8d32e44549a6e6384e81de3b5f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMTAtMS0xLTA_da0e5610-2560-4f74-a207-4b704239f3e2">542,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1938096e05e425590b24e2476286cdc_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMTItMS0xLTA_3b46f00c-e100-4d05-8d50-344fbc701210">383,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6474ac452b754332a6d49fc58fae2431_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMTQtMS0xLTA_cd89eeb7-b521-40c2-99ff-6f327bab27d9">22,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13deb59210c04afabfb45b889d23aa75_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMTYtMS0xLTA_78066ecc-8481-4e8c-882d-eb24073af847">136,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63df9a42f4264b208b42e799c3b3da1e_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTEtMTItMS0xLTA_58d046b6-78e7-4253-ade2-a973d5826ba0">19,581</ix:nonFraction>)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTEtMTYtMS0xLTA_971b8f10-9b02-41c4-8348-00ccda60468c">19,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dae4c5996d045e093657ce638a3bfb4_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTItMTQtMS0xLTA_49486d2f-2fa7-454a-a048-4c7293524f11">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTItMTYtMS0xLTA_13eb2abb-8d1b-45cc-b616-1174c3e4a75e">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dcc627de1534b28a106aee5209d7631_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTctMTAtMS0xLTA_704bd837-9dc3-457a-9d3d-ea114116e755">2,001</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTctMTYtMS0xLTA_fbd7f8e7-fe9e-42a6-a09c-13a38ca8d93c">2,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica30a680c36b463799b9fbf697661fc8_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMi0xLTEtMA_5f9231f7-b7cf-49b1-85cd-aba2c111cc33">58,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30a680c36b463799b9fbf697661fc8_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtNC0xLTEtMA_c57e92b1-8ad3-4b47-b6f4-74b5668b1048">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac901e4b20854acb8c4c482c601cb2e0_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtNi0xLTEtMA_22b49c82-f6d6-4301-ba19-a634f6ec8bbb">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac901e4b20854acb8c4c482c601cb2e0_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtOC0xLTEtMA_572c5366-783e-4030-985d-9db2323bb94f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9760338be14744d8883d6b1a7be11ede_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMTAtMS0xLTA_47da2b9b-5bc6-4676-91f4-41bce01321bb">544,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf27002e9c9248dfb7f009f24e02a4c5_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMTItMS0xLTA_e5dab410-7d28-4668-9e03-9d1986391cb1">403,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25507beaf94543b3ac989067fe8f70f6_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMTQtMS0xLTA_91ddd9d3-1b96-4a32-bcab-1c82c62f438e">22,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMTYtMS0xLTA_8f6b1cc7-4e63-49d0-8f79-5d71cf2e537f">118,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 7 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June&#160;30, 2020 </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.644%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional paid-in</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>shareholders&#8217; (deficit)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">equity </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5952bd509a3b4bbd95542c5ad8829fd2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0yLTEtMS0w_8f606c04-1506-4167-ae0b-412d5020aaca">42,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5952bd509a3b4bbd95542c5ad8829fd2_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi00LTEtMS0w_278e5fea-bf51-4136-ad54-2b4289941bbc">429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24d453b62e5f4a758dc24ff5f07cdf8c_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi02LTEtMS0w_c3e23c0f-f2a7-45fe-9a48-ba127ce6a183">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d453b62e5f4a758dc24ff5f07cdf8c_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi04LTEtMS0w_0b500382-efbf-4d37-8258-b4b46cd85b0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f1dde962144218da7200782d318a3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xMC0xLTEtMA_38da1472-f69c-49ed-ad88-13aad52b9894">434,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e185af4c95c4cbabd2d62ccb442cefe_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xMi0xLTEtMA_7d1ef277-9ac2-40c2-abeb-5a808a19c165">391,215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ce40436c834ffd88b04bc577cb05f9_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xNC0xLTEtMA_fb7a6b19-679f-4003-ae46-d06ddfc93d8f">22,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe02fc3397f469095911d0d65984e6a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xNi0xLTEtMA_749d0623-6e84-4a7b-8092-b9803ef3bed9">5,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe02fc3397f469095911d0d65984e6a_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xOC0xLTEtMA_c21a1d36-2811-4e6e-8904-44f98635ef54">49,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i398b06c595444f7caeaba916451c29fa_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0yMC0xLTEtMA_9705b99c-a950-4b9f-b130-d5fb6d2fbed8">29,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47b79ad2b6fa4d43b3bc4e7c2bffdfe1_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMy0xMi0xLTEtMA_fdb85eb7-449f-48f9-a2ad-df7d4503e4d6">865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMy0yMC0xLTEtMA_a758d11f-2562-47bf-8acd-0f65eaec4e0d">865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5365f5787064a8588bd454e8fd0fe11_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNC0xNC0xLTEtMA_3c36f195-e5ac-4418-879b-d689cee6b804">821</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNC0yMC0xLTEtMA_4bcffdf2-331c-41f7-a390-646453face3c">821</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNS0yLTEtMS0w_7f030756-e4d4-4bbb-a489-157e23ae3126">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNS00LTEtMS0w_c3ed428e-fb41-4803-a1fa-a392733a4013">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNS0xMC0xLTEtMA_7c28e1a1-944a-4546-a3a7-b6aff7a60abf">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNS0yMC0xLTEtMA_7d6b144a-1fd7-4872-b6ad-9c441e9fb7aa">1,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 private placement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi0yLTEtMS0w_3d053568-3ede-45ad-8438-5ef0238ed369">8,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi00LTEtMS0w_926de262-44bc-4cd4-8d30-b24b78b86a29">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94cdc3283e8b4906848c3ac05797508f_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi02LTEtMS0w_93fe8751-9766-4bda-8ed2-1b3bd3da661a">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cdc3283e8b4906848c3ac05797508f_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi04LTEtMS0w_d8112dd1-fe4d-4472-ab6d-bea1e745eaa4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi0xMC0xLTEtMA_5f918599-f483-472a-b158-5da345cd8d85">60,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi0yMC0xLTEtMA_2b3d844c-a92f-4242-b8cc-33136f28b9d6">60,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNy0yLTEtMS0w_b273d60c-7d9c-44ba-85e4-c1ece3a128a0">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNy0yMC0xLTEtMA_142ea143-5ec3-42e1-ae3d-219786829fef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOC0yLTEtMS0w_48633abe-43ec-4ece-8742-e9086c431819">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOC0xMC0xLTEtMA_84adde8d-dbef-47ab-9861-4f4cbcffe350">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOC0yMC0xLTEtMA_e4aa595a-deec-4f8e-971b-ad8b1ef68f89">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOS0xMC0xLTEtMA_359655d8-d9e3-4e44-856e-d4b5227ce618">742</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOS0yMC0xLTEtMA_9a3caa2e-50e0-4906-aaf5-82ed9b8604f3">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4a2221ed67f4b938f45988fa863f1e8_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMi0xLTEtMA_a95476d5-3b35-4f8c-b778-962ce2c8494a">51,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a2221ed67f4b938f45988fa863f1e8_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtNC0xLTEtMA_d6f9331b-0c52-4f1e-8a5c-108cd157c3b0">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefbaf7c014bb4111b59cf750ee917f08_I20200331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtNi0xLTEtMA_9096be05-04f1-4e6c-ad4d-54ff18c4ce9f">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefbaf7c014bb4111b59cf750ee917f08_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtOC0xLTEtMA_572a210d-fb5f-4410-8b1b-ffc6c2a4eb46">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295311c4e79a486380b4c0eede6381f5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTAtMS0xLTA_6e1c9f14-9690-45b0-9263-cd717306f8dd">497,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7cec52b45db74ffb865d0a2e924af088_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTItMS0xLTA_e98c2c97-2496-4056-820a-51e76e7228d9">392,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7dba2e7aac4498891de302ca71046c7_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTQtMS0xLTA_231062e7-50f0-4213-ac00-358da8623a96">23,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d918ae9e9cd4e17a845a2041f236bde_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTYtMS0xLTA_957366fa-c2bd-4400-a629-a8da35545da5">5,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d918ae9e9cd4e17a845a2041f236bde_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTgtMS0xLTA_003018df-f855-44f3-9934-edfe299a1d79">49,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee621425bbaf4880a450697c4e2573d6_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMjAtMS0xLTA_161db23e-7c9c-42d5-aa75-0d66d684351f">32,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb3815294ed64ba3bcb2123ce0004c19_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTEtMTItMS0xLTA_3542d9c3-51b7-4c15-8f9d-da44193d4dcb">30,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTEtMjAtMS0xLTA_d0ea6322-796b-4d16-8017-c8c8cf5539fd">30,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2da1cc6c35a94eaab32f7383d06ce563_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTItMTQtMS0xLTA_bde9bc55-3a1f-49b2-98e8-a5f3fe1a0e7f">1,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTItMjAtMS0xLTA_45fb225a-7f57-48c6-a686-41cadb60e77f">1,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMi0xLTEtMjgyNQ_5cd3fcc1-2389-4cfd-a353-b08bc8aba634">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtNC0xLTEtMjgyMw_b1de43e7-8f00-40e6-bc26-b6737d447ecc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMTAtMS0xLTI4MjU_62aa407f-c350-464d-877e-1c50b5f47b6c">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMjAtMS0xLTI4MjU_bc321763-d95b-4b8e-a9a8-2630c5f3b392">393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 private placement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTAtMS0xLTI4MjU_57a4e3eb-78aa-4806-9224-bc11e6784ccd">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMjAtMS0xLTI4MjU_4ffcc273-9b60-489b-a029-b8d2d99a0244">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2020 public offering</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="avdl:StockIssuedDuringPeriodSharesPublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTUtMi0xLTEtMjgzMA_770907b7-a0aa-4de9-baca-6bab9baf1ccd">11,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630" decimals="-3" name="avdl:StockIssuedDuringPeriodValuePublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTUtNC0xLTEtMjgzMg_ca02e5da-96a6-458e-b180-16a44724a475">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="avdl:StockIssuedDuringPeriodValuePublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTUtMTAtMS0xLTI4MzQ_87967958-f906-4ac3-9259-59464baafe8d">116,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="avdl:StockIssuedDuringPeriodValuePublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTUtMjAtMS0xLTI4MzY_74c7c3bc-87c8-4910-bf6e-2e29790a3c1d">116,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTYtMTAtMS0xLTI4Mjg_f4a3c246-216f-498d-b3eb-fd9b0b57e61d">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTYtMjAtMS0xLTI4Mjg_85b84eef-83e3-4bae-bcbd-7a6cf95ce425">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMTAtMS0xLTA_d763df7d-c1c1-4af6-9ed2-8c696e7918d8">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMjAtMS0xLTA_c2e83221-b0db-4733-b54d-601292b25bfa">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2a46ff8ddd543a681fb05ae9c5370ab_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMi0xLTEtMA_f60c1ced-7a1b-405d-86b6-37fcdd13b68f">63,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2a46ff8ddd543a681fb05ae9c5370ab_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtNC0xLTEtMA_be620b7c-da51-4d13-8dd6-a9c527487a14">635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i542e7a0b738049e785822075bec4dd2f_I20200630" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTgtNi0xLTEtMjgzOA_2fc0b2b0-dce2-4143-809a-2eaa844b651a">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i542e7a0b738049e785822075bec4dd2f_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTgtOC0xLTEtMjgzOA_1099a6ec-5427-4513-86e4-b532bed2d4e3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa9a8f10ae647138ff3b9ba07a34261_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTAtMS0xLTA_6cf00aea-8d4d-4f8b-9836-0aa3df314f8e">615,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic27ceaeb4d5e4740bf0c3a9528c54d02_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTItMS0xLTA_a522f06b-5922-4bd2-91a5-1571e8c0ebdb">361,206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a929bcc21e485a9d7ab75296127ff8_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTQtMS0xLTA_a97871fb-64ff-4aba-941e-e7755aa3747f">22,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic979207f9f324f33be7b2a93a0acb9c0_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTYtMS0xLTA_9138d1ff-7443-4516-9b94-747af0944c68">5,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic979207f9f324f33be7b2a93a0acb9c0_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTgtMS0xLTA_a9fe5af5-110e-4393-88db-ce0ae7ce00af">49,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b18f9096c56478ba558603f0009c83f_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMjAtMS0xLTA_5f2956a4-b1cf-407f-abb0-790d69bd275e">182,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 8 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNC0yLTEtMS0w_f7a32062-9151-4e1f-86df-a35bec5a0a1d">33,026</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNC00LTEtMS0w_d998c12e-c7fa-45df-8da5-17e768d72a21">30,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNi0yLTEtMS0w_f5982125-2a42-46e3-ba30-5dab5cd95edb">417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNi00LTEtMS0w_ee9293ea-c73f-445f-b853-4b2aed3657fd">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remeasurement of acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="avdl:AcquisitionRelatedContingentConsiderationRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNy0yLTEtMS0w_81fa4b9d-c0c9-44b0-8e17-67626cadce5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="avdl:AcquisitionRelatedContingentConsiderationRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNy00LTEtMS0w_7ea30aa5-1ccd-431a-b8bd-543604c9fec5">3,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remeasurement of financing-related contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="avdl:FinancingRelatedContingentConsiderationRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfOC0yLTEtMS0w_9878251a-5b5d-4b0f-a4b1-14a8b75deb87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="avdl:FinancingRelatedContingentConsiderationRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfOC00LTEtMS0w_4bcdd9e0-77b2-49ec-a37d-97525516914c">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discount and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfOS0yLTEtMS0w_a6ab36ac-adda-4f71-9271-39f4fe14972e">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfOS00LTEtMS0w_d80e0d19-d16e-41ad-b0f5-f2bd9b1ce01f">3,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in deferred tax and income tax deferred charge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTAtMi0xLTEtMA_37869f45-cda2-499b-8d8c-c73912b77395">6,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTAtNC0xLTEtMA_dda800c4-28d2-4417-9cc5-771000acd577">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTEtMi0xLTEtMA_89ad5fc9-f0ce-4170-af81-5110037050e3">3,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTEtNC0xLTEtMA_dde62f5d-7705-4967-b2dd-07b143e6afe0">1,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from the disposition of the hospital products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTItMi0xLTEtNDI_2e3bd5ff-8ba4-452d-8253-d21f3e5c5c67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTItNC0xLTEtNDI_d53b891e-d66d-4799-83a6-0841c9f731e5">45,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from the release of certain liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="avdl:GainLossOnReleaseOfCertainLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTItMi0xLTEtMA_cd14abf2-b375-4ede-919b-54a0d6afb8cd">166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="avdl:GainLossOnReleaseOfCertainLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTItNC0xLTEtMA_c6af0bcd-7b42-49f8-a802-3c1585461c19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTMtMi0xLTEtMA_6575c611-4ab1-459b-b1fd-49c799cf2b66">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTMtNC0xLTEtMA_94d553b7-88fc-4a6b-829b-86b222e4a3c0">477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net changes in assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTUtMi0xLTEtMA_3fd60219-2e6d-4eb7-9682-795d2405a194">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTUtNC0xLTEtMA_dcba06a0-872c-41a9-b8c0-13a5216730ec">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTYtMi0xLTEtMA_b79cfb5a-4089-4f3a-8434-8546708b6f09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTYtNC0xLTEtMA_7bb6b57e-e3ac-402c-9e0e-f301b1baf573">1,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTctMi0xLTEtMA_64781498-471b-4a13-839d-cba6bcab130c">3,106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTctNC0xLTEtMA_40585692-0091-481b-a0c6-4bace24caafb">1,149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTgtMi0xLTEtMA_6ca8c012-e4d0-4dcf-85b0-b1cd4ea8bd21">3,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTgtNC0xLTEtMA_c55c65cb-8538-4027-822e-7639b590ad7e">2,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable &amp; other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTktMi0xLTEtMA_19f026e0-ceb0-4a6b-9915-73767117ce51">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTktNC0xLTEtMA_6ad94bfe-65db-4f8a-87e9-26ef5d117e56">1,550</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjAtMi0xLTEtMA_7029e203-306c-485d-b4f9-2b3a40ff3f46">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjAtNC0xLTEtMA_57ddd8ad-5de8-4c49-9491-c8330555a434">6,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjEtMi0xLTEtMA_dc60c382-dd56-436e-9faf-e9d296c51206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjEtNC0xLTEtMA_b28218f3-3fd0-4d6e-b764-d04aa5943bc0">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earn-out payments for contingent consideration in excess of acquisition-date fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjItMi0xLTEtMA_3be87a43-5fa3-473e-9ba4-5ccd3ca46248">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjItNC0xLTEtMA_2a2a9aca-49b9-4a6f-be36-6d7ca24e3e55">3,736</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalty payments for contingent consideration payable in excess of original fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRoyalties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjMtMi0xLTEtMA_4f1857c9-3bb4-486b-b39a-164841c581a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:PaymentsForRoyalties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjMtNC0xLTEtMA_53f4f30d-f909-4c42-8d90-3c374e3bfa9b">608</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjQtMi0xLTEtMA_05a80f6a-6674-459c-bed3-cbd754973808">1,021</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjQtNC0xLTEtMA_97d62e37-203d-4a90-9455-ca428b5f9213">3,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjUtMi0xLTEtMA_4fb7b611-f285-4c72-ba50-f8d5644d677e">33,566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjUtNC0xLTEtMA_532f9489-6391-4f65-b8ab-ae0e1363ee07">19,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjgtMi0xLTEtMA_b04022f3-0515-40ee-9136-02f688543d04">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjgtNC0xLTEtMA_298df9c1-e46e-4e2d-94f3-a104b2a430e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from the disposition of the hospital products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzAtMi0xLTEtMA_9c6079de-75cd-4ade-9f41-af291d86583c">16,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzAtNC0xLTEtMA_4fccda6f-ea53-4aaa-9d6f-67d0237f6648">14,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzEtMi0xLTEtMA_ac121914-13eb-41f9-9c76-d31664da343a">66,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzEtNC0xLTEtMA_d719e2c9-20d3-4610-987d-c90405a3d772">15,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzItMi0xLTEtMA_dc655ebb-4afc-40cf-a8bf-d189b73d3920">53,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzItNC0xLTEtMA_c365a4b7-23a5-443e-b66f-c25e2a118159">97,878</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzMtMi0xLTEtMA_067b11bc-fe41-4fcd-b259-f8170069e8b8">29,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzMtNC0xLTEtMA_6ddcc940-d05b-4341-bc1b-c155eb8e3778">67,662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from the February 2020 private placement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzYtMi0xLTEtMA_e71ed576-1d6a-4d86-bc43-5935044c10a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzYtNC0xLTEtMA_b93a1d76-ecf2-4317-9f46-60b3b48d4736">60,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from the May 2020 public offering</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzgtMi0xLTEtMjg0NA_b0df525e-8165-467b-8231-ebcbdb88e467">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzgtNC0xLTEtMTc1Nw_84ba58fc-95b0-4aa3-9306-980eefb4ae67">116,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from stock option exercises and employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzgtMi0xLTEtMA_a0e72225-0a0a-4eaf-91c7-250cbcbc3142">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzgtNC0xLTEtMA_4cf5d7b1-9073-4a0e-b029-6a358d624df2">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDAtMi0xLTEtMA_ca8481ba-7d6d-4d39-9ed7-dd4a14437c26">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDAtNC0xLTEtMA_d5f8c060-72bc-40d8-8e2d-feac924e73b7">179,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDItMi0xLTEtMA_fcc66fd2-a082-4124-b49f-228cbd6dde48">478</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDItNC0xLTEtMA_2c0a8deb-7122-4e02-99ed-da9d3d0c4dc0">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDQtMi0xLTEtMA_3802e3f8-0e53-4e93-9ffb-99d9f0231a6f">4,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDQtNC0xLTEtMA_b96ad888-3493-4848-8d54-47e5ee136dc2">92,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDUtMi0xLTEtMA_883a3c7d-c70b-470c-9fea-25464aa2a9cd">71,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398b06c595444f7caeaba916451c29fa_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDUtNC0xLTEtMA_b7b04e05-eada-45b8-943d-8e5a0d6550c6">9,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDYtMi0xLTEtMA_b3bc9992-267a-4072-a768-c162d314394b">67,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b18f9096c56478ba558603f0009c83f_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDYtNC0xLTEtMA_1ead9a48-ec37-44af-8c06-4ce166b53912">102,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDktMi0xLTEtMA_f7337deb-df53-46c3-b86b-649a7c6a4b22">3,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDktNC0xLTEtMA_caf43dd5-d562-4110-a21a-2941b5c8c33e">3,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income taxes paid (refund)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNTAtMi0xLTEtMA_86a155e7-2ea3-4efd-989b-f69ea85d10f9">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNTAtNC0xLTEtMA_2e609343-440a-4af2-b55f-ab462a24e946">1,795</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 9 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)&#160;</span></div><div id="i50b89bc599794eeaa322f99bdef30cea_40"></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80MC9mcmFnOmY3ZTE4N2E3M2EzMDQ1M2ZhY2M1NGY3ZTE4MGQwMzJlL3RleHRyZWdpb246ZjdlMTg3YTczYTMwNDUzZmFjYzU0ZjdlMTgwZDAzMmVfNzgwOA_a3628d46-bddd-418b-8391-6a9993988026" continuedAt="i4f4e0a360f674f2a8bd4bc30d85423dc" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i4f4e0a360f674f2a8bd4bc30d85423dc" continuedAt="i5ed9fc9181a14438814bae69a1ed6c7e"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="avdl:NatureOfBusinessPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80MC9mcmFnOmY3ZTE4N2E3M2EzMDQ1M2ZhY2M1NGY3ZTE4MGQwMzJlL3RleHRyZWdpb246ZjdlMTg3YTczYTMwNDUzZmFjYzU0ZjdlMTgwZDAzMmVfNzgxOA_00755f86-d6bb-4964-a408-a4095ab2b7a3" continuedAt="i09776c6dae21491685e35508526f8438" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. Our lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#8220;EDS&#8221;) and cataplexy in adults with narcolepsy. We are primarily focused on the development and potential United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of FT218. In December 2020, we submitted a New Drug Application (&#8220;NDA&#8221;) to the FDA for FT218 to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The NDA for FT218 was accepted by the FDA in February 2021 and assigned a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) target action date of October 15, 2021.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of our lead product candidate, we continue to evaluate opportunities to expand our product portfolio. As of June 30, 2021, we do not have any approved and commercialized products in our portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are registered as an Irish public limited company. Our headquarters are in Dublin, Ireland and we have operations in St. Louis, Missouri, U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218 is a once-nightly formulation of sodium oxybate that uses our Micropump controlled release drug-delivery technology for the treatment of EDS and cataplexy in adults suffering from narcolepsy. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Sodium oxybate is approved in the U.S. for the treatment of EDS and cataplexy in patients with narcolepsy and is approved in Europe for the treatment of cataplexy in patients with narcolepsy. Since 2002, sodium oxybate has only been available as a formulation that must be taken twice nightly, first at bedtime, and then again 2.5 to 4 hours later.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, we announced the submission of our NDA to the FDA for FT218. On February 26, 2021, the FDA notified us of formal acceptance of the NDA with an assigned PDUFA target action date of October 15, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted a Phase 3 clinical trial of FT218, the REST-ON trial, which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient, last visit was completed at the end of the first quarter of 2020 and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-nightly FT218, the highest dose administered in the trial, demonstrated a statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test, or MWT, clinical global impression-improvement, or CGI-I, and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g also demonstrated a statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-nightly FT218 to be generally well tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence 3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of FT218 discontinued the trial due to adverse reactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the FDA granted FT218 Orphan Drug Designation, which makes the drug eligible for certain development and commercial incentives, including potential U.S. market exclusivity for up to seven years. Additionally, several FT218-related U.S. patents have been issued, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), as well as foreign patent offices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced that the first patient was dosed initiating an open-label extension (&#8220;OLE&#8221;)/switch study of FT218 as a potential treatment for EDS and cataplexy in patients with narcolepsy. The OLE/switch study is examining the long-term safety and maintenance of efficacy of FT218 in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-nightly FT218, regardless of whether they participated in REST-ON. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described FT218 improvements in disturbed nocturnal sleep (&#8220;DNS&#8221;), defined in REST-ON as the number of shifts from stages N1, N2, N3, and rapid eye movement (&#8220;REM&#8221;) sleep to wake and from stages N2, N3, and REM </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 10 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5ed9fc9181a14438814bae69a1ed6c7e" continuedAt="i0e92fd484b104264bc3904a7afbcd91e"><ix:continuation id="i09776c6dae21491685e35508526f8438"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sleep to stage N1.  FT218 also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1.  A second poster described the statistically significant improvements in the Epworth Sleepiness Scale, both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at Week 3, for the lowest 6 g dose, compared to placebo. FT218 did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional data supportive of the efficacy findings in REST-ON were presented at the annual meeting of the 35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 or Type 2. Additionally, a post-hoc analysis showed that FT218 was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Previously Approved FDA Products</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020 (the &#8220;Closing Date&#8221;), we announced the sale by Avadel Legacy Pharmaceuticals, LLC (the &#8220;Avadel Seller&#8221;) of the portfolio of sterile injectable drugs used in the hospital setting (the &#8220;Hospital Products&#8221;), which included our three commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to Exela Sterile Medicines LLC (&#8220;Exela Buyer&#8221;) pursuant to an asset purchase agreement (the &#8220;Purchase Agreement&#8221;) by and among the Avadel Seller, Avadel US Holdings, Inc., the Exela Buyer and Exela Holdings, Inc. This sale included the following FDA approved products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Bloxiverz (neostigmine methylsulfate injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -&#160;Bloxiverz is a drug used intravenously in the operating room to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Vazculep (phenylephrine hydrochloride injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -&#160;Vazculep is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Akovaz (ephedrine sulfate injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Akovaz was the first FDA approved formulation of ephedrine sulfate, an alpha- and beta- adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Nouress (cysteine hydrochloride injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Nouress is a sterile injectable product for use in the hospital setting to provide parenteral nutrition to neonates.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80MC9mcmFnOmY3ZTE4N2E3M2EzMDQ1M2ZhY2M1NGY3ZTE4MGQwMzJlL3RleHRyZWdpb246ZjdlMTg3YTczYTMwNDUzZmFjYzU0ZjdlMTgwZDAzMmVfNzgxNQ_843d2071-652d-41e2-a1b5-712499eddac4" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated balance sheet as of June&#160;30, 2021, which is derived from the prior year 2020 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP), the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#8217;s 2020 Annual Report on Form 10-K filed with the SEC on March 9, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80MC9mcmFnOmY3ZTE4N2E3M2EzMDQ1M2ZhY2M1NGY3ZTE4MGQwMzJlL3RleHRyZWdpb246ZjdlMTg3YTczYTMwNDUzZmFjYzU0ZjdlMTgwZDAzMmVfNzgxNg_125850a7-32a3-42fa-a081-954dd09581d5" continuedAt="i4c69e3d91782456a86bd35adb2c62c54" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prior to June 30, 2020, revenue was earned from the sales of pharmaceutical products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of our product, which occurs typically upon receipt by the customer. Our gross product sales were subject to a variety of price adjustments in arriving at </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 11 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0e92fd484b104264bc3904a7afbcd91e"><ix:continuation id="i4c69e3d91782456a86bd35adb2c62c54" continuedAt="ie3e090c512914b03bb6e367aa7ac03dc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and were estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a complete discussion of the accounting for net product revenue, see </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">: Revenue Recognition</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_43"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2: <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMzA4NA_490c49f3-6051-4725-a7d6-d874c21602d7" continuedAt="ibf268d46c5d9439fb586a501e701e1b4" escape="true"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMzA4Ng_e74ed7e5-94ca-464a-baf4-ac6182763609" continuedAt="i922af1ebc55e4a398779170ff76b31de" escape="true">Newly Issued Accounting Standards</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="ibf268d46c5d9439fb586a501e701e1b4" continuedAt="i35cbae448d0f41e89b41f49f34352cd5"><ix:continuation id="i922af1ebc55e4a398779170ff76b31de" continuedAt="i8c8d7d2de1f54f9999f63b3f2a8e4b32"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#8217;s amendments primarily impact ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. We adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on our unaudited condensed consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU is effective for our fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method. </span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i35cbae448d0f41e89b41f49f34352cd5"><ix:continuation id="i8c8d7d2de1f54f9999f63b3f2a8e4b32">The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i81950a1669ff43e2a55fa3ab8b6bbf14_I20201231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMjM0Nw_80b68a74-7118-42db-ab66-9699e2ba2a66">4.50</ix:nonFraction>%&#160;exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $<ix:nonFraction unitRef="usd" contextRef="i54a0f1be38254190aa94a522f6ed4974_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMjk0Mw_5d9adcd7-cc00-4f62-8aa7-c83805448ae9">26,699</ix:nonFraction> decrease in additional paid-in capital, a $<ix:nonFraction unitRef="usd" contextRef="if26cf9bd950645da82a913ea028f7f6a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMjk4OA_f79c04ae-618e-48f8-8b72-99f348601d93">12,939</ix:nonFraction> increase in long-term debt, and a $<ix:nonFraction unitRef="usd" contextRef="ie70c99023cd04e558a4e840886322480_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMzAyNQ_8048fd04-e326-462c-adc1-8744437dffc4">13,760</ix:nonFraction> increase to the opening balance of retained earnings.</ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3: <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNDAzNg_f1b37d1e-05e1-4047-a673-ac3f31ea480c" continuedAt="ib34b35915870446b8ad57882ad8d8097" escape="true">Disposition of the Hospital Products </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib34b35915870446b8ad57882ad8d8097" continuedAt="ieedfaee426bd4abb9a61028b6bb4109a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Closing Date, we announced the sale of our Hospital Products to the Exela Buyer pursuant to the Purchase Agreement (the &#8220;Transaction&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Purchase Agreement, the Exela Buyer agreed to pay a total aggregate consideration amount of $<ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMjcx_4364a7f8-ce45-4e79-92c2-f97f0fc0720f">42,000</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="avdl:DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMjg0_12ed5bb6-6261-43f5-b519-bb76cf88393b">14,500</ix:nonFraction> was paid on the Closing Date and an additional $<ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="avdl:DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzM0_ffb9dfe0-3a19-45ce-9d01-488077732040">27,500</ix:nonFraction> was paid in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzU1_3778c0a2-5225-4d2e-a722-3095fe25bdd7">ten</span> equal monthly installments following the Closing Date. During the year ended December 31, 2020, we collected four installment payments, totaling $<ix:nonFraction unitRef="usd" contextRef="icfe184fb8a604f6e9f281a0b6b76a459_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNTAz_8f1f8cdc-6af6-4af0-b4d5-1fc12574106a">11,000</ix:nonFraction> and during the six months ended June 30, 2021, we collected the remaining six installment payments, totaling $<ix:nonFraction unitRef="usd" contextRef="ia1494e8ed82d4b2ebf75bbcb4722f663_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNjA2_75e4e16f-f6b8-41b6-b864-b46d63c40963">16,500</ix:nonFraction>. In connection with the sale of the Hospital Products, the parties also agreed to cause the dismissal of the pending civil litigation related to Nouress in the District Court for the District of Delaware.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were party to a Membership Interest Purchase Agreement, dated March 13, 2012, by and among us, Avadel Legacy, Breaking Stick Holdings, LLC, Deerfield Private Design International II, L.P. (&#8220;Deerfield International&#8221;), Deerfield Private Design Fund II, L.P. (&#8220;Deerfield Fund&#8221;) and Horizon Sant&#233; FLML, Sarl (&#8220;Horizon&#8221;) (the &#8220;Deerfield MIPA&#8221;) and a Royalty Agreement, dated February 4, 2013, by and among us, Avadel Legacy, the Deerfield Fund and Horizon (the &#8220;Deerfield Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Deerfield MIPA (with respect to certain sections thereof) and the Royalty Agreement were assigned to the Exela Buyer. Pursuant to the Purchase Agreement, the Exela </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 12 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ieedfaee426bd4abb9a61028b6bb4109a" continuedAt="i5597bb91f203474a9bcbd2e21a138474"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Deerfield Royalty Agreement for obligations that arise after the Closing Date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were also party to a Royalty Agreement, dated December 3, 2013, by and between us, Avadel Legacy and Broadfin Healthcare Master Fund, Ltd. (the &#8220;Broadfin Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Broadfin Royalty Agreement was assigned to the Exela Buyer and the Exela Buyer assumed and shall pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Broadfin Royalty Agreement for obligations that arise after the Closing Date.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNDAzNA_7c42c7c6-562c-4754-877f-430e408fda37" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the major classes of assets and liabilities either transferred to the Exela Buyer or eliminated by us due to the sale of the Hospital Products in exchange for aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMjQ4MQ_e3277f22-4951-4c79-9173-c472207ec96b">42,000</ix:nonFraction>, less transaction fees of $<ix:nonFraction unitRef="usd" contextRef="icb55d6c3ae02430b9ec0541184cb90e7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMjUxMA_8f037628-c580-4e4c-be27-1382cbc56dce">2,928</ix:nonFraction>. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfMS0yLTEtMS0w_2bd8dfa2-bdce-46e1-9ae6-9f57e6f4578b">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfMi0yLTEtMS0w_bdb366e4-e151-457e-a56f-1d07e2a883d4">4,922</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfMy0yLTEtMS0w_b2d15124-15fc-4400-84db-17e8473d13e2">1,654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfNC0yLTEtMS0w_3330b6c0-42e4-4a4f-a102-7535b9052702">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfNS0yLTEtMS0w_3595644c-7a3e-4859-a70f-99a9fac169f4">1,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term contingent consideration payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfNi0yLTEtMS0w_2128692c-1bb6-4112-be9b-55dffa1007de">14,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net liabilities disposed of</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfNy0yLTEtMS0w_db0db7bf-d523-4aeb-bce9-24f80dac0608">6,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfOC0yLTEtMS0w_c0828299-2f78-4f88-854f-d2410a911ae3">42,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less transaction fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb55d6c3ae02430b9ec0541184cb90e7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfOS0yLTEtMS0w_5f7e308e-8877-46d0-ac51-4dbaa90901b9">2,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net gain on the sale of the Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb55d6c3ae02430b9ec0541184cb90e7_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfMTAtMi0xLTEtMA_f6761162-3493-4be4-96f2-6fc3add3ac2c">45,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated various qualitative and quantitative factors related to the disposition of the Hospital Products and determined that it did not meet the criteria for presentation as a discontinued operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited pro forma condensed combined statement of loss for the six months ended June 30, 2020 included below is being provided for information purposes only and are not necessarily indicative of the results of operations that would have resulted if the Transaction had actually occurred on the date indicated. <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNDAzNQ_65f2d2d4-a761-4436-95c4-b3f92f9a658b" continuedAt="id767cb1f73534c44a57bf8efae2f38a3" escape="true">The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id767cb1f73534c44a57bf8efae2f38a3" continuedAt="i2a7ac37e09c74faebbc420cb88ad71ed"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:39.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Pro Forma Condensed Combined Statement of Loss</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfNS0yLTEtMS0w_1e8d8184-2195-4114-9a99-4440811f5b9c">22,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfNS00LTEtMS0w_1a5e8992-05c9-4776-abf6-f3e004302ba2">22,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35be439684f94754a722ac71e050ffd4_D20200101-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfNS04LTEtMS0w_78ec7a09-9d36-4861-8454-1bf69de9a50e">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTYtMi0xLTEtMA_b3b9d937-ae8e-4375-b162-a2d601e9a857">11,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTYtNC0xLTEtMA_d0897d32-aa30-4e67-b642-54a62c1d1ce7">8,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35be439684f94754a722ac71e050ffd4_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTYtOC0xLTEtMA_c7072429-9916-45e5-94ff-7faa72725bde">19,963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTctMi0xLTEtMA_63592d6a-b1d3-4212-9b12-7aba9c348190">33,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTctNC0xLTEtMA_68103339-f733-4745-b024-6353b53bf39c">13,650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35be439684f94754a722ac71e050ffd4_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTctOC0xLTEtMA_fc39e643-b9ca-4f5f-a0b8-d88e8b2227d0">20,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMjMtMi0xLTEtMA_a2792944-9372-4156-8a10-1fc7ef6af3c4">25,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMjMtNC0xLTEtMA_9884b422-f627-4b3b-88fe-67b92015191d">13,215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35be439684f94754a722ac71e050ffd4_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMjMtOC0xLTEtMA_f47bb610-6f91-4a5e-bc05-37c72b830b4f">12,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Adjustments to the pro forma unaudited condensed combined statements of loss</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This adjustment reflects Product sales attributable to the Hospital Products.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This adjustment reflects the following estimated expenses attributable to the Hospital Products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Cost of products of $<ix:nonFraction unitRef="usd" contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzQ3MQ_9a721d0d-7987-43e1-8bc2-47d211b0e149">3,540</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Research and development expenses of $<ix:nonFraction unitRef="usd" contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzUxMg_fc34749b-52a4-4114-8a98-bebf7cd650fd">407</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Selling, general and administrative expenses of $<ix:nonFraction unitRef="usd" contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzU2NA_68dc3cbd-f883-49e3-8e7a-207f74dc1865">776</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Intangible asset amortization on acquired development technology for Vazculep of $<ix:nonFraction unitRef="usd" contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzY0OQ_2006b82f-a339-4afb-a9c6-47cb45f3516d">406</ix:nonFraction>. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Changes in fair value of related party contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzcyMQ_1423b6c4-09e2-41bd-b3ce-083270153fda">3,396</ix:nonFraction>.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The Company will no longer be responsible for these payments.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 13 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i5597bb91f203474a9bcbd2e21a138474"><ix:continuation id="i2a7ac37e09c74faebbc420cb88ad71ed"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">of $<ix:nonFraction unitRef="usd" contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzkzMA_b59b56a6-1758-4c56-8b0a-9b241cc3268f">435</ix:nonFraction> attributable to the Hospital Products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The Company will no longer be responsible for these payments.</span></ix:continuation></ix:continuation></div><div><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_49"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4: <ix:continuation id="ie3e090c512914b03bb6e367aa7ac03dc" continuedAt="i77365df5d2fc4cf1b3aaf80082216c56"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80OS9mcmFnOjljZjYxMTA2MDI1ZDQwNGM4MjBmZDljMDJkOTEzY2E2L3RleHRyZWdpb246OWNmNjExMDYwMjVkNDA0YzgyMGZkOWMwMmQ5MTNjYTZfNTQxOA_851a9825-31e5-4668-8b04-1659f60cec40" continuedAt="i903c9927655a475f804bd2006b055b2f" escape="true">Revenue Recognition</ix:nonNumeric></ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="i77365df5d2fc4cf1b3aaf80082216c56" continuedAt="ia28e2f874ade447fb1bcf556c04e9d67"><ix:continuation id="i903c9927655a475f804bd2006b055b2f" continuedAt="ie72765a2d42148c38a3283858ae2b197"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, we generated revenue primarily from the sale of pharmaceutical products to customers. On June 30, 2020, we sold the Hospital Products.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Revenue from product sales was recognized when the customer obtained control of our product and our performance obligations were met, which occurred typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, our gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserves to Reduce Gross Revenues to Net Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales were recorded at the net selling price, which included estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves were based on the amounts earned or to be claimed on the related sales and were classified as reductions of accounts receivable if the amount is payable to the customer, except in the case of the estimated reserve for future expired product returns, which are classified as a liability. The reserves are classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves take into consideration relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates to reduce gross selling price to net selling price to which it expects to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company&#8217;s estimates. If actual results in the future vary from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company maintained a returns policy that generally offered customers a right of return for product that has been purchased from the Company. The Company estimated the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue was recognized. The Company estimated product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other judgments and analysis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks, Discounts and Rebates </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to our wholesale customers. Customers charge the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates are estimated at the time of sale to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s source of revenue was from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company&#8217;s revenues by product, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 15: Revenue by Product</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 14 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia28e2f874ade447fb1bcf556c04e9d67"><ix:continuation id="ie72765a2d42148c38a3283858ae2b197"><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A receivable is recognized in the period the Company sells its products and when the Company&#8217;s right to consideration is unconditional. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CapitalizedContractCostNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80OS9mcmFnOjljZjYxMTA2MDI1ZDQwNGM4MjBmZDljMDJkOTEzY2E2L3RleHRyZWdpb246OWNmNjExMDYwMjVkNDA0YzgyMGZkOWMwMmQ5MTNjYTZfNDUxNA_48458935-e936-469d-960c-4a204ebd55d5"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CapitalizedContractCostNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80OS9mcmFnOjljZjYxMTA2MDI1ZDQwNGM4MjBmZDljMDJkOTEzY2E2L3RleHRyZWdpb246OWNmNjExMDYwMjVkNDA0YzgyMGZkOWMwMmQ5MTNjYTZfNDUxNA_558a840d-132e-42e9-9db0-b1c936eb1f88">no</ix:nonFraction></ix:nonFraction> material deferred contract costs at June&#160;30, 2021 or December 31, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price Allocated to the Remaining Performance Obligation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For product sales, the Company generally satisfied its performance obligations within the same period the product was delivered. Product sales recognized in the second quarter of 2020 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which the Company recognizes revenue.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_52"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5: <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RleHRyZWdpb246MmZhZjQyMmNmYjgzNDE1NGJhODA1NzlhZGIwOWYyOTVfMzQ5MQ_cbc2969a-7869-4a40-ba23-7adc4f33613d" continuedAt="i40c8b62ccd874a9ca6f7a40ff0dcf598" escape="true">Fair Value Measurement</ix:nonNumeric></span></div><ix:continuation id="i40c8b62ccd874a9ca6f7a40ff0dcf598" continuedAt="ia5e5321d9c464e4fb507d2fc1f2e14db"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting.  For example, we use fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221;&#160;defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, we may generally use one or each of the following techniques: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Quoted prices for identical assets or liabilities in active markets. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Unobservable inputs that reflect estimates and assumptions. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 15 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia5e5321d9c464e4fb507d2fc1f2e14db"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RleHRyZWdpb246MmZhZjQyMmNmYjgzNDE1NGJhODA1NzlhZGIwOWYyOTVfMzQ5Nw_49c61cd6-7263-4518-b1fd-a77bf2782a2f" escape="true"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6fa5ebeb65455e950a6328bba21698_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS0yLTEtMS0w_4c759559-0515-4c63-90dc-db32d8a6880f">91,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519f8147d1374176b85b3cdcff0e8382_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS00LTEtMS0w_e54cc102-75d9-42e2-8c59-f653bf35e9b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900add1be5b84828adfa900933a618f3_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS02LTEtMS0w_48525c21-4565-4f13-a58c-b4b2ffb08a46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87edd5f150b248eebd16c398e3be78c6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS04LTEtMS0w_80b62232-2182-4b52-adad-e1f1d7a42687">104,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee580d62d1d4006b9c4ee3195b16fe2_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS0xMC0xLTEtMA_38ff91bb-a506-4836-9404-64a2de315297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5483582b0b7743da9ffaa6daeddee5c8_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS0xMi0xLTEtMA_dec23551-388b-4473-9e60-54a6ef9ac5c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13d7d68555c549268d32a550db3aa3a8_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi0yLTEtMS0w_43f30ce0-c1a9-4f3d-9579-0668456fa741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2312d5c712024cd18f05cfc64afe708c_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi00LTEtMS0w_47c63840-bda8-4c88-9327-1315e6d2632b">23,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f20ec5b3421400ab560dc49247ce3d5_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi02LTEtMS0w_3e274bb2-5dbe-4bd3-959e-95ef7f4ffe7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1374539a6c0453996dd609930013a2c_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi04LTEtMS0w_4665d895-f8e5-4338-acc8-795818856d3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5900644d8ce46379de39a2d0857e260_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi0xMC0xLTEtMA_d3170b4e-5e37-418a-acfd-02dfcb84fab3">22,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f54424e7f4147e3abfa224100f76762_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi0xMi0xLTEtMA_9c4c883b-eec8-4300-8777-41b0d49cf08d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i391dd5fd75e44b6bb689e468e2f6998b_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy0yLTEtMS0w_fe4f90f8-28e3-4317-99b4-00561906e0fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa665aface774b5cba45e448c5017ef5_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy00LTEtMS0w_a11e255c-da3a-4515-bb80-5243a44e4230">17,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if495a6914a2043078c2ff45ec8e8cd94_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy02LTEtMS0w_ad87d7d1-d8d8-4701-81c4-af8b14a461ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819166dd8aad49adb09355ff41111edc_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy04LTEtMS0w_d9066c07-f0d5-456b-b24b-e3a7848e01f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff9730b64194e44b1624fd8387ff601_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy0xMC0xLTEtMA_0a3d1059-99d3-44fb-a655-7d251009ce63">18,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic787b137f02c471ab5fb441de2ccb356_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy0xMi0xLTEtMA_bb5f5840-ec1c-4ef2-ab53-24bfb573cab2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de1d5ad40c44bcc9def111356353120_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS0yLTEtMS0w_ad74e788-299d-4e17-91cd-62e66298fa96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f38d83a8549b6ac924b573fcd11f7_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS00LTEtMS0w_d59fa4fa-bc42-4a81-9587-8b094df9bbb9">3,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184178aa288147edb42ff605f41c2388_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS02LTEtMS0w_38632875-e510-42d8-b1f3-96251ec64051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3d99af014d24c818d1dc4b69ee59196_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS04LTEtMS0w_cad5fd73-1cf4-4e30-b9a3-7029aa586d3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d78585c18940df8a7e1e5478ef6cb2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS0xMC0xLTEtMA_aad0a040-d1f8-406c-9a61-545975a8e8e9">3,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3eac9312e543b5af4e5ec8d59fbec0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS0xMi0xLTEtMA_0a0d93a4-abcc-44f3-9c8d-1127d588410a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i860be6580c44499c8b2bbc5d5a7e3a36_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtMi0xLTEtMA_1b9c3181-cf54-41ef-8cac-b7aab6b09da4">91,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i224fa48116ff4bd6a9842fded9a71fdb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtNC0xLTEtMA_bd04987b-75db-469f-be49-2b15de3e871c">43,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43f54881920b4af98a41727d8004594f_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtNi0xLTEtMA_9fb16e51-df4a-4648-8f28-7e5470f7c4b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1938867c944920ae7b3cff817479c8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtOC0xLTEtMA_26844e3b-459b-439e-b6b1-c22089f59102">104,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5be2c3dab5b048debcaabab64882d9e1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtMTAtMS0xLTA_f641fe6f-e5b7-43a4-a71b-d2b11d7eb1ed">45,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c8795b315d846338c877c8df1d32455_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtMTItMS0xLTA_05c02892-e754-483e-882c-5948cf892018">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160; Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities.  During the periods ended June&#160;30, 2021 and December&#160;31, 2020, respectively, there were no transfers in and out of&#160;Level&#160;1, 2, or 3.  During the&#160;three and six months ended June&#160;30, 2021 and 2020, respectively, we did not recognize any other-than-temporary impairment loss. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s financial instruments, such as cash and cash equivalents, accounts receivable and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our $<ix:nonFraction unitRef="usd" contextRef="i65d25b85bcaa41adb6ed552acf50363b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RleHRyZWdpb246MmZhZjQyMmNmYjgzNDE1NGJhODA1NzlhZGIwOWYyOTVfMzA3Nw_65269b0a-a81e-4cb2-8b95-3e33788284aa">143,750</ix:nonFraction>&#160;aggregate principal amount of&#160;the 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input).  The estimated fair value of the 2023 Notes at June&#160;30, 2021 is $<ix:nonFraction unitRef="usd" contextRef="i65d25b85bcaa41adb6ed552acf50363b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RleHRyZWdpb246MmZhZjQyMmNmYjgzNDE1NGJhODA1NzlhZGIwOWYyOTVfMzQxMQ_34b7b2f6-dbd1-4582-8b0b-64a810943e76">147,523</ix:nonFraction>.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9: Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our debt obligations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_55"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMjI5MA_df2e78ed-012f-4fe2-8fa3-b1803d6c249f" continuedAt="ib563ec9db7854b5b9e9d48dec91df8aa" escape="true">Marketable Securities&#160;</ix:nonNumeric></span></div><ix:continuation id="ib563ec9db7854b5b9e9d48dec91df8aa" continuedAt="i0de8ba6880134247bd4537be9f323b6f"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in available-for-sale debt securities which are recorded at fair market value.  The change in the fair value of equity investments is recognized in our unaudited condensed consolidated statements of (loss) income and the change in the fair value of available-for-sale debt investments is recorded as other comprehensive loss in shareholders&#8217; equity, net of income tax effects.  As of June&#160;30, 2021, we considered any decreases in fair value on our marketable securities to be driven by factors other than credit risk, including market risk.  </span></div><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMjMwMQ_8bc2afe6-0115-480a-bb6f-e9a409348ec4" continuedAt="i126dd42f106b49109ecb966ecb558343" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;June&#160;30, 2021 and December&#160;31, 2020, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNC0yLTEtMS0w_724f3d64-5578-41c6-b68e-83e2c3acf482">90,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNC00LTEtMS0w_93897d36-4ddb-43b3-8288-101d72bd95e2">1,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNC02LTEtMS0w_935e04ac-109e-44cb-b893-ebe0c3615b27">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNC04LTEtMS0w_c2c8512d-52db-4d22-b0c3-6b068dbbb98a">91,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ff608828844c6798870117de00d1e1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNS0yLTEtMS0w_0a5a039e-ab8b-4297-9fec-76196d583d8c">22,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ff608828844c6798870117de00d1e1_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNS00LTEtMS0w_8e08305b-4567-4862-ae18-2537160da970">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7ff608828844c6798870117de00d1e1_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNS02LTEtMS0w_b56dcbe1-4cf5-441c-8b6e-011292acf51f">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ff608828844c6798870117de00d1e1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNS04LTEtMS0w_2d3a91b3-993f-4480-a9f7-5b446c6f41eb">23,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90450500044d427f8c232f666584b39e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNi0yLTEtMS0w_c3875316-479b-40ba-a4ad-0c97050c4ba1">17,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90450500044d427f8c232f666584b39e_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNi00LTEtMS0w_167dfcae-f5d2-4fb8-9be0-7e513b65ff96">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90450500044d427f8c232f666584b39e_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNi02LTEtMS0w_567fb708-1f7f-4c59-a8ba-cfa198560905">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90450500044d427f8c232f666584b39e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNi04LTEtMS0w_e4cdeb45-b61d-44c0-a5a2-b4cbf0770ad0">17,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOC0yLTEtMS0w_a5f10fde-fbd2-4c5b-8de1-acda97a9bef2">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOC00LTEtMS0w_6606bf82-2dc4-4654-bf13-45c31d9ad26b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOC02LTEtMS0w_64bfe77b-4234-4410-b3e9-c5c6d6997141">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOC04LTEtMS0w_3c6590db-c0f0-4967-96ac-f5ca2fc87f3e">3,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOS0yLTEtMS0w_017e12d0-4386-4a7c-89fb-319208702179">134,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOS00LTEtMS0w_61ade294-b617-4669-8785-eacaae529cd5">1,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOS02LTEtMS0w_624e5075-37b0-45dc-b987-d6ca7b076aa5">473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOS04LTEtMS0w_bfa3c46a-304d-434a-baa2-1f8ee6fe630b">135,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 16 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0de8ba6880134247bd4537be9f323b6f"><div style="margin-bottom:11pt;text-align:justify"><ix:continuation id="i126dd42f106b49109ecb966ecb558343"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNC0yLTEtMS0w_abb6ffb3-aacc-4d65-931f-54ec65dac9c2">103,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNC00LTEtMS0w_aae43dc8-dbb9-45c2-b4ed-c67593436558">1,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNC02LTEtMS0w_db3c1416-fd0c-4c83-810f-e8d7b9e1bda4">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNC04LTEtMS0w_6e7e57ad-cd61-4592-a35e-ac8572378324">104,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNS0yLTEtMS0w_a4a0372c-a870-496f-9927-afa4d7bf9903">21,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNS00LTEtMS0w_21774f1b-ca78-4cc1-a0ab-f58ae5a05842">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNS02LTEtMS0w_635f688b-d70e-4acb-b1be-bd8d2056417d">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNS04LTEtMS0w_dc266894-d2ba-40a5-b69d-a51cf5ac5e3f">22,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i629580901ade4561aeb0685c65e22554_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNi0yLTEtMS0w_f13fc8d5-3566-44e2-8abb-7d1a819485f0">18,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i629580901ade4561aeb0685c65e22554_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNi00LTEtMS0w_e92304d6-847b-4444-99b9-4f0f299c1df5">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i629580901ade4561aeb0685c65e22554_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNi02LTEtMS0w_05527cb1-21ac-4ddf-a80d-db77e7bd68e4">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i629580901ade4561aeb0685c65e22554_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNi04LTEtMS0w_4ea3a195-2b6c-491c-b242-36b6f52656f9">18,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNy0yLTEtMS0w_4df89f0b-882d-41db-b515-c5bdcdc153e2">3,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNy00LTEtMS0w_756fc5b7-5c82-4c36-9f2a-157fb669610d">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNy02LTEtMS0w_23e664ac-0121-4def-8ca0-122bf74afc7e">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNy04LTEtMS0w_51c23ce2-cb80-4272-9921-9fcf6bfbd1c9">3,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfOC0yLTEtMS0w_975144ca-56db-4dab-a3b0-e87dbcec3175">147,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfOC00LTEtMS0w_7819c700-0bc5-4cea-a0e9-72d7e21d4133">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfOC02LTEtMS0w_94457347-7ceb-41c8-93ec-ebf71372215b">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfOC04LTEtMS0w_22a57c50-8085-48a4-9c87-8ec705b16503">149,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine realized gains or losses on the sale of marketable securities on a specific identification method. We reflect these gains and losses as a component of investment and other income (expense), net in the accompanying unaudited condensed consolidated statements of (loss) income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized gross realized gains of&#160;$<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTEyNQ_33c9346d-2de0-476e-8375-5dc195911d2d">41</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTEzMg_a25add34-2b7b-4d61-8d51-f9aa6ad3f5eb">14</ix:nonFraction> for the&#160;three months ended June&#160;30, 2021 and 2020, respectively. These realized gains were offset by realized losses of $<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTI0Mg_df946c8d-0b9c-415c-980e-32e4f1c2805f">39</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTI0OQ_36cfabf6-c536-454a-87db-5ebc3baa665b">6</ix:nonFraction>&#160;for the three months ended June&#160;30, 2021 and 2020, respectively. We recognized gross realized gains of $<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTA5OTUxMTYzMDc0Mw_a26bcf76-5c8d-4f56-ad53-7a7a3e1a5954">52</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTA5OTUxMTYzMDc1MQ_c07eb8af-6ca2-4d3a-8a10-5825095fc8d8">290</ix:nonFraction> for the six months ended June&#160;30, 2021 and 2020, respectively. These realized gains were offset by realized losses of $<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTA5OTUxMTYzMDc4Mg_bc3ad53f-231f-4620-8444-a0c6d5a737b0">107</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTA5OTUxMTYzMDc5MA_e5458e58-6508-43a5-a773-d9418e5bc175">878</ix:nonFraction> for the six months ended June&#160;30, 2021 and 2020, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMjMwMw_4e9e0216-69c9-443c-bec0-5f2c3e9f8ce5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of our investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of June&#160;30, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5-10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ff608828844c6798870117de00d1e1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy0yLTEtMS0w_4a6c8e1f-9109-4580-a4d9-99750268f925">7,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ff608828844c6798870117de00d1e1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy00LTEtMS0w_dfddc4e8-0205-4d3d-8692-fe72928be247">15,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ff608828844c6798870117de00d1e1_I20210630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy02LTEtMS0w_a85b4cdf-1fa9-49f2-990f-d85065bad1a2">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ff608828844c6798870117de00d1e1_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy04LTEtMS0w_d34433be-ce51-4fd5-a5bf-3d99e91b3f26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ff608828844c6798870117de00d1e1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy0xMC0xLTEtMA_2d3a91b3-993f-4480-a9f7-5b446c6f41eb">23,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90450500044d427f8c232f666584b39e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC0yLTEtMS0w_b7191221-b1ed-42ab-aab6-d080e203de2f">4,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90450500044d427f8c232f666584b39e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC00LTEtMS0w_5f05ef43-853f-4c3e-b823-8d60ae6a7e80">10,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90450500044d427f8c232f666584b39e_I20210630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC02LTEtMS0w_1e9679ca-4780-44d8-b6c4-9dd75f725a48">881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90450500044d427f8c232f666584b39e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC04LTEtMS0w_a2c91661-6bf2-4a1e-ad2e-8f1ea787fe45">1,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90450500044d427f8c232f666584b39e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC0xMC0xLTEtMA_e4cdeb45-b61d-44c0-a5a2-b4cbf0770ad0">17,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi0yLTEtMS0w_8ea63b26-bb5f-41a1-b318-81045fcdd595">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi00LTEtMS0w_00841b4a-ca8a-48a9-a7bc-e3fa5863901c">1,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi02LTEtMS0w_bf92abee-8955-4146-9dd0-9efae183906c">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi04LTEtMS0w_eef94aec-b091-4ccf-b7a7-cf3f2db5c767">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi0xMC0xLTEtMA_3c6590db-c0f0-4967-96ac-f5ca2fc87f3e">3,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy0yLTEtMS0w_97145710-1f09-49a2-aea0-10728f25522e">12,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy00LTEtMS0w_2e8575c3-6361-492c-8623-fb4bb9e037b1">27,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy02LTEtMS0w_357a85f1-4789-4567-8d7f-62d65c729456">1,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy04LTEtMS0w_65351f95-167a-4646-a8a3-42b5020d4c88">1,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy0xMC0xLTEtMA_acf55a31-e705-48e1-8129-d0143b484a64">43,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our investment in available-for-sale marketable debt securities as current assets in the unaudited condensed consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in our investment portfolio. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross unrealized losses of our available-for-sale debt securities at June&#160;30, 2021 were immaterial. The unrealized losses are driven by factors other than credit risk and have been in an unrealized loss position for less than one year. We do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_58"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfNDM5_1fbef432-7d78-4f46-b291-a962dc30a65d" continuedAt="i95c87b933f8f4c0982e1aac8672e1baf" escape="true">Goodwill and Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i95c87b933f8f4c0982e1aac8672e1baf"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unamortizable goodwill is $<ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfNjQ_18ec4687-ca68-4559-a2d8-5e10e99faf7a"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfNjQ_e7373123-57c1-4a2d-a2f4-2bd8d42124c0">16,836</ix:nonFraction></ix:nonFraction> at June&#160;30, 2021 and December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization expense related to an amortizable intangible asset that was assumed by the Exela Buyer as part of the disposition of the Hospital Products on June 30, 2020 of $<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfMTA5OTUxMTYyODI5MQ_44fa1388-2c16-44c7-b0e3-e7e157e17204">203</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfMjc1_dde49888-f1f0-4987-9bbe-188682b45e83">406</ix:nonFraction> for the three and six months ended June 30, 2020.  Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  There was <ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfMzUw_5fc2e288-b4b6-407b-b8bc-ed3194e4057e"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfMzUw_c8371743-1d73-4cb6-8195-4e33ed4d8599">no</ix:nonFraction></ix:nonFraction> amortization expense recorded during the three and six months ended June&#160;30, 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_61"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RleHRyZWdpb246OGNjYWZmNjI0ZGVjNDFkZDkyYTcxN2Y4NzJkZDNlMThfMTM5Ng_59f62aa2-b98f-485e-bac9-4a1d6954f848" continuedAt="i23a19825dffe4ae2a3ee21d105c6eeea" escape="true">Contingent Consideration Payable&#160;</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i23a19825dffe4ae2a3ee21d105c6eeea" continuedAt="i2d51944db64e431ebc7df9887cd71ee6">Prior to the sale of the Hospital Products on June 30, 2020, we computed the fair value of the contingent consideration using several significant assumptions and when those assumptions changed, due to underlying market conditions, the fair value of these liabilities changed as well. Each of the underlying assumptions used to determine the fair values of these contingent liabilities could, and often did, change based on adjustments in current market conditions, competition and other factors. Prior to the sale of the Hospital Products, these changes had a material impact on our unaudited condensed consolidated statements of (loss) income and balance sheets. As part of the sale of the Hospital Products on June 30, 2020, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy and the Company under the Deerfield Royalty Agreement. As of June&#160;30, 2021 and December 31, 2020, the balance of the contingent consideration payable is $<ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="0" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RleHRyZWdpb246OGNjYWZmNjI0ZGVjNDFkZDkyYTcxN2Y4NzJkZDNlMThfOTkw_4d1f75c5-d506-4937-bf47-2ea337b6113d"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="0" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RleHRyZWdpb246OGNjYWZmNjI0ZGVjNDFkZDkyYTcxN2Y4NzJkZDNlMThfOTkw_f78a345b-5c6c-4ba9-8375-1e5372c34d7a">0</ix:nonFraction></ix:nonFraction>. </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 17 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i2d51944db64e431ebc7df9887cd71ee6"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RleHRyZWdpb246OGNjYWZmNjI0ZGVjNDFkZDkyYTcxN2Y4NzJkZDNlMThfMTM5NQ_a0c233d6-9beb-4661-97f6-7bb18638936f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes to the contingent consideration payable, a recurring Level 3 measurement, for the six-month period ended&#160;June 30,&#160;2020:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:78.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration Payable Rollforward:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398b06c595444f7caeaba916451c29fa_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfMi0yLTEtMS0w_bb0979e2-b85f-4874-9542-2efb98b2db62">17,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfMy0yLTEtMS0w_cf5bd4b7-2e03-4f65-a51b-62b0efc6b16a">4,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfNC0yLTEtMS0w_912c4e0e-308b-4495-a405-47096f746173">3,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposition of the Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfNS0yLTEtMS0xMTI0_5ea8b18b-e214-4645-b102-9e76f673462d">14,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b18f9096c56478ba558603f0009c83f_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfNS0yLTEtMS0w_33325813-6378-428b-9d69-51c35935b61f">1,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the unaudited condensed consolidated statements of (loss) income.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_64"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9: <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNjIzOA_68b1d2ef-f518-476b-ba6a-36262eea46ce" continuedAt="ia77db6bf077542bea1911e741d3931e6" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="ia77db6bf077542bea1911e741d3931e6" continuedAt="ie1b5fd76ee3149f8be3c0b92e8c3f6f4"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNjI0MQ_9fbf882b-58bc-4d6f-acd4-204b270da274" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.371%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of <ix:nonFraction unitRef="number" contextRef="i81950a1669ff43e2a55fa3ab8b6bbf14_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMS0wLTEtMS0wL3RleHRyZWdpb246NDkyNzJhMTdkNzZiNGM0NGI2YjY3NjU1ZTFmNjIyNmNfMjQ_39f00b79-213a-4626-ac31-4d819ce05df0"><ix:nonFraction unitRef="number" contextRef="i65d25b85bcaa41adb6ed552acf50363b_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMS0wLTEtMS0wL3RleHRyZWdpb246NDkyNzJhMTdkNzZiNGM0NGI2YjY3NjU1ZTFmNjIyNmNfMjQ_a3dee637-b1f2-4cac-a78c-9f86872ded21">4.50</ix:nonFraction></ix:nonFraction>% exchangeable senior notes due 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d25b85bcaa41adb6ed552acf50363b_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMS0yLTEtMS0w_65269b0a-a81e-4cb2-8b95-3e33788284aa">143,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81950a1669ff43e2a55fa3ab8b6bbf14_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMS00LTEtMS0w_12376bdb-6eb2-4943-9f8b-c6813ec5bc36">143,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ac2b9e70ab04d8db284fd554dcbf2da_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMi0yLTEtMS0w_6358327a-cf7e-4e70-8615-44123bdace8a">1,976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62b61fe78c654a8eabbae48f28674623_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMi00LTEtMS0w_171a07db-5c44-4cfa-a6f2-0f85e818aaa1">15,540</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac2b9e70ab04d8db284fd554dcbf2da_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMy0yLTEtMS0w_01490038-f5c3-40d6-b8c5-3a45e834aaa2">141,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b61fe78c654a8eabbae48f28674623_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMy00LTEtMS0w_87b49634-fa54-4eb5-8d05-424fc0b369f4">128,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfNi0yLTEtMS0w_e01781bc-0cd3-47c8-ba87-80d924cb0fa4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfNi00LTEtMS0w_09c03ea9-f3a5-4126-a69a-65933bae8f25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfNy0yLTEtMS0w_dbcafda8-d3b2-4247-9aee-50dbf050672b">141,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfNy00LTEtMS0w_7f8b08f6-9f86-4edb-ba0d-d5a201288868">128,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of exchangeable notes, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac2b9e70ab04d8db284fd554dcbf2da_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMTAtMi0xLTEtMA_4c9e6a9d-d76f-4645-8b1d-00f8ff0afdbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62b61fe78c654a8eabbae48f28674623_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMTAtNC0xLTEtMA_f61ad4eb-b5f1-48bb-b220-0592486fe552">26,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021 and 2020, the total interest expense was $<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjMzMQ_caf60f3b-0127-458d-953a-1bdb2220b0c5">1,930</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM0MQ_b9d6d4b3-278f-4df0-a828-c04d070b7a63">3,237</ix:nonFraction>, respectively, with coupon interest expense of $<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="avdl:CouponInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM1MQ_087803a2-b85c-44d9-9656-782974132b92"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="avdl:CouponInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM1MQ_affd4a08-a088-4874-bd94-f49003f5516f">1,617</ix:nonFraction></ix:nonFraction> for each period and the amortization of debt issuance costs and debt discount of $<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="0" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM1OA_603081c3-f8b8-4563-9178-86f7a484b125">313</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM2OQ_26649b9a-02f5-421c-9518-4c8b70bf3fbd">1,620</ix:nonFraction>, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2021 and 2020, the total interest expense was $<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM3OQ_54805e7e-73a4-47ce-bd34-3642b070e59f">3,859</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM4OQ_1728931a-64ad-453b-9366-58e9d90a4fe2">6,427</ix:nonFraction>, respectively, with coupon interest expense of $<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="avdl:CouponInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM5OQ_2055f7a0-806b-4780-b5f4-faecce1d15e0"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="avdl:CouponInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM5OQ_ef7a019b-210d-46bf-93fb-8a911ca38636">3,234</ix:nonFraction></ix:nonFraction> for each period and the amortization of debt issuance costs and debt discount of $<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjQwNw_fa47456d-8db6-4b5c-a7ef-c35b4af47303">625</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjQxNw_c88c7bb4-fd0b-4273-a0a2-33d24564862d">3,193</ix:nonFraction>, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 2: Newly Issued Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The adoption resulted in a $<ix:nonFraction unitRef="usd" contextRef="if26cf9bd950645da82a913ea028f7f6a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDkz_f79c04ae-618e-48f8-8b72-99f348601d93">12,939</ix:nonFraction> increase in long-term debt and a $<ix:nonFraction unitRef="usd" contextRef="i54a0f1be38254190aa94a522f6ed4974_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNTI5_5d9adcd7-cc00-4f62-8aa7-c83805448ae9">26,699</ix:nonFraction> decrease in the equity component of the 2023 Notes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2018, Avadel Finance Cayman Limited, a Cayman Islands exempted company (the &#8220;Issuer&#8221;) and an indirect wholly-owned subsidiary of the Company, issued $<ix:nonFraction unitRef="usd" contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE4NA_8d0e7850-d66d-46a4-8a39-f7fb3142770b">125,000</ix:nonFraction> aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTIwMA_bd932b3f-d173-4d15-9465-e77569009889">4.50</ix:nonFraction>% exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) in a private placement (the &#8220;Offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the 2023 Notes a <ix:nonNumeric contextRef="if7160598d23c4b518c759c6aa5a8d2b4_D20180216-20180216" format="ixt-sec:durwordsen" name="avdl:DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNjI0NA_ed6d9c62-d5a1-45ce-ab1e-428f24fac336">30-day</ix:nonNumeric> option to purchase up to an additional $<ix:nonFraction unitRef="usd" contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216" decimals="-3" format="ixt:numdotdecimal" name="avdl:DebtInstrumentOptiontoIncreaseFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTA3Mg_bf721cec-a548-46f9-9aa7-197cd614f596">18,750</ix:nonFraction> aggregate principal amount of the 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts of $<ix:nonFraction unitRef="usd" contextRef="if7160598d23c4b518c759c6aa5a8d2b4_D20180216-20180216" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTI4OQ_e837340d-22d6-4913-b028-8950efc50f6f">6,190</ix:nonFraction>, were approximately $<ix:nonFraction unitRef="usd" contextRef="if7160598d23c4b518c759c6aa5a8d2b4_D20180216-20180216" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTA5MA_c0bb1858-d217-4342-9fd5-1c342ec66113">137,560</ix:nonFraction>.  The 2023 Notes are the Company&#8217;s senior unsecured obligations and rank equally in right of payment with all of the Company&#8217;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes will be exchangeable at the option of the holders at an initial exchange rate of <ix:nonFraction unitRef="rate" contextRef="ibcdc3f2602ac4af79cdaff50261cf317_D20180216-20180216" decimals="INF" name="avdl:AmericanDepositorySharesConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTEwOA_850389a5-089d-424f-8b8b-43b8f14540e3">92.6956</ix:nonFraction> ADSs per $1 principal amount of 2023 Notes, which is equivalent to an initial exchange price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216" decimals="2" name="avdl:AmericanDepositarySharesOptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE0Ng_ea2aa805-f3d6-47ff-9b36-9b5b5e5e5986">10.79</ix:nonFraction> per ADS. Such initial exchange price represents a premium of approximately <ix:nonFraction unitRef="number" contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216" decimals="2" name="avdl:AmericanDepositarySharesPremiumPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTEyMQ_294dd234-8ec0-4faf-8a80-535c5e7848ca">20</ix:nonFraction>% to the $<ix:nonFraction unitRef="usdPerShare" contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216" decimals="2" name="avdl:AmericanDepositarySharesPurchasedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTEzMg_2e2874de-2aa2-4926-81bf-c9b0465411e1">8.99</ix:nonFraction> per ADS closing price on The Nasdaq Global Market on February 13, 2018.  Upon the exchange of any 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#8217;s election. Holders of the 2023 Notes may convert their 2023 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 18 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie1b5fd76ee3149f8be3c0b92e8c3f6f4" continuedAt="i8536ba40327043e397492461b78cdaa9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preceding August 1, 2022, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after August 1, 2022 and prior to the close of business on the business day immediately preceding the maturity date:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE1OA_ebaf9a35-35f7-46d5-9322-eec1885aa043">five</span> business day period immediately after any <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE3Mw_2f9ed925-ca6a-4374-8047-4f204d21b861">five</span> consecutive trading day period (the &#8220;Measurement Period&#8221;) in which the trading price per $1 principal amount of 2023 Notes, as determined following a request by a holder of the 2023 Notes, for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i8558d8d29eb84dbfa4e0793e914d9349_D20180216-20180216" decimals="2" name="avdl:DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE2NA_66d3905f-6bf9-4f6c-862b-42d77fb6b58f">98</ix:nonFraction>% of the product of the last reported sale price of the ADSs and the exchange rate on each such trading day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If a transaction or event that constitutes a fundamental change or a make-whole fundamental change occurs prior to the close of business on the business day immediately preceding August 1, 2022, regardless of whether a holder of the 2023 Notes has the right to require the Company to repurchase the 2023 Notes, or if Avadel is a party to a merger event that occurs prior to the close of business on the business day immediately preceding August 1, 2022, all or any portion of a the holder&#8217;s 2023 Notes may be surrendered for exchange at any time from or after the date that is <ix:nonFraction unitRef="day" contextRef="id828d13c94a04e7981051a01fa81ed95_D20180216-20180216" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMzgyNg_ca657d49-866e-4033-a9dd-5d6419e5a117">95</ix:nonFraction> scheduled trading days prior to the anticipated effective date of the transaction (or, if later, the earlier of (x) the business day after the Company gives notice of such transaction and (y) the actual effective date of such transaction) until <ix:nonNumeric contextRef="id828d13c94a04e7981051a01fa81ed95_D20180216-20180216" format="ixt-sec:durday" name="avdl:DebtInstrumentConvertibleScheduledThresholdTradingDays" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDA3NA_e579eafb-954b-42e9-9332-24a517fa7386">35</ix:nonNumeric> trading days after the actual effective date of such transaction or, if such transaction also constitutes a fundamental change, until the related fundamental change repurchase date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during any calendar quarter commencing after the calendar quarter ending on June 30, 2018 (and only during such calendar quarter), if the last reported sale price of the ADSs for at least <ix:nonFraction unitRef="day" contextRef="i619255c0fbb84c85be6f62b40e8f8667_D20180216-20180216" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDY0MQ_84e6bad7-e775-494a-895f-622b5a88c9c2">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="day" contextRef="i619255c0fbb84c85be6f62b40e8f8667_D20180216-20180216" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDcwNw_01a130eb-7ae5-439b-9477-8e1bad80f4fe">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="i619255c0fbb84c85be6f62b40e8f8667_D20180216-20180216" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDg1Ng_25d624ec-8f7a-4b3c-85bd-719adeffe6d7">130</ix:nonFraction>% of the exchange price on each applicable trading day. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the Company calls the 2023 Notes for redemption pursuant to Article 16 to the Indenture prior to the close of business on the business day immediately preceding August 1, 2022, then a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time prior to the close of business on the second business day prior to the redemption date, even if the 2023 Notes are not otherwise exchangeable at such time. After that time, the right to exchange shall expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the 2023 Notes may exchange its 2023 Notes until the redemption price has been paid or duly provided for.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i8536ba40327043e397492461b78cdaa9" continuedAt="i18e8ad61bfb748418c9b90272f82519c"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered the guidance in ASC 815-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. We determined that this exception applies due, in part, to our ability to settle the 2023 Notes in cash, ADSs or a combination of cash and ADSs, at our option. We have therefore applied the guidance provided by ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i18e8ad61bfb748418c9b90272f82519c">, as amended by ASU 2020-06.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfODE2_85a03b88-11cd-4177-b0ea-116e9eb51d17" continuedAt="ib3ea048a25084de69518eeaac09a1f64" escape="true">Income Taxes </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib3ea048a25084de69518eeaac09a1f64"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit was $<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMjc0ODc3OTA3MTE4Nw_110362ef-d922-4822-8026-38d8dde5ba12">3,765</ix:nonFraction> for the three months ended June&#160;30, 2021 resulting in an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0Mzk5MA_c515b2fe-b1f3-451b-8055-e1bcd173f352">16.1</ix:nonFraction>%.  The income tax expense was $<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMjc0ODc3OTA3MTE5OA_e6625379-40bc-45c1-8621-213b1a1914c5">5,292</ix:nonFraction> for the three months ended June&#160;30, 2020 resulting in an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0Mzk5Nw_3d45fc48-c662-4c01-9bd8-fc5bf8f10354">14.6</ix:nonFraction>%.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit was $<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMjc0ODc3OTA3MTExMg_97a0aca1-443a-42e9-a040-fb94a0d07f2d">6,372</ix:nonFraction> for the six months ended June&#160;30, 2021 resulting in an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTA5OTUxMTYzMDk5Nw_7eb8490d-2f64-4a77-b39b-fcf912f54fc8">16.2</ix:nonFraction>%.  The income tax benefit was $<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMjc0ODc3OTA3MTEyMg_8fac7b6d-37af-49c4-babb-818fc6d60016">4,218</ix:nonFraction> for the six months ended June&#160;30, 2020 resulting in an effective tax rate of (<ix:nonFraction unitRef="number" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0NDAwNA_124a6072-ff71-4544-a40f-ca987dc62571">16.4</ix:nonFraction>)%.  The net increase in the effective income tax rate for the six months ended June 30, 2021 as compared to the prior period in 2020 is primarily due to the discrete tax benefits recognized during the six months ended June 30, 2020 under the Coronavirus Aid, Relief and Economic Security Act, also known as the CARES Act, which did not occur during the six months ended June 30, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the six months ended June 30, 2021 and 2020, the Company received $<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIncomeTaxRefunds" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0NTQwNA_6053cb2f-28de-425c-aacf-1eaa0d914328">3,078</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIncomeTaxRefunds" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0NTQxMg_9a8bcd90-fa32-4853-9c80-02d3996d0c4c">2,036</ix:nonFraction>, respectively, of cash primarily related to refundable French Research &amp; Development Tax Credits generated in prior years.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 19 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTM4_83eef01e-a4a1-4b71-9a90-c748615d0694" continuedAt="i1665fc355976460985d3c25b46285dc9" escape="true">Other Assets and Liabilities&#160;</ix:nonNumeric></span></div><ix:continuation id="i1665fc355976460985d3c25b46285dc9"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTM5_4f3b8fcc-3ab5-45de-a903-620e0402d011" escape="true"><div style="margin-bottom:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized as follows:</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value-added tax recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfMi0yLTEtMS0w_1f5d7f92-d159-4ae3-983a-d017cdbe720c">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfMi00LTEtMS0w_a9348165-bce7-4117-8bd9-ed3046b924eb">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfMy0yLTEtMS0w_c61edc3d-d40c-4152-9d6d-f208a2d1e81c">3,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfMy00LTEtMS0w_c1be50eb-19b3-4b3b-9a90-c916de512c02">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepositsAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNC0yLTEtMS0w_8a50b28c-2c38-43e6-aa08-bd25a2145f7f">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepositsAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNC00LTEtMS0w_7afca60f-461d-4639-a4b4-1e06a9ca9711">1,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="avdl:GuaranteeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNS0yLTEtMS0w_d25547e4-8b5d-4d50-8e48-9e72349d130e">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="avdl:GuaranteeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNS00LTEtMS0w_a8bfaaab-1fcb-4b1f-9073-5b30ed4b04cb">318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNi0yLTEtMS0w_9b5dbbee-3517-450f-9dee-a69e47fbfbc6">18,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNi00LTEtMS0w_dd8a09fb-7442-42d4-92d4-bd01ffefc8a5">18,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivable from Exela (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:zerodash" name="avdl:ShortTermNoteReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNy0yLTEtMS0w_3be664f6-337f-41d8-998a-948b09e3c1a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="avdl:ShortTermNoteReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNy00LTEtMS0w_8e1c90a8-34a3-4d31-ba8c-96c251199405">16,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfOC0yLTEtMS0w_a5ad7f94-8708-4561-aec0-2e7540067e41">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfOC00LTEtMS0w_7ed38fd8-b3f6-459d-a990-63c039f9c607">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfOS0yLTEtMS0w_67ef26b1-ff73-4bdf-a2c1-052cb03d14aa">25,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfOS00LTEtMS0w_6f841dba-5b23-4091-b78f-82bb90feb235">38,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:4pt"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTMw_cd1fa1ff-6097-4e11-bb45-4ff8c954e781" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfMi0yLTEtMS0w_5d402712-aecd-493b-8a62-616a2e17ea33">24,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfMi00LTEtMS0w_8bafd740-82eb-4e56-9e6e-26bc7cbfb45e">18,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="avdl:GuaranteeNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNC0yLTEtMS0w_ec1aa4a1-d9a5-4ffb-8f4a-602e07b2a13f">910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="avdl:GuaranteeNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNC00LTEtMS0w_31191382-7a24-4cd8-931f-5dabcc3dd223">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNS0yLTEtMS0w_ac6b6280-6a6f-4f19-80e5-4924022afdf5">5,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNS00LTEtMS0w_7b6fc8d0-08d8-48b8-8bd5-971cebbb56d5">5,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="avdl:OtherNoncurrentReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNi0yLTEtMS0w_363511f7-91f1-40c2-b850-1672aae693a4">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="avdl:OtherNoncurrentReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNi00LTEtMS0w_89c8639b-5905-4643-8609-e0dcc5b53c1b">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNy0yLTEtMS0w_62eb3707-564d-4cc2-855c-6e6d40bea244">31,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNy00LTEtMS0w_552e80a7-ae3d-4437-8667-b778e81181de">24,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:4pt"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTMx_76d97282-c23d-4374-ac04-f59b0d7a7dec" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfMi0yLTEtMS0w_676b6196-e51b-40f7-902f-1fc61b242127">1,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfMi00LTEtMS0w_a2ebff90-1d06-40b8-af8c-55d65ace32e6">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfMy0yLTEtMS0w_cf77373d-e5c0-4383-adfe-11cb266d793e">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfMy00LTEtMS0w_773b15f4-ad3d-4b52-8854-f8f166953ab4">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="avdl:AccruedTradeDiscountsAndRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNC0yLTEtMS0w_6d21c3f6-f08d-42ac-9f6a-2aff3edd4bc5">821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="avdl:AccruedTradeDiscountsAndRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNC00LTEtMS0w_f8508f3e-9af4-4ac4-9225-c4dbdb3c456e">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsource contract costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="avdl:AccruedOutsourceContractCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNS0yLTEtMS0w_80c6c97f-f83c-4130-9258-1fdc81c22ee8">837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="avdl:AccruedOutsourceContractCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNS00LTEtMS0w_62835ab2-6a89-401d-b970-16bf2a11caee">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNi0yLTEtMS0w_67af0f69-76e9-47d2-a54e-5406cebc9c5c">4,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNi00LTEtMS0w_2d3fb175-e987-4947-aaa6-01bda10253bc">2,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNy0yLTEtMS0w_79d704ed-8235-424f-9895-3526de590bb2">7,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNy00LTEtMS0w_3870e51b-ba8e-4cdd-8722-eba264bb0612">6,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:1pt"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTU0_cf5b9c44-3494-4813-9485-3002eade5334" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="avdl:AccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfMi0yLTEtMS0w_e2528983-7528-4581-a1b6-05fc86a9ed23">2,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="avdl:AccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfMi00LTEtMS0w_ee745943-b42e-4f85-b47d-c494dd242de2">2,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due to Exela</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DueToAffiliateCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfMy0yLTEtMS0w_358389dd-243f-4602-946d-18619b8ffdf1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfMy00LTEtMS0w_f4568ef6-3763-4820-b9c5-75bd13b632c1">2,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="avdl:OtherGuarantorObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNC0yLTEtMS0w_fca6eea5-419b-48b1-98aa-056fb241f0ea">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="avdl:OtherGuarantorObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNC00LTEtMS0w_55f23266-1348-4eef-b055-dad01540a14c">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="avdl:OtherLiabilitiesMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNS0yLTEtMS0w_2cddafd4-59b9-45b3-bbd2-62a4b75092f0">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="avdl:OtherLiabilitiesMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNS00LTEtMS0w_0166d850-9ab2-40f6-9b4d-0814836e63a2">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNi0yLTEtMS0w_234ada92-6c24-45d3-ade0-773189845ea8">3,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNi00LTEtMS0w_d1b1074a-fc35-4eff-963f-6f4b157a4efb">5,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:1pt"><span><br/></span></div><div><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTQ1_86583a95-b191-4102-8e8e-43aa0739b3c0" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfMy0yLTEtMS0w_c96c3278-efc4-4007-83e7-3fa279244d51">3,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfMy00LTEtMS0w_15bd2c96-377d-479d-b364-2343f2ee658d">3,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:GuarantyLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNC0yLTEtMS0w_e35a03b4-dd3e-49da-a9f6-0ffc7cff7aaa">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GuarantyLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNC00LTEtMS0w_c483e8ec-d600-4db4-8dca-50a523005bcc">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" name="us-gaap:OtherLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNS0yLTEtMS0w_19280ab7-b7cd-47d0-8423-a06808d7b532">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" name="us-gaap:OtherLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNS00LTEtMS0w_d8b8eed8-b29b-4f90-be6b-243761e8f409">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNi0yLTEtMS0w_81ff94f1-8f2f-46dd-8b31-887aee00c8d7">4,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8983fe897240fb8db372157af242b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNi00LTEtMS0w_6efac3c0-9c3e-4536-bc1e-b630a9ebf907">4,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_73"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12: <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfMTY4Nw_bf649181-a903-4a27-b742-e1248044681a" continuedAt="i7ca2c10765b9449a9c858c877fddae4e" escape="true">Restructuring Costs</ix:nonNumeric></span></div><ix:continuation id="i7ca2c10765b9449a9c858c877fddae4e" continuedAt="i11d8f1c59af54471adc5b86bab3b66da"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 French Restructuring</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2019, the Company initiated a plan to substantially reduce all of its workforce at its V&#233;nissieux, France site (&#8220;2019 French Restructuring&#8221;).  This reduction was part of an effort to align the Company&#8217;s cost structure with our ongoing and future planned projects. The reduction in workforce was completed during 2020. Restructuring (income) charges associated with this plan recognized during the three and six months ended June&#160;30, 2021 and 2020 were immaterial. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 20 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i11d8f1c59af54471adc5b86bab3b66da" continuedAt="i60fb9cd7bcdb4b0b8eec08db560b7f79"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfMTY5Mg_e607b8f5-09fe-4ea8-adda-3abcd9b68a9e" continuedAt="i67c4ae207e35438c8717df3fffa77a70" escape="true"><div style="margin-bottom:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s cost reduction plan obligations for the six months ended June&#160;30, 2021:</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.913%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 French Restructuring Obligation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e8c3ff2db154d098fe60070506408f1_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfMi0yLTEtMS0w_d067104f-f38e-4220-8c27-b5dc4cdb721f">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03b1e76537a34ed8ae22e6fcbd623ceb_D20210101-20210630" decimals="-3" sign="-" name="avdl:RestructuringChargesBeforeGainLossDuetoCurtailment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfMy0yLTEtMS0w_bf4a4584-c352-45dd-bef3-e2cdea647b92">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a57a5a305f43858278dcd059cbe0d2_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfNC0yLTEtMS0w_edf84839-400f-404a-91d5-73ebbe1bb0f3">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a57a5a305f43858278dcd059cbe0d2_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfNS0yLTEtMS0w_ad926463-94fd-45e1-8e2b-f887ced8b853">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at June 30, </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id82ee84d494f49a1aa77a11e88225b6d_I20210630" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfNi0yLTEtMS0w_4a106fc1-fd91-4d06-8355-f7e9c8dde9bf">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 French Restructuring liabilities of $<ix:nonFraction unitRef="usd" contextRef="id82ee84d494f49a1aa77a11e88225b6d_I20210630" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfMzg0ODI5MDY5ODk1NA_4a106fc1-fd91-4d06-8355-f7e9c8dde9bf">107</ix:nonFraction> are included in the unaudited condensed consolidated balance sheet in accrued expenses at June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Corporate Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, the Company announced a plan to reduce its Corporate workforce by more than <ix:nonFraction unitRef="number" contextRef="i35238f47c33b4c629f04849c139b24b6_I20190331" decimals="2" name="avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfOTQx_f036d0d9-e9b3-42a3-969a-b399ca25d992">50</ix:nonFraction>% (&#8220;2019 Corporate Restructuring&#8221;). The reduction in workforce is primarily a result of the exit of Noctiva during the first quarter of 2019, as well as an effort to better align the Company&#8217;s remaining cost structure at our U.S. and Ireland locations with our ongoing and future planned projects. The reduction in workforce was completed during 2020. The restructuring charges associated with this plan recognized during the six months ended June&#160;30, 2021 and 2020 were immaterial.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i67c4ae207e35438c8717df3fffa77a70"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s cost reduction plan obligations for the six months ended June&#160;30, 2021:</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.428%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 Corporate Restructuring Obligation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ddd0a37b8ed4590bc03f9c4c94308ad_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOjQ4N2I4MDRkMGMzYjQ5YWU4OTFmYTg2MzQ4ODEzZGNjL3RhYmxlcmFuZ2U6NDg3YjgwNGQwYzNiNDlhZTg5MWZhODYzNDg4MTNkY2NfMi0yLTEtMS0w_fb84305c-a8c1-4fe2-9e46-314e9b46e99d">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ce335e1f12437bbd48bf21a9f38150_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="avdl:RestructuringChargesBeforeGainLossDuetoCurtailment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOjQ4N2I4MDRkMGMzYjQ5YWU4OTFmYTg2MzQ4ODEzZGNjL3RhYmxlcmFuZ2U6NDg3YjgwNGQwYzNiNDlhZTg5MWZhODYzNDg4MTNkY2NfMy0yLTEtMS0w_51011a7a-fe3d-44bd-b813-e8be5befa0cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecc1f49f09f748ce80b8c92a2ec072a3_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOjQ4N2I4MDRkMGMzYjQ5YWU4OTFmYTg2MzQ4ODEzZGNjL3RhYmxlcmFuZ2U6NDg3YjgwNGQwYzNiNDlhZTg5MWZhODYzNDg4MTNkY2NfNC0yLTEtMS0w_eda785f7-5d51-41c4-8dcd-595120e6ed66">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at June 30, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb7c2b0fb5945538e9a6a089566898e_I20210630" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOjQ4N2I4MDRkMGMzYjQ5YWU4OTFmYTg2MzQ4ODEzZGNjL3RhYmxlcmFuZ2U6NDg3YjgwNGQwYzNiNDlhZTg5MWZhODYzNDg4MTNkY2NfNi0yLTEtMS0w_ac6a47d4-ad20-48ed-a66d-f6a7cc3c9111">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i60fb9cd7bcdb4b0b8eec08db560b7f79">The 2019 Corporate Restructuring liabilities of $<ix:nonFraction unitRef="usd" contextRef="i8fb7c2b0fb5945538e9a6a089566898e_I20210630" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfMTU4OQ_ac6a47d4-ad20-48ed-a66d-f6a7cc3c9111">70</ix:nonFraction> are included in the unaudited condensed consolidated balance sheet in accrued expenses at June&#160;30, 2021.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_76"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMjEwMw_03906b15-0e0d-403f-959f-0f8395e2f15e" continuedAt="id3d8e1a4bdf6416ebd9f57855e81dab8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><ix:continuation id="id3d8e1a4bdf6416ebd9f57855e81dab8" continuedAt="i58bab53ad5b64086a7b8466d0c098de5"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of shares outstanding during each period. Diluted net (loss) income per share is calculated by dividing net (loss) income - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net (loss) income, diluted net (loss) income per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of our preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under our employee stock purchase plan (&#8220;ESPP&#8221;). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. We utilize the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of our ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under our ESPP has been calculated using the treasury stock method.  The dilutive effect of the performance share units (&#8220;PSUs&#8221;) will be calculated using the treasury stock method, if and when the contingent vesting condition is achieved. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 21 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i58bab53ad5b64086a7b8466d0c098de5" continuedAt="ieadbdd6fdf504829bf1344e9c9d70214"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMjEwMQ_af4f4069-e7a0-417f-b4df-a48b3c2dfff8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands is as follows:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (Loss) Income Per Share:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMy0yLTEtMS0w_be44abe6-38da-4a7b-a6ad-c66c917414d3">19,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMy00LTEtMS0w_00a2f95b-4b7e-41a7-af31-8ea253d06c88">30,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMy02LTEtMS0w_f7a32062-9151-4e1f-86df-a35bec5a0a1d">33,026</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMy04LTEtMS0w_d998c12e-c7fa-45df-8da5-17e768d72a21">30,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: interest from 2023 Notes, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNC0yLTEtMS0w_6ee4ac5a-73fc-4368-96a9-52b9a426faa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNC00LTEtMS0w_cd56b288-780b-43ab-83b7-786508f9b76e">3,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNC02LTEtMS0xMTYz_33f5234a-9d9d-4844-8091-684d47d30fdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNC04LTEtMS0w_8388f3e8-2359-47c2-ba62-c63638267318">6,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNS0yLTEtMS0w_5b561867-f1ef-46b6-9429-d7dfb23555aa">19,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNS00LTEtMS0w_43b4bd78-0b98-4b84-a8db-30c067cd17de">34,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNS02LTEtMS0w_f22cfbb0-eb66-4c0c-86e2-221c61387087">33,026</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNS04LTEtMS0w_414a1924-0afc-4fd5-b375-17612dd02212">36,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOC0yLTEtMS0w_6c1a549d-056e-429f-b00f-c83b035d0330">58,488</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOC00LTEtMS0w_f7fceb18-78cd-469a-8124-4d17cccefa16">54,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOC02LTEtMS0w_8fb76ee1-a630-458d-8d50-37f2ff64a29a">58,465</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOC04LTEtMS0w_0bed3a9b-088a-49ca-a98d-203c6e44a67e">47,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOS0yLTEtMS0w_f2717090-6619-4de4-bb5b-3f7e1796d213">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOS00LTEtMS0w_32289054-04da-4046-aecf-e9aedc5deea2">15,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOS02LTEtMS0w_81009e6e-8608-4bc8-8d92-5bcc4af6f160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOS04LTEtMS0w_3b2a9a36-fcf3-489e-ad8d-812123b32fcc">15,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTEtMi0xLTEtMA_60e5bc03-89e0-4727-ae02-a344059e17d9">58,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTEtNC0xLTEtMA_e417c68c-83ac-4a62-b001-585d7738cb4e">69,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTEtNi0xLTEtMA_57765d02-ab44-4b74-acf6-1f29b5aa8591">58,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTEtOC0xLTEtMA_e28ac080-a36b-4d07-8177-57ba5be3f268">63,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTMtMi0xLTEtMA_f73da056-e8d4-41ed-b11a-459342ecddb9">0.33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTMtNC0xLTEtMA_e297260e-753f-4b31-9712-999ab113f0a0">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTMtNi0xLTEtMA_d445187e-da52-41ac-9ebb-f920929401b6">0.56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTMtOC0xLTEtMA_6f5c0ace-3bfe-4eca-af26-c128af49ad01">0.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTQtMi0xLTEtMA_898d8a1e-882c-46fc-b5ab-aac7aaecc7d6">0.33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTQtNC0xLTEtMA_c7d83318-a28c-4017-a90a-bb31c91ba5fd">0.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTQtNi0xLTEtMA_e091bbd2-cec1-4ef8-8ac7-8e327e5c6b87">0.56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTQtOC0xLTEtMA_cddb2c67-c483-44b8-a691-23cab2240f4e">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieadbdd6fdf504829bf1344e9c9d70214">Potential ordinary shares of&#160;<ix:nonFraction unitRef="shares" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMTYwNw_ebfc0a01-f2cd-4b69-902f-3cc451b1bad7">15,586</ix:nonFraction>&#160;and&#160;<ix:nonFraction unitRef="shares" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMTYxNA_51dee93f-3cd4-4fe9-b41f-00b79b86ff9e">2,472</ix:nonFraction>&#160;were excluded from the calculation of weighted average shares for the three months ended June&#160;30, 2021 and 2020, respectively, and potential ordinary shares of&#160;<ix:nonFraction unitRef="shares" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMTA5OTUxMTYzMDEzNw_39489ad2-2ae8-4679-b551-e30d8491a8fd">15,426</ix:nonFraction>&#160;and&#160;<ix:nonFraction unitRef="shares" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMTA5OTUxMTYzMDE5OQ_c3ce4541-564f-45f3-9485-150c6233b96b">2,537</ix:nonFraction>&#160;were excluded from the calculation of weighted average shares for the six months ended June&#160;30, 2021 and 2020, respectively, because either their effect was considered to be anti-dilutive or they were related to shares from PSUs for which the contingent vesting condition had not been achieved. For the three and six months ended June&#160;30, 2021, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in these periods.</ix:continuation>&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_79"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RleHRyZWdpb246MWNkNTg4NWNhMjRiNDFhNGE4MmVlYjM2OTliM2UyZGVfMzg1_b64da03d-e60b-4a8d-b702-4e4354c16275" continuedAt="if8d78308319c41dca682aa586f25f804" escape="true">Comprehensive Loss&#160;</ix:nonNumeric></span></div><ix:continuation id="if8d78308319c41dca682aa586f25f804"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RleHRyZWdpb246MWNkNTg4NWNhMjRiNDFhNGE4MmVlYjM2OTliM2UyZGVfMzg5_9c0bfa0f-c537-40d5-8fb0-e7b0d187b8c2" escape="true"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the three and six months ended June&#160;30, 2021 and 2020, respectively, net of tax effects:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76a5acc12ee8481593b5f580d0c6acce_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNC0yLTEtMS0w_1b203df7-714e-4193-8c3c-436f4164f8fc">23,345</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2a319b7a49041b68e1f28bc975ffd5f_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNC00LTEtMS0w_656b0e8d-0a8a-4f79-bf1e-dade55c1556f">23,915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c6b3a49597d4114b95a4bce60988c0c_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNC02LTEtMS0w_68bf1f1a-d726-4498-8add-8ff4f957f4e4">22,627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02d0a6c7d54a44ae842a997b5e95ed2b_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNC04LTEtMS0w_85f447ee-22de-4065-aa16-948a1a47efcd">23,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1958fec3b1b4189a3494df42bf89998_D20210401-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNS0yLTEtMS0w_b8b5f917-029b-4534-9088-4d3ed4975a7d">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b5b7cd948cf83baaf96787cecc8_D20200401-20200630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNS00LTEtMS0w_c80d3e97-dc53-4ded-ab8a-2ff95449f780">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50064db877274880a1811d0f859ad19d_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNS02LTEtMS0w_44a0b0fb-0733-488e-ab9e-dd185c3dfada">602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7c4417a3344d92bec61dc810fc930e_D20200101-20200630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNS04LTEtMS0w_c89dfb6c-f573-4a43-a495-29ae5e173c40">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79d6697ec0004a62b02bcf4f6ceb19aa_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNi0yLTEtMS0w_d0479820-6637-4729-b0d3-1af93dc232ed">23,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b7b480e1084f46848cd8804e33cf56_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNi00LTEtMS0w_54b4fd1c-1a5c-4067-b643-0ec26a488cc4">23,733</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79d6697ec0004a62b02bcf4f6ceb19aa_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNi02LTEtMS0w_17a37809-6415-45fd-9437-3665bca1ddf4">23,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b7b480e1084f46848cd8804e33cf56_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNi04LTEtMS0w_3ba581d1-e91b-41d0-8617-c3ea1e7fcb3e">23,733</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain on marketable debt securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd3b0844231a4d02b15483cd3bc9cdd0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfOS0yLTEtMS0w_3351772c-b286-4ac8-b0bb-237326441e32">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea06e402349946f6b73a2366c3ff8a04_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfOS00LTEtMS0w_61e491e1-3914-4cc3-aa86-64fad314f242">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6ddfbe329ea4b859226b9d1e4159bbe_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfOS02LTEtMS0w_4470d49b-8df9-4406-aad4-7c4b3a2cf5bf">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ecf22fe804f4dffa050dc87558edfb6_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfOS04LTEtMS0w_9e3428af-8aef-4d91-a5b2-cc19b4e6c444">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income, net of $(<ix:nonFraction unitRef="usd" contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjljMjBlMjQxYzk0ZTQxNjFhZGY3MDFkZmIwNDU2NmRkXzEwOTk1MTE2Mjc4NDY_407ccac9-deb9-4224-838c-5fe692cb9753">78</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjljMjBlMjQxYzk0ZTQxNjFhZGY3MDFkZmIwNDU2NmRkXzEwOTk1MTE2Mjc4NTM_525364d7-b037-4fc4-bb74-b62282e494f5">81</ix:nonFraction>)  $(<ix:nonFraction unitRef="usd" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjljMjBlMjQxYzk0ZTQxNjFhZGY3MDFkZmIwNDU2NmRkXzQy_18b4c151-0c20-4283-b277-19273133432e">133</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjljMjBlMjQxYzk0ZTQxNjFhZGY3MDFkZmIwNDU2NmRkXzQ5_f84ceaf4-0cf8-43b0-8aef-ae05cca052dd">130</ix:nonFraction>) tax, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4e61467debc48beaa50fd50ce036c21_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMi0xLTEtMA_61915121-b419-4efa-8615-b6f59f5c6066">160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f91b0f2c8834815aac6916157b00fa5_D20200401-20200630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtNC0xLTEtMA_2de45e9f-311f-498c-aabe-c60a5088afbf">927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbba85bbb98c4e4fb64a84c0ec71d0a1_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtNi0xLTEtMA_d3676ba6-85d9-4406-9efc-7cdb02c1e38c">697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida13d64b815a426bbd81a3c5e429675b_D20200101-20200630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtOC0xLTEtMA_0377b9de-03ed-4f8e-baa5-56cc1f472083">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12d4cd39de345ecb292ceaccf92a42e_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTEtMi0xLTEtMA_20a64ead-3375-4477-8b52-0cfda5823898">879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4746ea4b2111416cbd83562dad4e70a7_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTEtNC0xLTEtMA_08a6a2dc-49e1-44d9-a535-c1ae018379eb">1,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12d4cd39de345ecb292ceaccf92a42e_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTEtNi0xLTEtMA_a92b1e4a-af56-432d-ad16-0c6071583ff7">879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4746ea4b2111416cbd83562dad4e70a7_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTEtOC0xLTEtMA_52311bd9-b6fc-4fac-b3b2-739c2164bdbf">1,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25507beaf94543b3ac989067fe8f70f6_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTItMi0xLTEtMA_9cda3fe9-bced-4c5f-9b40-1f7916a7f196">22,350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a929bcc21e485a9d7ab75296127ff8_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTItNC0xLTEtMA_46f167d9-f863-4b41-80b7-6fb2860d2232">22,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25507beaf94543b3ac989067fe8f70f6_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTItNi0xLTEtMA_ced603bb-100c-430d-9efa-ccf53850606e">22,350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a929bcc21e485a9d7ab75296127ff8_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTItOC0xLTEtMA_21131c14-7c57-4931-b953-07e8651d2cc5">22,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on the Company&#8217;s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_82"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RleHRyZWdpb246ZmVmM2MwOTQ0YTYwNGUzZThlOWRlZTBhNTRkMTcyM2JfOTE2_d4eda6c2-adb6-4694-9ef8-17a8387b091a" continuedAt="ib798f90c737442a38dfa17ec1e21e391" escape="true">Revenue by Product&#160;</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib798f90c737442a38dfa17ec1e21e391" continuedAt="ic978f6ffa6a148b8838f96951adf30f0">The Company has determined that it operates in <ix:nonFraction unitRef="segment" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RleHRyZWdpb246ZmVmM2MwOTQ0YTYwNGUzZThlOWRlZTBhNTRkMTcyM2JfODE_1b5624e8-e1e9-4efd-a58e-84e32a4765d1">one</ix:nonFraction> segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on our proprietary polymer based technology. The Company&#8217;s Chief Operating Decision Maker is the Chief Executive Officer (the &#8220;CEO&#8221;). The CEO reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions as well as resource allocations. All products were included in <ix:nonFraction unitRef="segment" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RleHRyZWdpb246ZmVmM2MwOTQ0YTYwNGUzZThlOWRlZTBhNTRkMTcyM2JfNTM5_da4b555c-fb73-40dc-a749-54a4f74bacfb">one</ix:nonFraction> segment because the Company&#8217;s products have similar economic and other characteristics, including the nature of the products and production processes, type of customers, distribution methods and regulatory environment.&#160;</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 22 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic978f6ffa6a148b8838f96951adf30f0" continuedAt="if98bfba6ccb34d45a67cbbf18c29a63b"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, we sold the Hospital Products. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. <ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RleHRyZWdpb246ZmVmM2MwOTQ0YTYwNGUzZThlOWRlZTBhNTRkMTcyM2JfOTIw_81c0d5df-dbae-4867-84c6-83c7df94424e" continuedAt="i084cff24e5b441d6884c50ac9a50addd" escape="true">The following table presents a summary of total product sales by these products:&#160;</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i084cff24e5b441d6884c50ac9a50addd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product Sales by Product:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bloxiverz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia015e8c7039f4253bf52fccb4e8ecb8c_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfMy00LTEtMS0w_e86d2d0e-4a76-4a18-b14c-bb1dd6e15308">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i549d337037a54337b23be1da5fc95857_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfMy04LTEtMS0w_7d58d2b2-2f13-414f-8613-192ab9a1e9b0">2,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vazculep</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98b6eab8d7b044f4b52fe5bb3feedf68_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNC00LTEtMS0w_32b1c50a-1e3d-4251-83dc-a7a9b9bd2094">4,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie747eb99af0f45f29bf4b24a2ba6c818_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNC04LTEtMS0w_a6a8a28b-d2a7-41a1-a81a-714c02d3a8a9">10,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Akovaz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8aa4c10c714d95a93ab30edbd0f6ac_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNS00LTEtMS0w_fbfe4e2d-3bfb-4600-873b-bede655792e9">4,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00da774065cf477491a056a3df163b4b_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNS04LTEtMS0w_b2c2b51d-6d7e-457a-ad19-f11dc552e355">9,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfc69dd306e94f2b91c2cea091afefa7_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNy00LTEtMS0w_f848401c-11c6-4d99-8c65-2d12d4ae07a7">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i636d00926a694de8b3a2561a4bd15037_D20200101-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNy04LTEtMS0w_8fc107c1-73df-4385-8e98-767ec41dd712">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfOC00LTEtMS0w_50fc565e-ecab-4168-9380-9064aee53b90">10,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfOC04LTEtMS0w_712a04cf-d241-457a-8c8e-bb92c023bd8a">22,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="if98bfba6ccb34d45a67cbbf18c29a63b" continuedAt="i797a1223489d4e4f8e237d3925d08fc8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, we sold the Hospital Products.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i797a1223489d4e4f8e237d3925d08fc8">.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_85"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMjU2Mw_daedd535-3b60-4595-9908-19bec47e340f" continuedAt="iae7bb3dc443e4ed2a3c2e81a48225c68" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><ix:continuation id="iae7bb3dc443e4ed2a3c2e81a48225c68" continuedAt="i5e428e29be514d7691e0439e99f79eda"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation &#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to potential liabilities generally incidental to our business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At June 30, 2021 and December 31, 2020, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#8217;s unaudited condensed consolidated financial position, results of operations, cash flows or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#8220;Jazz&#8221;) filed a formal complaint (the &#8220;Complaint&#8221;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#8220;Court&#8221;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#8220;Avadel Parties&#8221;). In the Complaint, Jazz alleges the sodium oxybate product (&#8220;Proposed Product&#8221;) described in the New Drug Application (&#8220;NDA&#8221;) owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#8220;patents-in-suit&#8221;). The Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Avadel Answer&#8221;) with the Court in response to the Complaint.  The Avadel Answer generally denies the allegations set forth in the Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, ii) a declaratory judgment of invalidity of each patent-in-suit, and iii) a declaratory judgement requiring delisting of US Patent No. 8731963 from FDA&#8217;s Orange Book. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, Jazz filed its Answer (&#8220;Jazz Answer&#8221;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#8217;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a preliminary injunction hearing date of November 23, 2021 (only relevant in the event that Jazz files a motion for a preliminary injunction by October 22, 2021), ii) a claim construction hearing date of August 2, 2022, and iii) a trial date of October 30, 2023.   </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, Jazz filed another formal complaint (the &#8220;Second Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11077079. The Second Complaint further includes </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 23 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5e428e29be514d7691e0439e99f79eda"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.&#160; &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Commitments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than commitments disclosed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 17: Contingent Liabilities and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Company's consolidated financial statements included in the 2020 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deerfield Guarantee</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our guarantee to Deerfield and the guarantee received by us from Armistice largely offset and when combined are not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our February 2018 divestiture of our pediatric assets, we guaranteed to Deerfield the quarterly royalty payment of&#160;<ix:nonFraction unitRef="number" contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630" decimals="INF" name="avdl:PercentageOfRoyaltyPayableOnNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMTUxMQ_68ad35ee-bed6-4d5b-8d16-90c17035c097">15</ix:nonFraction>%&#160;on net sales of the FSC products through February 6, 2026 (&#8220;FSC Product Royalties&#8221;), in an aggregate amount of up to approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i0d45c7fb17674e24b40b45929846b8f1_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMTY0NQ_f5ed88fe-7ba8-40ad-b2de-f97cb6dcad41">10,300</ix:nonFraction>.  Given our explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $<ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMTgwMA_66c2e9a8-42c5-43f8-8354-a400e4e60439">1,188</ix:nonFraction> at June&#160;30, 2021.  This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Armistice Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, guaranteed to us the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $<ix:nonFraction unitRef="usd" contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630" decimals="-3" format="ixt:numdotdecimal" name="avdl:GuaranteeAssetCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMjI2OA_4514c0fe-f126-4db6-8f49-da0678a0f4de">1,184</ix:nonFraction> at June&#160;30, 2021.  This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, we did not have any off-balance sheet arrangements, as defined in Item&#160;303(a)(4)(ii) of Regulation S-K.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 24 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND&#160;RESULTS OF OPERATIONS&#160;</span></div><div id="i50b89bc599794eeaa322f99bdef30cea_94"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">You should read the discussion and analysis of our financial condition and results of operations set forth in this Item 2 together with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties, and reference is made to the &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; set forth immediately following the Table of Contents of this Quarterly Report on Form 10-Q for further information on the forward looking statements herein. In addition, you should read the &#8220;Risk Factors&#8221; section in Part I, Item 1A of our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on March 9, 2021 and Part II, Item 1A in this Quarterly Report on Form 10-Q for a discussion of additional important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis and elsewhere in this Quarterly Report.</span></div><div id="i50b89bc599794eeaa322f99bdef30cea_97"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. Our lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#8220;EDS&#8221;) and cataplexy in adults with narcolepsy. We are primarily focused on the development and potential United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of FT218. In December 2020, we submitted a New Drug Application (&#8220;NDA&#8221;) to the FDA for FT218 to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The NDA for FT218 was accepted by the FDA in February 2021 and assigned a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) target action date of October 15, 2021. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of our lead product candidate, we continue to evaluate opportunities to expand our product portfolio. As of June 30, 2021, we do not have any approved and commercialized products in our portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218 is a once-nightly formulation of sodium oxybate that uses our Micropump controlled release drug-delivery technology for the treatment of EDS and cataplexy in adults suffering from narcolepsy. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Sodium oxybate is approved in the U.S. for the treatment of EDS and cataplexy in patients with narcolepsy and is approved in Europe for the treatment of cataplexy in patients with narcolepsy. Since 2002, sodium oxybate has only been available as a formulation that must be taken twice nightly, first at bedtime, and then again 2.5 to 4 hours later.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, we announced the submission of our NDA to the FDA for FT218. On February 26, 2021, the FDA notified us of formal acceptance of the NDA with an assigned PDUFA target action date of October 15, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted a Phase 3 clinical trial of FT218, the REST-ON trial, which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient, last visit was completed at the end of the first quarter of 2020 and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-nightly FT218, the highest dose administered in the trial, demonstrated a statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test, or MWT, clinical global impression-improvement, or CGI-I, and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g also demonstrated a statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-nightly FT218 to be generally well tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence 3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of FT218 discontinued the trial due to adverse reactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the FDA granted FT218 Orphan Drug Designation, which makes the drug eligible for certain development and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 25 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercial incentives, including potential U.S. market exclusivity for up to seven years. Additionally, several FT218-related U.S. patents have been issued, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), as well as foreign patent offices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced that the first patient was dosed initiating an open-label extension (&#8220;OLE&#8221;)/switch study of FT218 as a potential treatment for EDS and cataplexy in patients with narcolepsy. The OLE/switch study is examining the long-term safety and maintenance of efficacy of FT218 in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-nightly FT218, regardless of whether they participated in REST-ON. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described FT218 improvements in disturbed nocturnal sleep (&#8220;DNS&#8221;), defined in REST-ON as the number of shifts from stages N1, N2, N3, and rapid eye movement (&#8220;REM&#8221;) sleep to wake and from stages N2, N3, and REM sleep to stage N1.  FT218 also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1.  A second poster described the statistically significant improvements in the Epworth Sleepiness Scale, both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at Week 3, for the lowest 6 g dose, compared to placebo. FT218 did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional data supportive of the efficacy findings in REST-ON were presented at the annual meeting of the 35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 or Type 2. Additionally, a post-hoc analysis showed that FT218 was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe FT218 has the potential to demonstrate improved dosing compliance, safety and patient satisfaction over the current standard of care for EDS and cataplexy in patients with narcolepsy, which are twice-nightly oxybate formulations. If approved, we believe FT218 has the potential to take a significant share of the oxybate market. The current market size for the twice-nightly administration of oxybate products is an estimated $1.8 billion annually.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Micropump Drug-Delivery Technology</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Micropump drug-delivery technology allows for the controlled delivery of small molecule drugs taken orally, which has the potential to improve dosing compliance, reduce toxicity and improve patient compliance. Beyond FT218, we believe there could be other product development opportunities for our Micropump drug-delivery technology, representing either life cycle opportunities, whereby additional intellectual property can be added to a pharmaceutical product to extend the commercial viability of a currently marketed product, or innovative formulation opportunities for new chemical entities.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Previously Approved FDA Products</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, we announced the sale of our portfolio of sterile injectable drugs used in the hospital setting (the &#8220;Hospital Products&#8221;), including our three commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to Exela Sterile Medicines LLC (&#8220;Exela Buyer&#8221;).  This sale included the following FDA approved products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Bloxiverz (neostigmine methylsulfate injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -&#160;Bloxiverz is a drug used intravenously in the operating room to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Vazculep (phenylephrine hydrochloride injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -&#160;Vazculep is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Akovaz (ephedrine sulfate injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Akovaz was the first FDA approved formulation of ephedrine sulfate, an alpha- and beta- adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Nouress (cysteine hydrochloride injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Nouress is a sterile injectable product for use in the hospital setting to provide parenteral nutrition to neonates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 26 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Information</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an Irish public limited company. Our registered address is at 10 Earlsfort Terrace, Dublin 2, Ireland and our phone number is +353-1-920-1000. We file annual, quarterly and current reports, proxy statements and other documents with the SEC under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Our website is www.avadel.com, where we make available free of charge our reports (and any amendments thereto) on Forms 10-K, 10-Q and 8-K as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. These filings are also available to the public at www.sec.gov. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have five direct wholly-owned subsidiaries: (a) Avadel US Holdings, Inc., (b) Flamel Ireland Limited is an Irish limited company, which conducts business under the name Avadel Ireland, (c) Avadel Investment Company Limited, (d) Avadel Finance Ireland Designated Activity Company and (e) Avadel France Holding SAS. Avadel US Holdings, Inc., a Delaware corporation, is the holding entity of (i) Avadel Specialty Pharmaceuticals, LLC, (ii) Avadel Legacy Pharmaceuticals, LLC, (iii) Avadel Management Corporation, and (iv) Avadel CNS Pharmaceuticals LLC. Avadel Finance Ireland Designated Activity Company is the holding entity of Avadel Finance Cayman Limited. Avadel France Holding SAS is the holding entity of Avadel Research SAS. A complete list of our subsidiaries can be found in Exhibit 21.1 of our Annual Report on Form 10-K filed with the SEC on March 9, 2021.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Business Trends and Highlights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In operating our business and monitoring our performance, we consider a number of performance measures, as well as trends affecting our industry as a whole, which include the following:&#160;</span></div><div style="margin-bottom:9pt;padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Healthcare and Regulatory Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Various health care reform laws in the U.S. may impact our ability to successfully commercialize our products and technologies. The success of our commercialization efforts may depend on the extent to which the government health administration authorities, the health insurance funds in the E.U. Member States, private health insurers and other third-party payers in the U.S. will reimburse consumers for the cost of healthcare products and services.</span></div><div style="margin-bottom:9pt;padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Competition and Technological Change</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in the pharmaceutical and biotechnology industry continues to be intense and is expected to increase. We compete with academic laboratories, research institutions, universities, joint ventures, and other pharmaceutical and biotechnology companies, including other companies developing niche branded or generic specialty pharmaceutical products or drug delivery platforms. Furthermore, major technological changes can happen quickly in the pharmaceutical and biotechnology industries. Such rapid technological change, or the development by our competitors of technologically improved or differentiated products, could render our products, product candidates, or drug delivery platforms obsolete or noncompetitive.</span></div><div style="margin-bottom:9pt;padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Pricing Environment for Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The pricing environment continues to be in the political spotlight in the U.S. As a result, the need to obtain and maintain appropriate pricing for pharmaceutical products may become more challenging due to, among other things, the attention being paid to healthcare cost containment and other austerity measures in the U.S. and worldwide.</span></div><div style="margin-bottom:9pt;padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Generics Playing a Larger Role in Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Generic pharmaceutical products will continue to play a large role in the U.S. healthcare system. As such, we expect to see generic competition for our products in the future.</span></div><div style="margin-bottom:9pt;padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Access to and Cost of Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The process of raising capital and associated cost of such capital for a company of our financial profile can be difficult and potentially expensive. If the need were to arise to raise additional capital, access to that capital may be difficult, expensive and/or dilutive and, as a result, could create liquidity challenges for the Company.</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Net Loss from Operations in 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We sold our Hospital Products at June 30, 2020 and no longer generate revenue from sales of these products. We will incur substantial expenses to further the clinical development of and continue our preparations for the commercial launch of FT218, if approved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, we have seen the profound impact that the ongoing coronavirus (&#8220;COVID-19&#8221;) pandemic is having on human health, the global economy and society at large. We have continued to actively monitor the COVID-19 pandemic and have taken measures to mitigate the potential impacts to our employees and business, such as continuing to offer a work from home policy. We believe the impact of COVID-19 and measures to prevent its spread could impact our business in a number of ways, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 27 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including: i) possibly delaying any remaining development activities for FT218, the FDA review timeline of FT218, and/or our ongoing RESTORE open-label extension/switch study, ii) disruptions to our supply chain and third parties; and iii) requiring our employees to work from home for an extended period of time. An extended period of global supply chain and economic disruption could materially affect our business, results of operations, access to sources of liquidity and financial condition.  Despite progress in vaccination efforts, future developments and impact on our operations remain uncertain and cannot be predicted with confidence, including the duration of the COVID-19 pandemic, new strains of the virus, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or we, may direct, which may result in extending continued business disruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Highlights</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Highlights of our consolidated results for the three and six months ended June&#160;30, 2021 are as follows:&#160;</span></div><div style="margin-bottom:9pt;padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue was $0 for the three and six months ended June&#160;30, 2021, compared to $10,091 and $22,334 in the same periods last year, respectively. The year over year decrease was the result of the sale of the Hospital Products on June 30, 2020.</span></div><div style="margin-bottom:9pt;padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating loss was $21,936 and $36,747 for the three and six months ended June&#160;30, 2021, respectively, compared to operating income of $40,269 and $33,772 and for the same periods last year, respectively. The operating income for the three and six months ended June 30, 2020 was driven by sale of the Hospital Products on June 30, 2020.</span></div><div style="margin-bottom:9pt;padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net loss was $19,581 and $33,026 for the three and six months ended June&#160;30, 2021, respectively, compared to net income of $30,874 and $30,009 in the same period last year, respectively.</span></div><div style="margin-bottom:9pt;padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted net loss per share was $(0.33) and $(0.56) for the three and six months ended June&#160;30, 2021, respectively, compared to diluted net income per share of $0.49 and $0.58 in the same period last year, respectively.</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cash and marketable securities decreased $18,559 to $202,843 at June&#160;30, 2021, from $221,402 at December&#160;31, 2020. This decrease was driven by $33,566 of cash used in operations during the six months ended June 30, 2021, partially offset by $16,500 of installment proceeds received from the disposition of the Hospital Products. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_100"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. To prepare these financial statements, management makes estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosures of contingent assets and liabilities. Actual results could be significantly different from these estimates.&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are described in Note 1 of the audited consolidated financial statements included in our Annual Report Form 10-K for the year ended December 31, 2020 (the &#8220;2020 Form 10-K&#8221;). The SEC suggests companies provide additional disclosure on those accounting policies considered most critical. The SEC considers an accounting policy to be critical if it is important to our financial condition and results of operations and requires significant judgments and estimates on the part of management in its application. Our estimates are often based on complex judgments, probabilities and assumptions that management believes to be reasonable, but that are inherently uncertain and unpredictable. It is also possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alternative estimated amounts. For a complete discussion of our critical accounting policies, see the &#8220;Critical Accounting Policies&#8221; section of the Management&#8217;s Discussion &amp; Analysis in our 2020 Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_103"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 28 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial results (in thousands, except per share amounts) for the&#160;three&#160;months ended&#160;June&#160;30, 2021&#160;and&#160;2020, respectively:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comparative Statements of (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,091)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(918)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense (income)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,178)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating (loss) income </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,936)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(154.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,930)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from release of certain liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense - changes in fair value of contingent consideration payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss) income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,346)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,166&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,512)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (benefit) expense </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,765)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,581)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,455)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(163.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.49&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.82)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(167.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 29 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial results (in thousands, except per share amounts) for the&#160;six&#160;months ended&#160;June&#160;30, 2021&#160;and&#160;2020, respectively:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comparative Statements of (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,742)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring (income) costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(129.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense (income)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,438)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,185&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating (loss) income </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,747)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,519)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(208.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,427)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from release of certain liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense - changes in fair value of contingent consideration payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(435)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss) income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,398)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,189)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(252.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,372)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,218)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,154)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,026)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,035)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(210.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(196.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020 (&#8220;Closing Date&#8221;), we announced the sale of the Hospital Products, including our three commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to the Exela Buyer. As a result of the sale, the Company no longer recorded revenue, cost of products, intangible amortization and changes to the fair value of the contingent consideration related to these products subsequent to the Closing Date.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Research and Development Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses increased&#160;$2,705&#160;or&#160;66.7%&#160;during the&#160;three&#160;months ended&#160;June&#160;30, 2021&#160;as compared to the same period in 2020. This increase was driven by increased pre-NDA approval activities, primarily the purchase of raw materials in preparation for product launch, if FT218 is approved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Research and Development Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased&#160;$1,027&#160;or&#160;10.7%&#160;during the&#160;six&#160;months ended&#160;June&#160;30, 2021&#160;as compared to the same period in 2020. This increase was driven by higher pre-NDA approval activities, primarily the purchase of raw materials in preparation for product launch, if FT218 is approved, during the current period, partially offset by lower clinical studies expense due to the completion of the FT218 clinical study during the six months ended June 30, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 30 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Selling, General and Administrative Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Selling, general and administrative (&#8220;SG&amp;A&#8221;) expenses increased&#160;$8,079&#160;or&#160;113.9%&#160;during the&#160;three&#160;months ended&#160;June&#160;30, 2021&#160;as compared to the same prior year period, driven by the Company&#8217;s continued commercial preparations and launch readiness activities for potential approval of FT218. These activities included an increase in marketing and market research costs of approximately $3,000 and an increase in other launch planning and preparation activities totaling $1,400. Compensation costs increased by approximately $2,100 due to an increase in headcount, primarily in commercial and medical affairs, and legal and insurance costs increased by approximately $1,400.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Selling, General and Administrative Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses increased&#160;$11,178&#160;or&#160;74.5%&#160;during the&#160;six&#160;months ended&#160;June&#160;30, 2021&#160;as compared to the same prior year period, driven by the Company&#8217;s continued commercial preparations and launch readiness activities for potential approval of FT18. These activities included an increase in marketing and market research activities of approximately $3,800, and an increase in other launch planning and preparation activities totaling approximately $2,300. Compensation costs increased by approximately $3,200 due to an increase in headcount, primarily in commercial and medical affairs. Legal and insurance costs increased by approximately $2,500, which was offset by a decrease in other professional fees of approximately $400. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investment and Other Income (Expense), net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment and other income (expense), net increased for the three months ended June&#160;30, 2021 when compared to the same period in the prior year driven by an $800 legal settlement related to a bankruptcy claim recognized in the prior period and higher interest income of approximately $400 in the current period. </span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investment and Other Income (Expense), net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment and other income (expense), net increased for the six months ended June&#160;30, 2021 when compared to the same period in the prior year driven by an $800 legal settlement related to a bankruptcy claim recognized in the prior period, higher interest income of approximately $500, lower realized losses on our marketable securities of approximately $500 and higher foreign currency gains of approximately $400.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 31 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of $1,930 and $3,237 for the three months ended&#160;June&#160;30, 2021 and 2020, respectively, is related to interest on the 2023 Notes. Included in these amounts are coupon interest expense of $1,617 for each period and the amortization of debt issuance costs of $313 and $250 for the three months ended&#160;June&#160;30, 2021 and 2020, respectively. Prior period interest expense also included amortization of a debt discount of $1,370, which was eliminated upon our adoption of ASU 2020-06.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9: Long Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements included in Part 1, Item 1 of this Quarterly Report on Form 10-Q for further details for further details. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,568)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of $3,859 and $6,427 for the six months ended&#160;June&#160;30, 2021 and 2020, respectively, is related to interest on the 2023 Notes. Included in these amounts are coupon interest expense of $3,234 for each period and the amortization of debt issuance costs of $625 and $495 for the six months ended&#160;June&#160;30, 2021 and 2020, respectively. Prior period interest expense also included amortization of a debt discount of $2,698, which was eliminated upon our adoption of ASU 2020-06.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9: Long Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements included in Part 1, Item 1 of this Quarterly Report on Form 10-Q for further details for further details. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Tax (Benefit) Provision:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (benefit) provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,057)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Percentage of (loss) income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The income tax benefit was $3,765 for the three months ended June&#160;30, 2021 resulting in an effective tax rate of 16.1%. The income tax provision was $5,292 for the three months ended June 30, 2020 resulting in an effective tax rate of 14.6%. The income tax expense recorded in 2020 was the result of taxes recorded on the gain from the sale of the Hospital Products.</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Tax (Benefit) Provision:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (benefit) provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Percentage of (loss) income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit was $6,372 for the six months ended June&#160;30, 2021 resulting in an effective tax rate of 16.2%. The income tax benefit was $4,218 for the six months ended June 30, 2020 resulting in an effective tax rate of (16.4)%. The net increase in the effective income tax rate for the six months ended June 30, 2021 as compared to the prior period in 2020 is primarily due to the discrete tax benefits recognized during the six months ended June 30, 2020 under the Coronavirus Aid, Relief and Economic Security Act, also known as the CARES Act, which did not occur during the six months ended June 30, 2021. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 32 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash flows from operating, investing and financing activities, as reflected in the unaudited condensed consolidated statements of cash flows, are summarized in the following table:&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash (used in) provided by:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,662)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179,367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $33,566 and $19,417 for the six months ended June&#160;30, 2021 and 2020, respectively. Net cash used in operating activities for the six months ended June 30, 2021 was driven by net loss for the period and higher prepaid expenses due to the payment of annual insurance premiums, partially offset by cash received during the period related to research and development tax credits. Net cash used in operating activities for the six months ended June 30, 2020 was due to lower accounts payable, accrued expenses and other liabilities, and cash paid related to the earn-out and royalty payments for contingent consideration. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities was $29,315 for the six months ended June 30, 2021 and cash used in investing activities was $67,662 for the six months ended June 30, 2020.  Net cash provided by investing activities for the six months ended June&#160;30, 2021 was driven by proceeds from the disposition of the Hospital Products of $16,500, as well as higher net proceeds received from the excess of sales over purchases of marketable securities of $12,841.  Net cash used in investing activities for the six months ended June 30, 2020 was driven by higher net purchases of marketable securities of $82,162, partially offset by the proceeds from the disposition of the Hospital Products of $14,500.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the six months ended June&#160;30, 2021 was $149 related to proceeds from stock option exercises and employee stock purchase plan (&#8220;ESPP&#8221;) issuances. Net cash provided by financing activities for the six months ended June 30, 2020 of $179,516 is driven by the February 2020 private placement and May 2020 public offering that resulted in net proceeds of $60,639 and $116,974, respectively, as well as stock option exercises and ESPP issuances of $1,903.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Risk Management&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adequacy of our cash resources depends on the outcome of certain business conditions including the cost of our FT218 clinical development plan, our cost structure, and other factors set forth in &#8220;Risk Factors&#8221; within Part I, Item 1A of the 2020 Form 10-K.  To complete the FT218 clinical development and commercialization plan we will need to commit substantial resources, which could result in future losses or otherwise limit our opportunities or affect our ability to operate our business. Our assumptions concerning the outcome of certain business conditions may prove to be wrong or other factors may adversely affect our business, and as a result we could exhaust or significantly decrease our available cash and marketable securities balances which could, among other things, force us to raise additional funds and/or force us to reduce our expenses, either of which could have a material adverse effect on our business. Additionally, we are unable to estimate the near or long term impact of COVID-19, which may have a material adverse impact on our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If available to us, raising additional capital may be accomplished through one or more public or private debt or equity financings, collaborations or partnering arrangements.  Any equity financing would be dilutive to our shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalent and marketable security balances as of June&#160;30, 2021 and unused financing sources are expected to provide us with the flexibility to meet our liquidity needs in 2021, including its operating requirements related to the development of FT218.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 33 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_109"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation &#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to potential liabilities generally incidental to our business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At June 30, 2021 and December 31, 2020, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#8217;s unaudited condensed consolidated financial position, results of operations, cash flows or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#8220;Jazz&#8221;) filed a formal complaint (the &#8220;Complaint&#8221;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#8220;Court&#8221;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#8220;Avadel Parties&#8221;). In the Complaint, Jazz alleges the sodium oxybate product (&#8220;Proposed Product&#8221;) described in the New Drug Application (&#8220;NDA&#8221;) owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#8220;patents-in-suit&#8221;). The Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Avadel Answer&#8221;) with the Court in response to the Complaint.  The Avadel Answer generally denies the allegations set forth in the Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, ii) a declaratory judgment of invalidity of each patent-in-suit, and iii) a declaratory judgement requiring delisting of US Patent No. 8731963 from FDA&#8217;s Orange Book. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, Jazz filed its Answer (&#8220;Jazz Answer&#8221;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#8217;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a preliminary injunction hearing date of November 23, 2021 (only relevant in the event that Jazz files a motion for a preliminary injunction by October 22, 2021), ii) a claim construction hearing date of August 2, 2022, and iii) a trial date of October 30, 2023.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, Jazz filed another formal complaint (the &#8220;Second Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.&#160; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Commitments and Contractual Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosures regarding material commitments and contractual obligations are included in Part II, Item 7 of the Company&#8217;s 2020 Annual Report on Form 10-K and updated in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 16: Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;to the Company&#8217;s unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_112"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Interest Rate Risk</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to interest rate risk as a result of its portfolio of marketable securities. The primary objectives of our investment policy are as follows: safety and preservation of principal and diversification of risk; liquidity of investments </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 34 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sufficient to meet cash flow requirements; and competitive yield. Although our investments are subject to market risk, our investment policy specifies credit quality standards for our investments and limits the amount of credit exposure from any single issue, issuer or certain types of investment. Our investment policy allows us to maintain a portfolio of cash equivalents and marketable securities in a variety of instruments, including U.S. federal government and federal agency securities, European Government bonds, corporate bonds or commercial paper issued by U.S. or European corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, tax-exempt obligations of states, agencies, and municipalities in the U.S and Europe, and equities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A hypothetical 50 basis point change in interest rates would not result in a material decrease or increase in the fair value of our securities due to the general short-term nature of our investment portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_115"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company, with the participation of its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of June&#160;30, 2021, the end of the period covered by this quarterly report on Form 10-Q.&#160; The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), means controls and other procedures of a company that are designed to provide reasonable assurance that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to the Company&#8217;s management, including its Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.&#160; Based on their evaluation, as of the end of the period covered by this Form 10-Q, the Company&#8217;s Chief Executive Officer and Chief Financial Officer have concluded that the Company&#8217;s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) were effective as of June&#160;30, 2021.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rule 13a-15 or 15d-15 that occurred during the three months ended&#160;June&#160;30, 2021&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_118"></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i50b89bc599794eeaa322f99bdef30cea_121"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 16: Commitments and Contingencies&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Company&#8217;s unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report is incorporated by reference herein.</span></div><div id="i50b89bc599794eeaa322f99bdef30cea_124"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth below, there have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on March 9, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our product candidate and future product candidates, if approved by the FDA, may not obtain desired regulatory exclusivities, including orphan drug exclusivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Orphan Drug Act, as amended, the FDA may designate a drug as an orphan drug if it is intended to treat a rare disease or condition, which is defined as a patient population of fewer than 200,000 individuals in the United States, or a patient population greater than 200,000 where there is no reasonable expectation that the cost of developing the drug for the rare disease or condition will be recovered from sales of the drug in the United States. Generally, if a drug with orphan drug designation subsequently receives the first marketing approval for the disease or condition for which it has such designation, the drug is entitled to a period of marketing exclusivity, which precludes the FDA from approving another marketing application for the same drug for the same disease or condition for seven years, except in limited circumstances, such as if the FDA concludes that a subsequent same drug is clinically superior through greater safety, greater effectiveness, or a major contribution to patient care. A designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it received orphan designation. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our lead product candidate, FT218, obtained orphan drug designation for the treatment of narcolepsy from the FDA in January 2018, there is no guarantee that we will obtain approval or orphan drug exclusivity for FT218. Orphan drug designation does not give a product candidate any advantage in, or shorten the timeline for, the FDA regulatory review and approval process. In addition, because FT218 would not be the first sodium oxybate product to be approved for the treatment of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 35 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">narcolepsy, we must demonstrate that FT218 is clinically superior to any previously approved same drug in order to obtain orphan drug exclusivity for FT218, and we may be required to demonstrate clinical superiority for the approval and exclusivity of other product candidates in the future. Even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different drugs can be approved for the same condition.  Moreover, any orphan drug exclusive marketing rights may be lost if the FDA later determines that the request for designation was materially defective or if we are unable to assure sufficient quantity of the drug to meet the needs of patients with the particular rare disease or condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may claim that our product candidate or future product candidates infringe their rights, and we may incur significant costs resolving these claims. Additionally, legal proceedings related to such claims could materially delay or otherwise adversely affect commercialization plans related to our product candidate, if approved. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may claim infringement of their patents and other intellectual property rights by the manufacture, use, import, offer for sale or sale of our drug delivery technologies or our other products. For example, in connection with us seeking regulatory approval for a product candidate, a third party may allege that our product candidate infringes its patents or other intellectual property rights and file suit to delay/prevent regulatory approval and/or commercialization of such product. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Jazz Pharmaceuticals filed a complaint against us and certain of our subsidiaries in the United States District Court for the District of Delaware alleging infringement of certain of its patents.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to any claim of infringement, we may choose or be forced to seek licenses, defend infringement actions or challenge the validity or enforceability of those patent rights in court or administrative proceedings. If we cannot obtain required licenses on commercially reasonably terms, or at all, are found liable for infringement or are not able to have such patent rights declared invalid or unenforceable, our business could be materially harmed. We may be subject to claims (and even held liable) for significant monetary damages (including enhanced damages and/or attorneys&#8217; fees), encounter significant delays in bringing products to market or be precluded from the manufacture, use, import, offer for sale or sale of products or methods of drug delivery covered by the patents of others. Even if a license is available, it may not be available on commercially reasonable terms or may be non-exclusive, which could result in our competitors gaining access to the same intellectual property. We may not have identified, or be able to identify in the future, U.S. or non-U.S. patents that pose a risk of potential infringement claims.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the possibility of intellectual property infringement claims, a third party could submit a citizen petition to the FDA requesting relief that, if granted, could materially adversely affect the NDA and/or underlying product candidate. For example, such a third-party petition could, if granted, materially adversely affect the likelihood and/or timing of NDA approval, content of final product labeling, and/or resulting regulatory exclusivity (if any) for such product.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parties making claims against us may be able to sustain the costs of patent litigation more effectively than we can because they have substantially greater resources. In addition, any claims, with or without merit, that our product candidate, future product candidates or drug delivery technologies infringe proprietary rights of third parties could be time-consuming, result in costly litigation or divert the efforts of our technical and management personnel, any of which could disrupt our relationships with our partners and could significantly harm our financial positions and operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_127"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i50b89bc599794eeaa322f99bdef30cea_130"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. &#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES.&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i50b89bc599794eeaa322f99bdef30cea_133"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i50b89bc599794eeaa322f99bdef30cea_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;OTHER INFORMATION.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 36 -</span></div></div></div><div id="i50b89bc599794eeaa322f99bdef30cea_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311q22021.htm">Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) promulgated under the Exchange Act</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312q22021.htm">Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) promulgated under the Exchange Act</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321q22021.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322q22021.htm">Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*) (filed herewith)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Furnished herewith.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Indicates management contract or compensatory plan or arrangement.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.&#160;</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:40.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AVADEL PHARMACEUTICALS PLC</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August 9, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Gregory J. Divis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Duly Authorized Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer)</span></div></td></tr></table></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:40.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August 9, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas S. McHugh</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Duly Authorized Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 37 -</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311q22021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id92535147aaa4b9b8cab5e7d0bca248d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Gregory J. Divis, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 9, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312q22021.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5c62e6b0189a4f00b5b8ccc2bafd4de8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas S. McHugh, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 9, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321q22021.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i69d14a05edee4473bc60a9ae9f325323_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) for the period ended June&#160;30, 2021 (the &#8220;Report&#8221;), the undersigned hereby certifies in his capacity as Chief Executive Officer of the Company pursuant to 18&#160;U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 9, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322q22021.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0cf7f4210aae4a2ca50af29822652291_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) for the period ended June&#160;30, 2021 (the &#8220;Report&#8221;), the undersigned hereby certifies in his capacity as Chief Financial Officer of the Company pursuant to 18&#160;U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 9, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>avdl-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a7d49b9d-9e9c-4202-a2e9-33a099e78bd3,g:e5693fe9-19ce-4a74-abcb-b22740470bdd-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:avdl="http://www.avadel.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.avadel.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Coverpage" roleURI="http://www.avadel.com/role/Coverpage">
        <link:definition>0001001 - Document - Cover page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME">
        <link:definition>1002003 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical">
        <link:definition>1003004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewlyIssuedAccountingStandards" roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandards">
        <link:definition>2103102 - Disclosure - Newly Issued Accounting Standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewlyIssuedAccountingStandardsDetails" roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails">
        <link:definition>2404401 - Disclosure - Newly Issued Accounting Standards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalProducts" roleURI="http://www.avadel.com/role/DispositionoftheHospitalProducts">
        <link:definition>2105103 - Disclosure - Disposition of the Hospital Products</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalProductsTables" roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsTables">
        <link:definition>2306301 - Disclosure - Disposition of the Hospital Products - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalProductsNarrativeDetails" roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails">
        <link:definition>2407402 - Disclosure - Disposition of the Hospital Products - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails">
        <link:definition>2408403 - Disclosure - Disposition of the Hospital Products - Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails">
        <link:definition>2409404 - Disclosure - Disposition of the Hospital Products - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.avadel.com/role/RevenueRecognition">
        <link:definition>2110104 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://www.avadel.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>2411405 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://www.avadel.com/role/FairValueMeasurement">
        <link:definition>2112105 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://www.avadel.com/role/FairValueMeasurementTables">
        <link:definition>2313302 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementMeasuredonRecurringBasisDetails" roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails">
        <link:definition>2414406 - Disclosure - Fair Value Measurement - Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementNarrativeDetails" roleURI="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails">
        <link:definition>2415407 - Disclosure - Fair Value Measurement - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecurities" roleURI="http://www.avadel.com/role/MarketableSecurities">
        <link:definition>2116106 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://www.avadel.com/role/MarketableSecuritiesTables">
        <link:definition>2317303 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNarrativeDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails">
        <link:definition>2418408 - Disclosure - Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesSummaryofMarketableSecuritiesDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails">
        <link:definition>2419409 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesScheduleofMaturitiesDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails">
        <link:definition>2420410 - Disclosure - Marketable Securities - Schedule of Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.avadel.com/role/GoodwillandIntangibleAssets">
        <link:definition>2121107 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsDetails" roleURI="http://www.avadel.com/role/GoodwillandIntangibleAssetsDetails">
        <link:definition>2422411 - Disclosure - Goodwill and Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationPayable" roleURI="http://www.avadel.com/role/ContingentConsiderationPayable">
        <link:definition>2123108 - Disclosure - Contingent Consideration Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationPayableTables" roleURI="http://www.avadel.com/role/ContingentConsiderationPayableTables">
        <link:definition>2324304 - Disclosure - Contingent Consideration Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationPayableNarrativeDetails" roleURI="http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails">
        <link:definition>2425412 - Disclosure - Contingent Consideration Payable&#160; - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationPayablePayableBalanceDetails" roleURI="http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails">
        <link:definition>2426413 - Disclosure - Contingent Consideration Payable - Payable Balance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.avadel.com/role/LongTermDebt">
        <link:definition>2127109 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.avadel.com/role/LongTermDebtTables">
        <link:definition>2328305 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofDebtDetails" roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails">
        <link:definition>2429414 - Disclosure - Long-Term Debt Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails">
        <link:definition>2430415 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.avadel.com/role/IncomeTaxes">
        <link:definition>2131110 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.avadel.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2432416 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilities" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilities">
        <link:definition>2133111 - Disclosure - Other Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesTables" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables">
        <link:definition>2334306 - Disclosure - Other Assets and Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>2435417 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails">
        <link:definition>2436418 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesAccruedExpensesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails">
        <link:definition>2437419 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails">
        <link:definition>2438420 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails">
        <link:definition>2439421 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCosts" roleURI="http://www.avadel.com/role/RestructuringCosts">
        <link:definition>2140112 - Disclosure - Restructuring Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsTables" roleURI="http://www.avadel.com/role/RestructuringCostsTables">
        <link:definition>2341307 - Disclosure - Restructuring Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsNarrativeDetails" roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails">
        <link:definition>2442422 - Disclosure - Restructuring Costs - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsSeveranceObligationDetails" roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails">
        <link:definition>2443423 - Disclosure - Restructuring Costs - Severance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossIncomePerShare" roleURI="http://www.avadel.com/role/NetLossIncomePerShare">
        <link:definition>2144113 - Disclosure - Net (Loss) Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossIncomePerShareTables" roleURI="http://www.avadel.com/role/NetLossIncomePerShareTables">
        <link:definition>2345308 - Disclosure - Net (Loss) Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails" roleURI="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails">
        <link:definition>2446424 - Disclosure - Net (Loss) Income Per Share - Reconciliation of Basic and Diluted Calculation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossIncomePerShareNarrativeDetails" roleURI="http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails">
        <link:definition>2447425 - Disclosure - Net (Loss) Income Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLoss" roleURI="http://www.avadel.com/role/ComprehensiveLoss">
        <link:definition>2148114 - Disclosure - Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLossTables" roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossTables">
        <link:definition>2349309 - Disclosure - Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLossComponentsDetails" roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails">
        <link:definition>2450426 - Disclosure - Comprehensive Income (Loss) - Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLossNarrativeDetails" roleURI="http://www.avadel.com/role/ComprehensiveLossNarrativeDetails">
        <link:definition>2451427 - Disclosure - Comprehensive Loss - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuebyProduct" roleURI="http://www.avadel.com/role/RevenuebyProduct">
        <link:definition>2152115 - Disclosure - Revenue by Product</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuebyProductTables" roleURI="http://www.avadel.com/role/RevenuebyProductTables">
        <link:definition>2353310 - Disclosure - Revenue by Product (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuebyProductSummaryofRevenueDetails" roleURI="http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails">
        <link:definition>2454428 - Disclosure - Revenue by Product - Summary of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.avadel.com/role/CommitmentsandContingencies">
        <link:definition>2155116 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>2456429 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" abstract="false" name="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_StockIssuedDuringPeriodValuePublicOffering" abstract="false" name="StockIssuedDuringPeriodValuePublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_FinancingRelatedContingentConsiderationRemeasurement" abstract="false" name="FinancingRelatedContingentConsiderationRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OtherProductsMember" abstract="true" name="OtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" abstract="true" name="BusinessCombinationChangesinRelatedPartyPayableRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="avdl_VazculepMember" abstract="true" name="VazculepMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AccruedInterestCurrent" abstract="false" name="AccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_A450PercentExchangeableSeniorNotesDue2023Member" abstract="true" name="A450PercentExchangeableSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_OtherGuarantorObligationsCurrentCarryingValue" abstract="false" name="OtherGuarantorObligationsCurrentCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_MutualAndMoneyMarketFundsMember" abstract="true" name="MutualAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" abstract="true" name="TwoThousandNineteenCorporateFrenchRestructuringObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesOptionPricePerShare" abstract="false" name="AmericanDepositarySharesOptionPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="avdl_BloxiverzMember" abstract="true" name="BloxiverzMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" abstract="false" name="ResearchAndDevelopmentTaxCreditReceivableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositorySharesConversionRatio" abstract="false" name="AmericanDepositorySharesConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="avdl_BloxiverzVazculepAkovazandNouressMember" abstract="true" name="BloxiverzVazculepAkovazandNouressMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" abstract="true" name="DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_CorporateWorkforceReductionMember" abstract="true" name="CorporateWorkforceReductionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" abstract="false" name="RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_AcquisitionRelatedContingentConsiderationRemeasurement" abstract="false" name="AcquisitionRelatedContingentConsiderationRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" abstract="false" name="IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_CouponInterestExpense" abstract="false" name="CouponInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_PercentageOfRoyaltyPayableOnNetSales" abstract="false" name="PercentageOfRoyaltyPayableOnNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_DebtInstrumentOptiontoIncreaseFaceAmount" abstract="false" name="DebtInstrumentOptiontoIncreaseFaceAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesPremiumPercentage" abstract="false" name="AmericanDepositarySharesPremiumPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_GuaranteeCurrent" abstract="false" name="GuaranteeCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AccruedOutsourceContractCosts" abstract="false" name="AccruedOutsourceContractCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" abstract="false" name="DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" abstract="false" name="DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" abstract="true" name="TwoThousandNineteenCorporateRestructuringObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_GainLossOnReleaseOfCertainLiabilities" abstract="false" name="GainLossOnReleaseOfCertainLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" abstract="false" name="DebtInstrumentConvertibleScheduledThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OtherNoncurrentReceivables" abstract="false" name="OtherNoncurrentReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_GuaranteeNoncurrent" abstract="false" name="GuaranteeNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_StockIssuedDuringPeriodSharesPublicOffering" abstract="false" name="StockIssuedDuringPeriodSharesPublicOffering" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="avdl_AkovazMember" abstract="true" name="AkovazMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_NatureOfBusinessPolicyPolicyTextBlock" abstract="false" name="NatureOfBusinessPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" abstract="false" name="RestructuringChargesBeforeGainLossDuetoCurtailment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ShortTermNoteReceivable" abstract="false" name="ShortTermNoteReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" abstract="false" name="ResearchAndDevelopmentTaxCreditReceivableNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OtherLiabilitiesMiscellaneousCurrent" abstract="false" name="OtherLiabilitiesMiscellaneousCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_GuaranteeAssetCurrentCarryingValue" abstract="false" name="GuaranteeAssetCurrentCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" abstract="false" name="DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesPurchasedPricePerShare" abstract="false" name="AmericanDepositarySharesPurchasedPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" abstract="false" name="OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AccruedTradeDiscountsAndRebates" abstract="false" name="AccruedTradeDiscountsAndRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" abstract="false" name="EarnOutPaymentInExcessOfAcquisitionDateFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" abstract="false" name="DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>avdl-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a7d49b9d-9e9c-4202-a2e9-33a099e78bd3,g:e5693fe9-19ce-4a74-abcb-b22740470bdd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME" xlink:type="simple" xlink:href="avdl-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f498a612-7975-41cd-b6f1-19f5bd37dba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_57f29184-897a-45c0-aba7-720697ef3e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f498a612-7975-41cd-b6f1-19f5bd37dba5" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_57f29184-897a-45c0-aba7-720697ef3e62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0a94fb37-4b1b-4b08-b18f-1b548f4e493e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f498a612-7975-41cd-b6f1-19f5bd37dba5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0a94fb37-4b1b-4b08-b18f-1b548f4e493e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c752c82e-8486-474d-b4d6-4fd3689dfb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f498a612-7975-41cd-b6f1-19f5bd37dba5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c752c82e-8486-474d-b4d6-4fd3689dfb50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_28976c0a-eebe-4c6d-8bb4-37b426f738f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f498a612-7975-41cd-b6f1-19f5bd37dba5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_28976c0a-eebe-4c6d-8bb4-37b426f738f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3c19c9ce-5456-47bb-b579-414e8de0d2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f498a612-7975-41cd-b6f1-19f5bd37dba5" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3c19c9ce-5456-47bb-b579-414e8de0d2ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8826490c-b393-4ad3-92ad-0fc29108d2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f498a612-7975-41cd-b6f1-19f5bd37dba5" xlink:to="loc_us-gaap_RestructuringCharges_8826490c-b393-4ad3-92ad-0fc29108d2c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_9f8668ac-d91c-4f6f-b5e0-0c2cf1e58e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f498a612-7975-41cd-b6f1-19f5bd37dba5" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_9f8668ac-d91c-4f6f-b5e0-0c2cf1e58e8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6e92e2ba-e8ab-45d1-b566-30f3ca5d0459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8552d960-641f-411e-98be-0ec00a659511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6e92e2ba-e8ab-45d1-b566-30f3ca5d0459" xlink:to="loc_us-gaap_OperatingIncomeLoss_8552d960-641f-411e-98be-0ec00a659511" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_d9b8f74b-4469-4e8a-ab49-2fc0f2fc8bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6e92e2ba-e8ab-45d1-b566-30f3ca5d0459" xlink:to="loc_us-gaap_InvestmentIncomeNet_d9b8f74b-4469-4e8a-ab49-2fc0f2fc8bb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_f5054aaa-b0f4-4ee7-bae7-f9043d767a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6e92e2ba-e8ab-45d1-b566-30f3ca5d0459" xlink:to="loc_us-gaap_InterestExpenseDebt_f5054aaa-b0f4-4ee7-bae7-f9043d767a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GainLossOnReleaseOfCertainLiabilities_000e3bd2-a9df-42e3-a43c-8ad366027600" xlink:href="avdl-20210630.xsd#avdl_GainLossOnReleaseOfCertainLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6e92e2ba-e8ab-45d1-b566-30f3ca5d0459" xlink:to="loc_avdl_GainLossOnReleaseOfCertainLiabilities_000e3bd2-a9df-42e3-a43c-8ad366027600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2e17ca3c-9714-4462-9b76-c664dcff1f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6e92e2ba-e8ab-45d1-b566-30f3ca5d0459" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2e17ca3c-9714-4462-9b76-c664dcff1f3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9622b755-83d2-409d-996d-e10e22e77810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_31e2d89a-356b-4bee-ada3-b6fd6255d692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9622b755-83d2-409d-996d-e10e22e77810" xlink:to="loc_us-gaap_CostsAndExpenses_31e2d89a-356b-4bee-ada3-b6fd6255d692" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_149c5b80-d31e-4963-8a39-10b885ba0aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9622b755-83d2-409d-996d-e10e22e77810" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_149c5b80-d31e-4963-8a39-10b885ba0aa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_decc82b3-5a76-4276-9cc0-5e6ad995d00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7b7a251f-079b-4505-a3b0-7fd160c5a826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_decc82b3-5a76-4276-9cc0-5e6ad995d00f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7b7a251f-079b-4505-a3b0-7fd160c5a826" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ea3c2d8c-47d7-4f2b-88c3-9e377af0f8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_decc82b3-5a76-4276-9cc0-5e6ad995d00f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ea3c2d8c-47d7-4f2b-88c3-9e377af0f8cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="simple" xlink:href="avdl-20210630.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_875dffc0-bda8-4cba-9cd9-3845dd9dbcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a6be6a0d-7946-434e-bd58-c96bd0d389b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_875dffc0-bda8-4cba-9cd9-3845dd9dbcb4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a6be6a0d-7946-434e-bd58-c96bd0d389b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8f280916-a3e9-443d-b53c-f52c616ecf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_875dffc0-bda8-4cba-9cd9-3845dd9dbcb4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8f280916-a3e9-443d-b53c-f52c616ecf4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bebd5819-1060-4812-ba1f-995630eb5790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_14a16135-ed3b-499b-97b1-4a16a169f517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bebd5819-1060-4812-ba1f-995630eb5790" xlink:to="loc_us-gaap_NetIncomeLoss_14a16135-ed3b-499b-97b1-4a16a169f517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1ec66e2d-07e5-4940-af93-79f38bbb011f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bebd5819-1060-4812-ba1f-995630eb5790" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1ec66e2d-07e5-4940-af93-79f38bbb011f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="avdl-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_06a5e291-1e53-4ab8-902d-e67c0f19e596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_43574182-e6ef-4797-befb-78c3124513dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06a5e291-1e53-4ab8-902d-e67c0f19e596" xlink:to="loc_us-gaap_AssetsCurrent_43574182-e6ef-4797-befb-78c3124513dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_66553688-5170-4a6a-afc6-78095481155b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06a5e291-1e53-4ab8-902d-e67c0f19e596" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_66553688-5170-4a6a-afc6-78095481155b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1c17d645-1dd3-4b46-b2dd-d88b34404908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06a5e291-1e53-4ab8-902d-e67c0f19e596" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1c17d645-1dd3-4b46-b2dd-d88b34404908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4466772d-de69-4d4a-9f7b-21dce2129b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06a5e291-1e53-4ab8-902d-e67c0f19e596" xlink:to="loc_us-gaap_Goodwill_4466772d-de69-4d4a-9f7b-21dce2129b6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_dfa7bcd0-862c-4978-8aea-84ea11efb228" xlink:href="avdl-20210630.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06a5e291-1e53-4ab8-902d-e67c0f19e596" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_dfa7bcd0-862c-4978-8aea-84ea11efb228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_fcd02fd6-b38f-4c34-8bd7-2db78a6ec178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06a5e291-1e53-4ab8-902d-e67c0f19e596" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_fcd02fd6-b38f-4c34-8bd7-2db78a6ec178" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_198924a5-e930-495d-bf42-d5b89f69fe0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9da8aee3-eab4-4fbb-89da-3582ac554271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_198924a5-e930-495d-bf42-d5b89f69fe0a" xlink:to="loc_us-gaap_LiabilitiesCurrent_9da8aee3-eab4-4fbb-89da-3582ac554271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_15f62ab6-547e-4d64-b459-d1930f4e003f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_198924a5-e930-495d-bf42-d5b89f69fe0a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_15f62ab6-547e-4d64-b459-d1930f4e003f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7d7dc07b-d910-4fcd-ba6f-936940969371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_198924a5-e930-495d-bf42-d5b89f69fe0a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7d7dc07b-d910-4fcd-ba6f-936940969371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5bcd9923-6daa-489d-8e5f-ca4e34ba2b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_198924a5-e930-495d-bf42-d5b89f69fe0a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5bcd9923-6daa-489d-8e5f-ca4e34ba2b43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_825c806f-cb32-4854-87ec-ec8f35feb5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0dc53db6-a57d-4a1e-b601-2c92c208fde5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_825c806f-cb32-4854-87ec-ec8f35feb5d7" xlink:to="loc_us-gaap_PreferredStockValue_0dc53db6-a57d-4a1e-b601-2c92c208fde5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3852af1d-24eb-4913-b3f4-e62a400ebfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_825c806f-cb32-4854-87ec-ec8f35feb5d7" xlink:to="loc_us-gaap_CommonStockValue_3852af1d-24eb-4913-b3f4-e62a400ebfd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c27d0382-c412-4ebb-9f13-76ce4bc7440b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_825c806f-cb32-4854-87ec-ec8f35feb5d7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c27d0382-c412-4ebb-9f13-76ce4bc7440b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cc69cd18-2601-466b-9af3-b8effe93d264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_825c806f-cb32-4854-87ec-ec8f35feb5d7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cc69cd18-2601-466b-9af3-b8effe93d264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1db67e9a-b20a-43e6-90db-337e9fe8932c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_825c806f-cb32-4854-87ec-ec8f35feb5d7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1db67e9a-b20a-43e6-90db-337e9fe8932c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e175cda4-215d-4ed2-804a-bc5e7fd3c483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_532d6fd4-1ca7-49d4-be28-702dac482c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e175cda4-215d-4ed2-804a-bc5e7fd3c483" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_532d6fd4-1ca7-49d4-be28-702dac482c5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_be58a3e4-2888-4e97-a7c1-4f308624ec16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e175cda4-215d-4ed2-804a-bc5e7fd3c483" xlink:to="loc_us-gaap_AccountsPayableCurrent_be58a3e4-2888-4e97-a7c1-4f308624ec16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d71e755c-2031-485b-838e-9a3362e0b4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e175cda4-215d-4ed2-804a-bc5e7fd3c483" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d71e755c-2031-485b-838e-9a3362e0b4c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_bfc47924-79b4-407f-9962-62ec429d5087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e175cda4-215d-4ed2-804a-bc5e7fd3c483" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_bfc47924-79b4-407f-9962-62ec429d5087" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f4a18c11-bcf2-4494-903d-d74629fed13c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2c28cc7b-2b4e-4969-baac-b4cfce6eac82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f4a18c11-bcf2-4494-903d-d74629fed13c" xlink:to="loc_us-gaap_Liabilities_2c28cc7b-2b4e-4969-baac-b4cfce6eac82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_034f824d-af78-4a87-ab7f-c62b21fc8baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f4a18c11-bcf2-4494-903d-d74629fed13c" xlink:to="loc_us-gaap_StockholdersEquity_034f824d-af78-4a87-ab7f-c62b21fc8baf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_26eea90a-3220-4048-ac90-93f24419143d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_12bb00dc-6282-4045-b571-4ce1860ae559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_26eea90a-3220-4048-ac90-93f24419143d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_12bb00dc-6282-4045-b571-4ce1860ae559" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_c39f2c87-0469-4db7-92a5-cc2c266405ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_26eea90a-3220-4048-ac90-93f24419143d" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_c39f2c87-0469-4db7-92a5-cc2c266405ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_e860fe56-2d45-4826-ae42-d0fbba40631f" xlink:href="avdl-20210630.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_26eea90a-3220-4048-ac90-93f24419143d" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_e860fe56-2d45-4826-ae42-d0fbba40631f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3c7e7845-c4a1-4645-9dd0-fee3ecf54ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_26eea90a-3220-4048-ac90-93f24419143d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3c7e7845-c4a1-4645-9dd0-fee3ecf54ce3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="avdl-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_751cc6fc-8081-4a90-84e4-c9b82a67c303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4a53b695-4e60-4f80-8b51-722f4ba790e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_751cc6fc-8081-4a90-84e4-c9b82a67c303" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4a53b695-4e60-4f80-8b51-722f4ba790e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_47e81208-5175-41ef-b5b9-7246c85b61ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_751cc6fc-8081-4a90-84e4-c9b82a67c303" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_47e81208-5175-41ef-b5b9-7246c85b61ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_bdd74a50-f4ec-4237-9f44-b854180d0bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_751cc6fc-8081-4a90-84e4-c9b82a67c303" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_bdd74a50-f4ec-4237-9f44-b854180d0bba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_bb62df35-d2fc-4747-8698-4ff3b675c7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_751cc6fc-8081-4a90-84e4-c9b82a67c303" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_bb62df35-d2fc-4747-8698-4ff3b675c7c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7a1d71e5-37cc-4eb0-afa6-52d26220489f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_NetIncomeLoss_7a1d71e5-37cc-4eb0-afa6-52d26220489f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_27d54ff0-79f6-4558-b6dd-0c3ebb94ce40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_DepreciationAndAmortization_27d54ff0-79f6-4558-b6dd-0c3ebb94ce40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_58d16ae9-f33c-4f4d-93f6-db0a66f0b73a" xlink:href="avdl-20210630.xsd#avdl_AcquisitionRelatedContingentConsiderationRemeasurement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_58d16ae9-f33c-4f4d-93f6-db0a66f0b73a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement_fb9d93df-d117-44d2-96a4-024c4cbd3a4e" xlink:href="avdl-20210630.xsd#avdl_FinancingRelatedContingentConsiderationRemeasurement"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement_fb9d93df-d117-44d2-96a4-024c4cbd3a4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_a0120d06-eb79-44dd-ad13-eae5dec57553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_a0120d06-eb79-44dd-ad13-eae5dec57553" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ccb97501-aa8c-4959-add8-f8dc3eb6ce36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ccb97501-aa8c-4959-add8-f8dc3eb6ce36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e9cda0eb-6ea4-4d5f-a3b7-708ebbcecec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_ShareBasedCompensation_e9cda0eb-6ea4-4d5f-a3b7-708ebbcecec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_6a909c36-be47-4dd6-b65f-4ab83235257d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_6a909c36-be47-4dd6-b65f-4ab83235257d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GainLossOnReleaseOfCertainLiabilities_8f995580-0226-4bb5-824d-69bb24411b3b" xlink:href="avdl-20210630.xsd#avdl_GainLossOnReleaseOfCertainLiabilities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_avdl_GainLossOnReleaseOfCertainLiabilities_8f995580-0226-4bb5-824d-69bb24411b3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_8d2a5adb-a460-4b00-89ee-6964d264f071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_8d2a5adb-a460-4b00-89ee-6964d264f071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d43ce489-5df7-42c3-9df9-33af0edf8e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d43ce489-5df7-42c3-9df9-33af0edf8e08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1bff269b-412a-45d5-9368-cbb9308486b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1bff269b-412a-45d5-9368-cbb9308486b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8e10eb40-6b65-4073-a8d3-78fc088faab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8e10eb40-6b65-4073-a8d3-78fc088faab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_488fe204-8f87-4d5f-8068-c4467f12761f" xlink:href="avdl-20210630.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_488fe204-8f87-4d5f-8068-c4467f12761f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6adb85ca-be81-4718-98b7-a3f184752bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6adb85ca-be81-4718-98b7-a3f184752bb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_48cfbd2b-5bdc-42e2-8ef9-c91fa8c7781b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_48cfbd2b-5bdc-42e2-8ef9-c91fa8c7781b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_bff67850-2a3f-41c8-87a4-41c471e3d06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_bff67850-2a3f-41c8-87a4-41c471e3d06c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_95710805-6305-49b0-8470-e6cfdf5e3c63" xlink:href="avdl-20210630.xsd#avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_95710805-6305-49b0-8470-e6cfdf5e3c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_a789723f-1f43-49cc-b833-f0e85808c314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_PaymentsForRoyalties_a789723f-1f43-49cc-b833-f0e85808c314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_fdb5438e-6e59-4dbc-8a05-9543dd815303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4f3ee61-5de5-4754-aa18-c1a75f7e08cd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_fdb5438e-6e59-4dbc-8a05-9543dd815303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0dc2a395-6483-47ed-84e1-e7fe28fc3fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_a7306b80-7947-4237-904c-ad4713523511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0dc2a395-6483-47ed-84e1-e7fe28fc3fd1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_a7306b80-7947-4237-904c-ad4713523511" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_8e84aac0-19d4-4b11-9d92-79f51bbdaeac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0dc2a395-6483-47ed-84e1-e7fe28fc3fd1" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_8e84aac0-19d4-4b11-9d92-79f51bbdaeac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ae6c9eb7-c4f9-4a2b-a4c5-3cb4d20a4f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0dc2a395-6483-47ed-84e1-e7fe28fc3fd1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ae6c9eb7-c4f9-4a2b-a4c5-3cb4d20a4f17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_90ef8aca-5bf5-4f34-9731-d3ecbd5ab418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8f4037f9-e064-4ed2-8bc1-ac38b3345454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_90ef8aca-5bf5-4f34-9731-d3ecbd5ab418" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8f4037f9-e064-4ed2-8bc1-ac38b3345454" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb26eed6-e9ec-4fdb-9743-dffb5adab191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_90ef8aca-5bf5-4f34-9731-d3ecbd5ab418" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb26eed6-e9ec-4fdb-9743-dffb5adab191" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_12d93684-5cb4-4632-a276-49c7c1fe042d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_90ef8aca-5bf5-4f34-9731-d3ecbd5ab418" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_12d93684-5cb4-4632-a276-49c7c1fe042d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_ee3f9971-dc7e-4a07-9337-db9d77a21590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_90ef8aca-5bf5-4f34-9731-d3ecbd5ab418" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_ee3f9971-dc7e-4a07-9337-db9d77a21590" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1eb83d7a-e689-46e1-97b6-262055fb44b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_46eef32d-6f74-43f9-a529-36beebd1fe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1eb83d7a-e689-46e1-97b6-262055fb44b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_46eef32d-6f74-43f9-a529-36beebd1fe3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_eb03de8d-9598-4500-89e8-2a1055f7d3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1eb83d7a-e689-46e1-97b6-262055fb44b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_eb03de8d-9598-4500-89e8-2a1055f7d3a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_bef01582-2ea7-40b2-b45d-8beb0b2c19ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1eb83d7a-e689-46e1-97b6-262055fb44b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_bef01582-2ea7-40b2-b45d-8beb0b2c19ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_462adae3-e49a-440f-8539-aabd3f82e3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1eb83d7a-e689-46e1-97b6-262055fb44b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_462adae3-e49a-440f-8539-aabd3f82e3fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_7d40b0e3-0ca1-4e74-8af7-ed8ea284d61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1eb83d7a-e689-46e1-97b6-262055fb44b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_7d40b0e3-0ca1-4e74-8af7-ed8ea284d61c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_78bb62e1-2d56-4044-85c5-7eef8c19f882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1eb83d7a-e689-46e1-97b6-262055fb44b2" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_78bb62e1-2d56-4044-85c5-7eef8c19f882" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#FairValueMeasurementMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ab460681-3b74-4d0b-9931-e4b01b465370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cd237568-b50d-4a09-9102-069732d52f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_ab460681-3b74-4d0b-9931-e4b01b465370" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cd237568-b50d-4a09-9102-069732d52f11" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#MarketableSecuritiesSummaryofMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cbf0bc68-ab9e-4530-a590-38dee8780377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_bcda2a21-f03b-49ac-aa68-6384cee78ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cbf0bc68-ab9e-4530-a590-38dee8780377" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_bcda2a21-f03b-49ac-aa68-6384cee78ee0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_433fd780-4581-4f61-bd04-041816afcd10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cbf0bc68-ab9e-4530-a590-38dee8780377" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_433fd780-4581-4f61-bd04-041816afcd10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_164da712-ba86-48d9-829b-0bd56d85c1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cbf0bc68-ab9e-4530-a590-38dee8780377" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_164da712-ba86-48d9-829b-0bd56d85c1a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#MarketableSecuritiesScheduleofMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef415575-807e-4ada-914e-4fc98641e2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_16cb1f21-2115-48e6-8d30-9dbfb52fc9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef415575-807e-4ada-914e-4fc98641e2c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_16cb1f21-2115-48e6-8d30-9dbfb52fc9e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_27767c69-38ec-43e1-8a12-a01369bab537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef415575-807e-4ada-914e-4fc98641e2c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_27767c69-38ec-43e1-8a12-a01369bab537" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_9568b8b2-28a8-4f1e-aeef-3fa25020a4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef415575-807e-4ada-914e-4fc98641e2c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_9568b8b2-28a8-4f1e-aeef-3fa25020a4a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_4eb80ef0-f81b-470b-a9e7-c1909988ad4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef415575-807e-4ada-914e-4fc98641e2c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_4eb80ef0-f81b-470b-a9e7-c1909988ad4e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_528ce7d4-be20-4a04-8c54-635bcdbdff87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_4d86f44a-cdae-4fdb-b6f3-15578459cf15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_528ce7d4-be20-4a04-8c54-635bcdbdff87" xlink:to="loc_us-gaap_LongTermDebtCurrent_4d86f44a-cdae-4fdb-b6f3-15578459cf15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0eeac5fb-fd1e-417e-9477-092f24c37664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_528ce7d4-be20-4a04-8c54-635bcdbdff87" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0eeac5fb-fd1e-417e-9477-092f24c37664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e6493a50-ce8a-4ddb-bbdd-fe20933b2142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_528ce7d4-be20-4a04-8c54-635bcdbdff87" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e6493a50-ce8a-4ddb-bbdd-fe20933b2142" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_fe1a6d20-94bf-4a9a-83a7-f10a01199b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_528ce7d4-be20-4a04-8c54-635bcdbdff87" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_fe1a6d20-94bf-4a9a-83a7-f10a01199b16" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_914b06be-b84b-447f-9a58-9dc402ac1275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_bc70b585-23b3-44c1-ac49-5b301a316229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_914b06be-b84b-447f-9a58-9dc402ac1275" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_bc70b585-23b3-44c1-ac49-5b301a316229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_9a913281-20d2-41ff-adea-783ae17302bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_914b06be-b84b-447f-9a58-9dc402ac1275" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_9a913281-20d2-41ff-adea-783ae17302bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent_bb3e2c95-aad5-4158-bac1-f30fbf65c675" xlink:href="avdl-20210630.xsd#avdl_GuaranteeCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_914b06be-b84b-447f-9a58-9dc402ac1275" xlink:to="loc_avdl_GuaranteeCurrent_bb3e2c95-aad5-4158-bac1-f30fbf65c675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_b385ab37-f848-4759-aa38-3c77cd00784f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_914b06be-b84b-447f-9a58-9dc402ac1275" xlink:to="loc_us-gaap_IncomeTaxesReceivable_b385ab37-f848-4759-aa38-3c77cd00784f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ShortTermNoteReceivable_512dfbad-6ae4-45d8-a8d3-5e6f200d1705" xlink:href="avdl-20210630.xsd#avdl_ShortTermNoteReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_914b06be-b84b-447f-9a58-9dc402ac1275" xlink:to="loc_avdl_ShortTermNoteReceivable_512dfbad-6ae4-45d8-a8d3-5e6f200d1705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0e7c10d5-f933-4488-bc03-435eeb3725d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_914b06be-b84b-447f-9a58-9dc402ac1275" xlink:to="loc_us-gaap_OtherAssetsCurrent_0e7c10d5-f933-4488-bc03-435eeb3725d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_fcabf233-b3bc-4564-8146-b12dd36ff783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_914b06be-b84b-447f-9a58-9dc402ac1275" xlink:to="loc_us-gaap_DepositsAssetsCurrent_fcabf233-b3bc-4564-8146-b12dd36ff783" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_767f08b1-62af-45be-9e23-f9a77c65f52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0299a025-a0cb-4662-a5ae-0171fe863d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_767f08b1-62af-45be-9e23-f9a77c65f52e" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_0299a025-a0cb-4662-a5ae-0171fe863d41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent_8a6989a6-57d4-4c03-9af5-67073af09ef5" xlink:href="avdl-20210630.xsd#avdl_GuaranteeNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_767f08b1-62af-45be-9e23-f9a77c65f52e" xlink:to="loc_avdl_GuaranteeNoncurrent_8a6989a6-57d4-4c03-9af5-67073af09ef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_bbf5814e-c5c5-45b2-8fb7-5acfeed33e2b" xlink:href="avdl-20210630.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_767f08b1-62af-45be-9e23-f9a77c65f52e" xlink:to="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_bbf5814e-c5c5-45b2-8fb7-5acfeed33e2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables_e5410068-fec3-46e4-a98f-0b15dfe8e780" xlink:href="avdl-20210630.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_767f08b1-62af-45be-9e23-f9a77c65f52e" xlink:to="loc_avdl_OtherNoncurrentReceivables_e5410068-fec3-46e4-a98f-0b15dfe8e780" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_59645247-3dec-4d45-8bbc-7b1384db3b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_79f72b29-67e2-4d28-a3e8-d436e0c65301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_59645247-3dec-4d45-8bbc-7b1384db3b63" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_79f72b29-67e2-4d28-a3e8-d436e0c65301" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_e8db428d-6fdf-495a-9260-5e2ad9a8c825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_59645247-3dec-4d45-8bbc-7b1384db3b63" xlink:to="loc_us-gaap_RestructuringReserveCurrent_e8db428d-6fdf-495a-9260-5e2ad9a8c825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedTradeDiscountsAndRebates_ed9fcc02-0a31-4a90-9128-0d730d3dc20f" xlink:href="avdl-20210630.xsd#avdl_AccruedTradeDiscountsAndRebates"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_59645247-3dec-4d45-8bbc-7b1384db3b63" xlink:to="loc_avdl_AccruedTradeDiscountsAndRebates_ed9fcc02-0a31-4a90-9128-0d730d3dc20f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts_6799fbf8-0014-49e8-8ad8-3cd2e9011b8d" xlink:href="avdl-20210630.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_59645247-3dec-4d45-8bbc-7b1384db3b63" xlink:to="loc_avdl_AccruedOutsourceContractCosts_6799fbf8-0014-49e8-8ad8-3cd2e9011b8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_757e0ef9-1e85-4199-bbbd-4523f421bdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_59645247-3dec-4d45-8bbc-7b1384db3b63" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_757e0ef9-1e85-4199-bbbd-4523f421bdd8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f045c2c7-fa5b-4be8-ad61-0d6d6fd368a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_8829fd09-518d-49d3-a345-ddc09f3d8560" xlink:href="avdl-20210630.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f045c2c7-fa5b-4be8-ad61-0d6d6fd368a4" xlink:to="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_8829fd09-518d-49d3-a345-ddc09f3d8560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_ab3b07ef-4241-4d99-b11e-cc17b1d05efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f045c2c7-fa5b-4be8-ad61-0d6d6fd368a4" xlink:to="loc_us-gaap_DueToAffiliateCurrent_ab3b07ef-4241-4d99-b11e-cc17b1d05efb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent_82d75e1d-6d8e-43cc-b016-22aec0350d2a" xlink:href="avdl-20210630.xsd#avdl_AccruedInterestCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f045c2c7-fa5b-4be8-ad61-0d6d6fd368a4" xlink:to="loc_avdl_AccruedInterestCurrent_82d75e1d-6d8e-43cc-b016-22aec0350d2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_53f291dd-8093-4cd2-bde0-900426e37a49" xlink:href="avdl-20210630.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f045c2c7-fa5b-4be8-ad61-0d6d6fd368a4" xlink:to="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_53f291dd-8093-4cd2-bde0-900426e37a49" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_807c1c88-bea0-457b-b126-40ace1cf41b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_18e43be5-b46c-4859-a6ad-27edf926b82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_807c1c88-bea0-457b-b126-40ace1cf41b6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_18e43be5-b46c-4859-a6ad-27edf926b82f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_3f140fbd-6d17-467c-b820-1e4a1023ffc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_807c1c88-bea0-457b-b126-40ace1cf41b6" xlink:to="loc_us-gaap_GuarantyLiabilities_3f140fbd-6d17-467c-b820-1e4a1023ffc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_c1d8e532-205c-4238-8799-3f19b7b61732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_807c1c88-bea0-457b-b126-40ace1cf41b6" xlink:to="loc_us-gaap_OtherLongTermDebt_c1d8e532-205c-4238-8799-3f19b7b61732" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44b44f6d-700a-469f-800d-e1341fbbaf7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e982dab-e024-4cc1-891a-2a2ce02e7773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44b44f6d-700a-469f-800d-e1341fbbaf7b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e982dab-e024-4cc1-891a-2a2ce02e7773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_cf497098-f1c5-4d29-ac3c-a4499a72ee8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44b44f6d-700a-469f-800d-e1341fbbaf7b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_cf497098-f1c5-4d29-ac3c-a4499a72ee8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_4da75186-550f-414d-b801-3623f8792b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_15a18787-053d-4140-8acd-8ee55fa8873f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_4da75186-550f-414d-b801-3623f8792b48" xlink:to="loc_us-gaap_NetIncomeLoss_15a18787-053d-4140-8acd-8ee55fa8873f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_a2458851-6117-4aff-8950-1e4625b37c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_4da75186-550f-414d-b801-3623f8792b48" xlink:to="loc_us-gaap_DilutiveSecurities_a2458851-6117-4aff-8950-1e4625b37c4e" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>avdl-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a7d49b9d-9e9c-4202-a2e9-33a099e78bd3,g:e5693fe9-19ce-4a74-abcb-b22740470bdd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.avadel.com/role/Coverpage" xlink:type="simple" xlink:href="avdl-20210630.xsd#Coverpage"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/Coverpage" xlink:type="extended" id="i74886fbd36d94d4bbb4acf6960748058_Coverpage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b790f024-c771-4682-bfc4-577c853102e7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentType_b790f024-c771-4682-bfc4-577c853102e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_3279383b-ed84-4979-9b16-8e21b7df7323" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentQuarterlyReport_3279383b-ed84-4979-9b16-8e21b7df7323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d50ffccb-6cb9-48a5-aa22-4b74732a195b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentPeriodEndDate_d50ffccb-6cb9-48a5-aa22-4b74732a195b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_48765195-4cc5-418b-a2d2-5d6724829196" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentTransitionReport_48765195-4cc5-418b-a2d2-5d6724829196" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_618f22d6-b750-4774-8bd1-98bd00a93503" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityFileNumber_618f22d6-b750-4774-8bd1-98bd00a93503" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_07181b90-83bf-41ac-b3a5-64f668f13668" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityRegistrantName_07181b90-83bf-41ac-b3a5-64f668f13668" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0927c4b4-48df-4183-9cac-167edc18511c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0927c4b4-48df-4183-9cac-167edc18511c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cb4ca7b9-7716-454d-b7be-08bc4d2d7126" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityTaxIdentificationNumber_cb4ca7b9-7716-454d-b7be-08bc4d2d7126" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0d065ebb-15f2-4fd7-a054-aa01d0bd1d4b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityAddressAddressLine1_0d065ebb-15f2-4fd7-a054-aa01d0bd1d4b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6892b18e-64f1-4175-8c9e-e12738f4fadb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityAddressCityOrTown_6892b18e-64f1-4175-8c9e-e12738f4fadb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_e2e262c5-b34d-466f-a166-6b13e66c52b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityAddressCountry_e2e262c5-b34d-466f-a166-6b13e66c52b2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dc037b1d-96d9-4968-89ca-8565720f1c33" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityAddressPostalZipCode_dc037b1d-96d9-4968-89ca-8565720f1c33" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f1b310ee-4436-448a-a9f8-4006d4b5c2c5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_CityAreaCode_f1b310ee-4436-448a-a9f8-4006d4b5c2c5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6938b0b7-504f-4f88-abbd-dcb3d2f3f546" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_LocalPhoneNumber_6938b0b7-504f-4f88-abbd-dcb3d2f3f546" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_bd7b3640-4126-4355-9302-3595b23f4a3a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_Security12bTitle_bd7b3640-4126-4355-9302-3595b23f4a3a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_741446d6-672d-4599-9271-0cc7b3633155" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_TradingSymbol_741446d6-672d-4599-9271-0cc7b3633155" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2bbb90bf-b63b-4a4f-87c7-029d244dd22b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_SecurityExchangeName_2bbb90bf-b63b-4a4f-87c7-029d244dd22b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_5f4c947b-3d4e-4303-b2af-7f55069d7b0f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_NoTradingSymbolFlag_5f4c947b-3d4e-4303-b2af-7f55069d7b0f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4b51e406-7e6a-45f0-bf4b-67ed6478d34a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityCurrentReportingStatus_4b51e406-7e6a-45f0-bf4b-67ed6478d34a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3f53f2f4-b0e5-412d-a7e4-d8e5ae373769" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityInteractiveDataCurrent_3f53f2f4-b0e5-412d-a7e4-d8e5ae373769" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2fe584e1-4f18-49f8-8b54-ff1cd93ae8d6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityFilerCategory_2fe584e1-4f18-49f8-8b54-ff1cd93ae8d6" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4f3c7cd2-b6a0-484f-bd41-e4a74cc2c23d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntitySmallBusiness_4f3c7cd2-b6a0-484f-bd41-e4a74cc2c23d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_14a098bf-2c11-4e6a-883a-c6165d0b8922" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityEmergingGrowthCompany_14a098bf-2c11-4e6a-883a-c6165d0b8922" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_359db7f0-67e9-4693-bf2c-62ebae3c98e4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityShellCompany_359db7f0-67e9-4693-bf2c-62ebae3c98e4" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_36c9b038-534a-4d64-8f97-ecfdc1875e70" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_36c9b038-534a-4d64-8f97-ecfdc1875e70" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_85c87f7e-2c36-4281-a535-108c1aa88919" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityCentralIndexKey_85c87f7e-2c36-4281-a535-108c1aa88919" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6c9714e8-a9c0-4272-b67d-45eb69bfde19" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_CurrentFiscalYearEndDate_6c9714e8-a9c0-4272-b67d-45eb69bfde19" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3de54dd0-99c3-4f71-84ab-aa5186819982" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentFiscalYearFocus_3de54dd0-99c3-4f71-84ab-aa5186819982" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_556f239b-89cd-405d-854b-33a0a1d2111c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentFiscalPeriodFocus_556f239b-89cd-405d-854b-33a0a1d2111c" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_24dac630-562f-4fb5-a303-acdc103fbb40" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_AmendmentFlag_24dac630-562f-4fb5-a303-acdc103fbb40" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_74231afc-dc88-4c65-b6fe-d5c4a1cfb135" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntitiesTable_74231afc-dc88-4c65-b6fe-d5c4a1cfb135" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_526f8192-970a-4afe-92c7-a9f20353d79d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_74231afc-dc88-4c65-b6fe-d5c4a1cfb135" xlink:to="loc_dei_EntityListingsExchangeAxis_526f8192-970a-4afe-92c7-a9f20353d79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_526f8192-970a-4afe-92c7-a9f20353d79d_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_526f8192-970a-4afe-92c7-a9f20353d79d" xlink:to="loc_dei_ExchangeDomain_526f8192-970a-4afe-92c7-a9f20353d79d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_aa27ed99-a43c-4a93-8310-b961da4c251a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_526f8192-970a-4afe-92c7-a9f20353d79d" xlink:to="loc_dei_ExchangeDomain_aa27ed99-a43c-4a93-8310-b961da4c251a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNMS_53222a4d-c7dc-4b84-97a8-e048a63ff0da" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNMS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_aa27ed99-a43c-4a93-8310-b961da4c251a" xlink:to="loc_exch_XNMS_53222a4d-c7dc-4b84-97a8-e048a63ff0da" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="avdl-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="extended" id="ibf2d7fee832b4305b456b5a38644cc93_CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1f0d6a23-7038-45d8-b134-3ddf87a37d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1f0d6a23-7038-45d8-b134-3ddf87a37d21" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7acdb969-1d73-466c-b158-5d973b3bc7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_SharesOutstanding_7acdb969-1d73-466c-b158-5d973b3bc7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_aad1217e-4ffa-4a8c-af9b-81d8b095eb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockholdersEquity_aad1217e-4ffa-4a8c-af9b-81d8b095eb72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0b033ba7-0bde-4522-abc1-4e5de096715b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0b033ba7-0bde-4522-abc1-4e5de096715b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_649d5cd1-4f2f-4921-b73f-52aa2a5adfc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_NetIncomeLoss_649d5cd1-4f2f-4921-b73f-52aa2a5adfc8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_33541033-f6a9-4186-a41f-7df2057b72fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_33541033-f6a9-4186-a41f-7df2057b72fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b2571759-f36d-445f-b935-4d127ccb872a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b2571759-f36d-445f-b935-4d127ccb872a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_57970ab3-7021-49e0-9623-c9e2bdb17e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_57970ab3-7021-49e0-9623-c9e2bdb17e04" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_c2bd1124-89fd-44ae-bc81-f3d58d9e0dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_c2bd1124-89fd-44ae-bc81-f3d58d9e0dd8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_5d5c4db0-7eb9-4251-8f19-2728de075a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_5d5c4db0-7eb9-4251-8f19-2728de075a6c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_abf9af4b-40ca-4406-a7d3-1445ac185a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_abf9af4b-40ca-4406-a7d3-1445ac185a85" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0ba66e78-ee76-4128-ad44-40176e4382c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0ba66e78-ee76-4128-ad44-40176e4382c4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_75953811-6a98-4f96-9264-88e52794eac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_75953811-6a98-4f96-9264-88e52794eac8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a030e226-4442-44d4-8390-a5f98b3aae81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a030e226-4442-44d4-8390-a5f98b3aae81" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1620a299-99f6-4db0-95b0-1833466411da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1620a299-99f6-4db0-95b0-1833466411da" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering_a5fa444c-9b2e-4fbd-b61f-45233cab26b7" xlink:href="avdl-20210630.xsd#avdl_StockIssuedDuringPeriodSharesPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering_a5fa444c-9b2e-4fbd-b61f-45233cab26b7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodValuePublicOffering_ca0901ed-9bb0-470b-9645-b9c2ff49094d" xlink:href="avdl-20210630.xsd#avdl_StockIssuedDuringPeriodValuePublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_avdl_StockIssuedDuringPeriodValuePublicOffering_ca0901ed-9bb0-470b-9645-b9c2ff49094d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_779b30a0-a4aa-47ae-9cfc-45c808d3b318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f3e2bfe6-fe1b-4daa-a002-0f1ed962766a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_59feb8da-5fe5-4837-9c60-6c8e76d18d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1f0d6a23-7038-45d8-b134-3ddf87a37d21" xlink:to="loc_us-gaap_StatementTable_59feb8da-5fe5-4837-9c60-6c8e76d18d20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c60525bf-cda2-44a1-b132-11c7d397ebf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_59feb8da-5fe5-4837-9c60-6c8e76d18d20" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c60525bf-cda2-44a1-b132-11c7d397ebf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c60525bf-cda2-44a1-b132-11c7d397ebf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c60525bf-cda2-44a1-b132-11c7d397ebf7" xlink:to="loc_us-gaap_EquityComponentDomain_c60525bf-cda2-44a1-b132-11c7d397ebf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c60525bf-cda2-44a1-b132-11c7d397ebf7" xlink:to="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_eb7f6dae-dd29-4e79-a54a-ff7bcd240ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_CommonStockMember_eb7f6dae-dd29-4e79-a54a-ff7bcd240ff2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_ae1ceb7b-264f-4627-9b7b-db2560460e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_PreferredStockMember_ae1ceb7b-264f-4627-9b7b-db2560460e30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bb50bece-883d-4c3d-ae81-05e60ba9faee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bb50bece-883d-4c3d-ae81-05e60ba9faee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a0e64164-ad42-4e5a-ba3b-f96d4d9806b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_RetainedEarningsMember_a0e64164-ad42-4e5a-ba3b-f96d4d9806b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a96a665a-fa07-44c6-9f35-bbbe0875464d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a96a665a-fa07-44c6-9f35-bbbe0875464d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e09edde9-5f2b-44ce-a416-86cebd129f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_TreasuryStockMember_e09edde9-5f2b-44ce-a416-86cebd129f61" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_03cfd553-e86a-4280-a787-f01c74ff49c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_59feb8da-5fe5-4837-9c60-6c8e76d18d20" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_03cfd553-e86a-4280-a787-f01c74ff49c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_03cfd553-e86a-4280-a787-f01c74ff49c3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_03cfd553-e86a-4280-a787-f01c74ff49c3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_03cfd553-e86a-4280-a787-f01c74ff49c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f4838b9b-d0ea-446f-a9f4-e371ff10084d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_03cfd553-e86a-4280-a787-f01c74ff49c3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f4838b9b-d0ea-446f-a9f4-e371ff10084d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_292e1e39-d102-48e7-abb4-8a1bb2abbc90" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f4838b9b-d0ea-446f-a9f4-e371ff10084d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_292e1e39-d102-48e7-abb4-8a1bb2abbc90" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#NewlyIssuedAccountingStandardsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails" xlink:type="extended" id="i41e9faf12b044e81a963428e1efbceb6_NewlyIssuedAccountingStandardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_99992cef-a157-4e45-8ee4-b0ef4e9853c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_99992cef-a157-4e45-8ee4-b0ef4e9853c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e6ff5c93-cbdd-451b-9587-51eb5c0f1947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:to="loc_us-gaap_StockholdersEquity_e6ff5c93-cbdd-451b-9587-51eb5c0f1947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6b9576f3-684d-4fd8-b65a-dfacd4515f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:to="loc_us-gaap_LongTermDebt_6b9576f3-684d-4fd8-b65a-dfacd4515f7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b069a2e6-1aeb-49e8-9c16-4beaea8b63fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:to="loc_us-gaap_DebtInstrumentAxis_b069a2e6-1aeb-49e8-9c16-4beaea8b63fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b069a2e6-1aeb-49e8-9c16-4beaea8b63fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b069a2e6-1aeb-49e8-9c16-4beaea8b63fa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b069a2e6-1aeb-49e8-9c16-4beaea8b63fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ed8245a4-c9d6-46cb-9dad-6f2ab29ea534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b069a2e6-1aeb-49e8-9c16-4beaea8b63fa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ed8245a4-c9d6-46cb-9dad-6f2ab29ea534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_44fd4537-6a70-4a56-a859-b117e945ea03" xlink:href="avdl-20210630.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ed8245a4-c9d6-46cb-9dad-6f2ab29ea534" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_44fd4537-6a70-4a56-a859-b117e945ea03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fc53c829-e4f7-4101-8dbc-ca99ad97c80e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fc53c829-e4f7-4101-8dbc-ca99ad97c80e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fc53c829-e4f7-4101-8dbc-ca99ad97c80e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fc53c829-e4f7-4101-8dbc-ca99ad97c80e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fc53c829-e4f7-4101-8dbc-ca99ad97c80e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ba73ab05-08c4-4ad8-b00b-f753a0212145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fc53c829-e4f7-4101-8dbc-ca99ad97c80e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ba73ab05-08c4-4ad8-b00b-f753a0212145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c58d7c66-6113-4874-bb9e-a41fc9086a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ba73ab05-08c4-4ad8-b00b-f753a0212145" xlink:to="loc_us-gaap_SeniorNotesMember_c58d7c66-6113-4874-bb9e-a41fc9086a43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a4c4a941-3a5d-4c32-b2ad-f641819264b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a4c4a941-3a5d-4c32-b2ad-f641819264b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a4c4a941-3a5d-4c32-b2ad-f641819264b7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a4c4a941-3a5d-4c32-b2ad-f641819264b7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a4c4a941-3a5d-4c32-b2ad-f641819264b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6895e16c-c744-40a8-bc1b-9fc846a20a30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a4c4a941-3a5d-4c32-b2ad-f641819264b7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6895e16c-c744-40a8-bc1b-9fc846a20a30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_40e1e04d-a495-460d-be7a-7c1a56c599c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6895e16c-c744-40a8-bc1b-9fc846a20a30" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_40e1e04d-a495-460d-be7a-7c1a56c599c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6c439cfb-b46e-4352-9f0e-1bdc09690f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6c439cfb-b46e-4352-9f0e-1bdc09690f3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6c439cfb-b46e-4352-9f0e-1bdc09690f3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c439cfb-b46e-4352-9f0e-1bdc09690f3e" xlink:to="loc_us-gaap_EquityComponentDomain_6c439cfb-b46e-4352-9f0e-1bdc09690f3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7ef73f9e-067d-40da-b463-a6423b15ebf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c439cfb-b46e-4352-9f0e-1bdc09690f3e" xlink:to="loc_us-gaap_EquityComponentDomain_7ef73f9e-067d-40da-b463-a6423b15ebf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_edaa14dd-dd44-4259-9cfe-c0a3c06333e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7ef73f9e-067d-40da-b463-a6423b15ebf7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_edaa14dd-dd44-4259-9cfe-c0a3c06333e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_27bdc19c-2d55-41ff-aacb-912728ef4eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7ef73f9e-067d-40da-b463-a6423b15ebf7" xlink:to="loc_us-gaap_RetainedEarningsMember_27bdc19c-2d55-41ff-aacb-912728ef4eaf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#DispositionoftheHospitalProductsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails" xlink:type="extended" id="ie5f2165729994b1197a5a87615a46fdb_DispositionoftheHospitalProductsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_34a3e175-8fbc-4bb3-9a8f-929092780ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_34a3e175-8fbc-4bb3-9a8f-929092780ebf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_5a8613bd-2b1e-4d8b-803c-ebdda59cbfd9" xlink:href="avdl-20210630.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_5a8613bd-2b1e-4d8b-803c-ebdda59cbfd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_974540a5-171f-4faf-96b8-ad89535ed0a8" xlink:href="avdl-20210630.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_974540a5-171f-4faf-96b8-ad89535ed0a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_449968f6-3b94-442e-bbfd-d3ed427f2b1a" xlink:href="avdl-20210630.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_449968f6-3b94-442e-bbfd-d3ed427f2b1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_af90fb42-f52e-4d12-a7fb-bdf618e81337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_af90fb42-f52e-4d12-a7fb-bdf618e81337" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_a929b4d1-ba68-4abf-8ad7-ae0dafda3e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_a929b4d1-ba68-4abf-8ad7-ae0dafda3e91" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_594ad7c9-04bd-4947-ae20-3d9cb810533d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_594ad7c9-04bd-4947-ae20-3d9cb810533d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43e0718c-2331-4a2b-93a2-ce690d98d7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_594ad7c9-04bd-4947-ae20-3d9cb810533d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43e0718c-2331-4a2b-93a2-ce690d98d7f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_43e0718c-2331-4a2b-93a2-ce690d98d7f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43e0718c-2331-4a2b-93a2-ce690d98d7f6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_43e0718c-2331-4a2b-93a2-ce690d98d7f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16114cfc-ac7d-4b77-8a04-bc71eef04f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43e0718c-2331-4a2b-93a2-ce690d98d7f6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16114cfc-ac7d-4b77-8a04-bc71eef04f63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember_6ef70ee4-edea-44d4-b266-12377005b276" xlink:href="avdl-20210630.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16114cfc-ac7d-4b77-8a04-bc71eef04f63" xlink:to="loc_avdl_BloxiverzVazculepAkovazandNouressMember_6ef70ee4-edea-44d4-b266-12377005b276" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b949bf36-dabc-45c3-8d2a-3ae786962893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_594ad7c9-04bd-4947-ae20-3d9cb810533d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b949bf36-dabc-45c3-8d2a-3ae786962893" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b949bf36-dabc-45c3-8d2a-3ae786962893_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b949bf36-dabc-45c3-8d2a-3ae786962893" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b949bf36-dabc-45c3-8d2a-3ae786962893_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_06d1aed5-1646-44e3-859d-32fe35c029f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b949bf36-dabc-45c3-8d2a-3ae786962893" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_06d1aed5-1646-44e3-859d-32fe35c029f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_791f465b-cfe8-4ef2-9b4f-bd386a6e2aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_06d1aed5-1646-44e3-859d-32fe35c029f3" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_791f465b-cfe8-4ef2-9b4f-bd386a6e2aa2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="extended" id="i44d9c8b2912b4deebd45ea4142a4eee2_DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_2c088395-cdb7-4b8a-99fe-5f3167d9df6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_2c088395-cdb7-4b8a-99fe-5f3167d9df6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_c28cab76-61d9-47f3-acf1-42c189550b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_c28cab76-61d9-47f3-acf1-42c189550b76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_8ba72aa5-9cdb-48c7-99e4-d0422f9a435b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_8ba72aa5-9cdb-48c7-99e4-d0422f9a435b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_1f48ea20-7921-4364-8c8e-21382a4f831f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_1f48ea20-7921-4364-8c8e-21382a4f831f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_57c49af7-9cb6-4eb5-8701-4ad377e1e8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_57c49af7-9cb6-4eb5-8701-4ad377e1e8d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_c921d6ec-a02c-4f3f-a5c0-754be7874969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_c921d6ec-a02c-4f3f-a5c0-754be7874969" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_97a0d074-89b8-4164-a650-259cfaf29d11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_97a0d074-89b8-4164-a650-259cfaf29d11" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b507a939-73dd-456c-bb7b-03095d93a141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b507a939-73dd-456c-bb7b-03095d93a141" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_02710729-d5d2-4f3b-9b76-a875e4920220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_02710729-d5d2-4f3b-9b76-a875e4920220" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_83b1ba18-1c5f-4bef-82d7-876cf7ab5742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_83b1ba18-1c5f-4bef-82d7-876cf7ab5742" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fb4277dd-e29f-4575-bde2-10adfa03884d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fb4277dd-e29f-4575-bde2-10adfa03884d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d4323dc0-8f3d-4072-8801-3bd2502212e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fb4277dd-e29f-4575-bde2-10adfa03884d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d4323dc0-8f3d-4072-8801-3bd2502212e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d4323dc0-8f3d-4072-8801-3bd2502212e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d4323dc0-8f3d-4072-8801-3bd2502212e8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d4323dc0-8f3d-4072-8801-3bd2502212e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_467f44f0-82a4-4b97-af55-50e26dfd6437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d4323dc0-8f3d-4072-8801-3bd2502212e8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_467f44f0-82a4-4b97-af55-50e26dfd6437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember_0461195d-b36d-4ed4-a422-691b86ac094e" xlink:href="avdl-20210630.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_467f44f0-82a4-4b97-af55-50e26dfd6437" xlink:to="loc_avdl_BloxiverzVazculepAkovazandNouressMember_0461195d-b36d-4ed4-a422-691b86ac094e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_50753e05-98c0-47df-88df-b0cf072e547f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fb4277dd-e29f-4575-bde2-10adfa03884d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_50753e05-98c0-47df-88df-b0cf072e547f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_50753e05-98c0-47df-88df-b0cf072e547f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_50753e05-98c0-47df-88df-b0cf072e547f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_50753e05-98c0-47df-88df-b0cf072e547f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c7c9c7ae-592e-4c69-a439-a4dab2f0be03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_50753e05-98c0-47df-88df-b0cf072e547f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c7c9c7ae-592e-4c69-a439-a4dab2f0be03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f72d12c2-ad0b-4ae3-b4d1-a0ee9a561048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c7c9c7ae-592e-4c69-a439-a4dab2f0be03" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f72d12c2-ad0b-4ae3-b4d1-a0ee9a561048" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" xlink:type="extended" id="i9635a7c23bcb42168b08eac84610d4aa_DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ebc793f3-e93e-4b12-a088-cb10a3e79180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ebc793f3-e93e-4b12-a088-cb10a3e79180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9a870743-4b71-400e-a627-65cc559c0680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_CostsAndExpenses_9a870743-4b71-400e-a627-65cc559c0680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c6b380f7-7814-4f79-9829-2cd7408ae5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_OperatingIncomeLoss_c6b380f7-7814-4f79-9829-2cd7408ae5c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bb0dec3d-04cf-47b2-8a85-a215505b8f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bb0dec3d-04cf-47b2-8a85-a215505b8f91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_71733915-625b-4be3-9d05-5b9e44ec6440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_71733915-625b-4be3-9d05-5b9e44ec6440" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cca93c0e-9c92-4bc6-9f2f-4b30c696ce9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cca93c0e-9c92-4bc6-9f2f-4b30c696ce9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a98e425c-fece-4762-8c6b-04d05558650e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a98e425c-fece-4762-8c6b-04d05558650e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6c4a1bd9-23fd-451e-905a-56d29e5aaddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6c4a1bd9-23fd-451e-905a-56d29e5aaddf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9cfa748e-b103-45ba-9831-f429c44d1766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9cfa748e-b103-45ba-9831-f429c44d1766" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d75ffa3b-25cd-4f20-8fb4-085f64308e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d75ffa3b-25cd-4f20-8fb4-085f64308e55" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6b912f99-22b8-4a3c-b463-5e85c0384509" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:to="loc_srt_RestatementAxis_6b912f99-22b8-4a3c-b463-5e85c0384509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_6b912f99-22b8-4a3c-b463-5e85c0384509_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_6b912f99-22b8-4a3c-b463-5e85c0384509" xlink:to="loc_srt_RestatementDomain_6b912f99-22b8-4a3c-b463-5e85c0384509_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_d7c9754e-ff24-4226-af84-4f9ebeb52443" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_6b912f99-22b8-4a3c-b463-5e85c0384509" xlink:to="loc_srt_RestatementDomain_d7c9754e-ff24-4226-af84-4f9ebeb52443" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_97fea2c4-68eb-485a-a165-bd21998a1607" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_d7c9754e-ff24-4226-af84-4f9ebeb52443" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_97fea2c4-68eb-485a-a165-bd21998a1607" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_01bc011b-563f-4c24-9236-4c192443fd8d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_d7c9754e-ff24-4226-af84-4f9ebeb52443" xlink:to="loc_srt_RestatementAdjustmentMember_01bc011b-563f-4c24-9236-4c192443fd8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_47c26dd7-22fd-4a44-8867-1905cb93a5d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:to="loc_srt_StatementScenarioAxis_47c26dd7-22fd-4a44-8867-1905cb93a5d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_47c26dd7-22fd-4a44-8867-1905cb93a5d2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_47c26dd7-22fd-4a44-8867-1905cb93a5d2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_47c26dd7-22fd-4a44-8867-1905cb93a5d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ee723fa6-3923-4e56-b923-f89eb7d8ca98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_47c26dd7-22fd-4a44-8867-1905cb93a5d2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ee723fa6-3923-4e56-b923-f89eb7d8ca98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_a4ebc2a5-b58d-46c6-bc92-7f91bdf73aac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_ee723fa6-3923-4e56-b923-f89eb7d8ca98" xlink:to="loc_srt_ProFormaMember_a4ebc2a5-b58d-46c6-bc92-7f91bdf73aac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6abbaea6-4a47-41da-af4d-c6bc15104c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6abbaea6-4a47-41da-af4d-c6bc15104c69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6abbaea6-4a47-41da-af4d-c6bc15104c69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6abbaea6-4a47-41da-af4d-c6bc15104c69" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6abbaea6-4a47-41da-af4d-c6bc15104c69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b0f7fc5f-3ce6-4533-b52d-747745fc597f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6abbaea6-4a47-41da-af4d-c6bc15104c69" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b0f7fc5f-3ce6-4533-b52d-747745fc597f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_38d313ee-9cb2-4ad4-9520-388aaa18128d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b0f7fc5f-3ce6-4533-b52d-747745fc597f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_38d313ee-9cb2-4ad4-9520-388aaa18128d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#FairValueMeasurementMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="extended" id="iee4f2c6ee6f74e72b304c142ec132ba7_FairValueMeasurementMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76f05f3b-ac64-438f-8dc6-bf9c0d489857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_812458c9-8ec7-4739-b8a6-f2a93e3fc0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76f05f3b-ac64-438f-8dc6-bf9c0d489857" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_812458c9-8ec7-4739-b8a6-f2a93e3fc0a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_1defcbdd-0501-4e0e-ae19-a3b1da8daf35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76f05f3b-ac64-438f-8dc6-bf9c0d489857" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_1defcbdd-0501-4e0e-ae19-a3b1da8daf35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76f05f3b-ac64-438f-8dc6-bf9c0d489857" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_219a5e9f-1609-4c45-b052-ae813a372874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_219a5e9f-1609-4c45-b052-ae813a372874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_219a5e9f-1609-4c45-b052-ae813a372874_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_219a5e9f-1609-4c45-b052-ae813a372874" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_219a5e9f-1609-4c45-b052-ae813a372874_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f146780b-882b-4c0f-a1e1-9817d5882f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_219a5e9f-1609-4c45-b052-ae813a372874" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f146780b-882b-4c0f-a1e1-9817d5882f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d439ca6c-c538-4c6d-afb1-4e061783eb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f146780b-882b-4c0f-a1e1-9817d5882f2c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d439ca6c-c538-4c6d-afb1-4e061783eb6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b5eb186-3eef-4085-95ed-d07b836c1653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b5eb186-3eef-4085-95ed-d07b836c1653" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b5eb186-3eef-4085-95ed-d07b836c1653_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b5eb186-3eef-4085-95ed-d07b836c1653" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b5eb186-3eef-4085-95ed-d07b836c1653_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b5eb186-3eef-4085-95ed-d07b836c1653" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_57dbcdfc-2151-4e0f-a784-89a964de1239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_57dbcdfc-2151-4e0f-a784-89a964de1239" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_47586183-97b1-4edb-acf0-b9f240d3102c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_47586183-97b1-4edb-acf0-b9f240d3102c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0716931e-1c5c-4fd7-bfaa-e4a3c93738c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0716931e-1c5c-4fd7-bfaa-e4a3c93738c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca4a38c4-99ed-49e4-a095-61c3445ca2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca4a38c4-99ed-49e4-a095-61c3445ca2aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca4a38c4-99ed-49e4-a095-61c3445ca2aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca4a38c4-99ed-49e4-a095-61c3445ca2aa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca4a38c4-99ed-49e4-a095-61c3445ca2aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca4a38c4-99ed-49e4-a095-61c3445ca2aa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_25afe8c2-6be5-4a7e-b3f4-7a8f3fa21905" xlink:href="avdl-20210630.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_25afe8c2-6be5-4a7e-b3f4-7a8f3fa21905" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_9a2952db-9878-46d5-87cf-b7ef2548e603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_9a2952db-9878-46d5-87cf-b7ef2548e603" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cde8b38b-9599-4d55-82e9-d38e3daa9eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cde8b38b-9599-4d55-82e9-d38e3daa9eac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_2435c3e4-349e-4910-b713-1b8780f21eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_2435c3e4-349e-4910-b713-1b8780f21eed" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended" id="id37b8cd587914a0d8682e33e37d96e88_FairValueMeasurementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37d43a6a-4918-48b5-9027-b5a93f40604e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c052a561-a787-4355-a5cf-31d5aa409fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37d43a6a-4918-48b5-9027-b5a93f40604e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c052a561-a787-4355-a5cf-31d5aa409fd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_f8e049ee-645a-4cf9-bf6c-84992b187d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37d43a6a-4918-48b5-9027-b5a93f40604e" xlink:to="loc_us-gaap_LongTermDebtFairValue_f8e049ee-645a-4cf9-bf6c-84992b187d86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eb1115ed-73af-4038-bd90-379642f30fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37d43a6a-4918-48b5-9027-b5a93f40604e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eb1115ed-73af-4038-bd90-379642f30fa1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_55e8c608-ab04-4415-88e7-da645f4147da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eb1115ed-73af-4038-bd90-379642f30fa1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_55e8c608-ab04-4415-88e7-da645f4147da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_55e8c608-ab04-4415-88e7-da645f4147da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_55e8c608-ab04-4415-88e7-da645f4147da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_55e8c608-ab04-4415-88e7-da645f4147da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bbd3e371-3311-4785-9e52-260dca96fcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_55e8c608-ab04-4415-88e7-da645f4147da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bbd3e371-3311-4785-9e52-260dca96fcdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_19f62943-ae9c-4e83-85cf-b544fbf23df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bbd3e371-3311-4785-9e52-260dca96fcdf" xlink:to="loc_us-gaap_SeniorNotesMember_19f62943-ae9c-4e83-85cf-b544fbf23df1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d854dc8-6e37-4b40-ac6e-1d9524ee6bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eb1115ed-73af-4038-bd90-379642f30fa1" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d854dc8-6e37-4b40-ac6e-1d9524ee6bf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d854dc8-6e37-4b40-ac6e-1d9524ee6bf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d854dc8-6e37-4b40-ac6e-1d9524ee6bf5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1d854dc8-6e37-4b40-ac6e-1d9524ee6bf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c790dc2a-c346-4e58-ab2d-6b75b6c9a246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d854dc8-6e37-4b40-ac6e-1d9524ee6bf5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c790dc2a-c346-4e58-ab2d-6b75b6c9a246" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_669c88d6-c9d5-4836-80ee-becae7c2850c" xlink:href="avdl-20210630.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c790dc2a-c346-4e58-ab2d-6b75b6c9a246" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_669c88d6-c9d5-4836-80ee-becae7c2850c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#MarketableSecuritiesSummaryofMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="extended" id="i6fe0bc81e30d4b09b6d63151062177ed_MarketableSecuritiesSummaryofMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6e1f9bd8-d478-4fd3-a838-144843593446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6e1f9bd8-d478-4fd3-a838-144843593446" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eb026398-ecbb-4be9-9c13-41d2959062fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eb026398-ecbb-4be9-9c13-41d2959062fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2f6492af-a3a4-4873-89d7-b0a040c8b79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2f6492af-a3a4-4873-89d7-b0a040c8b79c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb1cf393-81fb-48b9-84d6-69deedf69175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb1cf393-81fb-48b9-84d6-69deedf69175" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_29ab94c0-ef89-4938-b37d-6345624c9ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_29ab94c0-ef89-4938-b37d-6345624c9ef0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_affcb53b-01e8-485d-b1b3-9506d4be56b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6e1f9bd8-d478-4fd3-a838-144843593446" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_affcb53b-01e8-485d-b1b3-9506d4be56b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4a40eebf-6966-4827-850c-b371a3d57a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_affcb53b-01e8-485d-b1b3-9506d4be56b4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4a40eebf-6966-4827-850c-b371a3d57a23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4a40eebf-6966-4827-850c-b371a3d57a23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4a40eebf-6966-4827-850c-b371a3d57a23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4a40eebf-6966-4827-850c-b371a3d57a23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4a40eebf-6966-4827-850c-b371a3d57a23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_d89ffc12-5aeb-4be3-ab56-91c0859c2dd8" xlink:href="avdl-20210630.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_d89ffc12-5aeb-4be3-ab56-91c0859c2dd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_de835002-443e-47a2-a384-4f706d579786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_de835002-443e-47a2-a384-4f706d579786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7b68250b-2fdd-4971-aa02-dfa36353d115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7b68250b-2fdd-4971-aa02-dfa36353d115" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_9bed4342-45c1-4e28-85bc-3ba4c76c92bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_9bed4342-45c1-4e28-85bc-3ba4c76c92bf" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#MarketableSecuritiesScheduleofMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="extended" id="ie0783280982f44b3a6c88ebf11626be6_MarketableSecuritiesScheduleofMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_606fb147-eb39-46d4-ad05-cb8ee20de7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_606fb147-eb39-46d4-ad05-cb8ee20de7f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_77b76fd4-3fbb-4ac8-bd84-4c4d73a9d6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_77b76fd4-3fbb-4ac8-bd84-4c4d73a9d6d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_15845e8b-999a-4f1a-82da-ab0fb8450774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_15845e8b-999a-4f1a-82da-ab0fb8450774" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_12de50da-c912-46e7-a1be-71470b790000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_12de50da-c912-46e7-a1be-71470b790000" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f989873f-e574-4939-a460-dafe711e9f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f989873f-e574-4939-a460-dafe711e9f81" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_5f000a26-0bd1-4fe1-a89d-1f39c7ae85f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_5f000a26-0bd1-4fe1-a89d-1f39c7ae85f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a403b7b1-58f3-4d83-9270-4d75b4b09484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_5f000a26-0bd1-4fe1-a89d-1f39c7ae85f6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a403b7b1-58f3-4d83-9270-4d75b4b09484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a403b7b1-58f3-4d83-9270-4d75b4b09484_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a403b7b1-58f3-4d83-9270-4d75b4b09484" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a403b7b1-58f3-4d83-9270-4d75b4b09484_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a403b7b1-58f3-4d83-9270-4d75b4b09484" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3827be39-17df-4909-b74e-398bce9c63fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3827be39-17df-4909-b74e-398bce9c63fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0189d76e-3994-4c0c-9deb-d92d7b0099c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0189d76e-3994-4c0c-9deb-d92d7b0099c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_7df29753-4f0b-4bc1-b7ec-868ee62596da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_7df29753-4f0b-4bc1-b7ec-868ee62596da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_3c6f2ee4-a762-4090-afa8-a05870d274e8" xlink:href="avdl-20210630.xsd#avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:to="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_3c6f2ee4-a762-4090-afa8-a05870d274e8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended" id="ic71d9e4c0ce142bfbdbf41f7fbcfe611_LongTermDebtScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3d85aa3e-3343-49fc-999a-0c4ea07d1f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3d85aa3e-3343-49fc-999a-0c4ea07d1f9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_f3962c62-4965-41ce-ae27-0db720886b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_f3962c62-4965-41ce-ae27-0db720886b40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_88c9a3c4-eb1a-4c35-ad2f-8d59daf59c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_LongTermDebt_88c9a3c4-eb1a-4c35-ad2f-8d59daf59c64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1b366dae-1f58-45ec-a595-e2f2af045f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_LongTermDebtCurrent_1b366dae-1f58-45ec-a595-e2f2af045f78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e1743a7e-133d-4e73-9a2b-57cbef546f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e1743a7e-133d-4e73-9a2b-57cbef546f27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_6cb9711c-f502-4320-9e10-4e713e78a6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_6cb9711c-f502-4320-9e10-4e713e78a6ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f9a63917-b6bd-4718-98f5-ec7c5b3f98f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f9a63917-b6bd-4718-98f5-ec7c5b3f98f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_01fed32f-6022-43bd-80ca-7a1c219dacee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_DebtInstrumentTable_01fed32f-6022-43bd-80ca-7a1c219dacee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b4628190-7be1-4cc2-b31c-6921d21a9c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_01fed32f-6022-43bd-80ca-7a1c219dacee" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b4628190-7be1-4cc2-b31c-6921d21a9c12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b4628190-7be1-4cc2-b31c-6921d21a9c12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b4628190-7be1-4cc2-b31c-6921d21a9c12" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b4628190-7be1-4cc2-b31c-6921d21a9c12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bd07a95b-2e82-46e9-9403-2a2038383625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b4628190-7be1-4cc2-b31c-6921d21a9c12" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bd07a95b-2e82-46e9-9403-2a2038383625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_053264b3-858c-418a-b931-5b6dcabb5105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bd07a95b-2e82-46e9-9403-2a2038383625" xlink:to="loc_us-gaap_SeniorNotesMember_053264b3-858c-418a-b931-5b6dcabb5105" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7afb6bc1-8d23-4a19-a569-d0bd105e49a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_01fed32f-6022-43bd-80ca-7a1c219dacee" xlink:to="loc_us-gaap_DebtInstrumentAxis_7afb6bc1-8d23-4a19-a569-d0bd105e49a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7afb6bc1-8d23-4a19-a569-d0bd105e49a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7afb6bc1-8d23-4a19-a569-d0bd105e49a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7afb6bc1-8d23-4a19-a569-d0bd105e49a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_59ced889-c934-4b16-8e77-dcfffcb39977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7afb6bc1-8d23-4a19-a569-d0bd105e49a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_59ced889-c934-4b16-8e77-dcfffcb39977" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_470f2da0-8ae5-40c7-82a6-fd80d31c9ec9" xlink:href="avdl-20210630.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_59ced889-c934-4b16-8e77-dcfffcb39977" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_470f2da0-8ae5-40c7-82a6-fd80d31c9ec9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="if50dcece78e342b4a57e2517e4f63318_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_020cd327-8dbc-45c9-b774-547588d3e7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_InterestExpenseDebt_020cd327-8dbc-45c9-b774-547588d3e7e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense_22f53b1b-887a-47d4-8127-304b67085113" xlink:href="avdl-20210630.xsd#avdl_CouponInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_CouponInterestExpense_22f53b1b-887a-47d4-8127-304b67085113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1ee53c3d-330d-4714-9e2f-540c3b64ffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1ee53c3d-330d-4714-9e2f-540c3b64ffdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_de80a68f-a7d3-4a59-97f5-0ce4f0108776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_LongTermDebt_de80a68f-a7d3-4a59-97f5-0ce4f0108776" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e10aba65-bd0d-473a-aa49-2be6210e4496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_StockholdersEquity_e10aba65-bd0d-473a-aa49-2be6210e4496" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3487a9a4-97dc-40ae-a6c5-1179f12f4734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3487a9a4-97dc-40ae-a6c5-1179f12f4734" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4214dbfb-7288-443c-9fc0-cf2fa1b78e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4214dbfb-7288-443c-9fc0-cf2fa1b78e8f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_2d8abf20-3144-4fc0-ae23-4156849712ed" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_2d8abf20-3144-4fc0-ae23-4156849712ed" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_3e8038f6-1664-446e-a537-d9376240a574" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_3e8038f6-1664-446e-a537-d9376240a574" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_06a6b663-cd3d-4de6-bd83-78a279ad230f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_06a6b663-cd3d-4de6-bd83-78a279ad230f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_bffc56a3-a516-446d-b5ab-acd5576ed086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_bffc56a3-a516-446d-b5ab-acd5576ed086" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio_078de8ea-0027-4ff4-897a-05a380e7c83d" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_AmericanDepositorySharesConversionRatio_078de8ea-0027-4ff4-897a-05a380e7c83d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare_d2c5a988-21b3-4cb6-a303-945e14d83d2b" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_AmericanDepositarySharesOptionPricePerShare_d2c5a988-21b3-4cb6-a303-945e14d83d2b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPremiumPercentage_83077426-0ea9-418b-a084-8f01d0a4de8e" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositarySharesPremiumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_AmericanDepositarySharesPremiumPercentage_83077426-0ea9-418b-a084-8f01d0a4de8e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_40ccb362-51ed-4d18-88cf-5da50bae7698" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositarySharesPurchasedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_40ccb362-51ed-4d18-88cf-5da50bae7698" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_b2c01d92-b0b4-4685-b369-2721fe2ff3c2" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_b2c01d92-b0b4-4685-b369-2721fe2ff3c2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_d328e07a-b534-48db-a6ad-c74232243e06" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_d328e07a-b534-48db-a6ad-c74232243e06" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_52082682-7391-4424-8914-ab6d5c20fcd3" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_52082682-7391-4424-8914-ab6d5c20fcd3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_8abe9faf-df46-4733-9543-3f5bd8909c70" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_8abe9faf-df46-4733-9543-3f5bd8909c70" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_d1aa9c68-b766-4823-83b5-281ba1d3fe0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_d1aa9c68-b766-4823-83b5-281ba1d3fe0f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_ba6c3010-e271-4086-acba-13d483efbef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_ba6c3010-e271-4086-acba-13d483efbef5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_64bfc08f-fe60-4698-885f-8de6a6458901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_64bfc08f-fe60-4698-885f-8de6a6458901" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6fcb3d11-0bc6-4875-aa3e-b6e0c95f25d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6fcb3d11-0bc6-4875-aa3e-b6e0c95f25d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6fcb3d11-0bc6-4875-aa3e-b6e0c95f25d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6fcb3d11-0bc6-4875-aa3e-b6e0c95f25d8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6fcb3d11-0bc6-4875-aa3e-b6e0c95f25d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6fcb3d11-0bc6-4875-aa3e-b6e0c95f25d8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_5946e798-1615-401e-b53e-43c9f1728e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_5946e798-1615-401e-b53e-43c9f1728e0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e26b921b-1199-48b5-8139-d3bf91943e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e26b921b-1199-48b5-8139-d3bf91943e56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_7c0602fc-eeb7-49be-be9b-1ad777667936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_7c0602fc-eeb7-49be-be9b-1ad777667936" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7aa895f7-4772-4dd7-9496-84b2bdfdc7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_us-gaap_DebtInstrumentAxis_7aa895f7-4772-4dd7-9496-84b2bdfdc7c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7aa895f7-4772-4dd7-9496-84b2bdfdc7c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7aa895f7-4772-4dd7-9496-84b2bdfdc7c1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7aa895f7-4772-4dd7-9496-84b2bdfdc7c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_344cdb8a-8f92-4aa8-af2a-161f96ec483c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7aa895f7-4772-4dd7-9496-84b2bdfdc7c1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_344cdb8a-8f92-4aa8-af2a-161f96ec483c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_9423624b-9b63-4d4d-99f8-fa7764afb85a" xlink:href="avdl-20210630.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_344cdb8a-8f92-4aa8-af2a-161f96ec483c" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_9423624b-9b63-4d4d-99f8-fa7764afb85a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4ac4d46f-042e-4627-a537-5c5e10a89787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4ac4d46f-042e-4627-a537-5c5e10a89787" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ac4d46f-042e-4627-a537-5c5e10a89787_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4ac4d46f-042e-4627-a537-5c5e10a89787" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ac4d46f-042e-4627-a537-5c5e10a89787_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6563ff7b-55f1-4fad-9378-ce9fae590b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4ac4d46f-042e-4627-a537-5c5e10a89787" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6563ff7b-55f1-4fad-9378-ce9fae590b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_916e558d-39e3-4802-b1d0-30996c223f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6563ff7b-55f1-4fad-9378-ce9fae590b2f" xlink:to="loc_us-gaap_ConvertibleDebtMember_916e558d-39e3-4802-b1d0-30996c223f2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9f1718d7-dd95-46e9-ae2a-099125d5558f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6563ff7b-55f1-4fad-9378-ce9fae590b2f" xlink:to="loc_us-gaap_SeniorNotesMember_9f1718d7-dd95-46e9-ae2a-099125d5558f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47730c0d-17c4-4296-b908-e9690f895c6c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47730c0d-17c4-4296-b908-e9690f895c6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_47730c0d-17c4-4296-b908-e9690f895c6c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47730c0d-17c4-4296-b908-e9690f895c6c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_47730c0d-17c4-4296-b908-e9690f895c6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_170bd4a5-0728-4fc8-ad03-a0953c01dd5a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47730c0d-17c4-4296-b908-e9690f895c6c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_170bd4a5-0728-4fc8-ad03-a0953c01dd5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_aec968c6-c8bc-4175-af98-9c1faa28d2ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_170bd4a5-0728-4fc8-ad03-a0953c01dd5a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_aec968c6-c8bc-4175-af98-9c1faa28d2ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e82f6ca8-11cc-419f-a06b-52b9007a3aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e82f6ca8-11cc-419f-a06b-52b9007a3aa5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e82f6ca8-11cc-419f-a06b-52b9007a3aa5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e82f6ca8-11cc-419f-a06b-52b9007a3aa5" xlink:to="loc_us-gaap_EquityComponentDomain_e82f6ca8-11cc-419f-a06b-52b9007a3aa5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a408b6ff-3105-4b89-a287-5cb930c7484f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e82f6ca8-11cc-419f-a06b-52b9007a3aa5" xlink:to="loc_us-gaap_EquityComponentDomain_a408b6ff-3105-4b89-a287-5cb930c7484f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9a2d496a-8b8f-4c03-be8e-bd4efcbb0936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a408b6ff-3105-4b89-a287-5cb930c7484f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9a2d496a-8b8f-4c03-be8e-bd4efcbb0936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0d898684-0e0b-4849-af99-e784fd1ae9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a408b6ff-3105-4b89-a287-5cb930c7484f" xlink:to="loc_us-gaap_RetainedEarningsMember_0d898684-0e0b-4849-af99-e784fd1ae9ed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#RestructuringCostsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="extended" id="i7015756592e14430a0372d2bdaa291a8_RestructuringCostsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a3ed12ff-11db-4fe0-af3e-91a6ee90ba54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_3b92515a-0329-46e4-8647-9360bf8634c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a3ed12ff-11db-4fe0-af3e-91a6ee90ba54" xlink:to="loc_us-gaap_RestructuringReserve_3b92515a-0329-46e4-8647-9360bf8634c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_6b647ff2-200d-42a2-87ff-1a8d79fb1440" xlink:href="avdl-20210630.xsd#avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a3ed12ff-11db-4fe0-af3e-91a6ee90ba54" xlink:to="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_6b647ff2-200d-42a2-87ff-1a8d79fb1440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6d2136d0-6a70-4367-897e-3ab8a7e2f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a3ed12ff-11db-4fe0-af3e-91a6ee90ba54" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6d2136d0-6a70-4367-897e-3ab8a7e2f0ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_31048932-d966-462a-a430-0c1799ad483b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6d2136d0-6a70-4367-897e-3ab8a7e2f0ce" xlink:to="loc_us-gaap_RestructuringPlanAxis_31048932-d966-462a-a430-0c1799ad483b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_31048932-d966-462a-a430-0c1799ad483b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_31048932-d966-462a-a430-0c1799ad483b" xlink:to="loc_us-gaap_RestructuringPlanDomain_31048932-d966-462a-a430-0c1799ad483b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_31048932-d966-462a-a430-0c1799ad483b" xlink:to="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_a00928da-89d0-4bc8-a031-5698decf50df" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:to="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_a00928da-89d0-4bc8-a031-5698decf50df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CorporateWorkforceReductionMember_5a107232-ac9e-462a-b802-5e24f9be1fe5" xlink:href="avdl-20210630.xsd#avdl_CorporateWorkforceReductionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:to="loc_avdl_CorporateWorkforceReductionMember_5a107232-ac9e-462a-b802-5e24f9be1fe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_208d760c-71e8-49ac-b89f-24d89cbf3d99" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateRestructuringObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:to="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_208d760c-71e8-49ac-b89f-24d89cbf3d99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5513f0b7-818f-4df4-8607-56b89ed0cbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6d2136d0-6a70-4367-897e-3ab8a7e2f0ce" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5513f0b7-818f-4df4-8607-56b89ed0cbf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5513f0b7-818f-4df4-8607-56b89ed0cbf9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5513f0b7-818f-4df4-8607-56b89ed0cbf9" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5513f0b7-818f-4df4-8607-56b89ed0cbf9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_9d44fc1d-bbb1-4dec-bad4-c5a62c6c3f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5513f0b7-818f-4df4-8607-56b89ed0cbf9" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_9d44fc1d-bbb1-4dec-bad4-c5a62c6c3f1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_b0d7df92-f778-44cc-83cd-5c89f9a41678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9d44fc1d-bbb1-4dec-bad4-c5a62c6c3f1e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_b0d7df92-f778-44cc-83cd-5c89f9a41678" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#RestructuringCostsSeveranceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="extended" id="ib40b57bd303146a9ad1b76897b63a1d1_RestructuringCostsSeveranceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_91f1367d-60c9-4b8e-8ee0-e7db686b99e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_91f1367d-60c9-4b8e-8ee0-e7db686b99e9" xlink:to="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2b481144-3d9e-433c-8395-343802f36511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:to="loc_us-gaap_RestructuringReserve_2b481144-3d9e-433c-8395-343802f36511" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_fdd0825a-8179-4319-a6c2-280fda885e49" xlink:href="avdl-20210630.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:to="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_fdd0825a-8179-4319-a6c2-280fda885e49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_8dcd496f-5c7e-4df8-83d5-dc94b5372085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:to="loc_us-gaap_PaymentsForRestructuring_8dcd496f-5c7e-4df8-83d5-dc94b5372085" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_a07224a6-f9eb-463e-b89b-7c78b7367cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_a07224a6-f9eb-463e-b89b-7c78b7367cef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_ab145677-07a9-41b5-a769-c440c8c8bcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9927b657-8851-4e5e-b8c9-09cf221264fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_91f1367d-60c9-4b8e-8ee0-e7db686b99e9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9927b657-8851-4e5e-b8c9-09cf221264fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_5136d4cc-8940-42d8-b75b-ee55b1c7d453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9927b657-8851-4e5e-b8c9-09cf221264fe" xlink:to="loc_us-gaap_RestructuringPlanAxis_5136d4cc-8940-42d8-b75b-ee55b1c7d453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5136d4cc-8940-42d8-b75b-ee55b1c7d453_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_5136d4cc-8940-42d8-b75b-ee55b1c7d453" xlink:to="loc_us-gaap_RestructuringPlanDomain_5136d4cc-8940-42d8-b75b-ee55b1c7d453_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5de3476b-e7e3-4ff7-bd2a-a373bb1cfc92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_5136d4cc-8940-42d8-b75b-ee55b1c7d453" xlink:to="loc_us-gaap_RestructuringPlanDomain_5de3476b-e7e3-4ff7-bd2a-a373bb1cfc92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_38a5ac4f-7656-4142-9a54-ca694665a802" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_5de3476b-e7e3-4ff7-bd2a-a373bb1cfc92" xlink:to="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_38a5ac4f-7656-4142-9a54-ca694665a802" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_1b3c10d7-56c5-4461-a0ad-e75bfbb185d6" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateRestructuringObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_5de3476b-e7e3-4ff7-bd2a-a373bb1cfc92" xlink:to="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_1b3c10d7-56c5-4461-a0ad-e75bfbb185d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_7b70a8dd-78e8-414a-823e-572f997ee902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9927b657-8851-4e5e-b8c9-09cf221264fe" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_7b70a8dd-78e8-414a-823e-572f997ee902" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7b70a8dd-78e8-414a-823e-572f997ee902_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7b70a8dd-78e8-414a-823e-572f997ee902" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7b70a8dd-78e8-414a-823e-572f997ee902_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7fa723ce-893f-49e7-83ec-e153454b6e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7b70a8dd-78e8-414a-823e-572f997ee902" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7fa723ce-893f-49e7-83ec-e153454b6e89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_e97ba4d2-f67d-4977-99b1-029e7d784da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7fa723ce-893f-49e7-83ec-e153454b6e89" xlink:to="loc_us-gaap_EmployeeSeveranceMember_e97ba4d2-f67d-4977-99b1-029e7d784da2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#ComprehensiveIncomeLossComponentsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails" xlink:type="extended" id="i74c1b859827448fda9ac9593fbf67a55_ComprehensiveIncomeLossComponentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7337e86-21b1-499c-b2e3-1e56fb14d9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b8110da9-e1d5-43bd-8e0e-94b4ae653706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7337e86-21b1-499c-b2e3-1e56fb14d9b6" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b8110da9-e1d5-43bd-8e0e-94b4ae653706" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_156dec52-647b-4532-a37f-c8e0c05b6084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b8110da9-e1d5-43bd-8e0e-94b4ae653706" xlink:to="loc_us-gaap_StockholdersEquity_156dec52-647b-4532-a37f-c8e0c05b6084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_86dcc6e5-6199-47ab-bfe1-ce65205da39b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b8110da9-e1d5-43bd-8e0e-94b4ae653706" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_86dcc6e5-6199-47ab-bfe1-ce65205da39b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d92400de-9abe-43a5-beb5-46d56b96f0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_75978110-56d7-42ed-bf2c-e84d11dbf7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7337e86-21b1-499c-b2e3-1e56fb14d9b6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_75978110-56d7-42ed-bf2c-e84d11dbf7c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d3ca41dc-0b92-427d-8107-30d827297dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_75978110-56d7-42ed-bf2c-e84d11dbf7c1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d3ca41dc-0b92-427d-8107-30d827297dc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d3ca41dc-0b92-427d-8107-30d827297dc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d3ca41dc-0b92-427d-8107-30d827297dc1" xlink:to="loc_us-gaap_EquityComponentDomain_d3ca41dc-0b92-427d-8107-30d827297dc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d3ca41dc-0b92-427d-8107-30d827297dc1" xlink:to="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_05a0e711-15dc-4e56-b042-6abfbed6fd93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_05a0e711-15dc-4e56-b042-6abfbed6fd93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_e9cdd04d-aa2f-47bb-961d-c95b5fd969f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_e9cdd04d-aa2f-47bb-961d-c95b5fd969f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3186411a-fc04-4fe4-a84d-1893b2b093f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3186411a-fc04-4fe4-a84d-1893b2b093f0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#RevenuebyProductSummaryofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails" xlink:type="extended" id="i9df9c83d6fb34828ab3f96a4c7570503_RevenuebyProductSummaryofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f9748938-9aac-4772-960d-82ce66c6ff75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_03da9ebe-e798-4726-9eb7-dd10a561643c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9748938-9aac-4772-960d-82ce66c6ff75" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_03da9ebe-e798-4726-9eb7-dd10a561643c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3616c664-b6c8-4ea5-bae9-c3c26617fcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9748938-9aac-4772-960d-82ce66c6ff75" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3616c664-b6c8-4ea5-bae9-c3c26617fcfc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_050aaafb-599e-4fe2-9765-aaf9431c7cf8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3616c664-b6c8-4ea5-bae9-c3c26617fcfc" xlink:to="loc_srt_ProductOrServiceAxis_050aaafb-599e-4fe2-9765-aaf9431c7cf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_050aaafb-599e-4fe2-9765-aaf9431c7cf8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_050aaafb-599e-4fe2-9765-aaf9431c7cf8" xlink:to="loc_srt_ProductsAndServicesDomain_050aaafb-599e-4fe2-9765-aaf9431c7cf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_050aaafb-599e-4fe2-9765-aaf9431c7cf8" xlink:to="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzMember_0cdfd058-0438-47b0-849c-1fa50d1b0526" xlink:href="avdl-20210630.xsd#avdl_BloxiverzMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:to="loc_avdl_BloxiverzMember_0cdfd058-0438-47b0-849c-1fa50d1b0526" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VazculepMember_4ea42388-f4f7-4311-8fb0-98b7189c1c9c" xlink:href="avdl-20210630.xsd#avdl_VazculepMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:to="loc_avdl_VazculepMember_4ea42388-f4f7-4311-8fb0-98b7189c1c9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AkovazMember_96cffa35-daaf-4d5c-9207-bed6723fb15d" xlink:href="avdl-20210630.xsd#avdl_AkovazMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:to="loc_avdl_AkovazMember_96cffa35-daaf-4d5c-9207-bed6723fb15d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherProductsMember_881b84d6-22e3-4933-9151-f087a34c2a7c" xlink:href="avdl-20210630.xsd#avdl_OtherProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:to="loc_avdl_OtherProductsMember_881b84d6-22e3-4933-9151-f087a34c2a7c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="i6c98847d130e4074ab9056ffba7c8f47_CommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_270f7ade-fcbc-47bf-9432-157fb7e7856d" xlink:href="avdl-20210630.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:to="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_270f7ade-fcbc-47bf-9432-157fb7e7856d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_991b8c68-d093-45cd-89cb-cda4df64cc87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_991b8c68-d093-45cd-89cb-cda4df64cc87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeAssetCurrentCarryingValue_8b35eabb-2e52-4f85-9d03-2abf883b57c6" xlink:href="avdl-20210630.xsd#avdl_GuaranteeAssetCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:to="loc_avdl_GuaranteeAssetCurrentCarryingValue_8b35eabb-2e52-4f85-9d03-2abf883b57c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_55aed148-cf59-4eec-95ba-e13fe1a575d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:to="loc_us-gaap_LossContingenciesTable_55aed148-cf59-4eec-95ba-e13fe1a575d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6983feed-0059-4221-9e86-2ea40725494e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55aed148-cf59-4eec-95ba-e13fe1a575d8" xlink:to="loc_srt_RangeAxis_6983feed-0059-4221-9e86-2ea40725494e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6983feed-0059-4221-9e86-2ea40725494e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6983feed-0059-4221-9e86-2ea40725494e" xlink:to="loc_srt_RangeMember_6983feed-0059-4221-9e86-2ea40725494e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2ec90904-396f-4f4d-8d6a-c2ca44e0177d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6983feed-0059-4221-9e86-2ea40725494e" xlink:to="loc_srt_RangeMember_2ec90904-396f-4f4d-8d6a-c2ca44e0177d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d4341a8-51c8-46b9-a551-75d5c6bcb024" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2ec90904-396f-4f4d-8d6a-c2ca44e0177d" xlink:to="loc_srt_MaximumMember_3d4341a8-51c8-46b9-a551-75d5c6bcb024" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>avdl-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a7d49b9d-9e9c-4202-a2e9-33a099e78bd3,g:e5693fe9-19ce-4a74-abcb-b22740470bdd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_16bf6766-63aa-4177-aa9d-12c031c36532_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_68ad263f-4474-4eeb-8cb4-dc3d11728492_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on marketable debt securities, net</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_276d19b0-b957-4c9c-8cc0-8a855e7a9574_negatedLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_66ed0bac-03a6-4a6e-a351-d92733121a2c_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_afccd35b-5d0e-49f2-aeb0-34e7a53ca22e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_1dc2c333-d927-4b77-90a1-5357a25021ce_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2dcc7a1d-9c92-424f-b68e-cf8d312d9024_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4d42875d-04ef-4dd0-b39b-b67dbdc630c8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_38274820-35e0-460c-88f9-d01b7ebb1c25_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_f12eb430-0336-41c5-9e65-9e971cd72537_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADSs, conversion ratio</link:label>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_label_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, Conversion Ratio</link:label>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_documentation_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositorySharesConversionRatio" xlink:to="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_6ef09082-3132-4127-befb-d07bd8fbcdcb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_168fa2f9-ca37-4642-8f93-5ade37ea88df_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b21be2df-9cca-4b92-8f69-d6a8413b0f46_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8d7ff5d3-1cae-49a5-94e4-05a6cf788970_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_c8c3396e-1354-4319-a950-8ce7b1bf06da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_52107c5d-7448-4b0e-93fa-90d08988f2d4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_f96be964-328b-463c-9fa1-1961fd5fd963_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_3af5eafc-b724-476f-8607-379a86ec23e5_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_fbcd34a6-619f-464b-bffe-bf7d23f21b40_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_15cac219-b93e-4b66-a8c3-14dbe0ffb181_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_457b6dac-1a8a-474b-9ee3-26900f279602_verboseLabel_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value-added tax recoverable</link:label>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Added Tax Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:to="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_0a053f40-3e6f-4079-a4df-c29d4d728060_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_cd7d97a6-e1b6-47e5-9f80-ade11b129235_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ShortTermNoteReceivable_ce913a4b-9ccd-463e-8dbf-ca566dc52206_terseLabel_en-US" xlink:label="lab_avdl_ShortTermNoteReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable from Exela (see Note 3)</link:label>
    <link:label id="lab_avdl_ShortTermNoteReceivable_label_en-US" xlink:label="lab_avdl_ShortTermNoteReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Note Receivable</link:label>
    <link:label id="lab_avdl_ShortTermNoteReceivable_documentation_en-US" xlink:label="lab_avdl_ShortTermNoteReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Note Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ShortTermNoteReceivable" xlink:href="avdl-20210630.xsd#avdl_ShortTermNoteReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ShortTermNoteReceivable" xlink:to="lab_avdl_ShortTermNoteReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5c071c06-0983-4af1-bf51-a1a7cfaba53c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuarantyLiabilities_b8e10e10-201e-4ede-8364-a31a9500f4cc_terseLabel_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee to Deerfield</link:label>
    <link:label id="lab_us-gaap_GuarantyLiabilities_label_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuarantyLiabilities" xlink:to="lab_us-gaap_GuarantyLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5ae207db-4063-4d05-b018-c0ab9f56e9bc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_bebe7fdc-a7b3-47cc-89f3-7876361ac32d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of the Hospital Products</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_9a7df06c-4877-40be-9707-8ac59e21c6bd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_c0f65f7b-86d9-416e-95dc-2a68f6dd03ef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_37aca276-8c63-4b49-a213-904ee0b77505_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party payable, beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_271cc588-1d54-4d1c-909d-f88d319d2340_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party payable, ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9a85fa7b-5c0f-4158-bc8c-a3ddefae5158_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_6394bcd5-4851-42b3-a3b1-9b39ad3393e3_terseLabel_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 French Restructuring Obligation</link:label>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_label_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Corporate French Restructuring Obligation [Member]</link:label>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_documentation_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Corporate French Restructuring Obligation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:to="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2c6537bc-ab89-408c-a705-0f29bdca56f5_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_92533864-3f25-4466-be4c-7e54f6d97540_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction fees</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_e5d7522d-7c08-4b82-9dfd-be8ac47e2a87_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less transaction fees</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_3ed4ae53-c204-4b77-a787-a92aef69e645_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e2db1de8-69c1-4d07-8d89-1c83646ffc9f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive (loss) income, net of $(78), $(81), $(133) and $(130) tax, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_b3362827-320d-425e-966f-c9e4fcf9b8a7_terseLabel_en-US" xlink:label="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_label_en-US" xlink:label="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Excluding Money Market Funds, Available For Sale [Member]</link:label>
    <link:label id="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_documentation_en-US" xlink:label="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Excluding Money Market Funds, Available For Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:href="avdl-20210630.xsd#avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:to="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_85a00935-0453-496a-86c3-ec6fef8a5d91_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_6f472c94-7ccd-4ac3-bf40-78f96ee9de32_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, liability</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_839ee582-dbea-4085-9e12-3866add1e062_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_BloxiverzMember_d27d0785-ba12-46b2-8caa-ffb180fa735f_terseLabel_en-US" xlink:label="lab_avdl_BloxiverzMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bloxiverz</link:label>
    <link:label id="lab_avdl_BloxiverzMember_label_en-US" xlink:label="lab_avdl_BloxiverzMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bloxiverz [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzMember" xlink:href="avdl-20210630.xsd#avdl_BloxiverzMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_BloxiverzMember" xlink:to="lab_avdl_BloxiverzMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_f3147100-20d6-4d49-8499-df2039f3c125_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Maturity Dates</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e21a3c77-af78-4c3d-aa79-adc1b34daed3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6959d1c9-4125-4fc5-b1b6-3d0dd6bf587d_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_1fd161dd-caaa-4300-aaaa-227ebd75c6fa_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at June&#160;30, 2021 and 488 issued and outstanding at December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b1391b44-e5fb-43a2-99a6-9c927eb4f5b9_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock option exercises and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_99ca337f-030d-4187-96ce-71b079f9b2cf_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3466140b-37d2-462e-9eaa-1148884d946d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_32fe9e22-20ef-48aa-a63d-8903213d36f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_28b1f770-4eb7-4daf-98d8-c1d57ffeb98c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1975e718-6e95-40cf-bfd3-c390797fbd0c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_40bb767f-b9f8-4fa9-a8f6-894a229dc957_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_5e2b9ead-cf0a-4a4f-b7b3-ae3a8f1f7e17_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ac42dbf2-4073-4e93-bb41-0cd4487af2e6_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_f76b2c30-34d5-42c9-af48-d59ab9043d1c_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS, option price per share (in dollars per share)</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Option Price Per Share</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Option Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:to="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_67fa521a-30a5-44f1-978a-8c6361f64c59_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:to="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MutualAndMoneyMarketFundsMember_856fcab2-c17b-4d45-8776-67555a895fbe_terseLabel_en-US" xlink:label="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual and money market funds</link:label>
    <link:label id="lab_avdl_MutualAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual And Money Market Funds [Member]</link:label>
    <link:label id="lab_avdl_MutualAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual And Money Market Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember" xlink:href="avdl-20210630.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MutualAndMoneyMarketFundsMember" xlink:to="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_c65fede1-71ec-42bd-9fd0-a3f46eb9e8b2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_f876c0f2-b073-42ff-ad15-18aa3f95c611_terseLabel_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Corporate Restructuring Obligations</link:label>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_label_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Corporate Restructuring Obligations [Member]</link:label>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_documentation_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Corporate Restructuring Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateRestructuringObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:to="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_VazculepMember_be6839f4-e39d-40db-916e-7c653bc7815c_terseLabel_en-US" xlink:label="lab_avdl_VazculepMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vazculep</link:label>
    <link:label id="lab_avdl_VazculepMember_label_en-US" xlink:label="lab_avdl_VazculepMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vazculep [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VazculepMember" xlink:href="avdl-20210630.xsd#avdl_VazculepMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_VazculepMember" xlink:to="lab_avdl_VazculepMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_47e9392c-3c12-4db1-8ce8-4cb3cc8427b1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_efc382c1-5663-4e5b-b201-98f58393c116_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_c23b2c68-8ac0-4cd2-b9b9-ee60ea050a42_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_1d2af287-bdbe-48ea-a4b6-bde27504a395_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_941e731a-58e1-419a-8cd9-dd5cd90d91e2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income - diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:to="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_121234ca-7a74-422e-a4d1-a7d27b3600a8_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_3dec06b7-2ba7-4f6d-8044-80bca60f5a03_terseLabel_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_label_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Tax Credit Receivable, Current</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_documentation_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Tax Credit Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:href="avdl-20210630.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:to="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c7a882c7-600d-4654-b455-fea8d8451e63_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_e5f1207e-c4bd-4ea6-a310-b5d21577d973_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of Hospital Products</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_5e5975ca-c362-4832-85d1-9c1a9c9a63af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from the disposition of the hospital products</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_26bce5cb-d1a3-4b6a-a1b4-b5d2c601856f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_7b3dfd79-1bba-4f47-8af2-9ecf0a881303_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency impact</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4a8963fa-12c7-4677-8046-444a82cd2198_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_593237e2-e835-49e9-91b6-64a30a432b2a_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_6f560363-9fbe-4a77-b28d-7f61e961efde_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_117e28c6-ae59-4f01-b7ae-0416c1480648_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_eff419e0-7cba-4d70-993c-6ae26003dc22_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_e1200e52-09b2-412a-ac87-c49a3cedcd62_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred contract costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4afb7a3f-c457-49c3-8a85-0c87322dd0b0_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8e006a7f-111e-4e27-81c1-4854f26c4dc9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_9fed3b13-d616-41db-8f14-0b394de0cddc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_302a65f0-29ee-4d0d-8716-b58bae195518_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of 4.50% exchangeable senior notes due 2023</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_c84a1e92-fbef-402f-85c6-0f7a57a5317f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_eba57785-b088-4faa-94e7-2aa06ed685c4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_357eec6c-a900-4315-897b-f783b998fd0d_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount of liability component</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_0db385fb-f18e-49e4-9460-51d89f46d820_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_327aefc2-88dd-46a1-a92c-affa7447888c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_46ff608e-1ec4-40c2-89da-b38753200e28_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_44c4a5f3-56d4-4391-8209-878062b6fa94_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b2bf19c8-aa7a-47cd-a3a0-1595b22582f2_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4fc60911-49d4-430b-97e5-7e327022c54d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_36ec6e72-3677-4227-b83b-442d09cfa000_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_85e86f28-8633-4961-aff8-8f1db3343bb1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member_39f8fe4b-943f-4edb-b14a-d9409b8bf561_terseLabel_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Exchangeable Senior Notes Due 2023</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member_label_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:href="avdl-20210630.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:to="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4b855adf-1c7f-4268-9675-a573f5289737_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering_0c17c74b-7eb6-447b-b173-e570be666469_terseLabel_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 public offering (in shares)</link:label>
    <link:label id="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering_label_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Public Offering</link:label>
    <link:label id="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering_documentation_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:href="avdl-20210630.xsd#avdl_StockIssuedDuringPeriodSharesPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:to="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_e67bc8b7-2d2e-4b9d-a4db-470e1d2dc00b_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f90138f6-460d-4f2b-951d-73323e2e4129_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government securities - U.S.</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_6cdf3f30-b8bf-4643-adfb-6a206a535e88_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty payments for contingent consideration payable in excess of original fair value</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_704263dc-8917-453c-8138-79c3e86628c7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0597e660-c48b-4297-b0a9-a879602c8de8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_8c883816-232a-4ea0-8294-a9b0b31c6861_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the May 2020 public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_f7cb317f-f565-4ea6-a177-2205cdbf511d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable &amp; other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_b8e5756f-18ba-4510-9ec1-024d2b97ae85_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_fc0271f9-b2ff-41cf-8b0e-6362897bbf01_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_1bdccf07-85c6-4887-a80e-dad475ce7f33_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (Loss) Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c8e8ee69-a30b-47ac-b1af-a1d7f382ac2c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_19e6c70c-725b-4216-9913-227953b90a7b_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets:</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b236c35d-1956-478c-b492-bf02bd7b6917_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_c2ea5d4f-223b-4a5f-af3c-a5ea658caf2b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_8b1d7ae1-520d-49cf-92ec-565b65fdfeb5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of exchangeable notes, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_ee394c68-b228-43a3-b730-6a1b1f545499_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, realized gain</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_aeaa0a88-9a81-4215-b564-a93e5fd7d4b4_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_26be5e12-4780-4e60-8828-46c131878df6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cff7a53c-3e01-49de-931f-154a7c81da54_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_9f2bb048-4956-4496-adf5-78822e8c518e_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_bc278c9d-438a-4ed3-b79f-372a4d2177fb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_3cc9f119-4eae-4017-8911-0f7264c53937_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_69a6c2cf-d174-4f78-b8ad-6ed579b2ea73_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to increase aggregate principal amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_label_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option to Increase Face Amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option to Increase Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:to="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_3820f6be-7ff0-4472-994a-81f83ffb68ad_terseLabel_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets at contract manufacturing organizations</link:label>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_label_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</link:label>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_documentation_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:href="avdl-20210630.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:to="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_97bed994-02cd-4628-a59a-7beabcb77bb1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_bccf7d4c-a6d7-4256-8419-08356aa962f3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than 10 Years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_c7863ebb-b60b-44b4-8b88-bbd7b14454e2_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_865ea1e5-c667-402b-bfd2-9d1e7d59f9cc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_f4c2f128-5c50-4181-a77f-bb78117ed480_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_5847eeaa-ee09-456b-a647-de0700019f97_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_80a5c87f-16f3-457d-87a5-99d23f41be5a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets:</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_fc01a9e1-a722-4e52-be1f-2e0910fdf6f4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_208e0122-4f23-47fc-b90b-98fefdf65792_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_441c2425-3c8b-4b6a-a7f9-a5afbc74117c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_92315b26-fe63-442b-af1a-6f02074dd59a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2020 private placement</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_1eb6c8ea-470b-4b00-bcd4-1883166a8ded_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_ec5c3a36-513e-4ff1-a973-4f16a4b7cabc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_4119b05c-6910-4142-a8de-48fb004aec25_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_ce1f97cf-e9f9-4b75-ac29-c1807423b5fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_95564d87-6c32-4a21-b382-2d131331a04b_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_5fde42f6-53dd-4831-9f0f-7eb51c3d6545_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_0de2a304-06a6-4cb0-b0f7-289a1f63dcb0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from income tax refunds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Income Tax Refunds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:to="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_1607152e-5256-4c10-b4aa-58ed97e2ac2b_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_5418f1b9-3894-4aa9-a3b4-ac994f0ca956_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_08979faa-c31d-46db-ab29-ffed09aeef6e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_44dcc749-000e-4925-90a6-b371dd143f45_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2020 private placement (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_9028a3be-c366-46af-bdc5-bd0abd61d3c9_verboseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_3f102bd9-8821-4002-95af-9acd751e8145_terseLabel_en-US" xlink:label="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges (income) for employee severance, benefits and other costs</link:label>
    <link:label id="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_label_en-US" xlink:label="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Before Gain (Loss) Due to Curtailment</link:label>
    <link:label id="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_documentation_en-US" xlink:label="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Before Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:href="avdl-20210630.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:to="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ab074272-a1f4-4466-af93-c9a23374966f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_2cd0ce69-cbe6-43c5-9075-402f17c912dc_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 58,488 issued and outstanding at June&#160;30, 2021 and 58,396 issued and outstanding at December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_7db79873-3557-4c02-a93f-b2db21d5572b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net liabilities disposed of</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_fe805e89-845e-40f6-abe8-57a581687857_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5acbca39-29fb-4ca5-af45-047c702dce30_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AkovazMember_cc82e416-b98d-465a-98c5-f7d3a92d5806_terseLabel_en-US" xlink:label="lab_avdl_AkovazMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akovaz</link:label>
    <link:label id="lab_avdl_AkovazMember_label_en-US" xlink:label="lab_avdl_AkovazMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akovaz [Member]</link:label>
    <link:label id="lab_avdl_AkovazMember_documentation_en-US" xlink:label="lab_avdl_AkovazMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akovaz [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AkovazMember" xlink:href="avdl-20210630.xsd#avdl_AkovazMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AkovazMember" xlink:to="lab_avdl_AkovazMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecurities_dbfcd8a4-b13a-40b2-8f29-6a2d5a8f14eb_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: interest from 2023 Notes, net of tax</link:label>
    <link:label id="lab_us-gaap_DilutiveSecurities_label_en-US" xlink:label="lab_us-gaap_DilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecurities" xlink:to="lab_us-gaap_DilutiveSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_1b1bc4ff-a9ac-40f0-9424-e82cf5b993f0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_3c8e946a-447c-42fa-86a5-c78be359975a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_ff726881-445e-43a9-8042-5e2c3fab7aea_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_01a84952-d0c4-4504-beee-c4cf391be00c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_f6b0e622-950b-4300-a137-447c8b88771b_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expense (income)</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_bd273ac6-1670-47b7-b8a9-7f57515e8361_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expense</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_870cce52-7111-4bc3-b65c-3c4cac5d7a46_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_364e399f-ed9e-4a0f-8e9d-7da0af59ebb5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term contingent consideration payable</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Amounts of Material Contingent Liabilities Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:to="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_9f2e57d8-ac0d-4105-b1fa-9e5fe6c351f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedInterestCurrent_cfc8da2b-7ad9-4e67-95d4-121708f33cf3_terseLabel_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_avdl_AccruedInterestCurrent_label_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest, Current</link:label>
    <link:label id="lab_avdl_AccruedInterestCurrent_documentation_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent" xlink:href="avdl-20210630.xsd#avdl_AccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedInterestCurrent" xlink:to="lab_avdl_AccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_aed7c60d-ca7d-429a-8042-0fbd690d7789_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9a144c11-b6ef-4fcb-9e4f-9890b50b70a5_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_aa9c5b2f-0e29-41f2-b66c-5dd73dff9071_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_1b9ea63d-899d-4b78-a9c9-758edf0e1fd6_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_666a1f56-cd92-4fa5-acdc-a0dcff1d97e3_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d60a72e8-7a9f-4385-a872-70c853d85f5d_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5ca66796-1fb6-4841-95b9-6c9c0d44a1bc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_c8d2bfee-cd4f-4fc8-83b5-4488d0a9adf3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the February 2020 private placement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b9c9dce3-f2af-4054-a6b2-611831316d5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_204d8534-fc35-4c1d-bd36-2341645788cb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_7bcdcc99-fcc9-4cf3-a3d9-069891d0e1e9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d1587b1c-7a2d-48b0-8ad7-1ca7d136886d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e1202a51-b0a4-4ef8-9be0-9f26f31bcfe9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_5e5d57ed-c7f9-415e-b842-ef27e65c59bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_bd913948-e8a4-4d4c-a584-969477a51694_terseLabel_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment installment term (in months)</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_label_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Installment Term</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_documentation_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Installment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:href="avdl-20210630.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:to="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7b59c30f-74d1-48c9-b7dd-2827f12cceec_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue by Product</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_14d5fffe-cafc-457a-be23-e019726526c0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d83b997e-e2b3-442d-aa8b-4acc65e4ac8b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2bc90679-36a2-4080-bf3a-cce04663497d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_c97d1e71-04ee-4525-88f2-8465d2ea5880_verboseLabel_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_label_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature Of Business Policy [Policy Text Block]</link:label>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for nature of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:href="avdl-20210630.xsd#avdl_NatureOfBusinessPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:to="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2623ae16-a8c5-49d1-b4f9-3e152bf40a39_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_8c8228ee-e018-47c6-9fc9-d2277b7e5e7a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1-5 Years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f4bfde37-5183-4574-acbd-647bfe2765b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fa630d70-24d7-4d96-8e05-519138f140ef_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a5560a30-9497-4cf9-8efe-140d864de93b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_9c4a0bd9-7a78-474d-a71e-5c63acb25bed_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c34be0ea-5a37-42bc-9def-a63f45e55226_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss:</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_70ff49fc-4f5d-467a-8931-0e230e0d28a2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3431353-b4a2-4da1-8ed8-207dcff49c9b_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeNoncurrent_bd83d8b1-6820-4bb3-b537-8487a549f70b_verboseLabel_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeNoncurrent_label_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Noncurrent</link:label>
    <link:label id="lab_avdl_GuaranteeNoncurrent_documentation_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent" xlink:href="avdl-20210630.xsd#avdl_GuaranteeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeNoncurrent" xlink:to="lab_avdl_GuaranteeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_7ee0f473-3d3d-4af5-b934-98ce4a161905_terseLabel_en-US" xlink:label="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected number of positions eliminated (as a percent)</link:label>
    <link:label id="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_label_en-US" xlink:label="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent</link:label>
    <link:label id="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_documentation_en-US" xlink:label="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:href="avdl-20210630.xsd#avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:to="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_058793cf-4e68-4bd7-94d4-380c8321fff4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_c31875bb-8231-46eb-8315-e56b1b61381c_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_84e4f576-e0f1-4f7c-949b-7d2f95a42c14_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_4be86854-bef2-46d4-8622-31bfa7164fa3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5c37db61-6b72-4944-b438-283c7d3a6f85_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense - changes in fair value of contingent consideration payable</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_f1d03de5-27da-4c01-924e-97689e04cfcf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense - changes in fair value of contingent consideration payable</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_bcd244e3-7e52-4a1c-9ecc-1a05a18e6d27_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_5efaff24-17bf-4dc3-8980-09246ef687d6_verboseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6071d5a5-0e9a-4168-a6a3-a8ffe7f43dfd_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_f379e129-509b-4098-85c7-0335e0ac06f3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_e878126b-5f99-48d3-998a-d484d39449dc_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_b706eeb0-0528-4b87-86c6-27a9193ea358_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_b3a11cb3-b8e8-4140-a98a-f58fe2837a30_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_abeb5991-a290-4a2c-bdcd-29c844d8b2aa_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_11ad2df4-8fce-4861-9de5-ae302d841778_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_6f4d95bc-f401-4f49-bfcd-c95f5d2d1a60_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_069b7eb6-fde5-4d7a-a3e8-7502916ab632_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_d0f83082-9ccc-4894-8b6c-04fd3ffd9ef7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:to="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_15c9c13b-e4de-449a-a69b-c558b08cf407_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_9615dbe7-11a4-422b-a55c-f2be10bbb409_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0c2f8a40-1014-4d57-b049-006c9d6ce979_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_41392bd0-4a45-449c-888f-ef1cca9bb9ad_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_146c3995-b20c-47f5-a695-ad475bf5e00a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_b4b8cec7-5fdd-421f-8a20-52b4ba73665f_verboseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale and Equity Securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_0179b4d9-7fe6-4079-8dad-d9489b72a6d9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_eda856da-4c8a-477c-8bde-6ab387750c2e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeAssetCurrentCarryingValue_1f57aa27-e9cd-4c49-923d-fd84466f8ccb_terseLabel_en-US" xlink:label="lab_avdl_GuaranteeAssetCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeAssetCurrentCarryingValue_label_en-US" xlink:label="lab_avdl_GuaranteeAssetCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Asset, Current Carrying Value</link:label>
    <link:label id="lab_avdl_GuaranteeAssetCurrentCarryingValue_documentation_en-US" xlink:label="lab_avdl_GuaranteeAssetCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Asset, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeAssetCurrentCarryingValue" xlink:href="avdl-20210630.xsd#avdl_GuaranteeAssetCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeAssetCurrentCarryingValue" xlink:to="lab_avdl_GuaranteeAssetCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_5feb47a2-df55-47e9-bf15-4cc3fc57b6b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, realized loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_62f4ff16-b5c1-49dd-859d-8c7c168778f4_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cec8e225-d79e-4867-9c4a-67ab5c8ee4b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_BloxiverzVazculepAkovazandNouressMember_9cb19707-f388-4248-bb4c-5d7d21069eeb_terseLabel_en-US" xlink:label="lab_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Business</link:label>
    <link:label id="lab_avdl_BloxiverzVazculepAkovazandNouressMember_label_en-US" xlink:label="lab_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bloxiverz, Vazculep, Akovaz and Nouress [Member]</link:label>
    <link:label id="lab_avdl_BloxiverzVazculepAkovazandNouressMember_documentation_en-US" xlink:label="lab_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bloxiverz, Vazculep, Akovaz and Nouress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:href="avdl-20210630.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:to="lab_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_0774ebe2-e5b2-48a8-b06c-15687aa99029_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on the sale of the Hospital Products</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_7d45e340-b7a8-4ef2-ada9-78ca97612313_negatedLabel_en-US" xlink:label="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out payments for contingent consideration in excess of acquisition-date fair value</link:label>
    <link:label id="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_label_en-US" xlink:label="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Out Payment In Excess Of Acquisition Date Fair Value</link:label>
    <link:label id="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_documentation_en-US" xlink:label="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the Earn Out Payment In Excess Of Acquisition Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:href="avdl-20210630.xsd#avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:to="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_6939fbc0-99ce-4ab8-8967-69a46c3ff6d9_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_892084bd-22d2-45fc-833c-31a39e47febc_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income (expense), net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedTradeDiscountsAndRebates_43ca64e9-02fe-4911-9eb7-cb89fc96a581_terseLabel_en-US" xlink:label="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer allowances</link:label>
    <link:label id="lab_avdl_AccruedTradeDiscountsAndRebates_label_en-US" xlink:label="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued trade discounts and rebates</link:label>
    <link:label id="lab_avdl_AccruedTradeDiscountsAndRebates_documentation_en-US" xlink:label="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedTradeDiscountsAndRebates" xlink:href="avdl-20210630.xsd#avdl_AccruedTradeDiscountsAndRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedTradeDiscountsAndRebates" xlink:to="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_6ce90080-4360-48db-af27-faf91dfef39a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_bb70dbdf-2d3e-4ac9-891e-b10cd0311bed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_a2265ee4-f215-43c3-87cf-42169c94737d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_33ba135e-a497-474d-ba71-430d95e43728_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_7063ea1a-e74f-4d64-bed7-8cbaf6a79421_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to purchase aggregate principal amount, term</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_label_en-US" xlink:label="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option To Purchase Aggregate Principal Amount, Term</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option To Purchase Aggregate Principal Amount, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:to="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e16bc520-af93-42e8-896d-a3fa00c15c65_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherProductsMember_a0c6c051-481a-415e-befa-2e39000cd1c2_terseLabel_en-US" xlink:label="lab_avdl_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherProductsMember_label_en-US" xlink:label="lab_avdl_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherProductsMember" xlink:href="avdl-20210630.xsd#avdl_OtherProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherProductsMember" xlink:to="lab_avdl_OtherProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c0541b83-e2f0-416f-8644-e0da7b409fcf_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_eb480ed4-ac02-48b9-9402-aa4391b07361_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_4dcae330-9a81-419a-9d3c-df96cd7c31df_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesPremiumPercentage_090dfafa-3adc-43a8-8bee-8a676fc91761_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS premium percentage</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPremiumPercentage_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Premium Percentage</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPremiumPercentage_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Premium Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPremiumPercentage" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositarySharesPremiumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesPremiumPercentage" xlink:to="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_1f031d84-dd71-42cd-a42d-b25ff25b712a_verboseLabel_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_label_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Tax Credit Receivable Non Current</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_documentation_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The non current portion of tax credit receivable on research and development as on the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:href="avdl-20210630.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:to="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_a179ce25-9e4e-4e78-8e27-52e27a51202e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_18e2e3a6-daea-468e-874d-7d9e94423de5_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_e3fbfb5f-dc4b-4bfb-b032-3dcf639c68ee_terseLabel_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_label_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Miscellaneous, Current</link:label>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_documentation_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:href="avdl-20210630.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:to="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_bad75352-9358-45e7-8b13-d847ff29766b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Newly Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNMS_99dfb7c7-cd1a-40a9-a96e-75d6d1698e00_terseLabel_en-US" xlink:label="lab_exch_XNMS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NASDAQ/NMS (GLOBAL MARKET) [Member]</link:label>
    <link:label id="lab_exch_XNMS_label_en-US" xlink:label="lab_exch_XNMS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NASDAQ/NMS (GLOBAL MARKET) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNMS" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNMS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNMS" xlink:to="lab_exch_XNMS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b94c667b-5e9e-4e13-b69b-9be61c6b427e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9f60c365-7e33-43f6-9f49-80910878db7a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_5e862b4c-5582-484d-93d2-463474e25a87_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share purchase plan share issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Ownership Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c5275bf3-49cf-4939-a797-8b45e33abc96_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from loans or conditional grants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_dc8e3054-16e8-4a23-88a2-8218915b61b1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9d431cfc-c156-4b52-8ac9-b2cdc5e2192a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_0b01191c-aa9c-4e22-9b5a-989dbbc1e909_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_9ae10773-d6ae-47d3-8a56-605edb955c07_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bd2b09b5-d0bd-48ec-b4d2-3f9d42a415ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, Revenue by Product</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b97d7b98-9e9e-43a5-81d8-8dccd42a439c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b68c5a03-0051-4bc4-a215-3cadc53615c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_98592c70-56fa-472d-9e79-59414fafe9a9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_c9c9bd88-13d3-4fcf-a0ae-ee0e088372bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_527455ac-d4e8-40c2-bd1b-5963d185d5e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_6000558f-7b7f-4b5c-a6de-68d26a9fed4b_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CouponInterestExpense_f4bd2fb2-7d29-4318-bf30-21973001ba7d_terseLabel_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon interest expense</link:label>
    <link:label id="lab_avdl_CouponInterestExpense_label_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Interest Expense</link:label>
    <link:label id="lab_avdl_CouponInterestExpense_documentation_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense" xlink:href="avdl-20210630.xsd#avdl_CouponInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CouponInterestExpense" xlink:to="lab_avdl_CouponInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_90812d23-67ea-411f-a5c1-17d5336e0066_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_ecbfa34a-23d6-4a46-a06e-13b6ecacc7e8_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Smaller Reporting Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_29e61549-800c-4ed5-be8c-bbd6fc7a9d84_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_fb7e56a3-13e5-4eb1-bf50-2dcb3a25650f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, nominal value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_98ef7e78-1829-4b2e-bb31-dba7cdd19547_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_a316cfdd-652b-4f96-b167-7f473db66d2b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_4052ee7a-949d-44b0-9938-3f82e27c53e9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b0cb52d6-ee88-4464-a38a-80730c1ad9fb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare_c1a39282-7797-4bbe-8089-d55c58140175_verboseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS purchased, price per share (in dollars per share)</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares Purchased, Price Per Share</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares Purchased, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositarySharesPurchasedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:to="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_83776a0d-b1e9-488f-a989-7eeb543bd5c2_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_8dd563fb-83d0-41a1-b3c0-9d53565e57dd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_62cddb1b-4acf-49f0-a73a-6a3a0b8d175e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_17f6446c-e13e-4d5e-9958-b88abfcb903a_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual and money market funds</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d1df1eb8-5821-467a-8aaa-d5264f61af47_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_942b8ea8-cd7c-4148-aefb-15b0c7058969_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_cf0728bd-bc05-419d-9fba-949740a4899a_terseLabel_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of royalty payable on net sales</link:label>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_label_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Royalty Payable On Net Sales</link:label>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_documentation_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of royalty that has to be paid by the company as per the royalty agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:href="avdl-20210630.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:to="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_955b3d2c-4ed7-4e4d-a7b0-695f31b7807d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_0f808ea4-00af-4c63-bf1e-eec447356286_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Exela</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_96b142f3-0b04-4fc6-9cae-b437b5df123e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_810f4ea0-8774-49dd-9fdc-7495bfda4173_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_c9c43d10-3474-4475-a905-6c9c515f19c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_ebbeaa43-863b-41e7-9c7a-cb74179b1a2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_426330b2-d333-40c1-926b-fd54713b9dbc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_30bd131a-96b0-4883-87df-98aa1d1d49a8_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3a92c6ae-971a-485d-a105-7670b983269a_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_ca8ec1f3-ebea-4768-af0a-fb844fb4d2d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:to="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_1fc28131-86ed-42ec-b578-9460e6d24e3e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_21bd8ac5-c40d-45b9-9fb2-c9d121d9725a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_6242d6f4-f431-4b1f-95fc-1ee802aab1ea_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_61c04c32-6e23-46d6-91f9-0c5daf85858c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2dbfab3f-59d2-44a1-8f21-1f665bc3999e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c7a059e3-fd8f-474f-b16f-806bd88debe1_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_761cf6d1-1d9d-4aee-a24e-a5e3db89de39_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e0fe8a96-a2c8-452b-8257-3e793a7ce881_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_136a765a-8012-4f50-bcb6-d67af9174e4c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_7e8b092e-ccdb-474e-9698-f4ef06179acd_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustments</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ebe4a165-46ee-4495-9329-2fedfa5ff6af_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_982b1057-fed1-4306-b81e-a5aa12a15728_terseLabel_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Prepaid Expenses and Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:href="avdl-20210630.xsd#avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:to="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_a7beb676-82c6-49d3-8d3d-9d6c9f4c4590_terseLabel_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued outsource contract costs</link:label>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_label_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Outsource Contract Costs</link:label>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_documentation_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Outsource Contract Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts" xlink:href="avdl-20210630.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedOutsourceContractCosts" xlink:to="lab_avdl_AccruedOutsourceContractCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_a1862088-5ee7-4c19-a98c-3913c8ea8786_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_40487f89-c974-4037-8de6-8cfa70936b95_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_a3cef988-7812-488d-a7d2-a548f881933b_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_5bc7647f-6340-4981-9f46-39150e6b86ce_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_24244f15-a415-4279-b14e-463f8762be22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of the Hospital Products</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_cb5b5f9e-4be2-4597-b7f7-f8b6cecae7d4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0ddc753c-6dc7-40ac-b96e-caf7ae3e6251_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_5a6d6819-4750-400d-8ead-a583b37ea627_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_138ab60c-9a81-4501-924c-e4418a4b10c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_3dad8675-1195-4532-a521-1decf7286850_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_StockIssuedDuringPeriodValuePublicOffering_7e447dcc-9392-4e73-8aaa-535ac7734ba9_terseLabel_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 public offering</link:label>
    <link:label id="lab_avdl_StockIssuedDuringPeriodValuePublicOffering_label_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Public Offering</link:label>
    <link:label id="lab_avdl_StockIssuedDuringPeriodValuePublicOffering_documentation_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:href="avdl-20210630.xsd#avdl_StockIssuedDuringPeriodValuePublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:to="lab_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c93d990-a1f9-4901-ac14-79855f33f77c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_ae698cd4-8ca2-4ca1-847b-dbd8f209cb4f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6f9d4a9b-f391-45ee-bae1-e4cce77ba2f9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_82135b66-ace8-4b29-9d6c-c412d6eb8661_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6c61d49-b394-4958-828c-53031f56ee53_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4260d68a-4fcf-48b9-83d2-6612e8701f77_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_8217f64b-34fc-4515-bb0e-f0caca4ecdec_terseLabel_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee to Deerfield</link:label>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantor Obligations, Current Carrying Value</link:label>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_documentation_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:href="avdl-20210630.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:to="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d47a1768-29f3-4262-8dab-30d08ba3469c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_ad9f1d42-b0e4-49db-bb2a-bc38ef16a349_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0605196b-fb0d-4217-84d0-a979532bdc4c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_16efe27c-019f-4e3c-bdeb-5f42a05e55ad_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_3338f9e4-b0a0-4980-9959-45cc1186a58f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid (refund)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement_dd5ca535-0869-4012-aa1b-2651976d3186_terseLabel_en-US" xlink:label="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of financing-related contingent consideration</link:label>
    <link:label id="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement_label_en-US" xlink:label="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Related Contingent Consideration Remeasurement</link:label>
    <link:label id="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement_documentation_en-US" xlink:label="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the remeasurement of financing related contingent considerations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:href="avdl-20210630.xsd#avdl_FinancingRelatedContingentConsiderationRemeasurement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:to="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_3a666eee-c902-4fff-8b4d-441c6e64aaef_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_NoTradingSymbolFlag_8730ac03-b1eb-4a23-bb71-913245b0c53b_terseLabel_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:label id="lab_dei_NoTradingSymbolFlag_label_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag" xlink:to="lab_dei_NoTradingSymbolFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6f8b35b7-5aff-4468-8fe6-a5c2f080eeee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_59289708-c1fa-4f75-845e-3ddece1dbf0e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_171b4d79-b1c0-43e6-9f97-2837ff8d805b_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_4e4502c2-6b91-4f82-b36a-3164a9be3d64_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_68fa911f-6ee1-4b76-a6fd-19225a21a399_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued restructuring (see Note 12)</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_94ffb22e-1c09-4e12-bbd0-75403ae075c5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e68da88e-7aeb-4319-8cbd-8cfb2164620b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_bf504186-4f8c-4dd7-b7cc-f68e2978bfda_negatedTerseLabel_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_label_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Research and Development Tax Credit Receivable</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_documentation_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in research and development tax credit receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:href="avdl-20210630.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:to="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_3beaece0-d533-465c-8696-8dc91d195377_terseLabel_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_label_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Receivables</link:label>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_documentation_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying amount of other noncurrent receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables" xlink:href="avdl-20210630.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherNoncurrentReceivables" xlink:to="lab_avdl_OtherNoncurrentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_5c6f4ea7-3b65-4471-882c-18b99d86f68d_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_426de2c9-13dd-4950-827e-fe53f227bdbd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_e60bd682-4024-4691-b63b-4938bb1a42c6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_11d089d3-1c35-4187-afe8-324d5e270dbc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs (income)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e3dbb291-183a-4db8-bf7f-184d8cf90a5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_bb9b3779-2839-4a88-a1f5-f3e5a56f3d1d_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5e61bee7-d409-414b-aa2f-4b22d52e404f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_57a53993-10dd-4cb1-8bc4-a405c9c28d20_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_b3178c8f-2564-45e1-bc45-4aef7bce352c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e458df58-78f3-45c6-8111-25ae1134b542_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5414e6ec-d15e-4ea2-93d1-e715e2f28d02_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c5022472-4591-42e7-8439-9016d9f1a550_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5-10 Years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_b199724f-9e91-4a0c-b9a6-9c375ead037e_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_715d18e8-8282-4c3c-9864-944f23e1bdfa_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_793e909f-387e-4b7a-aa28-dfb3d4caa93a_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of product of the last reported sale price of the American Depositary Shares and the exchange rate on each such trading day</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:to="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_9b0587e8-f2b6-4c4d-a6b7-032c5f215c9f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_5202a943-6313-4c3d-be07-e19fcde88107_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the disposition of the hospital products</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_8be1e8b0-00b9-48ca-9ecf-65106321c3bb_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other fixed-income securities</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82dd4f2e-fd56-4b45-bca5-beb90d107fc9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_11e9af2c-6b63-4b27-bf33-4d343fd98042_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_97719f6a-38b0-476d-a0ce-7ec428f38798_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4d7139a1-77fd-41b9-9007-917f4a8288f6_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d26da559-01d2-4f4c-b4c7-35eaaad9b93f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_2e863cf5-ccdc-4a32-b0b9-38d36b1022ee_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProFormaMember_02c0378b-bdfd-4bab-a025-961dc89950da_terseLabel_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma</link:label>
    <link:label id="lab_srt_ProFormaMember_label_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProFormaMember" xlink:to="lab_srt_ProFormaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0bbae7fd-aa9e-4db7-aac6-f9b8efbd956c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_9c8fe5fc-ee56-4a4f-9200-99afc3e46cb9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_63c87c10-43da-4d93-8639-50cf82b04ea5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6444bb0c-bdb5-473f-9e87-8bf3e818187c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation loss (income)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_31f2cb12-5c1e-4702-90b6-b3575844401f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_084f37b2-f5ee-40db-825d-8d9771889313_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6d17606d-7d63-48c9-9ada-5e532075feda_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_fecbf433-c3f9-4b48-9f9f-b9f527cb224f_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_9760c290-7acf-46ea-8fb7-66151c0ab386_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_350627a0-72a6-4bce-8e14-ce459eb95fa1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_89cfc603-ba0e-4c53-8af8-8f844cd84489_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_e1d202d3-048d-42b8-8381-fb6c7bbdfd83_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:to="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_08509c25-4680-448f-b611-ed93748f7c42_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_d7cafe2e-0742-4214-9e5d-65f352448fbd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GainLossOnReleaseOfCertainLiabilities_3b851867-4c6c-478c-98d0-24e00a0abbbe_terseLabel_en-US" xlink:label="lab_avdl_GainLossOnReleaseOfCertainLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from release of certain liabilities</link:label>
    <link:label id="lab_avdl_GainLossOnReleaseOfCertainLiabilities_3d40bd89-12f3-44c1-bd42-f32f4d37233f_negatedTerseLabel_en-US" xlink:label="lab_avdl_GainLossOnReleaseOfCertainLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from the release of certain liabilities</link:label>
    <link:label id="lab_avdl_GainLossOnReleaseOfCertainLiabilities_label_en-US" xlink:label="lab_avdl_GainLossOnReleaseOfCertainLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Release Of Certain Liabilities</link:label>
    <link:label id="lab_avdl_GainLossOnReleaseOfCertainLiabilities_documentation_en-US" xlink:label="lab_avdl_GainLossOnReleaseOfCertainLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Release Of Certain Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GainLossOnReleaseOfCertainLiabilities" xlink:href="avdl-20210630.xsd#avdl_GainLossOnReleaseOfCertainLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GainLossOnReleaseOfCertainLiabilities" xlink:to="lab_avdl_GainLossOnReleaseOfCertainLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_513a91c3-9ffa-4007-a707-e952b1f873e5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95fe8647-0749-4d0e-b474-c0cd63eb8335_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at January 1,</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c865ac87-7f7a-4da0-8fcd-a897154ef3ed_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at June 30,</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_fa3876eb-6cec-4d26-bf77-9df8d97ba53f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_3437e924-263c-470f-baa2-b9a4f68d7321_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d40ff16-dd33-43e7-90c7-3948c1f76d50_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_8765a5d3-e328-4c2e-97d9-96a6c2379a5f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_5766b4d4-79e4-41d2-963a-b143d6d5f75f_terseLabel_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional consideration paid in monthly installments</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_label_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_documentation_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:href="avdl-20210630.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:to="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3b4f0a81-add3-4686-beae-eea4d47e6287_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4faeb67c-8602-43bd-9c54-984f8cfa565e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6c19ba5e-7724-4850-8d46-baec203630bd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_ecf4f9c5-a76e-4ac7-91d9-ff39bf86a01b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a4cd38cd-509e-4a8d-a18f-4926c804cacd_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9495f215-9179-4469-9158-8fdc5c3c12c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a5fa7489-d423-4f4b-a1ae-3ddf3a6b0c33_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_61fad19c-a6c0-4c75-b394-5decae470886_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_9d6112bc-2fc9-4468-8385-b309c5614433_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f7e81fd6-107d-4f19-a5ec-9c3f483de669_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_b837be9f-c724-4f8b-9052-25489c27d14e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_806c016d-1e4a-43a4-8240-5b77c4900f28_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_6bfeb72f-6f6e-4611-8604-4af61a3388bb_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_851d6469-023a-48ed-9541-429bfb7ed1ca_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_01a41807-5173-4240-85b5-809fd96e9d9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_856e2da1-1d2e-4cb6-85b7-7b5fcec3623b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_8036b5cf-6b44-4651-8806-1ffe6c30d767_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_43c32a9b-58d5-4fef-8f10-08f614d93f67_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_622abc5a-d1ff-4f5f-87c2-5ef50f6bbd80_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive business days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Business Days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Business Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:to="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_21dbd4ae-22b3-4252-99df-8645d3c77f1b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ad8a25a3-d008-4927-b06d-a7179fa3126e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes in assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_807eb68d-284c-49df-b3b9-302c0588c91f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share purchase plan share issuance</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_03a5932c-4e83-42ae-b526-ece552106621_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d1ba8efa-4cea-4b8f-ba3f-884fcd1a1c9f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_fe58a5b6-acc8-4caf-82ea-4e7f2633acba_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CorporateWorkforceReductionMember_9262466a-a179-4437-8016-462b8c1b6cc2_terseLabel_en-US" xlink:label="lab_avdl_CorporateWorkforceReductionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Workforce Reduction</link:label>
    <link:label id="lab_avdl_CorporateWorkforceReductionMember_label_en-US" xlink:label="lab_avdl_CorporateWorkforceReductionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Workforce Reduction [Member]</link:label>
    <link:label id="lab_avdl_CorporateWorkforceReductionMember_documentation_en-US" xlink:label="lab_avdl_CorporateWorkforceReductionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Workforce Reduction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CorporateWorkforceReductionMember" xlink:href="avdl-20210630.xsd#avdl_CorporateWorkforceReductionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CorporateWorkforceReductionMember" xlink:to="lab_avdl_CorporateWorkforceReductionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeCurrent_3e2047b5-5c59-4f7e-9b7f-a4ec70b8e601_terseLabel_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeCurrent_label_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Current</link:label>
    <link:label id="lab_avdl_GuaranteeCurrent_documentation_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent" xlink:href="avdl-20210630.xsd#avdl_GuaranteeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeCurrent" xlink:to="lab_avdl_GuaranteeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_7eb0f33e-6c82-4d52-b2e9-74ef957a00e9_verboseLabel_en-US" xlink:label="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of acquisition-related contingent consideration</link:label>
    <link:label id="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_label_en-US" xlink:label="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Contingent Consideration Remeasurement</link:label>
    <link:label id="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_documentation_en-US" xlink:label="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the remeasurement of acquisition related contingent considerations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:href="avdl-20210630.xsd#avdl_AcquisitionRelatedContingentConsiderationRemeasurement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:to="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_b22200aa-6261-4e28-8b91-9fbaab0e6fac_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_c07d766b-6d93-4934-9858-34898679a1b7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_06d2b161-9837-4142-baf0-8e70b2314145_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1b7927a2-f2ee-4783-9e74-114401c0feb9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt discount and issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_77aa652f-3eb6-42e9-a467-068391634309_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_afb1808e-19cb-4943-91d0-19981964dd19_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_8f6c9a01-4685-47f6-b10b-f3edbf6aaf9d_terseLabel_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial cash consideration</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_label_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Initial Cash Consideration</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_documentation_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Initial Cash Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:href="avdl-20210630.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:to="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_61581999-d929-498a-af98-f6ed0308e21d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_3533548d-3d4d-4efc-aa8c-9a3855be3613_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_989fa6c6-eb11-496f-abab-f8a6b355b115_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Newly Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_f5fdc87c-2b9f-44c2-81f0-33861e0b3f89_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssetsCurrent_66243f6e-2edc-45c1-84ee-59d5d9c03128_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term deposit</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent" xlink:to="lab_us-gaap_DepositsAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_01001787-c8aa-429f-aba7-2a8d23cda631_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_348e2dda-8d9e-4657-9bb4-d666030055b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f25ff251-2c69-4593-b39f-e3de7fa7d6f9_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_1a97639d-ab28-48fd-bf46-83cb3c12b9be_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled threshold trading days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Scheduled Threshold Trading Days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Scheduled Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:to="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_9055f50a-d19a-41ba-bbdb-37a1b7827a05_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_863d2aaf-18f9-48bf-b191-4c53138b56f9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d5d0f698-0c39-434b-b344-abc5ba97cafc_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_56474521-d18a-49b8-b7ee-a2f14f8cd377_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_b060e8e3-3cdf-4c13-b332-3287697888f1_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b6c8ec37-3994-4d66-a33b-b55e7a15e4bb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_42039f68-5327-4f90-bc83-e6bf331f295d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 1 Year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_4c87b716-b9f4-45c1-aef2-e0a2a921c9ac_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_cb742414-9650-448a-bea3-949ecffad958_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Payable&#160;</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_0e1969ed-1396-46ec-aa82-84786574f8b2_terseLabel_en-US" xlink:label="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Payable Rollforward:</link:label>
    <link:label id="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_label_en-US" xlink:label="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Changes in Related Party Payable [Roll Forward]</link:label>
    <link:label id="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_documentation_en-US" xlink:label="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Changes in Related Party Payable [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:href="avdl-20210630.xsd#avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:to="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ea675b2d-589d-4033-9894-3170a43be445_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred tax and income tax deferred charge</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>avdl-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a7d49b9d-9e9c-4202-a2e9-33a099e78bd3,g:e5693fe9-19ce-4a74-abcb-b22740470bdd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avadel.com/role/Coverpage" xlink:type="simple" xlink:href="avdl-20210630.xsd#Coverpage"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/Coverpage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b347f434-13c1-462c-9d9c-cc7953e1c7cf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_74231afc-dc88-4c65-b6fe-d5c4a1cfb135" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b347f434-13c1-462c-9d9c-cc7953e1c7cf" xlink:to="loc_dei_EntitiesTable_74231afc-dc88-4c65-b6fe-d5c4a1cfb135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_526f8192-970a-4afe-92c7-a9f20353d79d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_74231afc-dc88-4c65-b6fe-d5c4a1cfb135" xlink:to="loc_dei_EntityListingsExchangeAxis_526f8192-970a-4afe-92c7-a9f20353d79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_aa27ed99-a43c-4a93-8310-b961da4c251a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_526f8192-970a-4afe-92c7-a9f20353d79d" xlink:to="loc_dei_ExchangeDomain_aa27ed99-a43c-4a93-8310-b961da4c251a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNMS_53222a4d-c7dc-4b84-97a8-e048a63ff0da" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNMS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_aa27ed99-a43c-4a93-8310-b961da4c251a" xlink:to="loc_exch_XNMS_53222a4d-c7dc-4b84-97a8-e048a63ff0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_74231afc-dc88-4c65-b6fe-d5c4a1cfb135" xlink:to="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b790f024-c771-4682-bfc4-577c853102e7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentType_b790f024-c771-4682-bfc4-577c853102e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_3279383b-ed84-4979-9b16-8e21b7df7323" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentQuarterlyReport_3279383b-ed84-4979-9b16-8e21b7df7323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d50ffccb-6cb9-48a5-aa22-4b74732a195b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentPeriodEndDate_d50ffccb-6cb9-48a5-aa22-4b74732a195b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_48765195-4cc5-418b-a2d2-5d6724829196" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentTransitionReport_48765195-4cc5-418b-a2d2-5d6724829196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_618f22d6-b750-4774-8bd1-98bd00a93503" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityFileNumber_618f22d6-b750-4774-8bd1-98bd00a93503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_07181b90-83bf-41ac-b3a5-64f668f13668" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityRegistrantName_07181b90-83bf-41ac-b3a5-64f668f13668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0927c4b4-48df-4183-9cac-167edc18511c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0927c4b4-48df-4183-9cac-167edc18511c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cb4ca7b9-7716-454d-b7be-08bc4d2d7126" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityTaxIdentificationNumber_cb4ca7b9-7716-454d-b7be-08bc4d2d7126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0d065ebb-15f2-4fd7-a054-aa01d0bd1d4b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityAddressAddressLine1_0d065ebb-15f2-4fd7-a054-aa01d0bd1d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6892b18e-64f1-4175-8c9e-e12738f4fadb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityAddressCityOrTown_6892b18e-64f1-4175-8c9e-e12738f4fadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_e2e262c5-b34d-466f-a166-6b13e66c52b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityAddressCountry_e2e262c5-b34d-466f-a166-6b13e66c52b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dc037b1d-96d9-4968-89ca-8565720f1c33" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityAddressPostalZipCode_dc037b1d-96d9-4968-89ca-8565720f1c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f1b310ee-4436-448a-a9f8-4006d4b5c2c5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_CityAreaCode_f1b310ee-4436-448a-a9f8-4006d4b5c2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6938b0b7-504f-4f88-abbd-dcb3d2f3f546" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_LocalPhoneNumber_6938b0b7-504f-4f88-abbd-dcb3d2f3f546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_bd7b3640-4126-4355-9302-3595b23f4a3a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_Security12bTitle_bd7b3640-4126-4355-9302-3595b23f4a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_741446d6-672d-4599-9271-0cc7b3633155" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_TradingSymbol_741446d6-672d-4599-9271-0cc7b3633155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2bbb90bf-b63b-4a4f-87c7-029d244dd22b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_SecurityExchangeName_2bbb90bf-b63b-4a4f-87c7-029d244dd22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_5f4c947b-3d4e-4303-b2af-7f55069d7b0f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_NoTradingSymbolFlag_5f4c947b-3d4e-4303-b2af-7f55069d7b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4b51e406-7e6a-45f0-bf4b-67ed6478d34a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityCurrentReportingStatus_4b51e406-7e6a-45f0-bf4b-67ed6478d34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3f53f2f4-b0e5-412d-a7e4-d8e5ae373769" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityInteractiveDataCurrent_3f53f2f4-b0e5-412d-a7e4-d8e5ae373769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2fe584e1-4f18-49f8-8b54-ff1cd93ae8d6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityFilerCategory_2fe584e1-4f18-49f8-8b54-ff1cd93ae8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4f3c7cd2-b6a0-484f-bd41-e4a74cc2c23d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntitySmallBusiness_4f3c7cd2-b6a0-484f-bd41-e4a74cc2c23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_14a098bf-2c11-4e6a-883a-c6165d0b8922" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityEmergingGrowthCompany_14a098bf-2c11-4e6a-883a-c6165d0b8922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_359db7f0-67e9-4693-bf2c-62ebae3c98e4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityShellCompany_359db7f0-67e9-4693-bf2c-62ebae3c98e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_36c9b038-534a-4d64-8f97-ecfdc1875e70" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_36c9b038-534a-4d64-8f97-ecfdc1875e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_85c87f7e-2c36-4281-a535-108c1aa88919" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_EntityCentralIndexKey_85c87f7e-2c36-4281-a535-108c1aa88919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6c9714e8-a9c0-4272-b67d-45eb69bfde19" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_CurrentFiscalYearEndDate_6c9714e8-a9c0-4272-b67d-45eb69bfde19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3de54dd0-99c3-4f71-84ab-aa5186819982" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentFiscalYearFocus_3de54dd0-99c3-4f71-84ab-aa5186819982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_556f239b-89cd-405d-854b-33a0a1d2111c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_DocumentFiscalPeriodFocus_556f239b-89cd-405d-854b-33a0a1d2111c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_24dac630-562f-4fb5-a303-acdc103fbb40" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_e8fb46cd-f61c-43d7-acb1-ab18a3bdbd13" xlink:to="loc_dei_AmendmentFlag_24dac630-562f-4fb5-a303-acdc103fbb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME" xlink:type="simple" xlink:href="avdl-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_aaf51be1-f806-4240-bdeb-cb826b7caeab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_RevenuesAbstract_aaf51be1-f806-4240-bdeb-cb826b7caeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_07e9faac-22b8-49bb-9af6-c37ecf85aa25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_aaf51be1-f806-4240-bdeb-cb826b7caeab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_07e9faac-22b8-49bb-9af6-c37ecf85aa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c10b6c5c-a622-4cb8-966c-d5056601186d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c10b6c5c-a622-4cb8-966c-d5056601186d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1ba9c562-bc9e-4d50-9bff-39b516fc354b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1ba9c562-bc9e-4d50-9bff-39b516fc354b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9688d55d-7436-4b03-bafc-56074a607c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9688d55d-7436-4b03-bafc-56074a607c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ee2174a1-920f-4396-8f47-e99e87efe380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ee2174a1-920f-4396-8f47-e99e87efe380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6099a1ff-c0b0-404e-8800-a054c3b44fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6099a1ff-c0b0-404e-8800-a054c3b44fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_fe819964-47c9-456b-89fe-0600230ff8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_fe819964-47c9-456b-89fe-0600230ff8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_64b9916c-69d7-4a9d-8336-608f48e8ea14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:to="loc_us-gaap_RestructuringCharges_64b9916c-69d7-4a9d-8336-608f48e8ea14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a1d02a65-eaba-4fe7-94f5-7b92ad658597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cdf91fd5-ab41-43b1-b6d8-0961f22f41ae" xlink:to="loc_us-gaap_CostsAndExpenses_a1d02a65-eaba-4fe7-94f5-7b92ad658597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6b6c1e3d-40fe-44a8-9080-b8ef112e4d13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_OperatingIncomeLoss_6b6c1e3d-40fe-44a8-9080-b8ef112e4d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_bb42744b-2847-4688-9f9b-ac71cf676d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_InvestmentIncomeNet_bb42744b-2847-4688-9f9b-ac71cf676d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_b4979e91-265a-45d8-b9be-9678b1a53e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_InterestExpenseDebt_b4979e91-265a-45d8-b9be-9678b1a53e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GainLossOnReleaseOfCertainLiabilities_0659177e-8de7-4f09-80cc-ee71497cfb8d" xlink:href="avdl-20210630.xsd#avdl_GainLossOnReleaseOfCertainLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_avdl_GainLossOnReleaseOfCertainLiabilities_0659177e-8de7-4f09-80cc-ee71497cfb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_15ff0f08-1785-45db-bb08-df9db409c53b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_15ff0f08-1785-45db-bb08-df9db409c53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6f7ff852-4340-4983-a5eb-f840909f92e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6f7ff852-4340-4983-a5eb-f840909f92e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1b6f0673-b13c-44f4-b701-045ab8ea4778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1b6f0673-b13c-44f4-b701-045ab8ea4778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6cf01110-8394-47ce-a98a-26bd7b6ad62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_NetIncomeLoss_6cf01110-8394-47ce-a98a-26bd7b6ad62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6efb04e8-9f84-4dca-93a8-55b5e51a4abb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_EarningsPerShareBasic_6efb04e8-9f84-4dca-93a8-55b5e51a4abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7749d9a8-04be-4bd9-b25e-6d3804f760cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7749d9a8-04be-4bd9-b25e-6d3804f760cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e226d98f-3846-427b-9924-e9e89a48eb45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e226d98f-3846-427b-9924-e9e89a48eb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_841312b5-1098-4178-9a18-f0214d6fd63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d170d3c8-71b0-4b9a-aff2-42b59e3e92b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_841312b5-1098-4178-9a18-f0214d6fd63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="simple" xlink:href="avdl-20210630.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6d4c77db-0cf1-4e59-adde-5163577b96c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d8167025-7901-4755-9c8e-cc6f3735fade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6d4c77db-0cf1-4e59-adde-5163577b96c7" xlink:to="loc_us-gaap_NetIncomeLoss_d8167025-7901-4755-9c8e-cc6f3735fade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_db078149-6073-4ac3-af66-8fca7fb14add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6d4c77db-0cf1-4e59-adde-5163577b96c7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_db078149-6073-4ac3-af66-8fca7fb14add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9ab0fa89-2923-454d-983a-8032e5b54e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_db078149-6073-4ac3-af66-8fca7fb14add" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9ab0fa89-2923-454d-983a-8032e5b54e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ebde91c3-13b4-4fb6-aa2f-5c445d3849d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_db078149-6073-4ac3-af66-8fca7fb14add" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ebde91c3-13b4-4fb6-aa2f-5c445d3849d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b5a2473d-74e1-4a6d-8303-914daa1c6d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_db078149-6073-4ac3-af66-8fca7fb14add" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b5a2473d-74e1-4a6d-8303-914daa1c6d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_dfd74f4d-c817-4ac5-9fcd-9f9dcee73f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6d4c77db-0cf1-4e59-adde-5163577b96c7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_dfd74f4d-c817-4ac5-9fcd-9f9dcee73f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" xlink:type="simple" xlink:href="avdl-20210630.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f10e515a-3dec-4c35-aec5-431bf6768124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_41444908-8024-4a9a-9ca4-1e76be7d65c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f10e515a-3dec-4c35-aec5-431bf6768124" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_41444908-8024-4a9a-9ca4-1e76be7d65c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="avdl-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7571d935-904f-4c40-8f95-a9f3a7c048b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5385e8d6-23f3-425c-a06f-b2b7355ba31c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7571d935-904f-4c40-8f95-a9f3a7c048b7" xlink:to="loc_us-gaap_AssetsAbstract_5385e8d6-23f3-425c-a06f-b2b7355ba31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cede45a5-aac6-4a55-8f95-dc849b0964f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5385e8d6-23f3-425c-a06f-b2b7355ba31c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cede45a5-aac6-4a55-8f95-dc849b0964f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7abdfae9-0412-4c8c-bf30-c9592b5ef145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cede45a5-aac6-4a55-8f95-dc849b0964f8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7abdfae9-0412-4c8c-bf30-c9592b5ef145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_c8350f67-7c0c-4c44-ac6d-f9ebfb213b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cede45a5-aac6-4a55-8f95-dc849b0964f8" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_c8350f67-7c0c-4c44-ac6d-f9ebfb213b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_e2ed276c-66b6-4fec-a33f-bc3e736960d9" xlink:href="avdl-20210630.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cede45a5-aac6-4a55-8f95-dc849b0964f8" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_e2ed276c-66b6-4fec-a33f-bc3e736960d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c9070348-bda3-4d6a-b0ce-b9ecb6c29f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cede45a5-aac6-4a55-8f95-dc849b0964f8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c9070348-bda3-4d6a-b0ce-b9ecb6c29f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_411aa20c-a5c3-433e-9939-643dccdacbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cede45a5-aac6-4a55-8f95-dc849b0964f8" xlink:to="loc_us-gaap_AssetsCurrent_411aa20c-a5c3-433e-9939-643dccdacbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a2206cd7-c3de-4c38-9cfe-b9a1d251d9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5385e8d6-23f3-425c-a06f-b2b7355ba31c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a2206cd7-c3de-4c38-9cfe-b9a1d251d9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_98e5074e-6f8d-4cc4-98ce-3a3b31fc3a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5385e8d6-23f3-425c-a06f-b2b7355ba31c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_98e5074e-6f8d-4cc4-98ce-3a3b31fc3a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_14b8a187-389f-4bd7-8053-352070971a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5385e8d6-23f3-425c-a06f-b2b7355ba31c" xlink:to="loc_us-gaap_Goodwill_14b8a187-389f-4bd7-8053-352070971a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_c2da10b5-2019-43b1-9eb6-5a44f4a86ca4" xlink:href="avdl-20210630.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5385e8d6-23f3-425c-a06f-b2b7355ba31c" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_c2da10b5-2019-43b1-9eb6-5a44f4a86ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c99ce95e-a6ed-41f2-9694-fbce6b3cc6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5385e8d6-23f3-425c-a06f-b2b7355ba31c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c99ce95e-a6ed-41f2-9694-fbce6b3cc6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_190610ae-561c-403b-abd1-1f222800d407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5385e8d6-23f3-425c-a06f-b2b7355ba31c" xlink:to="loc_us-gaap_Assets_190610ae-561c-403b-abd1-1f222800d407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_72c00cc4-cc84-41ee-9715-545e45a3c9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7571d935-904f-4c40-8f95-a9f3a7c048b7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_72c00cc4-cc84-41ee-9715-545e45a3c9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_55997748-e875-41de-9264-fe81ef36bd57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_72c00cc4-cc84-41ee-9715-545e45a3c9bd" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_55997748-e875-41de-9264-fe81ef36bd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3b9b7896-67d8-4ac5-87dc-7e891669c71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_55997748-e875-41de-9264-fe81ef36bd57" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3b9b7896-67d8-4ac5-87dc-7e891669c71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7e69b755-cb88-43e2-9998-5780d7a9ae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_55997748-e875-41de-9264-fe81ef36bd57" xlink:to="loc_us-gaap_AccountsPayableCurrent_7e69b755-cb88-43e2-9998-5780d7a9ae8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8986df93-abd6-4b0e-95be-37266ba13de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_55997748-e875-41de-9264-fe81ef36bd57" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8986df93-abd6-4b0e-95be-37266ba13de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_8b5dd2c2-e9ae-4961-bd5f-5cdd9e482ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_55997748-e875-41de-9264-fe81ef36bd57" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_8b5dd2c2-e9ae-4961-bd5f-5cdd9e482ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1e7b15df-6609-4e76-b716-64f7f8ff9ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_55997748-e875-41de-9264-fe81ef36bd57" xlink:to="loc_us-gaap_LiabilitiesCurrent_1e7b15df-6609-4e76-b716-64f7f8ff9ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fa0f47f1-a7da-47f5-b4b5-8210f9b58b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_72c00cc4-cc84-41ee-9715-545e45a3c9bd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fa0f47f1-a7da-47f5-b4b5-8210f9b58b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8a9a56eb-3046-4b11-8f88-1e4e3f447272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_72c00cc4-cc84-41ee-9715-545e45a3c9bd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8a9a56eb-3046-4b11-8f88-1e4e3f447272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_499214da-a2d3-4b61-9486-81ab757d504c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_72c00cc4-cc84-41ee-9715-545e45a3c9bd" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_499214da-a2d3-4b61-9486-81ab757d504c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b4ffc560-01d2-496b-b73f-e1300bfc4cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_72c00cc4-cc84-41ee-9715-545e45a3c9bd" xlink:to="loc_us-gaap_Liabilities_b4ffc560-01d2-496b-b73f-e1300bfc4cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_4d60fd2c-810f-48d4-8a9d-da25446b068c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_72c00cc4-cc84-41ee-9715-545e45a3c9bd" xlink:to="loc_us-gaap_StockholdersEquityAbstract_4d60fd2c-810f-48d4-8a9d-da25446b068c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_49ae11d8-3653-4aff-a05c-f68816a73917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4d60fd2c-810f-48d4-8a9d-da25446b068c" xlink:to="loc_us-gaap_PreferredStockValue_49ae11d8-3653-4aff-a05c-f68816a73917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_812129aa-f987-4f28-9068-6d75299fde34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4d60fd2c-810f-48d4-8a9d-da25446b068c" xlink:to="loc_us-gaap_CommonStockValue_812129aa-f987-4f28-9068-6d75299fde34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f7fbd210-76b5-4369-829e-c99e56cea8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4d60fd2c-810f-48d4-8a9d-da25446b068c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f7fbd210-76b5-4369-829e-c99e56cea8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d8c2de76-f354-4eb3-a68d-760f4084b407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4d60fd2c-810f-48d4-8a9d-da25446b068c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d8c2de76-f354-4eb3-a68d-760f4084b407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cf75f99a-945f-4984-b463-aacae8221c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4d60fd2c-810f-48d4-8a9d-da25446b068c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cf75f99a-945f-4984-b463-aacae8221c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_15772af6-b766-45bf-b6da-4f2dc049d022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4d60fd2c-810f-48d4-8a9d-da25446b068c" xlink:to="loc_us-gaap_StockholdersEquity_15772af6-b766-45bf-b6da-4f2dc049d022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bae8f6d5-036b-41a3-a23d-f3187f25fb14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_72c00cc4-cc84-41ee-9715-545e45a3c9bd" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_bae8f6d5-036b-41a3-a23d-f3187f25fb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="avdl-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ed3107a9-638e-435a-899c-4899b125fbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3c203f35-4ecd-43cb-9d0c-5d701571af80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed3107a9-638e-435a-899c-4899b125fbfa" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3c203f35-4ecd-43cb-9d0c-5d701571af80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ef8e7935-4d75-4ddd-bf69-60b3c65d6372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed3107a9-638e-435a-899c-4899b125fbfa" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ef8e7935-4d75-4ddd-bf69-60b3c65d6372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_0e905e8b-8eec-41ca-b8c3-c320211e330f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed3107a9-638e-435a-899c-4899b125fbfa" xlink:to="loc_us-gaap_PreferredStockSharesIssued_0e905e8b-8eec-41ca-b8c3-c320211e330f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_96c538e9-6518-41a7-8300-e0d375f5d80f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed3107a9-638e-435a-899c-4899b125fbfa" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_96c538e9-6518-41a7-8300-e0d375f5d80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b24927dd-13e2-4ea2-8687-d4614f6ab042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed3107a9-638e-435a-899c-4899b125fbfa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b24927dd-13e2-4ea2-8687-d4614f6ab042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f1c23dd5-59c7-4fbe-ba96-bb898754bed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed3107a9-638e-435a-899c-4899b125fbfa" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f1c23dd5-59c7-4fbe-ba96-bb898754bed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_374961f2-a027-4dfa-85b9-818b821a42a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed3107a9-638e-435a-899c-4899b125fbfa" xlink:to="loc_us-gaap_CommonStockSharesIssued_374961f2-a027-4dfa-85b9-818b821a42a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1461fab2-b2c4-47ba-9d0c-f4e9283e50b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed3107a9-638e-435a-899c-4899b125fbfa" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1461fab2-b2c4-47ba-9d0c-f4e9283e50b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="avdl-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_633a259c-2602-4742-aab5-152032886816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_59feb8da-5fe5-4837-9c60-6c8e76d18d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_633a259c-2602-4742-aab5-152032886816" xlink:to="loc_us-gaap_StatementTable_59feb8da-5fe5-4837-9c60-6c8e76d18d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c60525bf-cda2-44a1-b132-11c7d397ebf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_59feb8da-5fe5-4837-9c60-6c8e76d18d20" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c60525bf-cda2-44a1-b132-11c7d397ebf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c60525bf-cda2-44a1-b132-11c7d397ebf7" xlink:to="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_eb7f6dae-dd29-4e79-a54a-ff7bcd240ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_CommonStockMember_eb7f6dae-dd29-4e79-a54a-ff7bcd240ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_ae1ceb7b-264f-4627-9b7b-db2560460e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_PreferredStockMember_ae1ceb7b-264f-4627-9b7b-db2560460e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bb50bece-883d-4c3d-ae81-05e60ba9faee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bb50bece-883d-4c3d-ae81-05e60ba9faee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a0e64164-ad42-4e5a-ba3b-f96d4d9806b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_RetainedEarningsMember_a0e64164-ad42-4e5a-ba3b-f96d4d9806b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a96a665a-fa07-44c6-9f35-bbbe0875464d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a96a665a-fa07-44c6-9f35-bbbe0875464d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e09edde9-5f2b-44ce-a416-86cebd129f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7cf26fb-4183-40a9-b578-39e5f590c375" xlink:to="loc_us-gaap_TreasuryStockMember_e09edde9-5f2b-44ce-a416-86cebd129f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_03cfd553-e86a-4280-a787-f01c74ff49c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_59feb8da-5fe5-4837-9c60-6c8e76d18d20" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_03cfd553-e86a-4280-a787-f01c74ff49c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f4838b9b-d0ea-446f-a9f4-e371ff10084d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_03cfd553-e86a-4280-a787-f01c74ff49c3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f4838b9b-d0ea-446f-a9f4-e371ff10084d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_292e1e39-d102-48e7-abb4-8a1bb2abbc90" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f4838b9b-d0ea-446f-a9f4-e371ff10084d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_292e1e39-d102-48e7-abb4-8a1bb2abbc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1f0d6a23-7038-45d8-b134-3ddf87a37d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_59feb8da-5fe5-4837-9c60-6c8e76d18d20" xlink:to="loc_us-gaap_StatementLineItems_1f0d6a23-7038-45d8-b134-3ddf87a37d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1f0d6a23-7038-45d8-b134-3ddf87a37d21" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7acdb969-1d73-466c-b158-5d973b3bc7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_SharesOutstanding_7acdb969-1d73-466c-b158-5d973b3bc7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_aad1217e-4ffa-4a8c-af9b-81d8b095eb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockholdersEquity_aad1217e-4ffa-4a8c-af9b-81d8b095eb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0b033ba7-0bde-4522-abc1-4e5de096715b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0b033ba7-0bde-4522-abc1-4e5de096715b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_649d5cd1-4f2f-4921-b73f-52aa2a5adfc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_NetIncomeLoss_649d5cd1-4f2f-4921-b73f-52aa2a5adfc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_33541033-f6a9-4186-a41f-7df2057b72fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_33541033-f6a9-4186-a41f-7df2057b72fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b2571759-f36d-445f-b935-4d127ccb872a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b2571759-f36d-445f-b935-4d127ccb872a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_57970ab3-7021-49e0-9623-c9e2bdb17e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_57970ab3-7021-49e0-9623-c9e2bdb17e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_c2bd1124-89fd-44ae-bc81-f3d58d9e0dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_c2bd1124-89fd-44ae-bc81-f3d58d9e0dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_5d5c4db0-7eb9-4251-8f19-2728de075a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_5d5c4db0-7eb9-4251-8f19-2728de075a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_abf9af4b-40ca-4406-a7d3-1445ac185a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_abf9af4b-40ca-4406-a7d3-1445ac185a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0ba66e78-ee76-4128-ad44-40176e4382c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0ba66e78-ee76-4128-ad44-40176e4382c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_75953811-6a98-4f96-9264-88e52794eac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_75953811-6a98-4f96-9264-88e52794eac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a030e226-4442-44d4-8390-a5f98b3aae81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a030e226-4442-44d4-8390-a5f98b3aae81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1620a299-99f6-4db0-95b0-1833466411da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1620a299-99f6-4db0-95b0-1833466411da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering_a5fa444c-9b2e-4fbd-b61f-45233cab26b7" xlink:href="avdl-20210630.xsd#avdl_StockIssuedDuringPeriodSharesPublicOffering"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering_a5fa444c-9b2e-4fbd-b61f-45233cab26b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodValuePublicOffering_ca0901ed-9bb0-470b-9645-b9c2ff49094d" xlink:href="avdl-20210630.xsd#avdl_StockIssuedDuringPeriodValuePublicOffering"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_avdl_StockIssuedDuringPeriodValuePublicOffering_ca0901ed-9bb0-470b-9645-b9c2ff49094d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_779b30a0-a4aa-47ae-9cfc-45c808d3b318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_SharesOutstanding_779b30a0-a4aa-47ae-9cfc-45c808d3b318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f3e2bfe6-fe1b-4daa-a002-0f1ed962766a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56abf8bf-da4e-4c81-bfd9-ab3745748e0a" xlink:to="loc_us-gaap_StockholdersEquity_f3e2bfe6-fe1b-4daa-a002-0f1ed962766a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="avdl-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_11f66d7f-8708-4f7f-a132-a438c858091e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72446c30-62c9-4a25-b14e-a95c699da489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11f66d7f-8708-4f7f-a132-a438c858091e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72446c30-62c9-4a25-b14e-a95c699da489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9cec0b71-360c-4840-9dc9-c3734e5745c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72446c30-62c9-4a25-b14e-a95c699da489" xlink:to="loc_us-gaap_NetIncomeLoss_9cec0b71-360c-4840-9dc9-c3734e5745c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72446c30-62c9-4a25-b14e-a95c699da489" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_a2b3af5d-adb5-4b64-847d-889646b12a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_us-gaap_DepreciationAndAmortization_a2b3af5d-adb5-4b64-847d-889646b12a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_afb1d6e0-dc1c-48aa-a9de-1825067f22af" xlink:href="avdl-20210630.xsd#avdl_AcquisitionRelatedContingentConsiderationRemeasurement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_afb1d6e0-dc1c-48aa-a9de-1825067f22af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement_7a9e0b3a-234e-4ea8-9e7d-e27e1217dce4" xlink:href="avdl-20210630.xsd#avdl_FinancingRelatedContingentConsiderationRemeasurement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement_7a9e0b3a-234e-4ea8-9e7d-e27e1217dce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8f193c41-f344-4f87-b015-d06a628e97a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8f193c41-f344-4f87-b015-d06a628e97a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d8d83b2f-09d1-4809-b1b7-115bd3f409b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d8d83b2f-09d1-4809-b1b7-115bd3f409b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_267b4c65-cc69-416f-aa24-0cc135c5462f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_us-gaap_ShareBasedCompensation_267b4c65-cc69-416f-aa24-0cc135c5462f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_abad9811-3684-4c90-855a-07512a83333d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_abad9811-3684-4c90-855a-07512a83333d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GainLossOnReleaseOfCertainLiabilities_6290d352-4bea-4dd6-9343-0057adfd1c35" xlink:href="avdl-20210630.xsd#avdl_GainLossOnReleaseOfCertainLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_avdl_GainLossOnReleaseOfCertainLiabilities_6290d352-4bea-4dd6-9343-0057adfd1c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_367d4835-4d80-4135-bb81-05ceda50a4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_367d4835-4d80-4135-bb81-05ceda50a4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60c14550-fb4b-4eae-a17d-8559541719bf" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_416cb134-f6fc-459a-87d5-49e984448114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_416cb134-f6fc-459a-87d5-49e984448114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8fd14334-c41f-4dc2-aca0-440162ca2bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8fd14334-c41f-4dc2-aca0-440162ca2bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fb358388-9755-4185-b009-b7d231f0385c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fb358388-9755-4185-b009-b7d231f0385c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_6bde6b40-cfdd-478d-95d3-9cf7ff4d1419" xlink:href="avdl-20210630.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_6bde6b40-cfdd-478d-95d3-9cf7ff4d1419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1ed3c0c1-d8fa-47d3-847a-defad0deb074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1ed3c0c1-d8fa-47d3-847a-defad0deb074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5741cc91-fafe-49a8-8c3d-71e964e98834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5741cc91-fafe-49a8-8c3d-71e964e98834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_5b1ad48e-8a22-48d8-a140-36da30bf322f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_5b1ad48e-8a22-48d8-a140-36da30bf322f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_98be5afd-4aac-46f0-8f1d-f0596b21b3e7" xlink:href="avdl-20210630.xsd#avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_98be5afd-4aac-46f0-8f1d-f0596b21b3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_b1f4a756-23ef-4a47-aa35-760155154cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_us-gaap_PaymentsForRoyalties_b1f4a756-23ef-4a47-aa35-760155154cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_4407ff5c-fed9-4c77-9484-dc5ce8df5c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9f9bfea-04e8-4410-8d6e-a0b17ffd81a0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_4407ff5c-fed9-4c77-9484-dc5ce8df5c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_521a18bd-38ff-48d3-a92f-db26c02f3478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72446c30-62c9-4a25-b14e-a95c699da489" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_521a18bd-38ff-48d3-a92f-db26c02f3478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06524ccf-721c-4b02-b5d9-4763688d8e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11f66d7f-8708-4f7f-a132-a438c858091e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06524ccf-721c-4b02-b5d9-4763688d8e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ff4ccc7e-48ad-4282-860a-065309575198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06524ccf-721c-4b02-b5d9-4763688d8e6d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ff4ccc7e-48ad-4282-860a-065309575198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_e14cc4e7-75bb-438e-813c-d511b779f2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06524ccf-721c-4b02-b5d9-4763688d8e6d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_e14cc4e7-75bb-438e-813c-d511b779f2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_f2886f56-6b74-4184-a7e7-d8da4603e6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06524ccf-721c-4b02-b5d9-4763688d8e6d" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_f2886f56-6b74-4184-a7e7-d8da4603e6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_048c472c-c693-4bf7-af57-bfff51658d06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06524ccf-721c-4b02-b5d9-4763688d8e6d" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_048c472c-c693-4bf7-af57-bfff51658d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8dbb2d36-4607-43ec-9e90-b394cc77d57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06524ccf-721c-4b02-b5d9-4763688d8e6d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8dbb2d36-4607-43ec-9e90-b394cc77d57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_53e0dcc6-ac9e-47c8-8a82-dc19b31faddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11f66d7f-8708-4f7f-a132-a438c858091e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_53e0dcc6-ac9e-47c8-8a82-dc19b31faddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_6d6cf519-2a1a-4396-b478-d2575f03ea32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_53e0dcc6-ac9e-47c8-8a82-dc19b31faddc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_6d6cf519-2a1a-4396-b478-d2575f03ea32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_8ef9ab32-d587-4cf7-a170-1c2885a2710c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_53e0dcc6-ac9e-47c8-8a82-dc19b31faddc" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_8ef9ab32-d587-4cf7-a170-1c2885a2710c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_494c6eb3-7eee-4072-a8a1-3670957c23c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_53e0dcc6-ac9e-47c8-8a82-dc19b31faddc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_494c6eb3-7eee-4072-a8a1-3670957c23c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0dd0ed50-a538-47ba-a59a-ef4d08136a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_53e0dcc6-ac9e-47c8-8a82-dc19b31faddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0dd0ed50-a538-47ba-a59a-ef4d08136a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_f7458ace-9a9c-4f7a-af06-061566603141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11f66d7f-8708-4f7f-a132-a438c858091e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_f7458ace-9a9c-4f7a-af06-061566603141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b6380500-9963-4fc5-8a61-c5a5c12fbfd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11f66d7f-8708-4f7f-a132-a438c858091e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b6380500-9963-4fc5-8a61-c5a5c12fbfd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4b918836-0c16-4997-a620-4fea3f3afe16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11f66d7f-8708-4f7f-a132-a438c858091e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4b918836-0c16-4997-a620-4fea3f3afe16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db7b4b79-f754-4977-aa65-5cd392c78b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11f66d7f-8708-4f7f-a132-a438c858091e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db7b4b79-f754-4977-aa65-5cd392c78b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_e2876c89-6aae-4312-a1ec-db8ed7215c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11f66d7f-8708-4f7f-a132-a438c858091e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_e2876c89-6aae-4312-a1ec-db8ed7215c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_934c28d7-b68b-4c12-b3b7-60200ebb048a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e2876c89-6aae-4312-a1ec-db8ed7215c11" xlink:to="loc_us-gaap_InterestPaidNet_934c28d7-b68b-4c12-b3b7-60200ebb048a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_517eac1d-1d5a-4160-89e4-09e54ae78a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e2876c89-6aae-4312-a1ec-db8ed7215c11" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_517eac1d-1d5a-4160-89e4-09e54ae78a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="avdl-20210630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7170e2a5-be62-445b-b6eb-d46e11eee5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6a04210a-7e4b-4686-9fa5-6297c95f2b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7170e2a5-be62-445b-b6eb-d46e11eee5d4" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6a04210a-7e4b-4686-9fa5-6297c95f2b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="avdl-20210630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e02669d4-7b34-4f82-bf0b-aee7129965db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock_1595fe5f-6eca-4472-b5d6-247c6a335e23" xlink:href="avdl-20210630.xsd#avdl_NatureOfBusinessPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e02669d4-7b34-4f82-bf0b-aee7129965db" xlink:to="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock_1595fe5f-6eca-4472-b5d6-247c6a335e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c34f1224-8fc6-4acf-9e11-e930e25a3dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e02669d4-7b34-4f82-bf0b-aee7129965db" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c34f1224-8fc6-4acf-9e11-e930e25a3dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5078351e-0634-4bab-a64d-f9f26b1a41dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e02669d4-7b34-4f82-bf0b-aee7129965db" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5078351e-0634-4bab-a64d-f9f26b1a41dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_002eb2b8-0985-4d38-8475-7593c0a1f250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e02669d4-7b34-4f82-bf0b-aee7129965db" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_002eb2b8-0985-4d38-8475-7593c0a1f250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandards" xlink:type="simple" xlink:href="avdl-20210630.xsd#NewlyIssuedAccountingStandards"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NewlyIssuedAccountingStandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_4392f5e4-1cd3-4f97-9458-820e91595807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_db629269-c3ee-4561-8000-bea95f87694f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_4392f5e4-1cd3-4f97-9458-820e91595807" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_db629269-c3ee-4561-8000-bea95f87694f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#NewlyIssuedAccountingStandardsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_36004c9a-3c39-444c-832b-630b37551d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_36004c9a-3c39-444c-832b-630b37551d1a" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b069a2e6-1aeb-49e8-9c16-4beaea8b63fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:to="loc_us-gaap_DebtInstrumentAxis_b069a2e6-1aeb-49e8-9c16-4beaea8b63fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ed8245a4-c9d6-46cb-9dad-6f2ab29ea534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b069a2e6-1aeb-49e8-9c16-4beaea8b63fa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ed8245a4-c9d6-46cb-9dad-6f2ab29ea534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_44fd4537-6a70-4a56-a859-b117e945ea03" xlink:href="avdl-20210630.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ed8245a4-c9d6-46cb-9dad-6f2ab29ea534" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_44fd4537-6a70-4a56-a859-b117e945ea03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fc53c829-e4f7-4101-8dbc-ca99ad97c80e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fc53c829-e4f7-4101-8dbc-ca99ad97c80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ba73ab05-08c4-4ad8-b00b-f753a0212145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fc53c829-e4f7-4101-8dbc-ca99ad97c80e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ba73ab05-08c4-4ad8-b00b-f753a0212145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c58d7c66-6113-4874-bb9e-a41fc9086a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ba73ab05-08c4-4ad8-b00b-f753a0212145" xlink:to="loc_us-gaap_SeniorNotesMember_c58d7c66-6113-4874-bb9e-a41fc9086a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a4c4a941-3a5d-4c32-b2ad-f641819264b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a4c4a941-3a5d-4c32-b2ad-f641819264b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6895e16c-c744-40a8-bc1b-9fc846a20a30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a4c4a941-3a5d-4c32-b2ad-f641819264b7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6895e16c-c744-40a8-bc1b-9fc846a20a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_40e1e04d-a495-460d-be7a-7c1a56c599c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6895e16c-c744-40a8-bc1b-9fc846a20a30" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_40e1e04d-a495-460d-be7a-7c1a56c599c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6c439cfb-b46e-4352-9f0e-1bdc09690f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6c439cfb-b46e-4352-9f0e-1bdc09690f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7ef73f9e-067d-40da-b463-a6423b15ebf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c439cfb-b46e-4352-9f0e-1bdc09690f3e" xlink:to="loc_us-gaap_EquityComponentDomain_7ef73f9e-067d-40da-b463-a6423b15ebf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_edaa14dd-dd44-4259-9cfe-c0a3c06333e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7ef73f9e-067d-40da-b463-a6423b15ebf7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_edaa14dd-dd44-4259-9cfe-c0a3c06333e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_27bdc19c-2d55-41ff-aacb-912728ef4eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7ef73f9e-067d-40da-b463-a6423b15ebf7" xlink:to="loc_us-gaap_RetainedEarningsMember_27bdc19c-2d55-41ff-aacb-912728ef4eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bff3166-3c0d-4cce-9879-e3d084669408" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_99992cef-a157-4e45-8ee4-b0ef4e9853c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_99992cef-a157-4e45-8ee4-b0ef4e9853c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e6ff5c93-cbdd-451b-9587-51eb5c0f1947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:to="loc_us-gaap_StockholdersEquity_e6ff5c93-cbdd-451b-9587-51eb5c0f1947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6b9576f3-684d-4fd8-b65a-dfacd4515f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3baf5ac7-9879-4508-9ac1-4e4b6f848377" xlink:to="loc_us-gaap_LongTermDebt_6b9576f3-684d-4fd8-b65a-dfacd4515f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProducts" xlink:type="simple" xlink:href="avdl-20210630.xsd#DispositionoftheHospitalProducts"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProducts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_86563f54-c878-4678-b660-1e0e077d5d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_2cf22c19-7bb5-4c24-9a57-f7a6317f3cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_86563f54-c878-4678-b660-1e0e077d5d50" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_2cf22c19-7bb5-4c24-9a57-f7a6317f3cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#DispositionoftheHospitalProductsTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProductsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_923715d6-dcbb-4c3f-af3c-24385e32b092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_ff170afd-03fc-43b8-be9a-9d8d725f8a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_923715d6-dcbb-4c3f-af3c-24385e32b092" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_ff170afd-03fc-43b8-be9a-9d8d725f8a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_19daf47c-9ca2-48df-96a7-8f17612ad6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_923715d6-dcbb-4c3f-af3c-24385e32b092" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_19daf47c-9ca2-48df-96a7-8f17612ad6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#DispositionoftheHospitalProductsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_5c09e4e9-e149-40f3-a487-663b485f322e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_594ad7c9-04bd-4947-ae20-3d9cb810533d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_5c09e4e9-e149-40f3-a487-663b485f322e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_594ad7c9-04bd-4947-ae20-3d9cb810533d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43e0718c-2331-4a2b-93a2-ce690d98d7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_594ad7c9-04bd-4947-ae20-3d9cb810533d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43e0718c-2331-4a2b-93a2-ce690d98d7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16114cfc-ac7d-4b77-8a04-bc71eef04f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43e0718c-2331-4a2b-93a2-ce690d98d7f6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16114cfc-ac7d-4b77-8a04-bc71eef04f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember_6ef70ee4-edea-44d4-b266-12377005b276" xlink:href="avdl-20210630.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_16114cfc-ac7d-4b77-8a04-bc71eef04f63" xlink:to="loc_avdl_BloxiverzVazculepAkovazandNouressMember_6ef70ee4-edea-44d4-b266-12377005b276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b949bf36-dabc-45c3-8d2a-3ae786962893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_594ad7c9-04bd-4947-ae20-3d9cb810533d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b949bf36-dabc-45c3-8d2a-3ae786962893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_06d1aed5-1646-44e3-859d-32fe35c029f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b949bf36-dabc-45c3-8d2a-3ae786962893" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_06d1aed5-1646-44e3-859d-32fe35c029f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_791f465b-cfe8-4ef2-9b4f-bd386a6e2aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_06d1aed5-1646-44e3-859d-32fe35c029f3" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_791f465b-cfe8-4ef2-9b4f-bd386a6e2aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_594ad7c9-04bd-4947-ae20-3d9cb810533d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_34a3e175-8fbc-4bb3-9a8f-929092780ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_34a3e175-8fbc-4bb3-9a8f-929092780ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_5a8613bd-2b1e-4d8b-803c-ebdda59cbfd9" xlink:href="avdl-20210630.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_5a8613bd-2b1e-4d8b-803c-ebdda59cbfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_974540a5-171f-4faf-96b8-ad89535ed0a8" xlink:href="avdl-20210630.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_974540a5-171f-4faf-96b8-ad89535ed0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_449968f6-3b94-442e-bbfd-d3ed427f2b1a" xlink:href="avdl-20210630.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_449968f6-3b94-442e-bbfd-d3ed427f2b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_af90fb42-f52e-4d12-a7fb-bdf618e81337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_af90fb42-f52e-4d12-a7fb-bdf618e81337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_a929b4d1-ba68-4abf-8ad7-ae0dafda3e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_61e580df-ef65-49e0-903e-5e69843a5130" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_a929b4d1-ba68-4abf-8ad7-ae0dafda3e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_117ff30a-e485-47dc-8595-a88775ce7760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fb4277dd-e29f-4575-bde2-10adfa03884d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_117ff30a-e485-47dc-8595-a88775ce7760" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fb4277dd-e29f-4575-bde2-10adfa03884d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d4323dc0-8f3d-4072-8801-3bd2502212e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fb4277dd-e29f-4575-bde2-10adfa03884d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d4323dc0-8f3d-4072-8801-3bd2502212e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_467f44f0-82a4-4b97-af55-50e26dfd6437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d4323dc0-8f3d-4072-8801-3bd2502212e8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_467f44f0-82a4-4b97-af55-50e26dfd6437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember_0461195d-b36d-4ed4-a422-691b86ac094e" xlink:href="avdl-20210630.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_467f44f0-82a4-4b97-af55-50e26dfd6437" xlink:to="loc_avdl_BloxiverzVazculepAkovazandNouressMember_0461195d-b36d-4ed4-a422-691b86ac094e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_50753e05-98c0-47df-88df-b0cf072e547f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fb4277dd-e29f-4575-bde2-10adfa03884d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_50753e05-98c0-47df-88df-b0cf072e547f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c7c9c7ae-592e-4c69-a439-a4dab2f0be03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_50753e05-98c0-47df-88df-b0cf072e547f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c7c9c7ae-592e-4c69-a439-a4dab2f0be03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f72d12c2-ad0b-4ae3-b4d1-a0ee9a561048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c7c9c7ae-592e-4c69-a439-a4dab2f0be03" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f72d12c2-ad0b-4ae3-b4d1-a0ee9a561048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fb4277dd-e29f-4575-bde2-10adfa03884d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_2c088395-cdb7-4b8a-99fe-5f3167d9df6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_2c088395-cdb7-4b8a-99fe-5f3167d9df6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_c28cab76-61d9-47f3-acf1-42c189550b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_c28cab76-61d9-47f3-acf1-42c189550b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_8ba72aa5-9cdb-48c7-99e4-d0422f9a435b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_8ba72aa5-9cdb-48c7-99e4-d0422f9a435b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_1f48ea20-7921-4364-8c8e-21382a4f831f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_1f48ea20-7921-4364-8c8e-21382a4f831f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_57c49af7-9cb6-4eb5-8701-4ad377e1e8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_57c49af7-9cb6-4eb5-8701-4ad377e1e8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_c921d6ec-a02c-4f3f-a5c0-754be7874969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_c921d6ec-a02c-4f3f-a5c0-754be7874969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_97a0d074-89b8-4164-a650-259cfaf29d11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_97a0d074-89b8-4164-a650-259cfaf29d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b507a939-73dd-456c-bb7b-03095d93a141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b507a939-73dd-456c-bb7b-03095d93a141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_02710729-d5d2-4f3b-9b76-a875e4920220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_02710729-d5d2-4f3b-9b76-a875e4920220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_83b1ba18-1c5f-4bef-82d7-876cf7ab5742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7a3204f3-4e4b-44ca-ac7e-68ad447c6148" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_83b1ba18-1c5f-4bef-82d7-876cf7ab5742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_9d5d5245-d7e3-4b42-b725-303ab2b1f56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_9d5d5245-d7e3-4b42-b725-303ab2b1f56c" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6b912f99-22b8-4a3c-b463-5e85c0384509" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:to="loc_srt_RestatementAxis_6b912f99-22b8-4a3c-b463-5e85c0384509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_d7c9754e-ff24-4226-af84-4f9ebeb52443" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_6b912f99-22b8-4a3c-b463-5e85c0384509" xlink:to="loc_srt_RestatementDomain_d7c9754e-ff24-4226-af84-4f9ebeb52443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_97fea2c4-68eb-485a-a165-bd21998a1607" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_d7c9754e-ff24-4226-af84-4f9ebeb52443" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_97fea2c4-68eb-485a-a165-bd21998a1607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_01bc011b-563f-4c24-9236-4c192443fd8d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_d7c9754e-ff24-4226-af84-4f9ebeb52443" xlink:to="loc_srt_RestatementAdjustmentMember_01bc011b-563f-4c24-9236-4c192443fd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_47c26dd7-22fd-4a44-8867-1905cb93a5d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:to="loc_srt_StatementScenarioAxis_47c26dd7-22fd-4a44-8867-1905cb93a5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ee723fa6-3923-4e56-b923-f89eb7d8ca98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_47c26dd7-22fd-4a44-8867-1905cb93a5d2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ee723fa6-3923-4e56-b923-f89eb7d8ca98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_a4ebc2a5-b58d-46c6-bc92-7f91bdf73aac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_ee723fa6-3923-4e56-b923-f89eb7d8ca98" xlink:to="loc_srt_ProFormaMember_a4ebc2a5-b58d-46c6-bc92-7f91bdf73aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6abbaea6-4a47-41da-af4d-c6bc15104c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6abbaea6-4a47-41da-af4d-c6bc15104c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b0f7fc5f-3ce6-4533-b52d-747745fc597f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6abbaea6-4a47-41da-af4d-c6bc15104c69" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b0f7fc5f-3ce6-4533-b52d-747745fc597f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_38d313ee-9cb2-4ad4-9520-388aaa18128d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b0f7fc5f-3ce6-4533-b52d-747745fc597f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_38d313ee-9cb2-4ad4-9520-388aaa18128d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_1e4f97f7-8bc4-4ace-89dd-79886b0f93dc" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ebc793f3-e93e-4b12-a088-cb10a3e79180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ebc793f3-e93e-4b12-a088-cb10a3e79180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9a870743-4b71-400e-a627-65cc559c0680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_CostsAndExpenses_9a870743-4b71-400e-a627-65cc559c0680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c6b380f7-7814-4f79-9829-2cd7408ae5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_OperatingIncomeLoss_c6b380f7-7814-4f79-9829-2cd7408ae5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bb0dec3d-04cf-47b2-8a85-a215505b8f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bb0dec3d-04cf-47b2-8a85-a215505b8f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_71733915-625b-4be3-9d05-5b9e44ec6440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_71733915-625b-4be3-9d05-5b9e44ec6440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cca93c0e-9c92-4bc6-9f2f-4b30c696ce9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cca93c0e-9c92-4bc6-9f2f-4b30c696ce9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a98e425c-fece-4762-8c6b-04d05558650e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a98e425c-fece-4762-8c6b-04d05558650e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6c4a1bd9-23fd-451e-905a-56d29e5aaddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6c4a1bd9-23fd-451e-905a-56d29e5aaddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9cfa748e-b103-45ba-9831-f429c44d1766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9cfa748e-b103-45ba-9831-f429c44d1766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d75ffa3b-25cd-4f20-8fb4-085f64308e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_edac3d18-b166-4e45-89f8-4c3cdf157af2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d75ffa3b-25cd-4f20-8fb4-085f64308e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RevenueRecognition" xlink:type="simple" xlink:href="avdl-20210630.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b2aa5d1a-66d9-4689-b1db-ac2c5d761990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_362170eb-6a68-49a3-b3a6-e7a929b635c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b2aa5d1a-66d9-4689-b1db-ac2c5d761990" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_362170eb-6a68-49a3-b3a6-e7a929b635c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c2ff3f77-9ea3-4a1d-bf91-1920b6028133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_83f0ab56-a583-4a98-9e6b-5f502bf1c94b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c2ff3f77-9ea3-4a1d-bf91-1920b6028133" xlink:to="loc_us-gaap_CapitalizedContractCostNet_83f0ab56-a583-4a98-9e6b-5f502bf1c94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="avdl-20210630.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cba00c22-855c-4576-b9fe-02b2106057f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8ccbcd89-744a-40fa-b585-5ac245391596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cba00c22-855c-4576-b9fe-02b2106057f9" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8ccbcd89-744a-40fa-b585-5ac245391596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_44b51bc8-6ec7-4891-8b2b-ab632f6f4ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2d3eabda-570a-4cbd-89f8-4eeb26a27724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_44b51bc8-6ec7-4891-8b2b-ab632f6f4ace" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2d3eabda-570a-4cbd-89f8-4eeb26a27724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#FairValueMeasurementMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3982d5c8-89c7-423a-a259-4926ae37c631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3982d5c8-89c7-423a-a259-4926ae37c631" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_219a5e9f-1609-4c45-b052-ae813a372874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_219a5e9f-1609-4c45-b052-ae813a372874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f146780b-882b-4c0f-a1e1-9817d5882f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_219a5e9f-1609-4c45-b052-ae813a372874" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f146780b-882b-4c0f-a1e1-9817d5882f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d439ca6c-c538-4c6d-afb1-4e061783eb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f146780b-882b-4c0f-a1e1-9817d5882f2c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d439ca6c-c538-4c6d-afb1-4e061783eb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b5eb186-3eef-4085-95ed-d07b836c1653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b5eb186-3eef-4085-95ed-d07b836c1653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b5eb186-3eef-4085-95ed-d07b836c1653" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_57dbcdfc-2151-4e0f-a784-89a964de1239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_57dbcdfc-2151-4e0f-a784-89a964de1239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_47586183-97b1-4edb-acf0-b9f240d3102c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_47586183-97b1-4edb-acf0-b9f240d3102c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0716931e-1c5c-4fd7-bfaa-e4a3c93738c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_27d828c4-8396-4505-8738-c05b1be178ee" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0716931e-1c5c-4fd7-bfaa-e4a3c93738c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca4a38c4-99ed-49e4-a095-61c3445ca2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca4a38c4-99ed-49e4-a095-61c3445ca2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca4a38c4-99ed-49e4-a095-61c3445ca2aa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_25afe8c2-6be5-4a7e-b3f4-7a8f3fa21905" xlink:href="avdl-20210630.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_25afe8c2-6be5-4a7e-b3f4-7a8f3fa21905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_9a2952db-9878-46d5-87cf-b7ef2548e603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_9a2952db-9878-46d5-87cf-b7ef2548e603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cde8b38b-9599-4d55-82e9-d38e3daa9eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cde8b38b-9599-4d55-82e9-d38e3daa9eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_2435c3e4-349e-4910-b713-1b8780f21eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30453585-88c1-456a-ae7b-f0d02478c884" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_2435c3e4-349e-4910-b713-1b8780f21eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76f05f3b-ac64-438f-8dc6-bf9c0d489857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3a928d0-a313-4c53-9a30-8318b8446bdf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76f05f3b-ac64-438f-8dc6-bf9c0d489857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_812458c9-8ec7-4739-b8a6-f2a93e3fc0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76f05f3b-ac64-438f-8dc6-bf9c0d489857" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_812458c9-8ec7-4739-b8a6-f2a93e3fc0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_1defcbdd-0501-4e0e-ae19-a3b1da8daf35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76f05f3b-ac64-438f-8dc6-bf9c0d489857" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_1defcbdd-0501-4e0e-ae19-a3b1da8daf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b4ce3fc5-9c0c-419f-bb09-2b43f7ac51b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eb1115ed-73af-4038-bd90-379642f30fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b4ce3fc5-9c0c-419f-bb09-2b43f7ac51b7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eb1115ed-73af-4038-bd90-379642f30fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_55e8c608-ab04-4415-88e7-da645f4147da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eb1115ed-73af-4038-bd90-379642f30fa1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_55e8c608-ab04-4415-88e7-da645f4147da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bbd3e371-3311-4785-9e52-260dca96fcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_55e8c608-ab04-4415-88e7-da645f4147da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bbd3e371-3311-4785-9e52-260dca96fcdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_19f62943-ae9c-4e83-85cf-b544fbf23df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bbd3e371-3311-4785-9e52-260dca96fcdf" xlink:to="loc_us-gaap_SeniorNotesMember_19f62943-ae9c-4e83-85cf-b544fbf23df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d854dc8-6e37-4b40-ac6e-1d9524ee6bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eb1115ed-73af-4038-bd90-379642f30fa1" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d854dc8-6e37-4b40-ac6e-1d9524ee6bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c790dc2a-c346-4e58-ab2d-6b75b6c9a246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d854dc8-6e37-4b40-ac6e-1d9524ee6bf5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c790dc2a-c346-4e58-ab2d-6b75b6c9a246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_669c88d6-c9d5-4836-80ee-becae7c2850c" xlink:href="avdl-20210630.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c790dc2a-c346-4e58-ab2d-6b75b6c9a246" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_669c88d6-c9d5-4836-80ee-becae7c2850c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37d43a6a-4918-48b5-9027-b5a93f40604e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eb1115ed-73af-4038-bd90-379642f30fa1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37d43a6a-4918-48b5-9027-b5a93f40604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c052a561-a787-4355-a5cf-31d5aa409fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37d43a6a-4918-48b5-9027-b5a93f40604e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c052a561-a787-4355-a5cf-31d5aa409fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_f8e049ee-645a-4cf9-bf6c-84992b187d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37d43a6a-4918-48b5-9027-b5a93f40604e" xlink:to="loc_us-gaap_LongTermDebtFairValue_f8e049ee-645a-4cf9-bf6c-84992b187d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecurities" xlink:type="simple" xlink:href="avdl-20210630.xsd#MarketableSecurities"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d07beaa8-3b73-482b-ad2d-099852a0af0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_9b5b1a40-0aa5-4a25-892b-8d5137673937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d07beaa8-3b73-482b-ad2d-099852a0af0b" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_9b5b1a40-0aa5-4a25-892b-8d5137673937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#MarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_179d382b-0263-4bbc-81be-10cab84536f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_9fb186db-586a-45d2-82ca-aa2d2a6cb41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_179d382b-0263-4bbc-81be-10cab84536f6" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_9fb186db-586a-45d2-82ca-aa2d2a6cb41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1c447078-0eab-432d-aea9-31d78fbd0368" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_179d382b-0263-4bbc-81be-10cab84536f6" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1c447078-0eab-432d-aea9-31d78fbd0368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#MarketableSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3cbdbe7b-1e06-4984-8946-859027763af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_31d69c13-cd12-409b-905d-0b3fa5b3805b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3cbdbe7b-1e06-4984-8946-859027763af8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_31d69c13-cd12-409b-905d-0b3fa5b3805b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_075490da-5d40-4aeb-8905-43b5e665e043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3cbdbe7b-1e06-4984-8946-859027763af8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_075490da-5d40-4aeb-8905-43b5e665e043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#MarketableSecuritiesSummaryofMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f1aab928-11ab-4caa-992f-c1d99030adb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_affcb53b-01e8-485d-b1b3-9506d4be56b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f1aab928-11ab-4caa-992f-c1d99030adb6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_affcb53b-01e8-485d-b1b3-9506d4be56b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4a40eebf-6966-4827-850c-b371a3d57a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_affcb53b-01e8-485d-b1b3-9506d4be56b4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4a40eebf-6966-4827-850c-b371a3d57a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4a40eebf-6966-4827-850c-b371a3d57a23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_d89ffc12-5aeb-4be3-ab56-91c0859c2dd8" xlink:href="avdl-20210630.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_d89ffc12-5aeb-4be3-ab56-91c0859c2dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_de835002-443e-47a2-a384-4f706d579786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_de835002-443e-47a2-a384-4f706d579786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7b68250b-2fdd-4971-aa02-dfa36353d115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7b68250b-2fdd-4971-aa02-dfa36353d115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_9bed4342-45c1-4e28-85bc-3ba4c76c92bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9dbac862-eb1e-45d6-90c8-657054b418f5" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_9bed4342-45c1-4e28-85bc-3ba4c76c92bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6e1f9bd8-d478-4fd3-a838-144843593446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_affcb53b-01e8-485d-b1b3-9506d4be56b4" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6e1f9bd8-d478-4fd3-a838-144843593446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6e1f9bd8-d478-4fd3-a838-144843593446" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eb026398-ecbb-4be9-9c13-41d2959062fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eb026398-ecbb-4be9-9c13-41d2959062fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2f6492af-a3a4-4873-89d7-b0a040c8b79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2f6492af-a3a4-4873-89d7-b0a040c8b79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb1cf393-81fb-48b9-84d6-69deedf69175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb1cf393-81fb-48b9-84d6-69deedf69175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_29ab94c0-ef89-4938-b37d-6345624c9ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_d66c2717-c6a9-44c4-8b1c-561669693c56" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_29ab94c0-ef89-4938-b37d-6345624c9ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#MarketableSecuritiesScheduleofMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a0e2db90-ce7f-4c7d-acb5-fbfdb915fb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_5f000a26-0bd1-4fe1-a89d-1f39c7ae85f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a0e2db90-ce7f-4c7d-acb5-fbfdb915fb1a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_5f000a26-0bd1-4fe1-a89d-1f39c7ae85f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a403b7b1-58f3-4d83-9270-4d75b4b09484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_5f000a26-0bd1-4fe1-a89d-1f39c7ae85f6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a403b7b1-58f3-4d83-9270-4d75b4b09484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a403b7b1-58f3-4d83-9270-4d75b4b09484" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3827be39-17df-4909-b74e-398bce9c63fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3827be39-17df-4909-b74e-398bce9c63fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0189d76e-3994-4c0c-9deb-d92d7b0099c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0189d76e-3994-4c0c-9deb-d92d7b0099c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_7df29753-4f0b-4bc1-b7ec-868ee62596da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_7df29753-4f0b-4bc1-b7ec-868ee62596da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_3c6f2ee4-a762-4090-afa8-a05870d274e8" xlink:href="avdl-20210630.xsd#avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_010affcb-388c-46c4-a548-d492a81b3811" xlink:to="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_3c6f2ee4-a762-4090-afa8-a05870d274e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_5f000a26-0bd1-4fe1-a89d-1f39c7ae85f6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_606fb147-eb39-46d4-ad05-cb8ee20de7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_606fb147-eb39-46d4-ad05-cb8ee20de7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_77b76fd4-3fbb-4ac8-bd84-4c4d73a9d6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_77b76fd4-3fbb-4ac8-bd84-4c4d73a9d6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_15845e8b-999a-4f1a-82da-ab0fb8450774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_15845e8b-999a-4f1a-82da-ab0fb8450774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_12de50da-c912-46e7-a1be-71470b790000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_12de50da-c912-46e7-a1be-71470b790000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f989873f-e574-4939-a460-dafe711e9f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0d147194-c9bc-43d1-a3e1-cf5017235e3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f989873f-e574-4939-a460-dafe711e9f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="avdl-20210630.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f7ea6c3-1850-4ab4-8b54-9a3c41f93df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_62dd7de0-98d3-495f-adf6-c650c9ffa73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f7ea6c3-1850-4ab4-8b54-9a3c41f93df9" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_62dd7de0-98d3-495f-adf6-c650c9ffa73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/GoodwillandIntangibleAssetsDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#GoodwillandIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/GoodwillandIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_84fa1ac0-a4f6-4e2b-bf77-d7afb29943e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b4638e26-2694-4c17-b9f5-a7ce15bbca91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_84fa1ac0-a4f6-4e2b-bf77-d7afb29943e1" xlink:to="loc_us-gaap_Goodwill_b4638e26-2694-4c17-b9f5-a7ce15bbca91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5a6dc100-2fe0-4732-b799-3e11d1f49cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_84fa1ac0-a4f6-4e2b-bf77-d7afb29943e1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5a6dc100-2fe0-4732-b799-3e11d1f49cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentConsiderationPayable" xlink:type="simple" xlink:href="avdl-20210630.xsd#ContingentConsiderationPayable"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentConsiderationPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f4b43af9-fb6c-4951-b06c-2809735920bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4d8c62bf-5099-44ed-8ee1-cb7080a31ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f4b43af9-fb6c-4951-b06c-2809735920bb" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4d8c62bf-5099-44ed-8ee1-cb7080a31ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentConsiderationPayableTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#ContingentConsiderationPayableTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentConsiderationPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_acd17ab0-3571-4c52-916e-9dea32c1b367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1a426f86-866c-4a53-b8e1-e11190cd8b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_acd17ab0-3571-4c52-916e-9dea32c1b367" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1a426f86-866c-4a53-b8e1-e11190cd8b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#ContingentConsiderationPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1ca2eb9f-ce0c-4049-a9f5-95702227b373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_5cdc3fb0-8158-4cfc-ada8-b29f18e0d686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1ca2eb9f-ce0c-4049-a9f5-95702227b373" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_5cdc3fb0-8158-4cfc-ada8-b29f18e0d686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#ContingentConsiderationPayablePayableBalanceDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cc8d2440-d20b-4bda-aca1-6377cb8f614a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_f645fc34-a7d6-49a4-90bf-2d3a311cf334" xlink:href="avdl-20210630.xsd#avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cc8d2440-d20b-4bda-aca1-6377cb8f614a" xlink:to="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_f645fc34-a7d6-49a4-90bf-2d3a311cf334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_6ccc687d-dabb-4ce1-9562-caedcfacb459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_f645fc34-a7d6-49a4-90bf-2d3a311cf334" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_6ccc687d-dabb-4ce1-9562-caedcfacb459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_889718a9-fa39-4786-b794-86e1c1a003d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_f645fc34-a7d6-49a4-90bf-2d3a311cf334" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_889718a9-fa39-4786-b794-86e1c1a003d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_55c85cd5-6605-49c3-b137-afe5024c80ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_f645fc34-a7d6-49a4-90bf-2d3a311cf334" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_55c85cd5-6605-49c3-b137-afe5024c80ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_9b0e624e-898a-4cae-b8fd-f8469e3a4475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_f645fc34-a7d6-49a4-90bf-2d3a311cf334" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_9b0e624e-898a-4cae-b8fd-f8469e3a4475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_f9e75af2-2e18-49df-a886-4777753465f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_f645fc34-a7d6-49a4-90bf-2d3a311cf334" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_f9e75af2-2e18-49df-a886-4777753465f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebt" xlink:type="simple" xlink:href="avdl-20210630.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d7495556-d002-442e-b99e-917f7d0fcfd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_d5733fe9-281c-463f-a19b-fb0f84a7f2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d7495556-d002-442e-b99e-917f7d0fcfd1" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_d5733fe9-281c-463f-a19b-fb0f84a7f2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_48ca322c-a661-4ee3-81f8-50badb39123b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7f2ad06f-fb53-4795-a9d1-d41a1f9ace7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_48ca322c-a661-4ee3-81f8-50badb39123b" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7f2ad06f-fb53-4795-a9d1-d41a1f9ace7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8acba739-9e75-4aef-bb12-207e548fad99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_01fed32f-6022-43bd-80ca-7a1c219dacee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8acba739-9e75-4aef-bb12-207e548fad99" xlink:to="loc_us-gaap_DebtInstrumentTable_01fed32f-6022-43bd-80ca-7a1c219dacee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b4628190-7be1-4cc2-b31c-6921d21a9c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_01fed32f-6022-43bd-80ca-7a1c219dacee" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b4628190-7be1-4cc2-b31c-6921d21a9c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bd07a95b-2e82-46e9-9403-2a2038383625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b4628190-7be1-4cc2-b31c-6921d21a9c12" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bd07a95b-2e82-46e9-9403-2a2038383625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_053264b3-858c-418a-b931-5b6dcabb5105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bd07a95b-2e82-46e9-9403-2a2038383625" xlink:to="loc_us-gaap_SeniorNotesMember_053264b3-858c-418a-b931-5b6dcabb5105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7afb6bc1-8d23-4a19-a569-d0bd105e49a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_01fed32f-6022-43bd-80ca-7a1c219dacee" xlink:to="loc_us-gaap_DebtInstrumentAxis_7afb6bc1-8d23-4a19-a569-d0bd105e49a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_59ced889-c934-4b16-8e77-dcfffcb39977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7afb6bc1-8d23-4a19-a569-d0bd105e49a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_59ced889-c934-4b16-8e77-dcfffcb39977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_470f2da0-8ae5-40c7-82a6-fd80d31c9ec9" xlink:href="avdl-20210630.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_59ced889-c934-4b16-8e77-dcfffcb39977" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_470f2da0-8ae5-40c7-82a6-fd80d31c9ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_01fed32f-6022-43bd-80ca-7a1c219dacee" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3d85aa3e-3343-49fc-999a-0c4ea07d1f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3d85aa3e-3343-49fc-999a-0c4ea07d1f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_f3962c62-4965-41ce-ae27-0db720886b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_f3962c62-4965-41ce-ae27-0db720886b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_88c9a3c4-eb1a-4c35-ad2f-8d59daf59c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_LongTermDebt_88c9a3c4-eb1a-4c35-ad2f-8d59daf59c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1b366dae-1f58-45ec-a595-e2f2af045f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_LongTermDebtCurrent_1b366dae-1f58-45ec-a595-e2f2af045f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e1743a7e-133d-4e73-9a2b-57cbef546f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e1743a7e-133d-4e73-9a2b-57cbef546f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_6cb9711c-f502-4320-9e10-4e713e78a6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_6cb9711c-f502-4320-9e10-4e713e78a6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f9a63917-b6bd-4718-98f5-ec7c5b3f98f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9ffe665-0451-4b94-9346-13ce0ac8d855" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f9a63917-b6bd-4718-98f5-ec7c5b3f98f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d70c2d47-20ae-4e1b-90b8-2d2eae1de311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d70c2d47-20ae-4e1b-90b8-2d2eae1de311" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6fcb3d11-0bc6-4875-aa3e-b6e0c95f25d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6fcb3d11-0bc6-4875-aa3e-b6e0c95f25d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6fcb3d11-0bc6-4875-aa3e-b6e0c95f25d8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_5946e798-1615-401e-b53e-43c9f1728e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_5946e798-1615-401e-b53e-43c9f1728e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e26b921b-1199-48b5-8139-d3bf91943e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e26b921b-1199-48b5-8139-d3bf91943e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_7c0602fc-eeb7-49be-be9b-1ad777667936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2122079f-a4dc-47ea-841c-9dd9a59fc70a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_7c0602fc-eeb7-49be-be9b-1ad777667936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7aa895f7-4772-4dd7-9496-84b2bdfdc7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_us-gaap_DebtInstrumentAxis_7aa895f7-4772-4dd7-9496-84b2bdfdc7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_344cdb8a-8f92-4aa8-af2a-161f96ec483c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7aa895f7-4772-4dd7-9496-84b2bdfdc7c1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_344cdb8a-8f92-4aa8-af2a-161f96ec483c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_9423624b-9b63-4d4d-99f8-fa7764afb85a" xlink:href="avdl-20210630.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_344cdb8a-8f92-4aa8-af2a-161f96ec483c" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_9423624b-9b63-4d4d-99f8-fa7764afb85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4ac4d46f-042e-4627-a537-5c5e10a89787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4ac4d46f-042e-4627-a537-5c5e10a89787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6563ff7b-55f1-4fad-9378-ce9fae590b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4ac4d46f-042e-4627-a537-5c5e10a89787" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6563ff7b-55f1-4fad-9378-ce9fae590b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_916e558d-39e3-4802-b1d0-30996c223f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6563ff7b-55f1-4fad-9378-ce9fae590b2f" xlink:to="loc_us-gaap_ConvertibleDebtMember_916e558d-39e3-4802-b1d0-30996c223f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9f1718d7-dd95-46e9-ae2a-099125d5558f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6563ff7b-55f1-4fad-9378-ce9fae590b2f" xlink:to="loc_us-gaap_SeniorNotesMember_9f1718d7-dd95-46e9-ae2a-099125d5558f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47730c0d-17c4-4296-b908-e9690f895c6c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47730c0d-17c4-4296-b908-e9690f895c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_170bd4a5-0728-4fc8-ad03-a0953c01dd5a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47730c0d-17c4-4296-b908-e9690f895c6c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_170bd4a5-0728-4fc8-ad03-a0953c01dd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_aec968c6-c8bc-4175-af98-9c1faa28d2ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_170bd4a5-0728-4fc8-ad03-a0953c01dd5a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_aec968c6-c8bc-4175-af98-9c1faa28d2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e82f6ca8-11cc-419f-a06b-52b9007a3aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e82f6ca8-11cc-419f-a06b-52b9007a3aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a408b6ff-3105-4b89-a287-5cb930c7484f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e82f6ca8-11cc-419f-a06b-52b9007a3aa5" xlink:to="loc_us-gaap_EquityComponentDomain_a408b6ff-3105-4b89-a287-5cb930c7484f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9a2d496a-8b8f-4c03-be8e-bd4efcbb0936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a408b6ff-3105-4b89-a287-5cb930c7484f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9a2d496a-8b8f-4c03-be8e-bd4efcbb0936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0d898684-0e0b-4849-af99-e784fd1ae9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a408b6ff-3105-4b89-a287-5cb930c7484f" xlink:to="loc_us-gaap_RetainedEarningsMember_0d898684-0e0b-4849-af99-e784fd1ae9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_3b02e5a9-e9b8-4c1e-a84a-b44d73ee3d9b" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_020cd327-8dbc-45c9-b774-547588d3e7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_InterestExpenseDebt_020cd327-8dbc-45c9-b774-547588d3e7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense_22f53b1b-887a-47d4-8127-304b67085113" xlink:href="avdl-20210630.xsd#avdl_CouponInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_CouponInterestExpense_22f53b1b-887a-47d4-8127-304b67085113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1ee53c3d-330d-4714-9e2f-540c3b64ffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1ee53c3d-330d-4714-9e2f-540c3b64ffdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_de80a68f-a7d3-4a59-97f5-0ce4f0108776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_LongTermDebt_de80a68f-a7d3-4a59-97f5-0ce4f0108776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e10aba65-bd0d-473a-aa49-2be6210e4496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_StockholdersEquity_e10aba65-bd0d-473a-aa49-2be6210e4496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3487a9a4-97dc-40ae-a6c5-1179f12f4734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3487a9a4-97dc-40ae-a6c5-1179f12f4734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4214dbfb-7288-443c-9fc0-cf2fa1b78e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4214dbfb-7288-443c-9fc0-cf2fa1b78e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_2d8abf20-3144-4fc0-ae23-4156849712ed" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_2d8abf20-3144-4fc0-ae23-4156849712ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_3e8038f6-1664-446e-a537-d9376240a574" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_3e8038f6-1664-446e-a537-d9376240a574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_06a6b663-cd3d-4de6-bd83-78a279ad230f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_06a6b663-cd3d-4de6-bd83-78a279ad230f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_bffc56a3-a516-446d-b5ab-acd5576ed086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_bffc56a3-a516-446d-b5ab-acd5576ed086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio_078de8ea-0027-4ff4-897a-05a380e7c83d" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_AmericanDepositorySharesConversionRatio_078de8ea-0027-4ff4-897a-05a380e7c83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare_d2c5a988-21b3-4cb6-a303-945e14d83d2b" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_AmericanDepositarySharesOptionPricePerShare_d2c5a988-21b3-4cb6-a303-945e14d83d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPremiumPercentage_83077426-0ea9-418b-a084-8f01d0a4de8e" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositarySharesPremiumPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_AmericanDepositarySharesPremiumPercentage_83077426-0ea9-418b-a084-8f01d0a4de8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_40ccb362-51ed-4d18-88cf-5da50bae7698" xlink:href="avdl-20210630.xsd#avdl_AmericanDepositarySharesPurchasedPricePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_40ccb362-51ed-4d18-88cf-5da50bae7698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_b2c01d92-b0b4-4685-b369-2721fe2ff3c2" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_b2c01d92-b0b4-4685-b369-2721fe2ff3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_d328e07a-b534-48db-a6ad-c74232243e06" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_d328e07a-b534-48db-a6ad-c74232243e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_52082682-7391-4424-8914-ab6d5c20fcd3" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_52082682-7391-4424-8914-ab6d5c20fcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_8abe9faf-df46-4733-9543-3f5bd8909c70" xlink:href="avdl-20210630.xsd#avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_8abe9faf-df46-4733-9543-3f5bd8909c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_d1aa9c68-b766-4823-83b5-281ba1d3fe0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_d1aa9c68-b766-4823-83b5-281ba1d3fe0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_ba6c3010-e271-4086-acba-13d483efbef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_ba6c3010-e271-4086-acba-13d483efbef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_64bfc08f-fe60-4698-885f-8de6a6458901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_b9f20cfb-f48a-4476-be1b-adb88cb640c0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_64bfc08f-fe60-4698-885f-8de6a6458901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxes" xlink:type="simple" xlink:href="avdl-20210630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_02862312-5b9f-4723-9c36-341bb0059f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6492687d-b3e3-47e8-be0e-002e7619fd23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_02862312-5b9f-4723-9c36-341bb0059f7e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6492687d-b3e3-47e8-be0e-002e7619fd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1eb05fee-398d-49a7-b3c6-62b83c8d073b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_efb2e104-77cf-4cf4-a601-9920db0ad354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1eb05fee-398d-49a7-b3c6-62b83c8d073b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_efb2e104-77cf-4cf4-a601-9920db0ad354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bc041e04-84f2-4349-b807-40fea86257c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1eb05fee-398d-49a7-b3c6-62b83c8d073b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bc041e04-84f2-4349-b807-40fea86257c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_17e20df5-a6b1-46ca-a457-c84ebcd1f978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1eb05fee-398d-49a7-b3c6-62b83c8d073b" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_17e20df5-a6b1-46ca-a457-c84ebcd1f978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilities" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ffdfac28-0e25-4171-9599-bb39cbcc72af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_bb18619f-3e67-45eb-9c63-ddc10e34d4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ffdfac28-0e25-4171-9599-bb39cbcc72af" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_bb18619f-3e67-45eb-9c63-ddc10e34d4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_d07ed904-948a-4d8f-8c6b-042642cc5523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_4fb9dcdb-ce17-4d31-863f-e855574068fd" xlink:href="avdl-20210630.xsd#avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_d07ed904-948a-4d8f-8c6b-042642cc5523" xlink:to="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_4fb9dcdb-ce17-4d31-863f-e855574068fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_1d462d7d-dc4d-438c-b15c-6a0730a34eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_d07ed904-948a-4d8f-8c6b-042642cc5523" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_1d462d7d-dc4d-438c-b15c-6a0730a34eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_08a16c59-ded4-4434-a4ea-13ed89920353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_d07ed904-948a-4d8f-8c6b-042642cc5523" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_08a16c59-ded4-4434-a4ea-13ed89920353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_24993bb2-6133-4792-b476-b0da97dbd1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_d07ed904-948a-4d8f-8c6b-042642cc5523" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_24993bb2-6133-4792-b476-b0da97dbd1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_29b551d6-2b2e-4c72-8355-9a976cec3bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_d07ed904-948a-4d8f-8c6b-042642cc5523" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_29b551d6-2b2e-4c72-8355-9a976cec3bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_74067f3c-6a57-442b-826b-cb2631802a61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_74067f3c-6a57-442b-826b-cb2631802a61" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_b85fedd7-85d6-41b1-97e2-23118c5dc62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_b85fedd7-85d6-41b1-97e2-23118c5dc62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_c9a60643-46ad-4340-ae15-1fec7447effc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_c9a60643-46ad-4340-ae15-1fec7447effc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_bce9c251-ba4e-4164-a959-0070e40bc306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:to="loc_us-gaap_DepositsAssetsCurrent_bce9c251-ba4e-4164-a959-0070e40bc306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent_356056cc-c941-463d-b527-4a4319593b00" xlink:href="avdl-20210630.xsd#avdl_GuaranteeCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:to="loc_avdl_GuaranteeCurrent_356056cc-c941-463d-b527-4a4319593b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_6e99163b-be43-40e9-a95f-8e833ff1a42f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:to="loc_us-gaap_IncomeTaxesReceivable_6e99163b-be43-40e9-a95f-8e833ff1a42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ShortTermNoteReceivable_ce0e719a-ae5b-49c9-9065-870d5b74684d" xlink:href="avdl-20210630.xsd#avdl_ShortTermNoteReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:to="loc_avdl_ShortTermNoteReceivable_ce0e719a-ae5b-49c9-9065-870d5b74684d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_5f662fa1-2a00-46e3-b9e9-b4b9827538a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:to="loc_us-gaap_OtherAssetsCurrent_5f662fa1-2a00-46e3-b9e9-b4b9827538a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ddf87c57-d486-4161-99f5-d0ee4cbdb493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_e2fe7793-a519-454f-9944-ededd8e2cf78" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ddf87c57-d486-4161-99f5-d0ee4cbdb493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_3094a88a-972b-449d-ae22-daa24cfcb4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_aca26a11-8281-45df-9be2-5433bbd13506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_3094a88a-972b-449d-ae22-daa24cfcb4e2" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_aca26a11-8281-45df-9be2-5433bbd13506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_915f8b22-1b25-4b75-9fda-5e0efefa7a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_aca26a11-8281-45df-9be2-5433bbd13506" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_915f8b22-1b25-4b75-9fda-5e0efefa7a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent_6d7966e2-959a-4b1a-8eb1-40183a472257" xlink:href="avdl-20210630.xsd#avdl_GuaranteeNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_aca26a11-8281-45df-9be2-5433bbd13506" xlink:to="loc_avdl_GuaranteeNoncurrent_6d7966e2-959a-4b1a-8eb1-40183a472257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_740b0015-4ce0-4ccb-9912-9342397b6304" xlink:href="avdl-20210630.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_aca26a11-8281-45df-9be2-5433bbd13506" xlink:to="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_740b0015-4ce0-4ccb-9912-9342397b6304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables_eebed4da-14ac-445c-b55b-32ccc6441e28" xlink:href="avdl-20210630.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_aca26a11-8281-45df-9be2-5433bbd13506" xlink:to="loc_avdl_OtherNoncurrentReceivables_eebed4da-14ac-445c-b55b-32ccc6441e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1d0624d5-f924-47c9-8ab5-d0cc11ea2b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_aca26a11-8281-45df-9be2-5433bbd13506" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1d0624d5-f924-47c9-8ab5-d0cc11ea2b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_115d9301-0a8b-4442-b6be-6a7f2603cbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b1a0faa-e234-4936-9192-75ea660f1130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_115d9301-0a8b-4442-b6be-6a7f2603cbf8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b1a0faa-e234-4936-9192-75ea660f1130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_0d2dc842-f275-4260-bacd-26e506d3ea72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b1a0faa-e234-4936-9192-75ea660f1130" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_0d2dc842-f275-4260-bacd-26e506d3ea72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_961983e7-6567-4e8d-9c66-48c032d029d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b1a0faa-e234-4936-9192-75ea660f1130" xlink:to="loc_us-gaap_RestructuringReserveCurrent_961983e7-6567-4e8d-9c66-48c032d029d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedTradeDiscountsAndRebates_f2367e0c-fc3d-4206-89a7-0716ce7ccb52" xlink:href="avdl-20210630.xsd#avdl_AccruedTradeDiscountsAndRebates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b1a0faa-e234-4936-9192-75ea660f1130" xlink:to="loc_avdl_AccruedTradeDiscountsAndRebates_f2367e0c-fc3d-4206-89a7-0716ce7ccb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts_63de5d56-ec6f-4698-add8-a169c4543010" xlink:href="avdl-20210630.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b1a0faa-e234-4936-9192-75ea660f1130" xlink:to="loc_avdl_AccruedOutsourceContractCosts_63de5d56-ec6f-4698-add8-a169c4543010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_41c5af93-9deb-4600-9805-e83f1b1c31b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b1a0faa-e234-4936-9192-75ea660f1130" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_41c5af93-9deb-4600-9805-e83f1b1c31b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3217daef-f1b6-4e8f-9ac1-1ac43cb7e79f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b1a0faa-e234-4936-9192-75ea660f1130" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3217daef-f1b6-4e8f-9ac1-1ac43cb7e79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2b997096-48ba-4a82-af75-452baf74f21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_b4795aed-fe6a-452f-8f93-3df72e7eb747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2b997096-48ba-4a82-af75-452baf74f21d" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_b4795aed-fe6a-452f-8f93-3df72e7eb747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent_2598e9b9-6a0f-4339-a550-8c8a4646ee0b" xlink:href="avdl-20210630.xsd#avdl_AccruedInterestCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_b4795aed-fe6a-452f-8f93-3df72e7eb747" xlink:to="loc_avdl_AccruedInterestCurrent_2598e9b9-6a0f-4339-a550-8c8a4646ee0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_16d4aa2e-ef05-4d0f-b3fc-03c84a67aa17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_b4795aed-fe6a-452f-8f93-3df72e7eb747" xlink:to="loc_us-gaap_DueToAffiliateCurrent_16d4aa2e-ef05-4d0f-b3fc-03c84a67aa17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_b816eff4-1fb6-49ee-9fde-8a8cdde3623d" xlink:href="avdl-20210630.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_b4795aed-fe6a-452f-8f93-3df72e7eb747" xlink:to="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_b816eff4-1fb6-49ee-9fde-8a8cdde3623d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_4cf2fa8b-bb17-4dda-8eed-7febc899e60c" xlink:href="avdl-20210630.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_b4795aed-fe6a-452f-8f93-3df72e7eb747" xlink:to="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_4cf2fa8b-bb17-4dda-8eed-7febc899e60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a418b3fe-20cd-4c71-a64a-9bd6d04a1bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_b4795aed-fe6a-452f-8f93-3df72e7eb747" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a418b3fe-20cd-4c71-a64a-9bd6d04a1bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ba894d66-7213-4154-9492-7c332ad4e1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_a5afd29e-cbfc-4570-9ffd-852f40491f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ba894d66-7213-4154-9492-7c332ad4e1e3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_a5afd29e-cbfc-4570-9ffd-852f40491f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6f98ea01-156f-4784-8c93-8ad89ea68382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_a5afd29e-cbfc-4570-9ffd-852f40491f1a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6f98ea01-156f-4784-8c93-8ad89ea68382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_982f51d6-787d-4824-9bda-f3a49f87ce11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_a5afd29e-cbfc-4570-9ffd-852f40491f1a" xlink:to="loc_us-gaap_GuarantyLiabilities_982f51d6-787d-4824-9bda-f3a49f87ce11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_1caa924f-5cf7-4d3f-a7a2-7de048295520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_a5afd29e-cbfc-4570-9ffd-852f40491f1a" xlink:to="loc_us-gaap_OtherLongTermDebt_1caa924f-5cf7-4d3f-a7a2-7de048295520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6ca073da-ece1-49c8-a7ca-00eada1ff478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_a5afd29e-cbfc-4570-9ffd-852f40491f1a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6ca073da-ece1-49c8-a7ca-00eada1ff478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCosts" xlink:type="simple" xlink:href="avdl-20210630.xsd#RestructuringCosts"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d74a3ebb-4dd1-41e8-95ff-87fbe9232144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8dad51cf-b351-4913-9ee0-764e4912b636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d74a3ebb-4dd1-41e8-95ff-87fbe9232144" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8dad51cf-b351-4913-9ee0-764e4912b636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#RestructuringCostsTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_55a838c2-cfac-4c70-8b88-150dd60e8604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_b6f501b0-8424-4f25-8eb6-f5520cc22db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_55a838c2-cfac-4c70-8b88-150dd60e8604" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_b6f501b0-8424-4f25-8eb6-f5520cc22db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#RestructuringCostsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_975ce110-9569-4289-8d99-e9732631c890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6d2136d0-6a70-4367-897e-3ab8a7e2f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_975ce110-9569-4289-8d99-e9732631c890" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6d2136d0-6a70-4367-897e-3ab8a7e2f0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_31048932-d966-462a-a430-0c1799ad483b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6d2136d0-6a70-4367-897e-3ab8a7e2f0ce" xlink:to="loc_us-gaap_RestructuringPlanAxis_31048932-d966-462a-a430-0c1799ad483b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_31048932-d966-462a-a430-0c1799ad483b" xlink:to="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_a00928da-89d0-4bc8-a031-5698decf50df" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:to="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_a00928da-89d0-4bc8-a031-5698decf50df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CorporateWorkforceReductionMember_5a107232-ac9e-462a-b802-5e24f9be1fe5" xlink:href="avdl-20210630.xsd#avdl_CorporateWorkforceReductionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:to="loc_avdl_CorporateWorkforceReductionMember_5a107232-ac9e-462a-b802-5e24f9be1fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_208d760c-71e8-49ac-b89f-24d89cbf3d99" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateRestructuringObligationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_4c6db356-23e0-4f3d-b201-0c94c1dbd0b0" xlink:to="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_208d760c-71e8-49ac-b89f-24d89cbf3d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5513f0b7-818f-4df4-8607-56b89ed0cbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6d2136d0-6a70-4367-897e-3ab8a7e2f0ce" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5513f0b7-818f-4df4-8607-56b89ed0cbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_9d44fc1d-bbb1-4dec-bad4-c5a62c6c3f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5513f0b7-818f-4df4-8607-56b89ed0cbf9" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_9d44fc1d-bbb1-4dec-bad4-c5a62c6c3f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_b0d7df92-f778-44cc-83cd-5c89f9a41678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9d44fc1d-bbb1-4dec-bad4-c5a62c6c3f1e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_b0d7df92-f778-44cc-83cd-5c89f9a41678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a3ed12ff-11db-4fe0-af3e-91a6ee90ba54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6d2136d0-6a70-4367-897e-3ab8a7e2f0ce" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_a3ed12ff-11db-4fe0-af3e-91a6ee90ba54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_3b92515a-0329-46e4-8647-9360bf8634c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a3ed12ff-11db-4fe0-af3e-91a6ee90ba54" xlink:to="loc_us-gaap_RestructuringReserve_3b92515a-0329-46e4-8647-9360bf8634c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_6b647ff2-200d-42a2-87ff-1a8d79fb1440" xlink:href="avdl-20210630.xsd#avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a3ed12ff-11db-4fe0-af3e-91a6ee90ba54" xlink:to="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_6b647ff2-200d-42a2-87ff-1a8d79fb1440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#RestructuringCostsSeveranceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0683e4d1-15c5-4413-a835-4cad17c3efd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9927b657-8851-4e5e-b8c9-09cf221264fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0683e4d1-15c5-4413-a835-4cad17c3efd8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9927b657-8851-4e5e-b8c9-09cf221264fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_5136d4cc-8940-42d8-b75b-ee55b1c7d453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9927b657-8851-4e5e-b8c9-09cf221264fe" xlink:to="loc_us-gaap_RestructuringPlanAxis_5136d4cc-8940-42d8-b75b-ee55b1c7d453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5de3476b-e7e3-4ff7-bd2a-a373bb1cfc92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_5136d4cc-8940-42d8-b75b-ee55b1c7d453" xlink:to="loc_us-gaap_RestructuringPlanDomain_5de3476b-e7e3-4ff7-bd2a-a373bb1cfc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_38a5ac4f-7656-4142-9a54-ca694665a802" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_5de3476b-e7e3-4ff7-bd2a-a373bb1cfc92" xlink:to="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_38a5ac4f-7656-4142-9a54-ca694665a802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_1b3c10d7-56c5-4461-a0ad-e75bfbb185d6" xlink:href="avdl-20210630.xsd#avdl_TwoThousandNineteenCorporateRestructuringObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_5de3476b-e7e3-4ff7-bd2a-a373bb1cfc92" xlink:to="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_1b3c10d7-56c5-4461-a0ad-e75bfbb185d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_7b70a8dd-78e8-414a-823e-572f997ee902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9927b657-8851-4e5e-b8c9-09cf221264fe" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_7b70a8dd-78e8-414a-823e-572f997ee902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7fa723ce-893f-49e7-83ec-e153454b6e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7b70a8dd-78e8-414a-823e-572f997ee902" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7fa723ce-893f-49e7-83ec-e153454b6e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_e97ba4d2-f67d-4977-99b1-029e7d784da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7fa723ce-893f-49e7-83ec-e153454b6e89" xlink:to="loc_us-gaap_EmployeeSeveranceMember_e97ba4d2-f67d-4977-99b1-029e7d784da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_91f1367d-60c9-4b8e-8ee0-e7db686b99e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9927b657-8851-4e5e-b8c9-09cf221264fe" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_91f1367d-60c9-4b8e-8ee0-e7db686b99e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_91f1367d-60c9-4b8e-8ee0-e7db686b99e9" xlink:to="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2b481144-3d9e-433c-8395-343802f36511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:to="loc_us-gaap_RestructuringReserve_2b481144-3d9e-433c-8395-343802f36511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_fdd0825a-8179-4319-a6c2-280fda885e49" xlink:href="avdl-20210630.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:to="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_fdd0825a-8179-4319-a6c2-280fda885e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_8dcd496f-5c7e-4df8-83d5-dc94b5372085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:to="loc_us-gaap_PaymentsForRestructuring_8dcd496f-5c7e-4df8-83d5-dc94b5372085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_a07224a6-f9eb-463e-b89b-7c78b7367cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_a07224a6-f9eb-463e-b89b-7c78b7367cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_ab145677-07a9-41b5-a769-c440c8c8bcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c2b22d49-336b-4c5f-8016-9824f2a3dc17" xlink:to="loc_us-gaap_RestructuringReserve_ab145677-07a9-41b5-a769-c440c8c8bcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShare" xlink:type="simple" xlink:href="avdl-20210630.xsd#NetLossIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_efc2dbc5-ee4c-4db3-bc52-7de9f2251eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_315409e4-5cf4-4a48-a714-67e56c7ce892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_efc2dbc5-ee4c-4db3-bc52-7de9f2251eb7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_315409e4-5cf4-4a48-a714-67e56c7ce892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShareTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#NetLossIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_184271c1-bd8e-4958-bd84-0c4f1b77ca6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ba01c2c1-7eb1-4973-9520-29bd2f165661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_184271c1-bd8e-4958-bd84-0c4f1b77ca6e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ba01c2c1-7eb1-4973-9520-29bd2f165661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ce45b502-f3c7-4522-8350-1b94d5ff740c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_57e5dc15-48b5-45d4-bf2b-da9b89d27ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ce45b502-f3c7-4522-8350-1b94d5ff740c" xlink:to="loc_us-gaap_NetIncomeLoss_57e5dc15-48b5-45d4-bf2b-da9b89d27ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_cf9a80f3-6341-4d5b-82c3-46127bbe7778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ce45b502-f3c7-4522-8350-1b94d5ff740c" xlink:to="loc_us-gaap_DilutiveSecurities_cf9a80f3-6341-4d5b-82c3-46127bbe7778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_8f952939-9c7b-499e-8af7-4bc6cbd453ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ce45b502-f3c7-4522-8350-1b94d5ff740c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_8f952939-9c7b-499e-8af7-4bc6cbd453ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9d0a1437-e850-483d-a862-74861690042a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ce45b502-f3c7-4522-8350-1b94d5ff740c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9d0a1437-e850-483d-a862-74861690042a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_06608378-bbc1-4b3a-a94c-926f8e030d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9d0a1437-e850-483d-a862-74861690042a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_06608378-bbc1-4b3a-a94c-926f8e030d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_18fe4395-817e-4518-ac47-ec43e4aeaf74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9d0a1437-e850-483d-a862-74861690042a" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_18fe4395-817e-4518-ac47-ec43e4aeaf74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_216bb08c-43cb-40fa-96ff-65cf230efa75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9d0a1437-e850-483d-a862-74861690042a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_216bb08c-43cb-40fa-96ff-65cf230efa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cc8f66d0-97f2-4cdc-9e9f-da0c5ebda5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ce45b502-f3c7-4522-8350-1b94d5ff740c" xlink:to="loc_us-gaap_EarningsPerShareBasic_cc8f66d0-97f2-4cdc-9e9f-da0c5ebda5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_acda87a6-ecd5-4226-b009-ea1d70b9fd86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ce45b502-f3c7-4522-8350-1b94d5ff740c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_acda87a6-ecd5-4226-b009-ea1d70b9fd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#NetLossIncomePerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b19feb31-9740-467d-849a-769fdbc45012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0fecef81-137e-4560-b838-433e1f3ad864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b19feb31-9740-467d-849a-769fdbc45012" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0fecef81-137e-4560-b838-433e1f3ad864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLoss" xlink:type="simple" xlink:href="avdl-20210630.xsd#ComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5d42f0f1-4257-4ec5-a442-a45dc8c9b957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_409bc09e-7807-4583-b3cc-ba7b7c1fc27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5d42f0f1-4257-4ec5-a442-a45dc8c9b957" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_409bc09e-7807-4583-b3cc-ba7b7c1fc27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#ComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_ea84c908-6312-4ff5-944b-bfc32077d29a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bc204194-5e2c-4454-a5c7-710da8b4c1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_ea84c908-6312-4ff5-944b-bfc32077d29a" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bc204194-5e2c-4454-a5c7-710da8b4c1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#ComprehensiveIncomeLossComponentsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_adbfa709-8c3a-4306-9fde-ff41f99b068e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_75978110-56d7-42ed-bf2c-e84d11dbf7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_adbfa709-8c3a-4306-9fde-ff41f99b068e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_75978110-56d7-42ed-bf2c-e84d11dbf7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d3ca41dc-0b92-427d-8107-30d827297dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_75978110-56d7-42ed-bf2c-e84d11dbf7c1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d3ca41dc-0b92-427d-8107-30d827297dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d3ca41dc-0b92-427d-8107-30d827297dc1" xlink:to="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_05a0e711-15dc-4e56-b042-6abfbed6fd93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_05a0e711-15dc-4e56-b042-6abfbed6fd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_e9cdd04d-aa2f-47bb-961d-c95b5fd969f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_e9cdd04d-aa2f-47bb-961d-c95b5fd969f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3186411a-fc04-4fe4-a84d-1893b2b093f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_173fb7d9-d727-443e-8aaf-11284b081593" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3186411a-fc04-4fe4-a84d-1893b2b093f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7337e86-21b1-499c-b2e3-1e56fb14d9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_75978110-56d7-42ed-bf2c-e84d11dbf7c1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7337e86-21b1-499c-b2e3-1e56fb14d9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b8110da9-e1d5-43bd-8e0e-94b4ae653706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7337e86-21b1-499c-b2e3-1e56fb14d9b6" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b8110da9-e1d5-43bd-8e0e-94b4ae653706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_156dec52-647b-4532-a37f-c8e0c05b6084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b8110da9-e1d5-43bd-8e0e-94b4ae653706" xlink:to="loc_us-gaap_StockholdersEquity_156dec52-647b-4532-a37f-c8e0c05b6084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_86dcc6e5-6199-47ab-bfe1-ce65205da39b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b8110da9-e1d5-43bd-8e0e-94b4ae653706" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_86dcc6e5-6199-47ab-bfe1-ce65205da39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d92400de-9abe-43a5-beb5-46d56b96f0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b8110da9-e1d5-43bd-8e0e-94b4ae653706" xlink:to="loc_us-gaap_StockholdersEquity_d92400de-9abe-43a5-beb5-46d56b96f0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLossNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#ComprehensiveLossNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLossNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_032c38f4-060a-45d4-a196-c101a47ef601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_39a949d7-083d-442c-9fbe-9e2b07771fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_032c38f4-060a-45d4-a196-c101a47ef601" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_39a949d7-083d-442c-9fbe-9e2b07771fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RevenuebyProduct" xlink:type="simple" xlink:href="avdl-20210630.xsd#RevenuebyProduct"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RevenuebyProduct" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2cd063a5-b3bf-4dea-8048-720b4f0b262f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0d27b798-7f83-4874-9906-7567e4c97a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2cd063a5-b3bf-4dea-8048-720b4f0b262f" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0d27b798-7f83-4874-9906-7567e4c97a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RevenuebyProductTables" xlink:type="simple" xlink:href="avdl-20210630.xsd#RevenuebyProductTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RevenuebyProductTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5277fc9b-ae63-4a70-9e25-de1ee7e94d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ebc12b35-3208-435a-9e6a-54565a5c2f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5277fc9b-ae63-4a70-9e25-de1ee7e94d45" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ebc12b35-3208-435a-9e6a-54565a5c2f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#RevenuebyProductSummaryofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_32cbb5e9-b2dd-4cea-a7b4-c6d7f2effd42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_6c430295-1c9b-4926-b48e-5e6946bc67b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_32cbb5e9-b2dd-4cea-a7b4-c6d7f2effd42" xlink:to="loc_us-gaap_NumberOfOperatingSegments_6c430295-1c9b-4926-b48e-5e6946bc67b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3616c664-b6c8-4ea5-bae9-c3c26617fcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_32cbb5e9-b2dd-4cea-a7b4-c6d7f2effd42" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3616c664-b6c8-4ea5-bae9-c3c26617fcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_050aaafb-599e-4fe2-9765-aaf9431c7cf8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3616c664-b6c8-4ea5-bae9-c3c26617fcfc" xlink:to="loc_srt_ProductOrServiceAxis_050aaafb-599e-4fe2-9765-aaf9431c7cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_050aaafb-599e-4fe2-9765-aaf9431c7cf8" xlink:to="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzMember_0cdfd058-0438-47b0-849c-1fa50d1b0526" xlink:href="avdl-20210630.xsd#avdl_BloxiverzMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:to="loc_avdl_BloxiverzMember_0cdfd058-0438-47b0-849c-1fa50d1b0526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VazculepMember_4ea42388-f4f7-4311-8fb0-98b7189c1c9c" xlink:href="avdl-20210630.xsd#avdl_VazculepMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:to="loc_avdl_VazculepMember_4ea42388-f4f7-4311-8fb0-98b7189c1c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AkovazMember_96cffa35-daaf-4d5c-9207-bed6723fb15d" xlink:href="avdl-20210630.xsd#avdl_AkovazMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:to="loc_avdl_AkovazMember_96cffa35-daaf-4d5c-9207-bed6723fb15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherProductsMember_881b84d6-22e3-4933-9151-f087a34c2a7c" xlink:href="avdl-20210630.xsd#avdl_OtherProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5b5d2552-4dd9-450b-b111-4d90ee2ed02a" xlink:to="loc_avdl_OtherProductsMember_881b84d6-22e3-4933-9151-f087a34c2a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f9748938-9aac-4772-960d-82ce66c6ff75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3616c664-b6c8-4ea5-bae9-c3c26617fcfc" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f9748938-9aac-4772-960d-82ce66c6ff75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_03da9ebe-e798-4726-9eb7-dd10a561643c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9748938-9aac-4772-960d-82ce66c6ff75" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_03da9ebe-e798-4726-9eb7-dd10a561643c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="avdl-20210630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4509fb45-8dd7-4018-b670-2f748d9ace2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3e22ffdf-4eda-465b-bac3-004777557494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4509fb45-8dd7-4018-b670-2f748d9ace2b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3e22ffdf-4eda-465b-bac3-004777557494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20210630.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d3dc28b-3753-4e28-926c-203adf40b266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_55aed148-cf59-4eec-95ba-e13fe1a575d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d3dc28b-3753-4e28-926c-203adf40b266" xlink:to="loc_us-gaap_LossContingenciesTable_55aed148-cf59-4eec-95ba-e13fe1a575d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6983feed-0059-4221-9e86-2ea40725494e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55aed148-cf59-4eec-95ba-e13fe1a575d8" xlink:to="loc_srt_RangeAxis_6983feed-0059-4221-9e86-2ea40725494e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2ec90904-396f-4f4d-8d6a-c2ca44e0177d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6983feed-0059-4221-9e86-2ea40725494e" xlink:to="loc_srt_RangeMember_2ec90904-396f-4f4d-8d6a-c2ca44e0177d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d4341a8-51c8-46b9-a551-75d5c6bcb024" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2ec90904-396f-4f4d-8d6a-c2ca44e0177d" xlink:to="loc_srt_MaximumMember_3d4341a8-51c8-46b9-a551-75d5c6bcb024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55aed148-cf59-4eec-95ba-e13fe1a575d8" xlink:to="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_270f7ade-fcbc-47bf-9432-157fb7e7856d" xlink:href="avdl-20210630.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:to="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_270f7ade-fcbc-47bf-9432-157fb7e7856d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_991b8c68-d093-45cd-89cb-cda4df64cc87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_991b8c68-d093-45cd-89cb-cda4df64cc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeAssetCurrentCarryingValue_8b35eabb-2e52-4f85-9d03-2abf883b57c6" xlink:href="avdl-20210630.xsd#avdl_GuaranteeAssetCurrentCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ff88689f-e380-415b-b782-30f72174deec" xlink:to="loc_avdl_GuaranteeAssetCurrentCarryingValue_8b35eabb-2e52-4f85-9d03-2abf883b57c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>avdl-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:avdl="http://www.avadel.com/20210630"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:exch="http://xbrl.sec.gov/exch/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="avdl-20210630.xsd" xlink:type="simple"/>
    <context id="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1019bc0c2b514f86b75d4ae8aeaef1aa_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNMS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic78036265115448883cc73f95a586e3d_I20210805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-08-05</instant>
        </period>
    </context>
    <context id="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i695183555b394250b05b06d9bf6c9006_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ica8983fe897240fb8db372157af242b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d69f2653c7843348a441d3a40de400f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f33bcd282a7486eba6fd7888306a035_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icadf2fd8982949eb8a9a9a8130767bb6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea8152d9127347daa7d0be2b82d42c16_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idbfb2bb9bd2c454d9a2f913b904d527d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76af2cfe33334dc9a1f13f275e6567b3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54a0f1be38254190aa94a522f6ed4974_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie70c99023cd04e558a4e840886322480_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if26cf9bd950645da82a913ea028f7f6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9cd9c5deb61d480c855cc24b25d34b9b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i08d9e77f9bac4c3ab716300be3d8b8cf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i39b86180a03145e2ab56d7861d9b72a0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibd4c15b3c08b4cbd9427dacc880d2346_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4c9bed8d32e44549a6e6384e81de3b5f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic1938096e05e425590b24e2476286cdc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6474ac452b754332a6d49fc58fae2431_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i13deb59210c04afabfb45b889d23aa75_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i63df9a42f4264b208b42e799c3b3da1e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1dae4c5996d045e093657ce638a3bfb4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3dcc627de1534b28a106aee5209d7631_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ica30a680c36b463799b9fbf697661fc8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iac901e4b20854acb8c4c482c601cb2e0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9760338be14744d8883d6b1a7be11ede_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaf27002e9c9248dfb7f009f24e02a4c5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i25507beaf94543b3ac989067fe8f70f6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5952bd509a3b4bbd95542c5ad8829fd2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24d453b62e5f4a758dc24ff5f07cdf8c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i728f1dde962144218da7200782d318a3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e185af4c95c4cbabd2d62ccb442cefe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i39ce40436c834ffd88b04bc577cb05f9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7fe02fc3397f469095911d0d65984e6a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i398b06c595444f7caeaba916451c29fa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i47b79ad2b6fa4d43b3bc4e7c2bffdfe1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib5365f5787064a8588bd454e8fd0fe11_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i94cdc3283e8b4906848c3ac05797508f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib4a2221ed67f4b938f45988fa863f1e8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iefbaf7c014bb4111b59cf750ee917f08_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i295311c4e79a486380b4c0eede6381f5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7cec52b45db74ffb865d0a2e924af088_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id7dba2e7aac4498891de302ca71046c7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6d918ae9e9cd4e17a845a2041f236bde_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iee621425bbaf4880a450697c4e2573d6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifb3815294ed64ba3bcb2123ce0004c19_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2da1cc6c35a94eaab32f7383d06ce563_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia2a46ff8ddd543a681fb05ae9c5370ab_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i542e7a0b738049e785822075bec4dd2f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibfa9a8f10ae647138ff3b9ba07a34261_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic27ceaeb4d5e4740bf0c3a9528c54d02_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib2a929bcc21e485a9d7ab75296127ff8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic979207f9f324f33be7b2a93a0acb9c0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2b18f9096c56478ba558603f0009c83f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i81950a1669ff43e2a55fa3ab8b6bbf14_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icfe184fb8a604f6e9f281a0b6b76a459_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia1494e8ed82d4b2ebf75bbcb4722f663_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icb55d6c3ae02430b9ec0541184cb90e7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i35be439684f94754a722ac71e050ffd4_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4cd000c8b6964065a504a408890f9369_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9d6fa5ebeb65455e950a6328bba21698_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i519f8147d1374176b85b3cdcff0e8382_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i900add1be5b84828adfa900933a618f3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i87edd5f150b248eebd16c398e3be78c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ee580d62d1d4006b9c4ee3195b16fe2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5483582b0b7743da9ffaa6daeddee5c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i13d7d68555c549268d32a550db3aa3a8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2312d5c712024cd18f05cfc64afe708c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5f20ec5b3421400ab560dc49247ce3d5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if1374539a6c0453996dd609930013a2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5900644d8ce46379de39a2d0857e260_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f54424e7f4147e3abfa224100f76762_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i391dd5fd75e44b6bb689e468e2f6998b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaa665aface774b5cba45e448c5017ef5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if495a6914a2043078c2ff45ec8e8cd94_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i819166dd8aad49adb09355ff41111edc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ff9730b64194e44b1624fd8387ff601_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic787b137f02c471ab5fb441de2ccb356_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7de1d5ad40c44bcc9def111356353120_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i426f38d83a8549b6ac924b573fcd11f7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i184178aa288147edb42ff605f41c2388_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia3d99af014d24c818d1dc4b69ee59196_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia1d78585c18940df8a7e1e5478ef6cb2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c3eac9312e543b5af4e5ec8d59fbec0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i860be6580c44499c8b2bbc5d5a7e3a36_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i224fa48116ff4bd6a9842fded9a71fdb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i43f54881920b4af98a41727d8004594f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ide1938867c944920ae7b3cff817479c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5be2c3dab5b048debcaabab64882d9e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c8795b315d846338c877c8df1d32455_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65d25b85bcaa41adb6ed552acf50363b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic7ff608828844c6798870117de00d1e1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i90450500044d427f8c232f666584b39e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5797f9c7a7484005bbcaaea47685589d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i629580901ade4561aeb0685c65e22554_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3ac2b9e70ab04d8db284fd554dcbf2da_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i62b61fe78c654a8eabbae48f28674623_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idbec2bbcbbb34de89d1c27dd07788865_I20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-16</instant>
        </period>
    </context>
    <context id="if7160598d23c4b518c759c6aa5a8d2b4_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="ibcdc3f2602ac4af79cdaff50261cf317_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="i8558d8d29eb84dbfa4e0793e914d9349_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="id828d13c94a04e7981051a01fa81ed95_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="i619255c0fbb84c85be6f62b40e8f8667_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="i7e8c3ff2db154d098fe60070506408f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03b1e76537a34ed8ae22e6fcbd623ceb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id4a57a5a305f43858278dcd059cbe0d2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id82ee84d494f49a1aa77a11e88225b6d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i35238f47c33b4c629f04849c139b24b6_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:CorporateWorkforceReductionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7ddd0a37b8ed4590bc03f9c4c94308ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9ce335e1f12437bbd48bf21a9f38150_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iecc1f49f09f748ce80b8c92a2ec072a3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8fb7c2b0fb5945538e9a6a089566898e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i76a5acc12ee8481593b5f580d0c6acce_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia2a319b7a49041b68e1f28bc975ffd5f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8c6b3a49597d4114b95a4bce60988c0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02d0a6c7d54a44ae842a997b5e95ed2b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie1958fec3b1b4189a3494df42bf89998_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9b232b5b7cd948cf83baaf96787cecc8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i50064db877274880a1811d0f859ad19d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idb7c4417a3344d92bec61dc810fc930e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i79d6697ec0004a62b02bcf4f6ceb19aa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id4b7b480e1084f46848cd8804e33cf56_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibd3b0844231a4d02b15483cd3bc9cdd0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iea06e402349946f6b73a2366c3ff8a04_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if6ddfbe329ea4b859226b9d1e4159bbe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ecf22fe804f4dffa050dc87558edfb6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia4e61467debc48beaa50fd50ce036c21_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8f91b0f2c8834815aac6916157b00fa5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibbba85bbb98c4e4fb64a84c0ec71d0a1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ida13d64b815a426bbd81a3c5e429675b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id12d4cd39de345ecb292ceaccf92a42e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4746ea4b2111416cbd83562dad4e70a7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia015e8c7039f4253bf52fccb4e8ecb8c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:BloxiverzMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i549d337037a54337b23be1da5fc95857_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:BloxiverzMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i98b6eab8d7b044f4b52fe5bb3feedf68_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:VazculepMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie747eb99af0f45f29bf4b24a2ba6c818_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:VazculepMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8e8aa4c10c714d95a93ab30edbd0f6ac_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:AkovazMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i00da774065cf477491a056a3df163b4b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:AkovazMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icfc69dd306e94f2b91c2cea091afefa7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i636d00926a694de8b3a2561a4bd15037_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0d45c7fb17674e24b40b45929846b8f1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="day">
        <measure>avdl:day</measure>
    </unit>
    <unit id="segment">
        <measure>avdl:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF8zLTEtMS0xLTA_87043cdf-ee93-4895-b77c-f5e869056e20">0001012477</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF80LTEtMS0xLTA_ae6d2046-d791-4a3d-9422-ab6ba051165a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF81LTEtMS0xLTA_093b2b67-1eac-4fce-8855-906cd3a196a9">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF82LTEtMS0xLTA_944559f4-981e-45e2-b9e2-a903c5414961">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF83LTEtMS0xLTA_0b4c9f61-b384-4332-a7db-766d71ed4286">false</dei:AmendmentFlag>
    <dei:NoTradingSymbolFlag
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80L2ZyYWc6Yzk1MDE5MzM0MzI4NDdhZGI2NDlhMDY4ZjFiMTllMmQvdGFibGU6MjBkNDc3MjY3YjlmNDBjNDhiMDU0MTVjNmMwODVlYzgvdGFibGVyYW5nZToyMGQ0NzcyNjdiOWY0MGM0OGIwNTQxNWM2YzA4NWVjOF84LTEtMS0xLTA_de048aa5-7619-4738-b354-f897832ea523">true</dei:NoTradingSymbolFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i76af2cfe33334dc9a1f13f275e6567b3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMy0wLTEtMS0xNDk2_a9f5a3d8-5c77-42b7-b8e0-9ea3086db49c">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <avdl:DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm
      contextRef="icfe184fb8a604f6e9f281a0b6b76a459_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzU1_3778c0a2-5225-4d2e-a722-3095fe25bdd7">P10M</avdl:DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm>
    <avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted
      contextRef="i8558d8d29eb84dbfa4e0793e914d9349_D20180216-20180216"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE1OA_ebaf9a35-35f7-46d5-9322-eec1885aa043">P5D</avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted>
    <avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays
      contextRef="i8558d8d29eb84dbfa4e0793e914d9349_D20180216-20180216"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE3Mw_2f9ed925-ca6a-4374-8047-4f204d21b861">P5D</avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays>
    <dei:DocumentType
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjcw_83e76719-642b-475b-9b54-932d78cc1f34">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjYz_c508d4ac-6224-4b05-974a-41f32908c4a4">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yMzM_2082958f-0764-479a-a361-6fb21c9be91c">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjcx_2c10ab4c-d637-42b2-abef-653db26ac870">false</dei:DocumentTransitionReport>
    <dei:EntityRegistrantName
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY0_e5663ea9-31c5-4108-a412-a3de964420c2">AVADEL PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6OWVkYmVkOWNiMmQyNDIyOTkwZTZhN2Q2NzM5YzhlM2QvdGFibGVyYW5nZTo5ZWRiZWQ5Y2IyZDI0MjI5OTBlNmE3ZDY3MzljOGUzZF8wLTAtMS0xLTA_0392b88c-beb7-4032-bedf-f366b6f4d1ee">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6OWVkYmVkOWNiMmQyNDIyOTkwZTZhN2Q2NzM5YzhlM2QvdGFibGVyYW5nZTo5ZWRiZWQ5Y2IyZDI0MjI5OTBlNmE3ZDY3MzljOGUzZF8wLTEtMS0xLTA_414ff189-b56c-4a12-b69c-ec90e9a4c77a">000-28508</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6OWVkYmVkOWNiMmQyNDIyOTkwZTZhN2Q2NzM5YzhlM2QvdGFibGVyYW5nZTo5ZWRiZWQ5Y2IyZDI0MjI5OTBlNmE3ZDY3MzljOGUzZF8wLTItMS0xLTA_647e18c5-574b-48ee-8eb8-e864e654efca">98-1341933</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjcy_9b85c8fd-9455-4782-a396-c18e51bf6ba0">10 Earlsfort Terrace</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjcz_75d06ac9-1982-4e31-a8d8-db539577bb17">Dublin 2</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY1_66b56298-2c6b-4e53-8f74-63179aabeec3">IE</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjc0_8a1426bd-5d1a-4864-8fd2-a31b9a88e7ce">D02 T380</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY2_08b84e0b-c6dc-42bf-a9c2-cfbe4dbd92ad">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY3_ff321819-9376-4880-9443-b3ba3bd2b500">485-1200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i1019bc0c2b514f86b75d4ae8aeaef1aa_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6MDg3MDNjYzg1MWFlNGVmY2E3MTE0NDA2NWI4M2FjZTkvdGFibGVyYW5nZTowODcwM2NjODUxYWU0ZWZjYTcxMTQ0MDY1YjgzYWNlOV8xLTAtMS0xLTA_a1911051-2eb7-4de6-acaa-5790e20a10fa">American Depositary Shares*</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1019bc0c2b514f86b75d4ae8aeaef1aa_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6MDg3MDNjYzg1MWFlNGVmY2E3MTE0NDA2NWI4M2FjZTkvdGFibGVyYW5nZTowODcwM2NjODUxYWU0ZWZjYTcxMTQ0MDY1YjgzYWNlOV8xLTEtMS0xLTA_fac49352-c505-4c1b-80f1-ce839abd7bec">AVDL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1019bc0c2b514f86b75d4ae8aeaef1aa_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6MDg3MDNjYzg1MWFlNGVmY2E3MTE0NDA2NWI4M2FjZTkvdGFibGVyYW5nZTowODcwM2NjODUxYWU0ZWZjYTcxMTQ0MDY1YjgzYWNlOV8xLTItMS0xLTA_695067cc-23c9-46c9-9673-cb08d72fa1b4">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6MDg3MDNjYzg1MWFlNGVmY2E3MTE0NDA2NWI4M2FjZTkvdGFibGVyYW5nZTowODcwM2NjODUxYWU0ZWZjYTcxMTQ0MDY1YjgzYWNlOV8yLTAtMS0xLTA_8e086a40-317d-462d-aa10-722943e72be3">Ordinary Shares, nominal value $0.01 per share**</dei:Security12bTitle>
    <dei:EntityCurrentReportingStatus
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjc1_9fc24cb7-711d-4c91-973b-099d146a0853">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY4_5c39025d-86f8-4053-9952-31378173637e">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6ZTczYWIxMjVlYjNmNGI2YTk2MmQzMmQ0ZGYwYzNhZTkvdGFibGVyYW5nZTplNzNhYjEyNWViM2Y0YjZhOTYyZDMyZDRkZjBjM2FlOV8wLTItMS0xLTA_5dae123d-d509-4690-9214-6136a7e29f6a">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6ZTczYWIxMjVlYjNmNGI2YTk2MmQzMmQ0ZGYwYzNhZTkvdGFibGVyYW5nZTplNzNhYjEyNWViM2Y0YjZhOTYyZDMyZDRkZjBjM2FlOV8xLTMtMS0xLTA_7ce85343-976b-4d6c-bf41-669c2069ddab">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGFibGU6ZTczYWIxMjVlYjNmNGI2YTk2MmQzMmQ0ZGYwYzNhZTkvdGFibGVyYW5nZTplNzNhYjEyNWViM2Y0YjZhOTYyZDMyZDRkZjBjM2FlOV8yLTMtMS0xLTA_67c3f772-5d95-4c0a-983a-72cb99ec84c5">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNjY5_515f3bfe-752f-43e8-b310-00bdd0d5a0cb">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ic78036265115448883cc73f95a586e3d_I20210805"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xL2ZyYWc6NjI3MjYzZjc1MThlNDE3Mzk1NmFkY2ZhZTE0MGUxMTMvdGV4dHJlZ2lvbjo2MjcyNjNmNzUxOGU0MTczOTU2YWRjZmFlMTQwZTExM18yNTg0_714de0be-45d4-4225-92f6-187810a1995b"
      unitRef="shares">58596238</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMy0yLTEtMS0w_eb0c92af-8548-42ef-a3fe-6c619ce51491"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMy00LTEtMS0w_19cd7f69-a6a8-4838-a159-69a563474464"
      unitRef="usd">10091000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMy02LTEtMS0w_0007c612-b237-43c9-b8a1-737af248a4dd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMy04LTEtMS0w_6b481c01-1bda-4373-ab15-1781dea0b918"
      unitRef="usd">22334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNS0yLTEtMS0w_aa76004a-0ed5-498f-baf5-1742d00f2e34"
      unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNS00LTEtMS0w_44d6f025-7623-49a4-8423-a9820da9024b"
      unitRef="usd">3285000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNS02LTEtMS0w_a6270ed7-6019-4685-8251-3c81fce21c11"
      unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNS04LTEtMS0w_b2ed0cdc-71be-43e7-998d-36befcba2322"
      unitRef="usd">5742000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNi0yLTEtMS0w_e8c88b16-44d1-49a7-a4c6-0dc3101f8074"
      unitRef="usd">6762000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNi00LTEtMS0w_d22ac5c0-10b9-49f3-a18e-8fa781e5c2b9"
      unitRef="usd">4057000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNi02LTEtMS0w_ef93182a-abba-44c1-99d8-954bf6e976eb"
      unitRef="usd">10614000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNi04LTEtMS0w_f5e802d7-49ff-4250-94f9-9acab4a1102e"
      unitRef="usd">9587000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNy0yLTEtMS0w_dba3d722-085d-4c0e-bf1d-129cb9c96690"
      unitRef="usd">15174000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNy00LTEtMS0w_129a39fb-69cd-4fe4-98e1-df5fc57c80c1"
      unitRef="usd">7095000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNy02LTEtMS0w_2e643baa-c0ae-4c5c-970f-f7e4360f85d9"
      unitRef="usd">26186000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfNy04LTEtMS0w_26def7e0-995d-4cfb-b034-f054fb587c0f"
      unitRef="usd">15008000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOC0yLTEtMS0w_7f128277-aef2-4117-ac6e-6cce99b9cdc4"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOC00LTEtMS0w_44fa1388-2c16-44c7-b0e3-e7e157e17204"
      unitRef="usd">203000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOC02LTEtMS0w_e1d339bf-7c98-465f-9f16-a57aeeb584dd"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOC04LTEtMS0w_dde49888-f1f0-4987-9bbe-188682b45e83"
      unitRef="usd">406000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOS0yLTEtMS0w_6a4c5156-6753-4483-8abe-afb70feb20ae"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOS00LTEtMS0w_a9f2136c-eeda-4780-acc9-c161532ea089"
      unitRef="usd">918000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOS02LTEtMS0w_10ee71d6-233d-46a2-934d-fa74290f2e00"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfOS04LTEtMS0w_618c1950-5c15-495d-8a90-080d0f3fa4f6"
      unitRef="usd">3396000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTAtMi0xLTEtMA_b283fec6-12c7-4199-b6b4-49e0af3642d4"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTAtNC0xLTEtMA_150ac07c-f46e-4d82-b4cc-84495c03e170"
      unitRef="usd">45760000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTAtNi0xLTEtMA_71d54f28-dece-4ac0-8c60-5816feeed99f"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTAtOC0xLTEtMA_d9bf1e2b-c3a6-4990-a1b8-aadf216fd412"
      unitRef="usd">45760000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:RestructuringCharges
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTEtMi0xLTEtMA_469e8308-ac9c-4b5c-9fe4-b9a107c90d12"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTEtNC0xLTEtMA_979da852-34ba-4e93-8e99-8a3129babe1b"
      unitRef="usd">24000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTEtNi0xLTEtMA_2b36a5a1-0fc2-48ae-9dfa-cc195a9cc0fd"
      unitRef="usd">-53000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTEtOC0xLTEtMA_1a36700e-6985-43b8-bdec-0a0b008862d3"
      unitRef="usd">183000</us-gaap:RestructuringCharges>
    <us-gaap:CostsAndExpenses
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTItMi0xLTEtMA_bad34970-e5b9-408f-ab58-ea1ba26a78b4"
      unitRef="usd">21936000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTItNC0xLTEtMA_fd7eaaa2-032a-43fe-99f5-91aaa23a8091"
      unitRef="usd">-30178000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTItNi0xLTEtMA_b2f5d4ca-c0d3-4fef-b65f-d084f539b6ec"
      unitRef="usd">36747000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTItOC0xLTEtMA_074c9556-5c2d-46b1-89b7-6183114ac069"
      unitRef="usd">-11438000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTMtMi0xLTEtMA_39da5509-ca6f-43bd-ac1f-11404159de85"
      unitRef="usd">-21936000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTMtNC0xLTEtMA_6dc554e6-14f4-4c2c-9276-a15ddb381fd5"
      unitRef="usd">40269000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTMtNi0xLTEtMA_8f194359-2327-43b8-b34c-8531fe88a27b"
      unitRef="usd">-36747000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTMtOC0xLTEtMA_4a51f6ba-9b9e-43de-8e27-746a734f595f"
      unitRef="usd">33772000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTQtMi0xLTEtMA_7978fee7-871f-4c91-a382-752f15231989"
      unitRef="usd">432000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTQtNC0xLTEtMA_76283dbb-6684-402b-a27c-3baacfb9c188"
      unitRef="usd">-741000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTQtNi0xLTEtMA_f1d8c560-b739-4238-9b5a-fa86aceb1e6f"
      unitRef="usd">1042000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTQtOC0xLTEtMA_417e8247-8366-4cf5-81f0-09cc29a48e10"
      unitRef="usd">-1119000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InterestExpenseDebt
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTUtMi0xLTEtMA_b990f977-f42f-499b-ac26-6add0cb52263"
      unitRef="usd">1930000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTUtNC0xLTEtMA_9390171b-ed96-4e13-b3d0-a3c8b104a33a"
      unitRef="usd">3237000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTUtNi0xLTEtMA_c113cfe8-54dc-47ec-b4d6-62af1b0ed4d8"
      unitRef="usd">3859000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTUtOC0xLTEtMA_7f0aad2a-5365-43a6-949f-9a10fd206a28"
      unitRef="usd">6427000</us-gaap:InterestExpenseDebt>
    <avdl:GainLossOnReleaseOfCertainLiabilities
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTYtMi0xLTEtMTExMw_5dc11591-0d9c-4d82-9f76-93c3ff69f87f"
      unitRef="usd">88000</avdl:GainLossOnReleaseOfCertainLiabilities>
    <avdl:GainLossOnReleaseOfCertainLiabilities
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTYtNC0xLTEtMTExNQ_3cddee22-a5aa-43dd-ae38-2a4ad6f32c00"
      unitRef="usd">0</avdl:GainLossOnReleaseOfCertainLiabilities>
    <avdl:GainLossOnReleaseOfCertainLiabilities
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTYtNi0xLTEtMA_84be1b72-fd50-4d5f-b5dc-37b6ce56dea6"
      unitRef="usd">166000</avdl:GainLossOnReleaseOfCertainLiabilities>
    <avdl:GainLossOnReleaseOfCertainLiabilities
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTYtOC0xLTEtMA_ba4a9c5f-4b3c-4d10-97f6-0d36e0225abd"
      unitRef="usd">0</avdl:GainLossOnReleaseOfCertainLiabilities>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTctMi0xLTEtMA_2e58572b-15ae-4585-97b6-866d1b1e4af7"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTctNC0xLTEtMA_9734c134-8b28-4426-baa9-f97db8a1d8d1"
      unitRef="usd">-125000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTctNi0xLTEtMA_dca92baf-c376-4999-94b7-36755daf23ba"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTctOC0xLTEtMA_f2e65327-96e1-4a64-b1b0-7e1a30bab400"
      unitRef="usd">-435000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTgtMi0xLTEtMA_7c6dec19-af97-4430-8b6b-f83c84204379"
      unitRef="usd">-23346000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTgtNC0xLTEtMA_21e91a13-a37e-4ea0-99a8-bf0124b2b487"
      unitRef="usd">36166000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTgtNi0xLTEtMA_e88005a5-e6bc-4e8f-bd4c-7a64e4151de6"
      unitRef="usd">-39398000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTgtOC0xLTEtMA_0caf7cf0-224c-40bf-831a-e8095f4cff06"
      unitRef="usd">25791000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTktMi0xLTEtMA_110362ef-d922-4822-8026-38d8dde5ba12"
      unitRef="usd">-3765000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTktNC0xLTEtMA_e6625379-40bc-45c1-8621-213b1a1914c5"
      unitRef="usd">5292000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTktNi0xLTEtMA_97a0aca1-443a-42e9-a040-fb94a0d07f2d"
      unitRef="usd">-6372000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMTktOC0xLTEtMA_8fac7b6d-37af-49c4-babb-818fc6d60016"
      unitRef="usd">-4218000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjAtMi0xLTEtMA_be44abe6-38da-4a7b-a6ad-c66c917414d3"
      unitRef="usd">-19581000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjAtNC0xLTEtMA_00a2f95b-4b7e-41a7-af31-8ea253d06c88"
      unitRef="usd">30874000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjAtNi0xLTEtMA_f7a32062-9151-4e1f-86df-a35bec5a0a1d"
      unitRef="usd">-33026000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjAtOC0xLTEtMA_d998c12e-c7fa-45df-8da5-17e768d72a21"
      unitRef="usd">30009000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjItMi0xLTEtMA_23321c83-348e-4973-9cfb-44f2b1bd749f"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjItNC0xLTEtMA_5ea3ac30-91d2-4d04-959d-3345d04e1c86"
      unitRef="usdPerShare">0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjItNi0xLTEtMA_e9c674d7-a100-4d9a-a8fb-71c3da7b7c9d"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjItOC0xLTEtMA_41cb16a5-9ebd-4ad6-b63b-de1945356814"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjMtMi0xLTEtMA_c25c4b2c-c78c-45a6-9a99-023073c8be63"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjMtNC0xLTEtMA_d15b9f63-aa45-4d35-a647-ca8d04cb193e"
      unitRef="usdPerShare">0.49</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjMtNi0xLTEtMA_19ccec66-72fc-44ba-99e6-d644f3e1ec81"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjMtOC0xLTEtMA_513fa979-2643-4401-adb6-8444720e2130"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjUtMi0xLTEtMA_af22ec6d-38df-4eac-970c-e8de4bffc802"
      unitRef="shares">58488000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjUtNC0xLTEtMA_d9ec4807-8de6-4180-861f-2e5aa6545534"
      unitRef="shares">54272000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjUtNi0xLTEtMA_b04250f6-7e2c-45bb-bff2-e1e3363abe32"
      unitRef="shares">58465000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjUtOC0xLTEtMA_c5fe5138-9037-439c-b66d-b0c7d193d01f"
      unitRef="shares">47665000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjYtMi0xLTEtMA_c8f542ab-0631-424f-8cc5-cda138365a60"
      unitRef="shares">58488000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjYtNC0xLTEtMA_6de2933c-4ebd-48d8-8487-77e80b3f67b5"
      unitRef="shares">69942000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjYtNi0xLTEtMA_c4428f01-759b-47a1-a9d2-f53b64bc7899"
      unitRef="shares">58465000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8xOS9mcmFnOjFkZjNlM2M1ZmY0ZTQxNmFhYjkzZWNmNzY2MjA1ODQzL3RhYmxlOjFjZTQ0NzIwNWMyNTQzZGM5YTk1YTMwMWNiZjk2YzRiL3RhYmxlcmFuZ2U6MWNlNDQ3MjA1YzI1NDNkYzlhOTVhMzAxY2JmOTZjNGJfMjYtOC0xLTEtMA_bf21e3e3-0b05-451a-a2db-a97291a71650"
      unitRef="shares">63083000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfMy0yLTEtMS0w_be44abe6-38da-4a7b-a6ad-c66c917414d3"
      unitRef="usd">-19581000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfMy00LTEtMS0w_00a2f95b-4b7e-41a7-af31-8ea253d06c88"
      unitRef="usd">30874000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfMy02LTEtMS0w_f7a32062-9151-4e1f-86df-a35bec5a0a1d"
      unitRef="usd">-33026000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfMy04LTEtMS0w_d998c12e-c7fa-45df-8da5-17e768d72a21"
      unitRef="usd">30009000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNS0yLTEtMS0w_a0332955-77d7-41a9-87cb-70a0904275fb"
      unitRef="usd">116000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNS00LTEtMS0w_1e4a1534-7461-41e0-8bd2-974957bce385"
      unitRef="usd">182000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNS02LTEtMS0w_8af59f55-41e1-40b3-bd4f-a6cb3af52d5c"
      unitRef="usd">-602000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNS04LTEtMS0w_8954f619-0dcf-4041-978e-676bad4ec9aa"
      unitRef="usd">5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0wLTEtMS0wL3RleHRyZWdpb246ZDRlNDE2MDg4NjJiNDhmMGJmMjQ1MGIxZTQyOTA0YWJfMTA5OTUxMTYyNzg1OQ_407ccac9-deb9-4224-838c-5fe692cb9753"
      unitRef="usd">-78000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0wLTEtMS0wL3RleHRyZWdpb246ZDRlNDE2MDg4NjJiNDhmMGJmMjQ1MGIxZTQyOTA0YWJfMTA5OTUxMTYyNzg2NQ_525364d7-b037-4fc4-bb74-b62282e494f5"
      unitRef="usd">-81000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0wLTEtMS0wL3RleHRyZWdpb246ZDRlNDE2MDg4NjJiNDhmMGJmMjQ1MGIxZTQyOTA0YWJfNDE_18b4c151-0c20-4283-b277-19273133432e"
      unitRef="usd">-133000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0wLTEtMS0wL3RleHRyZWdpb246ZDRlNDE2MDg4NjJiNDhmMGJmMjQ1MGIxZTQyOTA0YWJfNDg_f84ceaf4-0cf8-43b0-8aef-ae05cca052dd"
      unitRef="usd">-130000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi0yLTEtMS0w_8371d6e7-ec68-4289-be6e-53dbf1994972"
      unitRef="usd">-160000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi00LTEtMS0w_a4c5187c-be1b-49b3-8c40-3363f85c23e9"
      unitRef="usd">927000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi02LTEtMS0w_a4fa5810-be4c-4b71-864e-d06db3ec546c"
      unitRef="usd">-697000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNi04LTEtMS0w_38d3e7bf-9ae8-49ca-99c6-17af5397a16c"
      unitRef="usd">283000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNy0yLTEtMS0w_e532ab5a-b189-419d-9bf6-fb4eb81747d2"
      unitRef="usd">-44000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNy00LTEtMS0w_79e55e52-1518-45b8-9e49-4a2ced4149f1"
      unitRef="usd">1109000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNy02LTEtMS0w_fe3a7125-df65-41fa-ab73-9b414bf4acbb"
      unitRef="usd">-1299000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfNy04LTEtMS0w_f42c4e82-0b09-4104-a266-ab7583276b8a"
      unitRef="usd">288000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfOC0yLTEtMS0w_e18fac73-6df7-4c71-b2d9-b22a181d789c"
      unitRef="usd">-19625000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfOC00LTEtMS0w_5bddcb9a-61d1-4741-b6e2-10ef2ddd3267"
      unitRef="usd">31983000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfOC02LTEtMS0w_987c85fb-a12b-478b-9c39-a10fd35f27c1"
      unitRef="usd">-34325000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yMi9mcmFnOmFkYWY0MTBjNDJlMDQzNDliYTFhM2IxNzAzNGUwYzM1L3RhYmxlOjc0NDIzYzQyNzhhYjQ1Y2M5MTI0MjkyYmViZGY2YTkwL3RhYmxlcmFuZ2U6NzQ0MjNjNDI3OGFiNDVjYzkxMjQyOTJiZWJkZjZhOTBfOC04LTEtMS0w_cc50949e-7869-4fd4-bda3-2c4d59019b70"
      unitRef="usd">30297000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNC0yLTEtMS0w_4ddc9351-8a12-4385-a98b-fb46af5afa2d"
      unitRef="usd">67142000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNC00LTEtMS0w_4c23ca8b-ca15-408e-984c-0da118da0988"
      unitRef="usd">71722000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNS0yLTEtMS0w_a792e006-b48c-4ad7-add8-85044f54c100"
      unitRef="usd">135701000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNS00LTEtMS0w_de8e0b1b-fcc7-43d6-9929-a5a51ccdc3bd"
      unitRef="usd">149680000</us-gaap:MarketableSecuritiesCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfOC0yLTEtMS0w_e566cbae-e9d2-4bac-95e3-7753e57af56d"
      unitRef="usd">2551000</avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfOC00LTEtMS0w_05a47fc5-980d-47e5-af2d-c9144b2a96a4"
      unitRef="usd">3326000</avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfOS0yLTEtMS0w_53aa5ab9-7ea8-4a16-9478-c787b2168521"
      unitRef="usd">25308000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfOS00LTEtMS0w_41399f71-cfb6-43ac-b569-ee3609aa10c7"
      unitRef="usd">38726000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTAtMi0xLTEtMA_d1ad9c73-0628-420f-93c5-56897cd473db"
      unitRef="usd">230702000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTAtNC0xLTEtMA_1d74efe9-af48-42c3-ae92-a33d86f805b5"
      unitRef="usd">263454000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTEtMi0xLTEtMA_d380d0e1-9c91-4efe-bc34-d665a306ef07"
      unitRef="usd">321000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTEtNC0xLTEtMA_919df937-06fb-4597-8a9a-528625c28deb"
      unitRef="usd">359000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTItMi0xLTEtMA_0981e611-3b03-4e2b-8be1-dfab50cbf665"
      unitRef="usd">2249000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTItNC0xLTEtMA_2c61ff35-455f-4a56-9b6f-d65fe7ce4ae8"
      unitRef="usd">2604000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTMtMi0xLTEtMA_d66d15d9-3d17-4786-8dbf-f28de72a31bb"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTMtNC0xLTEtMA_fb049b10-dfbf-4f6a-b953-136579c445eb"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTUtMi0xLTEtMA_fcedcbe1-7287-4dc6-88d2-a4368f2e87bc"
      unitRef="usd">983000</avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTUtNC0xLTEtMA_1e6d0292-869f-47bd-b028-38ecfa5bcbea"
      unitRef="usd">3445000</avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTYtMi0xLTEtMA_8d566361-c548-4205-9df7-415b40afc44d"
      unitRef="usd">31500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTYtNC0xLTEtMA_e1131c4d-0599-4faa-94f3-6bccc01d046a"
      unitRef="usd">24939000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTctMi0xLTEtMA_9b4c2586-e224-45a8-85bb-c790346f8994"
      unitRef="usd">282591000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMTctNC0xLTEtMA_8ffa101f-6455-4851-b60c-ce38bde9a07b"
      unitRef="usd">311637000</us-gaap:Assets>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjItMi0xLTEtMA_71f05ed9-150d-4963-8cbc-a1cc270f7289"
      unitRef="usd">494000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjItNC0xLTEtMA_1197edce-53a2-4907-9971-f1b13e324e90"
      unitRef="usd">474000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjMtMi0xLTEtMA_91b9cfce-1333-4ad4-ae15-6406d9e10deb"
      unitRef="usd">5116000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjMtNC0xLTEtMA_147e1a48-bc96-4448-b282-488ee97e322e"
      unitRef="usd">2934000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjQtMi0xLTEtMA_0b057b46-35c0-4357-9d2b-8b0467872ab8"
      unitRef="usd">7524000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjQtNC0xLTEtMA_281995cb-bfa6-4fe9-a13b-820af98fbfab"
      unitRef="usd">6501000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjYtMi0xLTEtMA_439c6787-1b55-400f-9683-c5e8a4278867"
      unitRef="usd">3146000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjYtNC0xLTEtMA_9d05c6e8-e331-48dc-b40b-e0fd802681f6"
      unitRef="usd">5200000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjctMi0xLTEtMA_43f92ae9-a1af-46cc-8e54-294f19cb5d31"
      unitRef="usd">16280000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjctNC0xLTEtMA_57d92cd6-a406-4bac-aee6-50ab7907e27f"
      unitRef="usd">15109000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjgtMi0xLTEtMA_d812668f-4f3b-4cee-b482-ec25383b696e"
      unitRef="usd">141774000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMjgtNC0xLTEtMA_c2878cc9-8df5-414c-9e82-29377f3ff78a"
      unitRef="usd">128210000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzAtMi0xLTEtMA_1f19f3c2-a862-4db1-8c74-57599a9f4726"
      unitRef="usd">1589000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzAtNC0xLTEtMA_e34cca18-ced0-45e6-ba19-4ca82a644e4c"
      unitRef="usd">1840000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzEtMi0xLTEtMA_a2e408b8-d783-43ba-a198-ac21625a9603"
      unitRef="usd">4068000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzEtNC0xLTEtMA_9c51f340-8c7f-4b1d-a8ab-4b1c69dec089"
      unitRef="usd">4212000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzItMi0xLTEtMA_d1e6075c-5070-46e4-928c-f00bb10cb8f3"
      unitRef="usd">163711000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzItNC0xLTEtMA_8aec312e-3000-439d-ba2d-14da8199db20"
      unitRef="usd">149371000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzM5_04af2bce-2da8-4e54-bae5-98c4fc0c37af"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzM5_941379c1-6fca-4ed4-bc95-c9b38afea73b"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzUz_6fbeae75-175a-4dbe-97ec-cd478abd10b9"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzUz_7eef6b4f-0cc5-4957-97c3-2cd23dea30b6"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzc1_ab79fb0c-b742-41f1-9a21-2a4c65447d84"
      unitRef="shares">488000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzc1_e1b2ddcf-8f12-41c4-8d09-55abfe9ad8a7"
      unitRef="shares">488000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzExMQ_7c8f2577-4fae-40f6-93d9-de9dd566e071"
      unitRef="shares">488000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjhlOGI2MDRiOWE0YTRiMzQ4YWQyNjBmMWUwN2RhMjRkXzExMQ_ae01df5a-50b7-481f-bab9-75c80a43d90f"
      unitRef="shares">488000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtMi0xLTEtMA_2ffb4dad-609f-432e-bbd2-bc3d3e467832"
      unitRef="usd">5000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzUtNC0xLTEtMA_0f8d2e5f-bcc3-4331-9671-ade7624b33d5"
      unitRef="usd">5000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzM4_4841ae98-d536-453f-8aed-e7dfbb7c0837"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzM4_ff2080d4-e9cd-499d-8b73-e425c4880d9c"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzUy_087afaac-63d5-48c0-9b94-53b710a35373"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzUy_d6fb286e-1463-404e-8ab3-7328422f3e07"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5Xzc0_0d02c78f-117c-415a-a76e-623b30226530"
      unitRef="shares">58488000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5Xzc0_27b46a39-f41e-449f-ad9c-e98a9a73098e"
      unitRef="shares">58488000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzExMA_cee9638e-2de1-4e0e-9558-deb740deb9f9"
      unitRef="shares">58396000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MjI2MjIxODllZDRhNWQ4MTE3NDcxNjYxODQzNGI5XzExMA_ea7fdd64-c22d-462b-9ff2-e4671e1b4bc9"
      unitRef="shares">58396000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtMi0xLTEtMA_3cb4a539-656c-4904-ba29-7aa6a2268c4d"
      unitRef="usd">584000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzYtNC0xLTEtMA_327ecb89-639a-4f46-94e6-dabb002a29d4"
      unitRef="usd">583000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzctMi0xLTEtMA_852d851f-62f2-4064-be2d-8d7aef2bd15f"
      unitRef="usd">544094000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzctNC0xLTEtMA_2aeb7475-3b7f-401d-96b5-78e2ab780fc4"
      unitRef="usd">566916000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzgtMi0xLTEtMA_f35ab531-afae-40d6-89f2-87bd2a166eb1"
      unitRef="usd">-403453000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzgtNC0xLTEtMA_34d07fbc-f4a2-4b2a-a5d2-abd81b73aa0a"
      unitRef="usd">-384187000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzktMi0xLTEtMA_917b5486-822a-41cc-a6c5-35bac29edf94"
      unitRef="usd">-22350000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfMzktNC0xLTEtMA_dc483204-9175-4647-9893-6f15779157cc"
      unitRef="usd">-21051000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNDAtMi0xLTEtMA_e9854407-ec72-4ce4-a4bc-4b16ef095636"
      unitRef="usd">118880000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNDAtNC0xLTEtMA_a172df69-2756-4961-b780-d14940e3c819"
      unitRef="usd">162266000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNDEtMi0xLTEtMA_10e1aeee-5b96-4b93-94af-6539c0cedf50"
      unitRef="usd">282591000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yNS9mcmFnOjg3MGY0YWU0NzhkMjQ1MDA4ODc2OTBiY2IxZjUyZmNiL3RhYmxlOjg3NDk5YWExODMxODQ2YTE4ZTAzMGZiNTIzZDc0NGY0L3RhYmxlcmFuZ2U6ODc0OTlhYTE4MzE4NDZhMThlMDMwZmI1MjNkNzQ0ZjRfNDEtNC0xLTEtMA_187d1405-5be0-4d55-8fb4-c4b2eb92dbfa"
      unitRef="usd">311637000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i8d69f2653c7843348a441d3a40de400f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0yLTEtMS0w_d70dd5b4-790c-4641-8b62-a2039daddbc2"
      unitRef="shares">58396000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8d69f2653c7843348a441d3a40de400f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi00LTEtMS0w_c3266461-20cd-43e6-989e-91662f198ba1"
      unitRef="usd">583000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i7f33bcd282a7486eba6fd7888306a035_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi02LTEtMS0w_19635dbd-3be6-4194-9769-a9c86d211e11"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7f33bcd282a7486eba6fd7888306a035_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi04LTEtMS0w_5081cc3f-31b2-4e85-bb73-2a35d611efcd"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icadf2fd8982949eb8a9a9a8130767bb6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0xMC0xLTEtMA_5f075251-6b5f-494f-9074-14be3e00d434"
      unitRef="usd">566916000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iea8152d9127347daa7d0be2b82d42c16_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0xMi0xLTEtMA_4dca8b56-05fb-4de2-867f-7cff05668043"
      unitRef="usd">-384187000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbfb2bb9bd2c454d9a2f913b904d527d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0xNC0xLTEtMA_d99839d9-6ded-4825-948f-de7a5907b4fd"
      unitRef="usd">-21051000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMi0xNi0xLTEtMA_dab9cee1-fe85-4eb4-aeb4-755dc43f30dd"
      unitRef="usd">162266000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i54a0f1be38254190aa94a522f6ed4974_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMy0xMC0xLTEtMA_5d9adcd7-cc00-4f62-8aa7-c83805448ae9"
      unitRef="usd">-26699000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie70c99023cd04e558a4e840886322480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMy0xMi0xLTEtMA_8048fd04-e326-462c-adc1-8744437dffc4"
      unitRef="usd">13760000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if26cf9bd950645da82a913ea028f7f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMy0xNi0xLTEtMA_2b9c1548-0db8-4877-9af8-c4bc8e94b611"
      unitRef="usd">-12939000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i9cd9c5deb61d480c855cc24b25d34b9b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNC0xMi0xLTEtMA_f225c9e4-45a8-4e71-938e-6088572a1d6b"
      unitRef="usd">-13445000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNC0xNi0xLTEtMA_bf34de4b-3f2d-4121-ac2b-0b926c85a772"
      unitRef="usd">-13445000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i08d9e77f9bac4c3ab716300be3d8b8cf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNS0xNC0xLTEtMA_19403e7b-f335-4628-bfd4-28c63d0436c7"
      unitRef="usd">-1255000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNS0xNi0xLTEtMA_6f49e596-0992-40e5-a983-b02de6333d6e"
      unitRef="usd">-1255000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNi0yLTEtMS0w_6f51a8bf-b4c3-4fac-871a-eb0579873ff4"
      unitRef="shares">23000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNi0xMC0xLTEtMA_3f41f222-c8f7-41ba-a38b-b5c8c8a04e53"
      unitRef="usd">106000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNi0xNi0xLTEtMA_642291af-76cc-4b2e-be0c-601a39d50c56"
      unitRef="usd">106000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNy0yLTEtMS0w_5712ff1c-4ab9-4fb5-837e-5c28826bc863"
      unitRef="shares">61000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNy00LTEtMS0w_b121ffdc-89f8-45c3-b797-d58e2066a259"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNy0xMC0xLTEtMA_deb18509-8c79-4a86-8b99-d96e22230822"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfNy0xNi0xLTEtMA_2eab86d2-b283-4a29-8a61-d64f8ff28132"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="i3197075046c24a1fa7b387edfcfc1a63_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOC0yLTEtMS0w_163e3a44-8b26-45b3-b27a-c502171a49ec"
      unitRef="shares">8000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOC0xMC0xLTEtMA_e5e02f29-f962-4833-bbe1-3daa9d1c991a"
      unitRef="usd">43000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOC0xNi0xLTEtMA_ac7f41bb-9d46-4e1f-9eba-f060d5624e62"
      unitRef="usd">43000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9d95027c8ca44f389fd06bea004e5745_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOS0xMC0xLTEtMA_6bbb7977-e8b8-4db9-940e-7e68ed596095"
      unitRef="usd">1728000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i695183555b394250b05b06d9bf6c9006_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfOS0xNi0xLTEtMA_017a7fd3-0539-4b52-86ff-7a3cde3d3ea8"
      unitRef="usd">1728000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="i39b86180a03145e2ab56d7861d9b72a0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMi0xLTEtMA_12a8a4f6-d915-4451-b85c-4cd1fbc16524"
      unitRef="shares">58488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i39b86180a03145e2ab56d7861d9b72a0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtNC0xLTEtMA_93ab5836-462a-4889-bfb7-e62ccd18c40c"
      unitRef="usd">584000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ibd4c15b3c08b4cbd9427dacc880d2346_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtNi0xLTEtMA_536ce4ca-4925-4b94-a167-fcf2abd81fe3"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ibd4c15b3c08b4cbd9427dacc880d2346_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtOC0xLTEtMA_9570a052-0e81-4631-b6a7-28307dc8d1b5"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4c9bed8d32e44549a6e6384e81de3b5f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMTAtMS0xLTA_da0e5610-2560-4f74-a207-4b704239f3e2"
      unitRef="usd">542093000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1938096e05e425590b24e2476286cdc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMTItMS0xLTA_3b46f00c-e100-4d05-8d50-344fbc701210"
      unitRef="usd">-383872000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6474ac452b754332a6d49fc58fae2431_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMTQtMS0xLTA_cd89eeb7-b521-40c2-99ff-6f327bab27d9"
      unitRef="usd">-22306000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i13deb59210c04afabfb45b889d23aa75_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTAtMTYtMS0xLTA_78066ecc-8481-4e8c-882d-eb24073af847"
      unitRef="usd">136504000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i63df9a42f4264b208b42e799c3b3da1e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTEtMTItMS0xLTA_58d046b6-78e7-4253-ade2-a973d5826ba0"
      unitRef="usd">-19581000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTEtMTYtMS0xLTA_971b8f10-9b02-41c4-8348-00ccda60468c"
      unitRef="usd">-19581000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1dae4c5996d045e093657ce638a3bfb4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTItMTQtMS0xLTA_49486d2f-2fa7-454a-a048-4c7293524f11"
      unitRef="usd">-44000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTItMTYtMS0xLTA_13eb2abb-8d1b-45cc-b616-1174c3e4a75e"
      unitRef="usd">-44000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3dcc627de1534b28a106aee5209d7631_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTctMTAtMS0xLTA_704bd837-9dc3-457a-9d3d-ea114116e755"
      unitRef="usd">2001000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTctMTYtMS0xLTA_fbd7f8e7-fe9e-42a6-a09c-13a38ca8d93c"
      unitRef="usd">2001000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="ica30a680c36b463799b9fbf697661fc8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMi0xLTEtMA_5f9231f7-b7cf-49b1-85cd-aba2c111cc33"
      unitRef="shares">58488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ica30a680c36b463799b9fbf697661fc8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtNC0xLTEtMA_c57e92b1-8ad3-4b47-b6f4-74b5668b1048"
      unitRef="usd">584000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="iac901e4b20854acb8c4c482c601cb2e0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtNi0xLTEtMA_22b49c82-f6d6-4301-ba19-a634f6ec8bbb"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iac901e4b20854acb8c4c482c601cb2e0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtOC0xLTEtMA_572c5366-783e-4030-985d-9db2323bb94f"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9760338be14744d8883d6b1a7be11ede_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMTAtMS0xLTA_47da2b9b-5bc6-4676-91f4-41bce01321bb"
      unitRef="usd">544094000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaf27002e9c9248dfb7f009f24e02a4c5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMTItMS0xLTA_e5dab410-7d28-4668-9e03-9d1986391cb1"
      unitRef="usd">-403453000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25507beaf94543b3ac989067fe8f70f6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMTQtMS0xLTA_91ddd9d3-1b96-4a32-bcab-1c82c62f438e"
      unitRef="usd">-22350000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOjBiNjExMTI3YjhhMjRlZTliMmJlNTBlODEzNzdiNmNkL3RhYmxlcmFuZ2U6MGI2MTExMjdiOGEyNGVlOWIyYmU1MGU4MTM3N2I2Y2RfMTgtMTYtMS0xLTA_8f6b1cc7-4e63-49d0-8f79-5d71cf2e537f"
      unitRef="usd">118880000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i5952bd509a3b4bbd95542c5ad8829fd2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0yLTEtMS0w_8f606c04-1506-4167-ae0b-412d5020aaca"
      unitRef="shares">42927000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5952bd509a3b4bbd95542c5ad8829fd2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi00LTEtMS0w_278e5fea-bf51-4136-ad54-2b4289941bbc"
      unitRef="usd">429000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i24d453b62e5f4a758dc24ff5f07cdf8c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi02LTEtMS0w_c3e23c0f-f2a7-45fe-9a48-ba127ce6a183"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i24d453b62e5f4a758dc24ff5f07cdf8c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi04LTEtMS0w_0b500382-efbf-4d37-8258-b4b46cd85b0c"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i728f1dde962144218da7200782d318a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xMC0xLTEtMA_38da1472-f69c-49ed-ad88-13aad52b9894"
      unitRef="usd">434391000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e185af4c95c4cbabd2d62ccb442cefe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xMi0xLTEtMA_7d1ef277-9ac2-40c2-abeb-5a808a19c165"
      unitRef="usd">-391215000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i39ce40436c834ffd88b04bc577cb05f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xNC0xLTEtMA_fb7a6b19-679f-4003-ae46-d06ddfc93d8f"
      unitRef="usd">-22806000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i7fe02fc3397f469095911d0d65984e6a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xNi0xLTEtMA_749d0623-6e84-4a7b-8092-b9803ef3bed9"
      unitRef="shares">5407000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7fe02fc3397f469095911d0d65984e6a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0xOC0xLTEtMA_c21a1d36-2811-4e6e-8904-44f98635ef54"
      unitRef="usd">-49998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i398b06c595444f7caeaba916451c29fa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMi0yMC0xLTEtMA_9705b99c-a950-4b9f-b130-d5fb6d2fbed8"
      unitRef="usd">-29199000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i47b79ad2b6fa4d43b3bc4e7c2bffdfe1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMy0xMi0xLTEtMA_fdb85eb7-449f-48f9-a2ad-df7d4503e4d6"
      unitRef="usd">-865000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMy0yMC0xLTEtMA_a758d11f-2562-47bf-8acd-0f65eaec4e0d"
      unitRef="usd">-865000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib5365f5787064a8588bd454e8fd0fe11_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNC0xNC0xLTEtMA_3c36f195-e5ac-4418-879b-d689cee6b804"
      unitRef="usd">-821000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNC0yMC0xLTEtMA_4bcffdf2-331c-41f7-a390-646453face3c"
      unitRef="usd">-821000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNS0yLTEtMS0w_7f030756-e4d4-4bbb-a489-157e23ae3126"
      unitRef="shares">146000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNS00LTEtMS0w_c3ed428e-fb41-4803-a1fa-a392733a4013"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNS0xMC0xLTEtMA_7c28e1a1-944a-4546-a3a7-b6aff7a60abf"
      unitRef="usd">1387000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNS0yMC0xLTEtMA_7d6b144a-1fd7-4872-b6ad-9c441e9fb7aa"
      unitRef="usd">1389000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi0yLTEtMS0w_3d053568-3ede-45ad-8438-5ef0238ed369"
      unitRef="shares">8680000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi00LTEtMS0w_926de262-44bc-4cd4-8d30-b24b78b86a29"
      unitRef="usd">87000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i94cdc3283e8b4906848c3ac05797508f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi02LTEtMS0w_93fe8751-9766-4bda-8ed2-1b3bd3da661a"
      unitRef="shares">488000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i94cdc3283e8b4906848c3ac05797508f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi04LTEtMS0w_d8112dd1-fe4d-4472-ab6d-bea1e745eaa4"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi0xMC0xLTEtMA_5f918599-f483-472a-b158-5da345cd8d85"
      unitRef="usd">60641000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNi0yMC0xLTEtMA_2b3d844c-a92f-4242-b8cc-33136f28b9d6"
      unitRef="usd">60733000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNy0yLTEtMS0w_b273d60c-7d9c-44ba-85e4-c1ece3a128a0"
      unitRef="shares">19000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfNy0yMC0xLTEtMA_142ea143-5ec3-42e1-ae3d-219786829fef"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="i0bc539f61b9343938fdb30916bd3b83d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOC0yLTEtMS0w_48633abe-43ec-4ece-8742-e9086c431819"
      unitRef="shares">40000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOC0xMC0xLTEtMA_84adde8d-dbef-47ab-9861-4f4cbcffe350"
      unitRef="usd">88000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOC0yMC0xLTEtMA_e4aa595a-deec-4f8e-971b-ad8b1ef68f89"
      unitRef="usd">88000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5ba68f64c2ba4306ab56909af7064a97_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOS0xMC0xLTEtMA_359655d8-d9e3-4e44-856e-d4b5227ce618"
      unitRef="usd">742000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6a915e8692ca4b1a9462000b3565f19e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfOS0yMC0xLTEtMA_9a3caa2e-50e0-4906-aaf5-82ed9b8604f3"
      unitRef="usd">742000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="ib4a2221ed67f4b938f45988fa863f1e8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMi0xLTEtMA_a95476d5-3b35-4f8c-b778-962ce2c8494a"
      unitRef="shares">51812000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib4a2221ed67f4b938f45988fa863f1e8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtNC0xLTEtMA_d6f9331b-0c52-4f1e-8a5c-108cd157c3b0"
      unitRef="usd">518000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="iefbaf7c014bb4111b59cf750ee917f08_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtNi0xLTEtMA_9096be05-04f1-4e6c-ad4d-54ff18c4ce9f"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iefbaf7c014bb4111b59cf750ee917f08_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtOC0xLTEtMA_572a210d-fb5f-4410-8b1b-ffc6c2a4eb46"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i295311c4e79a486380b4c0eede6381f5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTAtMS0xLTA_6e1c9f14-9690-45b0-9263-cd717306f8dd"
      unitRef="usd">497249000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7cec52b45db74ffb865d0a2e924af088_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTItMS0xLTA_e98c2c97-2496-4056-820a-51e76e7228d9"
      unitRef="usd">-392080000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id7dba2e7aac4498891de302ca71046c7_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTQtMS0xLTA_231062e7-50f0-4213-ac00-358da8623a96"
      unitRef="usd">-23627000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i6d918ae9e9cd4e17a845a2041f236bde_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTYtMS0xLTA_957366fa-c2bd-4400-a629-a8da35545da5"
      unitRef="shares">5407000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6d918ae9e9cd4e17a845a2041f236bde_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMTgtMS0xLTA_003018df-f855-44f3-9934-edfe299a1d79"
      unitRef="usd">-49998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iee621425bbaf4880a450697c4e2573d6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTAtMjAtMS0xLTA_161db23e-7c9c-42d5-aa75-0d66d684351f"
      unitRef="usd">32067000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ifb3815294ed64ba3bcb2123ce0004c19_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTEtMTItMS0xLTA_3542d9c3-51b7-4c15-8f9d-da44193d4dcb"
      unitRef="usd">30874000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTEtMjAtMS0xLTA_d0ea6322-796b-4d16-8017-c8c8cf5539fd"
      unitRef="usd">30874000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2da1cc6c35a94eaab32f7383d06ce563_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTItMTQtMS0xLTA_bde9bc55-3a1f-49b2-98e8-a5f3fe1a0e7f"
      unitRef="usd">1109000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTItMjAtMS0xLTA_45fb225a-7f57-48c6-a686-41cadb60e77f"
      unitRef="usd">1109000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMi0xLTEtMjgyNQ_5cd3fcc1-2389-4cfd-a353-b08bc8aba634"
      unitRef="shares">95000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtNC0xLTEtMjgyMw_b1de43e7-8f00-40e6-bc26-b6737d447ecc"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMTAtMS0xLTI4MjU_62aa407f-c350-464d-877e-1c50b5f47b6c"
      unitRef="usd">392000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMjAtMS0xLTI4MjU_bc321763-d95b-4b8e-a9a8-2630c5f3b392"
      unitRef="usd">393000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTAtMS0xLTI4MjU_57a4e3eb-78aa-4806-9224-bc11e6784ccd"
      unitRef="usd">-94000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMjAtMS0xLTI4MjU_4ffcc273-9b60-489b-a029-b8d2d99a0244"
      unitRef="usd">-94000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <avdl:StockIssuedDuringPeriodSharesPublicOffering
      contextRef="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTUtMi0xLTEtMjgzMA_770907b7-a0aa-4de9-baca-6bab9baf1ccd"
      unitRef="shares">11630000</avdl:StockIssuedDuringPeriodSharesPublicOffering>
    <avdl:StockIssuedDuringPeriodValuePublicOffering
      contextRef="ia4ccd93975074f71a9ff3eed2030e0d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTUtNC0xLTEtMjgzMg_ca02e5da-96a6-458e-b180-16a44724a475"
      unitRef="usd">116000</avdl:StockIssuedDuringPeriodValuePublicOffering>
    <avdl:StockIssuedDuringPeriodValuePublicOffering
      contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTUtMTAtMS0xLTI4MzQ_87967958-f906-4ac3-9259-59464baafe8d"
      unitRef="usd">116858000</avdl:StockIssuedDuringPeriodValuePublicOffering>
    <avdl:StockIssuedDuringPeriodValuePublicOffering
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTUtMjAtMS0xLTI4MzY_74c7c3bc-87c8-4910-bf6e-2e29790a3c1d"
      unitRef="usd">116974000</avdl:StockIssuedDuringPeriodValuePublicOffering>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTYtMTAtMS0xLTI4Mjg_f4a3c246-216f-498d-b3eb-fd9b0b57e61d"
      unitRef="usd">33000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTYtMjAtMS0xLTI4Mjg_85b84eef-83e3-4bae-bcbd-7a6cf95ce425"
      unitRef="usd">33000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i816da0b25c774ed6ac763c7fa1fcd76f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMTAtMS0xLTA_d763df7d-c1c1-4af6-9ed2-8c696e7918d8"
      unitRef="usd">769000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTMtMjAtMS0xLTA_c2e83221-b0db-4733-b54d-601292b25bfa"
      unitRef="usd">769000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="ia2a46ff8ddd543a681fb05ae9c5370ab_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMi0xLTEtMA_f60c1ced-7a1b-405d-86b6-37fcdd13b68f"
      unitRef="shares">63537000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia2a46ff8ddd543a681fb05ae9c5370ab_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtNC0xLTEtMA_be620b7c-da51-4d13-8dd6-a9c527487a14"
      unitRef="usd">635000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i542e7a0b738049e785822075bec4dd2f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTgtNi0xLTEtMjgzOA_2fc0b2b0-dce2-4143-809a-2eaa844b651a"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i542e7a0b738049e785822075bec4dd2f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTgtOC0xLTEtMjgzOA_1099a6ec-5427-4513-86e4-b532bed2d4e3"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibfa9a8f10ae647138ff3b9ba07a34261_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTAtMS0xLTA_6cf00aea-8d4d-4f8b-9836-0aa3df314f8e"
      unitRef="usd">615207000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic27ceaeb4d5e4740bf0c3a9528c54d02_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTItMS0xLTA_a522f06b-5922-4bd2-91a5-1571e8c0ebdb"
      unitRef="usd">-361206000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2a929bcc21e485a9d7ab75296127ff8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTQtMS0xLTA_a97871fb-64ff-4aba-941e-e7755aa3747f"
      unitRef="usd">-22518000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ic979207f9f324f33be7b2a93a0acb9c0_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTYtMS0xLTA_9138d1ff-7443-4516-9b94-747af0944c68"
      unitRef="shares">5407000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic979207f9f324f33be7b2a93a0acb9c0_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMTgtMS0xLTA_a9fe5af5-110e-4393-88db-ce0ae7ce00af"
      unitRef="usd">-49998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2b18f9096c56478ba558603f0009c83f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8yOC9mcmFnOjczMjgzNDg3NWIzNzQ5Y2ZiMTg0Mjk1NTBmZGJkNjU5L3RhYmxlOmUzM2E0ZDQzNTAxOTQ5YTI4MjQ0ZjRlMGE1OTBjMTQ1L3RhYmxlcmFuZ2U6ZTMzYTRkNDM1MDE5NDlhMjgyNDRmNGUwYTU5MGMxNDVfMTQtMjAtMS0xLTA_5f2956a4-b1cf-407f-abb0-790d69bd275e"
      unitRef="usd">182125000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNC0yLTEtMS0w_f7a32062-9151-4e1f-86df-a35bec5a0a1d"
      unitRef="usd">-33026000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNC00LTEtMS0w_d998c12e-c7fa-45df-8da5-17e768d72a21"
      unitRef="usd">30009000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNi0yLTEtMS0w_f5982125-2a42-46e3-ba30-5dab5cd95edb"
      unitRef="usd">417000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNi00LTEtMS0w_ee9293ea-c73f-445f-b853-4b2aed3657fd"
      unitRef="usd">975000</us-gaap:DepreciationAndAmortization>
    <avdl:AcquisitionRelatedContingentConsiderationRemeasurement
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNy0yLTEtMS0w_81fa4b9d-c0c9-44b0-8e17-67626cadce5b"
      unitRef="usd">0</avdl:AcquisitionRelatedContingentConsiderationRemeasurement>
    <avdl:AcquisitionRelatedContingentConsiderationRemeasurement
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNy00LTEtMS0w_7ea30aa5-1ccd-431a-b8bd-543604c9fec5"
      unitRef="usd">3396000</avdl:AcquisitionRelatedContingentConsiderationRemeasurement>
    <avdl:FinancingRelatedContingentConsiderationRemeasurement
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfOC0yLTEtMS0w_9878251a-5b5d-4b0f-a4b1-14a8b75deb87"
      unitRef="usd">0</avdl:FinancingRelatedContingentConsiderationRemeasurement>
    <avdl:FinancingRelatedContingentConsiderationRemeasurement
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfOC00LTEtMS0w_4bcdd9e0-77b2-49ec-a37d-97525516914c"
      unitRef="usd">435000</avdl:FinancingRelatedContingentConsiderationRemeasurement>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfOS0yLTEtMS0w_a6ab36ac-adda-4f71-9271-39f4fe14972e"
      unitRef="usd">625000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfOS00LTEtMS0w_d80e0d19-d16e-41ad-b0f5-f2bd9b1ce01f"
      unitRef="usd">3193000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTAtMi0xLTEtMA_37869f45-cda2-499b-8d8c-c73912b77395"
      unitRef="usd">-6228000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTAtNC0xLTEtMA_dda800c4-28d2-4417-9cc5-771000acd577"
      unitRef="usd">161000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTEtMi0xLTEtMA_89ad5fc9-f0ce-4170-af81-5110037050e3"
      unitRef="usd">3729000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTEtNC0xLTEtMA_dde62f5d-7705-4967-b2dd-07b143e6afe0"
      unitRef="usd">1511000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTItMi0xLTEtNDI_2e3bd5ff-8ba4-452d-8253-d21f3e5c5c67"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTItNC0xLTEtNDI_d53b891e-d66d-4799-83a6-0841c9f731e5"
      unitRef="usd">45760000</us-gaap:GainLossOnSaleOfBusiness>
    <avdl:GainLossOnReleaseOfCertainLiabilities
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTItMi0xLTEtMA_cd14abf2-b375-4ede-919b-54a0d6afb8cd"
      unitRef="usd">166000</avdl:GainLossOnReleaseOfCertainLiabilities>
    <avdl:GainLossOnReleaseOfCertainLiabilities
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTItNC0xLTEtMA_c6af0bcd-7b42-49f8-a802-3c1585461c19"
      unitRef="usd">0</avdl:GainLossOnReleaseOfCertainLiabilities>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTMtMi0xLTEtMA_6575c611-4ab1-459b-b1fd-49c799cf2b66"
      unitRef="usd">757000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTMtNC0xLTEtMA_94d553b7-88fc-4a6b-829b-86b222e4a3c0"
      unitRef="usd">477000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTUtMi0xLTEtMA_3fd60219-2e6d-4eb7-9682-795d2405a194"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTUtNC0xLTEtMA_dcba06a0-872c-41a9-b8c0-13a5216730ec"
      unitRef="usd">-2589000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTYtMi0xLTEtMA_b79cfb5a-4089-4f3a-8434-8546708b6f09"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTYtNC0xLTEtMA_7bb6b57e-e3ac-402c-9e0e-f301b1baf573"
      unitRef="usd">1353000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTctMi0xLTEtMA_64781498-471b-4a13-839d-cba6bcab130c"
      unitRef="usd">3106000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTctNC0xLTEtMA_40585692-0091-481b-a0c6-4bace24caafb"
      unitRef="usd">1149000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTgtMi0xLTEtMA_6ca8c012-e4d0-4dcf-85b0-b1cd4ea8bd21"
      unitRef="usd">-3078000</avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable>
    <avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTgtNC0xLTEtMA_c55c65cb-8538-4027-822e-7639b590ad7e"
      unitRef="usd">-2036000</avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTktMi0xLTEtMA_19f026e0-ceb0-4a6b-9915-73767117ce51"
      unitRef="usd">176000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMTktNC0xLTEtMA_6ad94bfe-65db-4f8a-87e9-26ef5d117e56"
      unitRef="usd">-1550000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjAtMi0xLTEtMA_7029e203-306c-485d-b4f9-2b3a40ff3f46"
      unitRef="usd">1199000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjAtNC0xLTEtMA_57ddd8ad-5de8-4c49-9491-c8330555a434"
      unitRef="usd">-6906000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjEtMi0xLTEtMA_dc60c382-dd56-436e-9faf-e9d296c51206"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjEtNC0xLTEtMA_b28218f3-3fd0-4d6e-b764-d04aa5943bc0"
      unitRef="usd">321000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjItMi0xLTEtMA_3be87a43-5fa3-473e-9ba4-5ccd3ca46248"
      unitRef="usd">0</avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue>
    <avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjItNC0xLTEtMA_2a2a9aca-49b9-4a6f-be36-6d7ca24e3e55"
      unitRef="usd">3736000</avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue>
    <us-gaap:PaymentsForRoyalties
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjMtMi0xLTEtMA_4f1857c9-3bb4-486b-b39a-164841c581a4"
      unitRef="usd">0</us-gaap:PaymentsForRoyalties>
    <us-gaap:PaymentsForRoyalties
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjMtNC0xLTEtMA_53f4f30d-f909-4c42-8d90-3c374e3bfa9b"
      unitRef="usd">608000</us-gaap:PaymentsForRoyalties>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjQtMi0xLTEtMA_05a80f6a-6674-459c-bed3-cbd754973808"
      unitRef="usd">1021000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjQtNC0xLTEtMA_97d62e37-203d-4a90-9455-ca428b5f9213"
      unitRef="usd">3458000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjUtMi0xLTEtMA_4fb7b611-f285-4c72-ba50-f8d5644d677e"
      unitRef="usd">-33566000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjUtNC0xLTEtMA_532f9489-6391-4f65-b8ab-ae0e1363ee07"
      unitRef="usd">-19417000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjgtMi0xLTEtMA_b04022f3-0515-40ee-9136-02f688543d04"
      unitRef="usd">26000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMjgtNC0xLTEtMA_298df9c1-e46e-4e2d-94f3-a104b2a430e3"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzAtMi0xLTEtMA_9c6079de-75cd-4ade-9f41-af291d86583c"
      unitRef="usd">16500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzAtNC0xLTEtMA_4fccda6f-ea53-4aaa-9d6f-67d0237f6648"
      unitRef="usd">14500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzEtMi0xLTEtMA_ac121914-13eb-41f9-9c76-d31664da343a"
      unitRef="usd">66213000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzEtNC0xLTEtMA_d719e2c9-20d3-4610-987d-c90405a3d772"
      unitRef="usd">15716000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzItMi0xLTEtMA_dc655ebb-4afc-40cf-a8bf-d189b73d3920"
      unitRef="usd">53372000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzItNC0xLTEtMA_c365a4b7-23a5-443e-b66f-c25e2a118159"
      unitRef="usd">97878000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzMtMi0xLTEtMA_067b11bc-fe41-4fcd-b259-f8170069e8b8"
      unitRef="usd">29315000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzMtNC0xLTEtMA_6ddcc940-d05b-4341-bc1b-c155eb8e3778"
      unitRef="usd">-67662000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzYtMi0xLTEtMA_e71ed576-1d6a-4d86-bc43-5935044c10a3"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzYtNC0xLTEtMA_b93a1d76-ecf2-4317-9f46-60b3b48d4736"
      unitRef="usd">60639000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzgtMi0xLTEtMjg0NA_b0df525e-8165-467b-8231-ebcbdb88e467"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzgtNC0xLTEtMTc1Nw_84ba58fc-95b0-4aa3-9306-980eefb4ae67"
      unitRef="usd">116974000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzgtMi0xLTEtMA_a0e72225-0a0a-4eaf-91c7-250cbcbc3142"
      unitRef="usd">149000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfMzgtNC0xLTEtMA_4cf5d7b1-9073-4a0e-b029-6a358d624df2"
      unitRef="usd">1903000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDAtMi0xLTEtMA_ca8481ba-7d6d-4d39-9ed7-dd4a14437c26"
      unitRef="usd">149000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDAtNC0xLTEtMA_d5f8c060-72bc-40d8-8e2d-feac924e73b7"
      unitRef="usd">179516000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDItMi0xLTEtMA_fcc66fd2-a082-4124-b49f-228cbd6dde48"
      unitRef="usd">-478000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDItNC0xLTEtMA_2c0a8deb-7122-4e02-99ed-da9d3d0c4dc0"
      unitRef="usd">-37000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDQtMi0xLTEtMA_3802e3f8-0e53-4e93-9ffb-99d9f0231a6f"
      unitRef="usd">-4580000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDQtNC0xLTEtMA_b96ad888-3493-4848-8d54-47e5ee136dc2"
      unitRef="usd">92400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDUtMi0xLTEtMA_883a3c7d-c70b-470c-9fea-25464aa2a9cd"
      unitRef="usd">71722000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i398b06c595444f7caeaba916451c29fa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDUtNC0xLTEtMA_b7b04e05-eada-45b8-943d-8e5a0d6550c6"
      unitRef="usd">9774000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDYtMi0xLTEtMA_b3bc9992-267a-4072-a768-c162d314394b"
      unitRef="usd">67142000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2b18f9096c56478ba558603f0009c83f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDYtNC0xLTEtMA_1ead9a48-ec37-44af-8c06-4ce166b53912"
      unitRef="usd">102174000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDktMi0xLTEtMA_f7337deb-df53-46c3-b86b-649a7c6a4b22"
      unitRef="usd">3234000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNDktNC0xLTEtMA_caf43dd5-d562-4110-a21a-2941b5c8c33e"
      unitRef="usd">3234000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNTAtMi0xLTEtMA_86a155e7-2ea3-4efd-989b-f69ea85d10f9"
      unitRef="usd">7000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV8zNC9mcmFnOmNkNWVmN2MwM2MxYjQ4ZmI4ZDg2MWFkMjg3YjYwMTMxL3RhYmxlOjY4ZjMwMmQ5YWQyMzRkNzg4ZGFjZmZjYjkzY2UxYTUzL3RhYmxlcmFuZ2U6NjhmMzAyZDlhZDIzNGQ3ODhkYWNmZmNiOTNjZTFhNTNfNTAtNC0xLTEtMA_2e609343-440a-4af2-b55f-ab462a24e946"
      unitRef="usd">-1795000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80MC9mcmFnOmY3ZTE4N2E3M2EzMDQ1M2ZhY2M1NGY3ZTE4MGQwMzJlL3RleHRyZWdpb246ZjdlMTg3YTczYTMwNDUzZmFjYzU0ZjdlMTgwZDAzMmVfNzgwOA_a3628d46-bddd-418b-8391-6a9993988026">Summary of Significant Accounting Policies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#x201c;Avadel,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; or &#x201c;us&#x201d;) is a biopharmaceutical company. Our lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#x201c;EDS&#x201d;) and cataplexy in adults with narcolepsy. We are primarily focused on the development and potential United States (&#x201c;U.S.&#x201d;) Food and Drug Administration (&#x201c;FDA&#x201d;) approval of FT218. In December 2020, we submitted a New Drug Application (&#x201c;NDA&#x201d;) to the FDA for FT218 to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The NDA for FT218 was accepted by the FDA in February 2021 and assigned a Prescription Drug User Fee Act (&#x201c;PDUFA&#x201d;) target action date of October 15, 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside of our lead product candidate, we continue to evaluate opportunities to expand our product portfolio. As of June 30, 2021, we do not have any approved and commercialized products in our portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are registered as an Irish public limited company. Our headquarters are in Dublin, Ireland and we have operations in St. Louis, Missouri, U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;FT218&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FT218 is a once-nightly formulation of sodium oxybate that uses our Micropump controlled release drug-delivery technology for the treatment of EDS and cataplexy in adults suffering from narcolepsy. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Sodium oxybate is approved in the U.S. for the treatment of EDS and cataplexy in patients with narcolepsy and is approved in Europe for the treatment of cataplexy in patients with narcolepsy. Since 2002, sodium oxybate has only been available as a formulation that must be taken twice nightly, first at bedtime, and then again 2.5 to 4 hours later.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 16, 2020, we announced the submission of our NDA to the FDA for FT218. On February 26, 2021, the FDA notified us of formal acceptance of the NDA with an assigned PDUFA target action date of October 15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We conducted a Phase 3 clinical trial of FT218, the REST-ON trial, which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient, last visit was completed at the end of the first quarter of 2020 and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-nightly FT218, the highest dose administered in the trial, demonstrated a statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test, or MWT, clinical global impression-improvement, or CGI-I, and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g also demonstrated a statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-nightly FT218 to be generally well tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence 3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of FT218 discontinued the trial due to adverse reactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2018, the FDA granted FT218 Orphan Drug Designation, which makes the drug eligible for certain development and commercial incentives, including potential U.S. market exclusivity for up to seven years. Additionally, several FT218-related U.S. patents have been issued, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#x201c;USPTO&#x201d;), as well as foreign patent offices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, we announced that the first patient was dosed initiating an open-label extension (&#x201c;OLE&#x201d;)/switch study of FT218 as a potential treatment for EDS and cataplexy in patients with narcolepsy. The OLE/switch study is examining the long-term safety and maintenance of efficacy of FT218 in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-nightly FT218, regardless of whether they participated in REST-ON. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described FT218 improvements in disturbed nocturnal sleep (&#x201c;DNS&#x201d;), defined in REST-ON as the number of shifts from stages N1, N2, N3, and rapid eye movement (&#x201c;REM&#x201d;) sleep to wake and from stages N2, N3, and REM &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sleep to stage N1.  FT218 also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1.  A second poster described the statistically significant improvements in the Epworth Sleepiness Scale, both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at Week 3, for the lowest 6 g dose, compared to placebo. FT218 did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional data supportive of the efficacy findings in REST-ON were presented at the annual meeting of the 35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 or Type 2. Additionally, a post-hoc analysis showed that FT218 was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Previously Approved FDA Products&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020 (the &#x201c;Closing Date&#x201d;), we announced the sale by Avadel Legacy Pharmaceuticals, LLC (the &#x201c;Avadel Seller&#x201d;) of the portfolio of sterile injectable drugs used in the hospital setting (the &#x201c;Hospital Products&#x201d;), which included our three commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to Exela Sterile Medicines LLC (&#x201c;Exela Buyer&#x201d;) pursuant to an asset purchase agreement (the &#x201c;Purchase Agreement&#x201d;) by and among the Avadel Seller, Avadel US Holdings, Inc., the Exela Buyer and Exela Holdings, Inc. This sale included the following FDA approved products:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Bloxiverz (neostigmine methylsulfate injection)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&#160;Bloxiverz is a drug used intravenously in the operating room to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Vazculep (phenylephrine hydrochloride injection)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&#160;Vazculep is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Akovaz (ephedrine sulfate injection)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Akovaz was the first FDA approved formulation of ephedrine sulfate, an alpha- and beta- adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Nouress (cysteine hydrochloride injection)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Nouress is a sterile injectable product for use in the hospital setting to provide parenteral nutrition to neonates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3: Disposition of the Hospital Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated balance sheet as of June&#160;30, 2021, which is derived from the prior year 2020 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP), the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#x2019;s 2020 Annual Report on Form 10-K filed with the SEC on March 9, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Prior to June 30, 2020, revenue was earned from the sales of pharmaceutical products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of our product, which occurs typically upon receipt by the customer. Our gross product sales were subject to a variety of price adjustments in arriving at &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and were estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a complete discussion of the accounting for net product revenue, see &lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;: Revenue Recognition&lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <avdl:NatureOfBusinessPolicyPolicyTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80MC9mcmFnOmY3ZTE4N2E3M2EzMDQ1M2ZhY2M1NGY3ZTE4MGQwMzJlL3RleHRyZWdpb246ZjdlMTg3YTczYTMwNDUzZmFjYzU0ZjdlMTgwZDAzMmVfNzgxOA_00755f86-d6bb-4964-a408-a4095ab2b7a3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#x201c;Avadel,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; or &#x201c;us&#x201d;) is a biopharmaceutical company. Our lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#x201c;EDS&#x201d;) and cataplexy in adults with narcolepsy. We are primarily focused on the development and potential United States (&#x201c;U.S.&#x201d;) Food and Drug Administration (&#x201c;FDA&#x201d;) approval of FT218. In December 2020, we submitted a New Drug Application (&#x201c;NDA&#x201d;) to the FDA for FT218 to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The NDA for FT218 was accepted by the FDA in February 2021 and assigned a Prescription Drug User Fee Act (&#x201c;PDUFA&#x201d;) target action date of October 15, 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside of our lead product candidate, we continue to evaluate opportunities to expand our product portfolio. As of June 30, 2021, we do not have any approved and commercialized products in our portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are registered as an Irish public limited company. Our headquarters are in Dublin, Ireland and we have operations in St. Louis, Missouri, U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;FT218&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FT218 is a once-nightly formulation of sodium oxybate that uses our Micropump controlled release drug-delivery technology for the treatment of EDS and cataplexy in adults suffering from narcolepsy. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Sodium oxybate is approved in the U.S. for the treatment of EDS and cataplexy in patients with narcolepsy and is approved in Europe for the treatment of cataplexy in patients with narcolepsy. Since 2002, sodium oxybate has only been available as a formulation that must be taken twice nightly, first at bedtime, and then again 2.5 to 4 hours later.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 16, 2020, we announced the submission of our NDA to the FDA for FT218. On February 26, 2021, the FDA notified us of formal acceptance of the NDA with an assigned PDUFA target action date of October 15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We conducted a Phase 3 clinical trial of FT218, the REST-ON trial, which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient, last visit was completed at the end of the first quarter of 2020 and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-nightly FT218, the highest dose administered in the trial, demonstrated a statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test, or MWT, clinical global impression-improvement, or CGI-I, and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g also demonstrated a statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-nightly FT218 to be generally well tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence 3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of FT218 discontinued the trial due to adverse reactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2018, the FDA granted FT218 Orphan Drug Designation, which makes the drug eligible for certain development and commercial incentives, including potential U.S. market exclusivity for up to seven years. Additionally, several FT218-related U.S. patents have been issued, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#x201c;USPTO&#x201d;), as well as foreign patent offices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, we announced that the first patient was dosed initiating an open-label extension (&#x201c;OLE&#x201d;)/switch study of FT218 as a potential treatment for EDS and cataplexy in patients with narcolepsy. The OLE/switch study is examining the long-term safety and maintenance of efficacy of FT218 in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-nightly FT218, regardless of whether they participated in REST-ON. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described FT218 improvements in disturbed nocturnal sleep (&#x201c;DNS&#x201d;), defined in REST-ON as the number of shifts from stages N1, N2, N3, and rapid eye movement (&#x201c;REM&#x201d;) sleep to wake and from stages N2, N3, and REM &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sleep to stage N1.  FT218 also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1.  A second poster described the statistically significant improvements in the Epworth Sleepiness Scale, both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at Week 3, for the lowest 6 g dose, compared to placebo. FT218 did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional data supportive of the efficacy findings in REST-ON were presented at the annual meeting of the 35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 or Type 2. Additionally, a post-hoc analysis showed that FT218 was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Previously Approved FDA Products&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020 (the &#x201c;Closing Date&#x201d;), we announced the sale by Avadel Legacy Pharmaceuticals, LLC (the &#x201c;Avadel Seller&#x201d;) of the portfolio of sterile injectable drugs used in the hospital setting (the &#x201c;Hospital Products&#x201d;), which included our three commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to Exela Sterile Medicines LLC (&#x201c;Exela Buyer&#x201d;) pursuant to an asset purchase agreement (the &#x201c;Purchase Agreement&#x201d;) by and among the Avadel Seller, Avadel US Holdings, Inc., the Exela Buyer and Exela Holdings, Inc. This sale included the following FDA approved products:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Bloxiverz (neostigmine methylsulfate injection)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&#160;Bloxiverz is a drug used intravenously in the operating room to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Vazculep (phenylephrine hydrochloride injection)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&#160;Vazculep is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Akovaz (ephedrine sulfate injection)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Akovaz was the first FDA approved formulation of ephedrine sulfate, an alpha- and beta- adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Nouress (cysteine hydrochloride injection)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Nouress is a sterile injectable product for use in the hospital setting to provide parenteral nutrition to neonates.&lt;/span&gt;&lt;/div&gt;</avdl:NatureOfBusinessPolicyPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80MC9mcmFnOmY3ZTE4N2E3M2EzMDQ1M2ZhY2M1NGY3ZTE4MGQwMzJlL3RleHRyZWdpb246ZjdlMTg3YTczYTMwNDUzZmFjYzU0ZjdlMTgwZDAzMmVfNzgxNQ_843d2071-652d-41e2-a1b5-712499eddac4">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated balance sheet as of June&#160;30, 2021, which is derived from the prior year 2020 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP), the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#x2019;s 2020 Annual Report on Form 10-K filed with the SEC on March 9, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80MC9mcmFnOmY3ZTE4N2E3M2EzMDQ1M2ZhY2M1NGY3ZTE4MGQwMzJlL3RleHRyZWdpb246ZjdlMTg3YTczYTMwNDUzZmFjYzU0ZjdlMTgwZDAzMmVfNzgxNg_125850a7-32a3-42fa-a081-954dd09581d5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Prior to June 30, 2020, revenue was earned from the sales of pharmaceutical products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of our product, which occurs typically upon receipt by the customer. Our gross product sales were subject to a variety of price adjustments in arriving at &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and were estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a complete discussion of the accounting for net product revenue, see &lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;: Revenue Recognition&lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;Revenue Recognition&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, we generated revenue primarily from the sale of pharmaceutical products to customers. On June 30, 2020, we sold the Hospital Products.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3: Disposition of the Hospital Products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Sales &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Revenue from product sales was recognized when the customer obtained control of our product and our performance obligations were met, which occurred typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, our gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserves to Reduce Gross Revenues to Net Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales were recorded at the net selling price, which included estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves were based on the amounts earned or to be claimed on the related sales and were classified as reductions of accounts receivable if the amount is payable to the customer, except in the case of the estimated reserve for future expired product returns, which are classified as a liability. The reserves are classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves take into consideration relevant factors such as the Company&#x2019;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#x2019;s best estimates to reduce gross selling price to net selling price to which it expects to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company&#x2019;s estimates. If actual results in the future vary from the Company&#x2019;s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with industry practice, the Company maintained a returns policy that generally offered customers a right of return for product that has been purchased from the Company. The Company estimated the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue was recognized. The Company estimated product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products &lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and other judgments and analysis. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chargebacks, Discounts and Rebates &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to our wholesale customers. Customers charge the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates are estimated at the time of sale to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s source of revenue was from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company&#x2019;s revenues by product, see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 15: Revenue by Product&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A receivable is recognized in the period the Company sells its products and when the Company&#x2019;s right to consideration is unconditional. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material deferred contract costs at June&#160;30, 2021 or December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction Price Allocated to the Remaining Performance Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For product sales, the Company generally satisfied its performance obligations within the same period the product was delivered. Product sales recognized in the second quarter of 2020 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which the Company recognizes revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMzA4NA_490c49f3-6051-4725-a7d6-d874c21602d7">Newly Issued Accounting Standards&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Guidance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#x2019;s amendments primarily impact ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. We adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on our unaudited condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU is effective for our fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method. &lt;/span&gt;&lt;/div&gt;The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#x2019;s 4.50%&#160;exchangeable senior notes due 2023 (the &#x201c;2023 Notes&#x201d;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $26,699 decrease in additional paid-in capital, a $12,939 increase in long-term debt, and a $13,760 increase to the opening balance of retained earnings.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMzA4Ng_e74ed7e5-94ca-464a-baf4-ac6182763609">Newly Issued Accounting Standards&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Guidance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#x2019;s amendments primarily impact ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. We adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on our unaudited condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU is effective for our fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method. &lt;/span&gt;&lt;/div&gt;The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#x2019;s 4.50%&#160;exchangeable senior notes due 2023 (the &#x201c;2023 Notes&#x201d;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $26,699 decrease in additional paid-in capital, a $12,939 increase in long-term debt, and a $13,760 increase to the opening balance of retained earnings.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i81950a1669ff43e2a55fa3ab8b6bbf14_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMjM0Nw_80b68a74-7118-42db-ab66-9699e2ba2a66"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockholdersEquity
      contextRef="i54a0f1be38254190aa94a522f6ed4974_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMjk0Mw_5d9adcd7-cc00-4f62-8aa7-c83805448ae9"
      unitRef="usd">-26699000</us-gaap:StockholdersEquity>
    <us-gaap:LongTermDebt
      contextRef="if26cf9bd950645da82a913ea028f7f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMjk4OA_f79c04ae-618e-48f8-8b72-99f348601d93"
      unitRef="usd">12939000</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquity
      contextRef="ie70c99023cd04e558a4e840886322480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80My9mcmFnOmRkYjJhNTRlMjdjNTRiNzJiZmVkY2JiZTE0ZGI5MTk0L3RleHRyZWdpb246ZGRiMmE1NGUyN2M1NGI3MmJmZWRjYmJlMTRkYjkxOTRfMzAyNQ_8048fd04-e326-462c-adc1-8744437dffc4"
      unitRef="usd">13760000</us-gaap:StockholdersEquity>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNDAzNg_f1b37d1e-05e1-4047-a673-ac3f31ea480c">Disposition of the Hospital Products &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On the Closing Date, we announced the sale of our Hospital Products to the Exela Buyer pursuant to the Purchase Agreement (the &#x201c;Transaction&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Purchase Agreement, the Exela Buyer agreed to pay a total aggregate consideration amount of $42,000, of which $14,500 was paid on the Closing Date and an additional $27,500 was paid in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzU1_3778c0a2-5225-4d2e-a722-3095fe25bdd7"&gt;ten&lt;/span&gt; equal monthly installments following the Closing Date. During the year ended December 31, 2020, we collected four installment payments, totaling $11,000 and during the six months ended June 30, 2021, we collected the remaining six installment payments, totaling $16,500. In connection with the sale of the Hospital Products, the parties also agreed to cause the dismissal of the pending civil litigation related to Nouress in the District Court for the District of Delaware.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We were party to a Membership Interest Purchase Agreement, dated March 13, 2012, by and among us, Avadel Legacy, Breaking Stick Holdings, LLC, Deerfield Private Design International II, L.P. (&#x201c;Deerfield International&#x201d;), Deerfield Private Design Fund II, L.P. (&#x201c;Deerfield Fund&#x201d;) and Horizon Sant&#xe9; FLML, Sarl (&#x201c;Horizon&#x201d;) (the &#x201c;Deerfield MIPA&#x201d;) and a Royalty Agreement, dated February 4, 2013, by and among us, Avadel Legacy, the Deerfield Fund and Horizon (the &#x201c;Deerfield Royalty Agreement&#x201d;). In connection with the closing of the sale of the Hospital Products, the Deerfield MIPA (with respect to certain sections thereof) and the Royalty Agreement were assigned to the Exela Buyer. Pursuant to the Purchase Agreement, the Exela &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Deerfield Royalty Agreement for obligations that arise after the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We were also party to a Royalty Agreement, dated December 3, 2013, by and between us, Avadel Legacy and Broadfin Healthcare Master Fund, Ltd. (the &#x201c;Broadfin Royalty Agreement&#x201d;). In connection with the closing of the sale of the Hospital Products, the Broadfin Royalty Agreement was assigned to the Exela Buyer and the Exela Buyer assumed and shall pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Broadfin Royalty Agreement for obligations that arise after the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the major classes of assets and liabilities either transferred to the Exela Buyer or eliminated by us due to the sale of the Hospital Products in exchange for aggregate consideration of $42,000, less transaction fees of $2,928. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term contingent consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net liabilities disposed of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less transaction fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net gain on the sale of the Hospital Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluated various qualitative and quantitative factors related to the disposition of the Hospital Products and determined that it did not meet the criteria for presentation as a discontinued operation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The unaudited pro forma condensed combined statement of loss for the six months ended June 30, 2020 included below is being provided for information purposes only and are not necessarily indicative of the results of operations that would have resulted if the Transaction had actually occurred on the date indicated. The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Pro Forma Condensed Combined Statement of Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%"&gt;Adjustments to the pro forma unaudited condensed combined statements of loss&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;This adjustment reflects Product sales attributable to the Hospital Products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;This adjustment reflects the following estimated expenses attributable to the Hospital Products:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Cost of products of $3,540.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Research and development expenses of $407.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Selling, general and administrative expenses of $776.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Intangible asset amortization on acquired development technology for Vazculep of $406. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Changes in fair value of related party contingent consideration of $3,396.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;of $435 attributable to the Hospital Products.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;The Company will no longer be responsible for these payments.&lt;/span&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMjcx_4364a7f8-ce45-4e79-92c2-f97f0fc0720f"
      unitRef="usd">42000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <avdl:DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMjg0_12ed5bb6-6261-43f5-b519-bb76cf88393b"
      unitRef="usd">14500000</avdl:DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration>
    <avdl:DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzM0_ffb9dfe0-3a19-45ce-9d01-488077732040"
      unitRef="usd">27500000</avdl:DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="icfe184fb8a604f6e9f281a0b6b76a459_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNTAz_8f1f8cdc-6af6-4af0-b4d5-1fc12574106a"
      unitRef="usd">11000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ia1494e8ed82d4b2ebf75bbcb4722f663_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNjA2_75e4e16f-f6b8-41b6-b864-b46d63c40963"
      unitRef="usd">16500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNDAzNA_7c42c7c6-562c-4754-877f-430e408fda37">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the major classes of assets and liabilities either transferred to the Exela Buyer or eliminated by us due to the sale of the Hospital Products in exchange for aggregate consideration of $42,000, less transaction fees of $2,928. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term contingent consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net liabilities disposed of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less transaction fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net gain on the sale of the Hospital Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMjQ4MQ_e3277f22-4951-4c79-9173-c472207ec96b"
      unitRef="usd">42000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="icb55d6c3ae02430b9ec0541184cb90e7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMjUxMA_8f037628-c580-4e4c-be27-1382cbc56dce"
      unitRef="usd">2928000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfMS0yLTEtMS0w_2bd8dfa2-bdce-46e1-9ae6-9f57e6f4578b"
      unitRef="usd">134000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfMi0yLTEtMS0w_bdb366e4-e151-457e-a56f-1d07e2a883d4"
      unitRef="usd">4922000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfMy0yLTEtMS0w_b2d15124-15fc-4400-84db-17e8473d13e2"
      unitRef="usd">1654000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfNC0yLTEtMS0w_3330b6c0-42e4-4a4f-a102-7535b9052702"
      unitRef="usd">407000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfNS0yLTEtMS0w_3595644c-7a3e-4859-a70f-99a9fac169f4"
      unitRef="usd">1095000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets>
    <us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfNi0yLTEtMS0w_2128692c-1bb6-4112-be9b-55dffa1007de"
      unitRef="usd">14900000</us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfNy0yLTEtMS0w_db0db7bf-d523-4aeb-bce9-24f80dac0608"
      unitRef="usd">6688000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ic67b5c1a5255452d9ea423ac5afd1c19_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfOC0yLTEtMS0w_c0828299-2f78-4f88-854f-d2410a911ae3"
      unitRef="usd">42000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="icb55d6c3ae02430b9ec0541184cb90e7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfOS0yLTEtMS0w_5f7e308e-8877-46d0-ac51-4dbaa90901b9"
      unitRef="usd">2928000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="icb55d6c3ae02430b9ec0541184cb90e7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOmU4NzhlMmYzMmZlMzQ3MTRiYjQzYmQ0OWY2YmFjNmM3L3RhYmxlcmFuZ2U6ZTg3OGUyZjMyZmUzNDcxNGJiNDNiZDQ5ZjZiYWM2YzdfMTAtMi0xLTEtMA_f6761162-3493-4be4-96f2-6fc3add3ac2c"
      unitRef="usd">45760000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfNDAzNQ_65f2d2d4-a761-4436-95c4-b3f92f9a658b">The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Pro Forma Condensed Combined Statement of Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%"&gt;Adjustments to the pro forma unaudited condensed combined statements of loss&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;This adjustment reflects Product sales attributable to the Hospital Products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;This adjustment reflects the following estimated expenses attributable to the Hospital Products:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Cost of products of $3,540.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Research and development expenses of $407.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Selling, general and administrative expenses of $776.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Intangible asset amortization on acquired development technology for Vazculep of $406. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt"&gt;Changes in fair value of related party contingent consideration of $3,396.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;of $435 attributable to the Hospital Products.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;The Company will no longer be responsible for these payments.&lt;/span&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfNS0yLTEtMS0w_1e8d8184-2195-4114-9a99-4440811f5b9c"
      unitRef="usd">22334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfNS00LTEtMS0w_1a5e8992-05c9-4776-abf6-f3e004302ba2"
      unitRef="usd">-22175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35be439684f94754a722ac71e050ffd4_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfNS04LTEtMS0w_78ec7a09-9d36-4861-8454-1bf69de9a50e"
      unitRef="usd">159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostsAndExpenses
      contextRef="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTYtMi0xLTEtMA_b3b9d937-ae8e-4375-b162-a2d601e9a857"
      unitRef="usd">-11438000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTYtNC0xLTEtMA_d0897d32-aa30-4e67-b642-54a62c1d1ce7"
      unitRef="usd">-8525000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i35be439684f94754a722ac71e050ffd4_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTYtOC0xLTEtMA_c7072429-9916-45e5-94ff-7faa72725bde"
      unitRef="usd">-19963000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTctMi0xLTEtMA_63592d6a-b1d3-4212-9b12-7aba9c348190"
      unitRef="usd">33772000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTctNC0xLTEtMA_68103339-f733-4745-b024-6353b53bf39c"
      unitRef="usd">-13650000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i35be439684f94754a722ac71e050ffd4_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMTctOC0xLTEtMA_fc39e643-b9ca-4f5f-a0b8-d88e8b2227d0"
      unitRef="usd">20122000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i62ff8c7aa0b84b0abd2a7b3583f2866e_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMjMtMi0xLTEtMA_a2792944-9372-4156-8a10-1fc7ef6af3c4"
      unitRef="usd">25791000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia51dfc9b13e04ccc804776fe947f2dc6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMjMtNC0xLTEtMA_9884b422-f627-4b3b-88fe-67b92015191d"
      unitRef="usd">-13215000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i35be439684f94754a722ac71e050ffd4_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RhYmxlOjFjMDQxMTY3M2Q4NjQyMjA5YzcwNWZjYzU0MjI1MWZjL3RhYmxlcmFuZ2U6MWMwNDExNjczZDg2NDIyMDljNzA1ZmNjNTQyMjUxZmNfMjMtOC0xLTEtMA_f47bb610-6f91-4a5e-bc05-37c72b830b4f"
      unitRef="usd">12576000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzQ3MQ_9a721d0d-7987-43e1-8bc2-47d211b0e149"
      unitRef="usd">3540000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzUxMg_fc34749b-52a4-4114-8a98-bebf7cd650fd"
      unitRef="usd">407000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzU2NA_68dc3cbd-f883-49e3-8e7a-207f74dc1865"
      unitRef="usd">776000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzY0OQ_2006b82f-a339-4afb-a9c6-47cb45f3516d"
      unitRef="usd">406000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzcyMQ_1423b6c4-09e2-41bd-b3ce-083270153fda"
      unitRef="usd">3396000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4cd000c8b6964065a504a408890f9369_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzkzMA_b59b56a6-1758-4c56-8b0a-9b241cc3268f"
      unitRef="usd">-435000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80OS9mcmFnOjljZjYxMTA2MDI1ZDQwNGM4MjBmZDljMDJkOTEzY2E2L3RleHRyZWdpb246OWNmNjExMDYwMjVkNDA0YzgyMGZkOWMwMmQ5MTNjYTZfNTQxOA_851a9825-31e5-4668-8b04-1659f60cec40">Revenue Recognition&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, we generated revenue primarily from the sale of pharmaceutical products to customers. On June 30, 2020, we sold the Hospital Products.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3: Disposition of the Hospital Products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Sales &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Revenue from product sales was recognized when the customer obtained control of our product and our performance obligations were met, which occurred typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, our gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserves to Reduce Gross Revenues to Net Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales were recorded at the net selling price, which included estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves were based on the amounts earned or to be claimed on the related sales and were classified as reductions of accounts receivable if the amount is payable to the customer, except in the case of the estimated reserve for future expired product returns, which are classified as a liability. The reserves are classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves take into consideration relevant factors such as the Company&#x2019;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#x2019;s best estimates to reduce gross selling price to net selling price to which it expects to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company&#x2019;s estimates. If actual results in the future vary from the Company&#x2019;s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with industry practice, the Company maintained a returns policy that generally offered customers a right of return for product that has been purchased from the Company. The Company estimated the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue was recognized. The Company estimated product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products &lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and other judgments and analysis. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chargebacks, Discounts and Rebates &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to our wholesale customers. Customers charge the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates are estimated at the time of sale to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s source of revenue was from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company&#x2019;s revenues by product, see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 15: Revenue by Product&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A receivable is recognized in the period the Company sells its products and when the Company&#x2019;s right to consideration is unconditional. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material deferred contract costs at June&#160;30, 2021 or December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction Price Allocated to the Remaining Performance Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For product sales, the Company generally satisfied its performance obligations within the same period the product was delivered. Product sales recognized in the second quarter of 2020 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which the Company recognizes revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:CapitalizedContractCostNet
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80OS9mcmFnOjljZjYxMTA2MDI1ZDQwNGM4MjBmZDljMDJkOTEzY2E2L3RleHRyZWdpb246OWNmNjExMDYwMjVkNDA0YzgyMGZkOWMwMmQ5MTNjYTZfNDUxNA_48458935-e936-469d-960c-4a204ebd55d5"
      unitRef="usd">0</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80OS9mcmFnOjljZjYxMTA2MDI1ZDQwNGM4MjBmZDljMDJkOTEzY2E2L3RleHRyZWdpb246OWNmNjExMDYwMjVkNDA0YzgyMGZkOWMwMmQ5MTNjYTZfNDUxNA_558a840d-132e-42e9-9db0-b1c936eb1f88"
      unitRef="usd">0</us-gaap:CapitalizedContractCostNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RleHRyZWdpb246MmZhZjQyMmNmYjgzNDE1NGJhODA1NzlhZGIwOWYyOTVfMzQ5MQ_cbc2969a-7869-4a40-ba23-7adc4f33613d">Fair Value Measurement&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting.  For example, we use fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d;&#160;defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, we may generally use one or each of the following techniques: &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Income approach, which is based on the present value of a future stream of net cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 - Quoted prices for identical assets or liabilities in active markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 - Unobservable inputs that reflect estimates and assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160; Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities.  During the periods ended June&#160;30, 2021 and December&#160;31, 2020, respectively, there were no transfers in and out of&#160;Level&#160;1, 2, or 3.  During the&#160;three and six months ended June&#160;30, 2021 and 2020, respectively, we did not recognize any other-than-temporary impairment loss. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s financial instruments, such as cash and cash equivalents, accounts receivable and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of our $143,750&#160;aggregate principal amount of&#160;the 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input).  The estimated fair value of the 2023 Notes at June&#160;30, 2021 is $147,523.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9: Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding our debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RleHRyZWdpb246MmZhZjQyMmNmYjgzNDE1NGJhODA1NzlhZGIwOWYyOTVfMzQ5Nw_49c61cd6-7263-4518-b1fd-a77bf2782a2f">&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9d6fa5ebeb65455e950a6328bba21698_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS0yLTEtMS0w_4c759559-0515-4c63-90dc-db32d8a6880f"
      unitRef="usd">91732000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i519f8147d1374176b85b3cdcff0e8382_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS00LTEtMS0w_e54cc102-75d9-42e2-8c59-f653bf35e9b3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i900add1be5b84828adfa900933a618f3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS02LTEtMS0w_48525c21-4565-4f13-a58c-b4b2ffb08a46"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i87edd5f150b248eebd16c398e3be78c6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS04LTEtMS0w_80b62232-2182-4b52-adad-e1f1d7a42687"
      unitRef="usd">104672000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7ee580d62d1d4006b9c4ee3195b16fe2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS0xMC0xLTEtMA_38ff91bb-a506-4836-9404-64a2de315297"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5483582b0b7743da9ffaa6daeddee5c8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNS0xMi0xLTEtMA_dec23551-388b-4473-9e60-54a6ef9ac5c8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i13d7d68555c549268d32a550db3aa3a8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi0yLTEtMS0w_43f30ce0-c1a9-4f3d-9579-0668456fa741"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2312d5c712024cd18f05cfc64afe708c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi00LTEtMS0w_47c63840-bda8-4c88-9327-1315e6d2632b"
      unitRef="usd">23056000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f20ec5b3421400ab560dc49247ce3d5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi02LTEtMS0w_3e274bb2-5dbe-4bd3-959e-95ef7f4ffe7c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if1374539a6c0453996dd609930013a2c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi04LTEtMS0w_4665d895-f8e5-4338-acc8-795818856d3e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib5900644d8ce46379de39a2d0857e260_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi0xMC0xLTEtMA_d3170b4e-5e37-418a-acfd-02dfcb84fab3"
      unitRef="usd">22155000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f54424e7f4147e3abfa224100f76762_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNi0xMi0xLTEtMA_9c4c883b-eec8-4300-8777-41b0d49cf08d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i391dd5fd75e44b6bb689e468e2f6998b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy0yLTEtMS0w_fe4f90f8-28e3-4317-99b4-00561906e0fa"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaa665aface774b5cba45e448c5017ef5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy00LTEtMS0w_a11e255c-da3a-4515-bb80-5243a44e4230"
      unitRef="usd">17853000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if495a6914a2043078c2ff45ec8e8cd94_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy02LTEtMS0w_ad87d7d1-d8d8-4701-81c4-af8b14a461ba"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i819166dd8aad49adb09355ff41111edc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy04LTEtMS0w_d9066c07-f0d5-456b-b24b-e3a7848e01f4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7ff9730b64194e44b1624fd8387ff601_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy0xMC0xLTEtMA_0a3d1059-99d3-44fb-a655-7d251009ce63"
      unitRef="usd">18999000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic787b137f02c471ab5fb441de2ccb356_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfNy0xMi0xLTEtMA_bb5f5840-ec1c-4ef2-ab53-24bfb573cab2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7de1d5ad40c44bcc9def111356353120_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS0yLTEtMS0w_ad74e788-299d-4e17-91cd-62e66298fa96"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i426f38d83a8549b6ac924b573fcd11f7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS00LTEtMS0w_d59fa4fa-bc42-4a81-9587-8b094df9bbb9"
      unitRef="usd">3060000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i184178aa288147edb42ff605f41c2388_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS02LTEtMS0w_38632875-e510-42d8-b1f3-96251ec64051"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia3d99af014d24c818d1dc4b69ee59196_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS04LTEtMS0w_cad5fd73-1cf4-4e30-b9a3-7029aa586d3f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia1d78585c18940df8a7e1e5478ef6cb2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS0xMC0xLTEtMA_aad0a040-d1f8-406c-9a61-545975a8e8e9"
      unitRef="usd">3854000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7c3eac9312e543b5af4e5ec8d59fbec0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfOS0xMi0xLTEtMA_0a0d93a4-abcc-44f3-9c8d-1127d588410a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i860be6580c44499c8b2bbc5d5a7e3a36_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtMi0xLTEtMA_1b9c3181-cf54-41ef-8cac-b7aab6b09da4"
      unitRef="usd">91732000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i224fa48116ff4bd6a9842fded9a71fdb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtNC0xLTEtMA_bd04987b-75db-469f-be49-2b15de3e871c"
      unitRef="usd">43969000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i43f54881920b4af98a41727d8004594f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtNi0xLTEtMA_9fb16e51-df4a-4648-8f28-7e5470f7c4b3"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ide1938867c944920ae7b3cff817479c8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtOC0xLTEtMA_26844e3b-459b-439e-b6b1-c22089f59102"
      unitRef="usd">104672000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5be2c3dab5b048debcaabab64882d9e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtMTAtMS0xLTA_f641fe6f-e5b7-43a4-a71b-d2b11d7eb1ed"
      unitRef="usd">45008000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1c8795b315d846338c877c8df1d32455_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RhYmxlOjM0ZDYwNTIwYjk4NjQ4ZGQ5NzljMDkwMzk2MjI1MWJkL3RhYmxlcmFuZ2U6MzRkNjA1MjBiOTg2NDhkZDk3OWMwOTAzOTYyMjUxYmRfMTEtMTItMS0xLTA_05c02892-e754-483e-882c-5948cf892018"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i65d25b85bcaa41adb6ed552acf50363b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RleHRyZWdpb246MmZhZjQyMmNmYjgzNDE1NGJhODA1NzlhZGIwOWYyOTVfMzA3Nw_65269b0a-a81e-4cb2-8b95-3e33788284aa"
      unitRef="usd">143750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtFairValue
      contextRef="i65d25b85bcaa41adb6ed552acf50363b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81Mi9mcmFnOjJmYWY0MjJjZmI4MzQxNTRiYTgwNTc5YWRiMDlmMjk1L3RleHRyZWdpb246MmZhZjQyMmNmYjgzNDE1NGJhODA1NzlhZGIwOWYyOTVfMzQxMQ_34b7b2f6-dbd1-4582-8b0b-64a810943e76"
      unitRef="usd">147523000</us-gaap:LongTermDebtFairValue>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMjI5MA_df2e78ed-012f-4fe2-8fa3-b1803d6c249f">Marketable Securities&#160;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in available-for-sale debt securities which are recorded at fair market value.  The change in the fair value of equity investments is recognized in our unaudited condensed consolidated statements of (loss) income and the change in the fair value of available-for-sale debt investments is recorded as other comprehensive loss in shareholders&#x2019; equity, net of income tax effects.  As of June&#160;30, 2021, we considered any decreases in fair value on our marketable securities to be driven by factors other than credit risk, including market risk.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s available-for-sale securities&#x2019; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;June&#160;30, 2021 and December&#160;31, 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine realized gains or losses on the sale of marketable securities on a specific identification method. We reflect these gains and losses as a component of investment and other income (expense), net in the accompanying unaudited condensed consolidated statements of (loss) income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized gross realized gains of&#160;$41 and $14 for the&#160;three months ended June&#160;30, 2021 and 2020, respectively. These realized gains were offset by realized losses of $39 and $6&#160;for the three months ended June&#160;30, 2021 and 2020, respectively. We recognized gross realized gains of $52 and $290 for the six months ended June&#160;30, 2021 and 2020, respectively. These realized gains were offset by realized losses of $107 and $878 for the six months ended June&#160;30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of our investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of June&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Debt Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 1 Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1-5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5-10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have classified our investment in available-for-sale marketable debt securities as current assets in the unaudited condensed consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in our investment portfolio. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross unrealized losses of our available-for-sale debt securities at June&#160;30, 2021 were immaterial. The unrealized losses are driven by factors other than credit risk and have been in an unrealized loss position for less than one year. We do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMjMwMQ_8bc2afe6-0115-480a-bb6f-e9a409348ec4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s available-for-sale securities&#x2019; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;June&#160;30, 2021 and December&#160;31, 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNC0yLTEtMS0w_724f3d64-5578-41c6-b68e-83e2c3acf482"
      unitRef="usd">90907000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNC00LTEtMS0w_93897d36-4ddb-43b3-8288-101d72bd95e2"
      unitRef="usd">1171000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNC02LTEtMS0w_935e04ac-109e-44cb-b893-ebe0c3615b27"
      unitRef="usd">346000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if6e2bc10cca44d0b9a26fdba1caf34ec_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNC04LTEtMS0w_c2c8512d-52db-4d22-b0c3-6b068dbbb98a"
      unitRef="usd">91732000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic7ff608828844c6798870117de00d1e1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNS0yLTEtMS0w_0a5a039e-ab8b-4297-9fec-76196d583d8c"
      unitRef="usd">22853000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic7ff608828844c6798870117de00d1e1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNS00LTEtMS0w_8e08305b-4567-4862-ae18-2537160da970"
      unitRef="usd">224000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic7ff608828844c6798870117de00d1e1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNS02LTEtMS0w_b56dcbe1-4cf5-441c-8b6e-011292acf51f"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic7ff608828844c6798870117de00d1e1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNS04LTEtMS0w_2d3a91b3-993f-4480-a9f7-5b446c6f41eb"
      unitRef="usd">23056000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i90450500044d427f8c232f666584b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNi0yLTEtMS0w_c3875316-479b-40ba-a4ad-0c97050c4ba1"
      unitRef="usd">17873000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i90450500044d427f8c232f666584b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNi00LTEtMS0w_167dfcae-f5d2-4fb8-9be0-7e513b65ff96"
      unitRef="usd">78000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i90450500044d427f8c232f666584b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNi02LTEtMS0w_567fb708-1f7f-4c59-a8ba-cfa198560905"
      unitRef="usd">98000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i90450500044d427f8c232f666584b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfNi04LTEtMS0w_e4cdeb45-b61d-44c0-a5a2-b4cbf0770ad0"
      unitRef="usd">17853000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOC0yLTEtMS0w_a5f10fde-fbd2-4c5b-8de1-acda97a9bef2"
      unitRef="usd">3055000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOC00LTEtMS0w_6606bf82-2dc4-4654-bf13-45c31d9ad26b"
      unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOC02LTEtMS0w_64bfe77b-4234-4410-b3e9-c5c6d6997141"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOC04LTEtMS0w_3c6590db-c0f0-4967-96ac-f5ca2fc87f3e"
      unitRef="usd">3060000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOS0yLTEtMS0w_017e12d0-4386-4a7c-89fb-319208702179"
      unitRef="usd">134688000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOS00LTEtMS0w_61ade294-b617-4669-8785-eacaae529cd5"
      unitRef="usd">1486000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOS02LTEtMS0w_624e5075-37b0-45dc-b987-d6ca7b076aa5"
      unitRef="usd">473000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOjIyZjZiYjVhZTA5ODQ2NTM4ZWRjMTU1MGY1OTdiY2E4L3RhYmxlcmFuZ2U6MjJmNmJiNWFlMDk4NDY1MzhlZGMxNTUwZjU5N2JjYThfOS04LTEtMS0w_bfa3c46a-304d-434a-baa2-1f8ee6fe630b"
      unitRef="usd">135701000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNC0yLTEtMS0w_abb6ffb3-aacc-4d65-931f-54ec65dac9c2"
      unitRef="usd">103404000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNC00LTEtMS0w_aae43dc8-dbb9-45c2-b4ed-c67593436558"
      unitRef="usd">1288000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNC02LTEtMS0w_db3c1416-fd0c-4c83-810f-e8d7b9e1bda4"
      unitRef="usd">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia8cc19b9e6344cee8b053b6c9713ee66_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNC04LTEtMS0w_6e7e57ad-cd61-4592-a35e-ac8572378324"
      unitRef="usd">104672000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNS0yLTEtMS0w_a4a0372c-a870-496f-9927-afa4d7bf9903"
      unitRef="usd">21811000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNS00LTEtMS0w_21774f1b-ca78-4cc1-a0ab-f58ae5a05842"
      unitRef="usd">350000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNS02LTEtMS0w_635f688b-d70e-4acb-b1be-bd8d2056417d"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8b044e7ef3cf42a5b7b6b9ad165c2b1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNS04LTEtMS0w_dc266894-d2ba-40a5-b69d-a51cf5ac5e3f"
      unitRef="usd">22155000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i629580901ade4561aeb0685c65e22554_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNi0yLTEtMS0w_f13fc8d5-3566-44e2-8abb-7d1a819485f0"
      unitRef="usd">18849000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i629580901ade4561aeb0685c65e22554_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNi00LTEtMS0w_e92304d6-847b-4444-99b9-4f0f299c1df5"
      unitRef="usd">155000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i629580901ade4561aeb0685c65e22554_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNi02LTEtMS0w_05527cb1-21ac-4ddf-a80d-db77e7bd68e4"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i629580901ade4561aeb0685c65e22554_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNi04LTEtMS0w_4ea3a195-2b6c-491c-b242-36b6f52656f9"
      unitRef="usd">18999000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNy0yLTEtMS0w_4df89f0b-882d-41db-b515-c5bdcdc153e2"
      unitRef="usd">3839000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNy00LTEtMS0w_756fc5b7-5c82-4c36-9f2a-157fb669610d"
      unitRef="usd">22000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNy02LTEtMS0w_23e664ac-0121-4def-8ca0-122bf74afc7e"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ac8e60e4eb8424fb315c82c4aa881b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfNy04LTEtMS0w_51c23ce2-cb80-4272-9921-9fcf6bfbd1c9"
      unitRef="usd">3854000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfOC0yLTEtMS0w_975144ca-56db-4dab-a3b0-e87dbcec3175"
      unitRef="usd">147903000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfOC00LTEtMS0w_7819c700-0bc5-4cea-a0e9-72d7e21d4133"
      unitRef="usd">1815000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfOC02LTEtMS0w_94457347-7ceb-41c8-93ec-ebf71372215b"
      unitRef="usd">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmFhNzdmMTY4YWM3NzQxYzY4ODc2YTY3ZmFmOTFhODQxL3RhYmxlcmFuZ2U6YWE3N2YxNjhhYzc3NDFjNjg4NzZhNjdmYWY5MWE4NDFfOC04LTEtMS0w_22a57c50-8085-48a4-9c87-8ec705b16503"
      unitRef="usd">149680000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTEyNQ_33c9346d-2de0-476e-8375-5dc195911d2d"
      unitRef="usd">41000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTEzMg_a25add34-2b7b-4d61-8d51-f9aa6ad3f5eb"
      unitRef="usd">14000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTI0Mg_df946c8d-0b9c-415c-980e-32e4f1c2805f"
      unitRef="usd">39000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTI0OQ_36cfabf6-c536-454a-87db-5ebc3baa665b"
      unitRef="usd">6000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTA5OTUxMTYzMDc0Mw_a26bcf76-5c8d-4f56-ad53-7a7a3e1a5954"
      unitRef="usd">52000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTA5OTUxMTYzMDc1MQ_c07eb8af-6ca2-4d3a-8a10-5825095fc8d8"
      unitRef="usd">290000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTA5OTUxMTYzMDc4Mg_bc3ad53f-231f-4620-8444-a0c6d5a737b0"
      unitRef="usd">107000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMTA5OTUxMTYzMDc5MA_e5458e58-6508-43a5-a773-d9418e5bc175"
      unitRef="usd">878000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RleHRyZWdpb246M2JiOGM3NjcxZTRlNGVmNDkwZDllMzBjNjZhZWY4ZGVfMjMwMw_4e9e0216-69c9-443c-bec0-5f2c3e9f8ce5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of our investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of June&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Debt Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 1 Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1-5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5-10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ic7ff608828844c6798870117de00d1e1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy0yLTEtMS0w_4a6c8e1f-9109-4580-a4d9-99750268f925"
      unitRef="usd">7563000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ic7ff608828844c6798870117de00d1e1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy00LTEtMS0w_dfddc4e8-0205-4d3d-8692-fe72928be247"
      unitRef="usd">15406000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="ic7ff608828844c6798870117de00d1e1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy02LTEtMS0w_a85b4cdf-1fa9-49f2-990f-d85065bad1a2"
      unitRef="usd">87000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="ic7ff608828844c6798870117de00d1e1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy04LTEtMS0w_d34433be-ce51-4fd5-a5bf-3d99e91b3f26"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic7ff608828844c6798870117de00d1e1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfMy0xMC0xLTEtMA_2d3a91b3-993f-4480-a9f7-5b446c6f41eb"
      unitRef="usd">23056000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i90450500044d427f8c232f666584b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC0yLTEtMS0w_b7191221-b1ed-42ab-aab6-d080e203de2f"
      unitRef="usd">4399000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i90450500044d427f8c232f666584b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC00LTEtMS0w_5f05ef43-853f-4c3e-b823-8d60ae6a7e80"
      unitRef="usd">10889000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i90450500044d427f8c232f666584b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC02LTEtMS0w_1e9679ca-4780-44d8-b6c4-9dd75f725a48"
      unitRef="usd">881000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i90450500044d427f8c232f666584b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC04LTEtMS0w_a2c91661-6bf2-4a1e-ad2e-8f1ea787fe45"
      unitRef="usd">1684000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i90450500044d427f8c232f666584b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNC0xMC0xLTEtMA_e4cdeb45-b61d-44c0-a5a2-b4cbf0770ad0"
      unitRef="usd">17853000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi0yLTEtMS0w_8ea63b26-bb5f-41a1-b318-81045fcdd595"
      unitRef="usd">1003000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi00LTEtMS0w_00841b4a-ca8a-48a9-a7bc-e3fa5863901c"
      unitRef="usd">1352000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi02LTEtMS0w_bf92abee-8955-4146-9dd0-9efae183906c"
      unitRef="usd">705000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi04LTEtMS0w_eef94aec-b091-4ccf-b7a7-cf3f2db5c767"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5797f9c7a7484005bbcaaea47685589d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNi0xMC0xLTEtMA_3c6590db-c0f0-4967-96ac-f5ca2fc87f3e"
      unitRef="usd">3060000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy0yLTEtMS0w_97145710-1f09-49a2-aea0-10728f25522e"
      unitRef="usd">12965000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy00LTEtMS0w_2e8575c3-6361-492c-8623-fb4bb9e037b1"
      unitRef="usd">27647000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy02LTEtMS0w_357a85f1-4789-4567-8d7f-62d65c729456"
      unitRef="usd">1673000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy04LTEtMS0w_65351f95-167a-4646-a8a3-42b5020d4c88"
      unitRef="usd">1684000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2de09fff9f5749cf8cf6cd62cdf54ae1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81NS9mcmFnOjNiYjhjNzY3MWU0ZTRlZjQ5MGQ5ZTMwYzY2YWVmOGRlL3RhYmxlOmZkY2RiMTM3NDcxMTRlYWY4OTBlNzlhYTVjMTc3ZWVhL3RhYmxlcmFuZ2U6ZmRjZGIxMzc0NzExNGVhZjg5MGU3OWFhNWMxNzdlZWFfNy0xMC0xLTEtMA_acf55a31-e705-48e1-8129-d0143b484a64"
      unitRef="usd">43969000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfNDM5_1fbef432-7d78-4f46-b291-a962dc30a65d">Goodwill and Intangible Assets&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unamortizable goodwill is $16,836 at June&#160;30, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded amortization expense related to an amortizable intangible asset that was assumed by the Exela Buyer as part of the disposition of the Hospital Products on June 30, 2020 of $203 and $406 for the three and six months ended June 30, 2020.  Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3: Disposition of the Hospital Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  There was no amortization expense recorded during the three and six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfNjQ_18ec4687-ca68-4559-a2d8-5e10e99faf7a"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfNjQ_e7373123-57c1-4a2d-a2f4-2bd8d42124c0"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfMTA5OTUxMTYyODI5MQ_44fa1388-2c16-44c7-b0e3-e7e157e17204"
      unitRef="usd">203000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfMjc1_dde49888-f1f0-4987-9bbe-188682b45e83"
      unitRef="usd">406000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfMzUw_5fc2e288-b4b6-407b-b8bc-ed3194e4057e"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV81OC9mcmFnOmNlMDBmYzhkODdlZDQ4MmM5YTYyYWRlNGZjNDMzYmM2L3RleHRyZWdpb246Y2UwMGZjOGQ4N2VkNDgyYzlhNjJhZGU0ZmM0MzNiYzZfMzUw_c8371743-1d73-4cb6-8195-4e33ed4d8599"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RleHRyZWdpb246OGNjYWZmNjI0ZGVjNDFkZDkyYTcxN2Y4NzJkZDNlMThfMTM5Ng_59f62aa2-b98f-485e-bac9-4a1d6954f848">Contingent Consideration Payable&#160;Prior to the sale of the Hospital Products on June 30, 2020, we computed the fair value of the contingent consideration using several significant assumptions and when those assumptions changed, due to underlying market conditions, the fair value of these liabilities changed as well. Each of the underlying assumptions used to determine the fair values of these contingent liabilities could, and often did, change based on adjustments in current market conditions, competition and other factors. Prior to the sale of the Hospital Products, these changes had a material impact on our unaudited condensed consolidated statements of (loss) income and balance sheets. As part of the sale of the Hospital Products on June 30, 2020, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy and the Company under the Deerfield Royalty Agreement. As of June&#160;30, 2021 and December 31, 2020, the balance of the contingent consideration payable is $0. &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes to the contingent consideration payable, a recurring Level 3 measurement, for the six-month period ended&#160;June 30,&#160;2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Payable Rollforward:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Disposition of the Hospital Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the unaudited condensed consolidated statements of (loss) income.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RleHRyZWdpb246OGNjYWZmNjI0ZGVjNDFkZDkyYTcxN2Y4NzJkZDNlMThfOTkw_4d1f75c5-d506-4937-bf47-2ea337b6113d"
      unitRef="usd">0</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RleHRyZWdpb246OGNjYWZmNjI0ZGVjNDFkZDkyYTcxN2Y4NzJkZDNlMThfOTkw_f78a345b-5c6c-4ba9-8375-1e5372c34d7a"
      unitRef="usd">0</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RleHRyZWdpb246OGNjYWZmNjI0ZGVjNDFkZDkyYTcxN2Y4NzJkZDNlMThfMTM5NQ_a0c233d6-9beb-4661-97f6-7bb18638936f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes to the contingent consideration payable, a recurring Level 3 measurement, for the six-month period ended&#160;June 30,&#160;2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Payable Rollforward:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Disposition of the Hospital Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the unaudited condensed consolidated statements of (loss) income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="i398b06c595444f7caeaba916451c29fa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfMi0yLTEtMS0w_bb0979e2-b85f-4874-9542-2efb98b2db62"
      unitRef="usd">17327000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfMy0yLTEtMS0w_cf5bd4b7-2e03-4f65-a51b-62b0efc6b16a"
      unitRef="usd">4344000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfNC0yLTEtMS0w_912c4e0e-308b-4495-a405-47096f746173"
      unitRef="usd">3831000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfNS0yLTEtMS0xMTI0_5ea8b18b-e214-4645-b102-9e76f673462d"
      unitRef="usd">14900000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="i2b18f9096c56478ba558603f0009c83f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82MS9mcmFnOjhjY2FmZjYyNGRlYzQxZGQ5MmE3MTdmODcyZGQzZTE4L3RhYmxlOjA3ZDEyZWI0YTBiMDQwM2NiNDc0NTdlNjQwZTlhOTk0L3RhYmxlcmFuZ2U6MDdkMTJlYjRhMGIwNDAzY2I0NzQ1N2U2NDBlOWE5OTRfNS0yLTEtMS0w_33325813-6378-428b-9d69-51c35935b61f"
      unitRef="usd">1914000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNjIzOA_68b1d2ef-f518-476b-ba6a-36262eea46ce">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount and issuance costs, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount of liability component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component of exchangeable notes, net of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended June&#160;30, 2021 and 2020, the total interest expense was $1,930 and $3,237, respectively, with coupon interest expense of $1,617 for each period and the amortization of debt issuance costs and debt discount of $313 and $1,620, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June&#160;30, 2021 and 2020, the total interest expense was $3,859 and $6,427, respectively, with coupon interest expense of $3,234 for each period and the amortization of debt issuance costs and debt discount of $625 and $3,193, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 2: Newly Issued Accounting Standards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The adoption resulted in a $12,939 increase in long-term debt and a $26,699 decrease in the equity component of the 2023 Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 16, 2018, Avadel Finance Cayman Limited, a Cayman Islands exempted company (the &#x201c;Issuer&#x201d;) and an indirect wholly-owned subsidiary of the Company, issued $125,000 aggregate principal amount of 4.50% exchangeable senior notes due 2023 (the &#x201c;2023 Notes&#x201d;) in a private placement (the &#x201c;Offering&#x201d;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the 2023 Notes a 30-day option to purchase up to an additional $18,750 aggregate principal amount of the 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts of $6,190, were approximately $137,560.  The 2023 Notes are the Company&#x2019;s senior unsecured obligations and rank equally in right of payment with all of the Company&#x2019;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#x2019;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2023 Notes will be exchangeable at the option of the holders at an initial exchange rate of 92.6956 ADSs per $1 principal amount of 2023 Notes, which is equivalent to an initial exchange price of approximately $10.79 per ADS. Such initial exchange price represents a premium of approximately 20% to the $8.99 per ADS closing price on The Nasdaq Global Market on February 13, 2018.  Upon the exchange of any 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#x2019;s election. Holders of the 2023 Notes may convert their 2023 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;preceding August 1, 2022, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after August 1, 2022 and prior to the close of business on the business day immediately preceding the maturity date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE1OA_ebaf9a35-35f7-46d5-9322-eec1885aa043"&gt;five&lt;/span&gt; business day period immediately after any &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE3Mw_2f9ed925-ca6a-4374-8047-4f204d21b861"&gt;five&lt;/span&gt; consecutive trading day period (the &#x201c;Measurement Period&#x201d;) in which the trading price per $1 principal amount of 2023 Notes, as determined following a request by a holder of the 2023 Notes, for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the ADSs and the exchange rate on each such trading day.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;If a transaction or event that constitutes a fundamental change or a make-whole fundamental change occurs prior to the close of business on the business day immediately preceding August 1, 2022, regardless of whether a holder of the 2023 Notes has the right to require the Company to repurchase the 2023 Notes, or if Avadel is a party to a merger event that occurs prior to the close of business on the business day immediately preceding August 1, 2022, all or any portion of a the holder&#x2019;s 2023 Notes may be surrendered for exchange at any time from or after the date that is 95 scheduled trading days prior to the anticipated effective date of the transaction (or, if later, the earlier of (x) the business day after the Company gives notice of such transaction and (y) the actual effective date of such transaction) until 35 trading days after the actual effective date of such transaction or, if such transaction also constitutes a fundamental change, until the related fundamental change repurchase date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during any calendar quarter commencing after the calendar quarter ending on June 30, 2018 (and only during such calendar quarter), if the last reported sale price of the ADSs for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the exchange price on each applicable trading day. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;If the Company calls the 2023 Notes for redemption pursuant to Article 16 to the Indenture prior to the close of business on the business day immediately preceding August 1, 2022, then a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time prior to the close of business on the second business day prior to the redemption date, even if the 2023 Notes are not otherwise exchangeable at such time. After that time, the right to exchange shall expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the 2023 Notes may exchange its 2023 Notes until the redemption price has been paid or duly provided for.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We considered the guidance in ASC 815-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Embedded Derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. We determined that this exception applies due, in part, to our ability to settle the 2023 Notes in cash, ADSs or a combination of cash and ADSs, at our option. We have therefore applied the guidance provided by ASC 470-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options&lt;/span&gt;, as amended by ASU 2020-06.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNjI0MQ_9fbf882b-58bc-4d6f-acd4-204b270da274">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount and issuance costs, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount of liability component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component of exchangeable notes, net of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i81950a1669ff43e2a55fa3ab8b6bbf14_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMS0wLTEtMS0wL3RleHRyZWdpb246NDkyNzJhMTdkNzZiNGM0NGI2YjY3NjU1ZTFmNjIyNmNfMjQ_39f00b79-213a-4626-ac31-4d819ce05df0"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i65d25b85bcaa41adb6ed552acf50363b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMS0wLTEtMS0wL3RleHRyZWdpb246NDkyNzJhMTdkNzZiNGM0NGI2YjY3NjU1ZTFmNjIyNmNfMjQ_a3dee637-b1f2-4cac-a78c-9f86872ded21"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i65d25b85bcaa41adb6ed552acf50363b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMS0yLTEtMS0w_65269b0a-a81e-4cb2-8b95-3e33788284aa"
      unitRef="usd">143750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i81950a1669ff43e2a55fa3ab8b6bbf14_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMS00LTEtMS0w_12376bdb-6eb2-4943-9f8b-c6813ec5bc36"
      unitRef="usd">143750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i3ac2b9e70ab04d8db284fd554dcbf2da_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMi0yLTEtMS0w_6358327a-cf7e-4e70-8615-44123bdace8a"
      unitRef="usd">1976000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i62b61fe78c654a8eabbae48f28674623_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMi00LTEtMS0w_171a07db-5c44-4cfa-a6f2-0f85e818aaa1"
      unitRef="usd">15540000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i3ac2b9e70ab04d8db284fd554dcbf2da_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMy0yLTEtMS0w_01490038-f5c3-40d6-b8c5-3a45e834aaa2"
      unitRef="usd">141774000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i62b61fe78c654a8eabbae48f28674623_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMy00LTEtMS0w_87b49634-fa54-4eb5-8d05-424fc0b369f4"
      unitRef="usd">128210000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfNi0yLTEtMS0w_e01781bc-0cd3-47c8-ba87-80d924cb0fa4"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfNi00LTEtMS0w_09c03ea9-f3a5-4126-a69a-65933bae8f25"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfNy0yLTEtMS0w_dbcafda8-d3b2-4247-9aee-50dbf050672b"
      unitRef="usd">141774000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfNy00LTEtMS0w_7f8b08f6-9f86-4edb-ba0d-d5a201288868"
      unitRef="usd">128210000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i3ac2b9e70ab04d8db284fd554dcbf2da_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMTAtMi0xLTEtMA_4c9e6a9d-d76f-4645-8b1d-00f8ff0afdbd"
      unitRef="usd">0</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i62b61fe78c654a8eabbae48f28674623_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RhYmxlOmU5NWM1ODQ2ZjdlZjRkZDQ5ZDMxZWMxNmU4ZTRhNDdjL3RhYmxlcmFuZ2U6ZTk1YzU4NDZmN2VmNGRkNDlkMzFlYzE2ZThlNGE0N2NfMTAtNC0xLTEtMA_f61ad4eb-b5f1-48bb-b220-0592486fe552"
      unitRef="usd">26699000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:InterestExpenseDebt
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjMzMQ_caf60f3b-0127-458d-953a-1bdb2220b0c5"
      unitRef="usd">1930000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM0MQ_b9d6d4b3-278f-4df0-a828-c04d070b7a63"
      unitRef="usd">3237000</us-gaap:InterestExpenseDebt>
    <avdl:CouponInterestExpense
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM1MQ_087803a2-b85c-44d9-9656-782974132b92"
      unitRef="usd">1617000</avdl:CouponInterestExpense>
    <avdl:CouponInterestExpense
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM1MQ_affd4a08-a088-4874-bd94-f49003f5516f"
      unitRef="usd">1617000</avdl:CouponInterestExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM1OA_603081c3-f8b8-4563-9178-86f7a484b125"
      unitRef="usd">313000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM2OQ_26649b9a-02f5-421c-9518-4c8b70bf3fbd"
      unitRef="usd">1620000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseDebt
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM3OQ_54805e7e-73a4-47ce-bd34-3642b070e59f"
      unitRef="usd">3859000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM4OQ_1728931a-64ad-453b-9366-58e9d90a4fe2"
      unitRef="usd">6427000</us-gaap:InterestExpenseDebt>
    <avdl:CouponInterestExpense
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM5OQ_2055f7a0-806b-4780-b5f4-faecce1d15e0"
      unitRef="usd">3234000</avdl:CouponInterestExpense>
    <avdl:CouponInterestExpense
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjM5OQ_ef7a019b-210d-46bf-93fb-8a911ca38636"
      unitRef="usd">3234000</avdl:CouponInterestExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjQwNw_fa47456d-8db6-4b5c-a7ef-c35b4af47303"
      unitRef="usd">625000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMjc0ODc3OTA3NjQxNw_c88c7bb4-fd0b-4273-a0a2-33d24564862d"
      unitRef="usd">3193000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:LongTermDebt
      contextRef="if26cf9bd950645da82a913ea028f7f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDkz_f79c04ae-618e-48f8-8b72-99f348601d93"
      unitRef="usd">12939000</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquity
      contextRef="i54a0f1be38254190aa94a522f6ed4974_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNTI5_5d9adcd7-cc00-4f62-8aa7-c83805448ae9"
      unitRef="usd">-26699000</us-gaap:StockholdersEquity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE4NA_8d0e7850-d66d-46a4-8a39-f7fb3142770b"
      unitRef="usd">125000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTIwMA_bd932b3f-d173-4d15-9465-e77569009889"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <avdl:DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm
      contextRef="if7160598d23c4b518c759c6aa5a8d2b4_D20180216-20180216"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNjI0NA_ed6d9c62-d5a1-45ce-ab1e-428f24fac336">P30D</avdl:DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm>
    <avdl:DebtInstrumentOptiontoIncreaseFaceAmount
      contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTA3Mg_bf721cec-a548-46f9-9aa7-197cd614f596"
      unitRef="usd">18750000</avdl:DebtInstrumentOptiontoIncreaseFaceAmount>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="if7160598d23c4b518c759c6aa5a8d2b4_D20180216-20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTI4OQ_e837340d-22d6-4913-b028-8950efc50f6f"
      unitRef="usd">6190000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="if7160598d23c4b518c759c6aa5a8d2b4_D20180216-20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTA5MA_c0bb1858-d217-4342-9fd5-1c342ec66113"
      unitRef="usd">137560000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <avdl:AmericanDepositorySharesConversionRatio
      contextRef="ibcdc3f2602ac4af79cdaff50261cf317_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTEwOA_850389a5-089d-424f-8b8b-43b8f14540e3"
      unitRef="rate">92.6956</avdl:AmericanDepositorySharesConversionRatio>
    <avdl:AmericanDepositarySharesOptionPricePerShare
      contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE0Ng_ea2aa805-f3d6-47ff-9b36-9b5b5e5e5986"
      unitRef="usdPerShare">10.79</avdl:AmericanDepositarySharesOptionPricePerShare>
    <avdl:AmericanDepositarySharesPremiumPercentage
      contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTEyMQ_294dd234-8ec0-4faf-8a80-535c5e7848ca"
      unitRef="number">0.20</avdl:AmericanDepositarySharesPremiumPercentage>
    <avdl:AmericanDepositarySharesPurchasedPricePerShare
      contextRef="idbec2bbcbbb34de89d1c27dd07788865_I20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTEzMg_2e2874de-2aa2-4926-81bf-c9b0465411e1"
      unitRef="usdPerShare">8.99</avdl:AmericanDepositarySharesPurchasedPricePerShare>
    <avdl:DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay
      contextRef="i8558d8d29eb84dbfa4e0793e914d9349_D20180216-20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE2NA_66d3905f-6bf9-4f6c-862b-42d77fb6b58f"
      unitRef="number">0.98</avdl:DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="id828d13c94a04e7981051a01fa81ed95_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMzgyNg_ca657d49-866e-4033-a9dd-5d6419e5a117"
      unitRef="day">95</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <avdl:DebtInstrumentConvertibleScheduledThresholdTradingDays
      contextRef="id828d13c94a04e7981051a01fa81ed95_D20180216-20180216"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDA3NA_e579eafb-954b-42e9-9332-24a517fa7386">P35D</avdl:DebtInstrumentConvertibleScheduledThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i619255c0fbb84c85be6f62b40e8f8667_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDY0MQ_84e6bad7-e775-494a-895f-622b5a88c9c2"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i619255c0fbb84c85be6f62b40e8f8667_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDcwNw_01a130eb-7ae5-439b-9477-8e1bad80f4fe"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i619255c0fbb84c85be6f62b40e8f8667_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfNDg1Ng_25d624ec-8f7a-4b3c-85bd-719adeffe6d7"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfODE2_85a03b88-11cd-4177-b0ea-116e9eb51d17">Income Taxes &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax benefit was $3,765 for the three months ended June&#160;30, 2021 resulting in an effective tax rate of 16.1%.  The income tax expense was $5,292 for the three months ended June&#160;30, 2020 resulting in an effective tax rate of 14.6%.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax benefit was $6,372 for the six months ended June&#160;30, 2021 resulting in an effective tax rate of 16.2%.  The income tax benefit was $4,218 for the six months ended June&#160;30, 2020 resulting in an effective tax rate of (16.4)%.  The net increase in the effective income tax rate for the six months ended June 30, 2021 as compared to the prior period in 2020 is primarily due to the discrete tax benefits recognized during the six months ended June 30, 2020 under the Coronavirus Aid, Relief and Economic Security Act, also known as the CARES Act, which did not occur during the six months ended June 30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the six months ended June 30, 2021 and 2020, the Company received $3,078 and $2,036, respectively, of cash primarily related to refundable French Research &amp;amp; Development Tax Credits generated in prior years.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMjc0ODc3OTA3MTE4Nw_110362ef-d922-4822-8026-38d8dde5ba12"
      unitRef="usd">-3765000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0Mzk5MA_c515b2fe-b1f3-451b-8055-e1bcd173f352"
      unitRef="number">0.161</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMjc0ODc3OTA3MTE5OA_e6625379-40bc-45c1-8621-213b1a1914c5"
      unitRef="usd">5292000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0Mzk5Nw_3d45fc48-c662-4c01-9bd8-fc5bf8f10354"
      unitRef="number">0.146</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMjc0ODc3OTA3MTExMg_97a0aca1-443a-42e9-a040-fb94a0d07f2d"
      unitRef="usd">-6372000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTA5OTUxMTYzMDk5Nw_7eb8490d-2f64-4a77-b39b-fcf912f54fc8"
      unitRef="number">0.162</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMjc0ODc3OTA3MTEyMg_8fac7b6d-37af-49c4-babb-818fc6d60016"
      unitRef="usd">-4218000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0NDAwNA_124a6072-ff71-4544-a40f-ca987dc62571"
      unitRef="number">-0.164</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ProceedsFromIncomeTaxRefunds
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0NTQwNA_6053cb2f-28de-425c-aacf-1eaa0d914328"
      unitRef="usd">3078000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <us-gaap:ProceedsFromIncomeTaxRefunds
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82Ny9mcmFnOmEyNzYzZjNiMDBlMTQ0ZmNiMTQ4NWU2ZTNhYmVjZGFmL3RleHRyZWdpb246YTI3NjNmM2IwMGUxNDRmY2IxNDg1ZTZlM2FiZWNkYWZfMTY0OTI2NzQ0NTQxMg_9a8bcd90-fa32-4853-9c80-02d3996d0c4c"
      unitRef="usd">2036000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTM4_83eef01e-a4a1-4b71-9a90-c748615d0694">Other Assets and Liabilities&#160;&lt;div style="margin-bottom:16pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Various other assets and liabilities are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prepaid Expenses and Other Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Value-added tax recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax receivable &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivable from Exela (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets at contract manufacturing organizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued restructuring (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued outsource contract costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due to Exela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTM5_4f3b8fcc-3ab5-45de-a903-620e0402d011">&lt;div style="margin-bottom:16pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Various other assets and liabilities are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prepaid Expenses and Other Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Value-added tax recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax receivable &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivable from Exela (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <us-gaap:ValueAddedTaxReceivableCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfMi0yLTEtMS0w_1f5d7f92-d159-4ae3-983a-d017cdbe720c"
      unitRef="usd">306000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfMi00LTEtMS0w_a9348165-bce7-4117-8bd9-ed3046b924eb"
      unitRef="usd">341000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfMy0yLTEtMS0w_c61edc3d-d40c-4152-9d6d-f208a2d1e81c"
      unitRef="usd">3983000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfMy00LTEtMS0w_c1be50eb-19b3-4b3b-9a90-c916de512c02"
      unitRef="usd">1018000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNC0yLTEtMS0w_8a50b28c-2c38-43e6-aa08-bd25a2145f7f"
      unitRef="usd">1418000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNC00LTEtMS0w_7afca60f-461d-4639-a4b4-1e06a9ca9711"
      unitRef="usd">1477000</us-gaap:DepositsAssetsCurrent>
    <avdl:GuaranteeCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNS0yLTEtMS0w_d25547e4-8b5d-4d50-8e48-9e72349d130e"
      unitRef="usd">274000</avdl:GuaranteeCurrent>
    <avdl:GuaranteeCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNS00LTEtMS0w_a8bfaaab-1fcb-4b1f-9073-5b30ed4b04cb"
      unitRef="usd">318000</avdl:GuaranteeCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNi0yLTEtMS0w_9b5dbbee-3517-450f-9dee-a69e47fbfbc6"
      unitRef="usd">18835000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNi00LTEtMS0w_dd8a09fb-7442-42d4-92d4-bd01ffefc8a5"
      unitRef="usd">18615000</us-gaap:IncomeTaxesReceivable>
    <avdl:ShortTermNoteReceivable
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNy0yLTEtMS0w_3be664f6-337f-41d8-998a-948b09e3c1a9"
      unitRef="usd">0</avdl:ShortTermNoteReceivable>
    <avdl:ShortTermNoteReceivable
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfNy00LTEtMS0w_8e1c90a8-34a3-4d31-ba8c-96c251199405"
      unitRef="usd">16500000</avdl:ShortTermNoteReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfOC0yLTEtMS0w_a5ad7f94-8708-4561-aec0-2e7540067e41"
      unitRef="usd">492000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfOC00LTEtMS0w_7ed38fd8-b3f6-459d-a990-63c039f9c607"
      unitRef="usd">457000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfOS0yLTEtMS0w_67ef26b1-ff73-4bdf-a2c1-052cb03d14aa"
      unitRef="usd">25308000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjU1NjZhZGIyMmQ5MTQ0ZGE4YmVjNGZhYjY1NzAxM2MxL3RhYmxlcmFuZ2U6NTU2NmFkYjIyZDkxNDRkYThiZWM0ZmFiNjU3MDEzYzFfOS00LTEtMS0w_6f841dba-5b23-4091-b78f-82bb90feb235"
      unitRef="usd">38726000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTMw_cd1fa1ff-6097-4e11-bb45-4ff8c954e781">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets at contract manufacturing organizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfMi0yLTEtMS0w_5d402712-aecd-493b-8a62-616a2e17ea33"
      unitRef="usd">24484000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfMi00LTEtMS0w_8bafd740-82eb-4e56-9e6e-26bc7cbfb45e"
      unitRef="usd">18256000</us-gaap:DeferredTaxAssetsNet>
    <avdl:GuaranteeNoncurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNC0yLTEtMS0w_ec1aa4a1-d9a5-4ffb-8f4a-602e07b2a13f"
      unitRef="usd">910000</avdl:GuaranteeNoncurrent>
    <avdl:GuaranteeNoncurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNC00LTEtMS0w_31191382-7a24-4cd8-931f-5dabcc3dd223"
      unitRef="usd">1050000</avdl:GuaranteeNoncurrent>
    <avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNS0yLTEtMS0w_ac6b6280-6a6f-4f19-80e5-4924022afdf5"
      unitRef="usd">5749000</avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent>
    <avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNS00LTEtMS0w_7b6fc8d0-08d8-48b8-8bd5-971cebbb56d5"
      unitRef="usd">5201000</avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent>
    <avdl:OtherNoncurrentReceivables
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNi0yLTEtMS0w_363511f7-91f1-40c2-b850-1672aae693a4"
      unitRef="usd">357000</avdl:OtherNoncurrentReceivables>
    <avdl:OtherNoncurrentReceivables
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNi00LTEtMS0w_89c8639b-5905-4643-8609-e0dcc5b53c1b"
      unitRef="usd">432000</avdl:OtherNoncurrentReceivables>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNy0yLTEtMS0w_62eb3707-564d-4cc2-855c-6e6d40bea244"
      unitRef="usd">31500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjljNWE4MTRmMzAwMDQ1YjViZjUzNDVjZTRjNDMzYjFkL3RhYmxlcmFuZ2U6OWM1YTgxNGYzMDAwNDViNWJmNTM0NWNlNGM0MzNiMWRfNy00LTEtMS0w_552e80a7-ae3d-4437-8667-b778e81181de"
      unitRef="usd">24939000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTMx_76d97282-c23d-4374-ac04-f59b0d7a7dec">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued restructuring (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued outsource contract costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfMi0yLTEtMS0w_676b6196-e51b-40f7-902f-1fc61b242127"
      unitRef="usd">1504000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfMi00LTEtMS0w_a2ebff90-1d06-40b8-af8c-55d65ace32e6"
      unitRef="usd">1697000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfMy0yLTEtMS0w_cf77373d-e5c0-4383-adfe-11cb266d793e"
      unitRef="usd">177000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfMy00LTEtMS0w_773b15f4-ad3d-4b52-8854-f8f166953ab4"
      unitRef="usd">520000</us-gaap:RestructuringReserveCurrent>
    <avdl:AccruedTradeDiscountsAndRebates
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNC0yLTEtMS0w_6d21c3f6-f08d-42ac-9f6a-2aff3edd4bc5"
      unitRef="usd">821000</avdl:AccruedTradeDiscountsAndRebates>
    <avdl:AccruedTradeDiscountsAndRebates
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNC00LTEtMS0w_f8508f3e-9af4-4ac4-9225-c4dbdb3c456e"
      unitRef="usd">1030000</avdl:AccruedTradeDiscountsAndRebates>
    <avdl:AccruedOutsourceContractCosts
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNS0yLTEtMS0w_80c6c97f-f83c-4130-9258-1fdc81c22ee8"
      unitRef="usd">837000</avdl:AccruedOutsourceContractCosts>
    <avdl:AccruedOutsourceContractCosts
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNS00LTEtMS0w_62835ab2-6a89-401d-b970-16bf2a11caee"
      unitRef="usd">473000</avdl:AccruedOutsourceContractCosts>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNi0yLTEtMS0w_67af0f69-76e9-47d2-a54e-5406cebc9c5c"
      unitRef="usd">4185000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNi00LTEtMS0w_2d3fb175-e987-4947-aaa6-01bda10253bc"
      unitRef="usd">2781000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNy0yLTEtMS0w_79d704ed-8235-424f-9895-3526de590bb2"
      unitRef="usd">7524000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjc1MjVjNTU4MTUxNzRmMDg4OGIzMzZmZTUxZGE0NzBmL3RhYmxlcmFuZ2U6NzUyNWM1NTgxNTE3NGYwODg4YjMzNmZlNTFkYTQ3MGZfNy00LTEtMS0w_3870e51b-ba8e-4cdd-8722-eba264bb0612"
      unitRef="usd">6501000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTU0_cf5b9c44-3494-4813-9485-3002eade5334">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due to Exela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <avdl:AccruedInterestCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfMi0yLTEtMS0w_e2528983-7528-4581-a1b6-05fc86a9ed23"
      unitRef="usd">2695000</avdl:AccruedInterestCurrent>
    <avdl:AccruedInterestCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfMi00LTEtMS0w_ee745943-b42e-4f85-b47d-c494dd242de2"
      unitRef="usd">2695000</avdl:AccruedInterestCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfMy0yLTEtMS0w_358389dd-243f-4602-946d-18619b8ffdf1"
      unitRef="usd">0</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfMy00LTEtMS0w_f4568ef6-3763-4820-b9c5-75bd13b632c1"
      unitRef="usd">2026000</us-gaap:DueToAffiliateCurrent>
    <avdl:OtherGuarantorObligationsCurrentCarryingValue
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNC0yLTEtMS0w_fca6eea5-419b-48b1-98aa-056fb241f0ea"
      unitRef="usd">275000</avdl:OtherGuarantorObligationsCurrentCarryingValue>
    <avdl:OtherGuarantorObligationsCurrentCarryingValue
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNC00LTEtMS0w_55f23266-1348-4eef-b055-dad01540a14c"
      unitRef="usd">319000</avdl:OtherGuarantorObligationsCurrentCarryingValue>
    <avdl:OtherLiabilitiesMiscellaneousCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNS0yLTEtMS0w_2cddafd4-59b9-45b3-bbd2-62a4b75092f0"
      unitRef="usd">176000</avdl:OtherLiabilitiesMiscellaneousCurrent>
    <avdl:OtherLiabilitiesMiscellaneousCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNS00LTEtMS0w_0166d850-9ab2-40f6-9b4d-0814836e63a2"
      unitRef="usd">160000</avdl:OtherLiabilitiesMiscellaneousCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNi0yLTEtMS0w_234ada92-6c24-45d3-ade0-773189845ea8"
      unitRef="usd">3146000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjNmMWZiMmQ4MDU1MDQ5OWE5ZWJkZTBlMDM4MzBmNDlhL3RhYmxlcmFuZ2U6M2YxZmIyZDgwNTUwNDk5YTllYmRlMGUwMzgzMGY0OWFfNi00LTEtMS0w_d1b1074a-fc35-4eff-963f-6f4b157a4efb"
      unitRef="usd">5200000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RleHRyZWdpb246NTkyNzM4MjE5ZGMyNGU4YzkzN2M4YjJlNjI0ZmMyNTVfMTQ1_86583a95-b191-4102-8e8e-43aa0739b3c0">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfMy0yLTEtMS0w_c96c3278-efc4-4007-83e7-3fa279244d51"
      unitRef="usd">3143000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfMy00LTEtMS0w_15bd2c96-377d-479d-b364-2343f2ee658d"
      unitRef="usd">3143000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:GuarantyLiabilities
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNC0yLTEtMS0w_e35a03b4-dd3e-49da-a9f6-0ffc7cff7aaa"
      unitRef="usd">913000</us-gaap:GuarantyLiabilities>
    <us-gaap:GuarantyLiabilities
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNC00LTEtMS0w_c483e8ec-d600-4db4-8dca-50a523005bcc"
      unitRef="usd">1053000</us-gaap:GuarantyLiabilities>
    <us-gaap:OtherLongTermDebt
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNS0yLTEtMS0w_19280ab7-b7cd-47d0-8423-a06808d7b532"
      unitRef="usd">12000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNS00LTEtMS0w_d8b8eed8-b29b-4f90-be6b-243761e8f409"
      unitRef="usd">16000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNi0yLTEtMS0w_81ff94f1-8f2f-46dd-8b31-887aee00c8d7"
      unitRef="usd">4068000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ica8983fe897240fb8db372157af242b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83MC9mcmFnOjU5MjczODIxOWRjMjRlOGM5MzdjOGIyZTYyNGZjMjU1L3RhYmxlOjI4YWJjNzE4NDAyZDRiOWFhOTM2MTgxMGI2YmViNjg1L3RhYmxlcmFuZ2U6MjhhYmM3MTg0MDJkNGI5YWE5MzYxODEwYjZiZWI2ODVfNi00LTEtMS0w_6efac3c0-9c3e-4536-bc1e-b630a9ebf907"
      unitRef="usd">4212000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfMTY4Nw_bf649181-a903-4a27-b742-e1248044681a">Restructuring Costs&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019 French Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2019, the Company initiated a plan to substantially reduce all of its workforce at its V&#xe9;nissieux, France site (&#x201c;2019 French Restructuring&#x201d;).  This reduction was part of an effort to align the Company&#x2019;s cost structure with our ongoing and future planned projects. The reduction in workforce was completed during 2020. Restructuring (income) charges associated with this plan recognized during the three and six months ended June&#160;30, 2021 and 2020 were immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth activities for the Company&#x2019;s cost reduction plan obligations for the six months ended June&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019 French Restructuring Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2019 French Restructuring liabilities of $107 are included in the unaudited condensed consolidated balance sheet in accrued expenses at June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019 Corporate Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2019, the Company announced a plan to reduce its Corporate workforce by more than 50% (&#x201c;2019 Corporate Restructuring&#x201d;). The reduction in workforce is primarily a result of the exit of Noctiva during the first quarter of 2019, as well as an effort to better align the Company&#x2019;s remaining cost structure at our U.S. and Ireland locations with our ongoing and future planned projects. The reduction in workforce was completed during 2020. The restructuring charges associated with this plan recognized during the six months ended June&#160;30, 2021 and 2020 were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth activities for the Company&#x2019;s cost reduction plan obligations for the six months ended June&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019 Corporate Restructuring Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The 2019 Corporate Restructuring liabilities of $70 are included in the unaudited condensed consolidated balance sheet in accrued expenses at June&#160;30, 2021.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfMTY5Mg_e607b8f5-09fe-4ea8-adda-3abcd9b68a9e">&lt;div style="margin-bottom:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth activities for the Company&#x2019;s cost reduction plan obligations for the six months ended June&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019 French Restructuring Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth activities for the Company&#x2019;s cost reduction plan obligations for the six months ended June&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019 Corporate Restructuring Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i7e8c3ff2db154d098fe60070506408f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfMi0yLTEtMS0w_d067104f-f38e-4220-8c27-b5dc4cdb721f"
      unitRef="usd">248000</us-gaap:RestructuringReserve>
    <avdl:RestructuringChargesBeforeGainLossDuetoCurtailment
      contextRef="i03b1e76537a34ed8ae22e6fcbd623ceb_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfMy0yLTEtMS0w_bf4a4584-c352-45dd-bef3-e2cdea647b92"
      unitRef="usd">-122000</avdl:RestructuringChargesBeforeGainLossDuetoCurtailment>
    <us-gaap:PaymentsForRestructuring
      contextRef="id4a57a5a305f43858278dcd059cbe0d2_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfNC0yLTEtMS0w_edf84839-400f-404a-91d5-73ebbe1bb0f3"
      unitRef="usd">13000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="id4a57a5a305f43858278dcd059cbe0d2_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfNS0yLTEtMS0w_ad926463-94fd-45e1-8e2b-f887ced8b853"
      unitRef="usd">-6000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="id82ee84d494f49a1aa77a11e88225b6d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOmVmYjk4NjdkYTFkODQwN2JhYmVmZjg1MTkxOWUxMzdlL3RhYmxlcmFuZ2U6ZWZiOTg2N2RhMWQ4NDA3YmFiZWZmODUxOTE5ZTEzN2VfNi0yLTEtMS0w_4a106fc1-fd91-4d06-8355-f7e9c8dde9bf"
      unitRef="usd">107000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id82ee84d494f49a1aa77a11e88225b6d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfMzg0ODI5MDY5ODk1NA_4a106fc1-fd91-4d06-8355-f7e9c8dde9bf"
      unitRef="usd">107000</us-gaap:RestructuringReserve>
    <avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent
      contextRef="i35238f47c33b4c629f04849c139b24b6_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfOTQx_f036d0d9-e9b3-42a3-969a-b399ca25d992"
      unitRef="number">0.50</avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent>
    <us-gaap:RestructuringReserve
      contextRef="i7ddd0a37b8ed4590bc03f9c4c94308ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOjQ4N2I4MDRkMGMzYjQ5YWU4OTFmYTg2MzQ4ODEzZGNjL3RhYmxlcmFuZ2U6NDg3YjgwNGQwYzNiNDlhZTg5MWZhODYzNDg4MTNkY2NfMi0yLTEtMS0w_fb84305c-a8c1-4fe2-9e46-314e9b46e99d"
      unitRef="usd">272000</us-gaap:RestructuringReserve>
    <avdl:RestructuringChargesBeforeGainLossDuetoCurtailment
      contextRef="ia9ce335e1f12437bbd48bf21a9f38150_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOjQ4N2I4MDRkMGMzYjQ5YWU4OTFmYTg2MzQ4ODEzZGNjL3RhYmxlcmFuZ2U6NDg3YjgwNGQwYzNiNDlhZTg5MWZhODYzNDg4MTNkY2NfMy0yLTEtMS0w_51011a7a-fe3d-44bd-b813-e8be5befa0cf"
      unitRef="usd">0</avdl:RestructuringChargesBeforeGainLossDuetoCurtailment>
    <us-gaap:PaymentsForRestructuring
      contextRef="iecc1f49f09f748ce80b8c92a2ec072a3_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOjQ4N2I4MDRkMGMzYjQ5YWU4OTFmYTg2MzQ4ODEzZGNjL3RhYmxlcmFuZ2U6NDg3YjgwNGQwYzNiNDlhZTg5MWZhODYzNDg4MTNkY2NfNC0yLTEtMS0w_eda785f7-5d51-41c4-8dcd-595120e6ed66"
      unitRef="usd">202000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i8fb7c2b0fb5945538e9a6a089566898e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RhYmxlOjQ4N2I4MDRkMGMzYjQ5YWU4OTFmYTg2MzQ4ODEzZGNjL3RhYmxlcmFuZ2U6NDg3YjgwNGQwYzNiNDlhZTg5MWZhODYzNDg4MTNkY2NfNi0yLTEtMS0w_ac6a47d4-ad20-48ed-a66d-f6a7cc3c9111"
      unitRef="usd">70000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8fb7c2b0fb5945538e9a6a089566898e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83My9mcmFnOmNlNDdhZGI0YTQyMDRmOTY4MWYyNjEwZWRlNTNkOGEyL3RleHRyZWdpb246Y2U0N2FkYjRhNDIwNGY5NjgxZjI2MTBlZGU1M2Q4YTJfMTU4OQ_ac6a47d4-ad20-48ed-a66d-f6a7cc3c9111"
      unitRef="usd">70000</us-gaap:RestructuringReserve>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMjEwMw_03906b15-0e0d-403f-959f-0f8395e2f15e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of shares outstanding during each period. Diluted net (loss) income per share is calculated by dividing net (loss) income - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net (loss) income, diluted net (loss) income per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of our preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under our employee stock purchase plan (&#x201c;ESPP&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. We utilize the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of our ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under our ESPP has been calculated using the treasury stock method.  The dilutive effect of the performance share units (&#x201c;PSUs&#x201d;) will be calculated using the treasury stock method, if and when the contingent vesting condition is achieved. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net (Loss) Income Per Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Add: interest from 2023 Notes, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&#x2014;employee and director equity awards outstanding, preferred shares and 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Potential ordinary shares of&#160;15,586&#160;and&#160;2,472&#160;were excluded from the calculation of weighted average shares for the three months ended June&#160;30, 2021 and 2020, respectively, and potential ordinary shares of&#160;15,426&#160;and&#160;2,537&#160;were excluded from the calculation of weighted average shares for the six months ended June&#160;30, 2021 and 2020, respectively, because either their effect was considered to be anti-dilutive or they were related to shares from PSUs for which the contingent vesting condition had not been achieved. For the three and six months ended June&#160;30, 2021, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in these periods.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMjEwMQ_af4f4069-e7a0-417f-b4df-a48b3c2dfff8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net (Loss) Income Per Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Add: interest from 2023 Notes, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&#x2014;employee and director equity awards outstanding, preferred shares and 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMy0yLTEtMS0w_be44abe6-38da-4a7b-a6ad-c66c917414d3"
      unitRef="usd">-19581000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMy00LTEtMS0w_00a2f95b-4b7e-41a7-af31-8ea253d06c88"
      unitRef="usd">30874000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMy02LTEtMS0w_f7a32062-9151-4e1f-86df-a35bec5a0a1d"
      unitRef="usd">-33026000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMy04LTEtMS0w_d998c12e-c7fa-45df-8da5-17e768d72a21"
      unitRef="usd">30009000</us-gaap:NetIncomeLoss>
    <us-gaap:DilutiveSecurities
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNC0yLTEtMS0w_6ee4ac5a-73fc-4368-96a9-52b9a426faa7"
      unitRef="usd">0</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNC00LTEtMS0w_cd56b288-780b-43ab-83b7-786508f9b76e"
      unitRef="usd">3237000</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNC02LTEtMS0xMTYz_33f5234a-9d9d-4844-8091-684d47d30fdc"
      unitRef="usd">0</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNC04LTEtMS0w_8388f3e8-2359-47c2-ba62-c63638267318"
      unitRef="usd">6427000</us-gaap:DilutiveSecurities>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNS0yLTEtMS0w_5b561867-f1ef-46b6-9429-d7dfb23555aa"
      unitRef="usd">-19581000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNS00LTEtMS0w_43b4bd78-0b98-4b84-a8db-30c067cd17de"
      unitRef="usd">34111000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNS02LTEtMS0w_f22cfbb0-eb66-4c0c-86e2-221c61387087"
      unitRef="usd">-33026000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfNS04LTEtMS0w_414a1924-0afc-4fd5-b375-17612dd02212"
      unitRef="usd">36436000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOC0yLTEtMS0w_6c1a549d-056e-429f-b00f-c83b035d0330"
      unitRef="shares">58488000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOC00LTEtMS0w_f7fceb18-78cd-469a-8124-4d17cccefa16"
      unitRef="shares">54272000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOC02LTEtMS0w_8fb76ee1-a630-458d-8d50-37f2ff64a29a"
      unitRef="shares">58465000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOC04LTEtMS0w_0bed3a9b-088a-49ca-a98d-203c6e44a67e"
      unitRef="shares">47665000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOS0yLTEtMS0w_f2717090-6619-4de4-bb5b-3f7e1796d213"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOS00LTEtMS0w_32289054-04da-4046-aecf-e9aedc5deea2"
      unitRef="shares">15670000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOS02LTEtMS0w_81009e6e-8608-4bc8-8d92-5bcc4af6f160"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfOS04LTEtMS0w_3b2a9a36-fcf3-489e-ad8d-812123b32fcc"
      unitRef="shares">15418000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTEtMi0xLTEtMA_60e5bc03-89e0-4727-ae02-a344059e17d9"
      unitRef="shares">58488000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTEtNC0xLTEtMA_e417c68c-83ac-4a62-b001-585d7738cb4e"
      unitRef="shares">69942000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTEtNi0xLTEtMA_57765d02-ab44-4b74-acf6-1f29b5aa8591"
      unitRef="shares">58465000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTEtOC0xLTEtMA_e28ac080-a36b-4d07-8177-57ba5be3f268"
      unitRef="shares">63083000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTMtMi0xLTEtMA_f73da056-e8d4-41ed-b11a-459342ecddb9"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTMtNC0xLTEtMA_e297260e-753f-4b31-9712-999ab113f0a0"
      unitRef="usdPerShare">0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTMtNi0xLTEtMA_d445187e-da52-41ac-9ebb-f920929401b6"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTMtOC0xLTEtMA_6f5c0ace-3bfe-4eca-af26-c128af49ad01"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTQtMi0xLTEtMA_898d8a1e-882c-46fc-b5ab-aac7aaecc7d6"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTQtNC0xLTEtMA_c7d83318-a28c-4017-a90a-bb31c91ba5fd"
      unitRef="usdPerShare">0.49</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTQtNi0xLTEtMA_e091bbd2-cec1-4ef8-8ac7-8e327e5c6b87"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RhYmxlOjRlMDNjMTA2YzNmNDQ4OWU4NjM0ZjNhNTViMjNkMWZlL3RhYmxlcmFuZ2U6NGUwM2MxMDZjM2Y0NDg5ZTg2MzRmM2E1NWIyM2QxZmVfMTQtOC0xLTEtMA_cddb2c67-c483-44b8-a691-23cab2240f4e"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMTYwNw_ebfc0a01-f2cd-4b69-902f-3cc451b1bad7"
      unitRef="shares">15586</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMTYxNA_51dee93f-3cd4-4fe9-b41f-00b79b86ff9e"
      unitRef="shares">2472</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMTA5OTUxMTYzMDEzNw_39489ad2-2ae8-4679-b551-e30d8491a8fd"
      unitRef="shares">15426</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83Ni9mcmFnOjdiZjA4YjYyNDMyOTQ5ZTg5OTRiNDRhNWY1NGJjYjg1L3RleHRyZWdpb246N2JmMDhiNjI0MzI5NDllODk5NGI0NGE1ZjU0YmNiODVfMTA5OTUxMTYzMDE5OQ_c3ce4541-564f-45f3-9485-150c6233b96b"
      unitRef="shares">2537</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RleHRyZWdpb246MWNkNTg4NWNhMjRiNDFhNGE4MmVlYjM2OTliM2UyZGVfMzg1_b64da03d-e60b-4a8d-b702-4e4354c16275">Comprehensive Loss&#160;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of accumulated other comprehensive loss for the three and six months ended June&#160;30, 2021 and 2020, respectively, net of tax effects:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.749%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gain on marketable debt securities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive (loss) income, net of $(78), $(81)  $(133) and $(130) tax, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss at June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect on the Company&#x2019;s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RleHRyZWdpb246MWNkNTg4NWNhMjRiNDFhNGE4MmVlYjM2OTliM2UyZGVfMzg5_9c0bfa0f-c537-40d5-8fb0-e7b0d187b8c2">&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of accumulated other comprehensive loss for the three and six months ended June&#160;30, 2021 and 2020, respectively, net of tax effects:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.749%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gain on marketable debt securities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive (loss) income, net of $(78), $(81)  $(133) and $(130) tax, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss at June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i76a5acc12ee8481593b5f580d0c6acce_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNC0yLTEtMS0w_1b203df7-714e-4193-8c3c-436f4164f8fc"
      unitRef="usd">-23345000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia2a319b7a49041b68e1f28bc975ffd5f_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNC00LTEtMS0w_656b0e8d-0a8a-4f79-bf1e-dade55c1556f"
      unitRef="usd">-23915000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8c6b3a49597d4114b95a4bce60988c0c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNC02LTEtMS0w_68bf1f1a-d726-4498-8add-8ff4f957f4e4"
      unitRef="usd">-22627000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02d0a6c7d54a44ae842a997b5e95ed2b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNC04LTEtMS0w_85f447ee-22de-4065-aa16-948a1a47efcd"
      unitRef="usd">-23738000</us-gaap:StockholdersEquity>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie1958fec3b1b4189a3494df42bf89998_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNS0yLTEtMS0w_b8b5f917-029b-4534-9088-4d3ed4975a7d"
      unitRef="usd">116000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9b232b5b7cd948cf83baaf96787cecc8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNS00LTEtMS0w_c80d3e97-dc53-4ded-ab8a-2ff95449f780"
      unitRef="usd">182000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i50064db877274880a1811d0f859ad19d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNS02LTEtMS0w_44a0b0fb-0733-488e-ab9e-dd185c3dfada"
      unitRef="usd">-602000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="idb7c4417a3344d92bec61dc810fc930e_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNS04LTEtMS0w_c89dfb6c-f573-4a43-a495-29ae5e173c40"
      unitRef="usd">5000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i79d6697ec0004a62b02bcf4f6ceb19aa_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNi0yLTEtMS0w_d0479820-6637-4729-b0d3-1af93dc232ed"
      unitRef="usd">-23229000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id4b7b480e1084f46848cd8804e33cf56_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNi00LTEtMS0w_54b4fd1c-1a5c-4067-b643-0ec26a488cc4"
      unitRef="usd">-23733000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79d6697ec0004a62b02bcf4f6ceb19aa_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNi02LTEtMS0w_17a37809-6415-45fd-9437-3665bca1ddf4"
      unitRef="usd">-23229000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id4b7b480e1084f46848cd8804e33cf56_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfNi04LTEtMS0w_3ba581d1-e91b-41d0-8617-c3ea1e7fcb3e"
      unitRef="usd">-23733000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd3b0844231a4d02b15483cd3bc9cdd0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfOS0yLTEtMS0w_3351772c-b286-4ac8-b0bb-237326441e32"
      unitRef="usd">1039000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iea06e402349946f6b73a2366c3ff8a04_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfOS00LTEtMS0w_61e491e1-3914-4cc3-aa86-64fad314f242"
      unitRef="usd">288000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if6ddfbe329ea4b859226b9d1e4159bbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfOS02LTEtMS0w_4470d49b-8df9-4406-aad4-7c4b3a2cf5bf"
      unitRef="usd">1576000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3ecf22fe804f4dffa050dc87558edfb6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfOS04LTEtMS0w_9e3428af-8aef-4d91-a5b2-cc19b4e6c444"
      unitRef="usd">932000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjljMjBlMjQxYzk0ZTQxNjFhZGY3MDFkZmIwNDU2NmRkXzEwOTk1MTE2Mjc4NDY_407ccac9-deb9-4224-838c-5fe692cb9753"
      unitRef="usd">-78000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjljMjBlMjQxYzk0ZTQxNjFhZGY3MDFkZmIwNDU2NmRkXzEwOTk1MTE2Mjc4NTM_525364d7-b037-4fc4-bb74-b62282e494f5"
      unitRef="usd">-81000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjljMjBlMjQxYzk0ZTQxNjFhZGY3MDFkZmIwNDU2NmRkXzQy_18b4c151-0c20-4283-b277-19273133432e"
      unitRef="usd">-133000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjljMjBlMjQxYzk0ZTQxNjFhZGY3MDFkZmIwNDU2NmRkXzQ5_f84ceaf4-0cf8-43b0-8aef-ae05cca052dd"
      unitRef="usd">-130000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia4e61467debc48beaa50fd50ce036c21_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtMi0xLTEtMA_61915121-b419-4efa-8615-b6f59f5c6066"
      unitRef="usd">-160000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8f91b0f2c8834815aac6916157b00fa5_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtNC0xLTEtMA_2de45e9f-311f-498c-aabe-c60a5088afbf"
      unitRef="usd">927000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibbba85bbb98c4e4fb64a84c0ec71d0a1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtNi0xLTEtMA_d3676ba6-85d9-4406-9efc-7cdb02c1e38c"
      unitRef="usd">-697000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ida13d64b815a426bbd81a3c5e429675b_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTAtOC0xLTEtMA_0377b9de-03ed-4f8e-baa5-56cc1f472083"
      unitRef="usd">283000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="id12d4cd39de345ecb292ceaccf92a42e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTEtMi0xLTEtMA_20a64ead-3375-4477-8b52-0cfda5823898"
      unitRef="usd">879000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4746ea4b2111416cbd83562dad4e70a7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTEtNC0xLTEtMA_08a6a2dc-49e1-44d9-a535-c1ae018379eb"
      unitRef="usd">1215000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id12d4cd39de345ecb292ceaccf92a42e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTEtNi0xLTEtMA_a92b1e4a-af56-432d-ad16-0c6071583ff7"
      unitRef="usd">879000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4746ea4b2111416cbd83562dad4e70a7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTEtOC0xLTEtMA_52311bd9-b6fc-4fac-b3b2-739c2164bdbf"
      unitRef="usd">1215000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25507beaf94543b3ac989067fe8f70f6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTItMi0xLTEtMA_9cda3fe9-bced-4c5f-9b40-1f7916a7f196"
      unitRef="usd">-22350000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2a929bcc21e485a9d7ab75296127ff8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTItNC0xLTEtMA_46f167d9-f863-4b41-80b7-6fb2860d2232"
      unitRef="usd">-22518000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25507beaf94543b3ac989067fe8f70f6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTItNi0xLTEtMA_ced603bb-100c-430d-9efa-ccf53850606e"
      unitRef="usd">-22350000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2a929bcc21e485a9d7ab75296127ff8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV83OS9mcmFnOjFjZDU4ODVjYTI0YjQxYTRhODJlZWIzNjk5YjNlMmRlL3RhYmxlOjNjNDM2MjYwZTNlODQzOWU5MDM2YWEwZDJkNzQ1NzJmL3RhYmxlcmFuZ2U6M2M0MzYyNjBlM2U4NDM5ZTkwMzZhYTBkMmQ3NDU3MmZfMTItOC0xLTEtMA_21131c14-7c57-4931-b953-07e8651d2cc5"
      unitRef="usd">-22518000</us-gaap:StockholdersEquity>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RleHRyZWdpb246ZmVmM2MwOTQ0YTYwNGUzZThlOWRlZTBhNTRkMTcyM2JfOTE2_d4eda6c2-adb6-4694-9ef8-17a8387b091a">Revenue by Product&#160;The Company has determined that it operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on our proprietary polymer based technology. The Company&#x2019;s Chief Operating Decision Maker is the Chief Executive Officer (the &#x201c;CEO&#x201d;). The CEO reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions as well as resource allocations. All products were included in one segment because the Company&#x2019;s products have similar economic and other characteristics, including the nature of the products and production processes, type of customers, distribution methods and regulatory environment.&#160;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020, we sold the Hospital Products. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3: Disposition of the Hospital Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The following table presents a summary of total product sales by these products:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Product Sales by Product:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bloxiverz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vazculep&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Akovaz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020, we sold the Hospital Products.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3: Disposition of the Hospital Products&lt;/span&gt;.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RleHRyZWdpb246ZmVmM2MwOTQ0YTYwNGUzZThlOWRlZTBhNTRkMTcyM2JfODE_1b5624e8-e1e9-4efd-a58e-84e32a4765d1"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RleHRyZWdpb246ZmVmM2MwOTQ0YTYwNGUzZThlOWRlZTBhNTRkMTcyM2JfNTM5_da4b555c-fb73-40dc-a749-54a4f74bacfb"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RleHRyZWdpb246ZmVmM2MwOTQ0YTYwNGUzZThlOWRlZTBhNTRkMTcyM2JfOTIw_81c0d5df-dbae-4867-84c6-83c7df94424e">The following table presents a summary of total product sales by these products:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Product Sales by Product:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bloxiverz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vazculep&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Akovaz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia015e8c7039f4253bf52fccb4e8ecb8c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfMy00LTEtMS0w_e86d2d0e-4a76-4a18-b14c-bb1dd6e15308"
      unitRef="usd">800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i549d337037a54337b23be1da5fc95857_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfMy04LTEtMS0w_7d58d2b2-2f13-414f-8613-192ab9a1e9b0"
      unitRef="usd">2201000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98b6eab8d7b044f4b52fe5bb3feedf68_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNC00LTEtMS0w_32b1c50a-1e3d-4251-83dc-a7a9b9bd2094"
      unitRef="usd">4915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie747eb99af0f45f29bf4b24a2ba6c818_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNC04LTEtMS0w_a6a8a28b-d2a7-41a1-a81a-714c02d3a8a9"
      unitRef="usd">10429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e8aa4c10c714d95a93ab30edbd0f6ac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNS00LTEtMS0w_fbfe4e2d-3bfb-4600-873b-bede655792e9"
      unitRef="usd">4196000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00da774065cf477491a056a3df163b4b_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNS04LTEtMS0w_b2c2b51d-6d7e-457a-ad19-f11dc552e355"
      unitRef="usd">9545000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfc69dd306e94f2b91c2cea091afefa7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNy00LTEtMS0w_f848401c-11c6-4d99-8c65-2d12d4ae07a7"
      unitRef="usd">180000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i636d00926a694de8b3a2561a4bd15037_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfNy04LTEtMS0w_8fc107c1-73df-4385-8e98-767ec41dd712"
      unitRef="usd">159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i035a81e773d84eccb0f4a0977f99852f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfOC00LTEtMS0w_50fc565e-ecab-4168-9380-9064aee53b90"
      unitRef="usd">10091000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84Mi9mcmFnOmZlZjNjMDk0NGE2MDRlM2U4ZTlkZWUwYTU0ZDE3MjNiL3RhYmxlOmQ5YTk5ZDhhODBmZjRjZTU5ZTc3MWNkNjYxNjdkMjg0L3RhYmxlcmFuZ2U6ZDlhOTlkOGE4MGZmNGNlNTllNzcxY2Q2NjE2N2QyODRfOC04LTEtMS0w_712a04cf-d241-457a-8c8e-bb92c023bd8a"
      unitRef="usd">22334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMjU2Mw_daedd535-3b60-4595-9908-19bec47e340f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to potential liabilities generally incidental to our business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At June 30, 2021 and December 31, 2020, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#x2019;s unaudited condensed consolidated financial position, results of operations, cash flows or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#x201c;Jazz&#x201d;) filed a formal complaint (the &#x201c;Complaint&#x201d;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#x201c;Court&#x201d;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#x201c;Avadel Parties&#x201d;). In the Complaint, Jazz alleges the sodium oxybate product (&#x201c;Proposed Product&#x201d;) described in the New Drug Application (&#x201c;NDA&#x201d;) owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#x201c;patents-in-suit&#x201d;). The Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#x201c;Avadel Answer&#x201d;) with the Court in response to the Complaint.  The Avadel Answer generally denies the allegations set forth in the Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, ii) a declaratory judgment of invalidity of each patent-in-suit, and iii) a declaratory judgement requiring delisting of US Patent No. 8731963 from FDA&#x2019;s Orange Book. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 18, 2021, Jazz filed its Answer (&#x201c;Jazz Answer&#x201d;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#x2019;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a preliminary injunction hearing date of November 23, 2021 (only relevant in the event that Jazz files a motion for a preliminary injunction by October 22, 2021), ii) a claim construction hearing date of August 2, 2022, and iii) a trial date of October 30, 2023.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 4, 2021, Jazz filed another formal complaint (the &#x201c;Second Complaint&#x201d;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11077079. The Second Complaint further includes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses.&#160; &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Material Commitments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than commitments disclosed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 17: Contingent Liabilities and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to the Company's consolidated financial statements included in the 2020 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deerfield Guarantee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of our guarantee to Deerfield and the guarantee received by us from Armistice largely offset and when combined are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with our February 2018 divestiture of our pediatric assets, we guaranteed to Deerfield the quarterly royalty payment of&#160;15%&#160;on net sales of the FSC products through February 6, 2026 (&#x201c;FSC Product Royalties&#x201d;), in an aggregate amount of up to approximately&#160;$10,300.  Given our explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $1,188 at June&#160;30, 2021.  This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Armistice Guarantee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with our February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, guaranteed to us the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $1,184 at June&#160;30, 2021.  This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Off-Balance Sheet Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, we did not have any off-balance sheet arrangements, as defined in Item&#160;303(a)(4)(ii) of Regulation S-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <avdl:PercentageOfRoyaltyPayableOnNetSales
      contextRef="i822ef9a632dd493ca409b73ddc200743_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMTUxMQ_68ad35ee-bed6-4d5b-8d16-90c17035c097"
      unitRef="number">0.15</avdl:PercentageOfRoyaltyPayableOnNetSales>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i0d45c7fb17674e24b40b45929846b8f1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMTY0NQ_f5ed88fe-7ba8-40ad-b2de-f97cb6dcad41"
      unitRef="usd">10300000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMTgwMA_66c2e9a8-42c5-43f8-8354-a400e4e60439"
      unitRef="usd">1188000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <avdl:GuaranteeAssetCurrentCarryingValue
      contextRef="i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV84NS9mcmFnOmRiNjYxZWZmZTc1OTQwNDNiYmQ2OTkzMDg4NTkwMWViL3RleHRyZWdpb246ZGI2NjFlZmZlNzU5NDA0M2JiZDY5OTMwODg1OTAxZWJfMjI2OA_4514c0fe-f126-4db6-8f49-da0678a0f4de"
      unitRef="usd">1184000</avdl:GuaranteeAssetCurrentCarryingValue>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756322394504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Aug. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-28508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AVADEL PHARMACEUTICALS PLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1341933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10 Earlsfort Terrace<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 T380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">485-1200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, nominal value $0.01 per share**<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Smaller Reporting Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,596,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001012477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNMS', window );">NASDAQ/NMS (GLOBAL MARKET) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares*<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AVDL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNMS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNMS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756322511336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,091,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,334,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,285,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,742,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">6,762,000<span></span>
</td>
<td class="nump">4,057,000<span></span>
</td>
<td class="nump">10,614,000<span></span>
</td>
<td class="nump">9,587,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">15,174,000<span></span>
</td>
<td class="nump">7,095,000<span></span>
</td>
<td class="nump">26,186,000<span></span>
</td>
<td class="nump">15,008,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">203,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">406,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Changes in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">918,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,396,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of Hospital Products</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,760,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,760,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs (income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="num">(53,000)<span></span>
</td>
<td class="nump">183,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense (income)</a></td>
<td class="nump">21,936,000<span></span>
</td>
<td class="num">(30,178,000)<span></span>
</td>
<td class="nump">36,747,000<span></span>
</td>
<td class="num">(11,438,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="num">(21,936,000)<span></span>
</td>
<td class="nump">40,269,000<span></span>
</td>
<td class="num">(36,747,000)<span></span>
</td>
<td class="nump">33,772,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment and other income (expense), net</a></td>
<td class="nump">432,000<span></span>
</td>
<td class="num">(741,000)<span></span>
</td>
<td class="nump">1,042,000<span></span>
</td>
<td class="num">(1,119,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="num">(1,930,000)<span></span>
</td>
<td class="num">(3,237,000)<span></span>
</td>
<td class="num">(3,859,000)<span></span>
</td>
<td class="num">(6,427,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_GainLossOnReleaseOfCertainLiabilities', window );">Gain from release of certain liabilities</a></td>
<td class="nump">88,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">166,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense - changes in fair value of contingent consideration payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(125,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(435,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">(Loss) income before income taxes</a></td>
<td class="num">(23,346,000)<span></span>
</td>
<td class="nump">36,166,000<span></span>
</td>
<td class="num">(39,398,000)<span></span>
</td>
<td class="nump">25,791,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="num">(3,765,000)<span></span>
</td>
<td class="nump">5,292,000<span></span>
</td>
<td class="num">(6,372,000)<span></span>
</td>
<td class="num">(4,218,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (19,581,000)<span></span>
</td>
<td class="nump">$ 30,874,000<span></span>
</td>
<td class="num">$ (33,026,000)<span></span>
</td>
<td class="nump">$ 30,009,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding - basic (in shares)</a></td>
<td class="nump">58,488<span></span>
</td>
<td class="nump">54,272<span></span>
</td>
<td class="nump">58,465<span></span>
</td>
<td class="nump">47,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted (in shares)</a></td>
<td class="nump">58,488<span></span>
</td>
<td class="nump">69,942<span></span>
</td>
<td class="nump">58,465<span></span>
</td>
<td class="nump">63,083<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GainLossOnReleaseOfCertainLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Release Of Certain Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GainLossOnReleaseOfCertainLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756403037544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (19,581)<span></span>
</td>
<td class="nump">$ 30,874<span></span>
</td>
<td class="num">$ (33,026)<span></span>
</td>
<td class="nump">$ 30,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation loss (income)</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="num">(602)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net other comprehensive (loss) income, net of $(78), $(81), $(133) and $(130) tax, respectively</a></td>
<td class="num">(160)<span></span>
</td>
<td class="nump">927<span></span>
</td>
<td class="num">(697)<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="num">(44)<span></span>
</td>
<td class="nump">1,109<span></span>
</td>
<td class="num">(1,299)<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive (loss) income</a></td>
<td class="num">$ (19,625)<span></span>
</td>
<td class="nump">$ 31,983<span></span>
</td>
<td class="num">$ (34,325)<span></span>
</td>
<td class="nump">$ 30,297<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756321645656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on marketable securities, tax</a></td>
<td class="num">$ (78)<span></span>
</td>
<td class="num">$ (81)<span></span>
</td>
<td class="num">$ (133)<span></span>
</td>
<td class="num">$ (130)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756319995880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 67,142<span></span>
</td>
<td class="nump">$ 71,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">135,701<span></span>
</td>
<td class="nump">149,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent', window );">Research and development tax credit receivable</a></td>
<td class="nump">2,551<span></span>
</td>
<td class="nump">3,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">25,308<span></span>
</td>
<td class="nump">38,726<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">230,702<span></span>
</td>
<td class="nump">263,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,249<span></span>
</td>
<td class="nump">2,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,836<span></span>
</td>
<td class="nump">16,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent', window );">Research and development tax credit receivable</a></td>
<td class="nump">983<span></span>
</td>
<td class="nump">3,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">31,500<span></span>
</td>
<td class="nump">24,939<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">282,591<span></span>
</td>
<td class="nump">311,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">5,116<span></span>
</td>
<td class="nump">2,934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">7,524<span></span>
</td>
<td class="nump">6,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">3,146<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">16,280<span></span>
</td>
<td class="nump">15,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">141,774<span></span>
</td>
<td class="nump">128,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">1,589<span></span>
</td>
<td class="nump">1,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">4,068<span></span>
</td>
<td class="nump">4,212<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">163,711<span></span>
</td>
<td class="nump">149,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at June&#160;30, 2021 and 488 issued and outstanding at December&#160;31, 2020, respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 58,488 issued and outstanding at June&#160;30, 2021 and 58,396 issued and outstanding at December&#160;31, 2020</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">544,094<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(403,453)<span></span>
</td>
<td class="num">(384,187)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(22,350)<span></span>
</td>
<td class="num">(21,051)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">118,880<span></span>
</td>
<td class="nump">162,266<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 282,591<span></span>
</td>
<td class="nump">$ 311,637<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Tax Credit Receivable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The non current portion of tax credit receivable on research and development as on the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756412754040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, nominal value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued (in shares)</a></td>
<td class="nump">488,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding (in shares)</a></td>
<td class="nump">488,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">58,488,000<span></span>
</td>
<td class="nump">58,396,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">58,488,000<span></span>
</td>
<td class="nump">58,396,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756312558280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Ordinary shares</div></th>
<th class="th"><div>Preferred shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th">
<div>Additional paid-in capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th">
<div>Accumulated deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive (loss) income</div></th>
<th class="th"><div>Treasury shares</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,927<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">$ (29,199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 429<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 434,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (391,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,806)<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(865)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(865)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">February 2020 private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,680<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">February 2020 private placement</a></td>
<td class="nump">60,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">60,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,812<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">32,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 518<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">497,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(392,080)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,627)<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,927<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">(29,199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 429<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">434,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(391,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,806)<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">30,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,537<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">182,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 635<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">615,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(361,206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,518)<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,927<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">$ (29,199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 429<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">434,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(391,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,806)<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate202006Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,396<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 162,266<span></span>
</td>
<td class="num">$ (12,939)<span></span>
</td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
<td class="num">$ (26,699)<span></span>
</td>
<td class="num">(384,187)<span></span>
</td>
<td class="nump">$ 13,760<span></span>
</td>
<td class="num">(21,051)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,812<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">32,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 518<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">497,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(392,080)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,627)<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">30,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">1,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">February 2020 private placement</a></td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_StockIssuedDuringPeriodSharesPublicOffering', window );">May 2020 public offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_StockIssuedDuringPeriodValuePublicOffering', window );">May 2020 public offering</a></td>
<td class="nump">116,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,537<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">182,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 635<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">615,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(361,206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,518)<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,396<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">162,266<span></span>
</td>
<td class="num">(12,939)<span></span>
</td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
<td class="num">(26,699)<span></span>
</td>
<td class="num">(384,187)<span></span>
</td>
<td class="nump">13,760<span></span>
</td>
<td class="num">(21,051)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(13,445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1,255)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,255)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,488<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">136,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">542,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(383,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,396<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">162,266<span></span>
</td>
<td class="num">$ (12,939)<span></span>
</td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
<td class="num">$ (26,699)<span></span>
</td>
<td class="num">(384,187)<span></span>
</td>
<td class="nump">$ 13,760<span></span>
</td>
<td class="num">(21,051)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(33,026)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,488<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">118,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">544,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(403,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,488<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">136,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">542,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(383,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(19,581)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,581)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,488<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">$ 118,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 544,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (403,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_StockIssuedDuringPeriodSharesPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Public Offering</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_StockIssuedDuringPeriodSharesPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_StockIssuedDuringPeriodValuePublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Public Offering</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_StockIssuedDuringPeriodValuePublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109244457&amp;loc=d3e16649-113920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756319593912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (19,581,000)<span></span>
</td>
<td class="num">$ (13,445,000)<span></span>
</td>
<td class="nump">$ 30,874,000<span></span>
</td>
<td class="num">$ (865,000)<span></span>
</td>
<td class="num">$ (33,026,000)<span></span>
</td>
<td class="nump">$ 30,009,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417,000<span></span>
</td>
<td class="nump">975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AcquisitionRelatedContingentConsiderationRemeasurement', window );">Remeasurement of acquisition-related contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_FinancingRelatedContingentConsiderationRemeasurement', window );">Remeasurement of financing-related contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">435,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="nump">313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,620,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
<td class="nump">3,193,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Change in deferred tax and income tax deferred charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,228,000)<span></span>
</td>
<td class="nump">161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,729,000<span></span>
</td>
<td class="nump">1,511,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from the disposition of the hospital products</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,760,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,760,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_GainLossOnReleaseOfCertainLiabilities', window );">Gain from the release of certain liabilities</a></td>
<td class="num">(88,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(166,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">757,000<span></span>
</td>
<td class="nump">477,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,589,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,353,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,106,000)<span></span>
</td>
<td class="num">(1,149,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable', window );">Research and development tax credit receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,078,000<span></span>
</td>
<td class="nump">2,036,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable &amp; other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,000<span></span>
</td>
<td class="num">(1,550,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,199,000<span></span>
</td>
<td class="num">(6,906,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Accrued income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">321,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue', window );">Earn-out payments for contingent consideration in excess of acquisition-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,736,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Royalty payments for contingent consideration payable in excess of original fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(608,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet', window );">Other assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,021,000)<span></span>
</td>
<td class="num">(3,458,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,566,000)<span></span>
</td>
<td class="num">(19,417,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the disposition of the hospital products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="nump">14,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,213,000<span></span>
</td>
<td class="nump">15,716,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,372,000)<span></span>
</td>
<td class="num">(97,878,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,315,000<span></span>
</td>
<td class="num">(67,662,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from the February 2020 private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,639,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from the May 2020 public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">116,974,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock option exercises and employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,000<span></span>
</td>
<td class="nump">1,903,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,000<span></span>
</td>
<td class="nump">179,516,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of foreign currency exchange rate changes on cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(478,000)<span></span>
</td>
<td class="num">(37,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,580,000)<span></span>
</td>
<td class="nump">92,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at January 1,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,722,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,774,000<span></span>
</td>
<td class="nump">71,722,000<span></span>
</td>
<td class="nump">9,774,000<span></span>
</td>
<td class="nump">$ 9,774,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at June 30,</a></td>
<td class="nump">$ 67,142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,174,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,142,000<span></span>
</td>
<td class="nump">102,174,000<span></span>
</td>
<td class="nump">$ 71,722,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,234,000<span></span>
</td>
<td class="nump">3,234,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid (refund)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="num">$ (1,795,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AcquisitionRelatedContingentConsiderationRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the remeasurement of acquisition related contingent considerations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AcquisitionRelatedContingentConsiderationRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Earn Out Payment In Excess Of Acquisition Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_FinancingRelatedContingentConsiderationRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the remeasurement of financing related contingent considerations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_FinancingRelatedContingentConsiderationRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GainLossOnReleaseOfCertainLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Release Of Certain Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GainLossOnReleaseOfCertainLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in research and development tax credit receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318365864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. Our lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#8220;EDS&#8221;) and cataplexy in adults with narcolepsy. We are primarily focused on the development and potential United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of FT218. In December 2020, we submitted a New Drug Application (&#8220;NDA&#8221;) to the FDA for FT218 to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The NDA for FT218 was accepted by the FDA in February 2021 and assigned a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) target action date of October 15, 2021.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of our lead product candidate, we continue to evaluate opportunities to expand our product portfolio. As of June 30, 2021, we do not have any approved and commercialized products in our portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are registered as an Irish public limited company. Our headquarters are in Dublin, Ireland and we have operations in St. Louis, Missouri, U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218 is a once-nightly formulation of sodium oxybate that uses our Micropump controlled release drug-delivery technology for the treatment of EDS and cataplexy in adults suffering from narcolepsy. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Sodium oxybate is approved in the U.S. for the treatment of EDS and cataplexy in patients with narcolepsy and is approved in Europe for the treatment of cataplexy in patients with narcolepsy. Since 2002, sodium oxybate has only been available as a formulation that must be taken twice nightly, first at bedtime, and then again 2.5 to 4 hours later.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, we announced the submission of our NDA to the FDA for FT218. On February 26, 2021, the FDA notified us of formal acceptance of the NDA with an assigned PDUFA target action date of October 15, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted a Phase 3 clinical trial of FT218, the REST-ON trial, which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient, last visit was completed at the end of the first quarter of 2020 and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-nightly FT218, the highest dose administered in the trial, demonstrated a statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test, or MWT, clinical global impression-improvement, or CGI-I, and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g also demonstrated a statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-nightly FT218 to be generally well tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence 3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of FT218 discontinued the trial due to adverse reactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the FDA granted FT218 Orphan Drug Designation, which makes the drug eligible for certain development and commercial incentives, including potential U.S. market exclusivity for up to seven years. Additionally, several FT218-related U.S. patents have been issued, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), as well as foreign patent offices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced that the first patient was dosed initiating an open-label extension (&#8220;OLE&#8221;)/switch study of FT218 as a potential treatment for EDS and cataplexy in patients with narcolepsy. The OLE/switch study is examining the long-term safety and maintenance of efficacy of FT218 in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-nightly FT218, regardless of whether they participated in REST-ON. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described FT218 improvements in disturbed nocturnal sleep (&#8220;DNS&#8221;), defined in REST-ON as the number of shifts from stages N1, N2, N3, and rapid eye movement (&#8220;REM&#8221;) sleep to wake and from stages N2, N3, and REM </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sleep to stage N1.  FT218 also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1.  A second poster described the statistically significant improvements in the Epworth Sleepiness Scale, both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at Week 3, for the lowest 6 g dose, compared to placebo. FT218 did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional data supportive of the efficacy findings in REST-ON were presented at the annual meeting of the 35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 or Type 2. Additionally, a post-hoc analysis showed that FT218 was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Previously Approved FDA Products</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020 (the &#8220;Closing Date&#8221;), we announced the sale by Avadel Legacy Pharmaceuticals, LLC (the &#8220;Avadel Seller&#8221;) of the portfolio of sterile injectable drugs used in the hospital setting (the &#8220;Hospital Products&#8221;), which included our three commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to Exela Sterile Medicines LLC (&#8220;Exela Buyer&#8221;) pursuant to an asset purchase agreement (the &#8220;Purchase Agreement&#8221;) by and among the Avadel Seller, Avadel US Holdings, Inc., the Exela Buyer and Exela Holdings, Inc. This sale included the following FDA approved products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Bloxiverz (neostigmine methylsulfate injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -&#160;Bloxiverz is a drug used intravenously in the operating room to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Vazculep (phenylephrine hydrochloride injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -&#160;Vazculep is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Akovaz (ephedrine sulfate injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Akovaz was the first FDA approved formulation of ephedrine sulfate, an alpha- and beta- adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Nouress (cysteine hydrochloride injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Nouress is a sterile injectable product for use in the hospital setting to provide parenteral nutrition to neonates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated balance sheet as of June&#160;30, 2021, which is derived from the prior year 2020 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP), the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#8217;s 2020 Annual Report on Form 10-K filed with the SEC on March 9, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prior to June 30, 2020, revenue was earned from the sales of pharmaceutical products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of our product, which occurs typically upon receipt by the customer. Our gross product sales were subject to a variety of price adjustments in arriving at </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and were estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a complete discussion of the accounting for net product revenue, see </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">: Revenue Recognition</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318452936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Newly Issued Accounting Standards<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Newly Issued Accounting Standards</a></td>
<td class="text">Newly Issued Accounting Standards<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#8217;s amendments primarily impact ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. We adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on our unaudited condensed consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU is effective for our fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method. </span></div>The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#8217;s 4.50%&#160;exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $26,699 decrease in additional paid-in capital, a $12,939 increase in long-term debt, and a $13,760 increase to the opening balance of retained earnings.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756320297448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Products<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Disposition of the Hospital Products</a></td>
<td class="text">Disposition of the Hospital Products <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Closing Date, we announced the sale of our Hospital Products to the Exela Buyer pursuant to the Purchase Agreement (the &#8220;Transaction&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Purchase Agreement, the Exela Buyer agreed to pay a total aggregate consideration amount of $42,000, of which $14,500 was paid on the Closing Date and an additional $27,500 was paid in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV80Ni9mcmFnOjhjNDlmMzY3Y2M2ODQ0YmFhOWY1MzAyZmI4NDg2NjljL3RleHRyZWdpb246OGM0OWYzNjdjYzY4NDRiYWE5ZjUzMDJmYjg0ODY2OWNfMzU1_3778c0a2-5225-4d2e-a722-3095fe25bdd7">ten</span> equal monthly installments following the Closing Date. During the year ended December 31, 2020, we collected four installment payments, totaling $11,000 and during the six months ended June 30, 2021, we collected the remaining six installment payments, totaling $16,500. In connection with the sale of the Hospital Products, the parties also agreed to cause the dismissal of the pending civil litigation related to Nouress in the District Court for the District of Delaware.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were party to a Membership Interest Purchase Agreement, dated March 13, 2012, by and among us, Avadel Legacy, Breaking Stick Holdings, LLC, Deerfield Private Design International II, L.P. (&#8220;Deerfield International&#8221;), Deerfield Private Design Fund II, L.P. (&#8220;Deerfield Fund&#8221;) and Horizon Sant&#233; FLML, Sarl (&#8220;Horizon&#8221;) (the &#8220;Deerfield MIPA&#8221;) and a Royalty Agreement, dated February 4, 2013, by and among us, Avadel Legacy, the Deerfield Fund and Horizon (the &#8220;Deerfield Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Deerfield MIPA (with respect to certain sections thereof) and the Royalty Agreement were assigned to the Exela Buyer. Pursuant to the Purchase Agreement, the Exela </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Deerfield Royalty Agreement for obligations that arise after the Closing Date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were also party to a Royalty Agreement, dated December 3, 2013, by and between us, Avadel Legacy and Broadfin Healthcare Master Fund, Ltd. (the &#8220;Broadfin Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Broadfin Royalty Agreement was assigned to the Exela Buyer and the Exela Buyer assumed and shall pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Broadfin Royalty Agreement for obligations that arise after the Closing Date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the major classes of assets and liabilities either transferred to the Exela Buyer or eliminated by us due to the sale of the Hospital Products in exchange for aggregate consideration of $42,000, less transaction fees of $2,928. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term contingent consideration payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net liabilities disposed of</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less transaction fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net gain on the sale of the Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,760&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated various qualitative and quantitative factors related to the disposition of the Hospital Products and determined that it did not meet the criteria for presentation as a discontinued operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited pro forma condensed combined statement of loss for the six months ended June 30, 2020 included below is being provided for information purposes only and are not necessarily indicative of the results of operations that would have resulted if the Transaction had actually occurred on the date indicated. The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Pro Forma Condensed Combined Statement of Loss</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Adjustments to the pro forma unaudited condensed combined statements of loss</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This adjustment reflects Product sales attributable to the Hospital Products.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This adjustment reflects the following estimated expenses attributable to the Hospital Products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Cost of products of $3,540.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Research and development expenses of $407.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Selling, general and administrative expenses of $776.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Intangible asset amortization on acquired development technology for Vazculep of $406. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Changes in fair value of related party contingent consideration of $3,396.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The Company will no longer be responsible for these payments.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">of $435 attributable to the Hospital Products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The Company will no longer be responsible for these payments.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318449352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, we generated revenue primarily from the sale of pharmaceutical products to customers. On June 30, 2020, we sold the Hospital Products.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Revenue from product sales was recognized when the customer obtained control of our product and our performance obligations were met, which occurred typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, our gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserves to Reduce Gross Revenues to Net Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales were recorded at the net selling price, which included estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves were based on the amounts earned or to be claimed on the related sales and were classified as reductions of accounts receivable if the amount is payable to the customer, except in the case of the estimated reserve for future expired product returns, which are classified as a liability. The reserves are classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves take into consideration relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates to reduce gross selling price to net selling price to which it expects to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company&#8217;s estimates. If actual results in the future vary from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company maintained a returns policy that generally offered customers a right of return for product that has been purchased from the Company. The Company estimated the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue was recognized. The Company estimated product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other judgments and analysis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks, Discounts and Rebates </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to our wholesale customers. Customers charge the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates are estimated at the time of sale to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s source of revenue was from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company&#8217;s revenues by product, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 15: Revenue by Product</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A receivable is recognized in the period the Company sells its products and when the Company&#8217;s right to consideration is unconditional. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material deferred contract costs at June&#160;30, 2021 or December 31, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price Allocated to the Remaining Performance Obligation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For product sales, the Company generally satisfied its performance obligations within the same period the product was delivered. Product sales recognized in the second quarter of 2020 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which the Company recognizes revenue.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756320297448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">Fair Value Measurement<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting.  For example, we use fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221;&#160;defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, we may generally use one or each of the following techniques: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Quoted prices for identical assets or liabilities in active markets. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Unobservable inputs that reflect estimates and assumptions. </span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,008&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160; Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities.  During the periods ended June&#160;30, 2021 and December&#160;31, 2020, respectively, there were no transfers in and out of&#160;Level&#160;1, 2, or 3.  During the&#160;three and six months ended June&#160;30, 2021 and 2020, respectively, we did not recognize any other-than-temporary impairment loss. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s financial instruments, such as cash and cash equivalents, accounts receivable and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our $143,750&#160;aggregate principal amount of&#160;the 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input).  The estimated fair value of the 2023 Notes at June&#160;30, 2021 is $147,523.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9: Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318435784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text">Marketable Securities&#160;<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in available-for-sale debt securities which are recorded at fair market value.  The change in the fair value of equity investments is recognized in our unaudited condensed consolidated statements of (loss) income and the change in the fair value of available-for-sale debt investments is recorded as other comprehensive loss in shareholders&#8217; equity, net of income tax effects.  As of June&#160;30, 2021, we considered any decreases in fair value on our marketable securities to be driven by factors other than credit risk, including market risk.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;June&#160;30, 2021 and December&#160;31, 2020, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,688&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine realized gains or losses on the sale of marketable securities on a specific identification method. We reflect these gains and losses as a component of investment and other income (expense), net in the accompanying unaudited condensed consolidated statements of (loss) income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized gross realized gains of&#160;$41 and $14 for the&#160;three months ended June&#160;30, 2021 and 2020, respectively. These realized gains were offset by realized losses of $39 and $6&#160;for the three months ended June&#160;30, 2021 and 2020, respectively. We recognized gross realized gains of $52 and $290 for the six months ended June&#160;30, 2021 and 2020, respectively. These realized gains were offset by realized losses of $107 and $878 for the six months ended June&#160;30, 2021 and 2020, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of our investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of June&#160;30, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5-10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,965&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our investment in available-for-sale marketable debt securities as current assets in the unaudited condensed consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in our investment portfolio. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross unrealized losses of our available-for-sale debt securities at June&#160;30, 2021 were immaterial. The unrealized losses are driven by factors other than credit risk and have been in an unrealized loss position for less than one year. We do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756412823240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Intangible Assets<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unamortizable goodwill is $16,836 at June&#160;30, 2021 and December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization expense related to an amortizable intangible asset that was assumed by the Exela Buyer as part of the disposition of the Hospital Products on June 30, 2020 of $203 and $406 for the three and six months ended June 30, 2020.  Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  There was no amortization expense recorded during the three and six months ended June&#160;30, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318448232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration Payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Contingent Consideration Payable&#160;</a></td>
<td class="text">Contingent Consideration Payable&#160;Prior to the sale of the Hospital Products on June 30, 2020, we computed the fair value of the contingent consideration using several significant assumptions and when those assumptions changed, due to underlying market conditions, the fair value of these liabilities changed as well. Each of the underlying assumptions used to determine the fair values of these contingent liabilities could, and often did, change based on adjustments in current market conditions, competition and other factors. Prior to the sale of the Hospital Products, these changes had a material impact on our unaudited condensed consolidated statements of (loss) income and balance sheets. As part of the sale of the Hospital Products on June 30, 2020, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy and the Company under the Deerfield Royalty Agreement. As of June&#160;30, 2021 and December 31, 2020, the balance of the contingent consideration payable is $0. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes to the contingent consideration payable, a recurring Level 3 measurement, for the six-month period ended&#160;June 30,&#160;2020:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration Payable Rollforward:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposition of the Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,914&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the unaudited condensed consolidated statements of (loss) income.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756412847032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,976)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of exchangeable notes, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021 and 2020, the total interest expense was $1,930 and $3,237, respectively, with coupon interest expense of $1,617 for each period and the amortization of debt issuance costs and debt discount of $313 and $1,620, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2021 and 2020, the total interest expense was $3,859 and $6,427, respectively, with coupon interest expense of $3,234 for each period and the amortization of debt issuance costs and debt discount of $625 and $3,193, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 2: Newly Issued Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The adoption resulted in a $12,939 increase in long-term debt and a $26,699 decrease in the equity component of the 2023 Notes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2018, Avadel Finance Cayman Limited, a Cayman Islands exempted company (the &#8220;Issuer&#8221;) and an indirect wholly-owned subsidiary of the Company, issued $125,000 aggregate principal amount of 4.50% exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) in a private placement (the &#8220;Offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the 2023 Notes a 30-day option to purchase up to an additional $18,750 aggregate principal amount of the 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts of $6,190, were approximately $137,560.  The 2023 Notes are the Company&#8217;s senior unsecured obligations and rank equally in right of payment with all of the Company&#8217;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes will be exchangeable at the option of the holders at an initial exchange rate of 92.6956 ADSs per $1 principal amount of 2023 Notes, which is equivalent to an initial exchange price of approximately $10.79 per ADS. Such initial exchange price represents a premium of approximately 20% to the $8.99 per ADS closing price on The Nasdaq Global Market on February 13, 2018.  Upon the exchange of any 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#8217;s election. Holders of the 2023 Notes may convert their 2023 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preceding August 1, 2022, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after August 1, 2022 and prior to the close of business on the business day immediately preceding the maturity date:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE1OA_ebaf9a35-35f7-46d5-9322-eec1885aa043">five</span> business day period immediately after any <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUwYjg5YmM1OTk3OTRlZWFhMzIyZjk5YmRlZjMwY2VhL3NlYzo1MGI4OWJjNTk5Nzk0ZWVhYTMyMmY5OWJkZWYzMGNlYV82NC9mcmFnOmFjN2VkY2Q5MmNiZjQyZDM4ZjRkM2M4MDMwMjYwYWQyL3RleHRyZWdpb246YWM3ZWRjZDkyY2JmNDJkMzhmNGQzYzgwMzAyNjBhZDJfMTA5OTUxMTYzNTE3Mw_2f9ed925-ca6a-4374-8047-4f204d21b861">five</span> consecutive trading day period (the &#8220;Measurement Period&#8221;) in which the trading price per $1 principal amount of 2023 Notes, as determined following a request by a holder of the 2023 Notes, for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the ADSs and the exchange rate on each such trading day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If a transaction or event that constitutes a fundamental change or a make-whole fundamental change occurs prior to the close of business on the business day immediately preceding August 1, 2022, regardless of whether a holder of the 2023 Notes has the right to require the Company to repurchase the 2023 Notes, or if Avadel is a party to a merger event that occurs prior to the close of business on the business day immediately preceding August 1, 2022, all or any portion of a the holder&#8217;s 2023 Notes may be surrendered for exchange at any time from or after the date that is 95 scheduled trading days prior to the anticipated effective date of the transaction (or, if later, the earlier of (x) the business day after the Company gives notice of such transaction and (y) the actual effective date of such transaction) until 35 trading days after the actual effective date of such transaction or, if such transaction also constitutes a fundamental change, until the related fundamental change repurchase date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during any calendar quarter commencing after the calendar quarter ending on June 30, 2018 (and only during such calendar quarter), if the last reported sale price of the ADSs for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the exchange price on each applicable trading day. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the Company calls the 2023 Notes for redemption pursuant to Article 16 to the Indenture prior to the close of business on the business day immediately preceding August 1, 2022, then a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time prior to the close of business on the second business day prior to the redemption date, even if the 2023 Notes are not otherwise exchangeable at such time. After that time, the right to exchange shall expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the 2023 Notes may exchange its 2023 Notes until the redemption price has been paid or duly provided for.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered the guidance in ASC 815-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. We determined that this exception applies due, in part, to our ability to settle the 2023 Notes in cash, ADSs or a combination of cash and ADSs, at our option. We have therefore applied the guidance provided by ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span>, as amended by ASU 2020-06.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318443768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit was $3,765 for the three months ended June&#160;30, 2021 resulting in an effective tax rate of 16.1%.  The income tax expense was $5,292 for the three months ended June&#160;30, 2020 resulting in an effective tax rate of 14.6%.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit was $6,372 for the six months ended June&#160;30, 2021 resulting in an effective tax rate of 16.2%.  The income tax benefit was $4,218 for the six months ended June&#160;30, 2020 resulting in an effective tax rate of (16.4)%.  The net increase in the effective income tax rate for the six months ended June 30, 2021 as compared to the prior period in 2020 is primarily due to the discrete tax benefits recognized during the six months ended June 30, 2020 under the Coronavirus Aid, Relief and Economic Security Act, also known as the CARES Act, which did not occur during the six months ended June 30, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the six months ended June 30, 2021 and 2020, the Company received $3,078 and $2,036, respectively, of cash primarily related to refundable French Research &amp; Development Tax Credits generated in prior years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756412847032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Assets and Liabilities</a></td>
<td class="text">Other Assets and Liabilities&#160;<div style="margin-bottom:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized as follows:</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value-added tax recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivable from Exela (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,308&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,726&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsource contract costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,524&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due to Exela</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,068&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318223160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Costs</a></td>
<td class="text">Restructuring Costs<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 French Restructuring</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2019, the Company initiated a plan to substantially reduce all of its workforce at its V&#233;nissieux, France site (&#8220;2019 French Restructuring&#8221;).  This reduction was part of an effort to align the Company&#8217;s cost structure with our ongoing and future planned projects. The reduction in workforce was completed during 2020. Restructuring (income) charges associated with this plan recognized during the three and six months ended June&#160;30, 2021 and 2020 were immaterial. </span></div><div style="margin-bottom:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s cost reduction plan obligations for the six months ended June&#160;30, 2021:</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 French Restructuring Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at June 30, </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 French Restructuring liabilities of $107 are included in the unaudited condensed consolidated balance sheet in accrued expenses at June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Corporate Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, the Company announced a plan to reduce its Corporate workforce by more than 50% (&#8220;2019 Corporate Restructuring&#8221;). The reduction in workforce is primarily a result of the exit of Noctiva during the first quarter of 2019, as well as an effort to better align the Company&#8217;s remaining cost structure at our U.S. and Ireland locations with our ongoing and future planned projects. The reduction in workforce was completed during 2020. The restructuring charges associated with this plan recognized during the six months ended June&#160;30, 2021 and 2020 were immaterial.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s cost reduction plan obligations for the six months ended June&#160;30, 2021:</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.428%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 Corporate Restructuring Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at June 30, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>The 2019 Corporate Restructuring liabilities of $70 are included in the unaudited condensed consolidated balance sheet in accrued expenses at June&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756316884856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net (Loss) Income Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of shares outstanding during each period. Diluted net (loss) income per share is calculated by dividing net (loss) income - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net (loss) income, diluted net (loss) income per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of our preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under our employee stock purchase plan (&#8220;ESPP&#8221;). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. We utilize the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of our ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under our ESPP has been calculated using the treasury stock method.  The dilutive effect of the performance share units (&#8220;PSUs&#8221;) will be calculated using the treasury stock method, if and when the contingent vesting condition is achieved. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands is as follows:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (Loss) Income Per Share:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,026)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: interest from 2023 Notes, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,581)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,026)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,488&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,465&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,488&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,942&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,083&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Potential ordinary shares of&#160;15,586&#160;and&#160;2,472&#160;were excluded from the calculation of weighted average shares for the three months ended June&#160;30, 2021 and 2020, respectively, and potential ordinary shares of&#160;15,426&#160;and&#160;2,537&#160;were excluded from the calculation of weighted average shares for the six months ended June&#160;30, 2021 and 2020, respectively, because either their effect was considered to be anti-dilutive or they were related to shares from PSUs for which the contingent vesting condition had not been achieved. For the three and six months ended June&#160;30, 2021, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in these periods.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756316956440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive Loss&#160;<div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the three and six months ended June&#160;30, 2021 and 2020, respectively, net of tax effects:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.749%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,738)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,733)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,733)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain on marketable debt securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income, net of $(78), $(81)  $(133) and $(130) tax, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,350)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,518)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,350)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,518)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on the Company&#8217;s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756491250248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue by Product<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Revenue by Product</a></td>
<td class="text">Revenue by Product&#160;The Company has determined that it operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on our proprietary polymer based technology. The Company&#8217;s Chief Operating Decision Maker is the Chief Executive Officer (the &#8220;CEO&#8221;). The CEO reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions as well as resource allocations. All products were included in one segment because the Company&#8217;s products have similar economic and other characteristics, including the nature of the products and production processes, type of customers, distribution methods and regulatory environment.&#160;<div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, we sold the Hospital Products. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following table presents a summary of total product sales by these products:&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.318%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product Sales by Product:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bloxiverz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vazculep</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Akovaz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,091&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, we sold the Hospital Products.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756316824824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation &#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to potential liabilities generally incidental to our business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At June 30, 2021 and December 31, 2020, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#8217;s unaudited condensed consolidated financial position, results of operations, cash flows or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#8220;Jazz&#8221;) filed a formal complaint (the &#8220;Complaint&#8221;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#8220;Court&#8221;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#8220;Avadel Parties&#8221;). In the Complaint, Jazz alleges the sodium oxybate product (&#8220;Proposed Product&#8221;) described in the New Drug Application (&#8220;NDA&#8221;) owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#8220;patents-in-suit&#8221;). The Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Avadel Answer&#8221;) with the Court in response to the Complaint.  The Avadel Answer generally denies the allegations set forth in the Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, ii) a declaratory judgment of invalidity of each patent-in-suit, and iii) a declaratory judgement requiring delisting of US Patent No. 8731963 from FDA&#8217;s Orange Book. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, Jazz filed its Answer (&#8220;Jazz Answer&#8221;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#8217;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a preliminary injunction hearing date of November 23, 2021 (only relevant in the event that Jazz files a motion for a preliminary injunction by October 22, 2021), ii) a claim construction hearing date of August 2, 2022, and iii) a trial date of October 30, 2023.   </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, Jazz filed another formal complaint (the &#8220;Second Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11077079. The Second Complaint further includes </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.&#160; &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Commitments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than commitments disclosed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 17: Contingent Liabilities and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Company's consolidated financial statements included in the 2020 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deerfield Guarantee</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our guarantee to Deerfield and the guarantee received by us from Armistice largely offset and when combined are not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our February 2018 divestiture of our pediatric assets, we guaranteed to Deerfield the quarterly royalty payment of&#160;15%&#160;on net sales of the FSC products through February 6, 2026 (&#8220;FSC Product Royalties&#8221;), in an aggregate amount of up to approximately&#160;$10,300.  Given our explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $1,188 at June&#160;30, 2021.  This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Armistice Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, guaranteed to us the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $1,184 at June&#160;30, 2021.  This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, we did not have any off-balance sheet arrangements, as defined in Item&#160;303(a)(4)(ii) of Regulation S-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756321671784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_NatureOfBusinessPolicyPolicyTextBlock', window );">Nature of Operations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. Our lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#8220;EDS&#8221;) and cataplexy in adults with narcolepsy. We are primarily focused on the development and potential United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of FT218. In December 2020, we submitted a New Drug Application (&#8220;NDA&#8221;) to the FDA for FT218 to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The NDA for FT218 was accepted by the FDA in February 2021 and assigned a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) target action date of October 15, 2021.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of our lead product candidate, we continue to evaluate opportunities to expand our product portfolio. As of June 30, 2021, we do not have any approved and commercialized products in our portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are registered as an Irish public limited company. Our headquarters are in Dublin, Ireland and we have operations in St. Louis, Missouri, U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218 is a once-nightly formulation of sodium oxybate that uses our Micropump controlled release drug-delivery technology for the treatment of EDS and cataplexy in adults suffering from narcolepsy. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Sodium oxybate is approved in the U.S. for the treatment of EDS and cataplexy in patients with narcolepsy and is approved in Europe for the treatment of cataplexy in patients with narcolepsy. Since 2002, sodium oxybate has only been available as a formulation that must be taken twice nightly, first at bedtime, and then again 2.5 to 4 hours later.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, we announced the submission of our NDA to the FDA for FT218. On February 26, 2021, the FDA notified us of formal acceptance of the NDA with an assigned PDUFA target action date of October 15, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted a Phase 3 clinical trial of FT218, the REST-ON trial, which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient, last visit was completed at the end of the first quarter of 2020 and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-nightly FT218, the highest dose administered in the trial, demonstrated a statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test, or MWT, clinical global impression-improvement, or CGI-I, and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g also demonstrated a statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-nightly FT218 to be generally well tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence 3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of FT218 discontinued the trial due to adverse reactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the FDA granted FT218 Orphan Drug Designation, which makes the drug eligible for certain development and commercial incentives, including potential U.S. market exclusivity for up to seven years. Additionally, several FT218-related U.S. patents have been issued, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), as well as foreign patent offices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced that the first patient was dosed initiating an open-label extension (&#8220;OLE&#8221;)/switch study of FT218 as a potential treatment for EDS and cataplexy in patients with narcolepsy. The OLE/switch study is examining the long-term safety and maintenance of efficacy of FT218 in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-nightly FT218, regardless of whether they participated in REST-ON. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described FT218 improvements in disturbed nocturnal sleep (&#8220;DNS&#8221;), defined in REST-ON as the number of shifts from stages N1, N2, N3, and rapid eye movement (&#8220;REM&#8221;) sleep to wake and from stages N2, N3, and REM </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sleep to stage N1.  FT218 also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1.  A second poster described the statistically significant improvements in the Epworth Sleepiness Scale, both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at Week 3, for the lowest 6 g dose, compared to placebo. FT218 did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional data supportive of the efficacy findings in REST-ON were presented at the annual meeting of the 35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 or Type 2. Additionally, a post-hoc analysis showed that FT218 was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Previously Approved FDA Products</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020 (the &#8220;Closing Date&#8221;), we announced the sale by Avadel Legacy Pharmaceuticals, LLC (the &#8220;Avadel Seller&#8221;) of the portfolio of sterile injectable drugs used in the hospital setting (the &#8220;Hospital Products&#8221;), which included our three commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to Exela Sterile Medicines LLC (&#8220;Exela Buyer&#8221;) pursuant to an asset purchase agreement (the &#8220;Purchase Agreement&#8221;) by and among the Avadel Seller, Avadel US Holdings, Inc., the Exela Buyer and Exela Holdings, Inc. This sale included the following FDA approved products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Bloxiverz (neostigmine methylsulfate injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -&#160;Bloxiverz is a drug used intravenously in the operating room to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Vazculep (phenylephrine hydrochloride injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -&#160;Vazculep is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Akovaz (ephedrine sulfate injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Akovaz was the first FDA approved formulation of ephedrine sulfate, an alpha- and beta- adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Nouress (cysteine hydrochloride injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Nouress is a sterile injectable product for use in the hospital setting to provide parenteral nutrition to neonates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated balance sheet as of June&#160;30, 2021, which is derived from the prior year 2020 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP), the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#8217;s 2020 Annual Report on Form 10-K filed with the SEC on March 9, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prior to June 30, 2020, revenue was earned from the sales of pharmaceutical products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of our product, which occurs typically upon receipt by the customer. Our gross product sales were subject to a variety of price adjustments in arriving at </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and were estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a complete discussion of the accounting for net product revenue, see </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">: Revenue Recognition</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>Revenue Recognition<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, we generated revenue primarily from the sale of pharmaceutical products to customers. On June 30, 2020, we sold the Hospital Products.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Disposition of the Hospital Products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, we sold products primarily through wholesalers and considered these wholesalers to be our customers. Revenue from product sales was recognized when the customer obtained control of our product and our performance obligations were met, which occurred typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, our gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserves to Reduce Gross Revenues to Net Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales were recorded at the net selling price, which included estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves were based on the amounts earned or to be claimed on the related sales and were classified as reductions of accounts receivable if the amount is payable to the customer, except in the case of the estimated reserve for future expired product returns, which are classified as a liability. The reserves are classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves take into consideration relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates to reduce gross selling price to net selling price to which it expects to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company&#8217;s estimates. If actual results in the future vary from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company maintained a returns policy that generally offered customers a right of return for product that has been purchased from the Company. The Company estimated the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue was recognized. The Company estimated product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other judgments and analysis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks, Discounts and Rebates </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to our wholesale customers. Customers charge the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates are estimated at the time of sale to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s source of revenue was from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company&#8217;s revenues by product, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 15: Revenue by Product</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A receivable is recognized in the period the Company sells its products and when the Company&#8217;s right to consideration is unconditional. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material deferred contract costs at June&#160;30, 2021 or December 31, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price Allocated to the Remaining Performance Obligation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For product sales, the Company generally satisfied its performance obligations within the same period the product was delivered. Product sales recognized in the second quarter of 2020 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which the Company recognizes revenue.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Newly Issued Accounting Standards</a></td>
<td class="text">Newly Issued Accounting Standards<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#8217;s amendments primarily impact ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. We adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on our unaudited condensed consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU is effective for our fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method. </span></div>The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#8217;s 4.50%&#160;exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $26,699 decrease in additional paid-in capital, a $12,939 increase in long-term debt, and a $13,760 increase to the opening balance of retained earnings.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_NatureOfBusinessPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for nature of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_NatureOfBusinessPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756316964952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Products - (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the major classes of assets and liabilities either transferred to the Exela Buyer or eliminated by us due to the sale of the Hospital Products in exchange for aggregate consideration of $42,000, less transaction fees of $2,928. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term contingent consideration payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net liabilities disposed of</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less transaction fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net gain on the sale of the Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,760&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Schedule of Error Corrections and Prior Period Adjustments</a></td>
<td class="text">The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Pro Forma Condensed Combined Statement of Loss</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Adjustments to the pro forma unaudited condensed combined statements of loss</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This adjustment reflects Product sales attributable to the Hospital Products.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This adjustment reflects the following estimated expenses attributable to the Hospital Products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Cost of products of $3,540.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Research and development expenses of $407.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Selling, general and administrative expenses of $776.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Intangible asset amortization on acquired development technology for Vazculep of $406. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:13.8pt">Changes in fair value of related party contingent consideration of $3,396.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The Company will no longer be responsible for these payments.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">of $435 attributable to the Hospital Products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The Company will no longer be responsible for these payments.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318281736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,008&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318251048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Schedule of Available-for-sale and Equity Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;June&#160;30, 2021 and December&#160;31, 2020, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,688&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Contractual Maturity Dates</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of our investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of June&#160;30, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5-10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,965&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318268920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Transactions</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes to the contingent consideration payable, a recurring Level 3 measurement, for the six-month period ended&#160;June 30,&#160;2020:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration Payable Rollforward:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposition of the Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,914&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the unaudited condensed consolidated statements of (loss) income.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318863176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,976)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of exchangeable notes, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318794536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div style="margin-bottom:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized as follows:</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value-added tax recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivable from Exela (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,308&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,726&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsource contract costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,524&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due to Exela</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule Of Long Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,068&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756410749624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring and Related Costs</a></td>
<td class="text"><div style="margin-bottom:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s cost reduction plan obligations for the six months ended June&#160;30, 2021:</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 French Restructuring Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at June 30, </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s cost reduction plan obligations for the six months ended June&#160;30, 2021:</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.428%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 Corporate Restructuring Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at June 30, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318269480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share Reconciliation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands is as follows:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (Loss) Income Per Share:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,026)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: interest from 2023 Notes, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,581)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,026)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,488&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,465&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,488&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,942&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,083&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318445992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the three and six months ended June&#160;30, 2021 and 2020, respectively, net of tax effects:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.749%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,738)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,733)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,733)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain on marketable debt securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income, net of $(78), $(81)  $(133) and $(130) tax, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,350)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,518)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,350)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,518)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756316816520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue by Product (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, Revenue by Product</a></td>
<td class="text">The following table presents a summary of total product sales by these products:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.318%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product Sales by Product:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bloxiverz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vazculep</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Akovaz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,091&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756319067784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Newly Issued Accounting Standards (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">$ 118,880<span></span>
</td>
<td class="nump">$ 136,504<span></span>
</td>
<td class="nump">$ 162,266<span></span>
</td>
<td class="nump">$ 182,125<span></span>
</td>
<td class="nump">$ 32,067<span></span>
</td>
<td class="num">$ (29,199)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">544,094<span></span>
</td>
<td class="nump">542,093<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
<td class="nump">615,207<span></span>
</td>
<td class="nump">497,249<span></span>
</td>
<td class="nump">434,391<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="num">(403,453)<span></span>
</td>
<td class="num">$ (383,872)<span></span>
</td>
<td class="num">(384,187)<span></span>
</td>
<td class="num">$ (361,206)<span></span>
</td>
<td class="num">$ (392,080)<span></span>
</td>
<td class="num">$ (391,215)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Book value of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Book value of long-term debt</a></td>
<td class="nump">$ 141,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756320253112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Products - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the disposition of the hospital products</a></td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="nump">$ 14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember', window );">The Business | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration', window );">Initial cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments', window );">Additional consideration paid in monthly installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm', window );">Payment installment term (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the disposition of the hospital products</a></td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Transaction fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Initial Cash Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payment Installment Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756323303896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Products - Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details) - The Business - Disposal Group, Disposed of by Sale, Not Discontinued Operations<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">$ (134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="num">(4,922)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="num">(1,654)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="num">(407)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="num">(1,095)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining', window );">Total long-term contingent consideration payable</a></td>
<td class="nump">14,900<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Net liabilities disposed of</a></td>
<td class="nump">6,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Aggregate consideration</a></td>
<td class="nump">42,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Less transaction fees</a></td>
<td class="num">(2,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Net gain on the sale of the Hospital Products</a></td>
<td class="nump">$ 45,760<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts of material contingent liabilities, for example, but not limited to, product or environmental liabilities or litigation, that remain with the entity despite the disposal of the disposal group that is classified as a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.Z.5.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7384-122677<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14472-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14453-108349<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14394-108349<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2510-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756425855688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Products - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,091<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="nump">21,936<span></span>
</td>
<td class="num">(30,178)<span></span>
</td>
<td class="nump">36,747<span></span>
</td>
<td class="num">(11,438)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(21,936)<span></span>
</td>
<td class="nump">40,269<span></span>
</td>
<td class="num">(36,747)<span></span>
</td>
<td class="nump">33,772<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total income before income taxes</a></td>
<td class="num">(23,346)<span></span>
</td>
<td class="nump">36,166<span></span>
</td>
<td class="num">(39,398)<span></span>
</td>
<td class="nump">25,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,285<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">6,762<span></span>
</td>
<td class="nump">4,057<span></span>
</td>
<td class="nump">10,614<span></span>
</td>
<td class="nump">9,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">15,174<span></span>
</td>
<td class="nump">7,095<span></span>
</td>
<td class="nump">26,186<span></span>
</td>
<td class="nump">15,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Changes in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense - changes in fair value of contingent consideration payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ProFormaMember', window );">Pro Forma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,963)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,438)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,772<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Pro Forma Adjustments | Pro Forma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,525)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,215)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Pro Forma Adjustments | Pro Forma | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Changes in fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense - changes in fair value of contingent consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 435<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ProFormaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ProFormaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318518856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Deferred contract costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318821208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Measured on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">$ 135,701<span></span>
</td>
<td class="nump">$ 149,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember', window );">Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">91,732<span></span>
</td>
<td class="nump">104,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">23,056<span></span>
</td>
<td class="nump">22,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">17,853<span></span>
</td>
<td class="nump">18,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">3,060<span></span>
</td>
<td class="nump">3,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">91,732<span></span>
</td>
<td class="nump">104,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">91,732<span></span>
</td>
<td class="nump">104,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">43,969<span></span>
</td>
<td class="nump">45,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">23,056<span></span>
</td>
<td class="nump">22,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">17,853<span></span>
</td>
<td class="nump">18,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">3,060<span></span>
</td>
<td class="nump">3,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756321533768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Narrative (Details) - Senior Notes - 4.50% Exchangeable Senior Notes Due 2023 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 143,750<span></span>
</td>
<td class="nump">$ 143,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Estimated fair value of long-term debt</a></td>
<td class="nump">$ 147,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756321556968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Marketable securities, realized gain</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Marketable securities, realized loss</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756322619928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Summary of Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">$ 134,688<span></span>
</td>
<td class="nump">$ 147,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">1,486<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(473)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">135,701<span></span>
</td>
<td class="nump">149,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember', window );">Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">90,907<span></span>
</td>
<td class="nump">103,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">1,171<span></span>
</td>
<td class="nump">1,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(346)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">91,732<span></span>
</td>
<td class="nump">104,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">22,853<span></span>
</td>
<td class="nump">21,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">23,056<span></span>
</td>
<td class="nump">22,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">17,873<span></span>
</td>
<td class="nump">18,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">17,853<span></span>
</td>
<td class="nump">18,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">3,055<span></span>
</td>
<td class="nump">3,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 3,060<span></span>
</td>
<td class="nump">$ 3,854<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756322836648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Schedule of Maturities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 135,701<span></span>
</td>
<td class="nump">$ 149,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">7,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">15,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">23,056<span></span>
</td>
<td class="nump">22,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">4,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">10,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">1,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">17,853<span></span>
</td>
<td class="nump">18,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">1,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">3,060<span></span>
</td>
<td class="nump">$ 3,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">12,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">27,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">1,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">1,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 43,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756321522952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 16,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318489304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingent Consideration Payable&#160; - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Contingent consideration payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,914,000<span></span>
</td>
<td class="nump">$ 17,327,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756316844392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration Payable - Payable Balance (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward', window );"><strong>Contingent Consideration Payable Rollforward:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Related party payable, beginning balance</a></td>
<td class="nump">$ 17,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments of contingent consideration</a></td>
<td class="num">(4,344)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Fair value adjustments</a></td>
<td class="nump">3,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Disposition of the Hospital Products</a></td>
<td class="num">(14,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Related party payable, ending balance</a></td>
<td class="nump">$ 1,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Changes in Related Party Payable [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756323247624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current maturities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">141,774<span></span>
</td>
<td class="nump">128,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount and issuance costs, net</a></td>
<td class="num">(1,976)<span></span>
</td>
<td class="num">(15,540)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying amount of liability component</a></td>
<td class="nump">141,774<span></span>
</td>
<td class="nump">128,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Equity component of exchangeable notes, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(26,699)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount of 4.50% exchangeable senior notes due 2023</a></td>
<td class="nump">$ 143,750<span></span>
</td>
<td class="nump">$ 143,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756312887112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 16, 2018 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares </div>
<div>Rate</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,930,000<span></span>
</td>
<td class="nump">$ 3,237,000<span></span>
</td>
<td class="nump">$ 3,859,000<span></span>
</td>
<td class="nump">$ 6,427,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_CouponInterestExpense', window );">Coupon interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,617,000<span></span>
</td>
<td class="nump">1,617,000<span></span>
</td>
<td class="nump">3,234,000<span></span>
</td>
<td class="nump">3,234,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,000<span></span>
</td>
<td class="nump">1,620,000<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
<td class="nump">3,193,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,880,000<span></span>
</td>
<td class="nump">182,125,000<span></span>
</td>
<td class="nump">118,880,000<span></span>
</td>
<td class="nump">182,125,000<span></span>
</td>
<td class="nump">$ 136,504,000<span></span>
</td>
<td class="nump">$ 162,266,000<span></span>
</td>
<td class="nump">$ 32,067,000<span></span>
</td>
<td class="num">$ (29,199,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AmericanDepositorySharesConversionRatio', window );">ADSs, conversion ratio | Rate</a></td>
<td class="nump">9269.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">544,094,000<span></span>
</td>
<td class="nump">615,207,000<span></span>
</td>
<td class="nump">544,094,000<span></span>
</td>
<td class="nump">615,207,000<span></span>
</td>
<td class="nump">542,093,000<span></span>
</td>
<td class="nump">566,916,000<span></span>
</td>
<td class="nump">497,249,000<span></span>
</td>
<td class="nump">434,391,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(403,453,000)<span></span>
</td>
<td class="num">$ (361,206,000)<span></span>
</td>
<td class="num">(403,453,000)<span></span>
</td>
<td class="num">$ (361,206,000)<span></span>
</td>
<td class="num">$ (383,872,000)<span></span>
</td>
<td class="num">(384,187,000)<span></span>
</td>
<td class="num">$ (392,080,000)<span></span>
</td>
<td class="num">$ (391,215,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Book value of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,939,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,939,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,699,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,760,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Book value of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,774,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,774,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm', window );">Option to purchase aggregate principal amount, term</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentOptiontoIncreaseFaceAmount', window );">Option to increase aggregate principal amount</a></td>
<td class="nump">$ 18,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="nump">6,190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from loans or conditional grants</a></td>
<td class="nump">$ 137,560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AmericanDepositarySharesOptionPricePerShare', window );">ADS, option price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AmericanDepositarySharesPremiumPercentage', window );">ADS premium percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AmericanDepositarySharesPurchasedPricePerShare', window );">ADS purchased, price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember', window );">Debt Instrument, Redemption, Period One | 4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted', window );">Number of business days</a></td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays', window );">Consecutive business days</a></td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay', window );">Percentage of product of the last reported sale price of the American Depositary Shares and the exchange rate on each such trading day</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember', window );">Debt Instrument, Redemption, Period Two | 4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays', window );">Scheduled threshold trading days</a></td>
<td class="text">35 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember', window );">Debt Instrument, Redemption, Period Three | 4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of stock price trigger</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesOptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares, Option Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesOptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesPremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares, Premium Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesPremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesPurchasedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares Purchased, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesPurchasedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositorySharesConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>American Depository Shares, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositorySharesConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_CouponInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Coupon Interest Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_CouponInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Scheduled Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Threshold Consecutive Business Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Option To Purchase Aggregate Principal Amount, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentOptiontoIncreaseFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Option to Increase Face Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentOptiontoIncreaseFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756316660424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">$ (3,765)<span></span>
</td>
<td class="nump">$ 5,292<span></span>
</td>
<td class="num">$ (6,372)<span></span>
</td>
<td class="num">$ (4,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">16.10%<span></span>
</td>
<td class="nump">14.60%<span></span>
</td>
<td class="nump">16.20%<span></span>
</td>
<td class="num">(16.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIncomeTaxRefunds', window );">Proceeds from income tax refunds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,078<span></span>
</td>
<td class="nump">$ 2,036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIncomeTaxRefunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIncomeTaxRefunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756410380392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expenses and Other Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivableCurrent', window );">Value-added tax recoverable</a></td>
<td class="nump">$ 306<span></span>
</td>
<td class="nump">$ 341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid and other expenses</a></td>
<td class="nump">3,983<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short-term deposit</a></td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">1,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_GuaranteeCurrent', window );">Guarantee from Armistice</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">18,835<span></span>
</td>
<td class="nump">18,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ShortTermNoteReceivable', window );">Receivable from Exela (see Note 3)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">457<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total &#160;</a></td>
<td class="nump">$ 25,308<span></span>
</td>
<td class="nump">$ 38,726<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ShortTermNoteReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short Term Note Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ShortTermNoteReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318332120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Non-Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Non-Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">$ 24,484<span></span>
</td>
<td class="nump">$ 18,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_GuaranteeNoncurrent', window );">Guarantee from Armistice</a></td>
<td class="nump">910<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent', window );">Right of use assets at contract manufacturing organizations</a></td>
<td class="nump">5,749<span></span>
</td>
<td class="nump">5,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_OtherNoncurrentReceivables', window );">Other</a></td>
<td class="nump">357<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total &#160;</a></td>
<td class="nump">$ 31,500<span></span>
</td>
<td class="nump">$ 24,939<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of other noncurrent receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756320345704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 1,504<span></span>
</td>
<td class="nump">$ 1,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Accrued restructuring (see Note 12)</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AccruedTradeDiscountsAndRebates', window );">Customer allowances</a></td>
<td class="nump">821<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AccruedOutsourceContractCosts', window );">Accrued outsource contract costs</a></td>
<td class="nump">837<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">4,185<span></span>
</td>
<td class="nump">2,781<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total &#160;</a></td>
<td class="nump">$ 7,524<span></span>
</td>
<td class="nump">$ 6,501<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedOutsourceContractCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Outsource Contract Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedOutsourceContractCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedTradeDiscountsAndRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedTradeDiscountsAndRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756316776808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AccruedInterestCurrent', window );">Accrued interest</a></td>
<td class="nump">$ 2,695<span></span>
</td>
<td class="nump">$ 2,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Due to Exela</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_OtherGuarantorObligationsCurrentCarryingValue', window );">Guarantee to Deerfield</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_OtherLiabilitiesMiscellaneousCurrent', window );">Other</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 3,146<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherGuarantorObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Guarantor Obligations, Current Carrying Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherGuarantorObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherLiabilitiesMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Miscellaneous, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherLiabilitiesMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756321601192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Non-Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other Non-Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 3,143<span></span>
</td>
<td class="nump">$ 3,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuarantyLiabilities', window );">Guarantee to Deerfield</a></td>
<td class="nump">913<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total &#160;</a></td>
<td class="nump">$ 4,068<span></span>
</td>
<td class="nump">$ 4,212<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuarantyLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11019-110243<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11049-110243<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuarantyLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756323519736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restructuring Costs - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember', window );">2019 French Restructuring Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_CorporateWorkforceReductionMember', window );">Corporate Workforce Reduction | Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent', window );">Expected number of positions eliminated (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember', window );">2019 Corporate Restructuring Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_CorporateWorkforceReductionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_CorporateWorkforceReductionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756319074632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs - Severance Obligation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember', window );">2019 French Restructuring Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, beginning balance</a></td>
<td class="nump">$ 248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Foreign currency impact</a></td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, ending balance</a></td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember', window );">2019 French Restructuring Obligation | Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment', window );">Charges (income) for employee severance, benefits and other costs</a></td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember', window );">2019 Corporate Restructuring Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, beginning balance</a></td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, ending balance</a></td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember', window );">2019 Corporate Restructuring Obligations | Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment', window );">Charges (income) for employee severance, benefits and other costs</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Before Gain (Loss) Due to Curtailment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RestructuringChargesBeforeGainLossDuetoCurtailment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756322581576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share - Reconciliation of Basic and Diluted Calculation (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (19,581)<span></span>
</td>
<td class="num">$ (13,445)<span></span>
</td>
<td class="nump">$ 30,874<span></span>
</td>
<td class="num">$ (865)<span></span>
</td>
<td class="num">$ (33,026)<span></span>
</td>
<td class="nump">$ 30,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecurities', window );">Add: interest from 2023 Notes, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,427<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToParentDiluted', window );">Net (loss) income - diluted</a></td>
<td class="num">$ (19,581)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (33,026)<span></span>
</td>
<td class="nump">$ 36,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted Average Number of Shares Outstanding, Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares (in shares)</a></td>
<td class="nump">58,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,465<span></span>
</td>
<td class="nump">47,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,418<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares (in shares)</a></td>
<td class="nump">58,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,465<span></span>
</td>
<td class="nump">63,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToParentDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToParentDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756318182904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">15,586<span></span>
</td>
<td class="nump">2,472<span></span>
</td>
<td class="nump">15,426<span></span>
</td>
<td class="nump">2,537<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756322595752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Loss) - Components (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 136,504<span></span>
</td>
<td class="nump">$ 32,067<span></span>
</td>
<td class="nump">$ 162,266<span></span>
</td>
<td class="num">$ (29,199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(19,625)<span></span>
</td>
<td class="nump">31,983<span></span>
</td>
<td class="num">(34,325)<span></span>
</td>
<td class="nump">30,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">118,880<span></span>
</td>
<td class="nump">182,125<span></span>
</td>
<td class="nump">118,880<span></span>
</td>
<td class="nump">182,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(23,345)<span></span>
</td>
<td class="num">(23,915)<span></span>
</td>
<td class="num">(22,627)<span></span>
</td>
<td class="num">(23,738)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="num">(602)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(23,229)<span></span>
</td>
<td class="num">(23,733)<span></span>
</td>
<td class="num">(23,229)<span></span>
</td>
<td class="num">(23,733)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized gain on marketable debt securities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(160)<span></span>
</td>
<td class="nump">927<span></span>
</td>
<td class="num">(697)<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">879<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(22,306)<span></span>
</td>
<td class="num">(23,627)<span></span>
</td>
<td class="num">(21,051)<span></span>
</td>
<td class="num">(22,806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (22,350)<span></span>
</td>
<td class="num">$ (22,518)<span></span>
</td>
<td class="num">$ (22,350)<span></span>
</td>
<td class="num">$ (22,518)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756323083224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on marketable securities, tax</a></td>
<td class="num">$ (78)<span></span>
</td>
<td class="num">$ (81)<span></span>
</td>
<td class="num">$ (133)<span></span>
</td>
<td class="num">$ (130)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756319647576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue by Product - Summary of Revenue (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,091<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_BloxiverzMember', window );">Bloxiverz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_VazculepMember', window );">Vazculep</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_AkovazMember', window );">Akovaz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_OtherProductsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_BloxiverzMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_BloxiverzMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_VazculepMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_VazculepMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_AkovazMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_AkovazMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_OtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_OtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139756320804712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_PercentageOfRoyaltyPayableOnNetSales', window );">Percentage of royalty payable on net sales</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Guarantee, liability</a></td>
<td class="nump">$ 1,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_GuaranteeAssetCurrentCarryingValue', window );">Guarantee from Armistice</a></td>
<td class="nump">1,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Guarantee, liability</a></td>
<td class="nump">$ 10,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeAssetCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Asset, Current Carrying Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeAssetCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_PercentageOfRoyaltyPayableOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of royalty that has to be paid by the company as per the royalty agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_PercentageOfRoyaltyPayableOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>76
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M9DF:J 0V3-@T<J&Y_<< S) "\(X^8)2L5.\5Z%PCMMO&AVH+O!7'(9K_K(%
M&_:#:8\%2F1:.T,>$S+$!+"3Q[EBB,NE7O\ZZ9PDMEO)DR][-1/-^%(4_.U,
ML=>>!6*:O&'YL C541-*?6@-3"!2&M'(7'DQ "5>\/ZY]_VO'IW-)':;>=NF
MCDYF^GECF:A36P$AIL<;TL WO^8Q@/1(9);$"43ITP HGA#2);B_JY+.81*[
MP[S73Q5'^VG#X;^OGEYH-H0Q *5."#R%32!22G7O!?*'2!VGOWF0SE\2N[\L
M\R_31]I=U#_QZ1(R8S*9ESX++42:LF+O+NBZFC&"_52<,TH/M3%ASID7'.H"
MDGF5FV[_X4.%(&J?]JC365!BMZ"@.HLDW2J^^!E]Z,?T,6'.F1L=Z@.2'=,'
MHO;"'GTZ3TKLGO1;]=.\UH+M=#-9<91OLYF60G>;YN=BL552/\0O2M^ZO[#J
MV[!:IGOT0C<,#]4"8-I3D$.Y0#;?.Q0(\,&!OP=[KU#G5XG=K_ZL0ON+RZ:1
M:2=!C4R8'T6NH1'(9FH$L.GB=KC+1GLO*#)>K*HW0U)[CFVNZM^BVZOMVZ?K
MZIW+P?4;?#[&P/4)/H_K=TL=??VJZXX5JR27*.5+/91S%NBY%O7;H_I$B4WU
M>F0FE!)9=;CF3#NA$J#O+X50;R?E .T[O*M_ 5!+ P04    " #62@E3(N?(
M<)T#  !Q"P  &    'AL+W=O<FMS:&5E=',O<VAE970S+GAM;*5676_B.!3]
M*U;4!Y#:Y@M"4@$2A8R&T12JALX\K/8A!4.B26S6-J7]]WOMI-F0N R[^X*_
MSCWWWF-S<X='RG[Q!&.!WO*,\)&1"+&_,TV^3G >\UNZQP1.MI3EL8 EVYE\
MSW"\449Y9CJ6Y9EYG!)C/%1[CVP\I >1I00_,L0/>1ZS]WN<T>/(L(V/C:=T
MEPBY88Z'^WB'(RR>]X\,5F;%LDES3'A*"6)X.S(F]ET82+P"_$CQD=?F2&;R
M0NDON9AO1H8E \(97@O)$,/PBJ<XRR01A/%7R6E4+J5A??[!_D7E#KF\Q!Q/
M:?8SW8AD9/@&VN!M?,C$$SU^Q64^?<FWIAE7O^A88BT#K0]<T+PTA@CRE!1C
M_%;J4#, 'KV!4QHX38/>)P9N:>!>ZJ%7&O0N]= O#53J9I&[$FX6BW@\9/2(
MF$0#FYPH]94UZ)42^4XBP> T!3LQ?EY,GF?S53A#T^5B%BZB8A8MO\]G$[D=
MK6!X"!>K""V_P-'#XU/X%7#S'R'J?%]&41?-%[ =HAOT',U0YZJ+KE!*T"JA
M!QZ3#1^: @*5[LQU&=1]$93S25 N>J!$)!R%9(,W&OO9>7OOC+T) E4J.1\J
MW3MG";\=R"URK6OD6(ZMB6=ZN;FE2^?_>0__L_<3,=SJR;B*S_V$+Q*QP% J
M!*);-*4YU*=$%HY7C.9D37.,_IB\<,&@!OQYQEVO<M=3[GJ?N%M L>QDE/,N
MO"I)KWM/!86G*&1I?!W?V$'?![5>Z]?4AKF6/^B=HF8:,M>U'.\4%NK(+"NH
M4"?9]JML^V?%78H$,[0^4?4D^VM$L%)>Q&]W9^3U*H?>67FAW$(Q)5!K&,-D
M_8[@X@C/8E7&I6/4*1QW=;H7W/V:!K;=T&FJP?A.0_(VYL:S&J"P#>KKQ1Y4
MN0]^^[3HQ8)?=09^]QH&WU:#[;I=! 5.3:VNO)!K^'3R/58?O^Q=)]B@G:CM
M60W%VJ# &304TQ!Y00,4MD&.[^HU\RO-_+.:K:B(LW^A&JBBT\%OA]]K_ ^G
M;8QMU_Y?A0X:(ML)&JBPC7)\7R]$4 D17"#$&0ET:0>Z.N4Y_4;F;9AK![6;
M*U+7D+D]MTD6:L@LI_94BNS-6@^18[93S1N'_ Y$%-^&:K?J#R>J+6KLW]MW
M4UNS/X-^LFC__J$OFM&'F.U2PE&&M^#*NAW /;&BP2L6@NY5!_-"!?1#:II
M3XR9!,#YEE+QL9 .JBY[_#=02P,$%     @ UDH)4RVMM.N] @  ] 8  !@
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M>\"RGRO#%XI4Y;^P*W,="\*-TB(KP51!EO#BR=[*.1P B*<>T"H!K8^ ]A&
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MG-/?P?DYXQ52\RZ([_G5+?#A^_ 1A BO6KBW"7?1?5D"ORR!;_/5=N0+--6
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MKJW='8\"R@W".P<XI1ZI;YZ12P2D3)IJ_@KXYM*/1',]<9/]\],18G,WRD<
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MW4,A<.W!W9'0DLI] &M4/4+SE7C.#1/D[XD -RR9%+Z9Y AP>R3DYJC:KYB
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M3[Y<_6MO(MPU;DP1IHV1N4!P/1*&W66:MIQ,W9P,;JA2M-F$FHE0*QDB'(P
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MX AW<P>P:X2'O-9WVUSYG&R'2;J<S-+2/322Z;;F#PZ#DJ.XYF"I];$)A"Q
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M:W-H965T<R]S:&5E=#$R+GAM;,59:V\KMQ']*X0*%"V@2G[=!VYM [9OTR1
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ML_$,8PX,DB0;5E(H:8D( H^!98I:HHW)TZRJ&<:H-S9@49CEG%YJ\HD+N(:
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MM@X_K0"('5?:VG,<SG2M.%[N"T">,_H$LM9<Z($4 Q0U.*T@LKE7@O22 EO
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M!J<G$9AVZ[6&TU78-&OM:&^%8TD?"C0^@>(;3>/J#%^@__0L?@)02P,$%
M  @ UDH)4]/[;Y%M!   ! L  !D   !X;"]W;W)K<VAE971S+W-H965T,38N
M>&ULG59M;]LV$/XK!ZT8$D"U)=O-VVP#=I*B'5H@2+OMP[ /M'BVN%"B1E)Q
MO%_?.\J2[2).T'Z1^'+WW'/'NR/':V,?7([HX:G0I9M$N??55;_OLAP+X7JF
MPI)VEL86PM/4KOJNLBAD4"IT?Y D9_U"J#*:CL/:G9V.3>VU*O'.@JN+0MC-
M'+593Z(T:A?NU2KWO-"?CBNQPB_H_ZCN+,WZ'8I4!99.F1(L+B?1++V:CU@^
M"/RI<.WVQL">+(QYX,E'.8D2)H0:,\\(@GZ/>(U:,Q#1^&^+&74F67%_W**_
M#[Z3+POA\-KHOY3T^22ZB$#B4M3:WYOU!]SZ\X[Q,J-=^,*ZD1V.(LAJYTVQ
M528&A2J;OWC:QF%/X2(YHC#8*@P"[\908'DCO)B.K5F#96E"XT%P-6@3.57R
MH7SQEG85Z?GIM2F]*E=8>J"A4Q*M".&Z$QNQT#CN>[+"LOULBSAO$ ='$,_@
M,V'F#FY+B?)0OT_L.HJ#EN)\\"+@[W79@V$2PR 9I"_@#3N7AP%O> 3O!A<>
M;I3+M'&U1?A[MG#>4GK\\P+XJ ,?!?#1\^!<0U>N$AE.(BH2A_81HU>#_.LO
MZ5GRVW.A?M'8J[AP9Y6QX WX',$)6C'+,/Y@7*6\T"1A9)UY!Z1%@<8VT/1=
M(V2FJ&J/,N@LA;+P*'3=H60[^]F!_=K1,CA\I 4-3JU*M529(#GAJ/PK%G(@
M2@GK'$O",@X/MK)<$*Z,09(UXE]3+EF]853J'0\8#$H5A./GV1&B5F*A-$EA
MATA6R#&M>W KLKQU9 ]^GT7MV'5#5>[14O'A=Y;<SM1>* ZLFEJ3%^RI67IR
M52J:-EQ"-Y$<>"'_I4JG5D?GH$HJ>VL9Z!E/^4#0JZ:A,2A9M\0H\\:ZW@^<
M=]SR#E0<Y()"0Q;)445BJJ <]LS-U);"(VJB0&29"W7D9N2,5E+PLO/T:_B3
MP1,J+'=*GA!;##070HLR(TK<IXCGS$$EK&_9_6AFLMSM$VH!\WI#_H<SX[/E
MA%):$_@FA@HM7UHQP7OEEINP+:GN<V%7S5'N'U4(YT*KE6@.G_C,'H5$#9]P
M);)&G96NZ0Q$N6F2)JS<()E2J"7<FXW0?@.SE<40D. K0>U[D :H&\RP6!#"
M,-WWJPW5:R56;4M<.7B3]. K)Z;1=,=R$ONPU5RTZO\N^UV;&J^A4L;2C<MY
MR&B?J(XU#*% P0V3W8K)6..[4T]O"V[X'&]E)""W_<,3NX)7.]4]<2?(M;#R
M"N;;&&S_\?>Q2B_A#:3G\7!PS@!=XAUUZV04#T>C4WB_:Q+[-7>2GL(POABF
M?"U4QC7U=30A3])1?)DDISM^!]XRM_@R'078(Q8%W3L6*V-]TY+:\Z'J/VQD
M1UW:53\^55R2\/8G4+HL*K=]\.<+O??<[=G?>YD42&7'[Z_0%DO?/%*ZU>Z)
M-VM>-COQYGWXF:I645UJ7))JTCM_%X%MWES-Q)LJO',6QM.K*0QS>J:B90':
M7QKCVPD;Z!Z^TV]02P,$%     @ UDH)4[MQ.<RK"@  ,QX  !D   !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&ULW5E;<]NX%?XK&-?MV#.T+%$77^)X1KEU
MO9--,O&F^]#I T1"$AH29 #0LOKK^YT#DB8E.]FTFS[T(;$(XMR^<P5XM2GL
M9[=6RHO[/#/N^<':^_+R]-0E:Y5+-RA*9?!F6=A<>CS:U:DKK9(I$^79:3P<
MSDYSJ<W!]16O?;#75T7E,VW4!RM<E>?2;E^HK-@\/Q@=- L?]6KM:>'T^JJ4
M*W6K_*?R@\73:<LEU;DR3A=&6+5\?C ?7;Z8T'[>\#>M-J[S6Y EBZ+X3 \W
MZ?.#(2FD,I5XXB#QYTZ]5%E&C*#&EYKG02N2"+N_&^YOV';8LI!.O2RRWW3J
MU\\/S@]$JI:RROS'8O.3JNV9$K^DR!S_+S9A;WQV()+*^2*OB:%!KDWX*^]K
M'#H$Y\,G".*:(&:]@R#6\I7T\OK*%AMA:3>XT0\VE:FAG#;DE%MO\5:#SE^_
M+<SJY%=E<_%*+?S5J0=/>G.:U/0O GW\!/U,_%(8OW;BM4E5VJ<_A2ZM0G&C
MT(OXJPQ_KLQ C(>1B(?QZ"O\QJV!8^8W?H(?F25>:9=DA:NL$G^?+YRW"(9_
M?(7YI&4^8>:3_QB][Z$7_.CI,:5'[>I<T?]2J9!.+(L,2>0N!4!2+4B@352^
M4%:,1[PR%!^L-HDN929D7E3&BV(I)H/I\,]"W2=K:59*+C(EG#*ZL,(47CF1
M5HJ(Q^)0C";CZ&PZ[/QZJQS$5@;LK&=U6,,4N#)_:5*HZRII$B62PGD7"8.2
M<C2*+LYFQ_@[C::3X;%XA\5$6KO59M51+M-RH3/MMR#.R\(H+(\FH^CL;")&
M\7D4CQH=DLI:>HN$K*SV&IK_Y4_G\2A^UO[=@?&PY738\GK]I>H)N]Q;(:UZ
M8#%*P2J\ZAL+SHWP0W$4SZ+9Q<6Q0-D0?JWPSRHE\I GBO)DQX&$'ODM"ML+
M#\=I PN4\U "!=@IL4$ ' +.\9#W'XZC>'P6H3"Z4G%IR[81BH=?0Z4*-NQS
M@-I@,!N=(9"L4#)9BU)97:3,D$37[I5<,+&]#L.>J;2W[WSB.QZ-@UH00(9T
MU1JT2#A]_\?@,([.IQ=!X"R:Q-^/ Z$W^0$XS.)IXY[1Q7@7ASG23+G$Z@5L
MUT:\0TR)^!)9L<FVX@8"L#Y/F!TER*T'+VE3)P(D+Q&=TFP%-S5L]074MR"5
M:5%Z,;_]Q/B=#&=4+J#/S])4Z+5B5"-<.<X[."'52PT.5GE;-"J*7/EUD0[$
MKX0!L0RMUZ'%!84E'!PC!B_PD& ( )I8S?H)1_9C8T@#+#UL)!O4(XE&ZUQ[
M"! WZ/P6[XUXHQ8V6#$C,T;GD9C?R51EXHTV[)&7<IM+(][J7$/1"-+KE1N7
M01M$V[W*2[(AJ1$\(I&4L_'P&>-N^6'T[#BH3V&3:@M<Q&:-LKL]*38&]*Y:
M.)UJTJ;6N_9)Q/&A* /B:30<(DM7*ZM6$AXN_YMRW-7T 9=66W8*!-RQH$RB
M%1"H7:KWRR7"VZQ:&H3-ETIF(0*T<5[[BEP-!1?55EDGRLI2L'O:^K&";J/)
M9([ZGZJ0R+<J::KO//$#<6. K#'UJ,791]L:R2%Z \YB9<%8A433!DP@%O(
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MT'%TUD3V#4+-\-G@A]5@D)G_5=3_/B,0%YBL^K;T*#OP456(N&4U\;QSB*2
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MT0B?EVMC-1V(+P](3'J)B9>8_&,&AZ/A?8G NP5+'J]18L$MM,S HS0\G9X
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MYZD'JG_A^X61!_>J;J6AXG+3/?T4H;("=%Y+JL-A81U,OUFK?P!02P,$%
M  @ UDH)4_QB6HB&!   K0P  !D   !X;"]W;W)K<VAE971S+W-H965T,C N
M>&ULW5=9;QLW$/XK@XT;V( AK5;R45L28"L-Z@!I#:=)'XH^4+LC+1LNN2&Y
MEM1?WQE2QRJ(A*0M^M 7+8\YOCDY&BZ,_>A*1 _+2FDW2DKOZYMNU^4E5L)U
M3(V:;F;&5L+3ULZ[KK8HBL!4J6Z6II?=2DB=C(?A[-&.AZ;Q2FI\M.":JA)V
M=8_*+$9)+]D</,EYZ?F@.Q[68H[OT+^O'RWMNELIA:Q0.VDT6)R-DKO>S?V
MZ0/!!XD+UUH#6S(UYB-O'HI1DC(@5)A[EB#H\XP35(H%$8Q/:YG)5B4SMM<;
MZ:^#[63+5#B<&/6K+'PY2JX3*' F&N6?S.)'7-MSP?)RHUSXA46D'1!QWCAO
MJC4S(:BDCE^Q7/NAQ7"='F#(U@Q9P!T5!92OA!?CH34+L$Q-TG@13 W<!$YJ
M#LH[;^E6$I\?/Z'SMLE]8Z6>P\0X[X9=3X+YNINOA=Q'(=D!(9?PUFA?.OA!
M%UCL\W<)T!95MD%UGQT5^*;1'>BGYY"E6>^(O/[6RGZ0U_\J*X4NX F5\%C
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M1PG>QL#4Z+:VAC>*0M/82S[%F,M>Z32N'EID0-.@5E'IV-E[^&WVF]2KFJE
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M,,F&^$-'$6@+@<51,"JE,+IA'6$3>($D_Y?*WA&;QP5[!X7<AJI+"&%LI'$
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M'!,Z/A6:EZ'E,[@OTO !*K#L^W$!PW=]6W8+(Z:,3?(W1>@0R;?V'!&(FCS
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MAMY5U$Z [BM%O=$3SL#P4J_^ U!+ P04    " #62@E3FKSXJJ@$   U"P
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M.BL9W+&LEH4NF(+>O3E1I^.!1A]&<I#M[%TT]OPW[ WA1G"]5/"1YRS_47^
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MYT%)M:&>]=3Y'NJW\(7(:POO%$?^')^0FX.O^=;767Z0\%.GCJ%(8\C3/#O
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M    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;,U5WV_:,!#^5TY9-;52U?R
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;(55;6_;-A#^*P>M&!)
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MG45I%.B\$)3Y7C .AI=[^0]02P,$%     @ UDH)4W*\(REK P  W0<  !D
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M,5O0(M%?Q/HW5B^H"C 2B:I^T7ICZP4C%!5*B[0&0P0ISS;_]+E.Q!8 VP<
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M]R&A3]L\ZC&S7,>T=\W"'C.7$-?=-;ON,?,))LZNV<V^F45,U]NUNMVW&I,
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MK$C)C=: >W;XP.B6<?0(FGQBZ%"11T6%WH%2D!*IR"?.,!)J</;^#@QE7']
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M*Z#]4M'![@(W?_UUF_T%4$L#!!0    ( -9*"5,A1QB)J (  *H'   9
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;*55WV_:,!#^5ZRH#ZW4-2$)](<
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M]4OVSU7QJI@E$73.TI_)6FXG@V@ UG1#BE1^8X??:%V07^9;L514G^!08^$
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M!=RLK(4LB3:FW&!522"%@TJ&0]^?X))0[B6QFUO*)!:U9I3#4B)5ER613S?
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M?>:D@"C^<TQ&[X_)5?COQO@'?:4"M7;=4^.V-\*T+::;[1KT3=N7WMS;[OY
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M0)B;4JJ:HMFJM:\W"FCA1#7WHR!(_)HRX66I.[M462H;Y$S I2*ZJ6NJ?E\
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M.A(4#0IJ:?W!0+##^"M5:R8TX5 :67#ZQM2JV@'7;E!NW(Q82303QRTK\TT
M90/,?2DE/FSLV.F_,ME?4$L#!!0    ( -9*"5-ED7P#SP(  &4(   9
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M-'1G%,.8_@-060/:7TAI-A-[<=1_%N,_4$L#!!0    ( -9*"5,P:PEK3 ,
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MXIQ8/"8XF8-V!_#]7"F[63B :M:?_ %02P,$%     @ UDH)4QV7[N5W!
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MZ^->.6_+Q$.+!6E<&==H#P&EC(!9&5.X[]G$./=)[&OW#L(Y6TN+AR@!I8N
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M3N$O')0G,DONK*@VN\\WHKA:;%V6678%9;?%Q,CTY6O+ER]%+_\ 4$L#!!0
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M&?7.WZEW'3\/I5Y[OM;X_.^D>CS?6ZZ/ORR_3D[>W@O.Z;:B/O\%4$L#!!0
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M460M4&0M4&0M4&0M4&0M_E/69VN7?QP_///6U-TAGPU_NYJ] 5!+ 0(4 Q0
M   ( -9*"5,'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ UDH)4T/N@:7N    *P(  !$
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M970R+GAM;%!+ 0(4 Q0    ( -9*"5,BY\APG0,  '$+   8
M  " @:T4  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #6
M2@E3+:VTZ[T"  #T!@  &               @(& &   >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ UDH)4[21^H+V!0  _A<  !@
M         ("!<QL  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( -9*"5/TH<7>WP(  .<)   8              " @9\A  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #62@E39NQ(*>P*  #<0@
M&               @(&T)   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ UDH)4^-\S&3&"   $"<  !@              ("!UB\  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( -9*"5./8=4:LA$
M .LL   8              " @=(X  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " #62@E30C)\"[X%  !=#0  &0              @(&Z
M2@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( -9*"5/Q
M*9RJ0@@  -05   9              " @:]0  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ UDH)4\PN*I\<"0  AAD  !D
M     ("!*%D  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M" #62@E3F9EM"S,(  !<%   &0              @(%[8@  >&PO=V]R:W-H
M965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( -9*"5/$L6G,]@8  (\2   9
M              " @>5J  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L!
M A0#%     @ UDH)4W'(&SS" @  A@8  !D              ("!$G(  'AL
M+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #62@E3T_MOD6T$
M   $"P  &0              @($+=0  >&PO=V]R:W-H965T<R]S:&5E=#$V
M+GAM;%!+ 0(4 Q0    ( -9*"5.[<3G,JPH  #,>   9              "
M@:]Y  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ UDH)
M4S'C[]E4 P  >@@  !D              ("!D80  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " #62@E3$BY[S1D$  !R"0  &0
M        @($<B   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( -9*"5/\8EJ(A@0  *T,   9              " @6R,  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ UDH)4]E&\4$T!0  C@T
M !D              ("!*9$  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " #62@E3ZG$8/:\#  !]"   &0              @(&4E@
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( -9*"5,*1YVW
M)00  "H)   9              " @7J:  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ UDH)4_MG3<5%"@  ]QH  !D
M ("!UIX  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #6
M2@E327Y9:H :   +3   &0              @(%2J0  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( -9*"5-B0'O,E@4  "@-   9
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M970S,"YX;6Q02P$"% ,4    " #62@E3S7T')(@$   H#   &0
M    @('/V   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M -9*"5/P *+,]@(  ( '   9              " @8[=  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ UDH)4Y[RA:]V P  Q0<  !D
M             ("!N^   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " #62@E3<KPC*6L#  #=!P  &0              @(%HY   >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( -9*"5.COF:*GP(
M *H%   9              " @0KH  !X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ UDH)4SCQ^*R-!   ,A0  !D              ("!
MX.H  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #62@E3
M>+D-\X\#   W"P  &0              @(&D[P  >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( -9*"5.T^::CO0,  "L*   9
M      " @6KS  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ UDH)4XM0)HP]!@  5!T  !D              ("!7O<  'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " #62@E3BF^I1P,"  !O!
M&0              @('2_0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( -9*"5-:@A&I+ 4  +0F   9              " @0P  0!X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ UDH)4^7Q,3=O
M @  >@4  !D              ("!;P4! 'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " #62@E3(4<8B:@"  "J!P  &0
M@($5" $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( -9*
M"5,,#XYC: 0  "H4   9              " @?0* 0!X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ UDH)4PB%XO0%!   ;A$  !D
M         ("!DP\! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M    " #62@E3R9(,*Y0"  #:!P  &0              @('/$P$ >&PO=V]R
M:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( -9*"5,W/:A"-0(  *@%
M   9              " @9H6 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL
M4$L! A0#%     @ UDH)4[06:<ZF @  P@8  !D              ("!!AD!
M 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " #62@E3YSZV
M/FT#  ":"@  &0              @('C&P$ >&PO=V]R:W-H965T<R]S:&5E
M=#0Y+GAM;%!+ 0(4 Q0    ( -9*"5.4E-1;]@<  ($I   9
M  " @8<? 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
MUDH)4Y6]'IG2 @  B @  !D              ("!M"<! 'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    " #62@E3 /02EB #   J"0  &0
M            @(&]*@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( -9*"5,'<@FOO (  #$'   9              " @10N 0!X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ UDH)4^SUU<#% @
MJP<  !D              ("!!S$! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    " #62@E3F)])[8T"  #Z!@  &0              @($#
M- $ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( -9*"5,5
M;):%? (  '$&   9              " @<<V 0!X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ UDH)4V61? // @  90@  !D
M     ("!>CD! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -9*"5-T7 XCE (  +H&   9              "
M@0E, 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ UDH)
M4R2(GTAA P  _@P  !D              ("!U$X! 'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    " #62@E37V%(6Y$"  "^!@  &0
M        @(%L4@$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( -9*"5.]O@E*_P(  (D/   -              "  315 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ UDH)4Y>*NQS     $P(   L
M ( !7E@! %]R96QS+RYR96QS4$L! A0#%     @ UDH)4^CM0, (!0  K2H
M  \              ( !1UD! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M -9*"5/22;QM$0(  !<F   :              "  7Q> 0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -9*"5/ B&UTZ0$  'XE   3
M              "  <5@ 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !(
- $@ KQ,  -]B 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>162</ContextCount>
  <ElementCount>330</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>39</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/Coverpage</Role>
      <ShortName>Cover page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Newly Issued Accounting Standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NewlyIssuedAccountingStandards</Role>
      <ShortName>Newly Issued Accounting Standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2105103 - Disclosure - Disposition of the Hospital Products</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalProducts</Role>
      <ShortName>Disposition of the Hospital Products</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2112105 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2116106 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2123108 - Disclosure - Contingent Consideration Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentConsiderationPayable</Role>
      <ShortName>Contingent Consideration Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2127109 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2131110 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2133111 - Disclosure - Other Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilities</Role>
      <ShortName>Other Assets and Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2140112 - Disclosure - Restructuring Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCosts</Role>
      <ShortName>Restructuring Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2144113 - Disclosure - Net (Loss) Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossIncomePerShare</Role>
      <ShortName>Net (Loss) Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2148114 - Disclosure - Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLoss</Role>
      <ShortName>Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2152115 - Disclosure - Revenue by Product</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RevenuebyProduct</Role>
      <ShortName>Revenue by Product</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2155116 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.avadel.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Disposition of the Hospital Products - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalProductsTables</Role>
      <ShortName>Disposition of the Hospital Products - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/DispositionoftheHospitalProducts</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2313302 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/FairValueMeasurement</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2317303 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/MarketableSecurities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2324304 - Disclosure - Contingent Consideration Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentConsiderationPayableTables</Role>
      <ShortName>Contingent Consideration Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/ContingentConsiderationPayable</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/LongTermDebt</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2334306 - Disclosure - Other Assets and Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesTables</Role>
      <ShortName>Other Assets and Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/OtherAssetsandLiabilities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2341307 - Disclosure - Restructuring Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsTables</Role>
      <ShortName>Restructuring Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/RestructuringCosts</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2345308 - Disclosure - Net (Loss) Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossIncomePerShareTables</Role>
      <ShortName>Net (Loss) Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NetLossIncomePerShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2349309 - Disclosure - Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveIncomeLossTables</Role>
      <ShortName>Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2353310 - Disclosure - Revenue by Product (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RevenuebyProductTables</Role>
      <ShortName>Revenue by Product (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/RevenuebyProduct</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Newly Issued Accounting Standards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails</Role>
      <ShortName>Newly Issued Accounting Standards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NewlyIssuedAccountingStandards</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Disposition of the Hospital Products - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails</Role>
      <ShortName>Disposition of the Hospital Products - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Disposition of the Hospital Products - Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails</Role>
      <ShortName>Disposition of the Hospital Products - Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Disposition of the Hospital Products - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails</Role>
      <ShortName>Disposition of the Hospital Products - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - Fair Value Measurement - Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurement - Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Fair Value Measurement - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementNarrativeDetails</Role>
      <ShortName>Fair Value Measurement - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Marketable Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails</Role>
      <ShortName>Marketable Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities - Summary of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Marketable Securities - Schedule of Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails</Role>
      <ShortName>Marketable Securities - Schedule of Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Goodwill and Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/GoodwillandIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Contingent Consideration Payable?? - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails</Role>
      <ShortName>Contingent Consideration Payable?? - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Contingent Consideration Payable - Payable Balance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails</Role>
      <ShortName>Contingent Consideration Payable - Payable Balance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - Long-Term Debt Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails</Role>
      <ShortName>Long-Term Debt Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2435417 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2436418 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails</Role>
      <ShortName>Other Assets and Liabilities - Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Non-Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - Restructuring Costs - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsNarrativeDetails</Role>
      <ShortName>Restructuring Costs - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2443423 - Disclosure - Restructuring Costs - Severance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails</Role>
      <ShortName>Restructuring Costs - Severance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2446424 - Disclosure - Net (Loss) Income Per Share - Reconciliation of Basic and Diluted Calculation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails</Role>
      <ShortName>Net (Loss) Income Per Share - Reconciliation of Basic and Diluted Calculation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NetLossIncomePerShareTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2447425 - Disclosure - Net (Loss) Income Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails</Role>
      <ShortName>Net (Loss) Income Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NetLossIncomePerShareTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2450426 - Disclosure - Comprehensive Income (Loss) - Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails</Role>
      <ShortName>Comprehensive Income (Loss) - Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/ComprehensiveIncomeLossTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2451427 - Disclosure - Comprehensive Loss - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLossNarrativeDetails</Role>
      <ShortName>Comprehensive Loss - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2454428 - Disclosure - Revenue by Product - Summary of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails</Role>
      <ShortName>Revenue by Product - Summary of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="avdl-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2456429 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="avdl-20210630.htm">avdl-20210630.htm</File>
    <File>avdl-20210630.xsd</File>
    <File>avdl-20210630_cal.xml</File>
    <File>avdl-20210630_def.xml</File>
    <File>avdl-20210630_lab.xml</File>
    <File>avdl-20210630_pre.xml</File>
    <File>exhibit311q22021.htm</File>
    <File>exhibit312q22021.htm</File>
    <File>exhibit321q22021.htm</File>
    <File>exhibit322q22021.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/exch/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>82
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "avdl-20210630.htm": {
   "axisCustom": 0,
   "axisStandard": 17,
   "contextCount": 162,
   "dts": {
    "calculationLink": {
     "local": [
      "avdl-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "avdl-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "avdl-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "avdl-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "avdl-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "avdl-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd"
     ]
    }
   },
   "elementCount": 410,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 1,
    "http://www.avadel.com/20210630": 3,
    "http://xbrl.sec.gov/dei/2021": 6,
    "total": 10
   },
   "keyCustom": 39,
   "keyStandard": 291,
   "memberCustom": 11,
   "memberStandard": 28,
   "nsprefix": "avdl",
   "nsuri": "http://www.avadel.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover page",
     "role": "http://www.avadel.com/role/Coverpage",
     "shortName": "Cover page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Newly Issued Accounting Standards",
     "role": "http://www.avadel.com/role/NewlyIssuedAccountingStandards",
     "shortName": "Newly Issued Accounting Standards",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105103 - Disclosure - Disposition of the Hospital Products",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalProducts",
     "shortName": "Disposition of the Hospital Products",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Revenue Recognition",
     "role": "http://www.avadel.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112105 - Disclosure - Fair Value Measurement",
     "role": "http://www.avadel.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116106 - Disclosure - Marketable Securities",
     "role": "http://www.avadel.com/role/MarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - Goodwill and Intangible Assets",
     "role": "http://www.avadel.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123108 - Disclosure - Contingent Consideration Payable",
     "role": "http://www.avadel.com/role/ContingentConsiderationPayable",
     "shortName": "Contingent Consideration Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127109 - Disclosure - Long-Term Debt",
     "role": "http://www.avadel.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131110 - Disclosure - Income Taxes",
     "role": "http://www.avadel.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133111 - Disclosure - Other Assets and Liabilities",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilities",
     "shortName": "Other Assets and Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140112 - Disclosure - Restructuring Costs",
     "role": "http://www.avadel.com/role/RestructuringCosts",
     "shortName": "Restructuring Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144113 - Disclosure - Net (Loss) Income Per Share",
     "role": "http://www.avadel.com/role/NetLossIncomePerShare",
     "shortName": "Net (Loss) Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148114 - Disclosure - Comprehensive Loss",
     "role": "http://www.avadel.com/role/ComprehensiveLoss",
     "shortName": "Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152115 - Disclosure - Revenue by Product",
     "role": "http://www.avadel.com/role/RevenuebyProduct",
     "shortName": "Revenue by Product",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2155116 - Disclosure - Commitments and Contingencies",
     "role": "http://www.avadel.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:NatureOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:NatureOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306301 - Disclosure - Disposition of the Hospital Products - (Tables)",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalProductsTables",
     "shortName": "Disposition of the Hospital Products - (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313302 - Disclosure - Fair Value Measurement (Tables)",
     "role": "http://www.avadel.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317303 - Disclosure - Marketable Securities (Tables)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324304 - Disclosure - Contingent Consideration Payable (Tables)",
     "role": "http://www.avadel.com/role/ContingentConsiderationPayableTables",
     "shortName": "Contingent Consideration Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME",
     "role": "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.avadel.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334306 - Disclosure - Other Assets and Liabilities (Tables)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables",
     "shortName": "Other Assets and Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341307 - Disclosure - Restructuring Costs (Tables)",
     "role": "http://www.avadel.com/role/RestructuringCostsTables",
     "shortName": "Restructuring Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345308 - Disclosure - Net (Loss) Income Per Share (Tables)",
     "role": "http://www.avadel.com/role/NetLossIncomePerShareTables",
     "shortName": "Net (Loss) Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349309 - Disclosure - Comprehensive Income (Loss) (Tables)",
     "role": "http://www.avadel.com/role/ComprehensiveIncomeLossTables",
     "shortName": "Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353310 - Disclosure - Revenue by Product (Tables)",
     "role": "http://www.avadel.com/role/RevenuebyProductTables",
     "shortName": "Revenue by Product (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Newly Issued Accounting Standards (Details)",
     "role": "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails",
     "shortName": "Newly Issued Accounting Standards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Disposition of the Hospital Products - Narrative (Details)",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails",
     "shortName": "Disposition of the Hospital Products - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "ic67b5c1a5255452d9ea423ac5afd1c19_I20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "ic67b5c1a5255452d9ea423ac5afd1c19_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Disposition of the Hospital Products - Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
     "shortName": "Disposition of the Hospital Products - Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "ic67b5c1a5255452d9ea423ac5afd1c19_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Disposition of the Hospital Products - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails",
     "shortName": "Disposition of the Hospital Products - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i35be439684f94754a722ac71e050ffd4_D20200101-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical)",
     "role": "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CapitalizedContractCostNet",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalizedContractCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Revenue Recognition - Narrative (Details)",
     "role": "http://www.avadel.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CapitalizedContractCostNet",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalizedContractCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - Fair Value Measurement - Measured on Recurring Basis (Details)",
     "role": "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
     "shortName": "Fair Value Measurement - Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i860be6580c44499c8b2bbc5d5a7e3a36_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i65d25b85bcaa41adb6ed552acf50363b_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Fair Value Measurement - Narrative (Details)",
     "role": "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
     "shortName": "Fair Value Measurement - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i65d25b85bcaa41adb6ed552acf50363b_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Marketable Securities - Narrative (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails",
     "shortName": "Marketable Securities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails",
     "shortName": "Marketable Securities - Summary of Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Marketable Securities - Schedule of Maturities (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
     "shortName": "Marketable Securities - Schedule of Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "ic7ff608828844c6798870117de00d1e1_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Goodwill and Intangible Assets (Details)",
     "role": "http://www.avadel.com/role/GoodwillandIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Contingent Consideration Payable\u00a0 - Narrative (Details)",
     "role": "http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails",
     "shortName": "Contingent Consideration Payable\u00a0 - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i398b06c595444f7caeaba916451c29fa_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Contingent Consideration Payable - Payable Balance (Details)",
     "role": "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails",
     "shortName": "Contingent Consideration Payable - Payable Balance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "ifc611bb658d347c4bc285217b32c35f6_D20200101-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - Long-Term Debt Schedule of Debt (Details)",
     "role": "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
     "shortName": "Long-Term Debt Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "avdl:CouponInterestExpense",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "0",
      "lang": "en-US",
      "name": "avdl:CouponInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.avadel.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValueAddedTaxReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435417 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValueAddedTaxReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436418 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails",
     "shortName": "Other Assets and Liabilities - Other Non-Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WorkersCompensationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails",
     "shortName": "Other Assets and Liabilities - Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WorkersCompensationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:AccruedInterestCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:AccruedInterestCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Other Non-Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "id82ee84d494f49a1aa77a11e88225b6d_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - Restructuring Costs - Narrative (Details)",
     "role": "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
     "shortName": "Restructuring Costs - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i35238f47c33b4c629f04849c139b24b6_I20190331",
      "decimals": "2",
      "lang": "en-US",
      "name": "avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i7e8c3ff2db154d098fe60070506408f1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443423 - Disclosure - Restructuring Costs - Severance Obligation (Details)",
     "role": "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails",
     "shortName": "Restructuring Costs - Severance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "id4a57a5a305f43858278dcd059cbe0d2_D20210101-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForRestructuring",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446424 - Disclosure - Net (Loss) Income Per Share - Reconciliation of Basic and Diluted Calculation (Details)",
     "role": "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails",
     "shortName": "Net (Loss) Income Per Share - Reconciliation of Basic and Diluted Calculation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DilutiveSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0d97841a81a14b3784e5d9ff08e2a6ae_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447425 - Disclosure - Net (Loss) Income Per Share - Narrative (Details)",
     "role": "http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails",
     "shortName": "Net (Loss) Income Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i13deb59210c04afabfb45b889d23aa75_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450426 - Disclosure - Comprehensive Income (Loss) - Components (Details)",
     "role": "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails",
     "shortName": "Comprehensive Income (Loss) - Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i76a5acc12ee8481593b5f580d0c6acce_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451427 - Disclosure - Comprehensive Loss - Narrative (Details)",
     "role": "http://www.avadel.com/role/ComprehensiveLossNarrativeDetails",
     "shortName": "Comprehensive Loss - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454428 - Disclosure - Revenue by Product - Summary of Revenue (Details)",
     "role": "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails",
     "shortName": "Revenue by Product - Summary of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "avdl:PercentageOfRoyaltyPayableOnNetSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456429 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "role": "http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "avdl:PercentageOfRoyaltyPayableOnNetSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i5952bd509a3b4bbd95542c5ad8829fd2_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS\u2019 EQUITY",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i47b79ad2b6fa4d43b3bc4e7c2bffdfe1_D20200101-20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i0fa9c816300f486d8e161a93c9ac5dee_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20210630.htm",
      "contextRef": "i822ef9a632dd493ca409b73ddc200743_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 39,
   "tag": {
    "avdl_A450PercentExchangeableSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]",
        "label": "4.50 Percent Exchangeable Senior Notes Due 2023 [Member]",
        "terseLabel": "4.50% Exchangeable Senior Notes Due 2023"
       }
      }
     },
     "localname": "A450PercentExchangeableSeniorNotesDue2023Member",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_AccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Interest, Current",
        "label": "Accrued Interest, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "AccruedInterestCurrent",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AccruedOutsourceContractCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Outsource Contract Costs",
        "label": "Accrued Outsource Contract Costs",
        "terseLabel": "Accrued outsource contract costs"
       }
      }
     },
     "localname": "AccruedOutsourceContractCosts",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AccruedTradeDiscountsAndRebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates",
        "label": "Accrued trade discounts and rebates",
        "terseLabel": "Customer allowances"
       }
      }
     },
     "localname": "AccruedTradeDiscountsAndRebates",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AcquisitionRelatedContingentConsiderationRemeasurement": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the remeasurement of acquisition related contingent considerations",
        "label": "Acquisition Related Contingent Consideration Remeasurement",
        "verboseLabel": "Remeasurement of acquisition-related contingent consideration"
       }
      }
     },
     "localname": "AcquisitionRelatedContingentConsiderationRemeasurement",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AkovazMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Akovaz [Member]",
        "label": "Akovaz [Member]",
        "terseLabel": "Akovaz"
       }
      }
     },
     "localname": "AkovazMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_AmericanDepositarySharesOptionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares, Option Price Per Share",
        "label": "American Depositary Shares, Option Price Per Share",
        "terseLabel": "ADS, option price per share (in dollars per share)"
       }
      }
     },
     "localname": "AmericanDepositarySharesOptionPricePerShare",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "avdl_AmericanDepositarySharesPremiumPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares, Premium Percentage",
        "label": "American Depositary Shares, Premium Percentage",
        "terseLabel": "ADS premium percentage"
       }
      }
     },
     "localname": "AmericanDepositarySharesPremiumPercentage",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_AmericanDepositarySharesPurchasedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares Purchased, Price Per Share",
        "label": "American Depositary Shares Purchased, Price Per Share",
        "verboseLabel": "ADS purchased, price per share (in dollars per share)"
       }
      }
     },
     "localname": "AmericanDepositarySharesPurchasedPricePerShare",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "avdl_AmericanDepositorySharesConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depository Shares, Conversion Ratio",
        "label": "American Depository Shares, Conversion Ratio",
        "terseLabel": "ADSs, conversion ratio"
       }
      }
     },
     "localname": "AmericanDepositorySharesConversionRatio",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "avdl_BloxiverzMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bloxiverz [Member]",
        "terseLabel": "Bloxiverz"
       }
      }
     },
     "localname": "BloxiverzMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_BloxiverzVazculepAkovazandNouressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bloxiverz, Vazculep, Akovaz and Nouress [Member]",
        "label": "Bloxiverz, Vazculep, Akovaz and Nouress [Member]",
        "terseLabel": "The Business"
       }
      }
     },
     "localname": "BloxiverzVazculepAkovazandNouressMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Changes in Related Party Payable [Roll Forward]",
        "label": "Business Combination, Changes in Related Party Payable [Roll Forward]",
        "terseLabel": "Contingent Consideration Payable Rollforward:"
       }
      }
     },
     "localname": "BusinessCombinationChangesinRelatedPartyPayableRollForward",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "avdl_CorporateWorkforceReductionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Workforce Reduction [Member]",
        "label": "Corporate Workforce Reduction [Member]",
        "terseLabel": "Corporate Workforce Reduction"
       }
      }
     },
     "localname": "CorporateWorkforceReductionMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_CouponInterestExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coupon Interest Expense",
        "label": "Coupon Interest Expense",
        "terseLabel": "Coupon interest expense"
       }
      }
     },
     "localname": "CouponInterestExpense",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted",
        "label": "Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted",
        "terseLabel": "Number of business days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day",
        "label": "Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day",
        "terseLabel": "Percentage of product of the last reported sale price of the American Depositary Shares and the exchange rate on each such trading day"
       }
      }
     },
     "localname": "DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Scheduled Threshold Trading Days",
        "label": "Debt Instrument, Convertible, Scheduled Threshold Trading Days",
        "terseLabel": "Scheduled threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleScheduledThresholdTradingDays",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Threshold Consecutive Business Days",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Business Days",
        "terseLabel": "Consecutive business days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveBusinessDays",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Option To Purchase Aggregate Principal Amount, Term",
        "label": "Debt Instrument, Option To Purchase Aggregate Principal Amount, Term",
        "terseLabel": "Option to purchase aggregate principal amount, term"
       }
      }
     },
     "localname": "DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentOptiontoIncreaseFaceAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Option to Increase Face Amount",
        "label": "Debt Instrument, Option to Increase Face Amount",
        "terseLabel": "Option to increase aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentOptiontoIncreaseFaceAmount",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Excluding Money Market Funds, Available For Sale [Member]",
        "label": "Debt Securities, Excluding Money Market Funds, Available For Sale [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments",
        "label": "Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments",
        "terseLabel": "Additional consideration paid in monthly installments"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Initial Cash Consideration",
        "label": "Disposal Group, Including Discontinued Operation, Initial Cash Consideration",
        "terseLabel": "Initial cash consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Payment Installment Term",
        "label": "Disposal Group, Including Discontinued Operation, Payment Installment Term",
        "terseLabel": "Payment installment term (in months)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the Earn Out Payment In Excess Of Acquisition Date Fair Value",
        "label": "Earn Out Payment In Excess Of Acquisition Date Fair Value",
        "negatedLabel": "Earn-out payments for contingent consideration in excess of acquisition-date fair value"
       }
      }
     },
     "localname": "EarnOutPaymentInExcessOfAcquisitionDateFairValue",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_FinancingRelatedContingentConsiderationRemeasurement": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the remeasurement of financing related contingent considerations",
        "label": "Financing Related Contingent Consideration Remeasurement",
        "terseLabel": "Remeasurement of financing-related contingent consideration"
       }
      }
     },
     "localname": "FinancingRelatedContingentConsiderationRemeasurement",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_GainLossOnReleaseOfCertainLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Release Of Certain Liabilities",
        "label": "Gain (Loss) On Release Of Certain Liabilities",
        "negatedTerseLabel": "Gain from the release of certain liabilities",
        "terseLabel": "Gain from release of certain liabilities"
       }
      }
     },
     "localname": "GainLossOnReleaseOfCertainLiabilities",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_GuaranteeAssetCurrentCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Asset, Current Carrying Value",
        "label": "Guarantee Asset, Current Carrying Value",
        "terseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeAssetCurrentCarryingValue",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_GuaranteeCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee, Current",
        "label": "Guarantee, Current",
        "terseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeCurrent",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_GuaranteeNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee, Noncurrent",
        "label": "Guarantee, Noncurrent",
        "verboseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeNoncurrent",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in research and development tax credit receivable.",
        "label": "Increase (Decrease) In Research and Development Tax Credit Receivable",
        "negatedTerseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_MutualAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual And Money Market Funds",
        "label": "Mutual And Money Market Funds [Member]",
        "terseLabel": "Mutual and money market funds"
       }
      }
     },
     "localname": "MutualAndMoneyMarketFundsMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_NatureOfBusinessPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for nature of business.",
        "label": "Nature Of Business Policy [Policy Text Block]",
        "verboseLabel": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfBusinessPolicyPolicyTextBlock",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent",
        "label": "Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent",
        "terseLabel": "Right of use assets at contract manufacturing organizations"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherGuarantorObligationsCurrentCarryingValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Guarantor Obligations, Current Carrying Value",
        "label": "Other Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Guarantee to Deerfield"
       }
      }
     },
     "localname": "OtherGuarantorObligationsCurrentCarryingValue",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherLiabilitiesMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities, Miscellaneous, Current",
        "label": "Other Liabilities, Miscellaneous, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLiabilitiesMiscellaneousCurrent",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherNoncurrentReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of other noncurrent receivables.",
        "label": "Other Noncurrent Receivables",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncurrentReceivables",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Products [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherProductsMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_PercentageOfRoyaltyPayableOnNetSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of royalty that has to be paid by the company as per the royalty agreement.",
        "label": "Percentage Of Royalty Payable On Net Sales",
        "terseLabel": "Percentage of royalty payable on net sales"
       }
      }
     },
     "localname": "PercentageOfRoyaltyPayableOnNetSales",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Tax Credit Receivable, Current",
        "label": "Research And Development Tax Credit Receivable, Current",
        "terseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditReceivableCurrent",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The non current portion of tax credit receivable on research and development as on the balance sheet date.",
        "label": "Research and Development Tax Credit Receivable Non Current",
        "verboseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditReceivableNonCurrent",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent",
        "label": "Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent",
        "terseLabel": "Expected number of positions eliminated (as a percent)"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_RestructuringChargesBeforeGainLossDuetoCurtailment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges Before Gain (Loss) Due to Curtailment",
        "label": "Restructuring Charges Before Gain (Loss) Due to Curtailment",
        "terseLabel": "Charges (income) for employee severance, benefits and other costs"
       }
      }
     },
     "localname": "RestructuringChargesBeforeGainLossDuetoCurtailment",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.",
        "label": "Schedule Of Prepaid Expenses and Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_ShortTermNoteReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Note Receivable",
        "label": "Short Term Note Receivable",
        "terseLabel": "Receivable from Exela (see Note 3)"
       }
      }
     },
     "localname": "ShortTermNoteReceivable",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_StockIssuedDuringPeriodSharesPublicOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Public Offering",
        "label": "Stock Issued During Period, Shares, Public Offering",
        "terseLabel": "May 2020 public offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPublicOffering",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "avdl_StockIssuedDuringPeriodValuePublicOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Public Offering",
        "label": "Stock Issued During Period, Value, Public Offering",
        "terseLabel": "May 2020 public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePublicOffering",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Nineteen Corporate French Restructuring Obligation [Member]",
        "label": "Two Thousand Nineteen Corporate French Restructuring Obligation [Member]",
        "terseLabel": "2019 French Restructuring Obligation"
       }
      }
     },
     "localname": "TwoThousandNineteenCorporateFrenchRestructuringObligationMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_TwoThousandNineteenCorporateRestructuringObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Nineteen Corporate Restructuring Obligations [Member]",
        "label": "Two Thousand Nineteen Corporate Restructuring Obligations [Member]",
        "terseLabel": "2019 Corporate Restructuring Obligations"
       }
      }
     },
     "localname": "TwoThousandNineteenCorporateRestructuringObligationsMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_VazculepMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vazculep [Member]",
        "terseLabel": "Vazculep"
       }
      }
     },
     "localname": "VazculepMember",
     "nsuri": "http://www.avadel.com/20210630",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Smaller Reporting Company"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag",
        "terseLabel": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_XNMS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NASDAQ/NMS (GLOBAL MARKET) [Member]",
        "terseLabel": "NASDAQ/NMS (GLOBAL MARKET) [Member]"
       }
      }
     },
     "localname": "XNMS",
     "nsuri": "http://xbrl.sec.gov/exch/2021",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r135",
      "r147",
      "r154",
      "r233",
      "r408",
      "r409",
      "r410",
      "r427",
      "r428",
      "r458",
      "r461",
      "r464",
      "r465",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r135",
      "r147",
      "r154",
      "r233",
      "r408",
      "r409",
      "r410",
      "r427",
      "r428",
      "r458",
      "r461",
      "r464",
      "r465",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r135",
      "r147",
      "r154",
      "r233",
      "r408",
      "r409",
      "r410",
      "r427",
      "r428",
      "r458",
      "r461",
      "r464",
      "r465",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r316",
      "r352",
      "r396",
      "r399",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r543",
      "r589",
      "r591",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProFormaMember": {
     "auth_ref": [
      "r154",
      "r287",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pro Forma [Member]",
        "terseLabel": "Pro Forma"
       }
      }
     },
     "localname": "ProFormaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r195",
      "r378",
      "r380",
      "r545",
      "r588",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r195",
      "r378",
      "r380",
      "r545",
      "r588",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r316",
      "r352",
      "r386",
      "r396",
      "r399",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r543",
      "r589",
      "r591",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r316",
      "r352",
      "r386",
      "r396",
      "r399",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r543",
      "r589",
      "r591",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r138",
      "r139",
      "r144",
      "r145",
      "r147",
      "r149",
      "r150",
      "r152",
      "r153",
      "r168",
      "r464",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Pro Forma Adjustments"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r3",
      "r132",
      "r133",
      "r134",
      "r138",
      "r139",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r168",
      "r236",
      "r237",
      "r412",
      "r428",
      "r459",
      "r464",
      "r465",
      "r466",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r3",
      "r132",
      "r133",
      "r134",
      "r138",
      "r139",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r168",
      "r236",
      "r237",
      "r412",
      "r428",
      "r459",
      "r464",
      "r465",
      "r466",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r3",
      "r132",
      "r134",
      "r138",
      "r139",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r152",
      "r153",
      "r168",
      "r236",
      "r237",
      "r412",
      "r428",
      "r459",
      "r464",
      "r465",
      "r466",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "As Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r148",
      "r154",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r148",
      "r154",
      "r287",
      "r397",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Loss:"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r138",
      "r139",
      "r140",
      "r142",
      "r201",
      "r202",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r300",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r412",
      "r427",
      "r428",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r466",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r485",
      "r486",
      "r502",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r55",
      "r511"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Total",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r78",
      "r85",
      "r86",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized gain on marketable debt securities, net"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r47",
      "r75",
      "r77",
      "r78",
      "r577",
      "r599",
      "r603"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r85",
      "r86",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r74",
      "r78",
      "r85",
      "r86",
      "r87",
      "r132",
      "r133",
      "r134",
      "r450",
      "r594",
      "r595",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r70",
      "r78",
      "r85",
      "r86",
      "r87",
      "r450",
      "r489",
      "r490",
      "r491",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r408",
      "r409",
      "r410",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r400",
      "r401",
      "r413",
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r115",
      "r336",
      "r348",
      "r349",
      "r497"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r115",
      "r254",
      "r255"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible asset amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails",
      "http://www.avadel.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r124",
      "r179",
      "r184",
      "r191",
      "r229",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r447",
      "r452",
      "r475",
      "r509",
      "r511",
      "r553",
      "r575"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r30",
      "r32",
      "r69",
      "r124",
      "r229",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r447",
      "r452",
      "r475",
      "r509",
      "r511"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r467"
     ],
     "calculation": {
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r209"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r207",
      "r243"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Adjusted Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r211",
      "r215",
      "r569"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "5-10 Years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r211",
      "r214",
      "r568"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "1-5 Years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r211",
      "r216",
      "r570"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than 10 Years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r211",
      "r213",
      "r567"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than 1 Year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r205",
      "r208",
      "r243",
      "r557"
     ],
     "calculation": {
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Total",
        "verboseLabel": "Mutual and money market funds"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "verboseLabel": "Changes in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.",
        "label": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized",
        "periodEndLabel": "Related party payable, ending balance",
        "periodStartLabel": "Related party payable, beginning balance",
        "terseLabel": "Contingent consideration payable"
       }
      }
     },
     "localname": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails",
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Net",
        "terseLabel": "Deferred contract costs"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r27",
      "r53",
      "r117"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "verboseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r110",
      "r117",
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at June 30,",
        "periodStartLabel": "Cash and cash equivalents at January 1,"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r110",
      "r487"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r293",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Ordinary shares, nominal value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Ordinary shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Ordinary shares, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r44",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Ordinary shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r44",
      "r511"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 58,488 issued and outstanding at June\u00a030, 2021 and 58,396 issued and outstanding at December\u00a031, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r81",
      "r83",
      "r84",
      "r91",
      "r562",
      "r585"
     ],
     "calculation": {
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Net other comprehensive income (loss)",
        "totalLabel": "Total comprehensive (loss) income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails",
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r90",
      "r99",
      "r561",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r316",
      "r326",
      "r327",
      "r328",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r346",
      "r347",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r387",
      "r394",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r94",
      "r545"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of products"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "terseLabel": "Total operating expense",
        "totalLabel": "Total operating expense (income)"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r122",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r330",
      "r337",
      "r338",
      "r340",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r123",
      "r130",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r346",
      "r347",
      "r348",
      "r349",
      "r498",
      "r554",
      "r555",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r42",
      "r342",
      "r555",
      "r574"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Principal amount of 4.50% exchangeable senior notes due 2023"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "negatedTerseLabel": "Equity component of exchangeable notes, net of issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r313",
      "r346",
      "r347",
      "r496",
      "r498",
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r62",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r63",
      "r123",
      "r130",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r346",
      "r347",
      "r348",
      "r349",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r63",
      "r123",
      "r130",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r339",
      "r346",
      "r347",
      "r348",
      "r349",
      "r355",
      "r356",
      "r357",
      "r358",
      "r495",
      "r496",
      "r498",
      "r499",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r326",
      "r343",
      "r346",
      "r347",
      "r497"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: unamortized debt discount and issuance costs, net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain",
        "terseLabel": "Marketable securities, realized gain"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Loss",
        "terseLabel": "Marketable securities, realized loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r125",
      "r424",
      "r434",
      "r435",
      "r436"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Change in deferred tax and income tax deferred charge"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.",
        "label": "Deposits Assets, Current",
        "terseLabel": "Short-term deposit"
       }
      }
     },
     "localname": "DepositsAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r115",
      "r259"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecurities": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share",
        "terseLabel": "Add: interest from 2023 Notes, net of tax"
       }
      }
     },
     "localname": "DilutiveSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining": {
     "auth_ref": [
      "r25",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r296"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts of material contingent liabilities, for example, but not limited to, product or environmental liabilities or litigation, that remain with the entity despite the disposal of the disposal group that is classified as a component of the entity.",
        "label": "Discontinued Operation, Amounts of Material Contingent Liabilities Remaining",
        "terseLabel": "Total long-term contingent consideration payable"
       }
      }
     },
     "localname": "DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r21"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax",
        "negatedTerseLabel": "Disposition of the Hospital Products"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r258",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Aggregate consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "auth_ref": [
      "r17",
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "negatedTerseLabel": "Less transaction fees",
        "terseLabel": "Transaction fees"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r6",
      "r7",
      "r18",
      "r262"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "negatedLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r18",
      "r262"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "negatedTerseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r6",
      "r7",
      "r18",
      "r262"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r18",
      "r257",
      "r262"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent",
        "negatedTerseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r18",
      "r262"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r115",
      "r258",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Net gain on the sale of the Hospital Products"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r26",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Disposition of the Hospital Products"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProducts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r395",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r39",
      "r128",
      "r506",
      "r605"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Due to Exela"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r92",
      "r144",
      "r145",
      "r147",
      "r148",
      "r149",
      "r157",
      "r159",
      "r161",
      "r162",
      "r163",
      "r168",
      "r169",
      "r465",
      "r466",
      "r563",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r92",
      "r144",
      "r145",
      "r147",
      "r148",
      "r149",
      "r159",
      "r161",
      "r162",
      "r163",
      "r168",
      "r169",
      "r465",
      "r466",
      "r563",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r164",
      "r166",
      "r167",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net (Loss) Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r487"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of foreign currency exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r85",
      "r86",
      "r87",
      "r132",
      "r133",
      "r134",
      "r139",
      "r150",
      "r153",
      "r171",
      "r233",
      "r354",
      "r359",
      "r408",
      "r409",
      "r410",
      "r427",
      "r428",
      "r464",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r494",
      "r594",
      "r595",
      "r596",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r328",
      "r346",
      "r347",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r468",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r467",
      "r468",
      "r470",
      "r471",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r328",
      "r387",
      "r388",
      "r393",
      "r394",
      "r468",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r328",
      "r346",
      "r347",
      "r387",
      "r388",
      "r393",
      "r394",
      "r468",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r328",
      "r346",
      "r347",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r468",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r328",
      "r346",
      "r347",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r472",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r218",
      "r219",
      "r226",
      "r227",
      "r228",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r339",
      "r353",
      "r454",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "auth_ref": [
      "r387",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.",
        "label": "Fixed Income Securities [Member]",
        "terseLabel": "Other fixed-income securities"
       }
      }
     },
     "localname": "FixedIncomeSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r115",
      "r451"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Gain on sale of Hospital Products",
        "negatedTerseLabel": "Gain from the disposition of the hospital products"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r251",
      "r252",
      "r511",
      "r552"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Guarantee, liability"
       }
      }
     },
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuarantyLiabilities": {
     "auth_ref": [
      "r294",
      "r295",
      "r559",
      "r581"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.",
        "label": "Guaranty Liabilities",
        "terseLabel": "Guarantee to Deerfield"
       }
      }
     },
     "localname": "GuarantyLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r179",
      "r183",
      "r187",
      "r190",
      "r193"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "(Loss) income before income taxes",
        "verboseLabel": "Total income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r395",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r7",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r19",
      "r22",
      "r23",
      "r24",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r126",
      "r419",
      "r421",
      "r423",
      "r432",
      "r437",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r127",
      "r152",
      "r153",
      "r178",
      "r417",
      "r433",
      "r438",
      "r587"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax (benefit) expense",
        "verboseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid (refund)"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r67",
      "r558",
      "r582"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "verboseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable &amp; other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Net changes in assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "verboseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r97",
      "r334",
      "r345",
      "r348",
      "r349"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense, debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r108",
      "r111",
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r96",
      "r97"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Investment and other income (expense), net"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Contractual Maturity Dates"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r57",
      "r124",
      "r185",
      "r229",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r448",
      "r452",
      "r453",
      "r475",
      "r509",
      "r510"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r50",
      "r124",
      "r229",
      "r475",
      "r511",
      "r556",
      "r579"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r61",
      "r124",
      "r229",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r448",
      "r452",
      "r453",
      "r475",
      "r509",
      "r510",
      "r511"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Liabilities, Fair Value Adjustment",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r6",
      "r7",
      "r18",
      "r20",
      "r24",
      "r262"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Net liabilities disposed of"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r42",
      "r327",
      "r344",
      "r346",
      "r347",
      "r555",
      "r576"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Book value of long-term debt",
        "totalLabel": "Net carrying amount of liability component"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedTerseLabel": "Less: current maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Estimated fair value of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r63",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r28",
      "r58"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r110",
      "r113",
      "r116"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r24",
      "r79",
      "r82",
      "r87",
      "r89",
      "r116",
      "r124",
      "r138",
      "r144",
      "r145",
      "r147",
      "r148",
      "r152",
      "r153",
      "r160",
      "r179",
      "r183",
      "r187",
      "r190",
      "r193",
      "r229",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r466",
      "r475",
      "r560",
      "r583"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0
      },
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net (loss) income",
        "totalLabel": "Net (loss) income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails",
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToParentDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.",
        "label": "Net Income (Loss) Attributable to Parent, Diluted",
        "totalLabel": "Net (loss) income - diluted"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToParentDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r5",
      "r136",
      "r137",
      "r140",
      "r141",
      "r154",
      "r155",
      "r156",
      "r203",
      "r204",
      "r234",
      "r235",
      "r381",
      "r382",
      "r383",
      "r384",
      "r411",
      "r429",
      "r430",
      "r431",
      "r462",
      "r482",
      "r483",
      "r484",
      "r503",
      "r549",
      "r550",
      "r551",
      "r598",
      "r599",
      "r600",
      "r601",
      "r603",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "Newly Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NewlyIssuedAccountingStandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r135",
      "r138",
      "r139",
      "r140",
      "r142",
      "r143",
      "r147",
      "r154",
      "r168",
      "r201",
      "r202",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r300",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r412",
      "r425",
      "r426",
      "r427",
      "r428",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r466",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r485",
      "r486",
      "r502",
      "r546",
      "r547",
      "r548",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Newly Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r179",
      "r183",
      "r187",
      "r190",
      "r193"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating (loss) income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r500"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r59"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r68",
      "r511"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Total",
        "verboseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Non-Current Assets:"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r445",
      "r446",
      "r449"
     ],
     "calculation": {
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation loss (income)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r80",
      "r83",
      "r85",
      "r86",
      "r88",
      "r90",
      "r354",
      "r488",
      "r493",
      "r494",
      "r561",
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r80",
      "r83",
      "r445",
      "r446",
      "r449"
     ],
     "calculation": {
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive (loss) income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "verboseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r71",
      "r75"
     ],
     "calculation": {
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net other comprehensive (loss) income, net of $(78), $(81), $(133) and $(130) tax, respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r72",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Unrealized gain (loss) on marketable securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossNarrativeDetails",
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r33",
      "r34",
      "r59",
      "r511"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "verboseLabel": "Other Assets and Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Other Non-Current Liabilities:"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r42",
      "r555",
      "r576"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-term Debt",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Schedule Of Long Term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other expense - changes in fair value of contingent consideration payable",
        "terseLabel": "Other expense - changes in fair value of contingent consideration payable"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r109",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "negatedLabel": "Royalty payments for contingent consideration payable in excess of original fair value"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "terseLabel": "Payments of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r103",
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedLabel": "Payments of contingent consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred shares"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r43",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred shares, nominal value (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r43",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r43",
      "r511"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at June\u00a030, 2021 and 488 issued and outstanding at December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r30",
      "r51",
      "r52"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]",
        "verboseLabel": "Prepaid Expenses and Other Current Assets:"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r29",
      "r31",
      "r248",
      "r249"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "verboseLabel": "Prepaid and other expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from the disposition of the hospital products"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIncomeTaxRefunds": {
     "auth_ref": [
      "r113",
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash received during the period as refunds for the overpayment of taxes.",
        "label": "Proceeds from Income Tax Refunds",
        "terseLabel": "Proceeds from income tax refunds"
       }
      }
     },
     "localname": "ProceedsFromIncomeTaxRefunds",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from the May 2020 public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "verboseLabel": "Proceeds from loans or conditional grants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds from the February 2020 private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r105",
      "r403"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "verboseLabel": "Proceeds from stock option exercises and employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r100",
      "r101",
      "r206"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "verboseLabel": "Proceeds from sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r37",
      "r38",
      "r260",
      "r511",
      "r571",
      "r580"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r504",
      "r505",
      "r506",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Contingent Consideration Payable"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r416",
      "r544",
      "r609"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r267",
      "r269",
      "r272",
      "r281",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r115",
      "r266",
      "r275",
      "r278"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring costs (income)"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r268",
      "r269",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r269",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring reserve, ending balance",
        "periodStartLabel": "Restructuring reserve, beginning balance",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r41",
      "r269",
      "r279"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Accrued restructuring (see Note 12)"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r269",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency impact"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r46",
      "r359",
      "r412",
      "r511",
      "r578",
      "r598",
      "r603"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r132",
      "r133",
      "r134",
      "r139",
      "r150",
      "r153",
      "r233",
      "r408",
      "r409",
      "r410",
      "r427",
      "r428",
      "r464",
      "r594",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r176",
      "r177",
      "r182",
      "r188",
      "r189",
      "r195",
      "r196",
      "r198",
      "r377",
      "r378",
      "r545"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Product sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails",
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r121",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r379",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues [Abstract]"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r78",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r212",
      "r217",
      "r220",
      "r221",
      "r222",
      "r224",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Capitalization, Long-term Debt [Line Items]",
        "terseLabel": "Schedule of Capitalization, Long-term Debt [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationLongtermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalizationLongtermDebtTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the long-term debt component of the capitalization of the entity. The table may be detailed by subsidiary (legal entity) and include information by type of debt detailed by instrument.",
        "label": "Schedule of Capitalization, Long-term Debt [Table]",
        "terseLabel": "Schedule of Capitalization, Long-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationLongtermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r63",
      "r130",
      "r346",
      "r348",
      "r355",
      "r356",
      "r357",
      "r358",
      "r495",
      "r496",
      "r499",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r7",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r19",
      "r22",
      "r23",
      "r24",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Earnings Per Share Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r149",
      "r150",
      "r152",
      "r153",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "auth_ref": [
      "r151",
      "r152",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.",
        "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustments"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProductsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "terseLabel": "Schedule of Related Party Transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r271",
      "r278",
      "r279",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r273",
      "r274",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r179",
      "r180",
      "r186",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r179",
      "r180",
      "r186",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, Revenue by Product"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r172",
      "r174",
      "r175",
      "r179",
      "r181",
      "r187",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r197",
      "r198",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Revenue by Product"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProduct"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenuebyProductSummaryofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/DispositionoftheHospitalProductsUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r120",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r66",
      "r85",
      "r86",
      "r87",
      "r132",
      "r133",
      "r134",
      "r139",
      "r150",
      "r153",
      "r171",
      "r233",
      "r354",
      "r359",
      "r408",
      "r409",
      "r410",
      "r427",
      "r428",
      "r464",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r494",
      "r594",
      "r595",
      "r596",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r171",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": {
     "auth_ref": [
      "r43",
      "r44",
      "r354",
      "r359",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan",
        "terseLabel": "Employee share purchase plan share issuance (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r43",
      "r44",
      "r354",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "February 2020 private placement (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Vesting of restricted shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r43",
      "r44",
      "r354",
      "r359",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r43",
      "r44",
      "r354",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee share purchase plan share issuance"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r43",
      "r44",
      "r354",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "February 2020 private placement"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Vesting of restricted shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r66",
      "r354",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r44",
      "r48",
      "r49",
      "r124",
      "r200",
      "r229",
      "r475",
      "r511"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Stockholders' equity",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "verboseLabel": "Schedule of Available-for-sale and Equity Securities"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r218",
      "r219",
      "r226",
      "r227",
      "r228",
      "r339",
      "r353",
      "r454",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r65",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r268",
      "r269",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r129",
      "r387",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "Government securities - U.S."
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValueAddedTaxReceivableCurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Value Added Tax Receivable, Current",
        "verboseLabel": "Value-added tax recoverable"
       }
      }
     },
     "localname": "ValueAddedTaxReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r163"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive securities\u2014employee and director equity awards outstanding, preferred shares and 2023 Notes (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r158",
      "r163"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted shares (in shares)",
        "verboseLabel": "Weighted average number of shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r157",
      "r163"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic shares (in shares)",
        "verboseLabel": "Weighted average number of shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSSINCOME",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Workers' Compensation Liability, Current",
        "verboseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "WorkersCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Z.5.Q2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=26872618&loc=d3e7384-122677"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2510-110228"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123422226&loc=d3e11019-110243"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123422226&loc=d3e11049-110243"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r611": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r612": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r613": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r614": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r615": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r616": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r617": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r618": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r619": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r621": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r622": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>83
<FILENAME>0001012477-21-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001012477-21-000011-xbrl.zip
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M\0@ZG96ZJ1!7,>LL)9)Z:9A"0C)IJ;:(9RKC2(;%(^Y+!WFF3U/#-"$$>R?
M+S)1 S/PB&304M" ?;GZN@BDG%Q9C7$E+?E@0&]:A)DQ#&-LN+(!!,U[A;.
M%H<T$RVK,2[J$,4IQM%)4YJ!L,A8FQUHXV+^$0Y\8:@SG<W(XR)39KWEQ##N
M3,9",%)PAV+G,<(TR-#B"-&$-_V.BSXN<P;(D6EM&0/#HV(V/@)_.<-Q0UJV
M,/29]NKK^$@FG,)2^]C(SS&/,RT9UP0Q' @%Q\TO#,DF%DH=)VCP<6F/< /8
M@4F)-.-(J SL%.$9=6)RQ)G6# 1#8R4EQ0#3,J.IL89@0JV'X3*+U11*F<Z]
MZK_OITR^T"IQ&ELK+.4:**NUH21D5%*'A/5<T,6CZDR$!"=/:,VL=8K&B (
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MW!]L2>8<RC(II2C"RE@"#XCYI,C;=@N 0B\'Y14O>!V102Q31%(LQA$9S+!
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M+]@O29(/;? E/QZW6_,<M/PELM"O(5"")5:IHIE(8_</ />,IH8:38TCAB.
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M [,703%<FX#[FKMD^"5SQ0TQ&/640DU/^>#7-G&H8JJ*J5Z6J09J^%[0C99
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MB7N7\;*BX]I*]60AF:/UB043_ FG$-RX'Y4*F)0*&(DA!)=YK35)$24:8$\
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MLF!!),.J+E^50T$$.*94Q032<*:5-ZZ*N4S=A7=>/+!:Y3W. S(_",4\1NV
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M&> FA>RD+W!WU3&HHLT:!.H5B_C46?2M,O2 IYX60*#</XY]?3JBL%E -GL
MF[T=%R@F2J6XHA!DG51()-BZL3657A"7BXL9ZQZLDC2IJ@A"=V$T"D)WEM =
M$R*)4DZ#B$"DK3K3.0=69 [*AQ (C42H(D28:%L^J]R9IJ7'-*EQPX\.-SU>
M&LSC'FUHVFA.7%QV]1J.SNW\%E+W1-0=QE67]2(P:10DQ@0(Z:HZC-Y#T)9P
MH;*Q5A3J-JPM[:R*XS0FJQD9#1FM8=H4&>U!C#8F1DW.CA*:00DI01A)P2L2
M("1N?$S6$5UE<5/:5GSJ/LES/IQV>2$7$_B\O_$3=K>9YC/&QNR.QM(+?)7+
MZE;<W0_NQ<[&+SLO=@YWM@]:&WM;K8/?-UYO_[[_8FO[]<'_]_\81O7/K>U7
M;W8.W[:P!1HVC6MV%ZO%WFJX;!K7[3C?Z=;%KK%S'':.:Q3FFI=&A:6H_X%.
M3OJ#VC'JYU;_FQ-VETQSAGWRL"'5G&L<W#Q(].)R)F)>R0,\Z(\WS@)JFHE,
MT0*557E=JSB8X ,X&@+3)&MF[-JZL$TZ1X2<@YSS^)47D'-FRCGCN6S4ZA1#
M LD=*YQ#-%BK*63J*4^<B61)X1S=),Y9L8+>&R&4FQD-6R?N[,$I]I@&TYS-
MTPM[OCPW)Y+80TCLQHE&2[T-N9 8Y9Q7G>T$N$0E*$%4M(F2NH",;%/:I"-2
M"-VFB V$[GRA.ZX_A$[4"0,^6 5"5(^8*4K$F)2*-.&,I:IZ@N53*Y"&9K M
MA@(9G*;KEB)XR&_A%4AESQ?7^Q7(9 ]ALE<W*CEY(K47"K@,! 27Q9.*=3DG
M(I0VFCE?M0MO2]8D7PK1NX@B!-$[$_2.5W$RU%H9//CLB@ZIBVQ37M#+B,O6
MY/+GXD*HMIR^-?;\(B'-V\I[Q$V_'^40V&;KJ_,)=/YS_T:GMK&4 @S[++;H
MJ@V+I#TE:=\XNBBX#96T NJKE%-2=3]1AD.0R3C!M#&J*@O>I@+C/LN+W7F=
M7$3L3HW=\:+?D<B@DH'$.05A8@ OB(=$<C2$*4.SJF*VK%&GCE>L]M/-QFS3
MBI%Y]&M:;JJ;@TQ!EIN2Y<)-A9(M<[4SZ3((%0*8) 4P*S*UP<M85J6J>A\S
M4]/<1-!8H'C1BF)]#K(&L3XUUL<4C=31LA 5.$$4B#*?P:6D0!+GM24Z,9T+
MUF6;DEG5\G]<K*_8,8X7_=X'&*7!<8&3QV9L2RURBJD/BZ6WBJ&Q%,T#R>_#
MC:+BAC*E3%6AF'L0A9Z*.V<8I, D-]PKJU(A/T';>OI<PDDALD"1FM6%_3ST
M#L)^%K ?TSR!&6U"L&!BEB"H"&!3@3VS7.O,<];&%=@STRZ,O2BPQUVU98E?
M74NZN9Z@PVR(I^I,=W4T!.G]8?3^=6-<U=%,;>:!@3.*@8B>@@E:@-326F>S
MT$P5>F]+@]WIEA?%<^].ARB>'L7C94*Y",%1 R%% D(F!=Y16[PT9PH-"Y%$
MJ%!LQ*QBT!A]FD&]<LS]61Z1\DW^ /+: WEM>UR=.)8$,=Y U(:#X-Y!H34#
M+C"JF'16$;ZV+MI$F0:E$"!\%T^=('QG!=_Q#* @:>:"5"Y%!N%I+&Z&\]6C
MH&PQ!:G+7;0990V"[XI%4,XS@!8A\V?I ^3S3?Y!9IN(V6X4\HDT*:)E $ET
M<;A4$F"9"9 )\9Z2X$WF5=8/;VNZ:L6]$>L-$36(]8=C?;SLM4N!4Y: E[E3
MG! ;P3L6@8KHJC-ET3-2;7S;-M<+@_7E+GO]_3%;O(M<,3EZ<.0&Z:C?+:,T
MO*QRG?YWVAF=/:SB+M9LQA%[XBK7_P2WXTZ,W6H#/W8^7W[VQ4= ]?KGU-06
M>()!>3E(.0T&J:Q8%2Z'[5:O?]SI%8?QL^N>IJIR[;]^)'I>ID$-Z)F('_:M
MP+FZNH-1/WQZZ0;[@X.1&Z7X9W5QU]]]H7T(:I][:)\WH]U+[;-IR;O_.R+A
M^,^>^\N>[G\\ZN[_ML-VMUYW]O_:)F\/7W=VO[X2;_]Z=;;W\9?CW;_>_+W'
M7A_M?GS]Z?^^[LKW1!1[^I" %:4$HCH6X5V28$T0.9# B[U_+)J_,W\>YBCC
M_%FP^6,%Y=H&"BH'5^9/%%41*0G!>FY<3DYSO[9.GMU1L>'6'UHG:7!.8C^W
MOCOCSDEN)I-M9^_7"5RUFS.QGG;#C=/147]0N#JB]_8D,_#-U_<J^^22ED"U
M=%5Z3 *K4X 0A3;.1TJ\_0&#W3F?'K;XX7Q:AOFDBRQ67F0@(4@0MBHAI0,'
M%B+C,3E.?'4FFK3)'8>B;W/:^?QJN2O+SI';_GG"[0R'ISC9GFBR!?J^.I26
M/0G@M6 @:*9@':/ G A*"J&C$9.2UZ-.F/W3T7#D>I7C@[/FJ69-HI[%&#*8
M3*M9$P282"Q(Z7Q.UD7C]-JZ,+<S+F[S4Z=F@%8Q::M_;=N6&[7^..VE<X^;
MDW:KFC/UJ^:VDN)D;/YDW/ZR^^J]#B8SJ775_#Q!L;("RZ.%F&R,4JE$-)VC
M L-5K_E3QB5"8RYZ71)?YHVA&;SS%K0,ACA19@_)TS/85@KIV*?!!8O1FL4*
MEY4I<)+*NS^G[O71D]CYC,EA#<N9^!&4ZP 08GA2#%\G2+"<O8@N@B(V@^ L
M@?>1@0\\\E25R^6L.#H-2OM"8#8EP0&!.6M@CF4SD&PB2[(LB2%4*=6\.(5*
M4W Q:<4*@_(HFP7,&6V WWO3NWF[</N#<A5N<-;(3;C-_O%QOX<[*+/#Z]L?
MB.%/9/=C$<,?=\KW=[OOMEX?[?WU2NP>;I=K"U_V/KZMKNOKWF\[\O^^[HKW
MHI)&R1J(DBL0DA>WWJ4(2<?LO0[$</V4.W X>1H\>7)FQ) H(-E0=:NT$8S7
M'))@,A3WJ<R!L!S;;V/3$/=*&C']WIR])Z:L1,X%4$62%#<^$+#>"I#<:TH<
MEUSS)NZ]X61JX&2**GMF5 (J5)&]1*2R$'H.FC,C&,L\$5UMO"W"SMO#9R+&
MM)]Z*@;RGD3"@C89*-4!!)4.G"XS4S'N.6%,R6+S^6W+/7PV8:3[:2<2JYI1
M.6XA"YI ")N+%V]#D6O&6:<YL2853C/M!=ZLF^C "\[0)LW0[2]5^;B4K.*F
M2@%-%$0B":R4Q1]-7HNJ:ZO-C4R@PJ6SF?,I.9UC5 ("8\4G5<Q#6>885%L*
M-%$O?+ UYW%[NR/,]-M[4VSH82VJ^6[HC2$8-PT>A-KKW3P>O'"R* TE59&L
MEE2)_,R"=L4B1;&:(&*%.NQ[N;RXG-5^'N)R2ER.;>9QIE/PIN"26P<B"P56
M) 71>4\(*Q"-HL(E;Q N5ZGMXT:YY&JX7;=UXCH1.KU6<">=D>MBO;=&2HC[
MM^B]LNS+8MB=WN:Y6<?(#7EM(EZ[T53)2!:-I!D4*]I>D*+W?2IZWT3M4F8^
M4ID+KPG1)G96O08PAZAY0)Y'KVT$\JR!/-YTVU5Q'BV!^ZH"'*$1K/(2=,7$
M7AN20R50E&I;VJ0.KC,MNM%TD1+"Z?%IMTJ\*"#*G=!Y6&NDE7:D?IJ+/!F6
MVRR/)J"WUVGDRL7&;3?HE1$=CAE[Z]S62&\3T=N-GDB92^<EI^#.#Z=$!<86
MQ6*TC\Q1I9*G:^N"\+:0MWVP?V-89 G0_'"-@FAN )K'HRDB$IU]@"Q<\3H\
M<^!D9.!\--1K[AQQ:^O<B#8UNAEH7JE@RIA.Z=>U]$/_^&20CE)OV/F<6MW^
M$,OH+XUP&;-V79Q[<]S6.[UB^O2B&'POC?;SH?N"O#<1[WT:5S&6:B^%*=J%
M%<H3- 1P*A2?399YSFR*V18GC;$VE[=3X^Y/>QAG:2ZRYREB$-F/B^PQ11.#
M,)P1 07B$H02&JRQ'%0NIM6V_ BA()NVB;R=P_\DR%ZQ:J?GQ?>'WZUY^M2!
MF-6MSSV'/:0ZNGQA]NW:W,AU$W#=WM:-3H;)&BD$T9""9E5_:@%.%&=.>*I2
M)E8J7G4RI*9MS*RZH&%)_F6"_!QVFQ#R4T-^3-XXJEG,R@+34H&PBD*UIP21
M"BM(XL%06W7A8&VFIMY=FG-E_IF$=/0SO1 ":*S[4)V+.V-!] ]NX#UK]I\/
MTW->QC;V3WTW79E].LILFDG^]<!V[;,8GV592N;;R6FC%W%AF7)AN=%WDI)$
M74H)I+=E8?'%9;;"95"2VT!"BEF2XC<;UI9VZI8O,T?1$T?5D$Z13A=/F2.=
MSIA.QW0Z-;I(<B(+G28"(DH))GL!07B6O&71YVICE=*VXK<W5A>53FLA_Y^1
M*U]Z>6!LK+34L1M\Z/3JK]<W"2RD,O,'YW_I]&+Y[3E7LR\]1<DE2NM/?%YE
M/7;"CW'+KAOE'*34<J':@76]L^K,7*\_*M\ZZA<<N]/8J79I"X;+Y0_/']4#
M7&_>YD[/]4*G"GQ6Y7Z.RQT.G]T\63<V4!??+=BY+W/2'];YFL\'J>NJ*IL_
M_]V)HZ-+3AE[XX7IR?5;G"\7<3KZ_EMN6>'Q!OV'0PPMU8)OSAJ._:RNN.8@
M2;RQ/DAKM14I.<<9R];ZF#(O,L6]9V;M\DU'5\W>3MR'!'Z0W"=PN=SD<]?]
MVYT-U_YS<X*6V?G-V'\[;.>#L_Y?/RAOO>-JGW1D]9TCN_'GQM;VB];+WS=>
M[VYL;K\YW-G<>''0>OEB\[L3L"F7OKE?:'7O8'NK51X=[+_8V=HX++\<')9_
M=K?W#@]:^[^V#LJ-;?^^_V)K^_7!I>>\_>K-SN';)MS?A$SSTTZO-3KJGY9/
MC<-_+^(-O+GDPMM7_WWP-'#N'72^M';+JXZ&K>W"Z?&NDA 3W42]+%XS=;T4
MEYOINI-A>G[YX.?8&9YTW=GS3J^^I/I-/U^LG!?T7O'2-\MP_7WG3U]0EK7/
MA#05:UT$UBZ^^(+0GM6$]HVRN'C./#.4??=I\HP^\#DNQ(/>^:.+-<^X4GBM
M>*UXK7BMBW.M^GZ?^@\;(P\M]]N,5J,_OJ?O[N?:^]S^A4/Y) -P2T[<5=!X
MA4?BVP:KLQB*>V&B>4-Q?1)SE0?A.CD21Z$>A<H_JM/]ZT<W4OY7>(3J??-Z
M1.[8*Y^DB?5*+IMCNUL31(&;/2,.[KM^W.N65VKH-H[[I[W[''I>R='!B=6H
MB;50 S!YU:-E'8G[5U98UA&XY_G,9;W]<_5R1Q;CO/L;/<&]_^*ZKA=2^ZJJ
M:NM6057,=G_4G)H["RF;J&RNZLT';03GPC@A:.2N*LQ</C_/(N&]L<63]S<O
M\VC"U]V/'[[N;7W@>W_M?-W[^DJ^9>\ZNX<?R.['3W3O\)?C=[_]\6GOXQMY
MG4?S2V?OX_:7W<,=_O;C4=5\M/ONL-O9/?ZC6U[?W=_:+I\3.WO'>Y^^S:/9
MK9J9'I;W?HR=_=^VS_9^^[.[_]?.V=OC-^7ZWXC=PUV^QW;86_8Z[W;(69U#
M<T#^?A\UB5%Z =J24!WFHV"\8N 8X3:6J>H#^V[IXX8FN\\(\8^+\J;YP??/
M*)SX]A>3W&XG##Z<V1;FO,Z"\!>YXJ_ F5)"46"D:B?&DZH.(R>P5"F6J37>
MT5D6JUT4\D*Y<D^YHC/G/D1FF-/"J.2=RE$;8SA1CG!Y;U"C)ID.T^P*T]0J
M+J./P'V!LZ!6@-7*@K/!J,@H393>W6I].3#]H) 7JA54*X]#;*A6IF0V<<5L
MDA@: L_ J6<@DI'@J^:GS!7"4X78<H@SZ)/=4%Y#ZD+JNN?)K)A9CL8:9H5-
MONH\9YVAG&BEO5?+73-A05CMR^[U62R9B99,4E!>9A!69+!$"Z#")YX(B8+/
MKB(WLANR6^/8;9*Z>*E0F6314J:YT-$Y'8E/S!L6!0OT!_0V>5T\Y+GI>>[Z
M"+^(P1DO%1"9/8B8&!BE,^B0,RGT9HC@,RSFBQ2'%-><^YZ$XJ+/GGEO?61!
M2!&M8]E2[BT143(=D>(:17'CU3VM-=Q&"RJF",(P"5:8##%I)XNH\R+'&53W
M1(9#AFL<PS6K> CRVO2\=BW=HO.V3%8*N8JZB>0%N.J'EC(&P3,G,6)9OT;3
MTHWO+)\1H/,%CCHQIMYSA,*/H'!&_KZ(07_9V_K$WCN;I>/1@ Q:0^$K#=XD
M C8Y3HR*7MBPMKYS?%*F?ZN?6Z.CU'*Q?U*S8OE]X^!-G6@'1%UAX@$I=RM=
M2;\^5L-^QKZ2:"6T$EH)K816:H25)@GS2.%(ICYQPZ2@ECAGA9.,996BL%I@
MF*=)&O#&CEVT+H:H(01"0&3%P#A7?C7<$"F$<<FNK3/55M8VHXD+@G>V$8RD
M2;"6,!XB$4E*XT0R@ABC.&/"$(Q@- *R8_WKB3"YV H29PJ$8@$*A"D8+83@
M.N:Z[37E;:VF;D6"N$5IA%::1AIEID*V/EI)E)#1&>8LY<D19K+.RJ$T:A3/
MCD6*F;>!2F& 1&] &*W!NFRJPM+!)"N\JM+/*6M;WA!I-,O^=LT/ ^^ET</;
M\JYT!_*'K3+8)QZMA%9"*Z&5T$IHI=6UTB3>CPW1!AE3T<I1&!*,E"$PX9F,
M7'CKWV_5K<K*_Z%^P&?A!A5A>-WI&SV@"3R@*O]O+-*4&9/!)@%"NN(!)4W!
M<I- $6.D9HY&Y>M(DQ"WSZI-G .( $::12L]B&:5E=1P*:7G5C!)/)&>J&A]
M5L$2HI!F&T>S8X$FG[F(27C@F440E%%P@7D@WC)5EDRG-6L6S:Y6ON%^52"Z
M=:,X],,#3RL=.,?M#;026@FMA%9"*Z&5T$IHI>6STB1^*S'1)JVS+?<O G=>
M4\4)\8E'XTW(C^*WUG)^<US-7[NQQ:?=SX?N"[JSD[BS!S=.#E,K"$_:0^9<
M5OEI!GR. I@)BD<BN JZN+-M)J?Q9A'6S87UDX2C$-:/ >OK*)7*PB9I%1!K
M&0B2)#AK.'C"8E*<\ZA2HV"]6ME0VU_2('2&J3J6.:SR %OGQS0Q/>J1"P=S
M:C71D@@5F' T.^VYT2GFD -UBM^#[.[(XMP9#D]3W#H=E*%[6>ZB'\\+"]=/
M[I];]M+D$6EM$EH;;WN@LJ3.^ R^R$\0V04PFCI(9<G2UFB>LUA;9[.J&HZ;
M9XUV%=%*:"6T$EII$:TT25)6=1B%Z6""$R)S8W,DRB='JO-_6LA9*98_7?<T
MH6"9@6 9/['+LZ"9,0;!9 V">@>.&P]>%H,:5]F0%S^,S*IX$2(8>1:MA%9:
M*"O--UB)J^%\5\/QJ*1@S%*70:L00'B6P"<20!'JN(V2!*F:MAJN5O;<GVDX
M*E==Q24'Y>&@$T:IC/.]^W[C-LRBQ";K'1@DLTG([&PL%BDU93G3PF+.6Q#9
M2S!<)Y"!&<.4#T858:]N5UO&A(C%A.QM+3(OO-9:!.'Z +A>=QSUE-&<8P!C
MLP$A P>OK88H36)$*<>D+<H#T;I8:,4D,[026ND)3@I/'Y2^RAG"-?!1U\#Q
M:'1,GAI)+)B@BVAU1H'QUD*T*C'&.#&,W;4*8J)?4T&+U(I60BLM8AAZ/%7V
M:QKTHQL>X6+XV(OA>,7 Y'S5F1X\,[PLAJPLBTY1B$IDDS,SE+,KZ#;(,5RQ
M3-GCDV[_+*7S&'3KY'00CMRP/.A6EU+_K5, XGHA8>[L,L6G+PU_O@GW=R\-
MAD>=DY?%[$AZ$Y#>_N98T)HJGGCQV(KJKXI1E]6KD)]V$(HS1S5UPJ:PMFX:
MM/N&,,8L![026@FMA%9:@/S9&Z+EY8561<TRN689CUHFF0C+Q3W+5C$0AA?5
MXA,%'IVSD09KJ5M;%WCL9\% C%2+5D(K+6+L$A?$^2^(8Y%+%W06U'NP410W
M/M$,-GD'F2@2I6(B*=:P!7&ULFCKV0Z^3/585Z),O:&K89F^5(\?%JE<Z;T9
MW$%#*Z&5T$IH);12DZPTWT#4O<MK;<2/I\/1<>J-AH?]C3*HU<6Y[DO7B3N]
M37?2&;ENO<U6:Y3-,8GR.OWOM#/LC-)!&GSNA'2NY5^GT/_0JS^EEO6HWB=1
M[P<WPEG*^RKU7$,R5:?"Z"U801+HI$R*TBIB956:2[.I-^*0#9"ST4IHI46T
MTM-EX^'*ND@KZUA<C%#M=(X<B.06A)<,C,H9M.,A)AYY<J9Y*^N,\OF:$0_3
M=V+Y%]>M$O3:K5TW"$<M3MNM"HA/G;#G^X.8!C#JGSROC#?L=SNQ50W&,M'E
MW:E\UAM%#7&$4R$3<UZJJ,N?"FEJYDC=YWPZHKPX97XZ&HY<KQI,9+9)NIL?
M;HS&>OM1YHP364&T5((0DH(W,H (D68?J)),K*U+TQ9F5ME[]P/'$V_J/2+"
MF[:G\*_',> $AFL2J]UQ&O_!E';';N91OUO&;KA=%-OH#(EK0N(::R]@>;&#
MX:KJ+."@L),%G[V&I%@HW&6"(*$B+K%*K(4:Y3X:Q4<1:''I C%>!!^+:Z>C
M"\$8$AD7ZMZ 1B$R+9ZOA8CD*B01"I0M*T+$6P&.*@TYY,*XT="<^-HZJA!4
M(:NI0F9&6JA"IF6M_3$5(G71A9(!2886*<*+^Z2<!F8XT3&82+TL*@0Y"SEK
M!3E+!.M3-)&S)(04UJFDN!$%*C%Q+_,L@D%(9U-'@ZK_#BI*VW@?'4E240),
M*@(BZZ+"&-%%CVDB&+>9)U;X3+ VL;/* D560U9[\IN>I$95H)8;8E4B,@DF
MI26>B<2$5LRH$,/W:6WR=G;(;S/@MYTK?N->J$Q(@%3,#B(2"29* ER([(,F
MM-AM;9T;WC::35&M"JD-J:TI-SU1RTZAA0M",J^EX)PY%87-09KL"L%QBM36
M,&I[=45M(1J;DM?@)2NN* D,K,T95.9,>^>9CG9MG;$VOZ,*/C(;,MOB,=L$
MQ$9Y3%[:PEV!")>=SUY(;XR-C#NG);JBS>"SMU=\I@U1*H4 1E2AM63*(\,B
MI"*VB>8N&U'U#^>J+<EB;/*MUE'%O31J=?O#)V_N,6937@8O]D]]-RWJ1N=4
M&<;W'(D%2CY&VZ)MT;9H6[0MVA9M.SO;+I,))PI_\9BM$RP+IH1G5:H%2]K:
MP#V/CJ:+\S[B\KR/XF3Z.%@1RCN]T#].+XI:1I=Q(I=Q^T9T7YI(A/(*M$D:
M!),<7$P,G-4\RJIYFB/%9;1M:29H1;&P*$:&7EZ&7@G;3D+=)#L;#"V,3+(P
M*II$%766!^N"C FINXG4?1WMLYIZDRD!ZPD#08, PX4!0D*(3A5:-V%RZGXB
MW*]6(X6Z7TA=C6R0CE)OV/F<'A[X6^E:BU@1$ZV$5D(KH9702F@EM!)::?FL
M-(E/2Z-+(DAK521")F*YDCI49R@<KQ)8)O%I;SJNM6;?')?LUWYL<6KW\Z'[
M@O[L1/[LSHUL/&&K( 3+P++3(*1PX$CQ9T70S'+)1*9T;5W<3ER9.!,/D=M
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M^,"9X<EX88DRP@3N I'::DE,GFT6!\+V@;"][HEI>4Y&2PI6*P7"1P=EA65
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M*?0_].I/J24Z*O%)E/C-OA!<6B5E-!!MXB"2$&"D2A"%EXSID!0U:^M:3-A
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M [W0G'9FG0+P0,#$-:*.3[K]LY1:]79'Z^1T$([<L#X2T+OX6Z? Q?4"]@?
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MTA$\3-VN5M2&G8UQA +)A<%<8H&J03:"QXTRT"\QUNG((-0.M!D4Y=_LIHS
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M 1X4L*;+$2R34_2,&5H\F,S9[L[1Y-W*(Q0C,>R9GY=8D4/H<6]4.!?IZ!3
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M>B/<%^.J]UG9#*H)_$>SPX/7P3M7@RY$S][[1(!7XYQ>ZARO&X\N<PM3,.?
M$+(3,\C&A54$C%_;4?3-2$B B1+(\98#,\XSL*&#PEK O+PI@9499/:6H%-"
MI7K1D"8 E9;&'75BB5D8PF+8LYAS9L]>.7?[71CE\ 8V<Z>;POA3$ = 6Y=V
MYE?_5&#M61 2:0RLSKE(>QB4M_@R(SA63/H@WW E6,<?</7H(H7;3NA9DN;P
MK< +-)K]CGT;&#/<]T3  .EF@":".:<@:84#-S;Y*P;MPP;?\L+.E'.) 8@G
MK(@N)1L9&+"54CE1!Y'V+*)8@.A-JA/6!K2^$$PHN/=PVW%151[N P$L*1,V
MW*D%'^]O903F9,*3+/VY*^UYO8OVMR4Z2#!*[F@;S_F.@BNM3S/*TP:I+N?^
M\^[1,3D\*+^#%3Y-U6G)5AU %YWUD;=TJE,<!&TO_&N(/:UE1AHP6XS&^K)4
M-#.H/J,>G2JV-=2B:(P0*P360RM2=!\:@-1QML5 :-$!WP1IPP1+\#[=,?H/
MO5245+LG;,:[?5"G_-=Y"G>LGM<'E+$S,K)W-TCQ2F$JM;ZB&/BA[55<.CBX
M W6.A''HX$S;0/6TL?',M)7S-5$,$+XN>%(]AT:EXFPZ'R?P=IJ!15(F18#D
MSHE5FZ:]:RS-*7R$N?PZ@V44E=MD"50U3]6::=,'RH,.E5UVW**#"W%:X7Y%
M(VYFH;R:<?BJ;\0 K%@R[CEIWV*VA69+P? IH,;50H-.Y5E1&K/1:6Y0SDCI
M+%[B? ZS%%^NFE4[K'=.'V 3O,1:>2\ =N%1UI&"M8:% FC8__NX,Q6"DUXF
M13D88T&%-,9EK]_^:X_L=2J;" IV8<P/>).I*1&CD5 _BDHNL@M85IR^ K$"
M[HFB',*LXPTB0'3X6Z_('GL&00#@Z]MF:L$<6R<\DZ#ZYQ6XHGC8M5\H(_A3
ML&9 %X#TXF N##X3S*9]#?!7-#"= HEWB8CVJ7UK+V$R,O!)\&TMEL[959BU
MQE"0^#A%']]H,+8& <8S4>O?!@+XEW"\3?]_.\XYX(6-RP:;]']1,LN2;1I)
M@1DA?Z&;(7Z17EV5/G5Y89'U@8T9%!5_D\,'P!3ZL-YXU[*MY@!/2 &[X/_[
M>[G^>%TM<</;U*N<+3QG54< IU+JZ-(G%/-S]8JMQ-Y@4BF,NC76H D^ <!'
MD2@G[# ?GHHJYK!C4 DLEZI-1!_4N00$)-8.\.J3%+D7&GQE\A%RIOFHT=09
M=M*Z91YX9VE=T*\95D)."DKSP]B83&]<8!N5DJR/A[AD!=Q\X%P:D1<HZSHM
MPVY(YO KT(GR18A-.X#7LK<$2;&"8OU%2QN!OHP1%BJ^EY?>JIC<L/H)2G =
M5RJJA@BHB]=?\U\PQ"&HNNT!-IHR[(_5?> YQ[D R(&W<PZ3!'GH)&YV]/'X
ML([C=)#(6JV&/^M6#-5H,ON[URZFX][E8N99S6MIOROMMU88\1(A"SM56R""
M@0-K&!#P#$ROC,(6S=#@X8?=>K[_50 8@FB75&:"')8+325SZL.@+"[E(956
M"9XX^R1 -?,3/3<<[\C:K<$) 4N/+F-B1J5G-6=.#0J 4(UQWN::(2Z"P0&3
ME@[%:,H@:AIC!S(C;S"1Y?1AT,J OVO!N21!*.#UD\HWF3C#UJV:&*IY;SU;
MR'5R<R)RW4-K@#SAU* :XO NKXVY&N_F]<CEJY%[O$UAD"7/4H:;J*>Q<7M3
MF$&#XW;M#B0,OJL0::R4'&#( ",>'0"^DW1@Q:TDJEY4AX2/IUJ5(=D$<,/X
MLYR8A0;/L7P=[.IHG./W@TS!WQ Q;<A\HF$[!T=31-,F20<S:XG"9B,:$VY1
MG*;):-)I6V"'F0/P% \H_,\O@3H7PQ1(P:5Q^C7IJA_W>7=_$@@O!P)BA^33
M_G#FIHT;PJ_F9.K:AO+<)G*;\N9X[FTY;RM(7UNXS__+??OYK6'#::)9S*3G
M,AIB3@!WF8A$(I7F7K7/?_TYO]Q27D^\F>B(U0K0M$VG-GRE:U13^%DEG6J[
MR#&[JX<N%CI$6,K ^L##K'=I>3WPRN$I&+^].>@ 8"CA*QGG%O*+L=V1*7?(
M$'_(::9 /07<"%YXZJ4A<J6#R<!PF\[R,'B1"GNL7N/X?PRR"XP4P1?9!>#
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M8[>;;[0VI..Y87;_3/W\SOR0B0B8IC(L(,Q$G'"J*$EXE+B)<B/J)AM;C'9
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M^R>81\4BQB4)J&!E*>58\)A((Y-(Z1 \6KVQQ=RH5:9G4*8CTX,+3SK.B1F
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M1I-VN%W$D;(!^^?R_>SIYC>LD^H2O#>/45^&BA&7&TP6 ;LH?66(&_LT<KW
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M;>W1X@W343$%=?N)@?^-"POQ)>Y,7MY.XT2[;13.1N8*QX@<T;PT1F J5$_
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MAC6=5_09I*@5_=J'%8",*B-5,R<873KJ-4TCC@ &V[>R;G6PUM12CJH)G7T
MP@B.KG=9:07<JR]@HE+4^JDG-/]JD[?:=/:2^M8E+!6UCE0:<(X$Z-<WZLSB
MB"4FQ9P<3M3F(AL#%Q4P1ICZ)C[6SIQ%'4 0>-/)>%#0,ET*)M*H$N>DL;4]
MK B]28_F<XE(K]>,;R-0@:J#/J,-FZ+!T :ME9D5O3ZX$94K(6JX=H893.IE
M:12K=,/>Y<0T-JR=8P^2E1L_^-,9#FU_?BI0Z,!N#L<Y&&K4WGGM*!6V'M 4
MA1L /TW-GXP19;YD)*@WZ52W2E,Q,8;EX$H]F56-IF&=UZA9!^RF$<Z.:6*>
M4E2T57+X6\,LCZ![MPK@E&6=C?5)?V*>ZHEX6P[&=I.<[M2DU$[(YY*7ON+P
MRLS+ZYF7KT@Y>NW(+@:C.7+9#%;,.0!-P@3JTD^GAS;1W,\$+&?9.>C)A)RC
M%V-90>& %U 311Q$#[2T_JKT+33>"J,6DYA.,XZS/;E_>?4,OM8J7E(,9'XS
MGL1";G1J[-;Y-7BP).]T2F-F9J**CYSDIASN3?Y*Q3%N]%&J0 4@4%J<EED!
M97"XWP#.R@.LT7."KTW0[#36#4,ULY"\B,(L<%DVG3O(T&QLI1H;_-/Z+':U
MYD-6KQ.!%N\5 NB($Q"+$S%G#E\O[APOH-X%Z*\R33: -OZNFQ]-#Q:\,LN'
M2D*.3LGE5$5 _ =9'[RTVC.$AZ2C2E,F!\L' JUXIZ(W'116>[8#I7H,&)$C
M)2OCGDT% 1_NU$D KD!MWUNO.[>&5ANXOH<9.^/%OEE>QW;D9?U*X%"NYWZ,
M%[R;A,9AN!5Q7U$2@QW6_=(D[Z0R;S2'DJU9#N7";>/[;C<_T?;Q\UN..A?#
M^5/T;/C@35@,1V?&ID1.N4S3@13ZO-Q-2^!?YUFJ++^Y%@1&7"[+J:('/,@F
M7*GF;.4AHU5N*S_UG'9G0L\S&YK7'?%Z\I$*%W8^)S3>AKM/9ZGLU++9 ,2U
M "T\#NQH-M 6&T7OA3N=OY)=$#.[(;!$LJD2,8_]Q,0\HLQ-9*RE'U$O^/_9
M^]*F-I)E[;^B(.X;,1-!<6I?[!N.8(S'UQ,C,9[!XX OCEI!6$@<+6;Y]6]6
MM806P&S""-/GWN,#J-5=797YY)-969G*)LJI,U\^Y*UP0AF9S3'%<T=?8,0^
M'W\YR5&8V+U4J<"6%(J\XA,HR2==6G%XD7&*7UI*U]:GT];F%ZZYT(8)% V3
MB$L3D)'8(VXI&!<7A CB3G7'<#!*<V(UL83#0FH>13 I83!A5MI85I,L9@S7
MJ[F4U11@VC7' 1%&(^(T&F2"P\@1#\L;'4E:K[WI]BZE#U_.)\XN;#[F!XN4
M8DG(N+ 7/A\2R]YMSE6IZH*-$U9(#FQL =8>.7 &&*FR6!Z[]M"/YR,[?;C=
M6!?^*N&.S4ZGYZM@<>58_1US0#N;Y+]F,E^V+X))/Z^U_7TF\EZVB>?C_-,P
M_@ F8E#V5(N5O2Y!J-K_OASZF8:CLO]\D;2RL5 >Z[*Q'V37.#3 >>X/<P93
M*E(ZWM._9A33L?Z27P^^V9Y_AU_SW8^!GK5[H\%XD.-]]O;11)F>TOC_2.*:
MF6;L5#&)<0QALFL_WOP9;T&'=@F87@0_<EBMTQN,2I+'Q9YSB3_V+Q3JNC4J
MNP^3O6GP14?CO\/#QS&3;K5_>];HYMAD9M87>S5E9S+SPWGZ5C:/%\CW1F/3
MY^T>&$OG;&'_]/BXTXZ#Z]XT#V7SG[<-B>4D)CP8 JN$!>QUXTR.1ZE3,V'_
MXTG)I+\RDGE@58CEFE&7^;S=A%4S,_L.%^][$:UYV.G,.TOV[8Y&"+IVA3H<
MV?X^>.'CH(2Y\NC[HRO(=XY*B%>-1S["\+MM]__-I^"V+G1IL"+G%DCSXEC5
M'T>[GW=Q\_"/PWR$JGG^\;2U\W=[=V?_I+7CQ>[GO]O-?.SJ\"M9I$7-H[V#
MO5PP]:B5CU"=M[;>D=;[/PZVMS9)Z[QSL/?^P\GVY]VS[9U_<SDNT?SXQ3M/
MC306*2USD04.C,A2AI0-GB?&)&%A,?6>E^-OU/N0XR[&6YD4?!&(;/!)&+UX
M;B%/>Z/,>Z,9;9[UC%R7CR[<>!;AY@<OG$4043!*@O%<\LB3$UCE<PPDT4AX
M<"MZ1F#67!27?%S2!&#QJ)J_"\M1Q2<*)LYN;-OAS)'/]49LEPAT219NYX,C
M)3/FXA!)9J;5]K0;P+,R&(]W>3)"%ON2LW;AEXU&"6G'4WMTW(DE!7L$X#MS
MO!3F, +<?LOI.R4>,'.G_(QJ2VA\NXO72.TN('"[)" /0&C&V53E!M4KSUY]
M;8F)N2GH7I":*U\YE22=R?Q-JL:4/3 W+@<Q+AY;[KW1^'WZDNW98[:N,FTE
M42L_[: -P^G[@S/@70/?;[M\3>ST3B;;$\<YGQU&<3XVANWN\0C&,!K,+_',
MI);DMN%!/\9&)Y>UJ=XN9R\,QJE_P[@/]QR7P9FAA=/!E,4O.Z>]DYP$5FY4
M!<B.1^,\D'P*^9MM=XK9+&ENH R9,N0LNC%YGQG6T529-QH+19!_.@Z7N8G.
MQPY*>1;\^FI0JU9FQKRLE\O)ZVIZP$)GR9J=Q)((4^4)HBH?969:JV49')3<
M,A?S'E+L'Y5$H/D,U<%@='1<,9?RE>J&QQWK8\7(?1OF#(97I:F-"F,JV]%5
M?N&XFA(HZ$RJY^>L?F-!+_H[ RDA'L=N*/C0G=DM&Y^RR.APVJ[VQL;C6[A[
MP8Z<UC?U>?*@,M7+ &/S<8>T4,2UE'%J T -7CV6N%WF2(]=,&BI0OJTI8-@
M" NE@_B&J*IVE83&DLX+*WN1@CZ8E^))DLE%H0([R:0"FQ#MT02T9W=8ZY7\
MH2O9K!*:O[>2XYSG<6[.--%LUD,K3MCXPN$T8#0HNS6=<EBHG9>@N(CS"7=C
MBSV#)6#MK]^@60FGYQJ+DI$?IJU=>9L3*C/A$;.87KA!9=('<08'*P^[^,FV
M'V92@O*M"V% ,#W]67LS900WLY'V+/N:MUD5*M\,Q+4:/H8:_EG(&VF@QL=1
MKTIR+=J6Y6BJ.%>J2J&XOE0BK12P!M&G63UZY>H-VC (V[_MVJWG*_[['1FX
MS2W']YJ>K\J1M>HYY?YC2)@YJC/_Q(OO!?"A_#!GH><O37]S.6TQH_?L[:;?
M@IG]5MVMFVEJ9WS>?;U"_GZ_YWK]L:NU/G.SB0$I6=KNK%Q:,G(JC[8:+N!7
MMY;PIY%P!A+^J3NS8+,K/SFE-#V,5+)+IT9O<='J,G>74[3$LTC1NCD*][AA
MWW_\00RC3MQ.%P'@JL+N9C?\.87"L1L?MKM_QWSN#Z3ZM\S.=K+LON0P<>OD
M"S=>$A\D4E0RQ 71R)$4D%7*):HTM9?+U5P/LX2O$@_?F0\R%*0"%,JE)":D
M^,KXY"10$^;#K>4\48XU5B(T9O@SIV0G9Q&OXN2_C)G=.M #L&'LUWD/>9:<
M9SN?OS[6M'$@R/LJ<)R??'4_K"[ 6SM4]K1*&6R PQ"_U^MF?O6N7;SQU$V
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MCTIK1('5@BW,^S_$!R1IE)(:G:Q97L61.E-E9?684YF8!I_4:L&-D]8;H$-
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M,=]L/0^1S0VL^G!XT(^Q?'O0/FT<P9(=W##4JP9V$AL!*%:W-\P3U]OO@A#
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MPHE$*6#@5%XSI E.*.J@8'&)"Y:OO:&7CXX]YU)>-28]'TQ:;2;U<^<G_3A
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MRXSQTD*F2M/^YRY]$Y,%32:289RXED%'(HDUS!OK18CQRU;IF\@Q0;=K1[M
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M0@G/D&02_&U#/=*2,I0<=\Y$S)0C:V^H6I?\P4?P:]"M0;<&W6<%NO7VQ?)
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M8.[&PCF_W.,L^]E5KR BKT$]YY?GG#5/OM!D8C!4(&^E19PI<#4PA]E/%/-
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M,B*6)T5/'-5JX+2!T]J8\PV</AV<SDQ_&4$9>FN0L!3@%&N";*XB4M1:C6.
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M_NTV62?,DI!+P7+#>/ *G&L:9'362\I<L)<&.\XCY1#>%WXZQ[=\#B_?55'
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M%ODT'[E36GEE2$!*48>XC Y982PRQN7&!.=R+^\=N:M?Q4P#0<\'@FH8N6N
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M>/5U=>2^"&V!:*%B<,P2RXG2AG'-?>341J6U5C?H?OKK=.PPVHK;YK@!LML
MV9>Y&)-55D1-<H2IMH@+QI'&2B'N6? <''.3IZHN<E5)US,FPF@D=2*IVE)&
MK;"Y\Z"_7%3,&A.US%7N@G/J!LU(&TE]($F=!6&<PB"3.D?>"0;R&3PR5AE$
M(W@^X K%7&&05'7OQJ*-I-;77Q @?=Q;E><TYTIA0Q0A'D<EM/%$^QLT![V"
M8*J1V:7)["Q> 2X=MCA:A',&,JM4 )G5 7E/E'#,1^/-REN)+\KL<V:8>MGB
M>@MI]:!2.2>Y88QSKZD-3A+O%,'1:8;##?IU-D+Z0$+*YQ2K]M%*AZ+(04@-
M9RB%AA'5)HA <N8X*-9[-^5=-A?3:\E\J?)=,C.Z31W&T@.L]^L[7+=)O77T
M]>:O7VOLOE76C/92ZCPX&!$WDEI,K8L\2A<LT<9,LF:NL[":T.PCP7DQ%]'P
MF.=:48RD3.7#.=7(@N>$"+BTS#MP=4,5FJ7T(L'PK4.SSZ7'>H-O#;XM&*?<
MYI8K' A6/'*IN'(>7$H>&'-1R$DR3H-OM<"W61Q(<,NC)PX 323Z=)DC*\%F
MQ<%1:<#'=(Y/CIZ6T'.UP;<&W^KSWHW]]E+Q;18S2^&27&&-)"<B,<9YI#E8
M<DQ*89TAWD?>V&\-OKUV?&OLM^>$;[-P([-&*.()"II8Q(G'2$F2(\>"(2&/
MSK+PC.RWRZO)$^O6U>7D=2\W7!J)0#/(ESG(I0;@ZU\2_[4W"#"*T^"S/5/T
M,E!,73/X$2I6-Q_L:(XJMF21>X@0_3TFNM9*_QZEWLV,U6#&:GF/I9)VU/V(
M<"G%\4W;K-N\8:WQX19>E/7,@O_$*2.&>TPM$5PQ!W]UVGF/KZZ-;YRGQW&>
MMN;3E1D3),^I0Y8JB;AQ"EEL+:(L9U1R3@*C*V_)*F9-\] &@IX'! 6#9>"8
M,JXUEU':G!G*I'0L1F4PO[HJOL&9Y>+,7,4["5R30!#3A"/N'$/& .)('HUG
MA$?* 6>HJE.'O@9E&I2Y&F6B]#Y:4(\Z&&Z5T)1*JSWL<R*TM>'JDO?&T'DT
M )K/',^QY]HBY:-&G&,) .0Y2NVO0#VX*&Q,AH[(7V!E5@-!+Q*"6'"1TA@4
MYI'[& T6V#N5"Z%"RL"^NMB]P9GEXLSL-$H'QJDR$2D3(N)>$V2$I<@YHBT/
MTG'.5]YJ5J>JLB5%WV\,&'/M3B:W0.GZ-Y279?#U*G"O*MLG=>YG'5W^ZU:D
M%/?K3'Q-D=E5C8]F!PS_ V(-$_S!%+W$L;_5FW5A7!\40_AH W[M[?U==HIK
MZEYN)_JM[?51:]J(_)W&N_]W'[ON/SWS38^W#CH'K72/--[TKMN?CML'[_=W
M/\ L;KS_L=O]> 3WH>WNYQ__]W3S".:0M+8W8<P.GKGSG>/<.>,T\L&"Q4(I
M1XHIAT0,4E-G=2[8RMO\$CJ,U5MNS_NU0VZVY^O;GMNM[X(*)KG/D<6I+" Z
MCJS-X1])J:+@[?,H5MXJ<G%[9K?;GO?L<=QLSU>P/3^=?"?*<D<$01CV!<"E
M8LC2/$=$TYP1QCBC 1R\RW* RO9MM]J3]^R@W.S)U[ GQ?>HN LF<MB342'.
M+*[< A.P -V.!4!:VI/XDCTY,L?GNPF>;QGX((?CU]67WY08KW8.]:T(=<%#
M(USF8'(YKFPP1N#H!78!,^DHN;NEWE2:+U$^BXE\KG^71 /F4X(L)V DAVA2
M\J< *R0*'8636$J0,'F)A#UC]LJ7+;"WL0VC)N"N4*<42TS\QCBIP;D6N05?
MVXB&:>D)Q;3][DQ,J0]<!!T1(R0BKL&--<8&!/()"*N4B2GZKB\AF;UE5*R1
MU?HJ5VNM40+^A>7G@4<KN0$#"0>7$X\-:;B6:B&U,^7JF<RE-1(IX2=G9CI$
MAW+G+::.!*;<RENI7Q8U],L6V-L41!G"O.0VZ55.I;5>$<.<")QJF0O;L"T]
MH9ANS90K9GENM0\(L^ 1CRH@"XX+$M(Y$GE.L6(IM^9BY./IE.NK2J=>$N/2
M/0_Y7VM%ZZU?_\7@-Z&>.\\ &AA8W\Y235TPSD5- =##U07[37K 4M%Z<SYB
M0;&1/!B/&,L%&%5YCI05-(4(O1&*,J75REN5+RO?NC8%^0U\-?!U&_CB.9<I
MM9(20CB1#LQ/)B3UQO.08Y-?78_?)%@^'K+-!7FP,M)0[Q#7@:!$T(J,8 (Y
M8@(FBN4ZV)1B22]I:M9@6X-MKPC;&M.L/@ V,\V,II8$;I")0B+.J$?&$PFF
MF<0Y$8K%F#>F60-?KQZ^&M/L.2#;7(A04$:(!8/,R@CV630.668IRIEVE$AN
M?57]\HQ,LV52QN2U;[^V[MRX.^Z84?"79JFG)/6:4+I7T_2&P=SZ_C@1VDQG
MY[7JB>7/3ZT5R6W.A*D0.+?!1,T%9Y89IY7&,H]!Q1Q'V9"*UDBE?)R/8VKG
M#8L!5(I+ITY.1*0MQXC$7!-I\DBT+%L',[&$Y*OER<[SX!UM0+0!T9LGUE#P
M7+5U8,H%KH31/C<V%U1+0O,85<-<6BL0G0N9<AF)S,$NCTHRQ"TG2&&;(QD3
M'P_VE";Z'0!109;0]K@!T09$&Q!M+-$7 :(S2Q3L3XF9M0@6W2'.L$]IB@8Y
M%P53 DLL0V.)-B#:@&ACB38@.@^B<Q%B2@@CCB1"))$CKAE!5@N&<!Z4%,13
MY\1+LD3+\/&_2L+MLY+*ZJW:XR[(B3M'4S)W[X/Q<%3$DV7+(L&_$D::A'%[
M/V0AQN!&B31\!+^EI&K3._GO_Z,HR?\8@G2:L2]2G!@DTX?>L/JIG,$R?!R+
MGNFYPG1@[/"';NB-AHG2Q'1AH>#'07 =,QP6L4BQYG%)=V)N$GX^,L.LZ(+P
MPJO!W4&0,]/I9(=E'?(P@\N'\*S@UQ8J66':$X@4O;$I=].-)O[MO^W@7V_/
MWRE]KY1[@:T"%!):YYJ'8 RC-&IM?8@,NV"^*[HR_Z7)P[IFL%?TIKM2+Y^)
MYL(BYY<N<GMK>S,CXLWT[9YBHV6/\_#+)^#?YR1Q"700"YHC[*5=_SD<]@$A
M>GL;Q=#!#AX/PC8\YL\.Z)6G52"\54P42'<7[M,^:&W\P.T/F[2U\;D$]MWM
M#EP/8]C^BG<W-EGKH%V ,NB$__E\LOO-'UK*Y6[WGRXHA*.M[4]X9WOGJ/WA
MZ^GN]GYGZQN,;?O/_?;VYQ^M;7?2HG]%V'#TN^?!&^DH,MY*Q*7FR8Y6B.1&
M,95;K(FI]#V(:O#K24G;7*NHL<M9SCDU3/EH2!X<"6 !,$U6L@ Z^3!)\F ,
M5OCG\#/ ES-[DOT]Z/NQ&TV/%Q? ]X)@7R6C?]0&F_^] &35%OKU#)V?4:=S
M%66,1AK"E54P]5%++8CQ %X15SI@@OK9/F"N#X"X71B.!X5@1ED!D V@"S@,
M>-S+KC3?AI48+)=NY6/[_3D;#B;3)3ON"!0ZP/^B*,)ZVS#8BEOE@$$6)[(Y
M/+/E\&L3Q8W-[\0*27E0*)!05K5[9(0*2/' J.&Y%)ZLO.WWP@5++)LLZFII
M&WB0MD[_,/VAY#@!I0WBE71_<5IM4=#MA_L&5LN%<6DL@9HNQ7*XFBC/.N-D
M:)4;9-#O=()'@] )9AC2[0<@U^E+9U_)K$G61KKM>)#^>C@HPL@,3K+#?N<$
MGCRY8!3<?@^$<N]D+=N^Q(1YMU^$F)UMB6P#=M<PC;9E?L!-BF%E^)17;1X'
M-TX$&=E6C(6#CW]+'Z9[4?S'N\VM\B?RQ^^31VUN@8'SLPA'R2#IQZ*:F-)^
M*7K5OBWGI9>9\V83##T]N)^!;13@:AA=>7E9V0.WZ,+8LC[8G,GFZ9^-W4_&
M/H3O94<!/C/)Q!K"#*4O=D#9E$\<KF7KG=GLPZ6#,%D!>'@CQL]-C-O;+?'=
M&VZ%$ Y%F'K$L7?(Y%PCP0V/.0?W*-KKY3BSP9EQ)6\7Y.1LL^P;V/_# G2:
M&60!]D&_"V*9=N7$6 <1AQN#6@/]Z,Z)=KIOSXS ]DE8D'X[NVOZ_N27M.'@
M1Q?2W@=L.3DL+W>@;_L@U_ G#[<>%'9<7MH-H_UD\J<[#,)><ASZ@ *A][,8
M]'OIO=;FU/YYX_\JQ3]1M9Q6N3J'_6&1OO & ,DD^?_CJ/"C_6DNV]P7)Z8"
MGGW%6!#K\>CJK\R9%"ZY+(,GLBA01FF&%MREN7_WS]K$'9J]@.P@F!_(1!CP
M&],Y,B?#E7^=-Y[ <EJ8Q\4IN-J[JOZ]U,;YI<VR8.-$K6RT8&LZR[CGPLC<
M61N)<C1!EEVYQN0CM$XVWU;O+.4J2Z&M50#N%*WPI2C]3W]X6(Q J4YL70#Y
M+R$\M&M5WO%->F[A;O *[?X(QO\F R]H*B%3*+@P_J?T2->RAW8+W7[PXT[8
MBHL.XL>99?#GR>3#U^LJ?CSZKHC#7OB(O#4!<25SL$V=1(JYW$<-C@X/BT*/
MX8H8X0-A.2=>*OA=8..T@7^]]XNN8C+7(AB=_:-23Y6M\28Q)- LV7#<[2;3
M,FW5_FAFN&9#L#>&R<&$'3R<J;,W=W,T4P127(4XEX+A+]_S[;^KESG33V6H
M$\2H8PZ'X<WTAS] I1YVS,F;HE<*0_FE/\Z#81K90IBS'&CU\0S<UW %\)-\
MV<F3)Q^OE1\MA&ZKS[A:DSB_\F.\1N[XF6!7/_2Z;UXW6,K6&!'/:;#J1K?]
M1:;S+5K>W>'22T[N*I/H:8ZH+L0+<145'X!:;<%U^\-LLY<\IELD0K_46?E2
M'-]@3FZXNVIU@GOY^TZ,E.S+5 %,_O!FN7O@-D=3]=X@R6!MYN:&<W-Y7VYV
M75ON)?5J7O;\/_4CE\K]4_]FS^ D'!<PGM.FBVK3V>>F/,28B*!<CIF.G IF
MHZ#1.<N#"LXJ=VM>T\FYV_M!O_LN!?-A"-^*T?Z[20!O\W@2#UPO@]NA3K3A
M=_5PJVR:[B>Q \_8W=C?W]KXL[M[\/E@=_NKV-UVK/6M_:-]L'/</O _6@=[
M>#&;9G>CL[\%]][ZL,E;'W:[;1A/>[O3:9^ZXQWZB;8/-FF;?CK9VO@<6R=S
MS0Z#DIYZ#(ZQR5-35:*0)=PA:XGW,A#P)Q+%#[Z8C=AT&FOPJ(YX)+CVC $<
MY49P^,%29@/Q1D2GA1+Y#:@@;YS7UT#5@T/5K%U9[H7RU%)$(V&($QX3?SI+
M73.,U88$;3$8PZL47VSD\NP;ECT7"_(?<^K&G7#X$$7=#=OM!.*TLC(8JWQN
M,>>16["X@K"6Q1!\E.H&)E<#<36!N/:[.6N,44M2 !Z1P#P":YH@Q<J3>*.M
MMIYBS5?>\E5]?^Z+ALRZMN(=<IX'J[6).'(1J;8@XI0;FHZA%5&-!?.LQ'MF
MP1AIE*'*(D]-#A:,(<@H8E .'A>FGL&G>N4MP:N<WINWJZX$V/4W8=9_]'^:
M!XF W0CA;NI]/F>$4T$9PQW!#K:^U\)H9BS#P5N/HS0WB1DU"%<7A/LR9\!$
M&P,/U"-FHT5<8HQ4SBRRP0<I1*YIT,F (?H%MJYOQ'O:I1=[D^<<2^$BAQ\T
M,5A(PWPDDEE^DVX<C7C71[QG!HRECEI!/)(^#XB+W"3648TB(=X)00,38N6M
M7A5\6=Q\CV"_3'.78+#A>D2HWY6O++I4=IQM0DL/"-TN.JF]9U@&S2.UFKC$
M]ISJZ6*()F].\^J&S_.G>5%Q!4OC$"%.(K"L-5)."D1+$F\3<&YR<##5O4_S
MFNA1;258,NDQUE0:J;D/RC)#A22&6T\$9C<Y_VHD^)$E>&9AJ0A><>X(RL%:
M1IPI@530"N4R#XX3[W-"08+%2XT/U9_>>/MB!O\3MDAK*(\>?GY>BF; 3!A%
M0@[0HGAPSN+(P;++\ZBU$C0V4;?GHS2VYH\-!8Y.2!%0<,8B3J1"FBF,-)9@
M] 7!K,;EN0*8\<OES'\&U'(-SC8X^[@X"RXT(=9*H3SCN>/648!7DEM&'1-1
M-N'/9X6S<QEHA!K,742><E*%/Y5++8RMI@Y39KTR%7LGXR\&9U]O]+1^ [[E
MJYUQ!EYDKG@ .KOKOG=I]?$OJ146JK)SG1M"*>-*>QY2\W#*<L\T%1Z#WZR>
M"Z_""R%6N+A[ZL-D]NNMLG9Q_%EVNTV]!&Y'47]N1UD/;L>'Y=-XU^]VBU%)
M [7>\^_*7;$7>JX(P_HQ+K:GE+W=ST6R<W:_[7;![H%G?3IJ;[2+G>XG"L\]
M;6WL\7:BU/WVST4:C0\?P<YYWX%O@MWS5;0WUG&+_E7L;L#SMEM'6QM[<+]U
MN/=?L77PE;:.OGL3O$]-<IF5&*P?+9#66"&B;7 \#XSCN C9)N36,N\X9X$'
M3PUS-"AB.*R9<%(M$FD\R3Z?6_R2!NK<\C_EYE\P&1?90*XF.?KUM)]?)A$X
M!8B$A12$^UQJ$C!G.F@=<QV\N8[DZ$'QZ4HU=OE*_@<TUUXU#PMS=V- ?^PU
MGF?(+(;9<&P/$F/RJ)\=@DZ&10+-VRF,+3KP;O!8V)8E;]])(D8K/%P!%\#5
MB<;0CH=P_]1=;U ,$Q/-A!)Y0D53;NXX+@G4.N9H."XF&]YU3-%-5'\5:W)Z
M]B2\/7WRR6HB$1SV>_"PHG<P'L ?W,3?7)WC:DQT;:/0Z< KC*LH.7PM?7MD
MCE>ST#WL]$\JSL=$R@QWGU(25N1OX/..X#$5-VAZB<0K6%HAX.44O<2AX^!%
MAR6CV_1MSQ$S)OIG0))A2>E\^0P>[8=>(AXM2E8Z6_+;E ^<3(WK#V%>?IOQ
MSG7"7N*(#J&:K7!\F*BJA[]G1T6GD]F2^W \&,#,I8^'8[<_N8>#[00?#X))
M,V=AS0)LM<0Z[=>R]=$YLY&47]X(+B1ZPHR1J3&9)B94'(N]_D1N]])JGGLG
M\/D35>/A9.^DF>B<"<,JS*4M1H,)7^0@,[Y;]!(+7DE'E_Y2S7_)FQ<F9'OE
M$IP;?:?X$> _</^2Q<]D9P3:QH,/.5PBW_?4"EU-;S7N5+3?$ZI*^ ;L'S/<
MSV*G?S1,P^\4_SLNX-8G:\LSX>J&%%N)5/0D([3:+ZO97^;T-/O['"4J3,S'
MGEO+?IN0BJ9+IJRB,+N=M$>KX%*GDD #\GJ>AG3ZU[.OP4X!&2H90LT4-Z9B
M^;57+N>74<G@NU$2*\+ZOP,A'94BF"XZ^S,LX09@S%':5N>?"9>?/<_LP>.'
MHVS]I_&AL_B"V6''K4X_^_H%W)-.VJ^3%S_[I&5Z9J\DC(?!# [[@XD@3#[^
M#XBT.[DX>?_YS[NS:[Z ,,%6'%UU69+7R:7OVE\NO2C[+3%D@42 E'5.*J+;
MR3M/W\X,D@#/F%\_SD2G7(;),@/BA[U0L<D.^[X8=[/^\8F%:3_#ZNF:@Y\&
MT@.K<L9:/9E8#[;6H+ 51VNZ4=J8&X/Q7K9^"%A<D;N>W08LPK-O]H\28[,]
M^>7[EHA8].(@851J\IH8>!,>A$K)I"T B_:W2<"<M?MKF<H9T9*M9@3G0G&E
MTD^*,*5$^DF#\R1DFNM_P6Z"WZ74C%PSKX?EK8<(#)2T41<H=<^V?(0=EQ!O
M0EL[3#RA):<P*,'$U3L(_PM:9#2LX-R4+0$Z1;?2027;:$B$NNDMDC[LE4.9
M?'DUZ\(+EV3"WG3-WD1O@&[K#WKA9#C!PU*CK$Y4Q;QBN8AASPZH*LTV!:JT
M/.?W>P9J,*F2"I+@\V*0K?>&H.4F%O@XD>Q,[)+?+HI-=>W9_BS57R4V"7A@
M>R=="'HB)&5U3I[6LG(GG+O/G%$%6JF8B%DI<I6ZR8:AA#-X2G%!/L^V4"]9
MYOTQ+&:,1<G!^#/Q6L=R4><,BE4P74:@S),*[Q:5Q;4*O_?05'+.6+"+WD]8
MT:38SBAOS^_OWRL<2D3/@Y)KL%?2&Y>,M^<F<1C"CP3A!0!L.FSHF$'%='LP
M]A5]+WSEPAC@;\&  %1/G3X4WOG:VYP?]:4W*%_N\KM43TX"6 PJ6NI.X@).
MYNP5X)'%0;^;O:\ J[0TM@8F ="?_?Z/M8M1G><I3D2=4_R5Z"03?K*)YW7^
M[07DG$!4:#EWHSM(R'D)*RWC,!I.KC%9\D_ \+Y$5":;^<P(G=PHM0^(IL*+
M?E;V@TF\YZ5629;&T7[A]J?P/;&\]V ;7.SB\L*,PG)S4#(/MI-5'@['I5,"
M%C)HMO*@:$ZN*C29P'$_ 0/8XK&\9,\,2B?@<&I*^-*^@ZOL>:;WLX>=2=ZP
M8J8MQ;5\X-0*!(,]3.7^]^3G=A.A_>P1Y=7S=-_3SR;]>=(].J&WEW8/W&24
ME'$)":-!Z7B> 7UZ=3!5P%E*[FSZHDF3!%MW.DEKRXSTUG)'P,M._<K+=L3%
M50);!UR\8KA?[HQJ;F/I6)U%5-))\V@XMT E>L_;15-+""[>#Z8"[R2FL$CM
M_L_*L:43JR#[K=^#4:8>#3]-[\RA*!]2R?T9RB6UUNV7MRT;-5WU3%CT+3?J
MET^9.$F_3U55A1/)V1P-QI</<7V\!PN75=^DYU14N<7.+IP^9#+##+;3"] Q
MD]?GER@9TZO" ]<ZCE\2F;_/;N<_5MMRZO%=M!//_*'%NU_B%BWZ/9?X.QOK
M#^G*$'!A<ISK2GLNCOBBRW&+WF*OM*, >PX=!6X7/*^-R-?)X:V"]7>.V=<(
M96]Y8-&:!E#GSZ">]01<KV9* "P-,C?WPKXZ8ITT#ZI?8@3)W\P.!4?9?^8"
M[U6TXNQ5GO2H?"[487HG_^_P!KTT%VWY=.0 +ELO'=Y4+252+/\]Z/V,8/3_
M+9Y&G)W:5)MX?DW[X]&P\&>=>GI3T^'BZ<VSWNZWE/</8U.ZI',U(_=]Z[I(
MRD8(@UB$CL_.7O*9&\5E5P]3#+*?II..%-,)U'B0[4U?+PG<[*U+IQ2^,?MX
M$%P )5E:F^-A%:1:'W3+QE;I!':PET*@_1A3["1]O3R9!"&R98-$4\K8Z$R\
M7G 4XV-Z[5XO5(Y9&:SZ_]O[TN6VD63=5T'X]IR0S@5I@JLHS^D(M21W:\:V
MW)(\<\^O"1 HBFB# !N+)/;3WURJL'"125D6 :HF8MH4B:4J*S,KER^SD-+O
MQ2A*T:IHMZPCV"7N,'VJSO^B<_N$"YX% H(P9H0' =X7%L M+Q NSI_P&U 3
M'<]P3KF=F3V784MI?:S#>7-@]0<<7<=()/O.]8\_BPA-;K"@+L=7/,#/]APS
MU)?!)Y'0:0$9?+O1?FTXI)LO#Q]__T__R'8[/2&PJ0P6.?=&C2/7ZC>&+<<:
MM#H]IS7$(N?E#A1_XQ6&105C59Z]([>G]]>G^6%RR20*T]M)SGY]\HG[6805
MKU9.)B]3(86'(2R,N=FWMQA(PR@EG5:-KTIGE)R?P:L>" ?@SWE,/VU3QN5V
M>\Y@/+(&_4%7M+NC;FO4[0W;PZ-N?W0TMNC@^B56VZJJ(-/@ER-?AG_B4X0X
M!,FI'45S,(3^A3JQ,J4$+\^*_]OZ]/M_QCWA'AV-16,PLH\:W9;M-D9M5S3&
MPX$SZKN.[78M*KSJK&B@W32,7T&E\0FDX K!-NLE:W87LVC9X<:"4;O%_0;Y
MSL%?"%5#6O0$.+7;;W%$8F3[] OQO!<7[LQ@/G0P^G;,.!P<=2UL8V=U1QWX
M+'KN<#QN@4=L]VVAF?$EF/'V_N/)?_I]IRV&R(=MI]?H=L9'C:-.K]N /:DE
MNJ*/00E@1M,Z.EH^P]-F-!)K(Q4ZIEPI,$K.'O#'2% D;XK'S?TE7 [21_@4
MTF?YP;II@'X=)2%=ANN 3\"(':5AD7\C,;6]P.6<)24*)*Z,.3@3@1IDQ;>T
MF'-;<+W%_*I-/,I0+9EX.=E.;:Y,^&C'F.AY#QQG&A\2M\GJ<FK_$4;(M?$$
M;.E)Z$LF.Q6D0,T%2S&-,U-@:7,O8PR?7?_2U*JD>\D:S;@2BP<3K7)+D/B+
M]N7)?[H][-P*^__8:J,I.NHWCL;=8<.U6_W!D=T:=UW!*G>Y'O!QE<L<42EU
M6Y\ Q>K8R^5XW/A%BN#U1 !Y3R*"B90B=YOM+KO1H2?DKRPS#;F]KN=2N("A
MN0$%%AI*Y<0T7[LP7Q-C_*X84Z@!--=%(J;JJ9T#^_"@>WB R4]XX14?BXW:
MZ+KQS^86::NG[EJO--W5?2S=M7E5V=#*JLIVD"-;?2[M[JK8+F[./QIMF6+:
M_+\?3SZ=_'K^\?S3C<Q>71MG%]>G7ZZO+RX_&2>?SN#_)Q_^]_KBVKA\;[R_
M^'3RZ?3BY(-Q>OGI[.)&7L./NCJ__O+AAJZ[_'Q^=8*_7J_+=6VXQ-U5A8,O
MS\KKLEH*?)W!@K"*+HUCU"&$FPYL?QY[/SI?LJ5!OGG^\4>3=\N!'Q!*(DSA
MJ2YH=O'@B%F"&5LV?1&Y8A_6<5Y?5,7(%J/G_@9HXP3)<:?_ HKG2=RT5$6W
M^MSN:MA._QNFP$IAZKM8#\2.CUL6:5N*M(K-Y_E&Q,%P23E>M[*>9Q$^"H]!
M@\1H@V-V*RC+F+F,6U01%3*=*CVCBMS 5,+T[6PF46#"C\4])3?5 '[/<@7+
MF=#?F\9U.,V<5"]@CPKGB,:0K:PJ>M!:0D6%:6_Y_B)0LOCVQ4(PRI* #<@$
MH(HO<3LG'%VY8I!6QB_2#X'J&58);KBW([?AAR'!R N4);">%]R%/@)"O/@K
M/RT%NS-"2J#_;,H7C&&":(_"]*:VFX&/51V0G9)C$\T-RKM?94#4]_+U'^3K
MK[/7R[![D8&F4XH94'U!Z(,'I-"N-U3KAQ$ =*.#),Y<\4=I3=3*T5LYL669
MFZ2-L8(VN*!>0"@V;,7"-4CS%<(D*7 %Y#/>@S<61H69<20 ^ )1<<:%R;)A
MG2A16Y^PEP"^#/[]I7G=1&1:&N7PA?,'9T)H><(Q,)^J3,?U^6E>!(3U9Y$S
M,8:%@D4>46%(&W&OQ'$6! -FH@B$):93O 5AH6.F!3.90S1S[!1!XEQAJK0)
M,)+KC<<%- *N/F9<6>CYJA(B$(;@80TJ)V@+"[F*R1>D6A0X:YUX$\+IFU*]
MPL_>T 0<;-0[XD5WE4?V$!Z'BY$S$I[C%(,0>!5XYG<BNO/$?85J[:M%UVU1
M)ERL852!KD^!VK]X7&5MI:EQ\,F.7?O/8^/D7V<?#C.]R'>82D4OU,_:P3S[
M27Y]+Q:_ <6=?06J2'Z;QCEN&G'O(R^<E89%Z&MX0=.X!,WOX_ZA"D =T#AD
M IG&^YLVE@N1%L*]&:/JG#K#0A#8@1L!SA]K)V$1!(BBVT HOAV3%IRJ> ^H
MY85J4U6*D<#6E60U8N!P@ ;$&AY[CJ5]1NP+,6/30M'L_.PZK_'%K@/@E,Q\
M\3"GP+E+"IHV*C  8.7%+(9)_EL0#F86>2"!'NWHH&PYXDE&J+@3?CC+"N;R
MDO]R:;(:!&Z V2C>AR'C=K@(ME 47]@"WQ?J8"ES?X<D'#.):6?/BO;S[D]4
MW9)0J<7&1;;2%H+W$9'I^?0E4OIQ$F],SAN)@L]?@$D'VT%_,=\'<0CPD$)N
M1N[V-HS@EK!)QN>(]M(938?F]R7&'(P0QDFQ&/GLR_O"%!'SE!@RM;%83V'U
M5 R\^JF^QV&N.?8Q?$1([T76A@7762#,C$@R0\, $S^R-$L\S*A'1AIEC\$K
MP 3QPJ:11X6-<D X+,>#F7EEEXJ\98?**C#VQ6,X0O[XBL3%M]P!B;=KSD4L
MG[0+%#7V-_0S&<HI%ASC.G[TG"B<I=,9IWFP:)[\/%+T+DAM ZMKP4P P1?.
M)("I2>]P2<>#^EZK9^(436^J&4.3NZAQKLO#\THM#&+;IV??VM.I;4SF;H37
MI<D\(@$!FL/6%-Z* *NJ<>/##IDTBJE([!$P:)(CC$4:A:"\@YA4;\0/;<#*
M!"$]$E/(CN>N&E(F&JJM!;I)FU-A!HM!7L*"ON42LO+CSU/LB;/ZX1L]%,;O
MH0O=;K7:YN+J8Y$LU=6-A(#5N;,]GWQ>5/(EQB$VF6+!UP@&87^%JY-[S*EG
M=L'8B^!7&R]P<;\Q50@EX'HMH]WLH7+J&A,$=7.Q90U &M^J@\MV<ZM?Z.=H
M!\"#0';VUFE_SQQ7%#3<5%=MX&"F%3?2?K$F$R\$#>V-T05-28O+"CO>D'.P
M &_:Q B(+%2[,&VNFVZJ-5^9?]-FB9L4FQ\3U& =PX$KR2SF$DUEES&!K\ZO
M;QJ7GU2%,%>(D\%C@)YPPRGN?:;LJ-L8P:/@KYD/MO8H;!049IRD[IQ%1@3R
MN[;5SD64P-MV7!@AR$<VM-A#"[2@6DSCU YLUS;!O$7D2J85*#62H@GJ>S9;
M:SX6'<H7F?S7G0=/E.^;@KX@BG#UI$ S@3F&Y5<"GO%+JNU@&QESHW=H=,P,
MI#3E!_)H28EL3*^,^X'#3L 8]XWV@*6CB1604E%-PASS/C2H.+NT<Q669@)?
MP=R!]AC+D9:WB'(5+-?,%5.JV;5YV3$B0^ ?BN^@&(#T.+8T_A7%X:>IL /8
MC\8I!9-0^Y*2)><IDCW.>*%!<*(PYFTIF40"^:S!_L8<Z3D+O2Q2*(=U;""&
M AP-):'WH$#A562+PUK#0H'\?_SWC9DSP:T?CCBR%0G2'(W"N.CZTU\O&A>F
MW-U P.Z%^ HSR3<%.TELYZO$(ODAME5 \C%8!)M[FT8?J(X/&(!NAD]^'#XW
M!3'*Y?N/46H%C<F/"T<@^G=2@R)[T-JOY!'9:2!O.G$O\)VP 4:R>9KL-P:[
MI\,)!#1H:><#8H2.1[,EA;FP0U+I4C84-&&,>(HSRANG9&)]$&"HT3:L9N=O
MIG$'^H*JF'O-]M^0,QULC89$G<U$@I9(N]G''[R__F*WC"^,PRG8513V[C2'
M\ 7L^5-L9@1/Y2!AD )/@)TP_)MLYX+7%1J^K!<OIA8!?V0_QYQ+#9?]"GN1
M5OM=2/(/.\@ A?D^*SN!2()=1C.L022W]4R@$,CV8+Q%3$&<62&@B6R A7SK
MH16%N[I,:BP%'C26I8QEZ56L=+N*W)H[X9AHP[C5':;*\LQ>(9J%'@DHVJ^"
M0D%^&GMW"&U%EN2JDAA;9QAS84<QZD>52T%3'G_"># Q?T.E^>B1LIT41PG(
M:> >(9FU'W$ KI"<X5M0ZZEP%FA?!H=25])%T<#&;3/8'@C'F.3^E>R<@.^Y
MB6S8IF!VQN5XC%Y(%JZ[_GQSF5?6@"E".X%-"4D@9:!&$])]^Z[:J(G-*I=$
MTI5M/KECD.7FRK+JO 5'@&GWH %^H? Y^%O*^%U^.%?T?AO#!@KJD,W?;+<A
M^SGGS-R#15[<RC]F2P;>6'X3[(3B ?UVE;?UP^"V <H! P9CD;!?O6"""60
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M!&4T )<D3R>6AFF7$2T8:BWWC(\E0B@[EL+XR6H>&2//]QG.B$K,7W&H0BU
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M/G(9.#>000?"NZ,2^\*=(BKZ$<G$B]P&0O3I6"'\L4A+.E T$MYT1&>@H6+
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M]?PTD7]SEB[;\&0O<03&8& :3%(7]PRU3XG<+9>!]$VA9%42IUI%S3Z)Q/B
MG;BH)OTR/QL"$\2MMK5;B?HW-JWT.3>]!&M79[EE,'N2@B"DSA5"NEK(: B\
MQ=V"R^X+)Q#'>:R'/$S:7,"ODYD2Q&BAU#&'LZ6G:N,I=*3:C)7*8,:RU:O<
MHGCS$%@*SH3- T\9[MZWTP"40-Y'S\N+VNK=7&7+9,J%C'J"0K_\U\59PQKN
M<2J:.XH*.RKVEZ&4=(PM@1+>361ZC@F3]9P!#@^YY O\$1N\DC3OMJU(ES6@
MF&'T 6,E'K4<HI!%8$Q2S#RR@<0N@.R6A^T6PBFG@6.N8$91(PN+Q$16U6:]
MST)J@WF'1W_(O RK<+6$V?OQB70S5[AEK@(\ ;N\W7(KW6*1&\\[5H>JB.G,
M#^="GJ&A,D(F[Z'<"A(')2%J(1U-8:/G\96%?X*N$;IH#G<Y+Q2Y91'W N_)
MKH#9(&>D2<"APY8S,SI&A'>T0K0^2U-1E[L\^X0@+%,W+%L M0VJ!VJKG)[(
M HW'AG>(]?:QAX A5RA?C@['Q: !^?G%/F ,2U!UAX5.H B8QO(\&"%V6Z%^
MI/GV(PTY9&>E:+"#Q>75^<HV5J5&4K!YP2A=+X[2&6]X4G:Q589/MIX,<U#F
MAILKB?@=AW_QWDB 79BE=G.1Q^1369+)6@ZRPQ0PP^N%W(L5)@6NWLK?I)I;
M&@_K/5!3^>"E>!=.M^'D<$G2S=6G:Q5-Z!BN=]CLR*U>Z@2T?%Y7TT!DR<SC
M@O';2.J2.WB:;+NB\G2F]$*+:QZK2E_21]Q7OG#B%_-)?DR4K,L/L!O,B%J3
MN)Z3]6B ,8T]5U!6/0]W4Z WS<O;5^IZDZI<,17H!5D?5]JG^)?2\5E9;P<!
M%M$M[2TPOJP3&772DVB7-2_+L'B%CGFLK&WEBB U$^'PG[)_*>VG>1Z38\?W
M%%.?2TQ8L?4$KS.N!K,5[\!J'\PT?X'Y:UK$_SYCRV48RW=B>7:D1/-YY.GO
MPNEU2H*SV@TJC24+R'M JR:9Q 8KDN63@!E?&4L,2*P1(#]\"*M]V2OIY]&1
M[JVGK66Y;]9/5LML#?D8EI_:;;/3Z6;E.8C+Y$TEY@[AV 745,< DCG,L O\
MGCNET*>L39@J89):12HW51B.GY==WG"ALGP_ I"UXK++#)7F8]R$F WX9MCI
M,YMT^N:@.W@J]Q79I\R+.1K."QQY#.9/W9;9[@_EBSOF8-!FLT*^?',F77KZ
MAN//@R_4^#3RL!_N:*[9N.ILC(&_G(&MH=D[LC(^:K7[S\_ @4B*K NW' VZ
M\I6@9EO#%:IU+=-JAGEIACG#L#YV6%6,DY]T32QTT&IV.GS(''[N]0^?GX7<
MPA@D*^6C0*9J-;M2&\((CIZ%H33[/ O[G-KQ1*(;L'<2%2'%>8E7W@[P)^O(
M[/6&9'X!/YA'W8Z*]"\R"D4"P"ZSS&ZKC1>I8X3DA98Z+86ZRY0,KWRG0GW7
MZ_>Y8QV,4?79*7C-X.UFONACFR"\C\(9%"D(QV,\'AG?8/7-7JN%;T!8&OQ*
MT1E*%0HWSL^7R+HK@P>IPGEK-]'GK-+:[/!;J]7:Z/3;RAUU>QI)3,Z)XX0I
M]QD[E]WW?C2\:$O/N[X%&S=YUA95D#5X%S_QU/C\6 1.G,DC8V#M(I=@XQ(!
MFJWE#,33\6:8V,M/K\G.UU1XD-+1I%@XQ7U=03N$ZD4R*;AJ5!@3RNK(^*P2
MU< Q5JG]=#HKQ)5DJ)!=/-E(VY[BF.GU>'X0/M:73>8D?I5<6'F.M<P[EHM4
M6#TXL 536H);NB(9*.)+#^56VOESFUB@5CRX.VOG5^B!B2%E!<#,-!$0(YME
M\QN\61E.Q%K?TAE+!4[!W ^=P4YAT\+!Y)_"A#K=LK8ML.TWF#5K5R8/\2Q7
MS!7*Y:0M1#$ WCJR0^_41E6J8Z8OLOOS2N8;66P7I[>WL#9Q 7BL>C(4HJ Y
MJW I!YW\M8(>JF)*8&T5PORDRLS?IZZ@<M;%1\PE"E+=AAELC_NB9-U.9!Y@
M1<B;N^FO"J++7S A (,L+NH?J7N;![QS490%*[@/XZ,*0@L+A(F[PA$J7!9>
M$&.R(K%Q\,B6QQUS&>5#_CJ"'(\RT5HM^H6WRA2C@HEF%=_8=#Z5&5V;CJJ?
M"%F67([.IX&,RN--3>."J$K5W#(5)(\?S3IS9AVN47%@CH.:D&7OS::B:L#)
M.A[;JN#%\2(GG<9T$&*&O989!K;AN><YG^=W2W:W[>.!>AQJS]O:2F771"Z6
MJ";"7B-/IJ6#'#.V6<&:)F'S"H*Q:C?_+"]69WO'PBD:3WD)<+8UG>6#^"][
M.GL'@BO[5TM!+LO?+JRMSC;6EFZ:LBJ_?%3=_'+US>:K7"/GP#!=S?Q4XSCO
M9<KME](IG>&X!/)4&^$!&:YXF$O@QB:=13]+"O$.J5ZS, M3AV(M_+'HI_(W
MRTXT_P5OX ^,0RH&1M:W6-V0W-+55]HD O9J -E]>Q:+8_7A'7J\OCT_]@(B
M'MWTKOR&%2=/T OY9RF*PV&SW1^B-"81_-]5+Y:"VB1!?9NXR[]U^\TNW[GR
MYU;3>N)OO4[_27<^-EC+:K8'3QV0'NQ>#;:[T6/?DCRP3(#4H4S_SYO.FX4H
MYW%[]F!895'&,-[2D2\D<\^M3(??TJ6M%;N G/@C<VKAC-YL=*F>_NN9_G"3
MZ;,!NQL"+-EK+38E,)GRD??V<]S;2\20<KY@]UM=HH%>_>+J1^$]?V[O"R=D
MV8CGE0]IM4D[#"XW*"AFJ!E6C6J;Q]Q;W&I()H;>&@=G,DETJ(7J67:4S;D+
MSY>K/FL]RD@$!KR+FQ0[6L5 M6*6U7.D%$_$H;[K/ R.C?RPCNP0VP"&4_&\
MW+1?++(!;3::\&LC7$LSU6K:_*0YZ@E4^]L&6WSGD1W^N2CZW,37KWR)5WYC
M1Q_9SM?;"&LW&Y*='4>(\7A11 S\=[ $*JN:B2A!1UP]O8FV^=;T%]=D&[*U
MC$K92:LIMJ23MYIA<681/K5*4Z,<:OO=:K?A*?R_Q70US[U.GN-"',URFN5>
M;&H'S'.'-6:W[!GM[0R3E:Q7Q05J-5LOO3X[F.A*3V5S)AG3_VIJ>>;E=@H.
M>_PD^W.!")OX!!L2LM*LLW%L5U.LDA2KY#.>T_>UVLUVQ560:C(X6SRX7._4
MK\QCW.]5ZICMHYY>HTJOT0$MDO9)*KL^VB?Y7I^D!A9!=M@:UL,4.ZXI'^6'
MFH^/"<X*NM9#</KFH-_><O-YA(E^E')[U6O4-5N]@5ZC2J]1VQRTMC7B]!J]
ML*[K-W<C1O6S$^H=.;@6/I[ ;*JV!%PM7#@E[TY\G\GPJFUMJV=:@ZYV6"N]
M2 .S-=1!A6JOT9'9&@SU&E5ZC2RKT]S-&M7/:*AW<.$B2.S@EAI[4#L?+/2&
MP?$9O3JP\#*Y!^T2O;#;VNKH%:KT"AW $FT>U]:K4^V\@XXGU-$T.)7'.GN!
M,;:]R+BS_50LM !4?=J>;BZ\:CM;0Q7JL$I#ZTBO4*57Z "62,,4*KLZ&J;P
M"B()OV(/T3#(#N-8ZB%>SVC"U'-=7]3)//@N:SN;KEZEC=5;MV<.^B_E#M5T
M@7:*)*'UT1&?2B\2V0@:I_ *X@I7(DXB, CXG!,GC.M:Y% _T^"[+.NG[3RO
M>I7:+PH8J>D"[3;/T-5Q@\HNCHX;?&_<H/HEUS<AQ@C"Q<)K;$B/K?V65O^E
M+>F-6Y#50Z;X\-BGV=G;=&.KBZ.T9\M[T&F9UF"+6+A>VKHL;:]M6M:V]N0>
M+V_]5M :M'4IQFMH8)BWD3GPJ4VQ/#YXUV&./=.(!VS,;.T@5$8;ZJ5=&[)O
MF>W^$Q'H>GDKO[P'_;;9;FW?66(?E[:&JV?UNLT7;PM2/QNFWGB.B^!.Q DU
MFL!"4C[Q51HR!S)*<V@:@4AV':*IGP1U.[K[1+57Z&#0W:(9JUZ=%_:D36N@
M2W@JOD:]H^9NUJA^ED*] 1T7>-@*V HJ=[/K,$?]9.4  QDOGNG4Z[--(\3.
M0*]/5=?',CNM;2/K>HU>.J37W$W[G/J9 _4.'% AR#@*IT8D?#KJ%&M&87SX
MO>_9(\_W$D^WK7Q"ZYQMZQ"USU,'5*Y>)2U&>H%T+<@K#!U<4E9!83X;AK-M
MSPEC9L_MD:]C#G6H(-%>TQ,B0VU] $-E5P<61\M/M5?H"::$#CO4$'-Y\*&(
MM!R)<1@)]5=B/^P^W+!O$*YVQ^QTMP!?;DN&&GE8>[:TG;YI]76-T+XN[T%O
M:/:LMI;<6AHT!U:_V]Q>[;XZ8Z;><9&+S' Q#D8B$&,O.<S")+N.=>R;/NR8
M@[[&HN_ARO;,]G!;H*U>W;JL[L$03XC3<EM3,V9@-;= 6.N83 UC,I]$4JZ
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M-F8B,N*)'2&TRO7\-!'NCP@C;NB ,VV..T!0-TSQ^$%%DH*26/'K'N\1/X!
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M]JUN[?.CFN7JPW)#LW>D,2":XUY0R9FM=OTY;K\Q(%9+8T#V#0/2WL@$7<*
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M@\W-3 *9]QUH<?B>N,5"O3<N@[@=MG2^U'!(.]R4B]U4>,F43=&4J&RQJ1;
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MY:T!\VU]AUDW=C^(O#T2-=@[9.#VBGVF,;.N\@!E'<)F#4-&8*HL?[4EL_!
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M@WOH-.?!*$6LP+D@:2DE<#H18!0X!V,L:[-7<*?+7V&_6##@R3I/A-)EDP:
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M'YE./XX[\*,"H/1^>@IYTI7^@H,0D^<>!<I4!(*A5\2("T=/"RLC@+$ C5:
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MD- EYR)+SD)*;>X+NQU7G_;9VBP*%?7R8*GS"[!K+S=+GM_\J-;I\RV%K)E
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M125Z]]E:'$Q(),4@$L\B*]G-B=Y^XC?/92<3[N"STY[6.X@7#8Z0\?!^O)C
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MR?OGS]Z]QW]_>_[J_;O7O[S[]R=OG__[ZY?/GK]]]_P_?G_Q_K^NPVO9F..
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M.?P?'J'<::Q,,8TB%F!Y;5"6X*P2L<Y.;WN,PT=NPVIO.\JKQ%Z-;D<W\VE
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MZPTRB9Z:5,(0[0TETBM-O%6.!,8,.*G TZT3M%M*<?9\\/"^<C]TS0:R=86
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MAFX(7<?@#&.19%5JK 2GQ &C91!,@+%>YSIE)1U /PPM#<7:3<&I?@7W8KJ
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M]6X&[O%]GS>+T=.+\XO)LO'J\YPA+M8;\/E)FBTWPE93G#&"1IH(,U$2R3%
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M/\5Y])<0(+JQ[\70C$RZV]D*-V"C8L"#QGT(A#U@?%32M >+^XP].%#<>_&
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MO)35+)(J86F$8)2S'"+!(\@CC6%"*(MUGDKS&[_*C:>%79LSU>G:M#G8]*X
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ME;:^FXV__Q$8Y8%Z?%H4+TJ!RBS-2[NY;"L]+96>VT8-YC4NVI:.U<JG(<.
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M]<76[\+4)G1#W8UD@B,Y,MF<+#EX ]@*=%HWZ2D!"XGYH!2VN)B3Y&D+COF
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M>_D+1V1<&R-T*@YJ9G(,0S??X$)D1N: -2ACM33I,3^H/W!,SJ3.0(^A^YY
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M4OJD53@#[G"+T0N,/?/#5N9D+_2NKV8C=W+?+[(^J2M](#R0/R@2TI[Y)KZ
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M$4J=VA ZSS@VGM_+;(O*+6NIDY=:;%MX>&Y>N'8_.;YPW:%W<+G$!K1G5CK
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M.F@0ETHIR@(*@,U_ 4J9 )QB!033)5-0X;SPJYSN-.W8Z.S;YOG91O@::^1
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M ^&;#MSQ[,8@U*):E'X2#&IK!H'SU@H-&R3L-?2V37?3GGN"<IQ*3!A 6FB
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MD<<Z;(3 'E,')2'N]*_3.9L+,W15K](6HK%IQK8B]$2BDF4E)B"G&@)C4>:
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MX!>%-<#:M,9N]3G_<!%? Z!X%"<VQ'S!A?_,*$LV^SR7ZL?_4J\3R)%.&<D
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M[7XUCMK,&FVBWO=UPC/V76"8,$/?$W:"[,P=8K?QXK3(/IAO6W"9I!#S0FB
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M[_QMY'1TMMA,1K'>"0E'8M%2 V<N<D3G/.\BIKGUVLUP\E2.4O>7;-^WK>O
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MVTS7/77BM]48X-I#EOB?IM7?)FL@I/][MC[0WD!,(X^!%70>A!=R/:3/U^:
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MS+/TD'@]^:<%"1A"K53B(0CZ-OJ-C@RZL5RWJ!LN['9!QC:6;1\U#<"UO]P
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M("#87+O(&6? %Q*$$=Y&KXL(2K?QES:BK^?Y.-T@YHZSU+UJGK+!:F^X#F_
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MC %-KC<W-:]3<.\=?<\VJG+<"!W?HV808-E%R;-&$A^.,;FRLA>E:SQ$QGF
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M[JI,/U[ESHS(6Y>.7"6PCM>S<NO!.^%!Q&05<YAU; .J>XCI-^[N#U?[ZF4
MT+JB_,(DDW-,'%UYQ\]RF<WS^G-DC?/BU_%T-A\OO[V:$ADD4I+WS:>\^.\S
M^O6O>?EIEFIG@7/QCT)@*9.P@4+, LJ2E^W0:4#!M68ZN-)H9L8!F>S70^UO
M*0P51SLOL2]Y'F8=>@3G*>3$Y(<\_S*.>9U-;KF5TG,-1NA0$VHE^,0TZ."S
M4CD:I=KY!O?3U&]M<;]>0@=:&@3B2#B92/A4DPO)XY[,/E<YG?L_HQC1R\CJ
M28<7Q$XTX(NH^=R21>--S+[-R>FC9/5;M-MG2-25K@8!O0]Y0K_Z^$N>DN6?
MK*H>3L?3<<UI78Z_Y N^T+NLA(Y0<J2@SAHRXN0[D4VGA:6U,YKE)AC<C+Y^
MJV?[ V,#[0T"E4>GL_ER_(]UKX=RI_^)B0IY2.2FRYH"H#FM-Z81M$G"9XV8
M4AN+^#A=_=:R]H?"#K4U@!CK8D+BNAAFK;Y(ONVZHN9]GM12O]49Q:C6CEOE
M,@F-2>(L($6/DD-1PD>E$K>F31^^S6GLM\*T/TPVTN(@K.-%]YO9S0.-"VN?
MK"X%90"R^+3>BJB31(("YG0Q2C*7M6Z"RL?IZKG6L\=SI^[4U76%<J>UFN>7
M!>]SG'V<KI;93;(WJZ^\YRD=U$1^C[:.ZAB_<U]R62L6:@/#Q!&,J6T[C?,$
MK!0 HX@Z6<.][^7NJZNZQ>^\YH3$_8P^__M(&L$MRP',:@2K1PE!HH%L5\-9
MC=11]2&(2PK[O?EK@:<M[_AVT]4PJ\GO6H$W.%^'2GM4A&_PU"86['':#VS1
MHBA%%FO!9\(%.?P)0O$<N!<L&";J-/&G;-&.<55#/_Y']1K7KZG>XYN\'#E9
M& 9M +6KK'M'0J#H6A?-1"@\>M6F,?'#-#T-J[4-9NX<_W:CCV':J9<XGO\'
M3L[RKQEKUY'JB^YBF>Y]3@>VZ/OT=61]+E]TK0/+%7P",A:% *=UK),Z:K9_
MR4!*KC)@VI8V>>V/4;6OG;GOV5=;L(LQQ$2[NU4*0;&"M49!@Z:-7NEZY^';
M'#@\2E:_UJ8SC-PV,=VIXNE8F57>XTY>T"-/:V1Q[J/U$'9'J:!YB Y,CA:4
MHQW+!4'.-KG HIA2\T2?G-VYRI:]?,OZ^/9HFJYUW3P7?WH[)4?T;#X?3S\^
MP\5X/3OI:G&()#.&A* MH\410SH_+LDY"(/"6M$FK.N4C0';M6TP^'"SF4.K
M^NG8P0OF9[>8WR-,W.4UC2SG5MP=PJ1*[T32!&?G*YR%1$"A/2A/$,K21B/;
MY)H=Q)7;<'4=U<G)T_G=Q3:*$KUPB0%*3A%-U!(\2@9.<A><4B8TNN_LC(4!
MF])ML/>@BWA0%0_@DO22\6??KMF5E_/\WV=Y&K^M*A<%]ZBS+\ -(W%&I2$P
M+0 S!?8HK7"VC1.P 7$#P>-A8?,0>#O2X9!@>1]#YQ6+A2MC'0O@'#E,*K("
MR#,'[[A-FGY81)N&B!L0-Q!8=@6(AP#7D78&"KC%Y;H]+U5-2OJ()@(MSWIE
M;!)@"9Q<9&:X=3('TZ;P>!/J!@*YKB"Q >3VTL^0,/?LV^6W?QOG><U*_?:Z
MYJ2N5JH,.@?N#,B<"RCF-'B=$R1F@Y,F<J/;W,AL1E^_U6V#VX&[TN20\'E]
MS=WE[WQU"YN<<%&1P'QM(,#JT"Y:AI'IP$.F]9<;GZ9M0N9 K&2'.-G$4':B
MM"$A\M7T\]ERL9(8/S?^VJ804XD@N%Z9?-I=K*N#@M ;E3(7LO$MTEVB!H*V
M[J'P$.CVU,M (2;.65%6.\,=;0QVY56L$G,*JS=10K$D.6L=<=PE:B#;;R\0
MVT4O X68O.B@:KGQDN<ZZ:/.]4L60D&$7'M >TG2BHT/4.\2U6^=>;\0VT4O
M0X#8>(K3.,;)J^EB.3^[["L>D>BMXO&>_ E5QVTC\QH,CU(I'5$@MH'7_00-
M!%K]!@\=Z&H D#N9XW1!;[ZJXJUUZ.4>[A8G],C%_;\Z7\:2*2UK%H:C=57'
MW2%@M@$*2TPHZZ)S;8Z<N^2B9^^O"UC-!J+C'O%=+X!'OYXMSU9UF;_.IOG;
MKSC_/2]?GDW311,[H;%D%P68D#4HM!F"+ HLNB(+BMK3^'OWRIN\J%](]:?^
M62-=#,!N'L_FGV=S7.;G.2P_U+WE?/M9#V! X;4@A]8[ZT"95/V96"#87(16
M+AO6YO#O4;+Z#3IZAV'WJAL #G_[\,OL2YY/5QO%QTSBRHM[^8HINR =\:6]
M!Y4T\26RAR1=E@G1Y\UZE6\-R4TI[->I' PZFRAT $!].?Z:SUL6W6%%**FC
M))=&DF-#S@UGM-S((^>!UB K@N?<Z(;N8:+Z[4TU&#AVI;8A(+"#N/'UU4!9
M4YBN\XPQ&@5*N@(NU5$%Q4>6E/-.;S35JI>DL-?#Z!$\D$B^-UP,8%$<?<'Q
MI(KPY6Q>^WY?+?*;F\[(<:&TBQ[<*N792@_!H8$BT,LL2V38IF9Z4PH'<FMS
M>!#=;@?30J.#:+RQ%NT]V:0CGG*)(25@FJUNJS+M<-R3-0@\H4M89)N>&P^2
M-) +GO[1V(G.=C>4LR5.#EFYT$5%^T;/;52;<)"J]D<3PH.*U?AH('!%4-Q3
M[!V8!Q&4+!:CYJ&Q8S7H8H0<..<UK<1*K%DFTD%(GH&TWBA1)"O8^*KQ!RY&
MV 9[[8H1ME'Q %S(U[/I1WK::74O:C"ZNJ_0.KMHF ,,C/8,Q6OTF2TD-$H7
MQ95-;:XL[Z-F((@[+#!F'6MI@$B[&((4$OFKEJ @.7D2MB;>92U &)8B>E-B
MH_JL^^GI%VW[Z_D[P-E!Z . SH<\'<_F;V;+R],K,NY&>"7)Z_1DZ[.3X'0]
MZ-=*E5"$3*7-1GJ'E&$!9A?]WNF+NX^P!X"6*HM;%_ \.:W2JN1;4K0<%*OA
M4 :>O!8J9Q-*FQ#S+BU//[;<?SO;4T.#P]@;/+U8>=%Z6F("(4I5FUWJ:K9%
M A.L#B9Z%*I-EYF'*.IY".*>FGX4.#N*O>_$EB.EV;L\C[FVOH^?</HQUQ5U
MS>X^/\NDY8L\2&-\="X9B#YI4$X:<"QG"#EBME$XS6Y=_CZ0Z++EBX>$G%U5
M/3N0W =@DKH]-I0V*8D&Z\V@(^8#>1!,6-KST<NBF&&J<6G1P6[(GD"NZSZ;
M;7^X&,"BN&E%CG$^_U99/)V=39>CR+1 ;7@MCJ&=2&H-6/U:R9-&5,R7U";C
M]3&JGOYQQXY@>72KWT-S T!AC=).SJ.T2PF/BLM,>=I0*(ROW9^*AU!,!*>\
M%X$[FUP;5_%><IY^7-(-[O;7U3 [=:V3=M<.S^6M^P[W6_<^IX/[K._3U]']
MU;7Y>E7'=5CJ:OK>U6LO;Q1J\6]&=""#E82CVB0ND:O)O'=D@!@6UJ8[\>8T
M[M^;>?&I_K\^_PM.ZAMKFO<]RKAJ6^>##IRL+##$FNTMZD 'DHU+FDMKK/2R
MS27?#L3VNYTVPMK=ALYME=AA DESF[9[%]9'GM;(OC7LPKH%\KCU25:\,6'J
MG.A VQH/&3B+&)S2TI0V?LCAK-S)'.NH]6L/GJ;C/%_B>'K^J[7?<6UYE-H-
M(@70KOH1.@EP(B(@BB30Q*!XFXS[K4E],A9N&YS=4P774(&#2)"[)LGC"2X6
MXS+.Z=FWBP[]9SCY%9>5^V_/<9EO=9+E42G+K .6,5! 1!L'9O0U(+*NA,2D
M<:W7\-94]QMR' BY!U/KTPD[NDBSV^BYC;;M@Z39;0%/&4,*M2:$9V8HYEUU
M>E$&G*Y1KS422_/%WW@#OYG]?#M+^GU>3S/Y954PPY/QD4N(B0M0S(<Z,I,<
MZ2 +ZB =TVV"MLUI?#);]C;(NN\ KX'*!G"<MQEGKV>+Q8A9K3RK'=X3A5H*
M,P58Q!J9\J"S,3HSU::6>',:G\PNW!Z,6ZOLZ>RY'\Y.3W'^;5;N^V7'^_!&
M[VJT-V_/Y^'WZ\(1@Q<..*]>740$[T6!R)/W3#),X:D'W(^OM_6E)I82@Y;D
M5?-<3^G)X <>)'C-3%(A:Q/:7;]]A[@GLT-O@Z7MC.+V2AK UOQ0!QZ%BN4<
M"AA?9Q [8:&F;T"0EJ-,VJ)HU-!WCR9<37-K.E7\ANVUMM'" ,#4:1V_3P&C
M,P)RX+F>1QGR<6L6G+9,JZ"X:Y2"^N.WU]H*5BW;:VVCX[ZS$+_7TBDY3Q:
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M6(\#L)G;I4RPQ)7EM!=$'TBFDD)/E!1ZQJ(9MT+J+-N,RGQ">5.'B>';Z6T
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M__HD^B)8*A&*JJ,FE"6/IU9\AQR=2]$H<H<&JY'_[:#V(\W>DIW)I&HFMQ&
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M4BY-9#."X/C;]]OCS64>@D_&0;2FMI,6$IR,&H3C,? LRWG:(K]!9K>"YK]
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M83Z06(:&X/W&:BN!,E\D\@HR[>QA-SIP9@4=TI \WA[2Z)@ C4(5'Y$7U)U
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M<TC-G=/?[GNXH972HC,@^.9=HD\0!4K@I.KK*)_L8YLJC4,I'58!GLUW:"K
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M+(E6>;D-@0Q",(;K.8FD_!9PW#6=!K]%: P.*1U9P3%((!0:R0F*9=@=+8E
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M,'8*^WB7QVYW/7H_L/SUMQ7=O<G3WP%02P,$%     @ UDH)4]Y^ONF]!
M&!4  !0   !E>&AI8FET,S(Q<3(R,#(Q+FAT;>U8;7/;-@S^OE^!.K>^W$7O
M=A*_-'>N[:[I=7$;J]?UTXZ6*(LK):HD%<?[]0,I*TWKN-MNZ]KLZ@\ZVR#
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M(<!8W,M 3M.MV-1A^>]ST!X5)\A_VPMA5"VQ/$"OWB?<T683BT?NYM.]SM%
MV2=$&=I3,'?A=?RJ6F8?N?H=+>TG^;][(3>Y;BH!^@1*<)9 @^\Q>?PY5M8W
M7K:^&^+/:<%P&_0S[LGA$KL7,TW?MK(=&_?MF'FVQF^ULP>NENYUET]NITI1
M7\_U)>78-&_HUGW5!S+:'N)_4"$+9&2E=ZOL.E+OO/S:/.NK.'LI>/(G4$L!
M A0#%     @ UDH)4]4/3M9*ZP$ Q<P7 !$              ( !     &%V
M9&PM,C R,3 V,S N:'1M4$L! A0#%     @ UDH)4Y(*+RJK$   =*T  !$
M             ( !>>L! &%V9&PM,C R,3 V,S N>'-D4$L! A0#%     @
MUDH)4^GW(5+A(0  ^48! !4              ( !4_P! &%V9&PM,C R,3 V
M,S!?8V%L+GAM;%!+ 0(4 Q0    ( -9*"5/>LP*6 48  /H$ P 5
M      "  6<> @!A=F1L+3(P,C$P-C,P7V1E9BYX;6Q02P$"% ,4    " #6
M2@E3A8LP S7!   6VP< %0              @ &;9 ( 879D;"TR,#(Q,#8S
M,%]L86(N>&UL4$L! A0#%     @ UDH)4R3R;,,#>P  184% !4
M     ( ! R8# &%V9&PM,C R,3 V,S!?<')E+GAM;%!+ 0(4 Q0    ( -9*
M"5,@&@2Z& @  %8J   4              "  3FA P!E>&AI8FET,S$Q<3(R
M,#(Q+FAT;5!+ 0(4 Q0    ( -9*"5.)$D.7%@@  )(I   4
M  "  8.I P!E>&AI8FET,S$R<3(R,#(Q+FAT;5!+ 0(4 Q0    ( -9*"5/>
M?K[IO00  !@5   4              "  <NQ P!E>&AI8FET,S(Q<3(R,#(Q
M+FAT;5!+ 0(4 Q0    ( -9*"5.]T5]1R@0  &\4   4              "
M ;JV P!E>&AI8FET,S(R<3(R,#(Q+FAT;5!+!08     "@ * )("  "VNP,
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
